Académique Documents
Professionnel Documents
Culture Documents
Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
Edited by
Jane N. Zuckerman
Academic Centre for Travel Medicine and Vaccines,
Royal Free and University College Medical School, London, UK
All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval
system, or transmitted, in any form or by any means, electronic, mechanical, photocopying,
recording, scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act
1988 or under the terms of a licence issued by the Copyright Licensing Agency Ltd, 90 Tottenham Court
Road, London W1P 0LP, UK, without the permission in writing of the publisher.
John Wiley & Sons (Asia) Pte, Ltd., Clementi Loop 02-01,
Jin Xing Distripark, Singapore 129809
A catalogue record for this book is available from the British Library
ISBN 0-471-49079-2
Typeset in 9/10pt Times from the authors disks by Vision Typesetting, Manchester
Printed and bound in Great Britain by Antony Rowe Ltd, Chippenham, Wiltshire
This book is printed on acid-free paper responsibly manufactured from sustainable forestry,
in which at least two trees are planted for each one used for paper production.
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
Contents
List of Contributors . . . . . . . . . . . . . . . . . . . . . . . . . . vii 8 Vector-borne Parasitic Diseases . . . . . . . . . . . . . 91
Indran Balakrishnan and Stephen H. Gillespie
Foreword . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
SECTION III
Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xi PREVENTION AND MANAGEMENT OF
TRAVEL-RELATED DISEASE . . . . . . . . . . . . . . . 125
SECTION I 9 Tropical Skin Infections . . . . . . . . . . . . . . . . . . 127
TRAVEL MEDICINE . . . . . . . . . . . . . . . . . . . . . . . . 1 Francisco Vega-Lopez and Verity Blackwell
1 Trends in Travel . . . . . . . . . . . . . . . . . . . . . . . . . . 3 10 Travelers Diarrhea . . . . . . . . . . . . . . . . . . . . . . 153
Thomas L. Treadwell Luis Ostrosky-Zeichner and Charles D. Ericsson
Contributors
Susan Anderson Clinical Assistant and Professor of Christopher J. Ellis Consultant Physician, Department of
Medicine, Office of Medical Education, Stanford University Infection and Tropical Medicine, Birmingham Heartlands
School of Medicine, 251 Campus Drive, MSOB X-365, Hospital, Bordesley Green East, Birmingham B9 5SS, UK
Stanford, CA 94305-5490, USA
Charles D. Ericsson Professor of Medicine, Head,
Michael Bagshaw Head of Medical Services, British Clinical Infectious Diseases and Director, Travel Medicine
Airways Health Services, Waterside, PO Box 365 (HMAG), Clinic, Division of Infectious Diseases, Department of
Harmondsworth UB7 0GB, UK Internal Medicine, University of Texas Houston Medical
School, 6431 Fannin Street, JFB, 1.728, Houston, TX
Indran Balakrishnan Clinical Lecturer, Department of
77030, USA
Medical Microbiology, Royal Free and University College
Medical School, Rowland Hill Street, London NW3 2PF, Philip R. Fischer Professor of Pediatrics, Mayo Medical
UK School, Mayo Clinic, 2000 First Street SW, Rochester, MN
55905, USA
Nicholas J. Beeching Senior Lecturer in Infectious
Diseases, Liverpool School of Tropical Medicine, Kenneth L. Gamble Executive Director, Missionary
Pembroke Place, Liverpool L3 5QA, UK Health Institute, Toronto General Hospital, 200 Elizabeth
Street, Eng-212, Toronto, ON M5G 2C4, Canada
Norman T. Begg Head of Medical Affairs,
GlaxoSmithKline, Stockley Park West, Uxbridge, J. Simon R. Gibbs Consultant Cardiologist, National
Middlesex UB11 1BT, UK Heart and Lung Institute, Imperial College of Science,
Technology and Medicine, Department of Cardiology,
Peter J. Benton Surgeon Commander, Institute of Naval
Charing Cross Hospital, London W6 8RF, UK
Medicine, Alverstoke, Gosport, Hampshire PO12 2DL, UK
Stephen H. Gillespie Professor of Medical Microbiology,
Frank J. Bia Professor of Medicine and Laboratory
Royal Free and University College Medical School,
Medicine, Yale University School of Medicine, 333 Cedar
Rowland Hill Street, London NW3 2PF, UK
Street, New Haven, CT 06520-8030, USA
John C. Goldstone Consultant Anaesthetist, Academic
Verity Blackwell Specialist Registrar in Dermatology,
Department of Anaesthetics, 1st Floor Crosspiece, The
The Middlesex Hospital, 1st Floor, Arthur Stanley House,
Middlesex Hospital, Mortimer Street, London W1N 8AA,
Tottenham Street, London W1P 6PG, UK
UK
Robert Bor Professor, Psychology Department, London
Robert Grenfell Public Health Physician, Grenfell
Guildhall University, Calcutta House, 1 Old Castle Street,
Health Consulting Pty Ltd, 126 Barnes Boulevard,
London E1 7NT, UK
Horsham, Victoria 3400, Australia
Eric Caumes Consultant Dermatologist, Department of
Elaine C. Jong Clinical Professor of Medicine,
Infectious Diseases, Hopital Pitie Salpetrie`re, 4783
University of Washington, Seattle, and Co-Director, Travel
Boulevard de LHopital, 75651 Paris, Cedex 13, France
and Tropical Medicine Service, Hall Health Travel Clinic,
Ann L. N. Chapman Specialist Registrar, Department of Box 35-4410 Seattle, WA 98195-4410, USA
Infection and Tropical Medicine, Birmingham Heartlands
Jay S. Keystone Professor of Medicine, University of
Hospital, Bordesley Green East, Birmingham B9 5SS, UK
Toronto, Tropical Disease Unit, Toronto General Hospital,
Claire Davey Consultant Ophthalmologist, 200 Elizabeth Street, Eng-212, Toronto, ON M5G 2C4,
Royal Free Hampstead NHS Trust, Pond Street, London Canada
NW3 2QJ, UK
David G. Lalloo Senior Clinical Lecturer in Tropical
Alex T. Dewhurst Research Registrar in Anaesthesia Medicine, Alistair Reid Venom Research Unit and WHO
and Transport Medicine, Academic Department of Collaborating Centre for the Control of Antivenoms,
Anaesthetics, 1st Floor Crosspiece, The Middlesex Liverpool School of Tropical Medicine, Pembroke Place,
Hospital, Mortimer Street, London W1N 8AA Liverpool L3 5QA, UK
viii CONTRIBUTORS
Ted Lankester Director, InterHealth, 157 Waterloo Theresa Richardson Specialist Registrar, Department of
Road, London SE1 8US, UK Ophthalmology, Royal Free Hampstead NHS Trust, Pond
Street, London NW3 2QJ, UK
Robert J. Ligthelm Consultant Physician,
Havenziekenhuis and Instituut voor Scheeps en Kathryn N. Suh Consultant in Infectious Diseases,
Tropenziekten, Haringvliet 2, 3002 TD Rotterdam, The Department of Medicine, Division of Infectious Diseases,
Netherlands Queens University, Kingston, Ontario, Canada
Louis Loutan Head of Unit and Senior Consultant, Dominique Tessier Medical Director, Medisys Travel
Travel and Migration Medicine Unit, Department of Health Clinic, 500 Sherbrooke St West, 11th Floor,
Community Medicine, University Hospital of Geneva, Rue Montreal, Quebec H3E 1X5, Canada
Micheli-du-Crest 25, 1211 Geneva 14, Switzerland R. David G. Theakston Professor of Medical Biology,
Debbie Lovell Research Clinical Psychologist, Oxford Alistair Reid Venom Research Unit and WHO
University Psychiatry Department, Warneford Hospital, Collaborating Centre for the Control of Antivenoms,
Oxford OX3 7JX, UK Liverpool School of Tropical Medicine, Pembroke Place,
Liverpool L3 5QA, UK
Maria D. Mileno Assistant Professor of Medicine,
Department of Medicine, Brown University School of Thomas L. Treadwell Chief, Infectious Disease,
Medicine, and Director of The Travel Medicine Service, Metrowest Medical Center, Framingham Union Campus,
The Miriam Hospital, Providence, RI, USA 115 Lincoln Street, Framingham, MA 01702, USA
David R. Murdoch Clinical Microbiologist, Canterbury Pieter-Paul A. M. van Thiel Consultant Physician,
Health Laboratories, P.O. Box 151, Christchurch, New Department of Infectious Diseases, Tropical Medicine and
Zealand Aids, Academic Medical Centre, University of Amsterdam,
Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Virginia Murray Deputy Medical Director, Medical
Toxicology Unit, Avonley Road, London SE14 5ER, UK Francisco Vega-Lopez Consultant Dermatologist, The
Middlesex Hospital, 1st Floor, Arthur Stanley House,
Hans D. Nothdurft Director, University Travel Clinic, Tottenham Street, London W1P 6PG, UK
Department of Infectious Diseases and Tropical Medicine,
University of Munich, Leopoldstrasse 5, 80802 Munich, Sharon B. Welby Clinical Lecturer in Travel Medicine,
Germany Liverpool School of Tropical Medicine, Pembroke Place,
Liverpool L3 5QA, UK
Luis Ostrosky-Zeichner Clinical Fellow, Division of
Infectious Diseases, Department of Internal Medicine, Robert E. Wheeler President, Voyager Medical
Univesity of Texas Houston Medical School, 6431 Fannin Seminars, 9 Corduroy Road, Amherst, NH 03031-2724,
Street JFB 1.728, Houston, TX 77030, USA USA
Linda Papadopoulos Senior Lecturer, Psychology Arie J. Zuckerman Professor of Medical Microbiology,
Department, London Guildhall University, Calcutta House, Royal Free and University College Medical School,
1 Old Castle Street, London E1 7NT, UK Rowland Hill Street, London NW3 2PF, UK
Justin Parker Lecturer, Psychology Department, London Jane N. Zuckerman Medical Director of Academic
Guildhall University, Calcutta House, 1 Old Castle Street, Centre for Travel Medicine and Vaccines and Royal Free
London E1 7NT, UK Travel Health Centre, Royal Free and University College
Medical School, Rowland Hill Street, London NW3 2PF,
Andrew J. Pollard Pediatric Infectious Disease Society UK
Clinical Fellow, BC Research Institute for Childrens and
Womens Health, Room 375, 950 West 28th Avenue,
Vancouver, BC V5Z 4H4, Canada
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
Foreword
Travel medicine is one of the newer and important areas guidance on contraception, safety of food and water, and
of medicine requiring specialist knowledge, academic hygienic and other precautions.
centres and dedicated clinical services to meet the health It is well known that medical students, nurses, doctors
and medical needs of the increasing number of leisure and and other health care professionals, particularly in the
business travellers, and also to cater for the medical as- industrialised and developed countries, receive little
pects of population movements related to economic, pol- training in tropical medicine and in diseases and hazards
itical and social factors. outside their own environment. Yet many infectious dis-
Health, preventive medicine, environmental factors eases largely ignore temperature gradients. This has now
and safety are essential considerations, not only for the been recognised by a number of universities and medical
traveller but also for the host country and for the country schools in North America, Europe, Australia and the Far
of residence on return. The hundreds of millions of people East, which have established academic departments in
who travel between countries each year inuence travel and geographical medicine.
profoundly the epidemiology of disease, particularly in- The opportunity to advance the subject of travel medi-
fections, the environment, facilities and natural resources, cine arose when Jane Zuckerman proposed the establish-
and they also have a marked impact on economic, demo- ment of an academic centre at the Royal Free Hospital
graphic, technological and cultural factors. School of Medicine of the University of London. The
Disease knows no frontiers and almost any place in the concept and the need for such a centre was approved by
world can be reached within 2436 hours, which is less the Research and Development Committee, by the Edu-
than the incubation period of most infectious diseases. cation Committee and subsequently by the Council of the
Health care professionals must be able to prevent, ident- School, and the Centre for Travel Medicine and Vaccines
ify and treat all known infectious diseases irrespective of was opened in 1995. The Royal Free Hampstead NHS
geographical and climatic limitations. They must be well Hospital Trust supported the Schools initiative and,
versed in the development of new and improved vaccines later, the proposal for a dedicated travel clinic to serve the
and the rapid advances in the development of new drugs sta, students and patients and the travelling public.
and treatments. On a more personal note, my wife and I are proud of
While the discipline of travel medicine evolved initially the achievements of our daughter, Jane, and of her dedi-
from infectious diseases, tropical medicine and preventive cation to the advancement of her subject, and we are
medicine, and historically from quarantine and interna- condent that this volume on the principles and practice
tional health regulations, the subject encompasses the of travel medicine will meet with the success it so clearly
whole range of clinical and preventive medicine; this in- deserves.
cludes care of the traveller with special needs, such as
children, the elderly, pregnant women and the disabled,
and travellers with cardiovascular, respiratory, meta- Arie J. Zuckerman
bolic, renal, gastrointestinal, neurological and malignant Professor of Medical Microbiology in the
diseases, and other conditions, including behavioural dis- University of London
orders. Important components of travel medicine include Principal and Dean of the Royal Free Hospital School of
not only vaccinations and prophylaxis against malaria Medicine and of the Royal Free and University College
but also advice on accident prevention, sexual health and Medical School, 19891999
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
Preface
The specialty of travel medicine has evolved rapidly as a Knowledge of all these aspects of travel health and
result of the massive increase in international travel facili- medicine are, therefore, an essential requirement for the
tated by the introduction of economical and fast air trans- many health care professionals providing advice to and
port across the world, the construction of transcontinen- clinical care of the traveller. This volume of Principles and
tal road and rail connections, giant ship cruisers, travel to Practice of Travel Medicine is addressed to practising
and exploration of regions and areas that were previously physicians and nurses in primary care, occupational
inaccessible or remote, and the explosive increase in health and hospital settings, and to public health phys-
tourism. The World Tourism Organisation, for example, icians, pharmacists and administrators, and, as a source
has predicted that international travel, currently in excess textbook, to undergraduate and postgraduate students. A
of 500 million people each year, will increase by 80% welcome recent development has been the implementa-
between 1995 and 2010. This also means exposure of tion of teaching of the discipline of travel health and
travellers to genes, bacteria, viruses, fungi and parasites medicine in the form of postgraduate diploma and degree
and other health hazards in the new environment, and the courses as well as study days. Teaching of the subject in
transfer of genes and microorganisms across continents the undergraduate curriculum is a feature in medical
to the host population. schools, and it has been introduced successfully at the
Travel medicine extends well beyond diseases of warm Royal Free and University College Medical School, in-
climate and the exigencies of travel and tropical life. It cluding the provision of a special study module. We hope
includes exposure to new environments and new cultures, that this book will serve the students well.
and new hazards ranging from high-altitude and deep-sea I am grateful to my many friends and colleagues who
environments to medical problems of cosmic radiation have contributed so willingly and enthusiastically to this
and space travel; emerging and re-emerging infections; book, through which we hope to stimulate health care
safe food, safe water, safe clothing; natural and accidental professionals to consider issues in travel medicine as part
disasters; and issues such as jet lag, fear of ying, air rage of their clinical practice. I also hope that this text may
and tourist risk of violence. Extensive knowledge of cur- enhance the prole of travel medicine and contribute to
rent and new vaccines and of prophylactic and thera- its development as a distinct specialty, which may subse-
peutic drugs is essential. The re-emergence of infections quently be recognised as a component of training in
such as diphtheria and syphilis in parts of eastern Europe, infectious disease and tropical medicine as well as part of
the HIV pandemic, increasing numbers of cases of the undergraduate curriculum.
legionella infection in travellers, the epidemiology of I would also like to express my gratitude to the editor-
drug-resistant malaria, extensive outbreaks of dengue fe- ial and production sta of John Wiley & Sons, in particu-
ver and antigenic shifts of inuenza A are examples of the lar Charlotte Brabants and Suzanne Kriston, for their
imperative need for rapid access to accurate information patience and unwavering support.
an internationally recognised epidemiological database. Finally, I am particularly indebted to my parents for
Travellers with special needs must be evaluated with their continued support and encouragement and without
care and advised accordingly. They include the diabetic whom the inspiration for and concept of this book would
traveller, the immunocompromised, those with car- never been realised.
diovascular, renal, neurological, gastrointestinal, malig-
nant and other disorders, psychological and psychiatric Jane N. Zuckerman
illnesses, pregnant women, children and the elderly. London
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
Section I
Travel Medicine
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
Trends in Travel
Thomas L. Treadwell
Metrowest Medical Center, Framingham, Massachusetts, USA
30000 80%
Increases in publication (books and magazines) about 25000
20000 41% 79%
1990
travel and adventure. 15000
96%
1999
Although there has been a steady rise in tourism for the 10000 79%
5000 129%
past several decades, both global and local inuences may 0
Africa
Caribbean
Central
America
South
America
Southern
Asia
Middle
East
also serve to reduce tourist arrivals in some years and
regions. Rising fuel/transportation costs, political insta-
bility, and conicts are obvious causes of focal declines in
tourism (e.g. falling tourism recently in the former Yugo-
slavia and Mexico).
Figure 1.3 Tourist arrivals (thousands): 10 year growth rate
(%) and total arrivals in selected regions. (From WTO, 2000)
DESTINATIONS
Many developing countries are currently enjoying
All travel, and in particular long-distance travel, has asso- double-digit annual growth rates in tourism. For
ciated health risks. Even the European business tourist example, in the years 19951998, Central America had
staying in a ve-star hotel in North America is more nearly a 10% annual growth rate, and Cuba grew at a
likely to be unwell than if he or she had remained back at rate of nearly 25% per year. Several countries in Africa,
the oce. Although the majority of international tourism even countries with poor economic conditions and af-
is between developing countries, a major trend in interna- fected by political turmoil, have enjoyed recent growth
tional travel is the increase in exotic destinations. From rates in excess of 20% per year. Figure 1.3 depicts the
the travel medicine standpoint, the increase in travel to 10-year growth of selected regions of particular interest to
developing countries has the most important implica- travel clinics.
tions.
Europe has always dominated as the leading destina-
tion for tourists, with a 60% market share and nearly 400 ECONOMICS OF INTERNATIONAL
million tourist arrivals in 1999 (Figure 1.2). Reasons for TOURISM
this domination include the proximity of European coun-
tries to one another, the ease of air, rail, and car transpor- Tourism is currently the fastest growing major economy
tation among the European countries, the advanced in the world. In the past ve decades, there has been
structure of the European tourist industry, and Europes approximately 7% annual growth in international travel,
popularity as a destination, particularly for European and it was estimated that four and a half trillion dollars
and American tourists. The Americas are a distant second would be spent on international tourism in the year 2000
in tourist arrivals, with approximately 20% of the total (WTO, 2000). Tourism receipts are the leading export
international arrivals in 1999 (123 million). In fact, all of item in the world, now leading automotive products,
the top 15 tourist destinations except for China (a recent food, and oil. One in nine workers worldwide is employed
arrival to this list) are in Europe or America. Twenty-ve in this industry, and for nearly 40% of countries tourism
years ago, the top 15 tourist destinations controlled more is the major source of currency (Wilson, 1995).
than 95% of the market. While these regions have con- In tourist receipts, the United States leads all other
tinued to dominate the tourist industry and to enjoy countries, receiving nearly 75 billion dollars in 1999. Not
growth, their share has dipped to less than two-thirds. In surprisingly, Europe has more than half of total tourist
the years 1995 to 1998, international tourism grew at 4% receipts: the list of the worlds top 15 tourism earners
per annum (the United States 2.3% and Europe 4.3%). In includes nine European countries. However, in parallel
contrast, more impressive growth rates are being seen in with the increases in tourist destinations to less-develop-
many developing areas. The most rapidly growing tourist ed regions, other areas of the world are garnering an
areas are East Asia/Pacic, the Middle East, and Africa. increased share of the tourist market. The most rapid
TRENDS IN TRAVEL 5
Table 1.1 Worlds top international tourism spenders (1998) Africa
1.7M
1000000
Central/South
Country Spend ($US billions) 750000 America
500000 Southern Asia
1. United States 56.1
250000
2. Germany 46.9 Middle East
3. Japan 32.3 0
4. United Kingdom 28.8 lia nce any taly and U
K
U
S
ra I rl
5. France 17.8 u st Fra erm ze
A G i t
6. Italy 17.7 Sw
7. Netherlands 11.0
8. Canada 10.8 Figure 1.4 International arrivals in selected developing areas
9. China 9.5 (1999). (From WTO, 2000)
10. Austria 9.2
20%
VFR, Health, Religion SUMMARY
Business, Professional
The vagabond, when rich, is a tourist (Paul Richard, The
Pleasure Scourge of Christ, 1929). Peoples psychological need to
62% 18% travel, in the setting of global economic expansion and
improved transportation, has resulted in the rapid
Figure 1.5 International tourism: type of travel (1998). growth of international tourism. Health care workers
VFR : visiting friends/relatives. (From WTO, 2000) interested in emporiatrics should pay particular attention
to increased numbers of elderly travelers and to increases
than other types of tourism, the adverse health problems in tourism to developing regions of the world.
of this type of travel have been well documented (Kem-
merer et al., 1998). Economic globalization and expan-
sion of foreign markets in developing regions will increase REFERENCES
business travel to higher risk areas.
One-fth of international tourism is for visiting friends/ Handszuh H and Waters S (1997) Travel and tourism patterns.
relatives, for health reasons, or for religious pilgrimage. A In Textbook of Travel Medicine and Health (eds Dupont H and
particularly common type of tourism from industrialized Steen R), pp 2026. Decker, Hamilton, Ontario.
regions is the immigrant family visiting their native coun- Kemmerer T, Celtron M, Harper L and Kozarsky P (1998)
Health problems of corporate travelers: risk factors and man-
try. Very often, family groups include children born in
agement. Journal of Travel Medicine, 5, 184187.
Europe or North America traveling to less-developed Mackay D (1981) The British citizen abroad. The present state of
regions for lengthy stays with relatives. This type of tropical medicine in the United Kingdom. Transactions of the
tourism carries a particularly high risk for the travelers Royal Society of Tropical Medicine and Hygiene, 75 (suppl.),
and is a challenge for the travel clinic and physicians 4547.
preparing them for their trip. All of the cases of typhoid Wilson M (1995) Travel and the emergence of infectious diseases.
fever and most of the malaria seen in our travel clinic Emerging Infectious Diseases, 1, 3946.
during the past 15 years have been associated with family WTO (2000) World Tourism Highlights, 2nd edn. World Tourism
travel to developing areas. As immigrant populations Organization, Madrid. www.world-tourism.org
from Africa, Southern Asia, and developing parts of the
Americas mature, this type of tourism will undoubtedly
increase.
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
Infectious and parasitic diseases are causing considerable Tropical infectious diseases in a classical sense are limited
morbidity and mortality worldwide. They are by far the geographically to areas where specic conditions of tropi-
leading cause of death in developing countries (Figure cal climate and ecology must be present as a conditio sine
2.1), where infections are the major reason for the enor- qua non for the transmission and spread of the pathogen
mous loss of life years as a result of disability and prema- responsible (specic diseases of the tropics). Typically,
ture death (WHO, 1999), especially during childhood. these diseases are transmitted by specic vectors (e.g.
In industrialised countries, many infectious diseases malaria, arbovirus infection, leishmaniasis, trypano-
were controlled successfully during the twentieth century somiasis, lariasis), or require special intermediate hosts
by improvements in hygiene and nutrition as well as by (e.g. schistomiasis and other trematode infections), speci-
the availability of anti-infective chemotherapy and pre- c reservoirs (e.g. Lassa fever, monkeypox) or micro-
ventive measures (e.g. vaccines). As a consequence, the ecological conditions (e.g. stronglyoidiasis).
importance of infectious diseases has been regarded as Of all infectious diseases specic to the tropics, malaria
becoming very small, and probably vanishing completely, is the main cause of death (WHO, 1998). Other tropical
at least in the developed world. However, during the last diseases, such as schistosomiasis and lariasis, are re-
two decades infectious diseases have regained consider- sponsible for chronic morbidity and severe limitation of
able signicance and interest even in high-income coun- activity in very large populations (Table 2.3).
tries. The reasons for this are varied: There are many other infectious diseases (e.g. cholera,
leprosy, geohelminthic infections) that may be transmit-
Medical advances for the treatment of malignancies ted principally worldwide but nowadays are conned
and chronic diseases have resulted in a growing popu- mainly or exclusively to developing countries in the
lation of immunocompromised patients susceptible to
tropics (Table 2.3). This is usually due to socioeconomic
opportunistic infections that may limit severely the conditions and is largely independent of a tropical cli-
success of modern therapies (e.g. transplantation). mate or other specic conditions associated with a tropi-
New and old pathogens have been determined to either
cal environment. Nevertheless, these infections are often
cause or contribute to cancers (e.g. hepatocellular car- regarded as tropical infectious diseases in a broader sense
cinoma) or other diseases not considered to be asso- (typical diseases of the tropics).
ciated in the past with infection (e.g. peptic ulcer dis-
In addition to specic and typical tropical infectious
ease). diseases, developing countries also carry the main burden
Changes in modern life styles (e.g. travel, outdoor activ- of the most important infectious diseases occurring
ities, drug abuse) have created new risks of acquiring
worldwide (Table 2.4). Last but not least, developing
certain infections. countries are usually more aected by emerging and re-
Emerging and re-emerging infectious diseases (Table emerging diseases (Table 2.1), as appropriate actions are
2.1) as well as emerging resistance against anti-infective
usually severely limited by lack of resources and weak
drugs (Table 2.2) have clearly shown their potential for health system structures. Often, this also applies to the
global spread.
Figure 2.1 Causes of death in the developed and developing world in 1997 (WHO, 1998)
Table 2.1 Important examples of emerging and re-emerging Table 2.2 Important examples of emerging resistance
infectious diseases
Methicillin-resistant Staphylococcus aureus (MRSA)
Emerging Re-emerging Glycopeptide-resistant enterococci and staphylococci
Gram-negative enterobacteria
HIV/AIDS Tuberculosis Streptococcus pneumoniae and Neisseria spp.
Lyme disease Malaria Salmonella and other bacteria causing diarrhoeal disease
Haemolytic uraemic syndrome Cholera Tuberculosis
EHEC Dengue fever Malaria (Plasmodium falciparum)
Hanta pulmonary syndrome Rift valley fever HIV
Japanese encephalitis African trypanosomiasis
Cyclosporiasis Plague
Ebola haemorrhagic fever West Nile fever
Lassa fever
Ross River fever
Nipah virus disease
business and education; however, in some regions of the
world, migrant workers and refugees contribute substan-
tially to international migration (Table 2.5).
EHEC : enterohaemorrhagic Escherichia coli. In 1996, Germany was ranked as the worlds top
spender on international tourism (Table 2.6), with 77.7
emergence of resistance against available drugs in major million international departures, including more than 4
pathogens (Table 2.2). million destinations to developing countries in tropical
and subtropical regions. On the other hand, more than
9% of the population registered in Germany during 1997
were foreign nationals, with 75% originating from coun-
DIMENSIONS OF INTERNATIONAL tries outside the European Union, and an increasing
TRAVEL AND MIGRATION number of foreigners originating from tropical countries.
The main reasons for nontourist immigration to Ger-
During recent decades, global migration has expanded many, as is the case in the whole of Europe, are work,
tremendously (Figure 2.2). In 1997, the gures for world- family reunication, education and political reasons
wide travel exceeded 600 million international arrivals, (refugees, asylum seekers). There is a considerable uctu-
and it is estimated that there will be more than 1 billion ation of this population, with both immigration and emi-
travellers per annum before the year 2015 (WTO, 1998). gration rates of approximately 10% per annum (Statis-
The reasons for international travel are mainly tourism, tisches Bundesamt, 1998).
EPIDEMIOLOGY OF HEALTH RISKS AND TRAVEL 9
Table 2.3 Global burden of tropical infectious diseases (thousands, WHO estimates in 1997)
Cases
Persons with
New All severe limitation
Disease Deaths (incidence) (prevalence) of activity
Figure 2.2 Development of international travel (WHO, 1998; OECD, 1998). Asterisk indicates projected gures
Table 2.5 International migration in 1997 Table 2.6 German travellers in 1996
Hospitalised abroad
Hepatitis A
Gonorrhoea
Animal bites with rabies risk
0.1% 100
Hepatitis B (expatriates) Air evacuation
Typhoid (India, NW Africa, Peru)
Cholera
Figure 2.3 Health problems during a stay in developing countries: incidence rate per month (Steen and Dupont, 1994)
Table 2.8 Imported cases of viral haemorrhagic fever that data are incomplete. Studies based on data collated by
may be transmitted directly from human to human in health insurance and assistance companies based over-
developed countries, since 1967 seas are also biased. One important source of bias is that
the dierent reasons for travel (tourism, business, resi-
Year Virus Imported to dence, immigration, etc.) are rarely taken into account.
And even the apparently uniform group represented by
1967 Marburg Germany and Yugoslavia tourists comprises backpackers, trekkers, subaqua
1971 Lassa USA
divers, organised groups, and so on. These studies have
1974 Lassa Germany
formed the basis for an incidence scale of the main dis-
1975 Marburg South Africa
1976 Ebola-Zaire UK
eases and conditions contract-ed while travelling (Figure
1976 Lassa USA 2.3) (Steen and Dupont, 1994).
1989 Ebola-Reston USA Some large studies have been based on questionnaires
1992 Ebola-Reston Italy in which travellers describe health problems arising dur-
1994 Ebola-Ivory Coast Switzerland ing the trip (Kendrick, 1972; Reid et al., 1980; Peltola et
1995 Ebola-Zaire Italy al., 1983; Steen et al., 1987). The response rate to such
1996 Ebola-Reston USA questionnaires is about 75%.
1996 Ebola-Zaire South Africa The proportion of travellers who fall ill varies from 15
2000 Lassa Germany and UK to 43%: 1209 (15%) of 7886 Swiss travellers (Steen et al.,
1987), 5644 (21%) of 26 119 American travellers (Ken-
drick, 1972), 868 (33%) of 2665 Finnish travellers (Peltola
destination. Field studies carried out by local physicians et al., 1983) and 950 (43%) of 2211 British travellers (Reid
show that the frequency of the dierent diseases varies et al., 1980). Among the Swiss travellers, 1.6% consulted a
according to the region visited. Studies of travellers on specialist in tropical medicine on their return, while 4.2%
return to their country of origin generally focus on dis- saw a family doctor (Steen et al., 1987); 5.4% of the
eases such as malaria, viral hepatitis, dengue fever, leptos- American travellers saw a doctor on their return (Ken-
pirosis, schistosomiasis, cutaneous larva migrans and drick, 1972). Five per thousand travellers in both studies
leishmaniasis; more general studies do not provide a were admitted to hospital.
clearer picture of travel-associated diseases, either be- Most physicians agree that diarrhoea represents half to
cause the study populations are too small, or because the two-thirds of health problems; upper respiratory tract
12 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
infections are in second place (1431%) followed by fever gastrointestinal disorders for 20% (Raju et al., 1992). In
(1215%). Skin conditions aected 12% of Swiss travel- both these studies (carried out in islands particularly
lers in one study, making this the fth most frequent popular with tourists), diarrhoea, upper airway infections
health problem (Steen et al., 1987). (excluding otitis) and fever were less-frequent presenting
Sexually transmitted diseases are also a frequent cause illnesses than in Nepal.
of morbidity. Genital discharges and ulcerations were It is thus clear that travel diseases vary according to the
reported by 0.6% and 0.1%, respectively, of 7886 Swiss country visited: diarrhoea and upper airway infections
travellers (Steen et al., 1987). In a cohort of 2665 Finnish are prevalent in colder, mountainous regions such as
travellers, 39% of round-the-world travellers and 30% of Nepal, while skin conditions and supercial injuries are
tourists to Thailand reported at-risk sexual behaviour more common in coastal areas.
(Peltola et al., 1983). In a German study of 17 042 travellers who sought
These studies show dierences according to the desti- medical advice on their return, the main presenting symp-
nation and type of travel. In the cohort of Swiss travellers, toms were diarrhoea (n : 11 795; 69%), fever (n : 3408;
health problems were signicantly more frequent among 19%) and skin conditions (n : 1875; 11%) (Nothdurft
young adults, travellers to West Africa, backpackers, and Loscher, 1993). In a French study involving 926
those travelling for long periods, people working abroad travellers, the main presenting illnesses were fever
and travellers staying with local residents; malaria was (n : 406; 43%), due to malaria in 272 cases (66%); gas-
most frequent on return from Africa (Steen et al., 1987). trointestinal infections (n : 119; 12%); skin infections
Sunburn and insect bites were most frequent in Finnish (n : 73; 7%); and sexually transmitted diseases (n : 23;
tourists having stayed in Thailand (Peltola et al., 1983). 2%) (Cuzin-Ferrand et al., 1993). In the tropical medicine
Tourists fall ill especially with respiratory and gastroin- department in Paris the main reasons for consultation
testinal diseases, more often than people who travel on were skin conditions (33.9%), gastrointestinal disorders
business (Reid et al., 1980). (24.8%) and fever (28.4%) (Caumes et al., 1991b). Five
Studies carried out in the eld by local doctors provide patients (4.6%) had two conditions, giving a total of 114
useful information on travel-associated diseases. Two problems in 109 patients. No rm diagnosis could be
such studies have been conducted in Nepal. Among the made in 31 cases; most of these patients had diarrhoea (19
12 437 French tourists who stayed in Nepal in 1984, 838 cases) of fever (eight cases) which resolved spontaneously.
(6.7%) consulted the doctor at the French Embassy; they Annually, there are approximately 10 000 reported
had a total of 860 health problems, including 255 cases of cases of imported malaria in Europe (Legros and Danis,
diarrhoea (29.6%), 151 ear, nose and throat (ENT) infec- 1998). Malaria is the main cause of fever on return to
tions (17.7%), 107 skin conditions (12.4%), 69 cases of France, accounting for 45% and 66% of cases in the two
fever (8%) and 36 sexually transmitted diseases (4%). Ten French studies (Caumes et al., 1991b; Cuzin-Ferrand et
travellers (0.08%) were admitted to hospital, nine (0.07%) al., 1993). In the German study, malaria accounted for
were evacuated, 15 (0.12%) were repatriated, two under- only 6% of fevers on return (Nothdurft et al., 1992; Noth-
went surgery locally, and one died (Caumes et al., 1991a). durft and Loscher, 1993), explained by the dierent selec-
The 151 ENT infections comprised 28 cases of otitis tion criteria of the population studied.
(3.2%), 34 of pharyngitis (3.9%), 40 of sinusitis (4.6%), 45 Estimates of the risk of individual malaria infection
of bronchitis (5.2%), and four of pneumonia (0.4%), one have so far largely been based upon infection rates in the
of which was fatal. The 107 skin conditions consisted of local population. Assumptions based on the completely
bacterial (4.3%) or fungal skin infections (1.8%), scabies dierent risk behaviour of travellers and locals in endemic
(2%) and allergies (1.5%). Only three cases of fever were areas are naturally only inaccurate approximations, ac-
due to malaria (Nepal is not a major endemic zone for cepted, however, in the absence of better methods of
malaria), whereas 11 were due to typhoid. The other calculation (Muehlberger et al., 1998). Thus, the world-
study carried out in Kathmandu involved 19 616 travel- wide highest risk of malaria has been calculated as being
lers of all nationalities presenting to a private clinic in West Africa (approximately 2% of all unprotected
(Shlim, 1992). The main illnesses were gastrointestinal travellers), followed by the more frequently visited East
infections (31%), respiratory tract infections (21%) and Africa (Steen et al., 1990).
skin conditions (10%); the frequency of diarrhoea (shigel- A more realistic assessment of the risk of malaria infec-
losis and giardiasis) was higher during the hot season tion in travellers can be made from the evidence of specic
preceding the monsoon. antibodies against the immunodominant surface protein
Travellers to the Maldives and Fiji appear to have a of the sporozoites, the circumsporozoite protein (CSP).
dierent pattern of illnesses. In the Maldives, ear infec- Several studies of nonimmune travellers demonstrated
tions (often otitis externa), supericial injuries (often due that the risk of transmission is quantiable geographi-
to coral and shellsh) and solar allergies represented, cally by the evidence of CSP antibodies. In one study, the
respectively, 24%, 14% and 13% of presenting illnesses seroconversion rate of CSP antibodies in travellers to
(Plentz, 1992). In Fiji, ear problems, injuries (some con- Kenya was as high as 4.9% after return, indicating a high
tracted in the marine environment) and skin rashes (often exposure risk in that country (Jelinek et al., 1998) (Table
related to sun exposure) each accunted for 10% of visits 2.9).
to a doctor, while skin infections accounted for 13% and Dengue fever is probably also common as an imported
EPIDEMIOLOGY OF HEALTH RISKS AND TRAVEL 13
Table 2.9 Antibody reactions to circumsporozoite (CS) antigen of Plasmodium falciparum among international travellers:
distribution and geometric mean titres (Jelinek et al., 1998)
Seropositive travellers/
Geographical All travellers Positive? travellers all travellers to area
area (n : 2131) (n : 104) (%) Risk ratio@
Fitness to Travel
Dominique Tessier
Medisys Travel Health Clinic, Montreal, Canada
Mr/Mrs
______________________________
Medical Director
Travellers Clinic
Figure 3.1 Letter of authorisation
Pretravel Visit
Diarrhoea
Before any trip far from home or involving dicult living
conditions without ready access to health care, a preg- Prophylactic antimicrobial agents are not generally rec-
nant woman should consult her obstetrician and have a ommended for pregnant travellers. The use of
careful assessment. An ultrasound should be carried out uoroquinolones such as ciprooxacin is contraindi-
to eliminate an extrauterine pregnancy or a placenta cated. As an alternative for the self-treatment of travellers
praevia. The pregnant traveller and her companion diarrhoea, co-trimoxazole, azithromycin or clarith-
should be informed of signs of possible labour or compli- romycin may be oered. Bismuth subsalicylate (Pepto-
cations and of the basic emergency procedures to be Bismol) should be avoided.
performed if needed. A placental cord clamp can be car-
ried.
Pregnancy increases the risk of thrombophebitis, as Travel Insurance
does a long trip at high altitude. A pregnant woman with
varicose veins or an increased risk of vein thrombosis Travel insurance can and should be obtained before de-
should follow carefully the following recommendations: parture. After the 24th week of pregnancy, this insurance
drink a lot of water; request an aisle seat to enable leg should include coverage for the newborn baby, in case of
stretching; walk a few steps every hour; do not cross your premature labour.
legs; and do not use sleeping pills or a muscle relaxant
which might increase blood stasis. In the presence of
severe anaemia (haemoglobin less than 8.5 g%), oxygen THE ELDERLY TRAVELLER
should be provided during air travel. Arrangements need
to be made by an experienced physician at least 1 week in There is no age limit for travel. Health conditions, includ-
advance. ing cognitive tness, are the only aspects that should be
evaluated. All aged travellers should remember that they
will usually have a decreased resistance to long trips and
Susceptibility to Infection strenuous eort. Luggage should be sensible, using por-
ters when available, or the new form of luggage on wheels.
Vaccines
Vaccine Notes
Vaccines
Diphtheria
There is a very large and increasing number of vaccines Hepatitis A, B and A, B
available worldwide. Although most are safe for im- Hib
munocompromised persons, some precautions are Inuenza
necessary with live attenuated vaccines (Tables 3.1 and Japanese encephalitis Rare indications
3.2). These include the yellow fever vaccine, the Bacille Lymerix Probably safe
CalmetteGuerin (BCG, against tuberculosis) vaccine, Meningococcal
the oral polio (Sabin) vaccine, measles, mumps and ru- Pertussis Prefer acellular
bella (MMR) vaccine, oral typhoid vaccine, oral cholera Polio, inactivated
vaccine and the new varicella vaccine. All inactivated or Pneumococcal
component vaccines can be oered to immunocom- Rabies Pre- or postexposure
Tetanus
promised individuals if exposed. Among those, some are
recommended strongly for them, such as inuenza and
pneumococcal vaccines. These vaccines represent no risk
for HIV or persons with AIDS. Some severely im- indicating a contraindication for the vaccine can be con-
munocompromised individuals may respond poorly to sidered. This certicate can only be delivered by an
immunisation. Other strategies may thus be needed to authorised yellow fever centre. The list of these clinics is
protect them, such as passive immunisation with specic available on the Web at the LCDC site, Health Canada
immunoglobulins or preventive medication or rapid (see Additional Resources). The traveller should be aware
treatment. All immunisations should be given by person- that, in the face of an epidemic, he or she could be denied
nel with special training and a good understanding of the entry in some countries if not immunised.
principles and risks.
Severe complications have been reported after im-
munisation with live vaccines in immunosuppressed
hosts. Bacille CalmetteGuerin (BCG) Vaccine
Hepatitis A Vaccine
Several inactivated and attenuated hepatitis A vaccines tact with infected adults, children in nappies, and infected
have been developed and evaluated in human clinical animals; drinking contaminated water; coming into con-
trials and in nonhuman primate models of hepatitis A tact with contaminated water during recreational activ-
virus infection (DHondt, 1992); however, only inac- ities; and eating contaminated food (USPHS/IDSA,
tivated vaccines have been evaluated for ecacy in con- 1999).
trolled clinical trials (Innis et al., 1994). The vaccines Health care providers should advise immunocom-
licensed currently are Havrix (SmithKline Beecham Bio- promised persons not to eat raw or undercooked eggs
logicals), Vaqta (Merck and Co., Inc.), Avaxim (Pasteur (including foods that might contain raw eggs, e.g. some
Merieux Connaught) and Epaxal (Berna Products). All preparations of Hollandaise sauce, Caesar and other
four are inactivated vaccines. salad dressings, and mayonnaise); raw or undercooked
poultry, meat or seafood; or unpasteurised dairy prod-
ucts. Poultry and meat should be well cooked and should
Environmental Risks not be pink in the middle (internal temperature more than
73.8 C). Produce should be washed thoroughly before
Food and Water being eaten (USPHS/IDSA, 1999).
Cryptosporidium can also be transmitted by drinking
The risk of infection from food and water among im- contaminated water, ice made from contaminated tap
munocompromised persons is increased during travel to water, fountain beverages served in restaurants, bars, the-
developing countries. Persons who travel to such coun- atres, and eating contaminated food (USPHS/IDSA,
tries should intensify food and water precautions (Table 1999). Nationally distributed brands of bottled or canned
3.3). They should be advised that ice made with tap water, carbonated soft drinks are safe to drink. Commercially
unpasteurised milk and dairy products (common), and packaged noncarbonated soft drinks and fruit juices that
items sold by street vendors are usually unsafe. Foods do not require refrigeration until after they are opened
and beverages that are generally safe include steaming- (i.e. those that can be stored unrefrigerated on grocery
hot food, fruit peeled by the traveller, bottled (especially shelves) are also safe (Health Canada, 1994). Im-
carbonated) beverages, hot coee and tea, beer, wine, and munocompromised persons should avoid eating raw oy-
water brought to a rolling boil for 1 min. Treatment of sters because cryptosporidial oocysts can survive in oy-
water with iodine or chlorine might not be as eective as sters for more than 2 months and have been found in
boiling but can be used when boiling is not practical oysters taken from some commercial oyster beds.
(USPHS/IDSA, 1999). Water puriers can be of some
value.
Persons from developed countries who travel to devel- Special Topics
oping countries are at substantial risk of hepatitis A
infection (Steen et al., 1994). All hepatitis A seronegative Restrictions on Crossing International Borders
individuals should be oered the vaccine or, if severely
immunosuppressed, immunoglobulin. Before scheduling a trip to a foreign country, HIV-infec-
Immunocompromised persons should be educated and ted individuals should be made aware that a number of
advised about the many ways that Cryptosporidium can countries screen for evidence of HIV infection and can
be transmitted. Modes of transmission include direct con- deny entry to seropositive individuals. In Canada, an
20 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
unocial list of entry requirements for crossing interna- laxis), co-trimoxazole might oer some protection against
tional borders may be obtained from the Laboratory travellers diarrhoea. The risk of toxicity should be con-
Centre for Disease Control (see Additional Resources). sidered before treatment with co-trimoxazole is initiated
Such requirements may change without notication and solely because of travel.
verication with consulates or embassies is advisable. Antimicrobial agents such as uoroquinolones should
be given to all patients before their departure, to be taken
empirically (e.g. 1 g stat. followed, if diarrhoea persists, by
Susceptibility to Infection 500 mg of ciprooxacin twice a day for 3 days) should
travellers diarrhoea develop. Fluoroquinolones should
Many infections encountered by travellers are associated be avoided for children aged less than 18 years and preg-
with increased morbidity and mortality in immunocom- nant women, and alternative antibiotics should be con-
promised persons. These individuals are more likely to sidered. Travellers should consult a physician if the diar-
have adverse reactions to drugs used to treat infection rhoea is severe and does not respond to empirical
(Health Canada, 1994). therapy, if their stools contain blood, if fever is accom-
panied by shaking chills, or if dehydration develops. Anti-
Malaria. Malaria is a common and serious infectious peristaltic agents (e.g. diphenoxylate and loperamide) can
disease, transmitted by mosquito bites from dusk to be used to treat mild diarrhoea. They can also supplement
dawn. Personal protective measures are very eective in the antibiotic treatment if needed (a plane to catch for
reducing the risk of acquiring malaria. All travellers to example). These agents should not be administered to
endemic areas should be counselled about the use of patients who have a high fever or who have blood in the
insect repellent containing DEET on exposed skin, the stool.
use of bed nets and to wear clothing that reduces the Some experts recommend that HIV-infected persons
amount of exposed skin. An insecticide such as permeth- who have Salmonella gastroenteritis should be given anti-
rin or deltamethrin on clothes and bed nets can reduce microbial therapy to prevent extraintestinal spread of the
the risk further. pathogen. However, no controlled study has demon-
In many endemic areas, a medication to reduce the risk strated a benecial eect of such treatment, and some
signicantly, but never completely, should be taken. studies of immunocompetent persons have suggested that
Some of these medications are metabolised at the cytoch- antimicrobial therapy can lengthen the shedding period.
rome P . Meoquine is a good example. Drug interac- The uoroquinolones, primarily ciprooxacin (750 mg
thus be a concern. Other drugs may contain a
tion should twice a day for 14 days), can be used when antimicrobial
medication the HIV-infected person is already taking, at therapy is chosen (USPHS/IDSA, 1999). Fluoro-
a dierent dose. For example, Malarone contains quinolones should not be used during pregnancy.
atovaquone. Other medications could be used with ac-
ceptable ecacy for individuals with an already compli-
cated therapy or those who have experienced severe side- SPECIAL SITUATIONS
eects with previous changes in regimens. Azithromycin,
rarely used in practice because of limited ecacy, and Persons with physical impairments, including mobility,
primarily cost, is an example. Doxycycline, increasingly hearing, seeing or cognitive problems need more atten-
used for chloroquine-resistant areas, can increase the risk tion. They should be informed of special services available
of photosensitivity or of a recurrence of candidiasis. for them in most hotels, airplanes or cruises. They should
Malaria can kill any healthy individual in just 3 days. also know that they might not be accepted for some
Because HIV-infected persons are more likely to experi- journeys; for example, severe vision problems could mean
ence fever as a symptom of opportunistic infection, ma- that a traveller would not be accepted alone on a cruise
laria could go unrecognised and lead to death or severe ship.
complications. Travellers and health care providers alike
must consider the diagnosis of malaria in any febrile illness
that occurs during or after travel to a malaria-endemic area
(Health Canada, 1997). Contagious Diseases
Diarrhoea. Prophylactic antimicrobial agents are not Infectious diseases that are airborne or easily transmiss-
generally recommended for travellers; however, for im- ible by contact are contraindications to travel. They may
munocompromised travellers, antimicrobial prophylaxis require the intervention of Public Health Ocers. In
may be considered, depending on the level of im- cases of doubt, always consult the Public Health authori-
munosuppression and the region and duration of travel. ties for clearance before departure.
The use of uoroquinolones such as ciprooxacin
(500 mg per day), can be considered when prophylaxis is
deemed necessary. As an alternative (e.g. for children, INSURANCE
pregnant women and persons already taking co-
trimoxazole for Pneumocystis carinii pneumonia prophy- Most travellers should obtain health insurance for travel
FITNESS TO TRAVEL 21
before leaving home. A signed contract is highly prefer- Health Canada (1994) Statement on travellers and HIV/AIDS.
able to the glossy pamphlet of the cover oered to all Canadian Medical Association Journal, 152, 379380.
carriers of a specic credit card. Pre-existing medical Health Canada (1997) Canadian recommendation for the pre-
vention and treatment of malaria among international travel-
conditions do not preclude insurance cover: a higher
lers. Canada Communicable Disease Report, 23, S5.
premium can be oered, or the pre-existing condition Innis BL, Snitbhan R, Kunasol P et al. (1994) Protection against
would not be covered but accidents and other problems hepatitis A by an inactivated vaccine. JAMA, 271, 2834.
would be. Steen R, Kane MA, Shapiro CN et al. (1994) Epidemiology and
A booklet produced by the International Association prevention of hepatitis A in travelers. JAMA, 272, 885889.
for Medical Assistance to Travellers (IAMAT) is a good USPHS/IDSA (1999) Guidelines for the Prevention of Opportunis-
resource for nding English-speaking physicians. tic Infections in Persons Infected with Human Immunode-
ciency Virus, 48(RR10), pp. 159. US Public Health Service
and Infectious Disease Society of America, Washington DC.
CONCLUSION
Given the many variations in health services available for Travel medicine embraces a wide variety of medical
travelers at diverse local, national, and international loca- specialties: experienced and knowledgeable practitioners
tions, a consistent system for travel clinic nomenclature are to be found among the physicians, nurses, and other
helps clients and colleagues easily distinguish among or- clinical providers of internal medicine, family practice,
ganizational models. In the descriptions that follow, pediatrics, emergency medicine, occupational medicine,
travel clinic types are named on the basis of the level of infectious diseases, tropical medicine, military medicine,
services provided (Table 4.1). The services range from and refugee/migration medicine. Other health care
administration of travel immunizations only (travel im- workers, health educators, mental health professionals,
munization clinics), to clinics where immunizations are and medical social workers who have international work
One of the challenges of the travel clinic encounter is to Bia F (ed.) (2000) The Travel Medicine Advisor. American Health
impart the large amount of travel health advice and infor- Consultants, Atlanta GA.
mation applicable to a given trip in a way that can be Dardick KD and Baker ME (1997) Travel medicine and travel
clinics, US and Canada. In Textbook of Travel Medicine and
remembered by the patient within the time allocated for Health (eds HL DuPont and R Steen), pp 3439. Decker,
the travel clinic encounter (typically 4560 minutes). Hamilton, Ontario.
Most travel clinics nd that the preparation of patient DuPont HL and Steen R (eds) (1997) Textbook of Travel Medi-
information brochures, preprinted prescriptions, and cine and Health. Decker, Hamilton, Ontario.
printed instructions on what to do for vaccine-associated Freedman D (ed.) (1998) Travel medicine. Infectious Disease
side-eects will save signicant time during the travel Clinics of North America, 12.
clinic appointments. The printed materials enable Hargarten SW, Baker TD and Guptill K (1991) Overseas fatali-
multiple providers to communicate the advice on each ties of United States citizen travellers: an analysis of deaths
relevant topic and provide prescriptions according to the related to international travellers. Annals of Emergency Medi-
cine, 20, 622626.
practice standards determined for the given travel clinic. Hill D and Behrens R (1996) A survey of travel clinics through-
Health topics that have proven useful in the University of out the world. Travel Medicine, 3, 4651.
Washington travel clinics over the years include: Jong EC (ed.) (1999) Travel medicine. Medical Clinics of North
America, 83.
Summary of adverse side-eects of travel immuniz-
Jong EC and McMullen R (eds) (1995) The Travel and Tropical
ations and instructions on when and how to call for Medicine Manual, 2nd edn. WB Saunders, Philadelphia.
help Jong EC and McMullen R (1997) Travel medicine problems
Destination country information encountered in emergency departments. Emergency Clinics of
Generic plus brand names of malaria chemopro- North America, 15, 261281.
phylaxis drugs throughout the world Jong EC and Southworth M (1983) Recommendations for pa-
Insect precautions and repellents tients traveling. Western Journal of Medicine, 138, 746775.
Food and water precautions Reid D and Keystone JS (1997) Health risks abroad: general
Travelers diarrhea management and self-treatment considerations. In Textbook of Travel Medicine and Health
(eds HL DuPont and R Steen), pp 39. Decker, Hamilton,
Hepatitis A and B
Ontario.
Sexually transmitted infections Ryan ET and Kain KC (2000) Health advice and immunizations
Sun exposure precautions for travel. New England Journal of Medicine, 242, 17161725.
High-altitude illness Steen R and Lobel HO (1995) Epidemiologic basis for the
Dengue fever practice of travel medicine. Journal of Wilderness Medicine, 5,
Japanese encephalitis 5666.
Schistosomiasis
28 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
ADDITIONAL RESOURCES International Society of Travel Medicine (ISTM), P.O. Box
871089, Stone Mountain, GA 30087
Useful Web Sites for Travel Clinics Reference: Biannual International Conference and members e-
mail discussion list.
http://www.istm.org
American Society of Tropical Medicine and Hygiene (ASTMH),
60 Revere Dr., Suite 500, Northbrook, IL 60062.
ProMED, c/o Federation of American Scientists, 307 Mass-
Reference: Annual Meeting, Certicate Program, and clinical achusetts Ave. NE, Washington, DC 20002.
group members e-mail discussion list.
http://www.fas.org/promed
http://www.astmh.org
World Health Organization (WHO), Avenue Appia 20, 1211
Centers for Disease Control and Prevention (CDC), Atlanta, GA Geneva 27, Switzerland.
30333.
Reference: International Travel and Health Information.
Reference: Travelers Health section; also, full-text version of http://www.who.org
Health Information for International Travel, 20012002.
http://www.cdc.gov
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
MMMM
Section II
Cholera
0.1 Vaccine-preventable Diseases
Figure 5.1 Incidence rate of health problems during a stay in There are several infectious diseases in travellers that are
developing countries. (Adapted from Steen et al., 1987) potentially preventable by vaccination. By far the most
common is hepatitis A. In the USA and Europe, between
30 and 50% of all cases of hepatitis A are travel-asso-
febrile respiratory tract infection in travellers to be 1261 ciated; imported hepatitis A can also be the source for
per 100 000 travellers for a stay of 1 month in a develop- onward transmission within the community after return-
ing country, i.e. an attack rate of 1.26%. ing home, especially in children. The relative risk of hepa-
The pathogens causing respiratory infection in travel- titis A in travellers, compared with staying at home, was
lers are generally speaking the same as those in nontravel- estimated in a UK study to be 20 for travel to eastern
lers. Three are, however, worthy of special mention: Europe, 235 for Africa and 1835 for the Indian subconti-
Legionnaires disease (Legionella pneumophila), tubercu- nent (Behrens et al., 1995). Another study, in Swiss travel-
losis (Mycobacterium tuberculosis) and inuenza. Legion- lers, expressed the risk as an absolute risk: 300 per 100 000
naires disease causes occasional outbreaks among tour- per month for a stay in a tourist hotel, rising to 2000 per
ists, often associated with a contaminated hotel water 100 000 per month (i.e. one in 50) for a backpacking trip
system. During 1999, there were 289 cases of travel-asso- (Steen et al., 1994). Hepatitis A is underdiagnosed, par-
ciated Legionnaires disease in Europe (Public Health ticularly in children in whom the infection may be mild or
Laboratory Service, 2000) and the case fatality rate was inapparent; thus these studies underestimate the true bur-
signicant. Tuberculosis in travellers is uncommon, and den in travellers.
most infections occur in those visiting friends and family Typhoid fever is common in many countries. There are
in endemic countries, or in those working abroad in the an estimated 16 million cases worldwide. The risk to
long term, such as aid workers. Another risk to travellers travellers is more dicult to assess than for hepatitis A, as
is the potential for spread of infection on board aircraft. typhoid fever is typically an epidemic, rather than an
Transmission of tuberculosis on board aircraft has been endemic, disease, so the risk for travel to any particular
described, the risk being greatest for long-haul ights country will depend on whether there is an epidemic at
lasting more than 8 h (WHO, 1997). the time of the visit. Steen (Steen et al., 1987) estimated
EPIDEMIOLOGY AND SURVEILLANCE OF TRAVEL-RELATED DISEASES 33
the overall risk for travel to a developing country to be 30 travellers who plan to work or study there, in an eort to
per 100 000 per month. An additional risk for travellers is prevent importation.
the emergence of antibiotic-resistant strains of Salmonella Japanese B encephalitis is also rare in travellers. There
typhi in some countries, especially in Africa and South- have been sporadic reports in the literature; the risk is
east Asia. probably of the order of one per million. Vaccination is
Travellers are also potentially at risk for hepatitis B, only recommended for longer rural stays in endemic
with infection occurring through a variety of routes, in- countries of Southeast Asia and the Far East.
cluding sexual intercourse, injecting drug use, blood Another rare vaccine-preventable disease is tick-borne
transfusions and tattooing. The risk in short-term travel- encephalitis. There are no reliable estimates of the numb-
lers has not been well documented; however, in profes- er of cases. The risk is conned to forested areas of central
sionals working abroad it is 80420 per 100 000 per and eastern Europe, parts of Scandanavia and Russia,
month of stay (these gures including both symptomatic where the tick vector is present.
and asymptomatic disease) (Steen, 1990). Bites from potentially rabid animals are common in
Meningococcal infection requires close contact for travellers. Between 0.2% and 0.5% of travellers are bitten
transmission to occur. It is thus rare in most travellers, per month of travel (Bernard and Fishbein, 1991); how-
except in pilgrims (see below) or in travellers living in ever, the risk of rabies is remote, even in the unvaccinated
close proximity to locals in areas where epidemic disease traveller who does not receive postexposure prophylaxis.
is common, e.g. staying with relatives in the African men-
ingitis belt or in hikers camping in Nepal. Vaccines are
available against serogroups A, C, W135 and Y of Neis- Sexually Transmitted Diseases
seria meningitidis. In the African meningitis belt, most
cases are due to serogroup A and this is also true in Travel increases opportunities for casual or commercial
Nepal; in other countries, serogroup B, and sometimes sex. Approximately 5% of travellers from Europe to de-
serogroup C, strains predominate. veloping countries reported at least one casual sexual
Yellow fever infections are only reported occasionally encounter while travelling (Laga, 1992). Unprotected sex-
in travellers. A yellow fever vaccination certicate is re- ual activity places the traveller at risk of many sexually
quired for travel to some countries, although this is main- transmitted diseases (STDs) (including hepatitis B and
ly to prevent spread of the disease rather than to protect human immunodeciency viral (HIV) infection, both of
the individual traveller. which are considered elsewhere in this chapter). Most
Cholera vaccination is no longer mandated or recom- STDs are also common at home; thus in a sexually active
mended for travellers. The risk of infection in travellers is traveller it is dicult to determine whether an STD was
negligible; it has been estimated to be about 0.2 per acquired at home or abroad, particularly if the incubation
100 000 (Wittlinger et al., 1995). period is long. This means that reliable data on the inci-
The risk of poliomyelitis in an unvaccinated traveller dence of travel-associated STDs are dicult to obtain. In
during the 1980s was estimated as 2 per 100 000 (Kubli et addition, many STDs are asymptomatic, so even if
al., 1987); however, this risk is now declining as a result of screening is undertaken (and this is unusual) it is usually
the global polio eradication eort (see below). Vaccina- impossible to determine when and where the infection
tion is still, however, indicated for travel to many coun- was acquired. Molecular typing methods have been use-
tries. In industrialised countries importations now ac- ful in helping trace the international spread of HIV infec-
count for a signicant proportion of the few residual polio tion, but they are not yet widely available for other more
cases: for example, 5 of 21 cases in England and Wales common STDs. Antibiotic resistance is a useful marker
between 1985 and 1991 were travel-associated; the re- for identifying some travel-associated STDs; for example,
mainder were vaccine-associated or source unknown penicillinase-producing strains of Neisseria gonorrhoeae
(Joce et al., 1992). The greatest risk nowadays is for travel- are much more common in developing countries (es-
lers to the Indian subcontinent, where approximately half pecially Southeast Asia) than in Europe or the USA.
of all the worlds polio cases are reported. Steen (Steen et al., 1987) found an incidence of gonor-
Diphtheria is also rare in travellers, although a global rhoea in travellers of 300 per 100 000 per month of travel,
estimate of risk has not been published. There were only which is similar to the risk for hepatitis A.
21 travel-associated cases in England and Wales, a popu- The age and sex distribution of travel-acquired STDs
lation of 50 million, between 1970 and 1987 (Begg, 1988). diers from infections acquired at home. In most develop-
The risk has increased in recent years for travellers to the ed countries, the highest rates of indigenous STDs are in
former USSR (see below). teenagers and young adults. Travel-associated cases tend
In countries where measles is close to elimination, im- to occur more commonly in older adults, particularly
ported measles now accounts for a signicant proportion adult males.
of the burden of disease. For example, in England and The vast majority of travel-associated STDs are those
Wales, 24% of sporadic measles cases between 1995 and which are also common at home: gonorrhoea, chlamydia,
1999 were either imported or associated with importation trichomoniasis, herpes simplex and genital warts; how-
(M. Ramsay, 2000, personal communication). In the ever, some infections are much commoner in tropical
USA, measles vaccination is required by some states for countries and are thus more readily identiable as travel-
34 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Table 5.1 Causes of death related to international travel Bites and stings are common, although most are harm-
(n : 2463) less or cause only minor distress. Some can be painful (e.g.
scorpion bites) but very few require specic treatment, e.g.
Cause of death Number (%) antivenom. Fatalities due to snake bites or venomous
insects are very rare in travellers. The greatest risk from
Cardiovascular disease 1207 (49.0)
insect bites in travellers is due to malaria, dengue, and
Other, noninjury deaths 713 (28.9)
Injury deaths 543 (22.0)
other infections for which insects act as vectors.
Motor vehicle 161
Drowning 97
Air crash 43 THE CHANGING EPIDEMIOLOGY OF
Poisoning 39 DISEASE IN TRAVELLERS
Burns 22
Other 181
As travellers seek increasingly exotic locations, they be-
come exposed to new risks; for example, a rise in imported
Adapted from Hargarten et al. (1991). schistosomiasis has been observed in some countries, fol-
associated. Examples include chancroid (Haemophilus lowing the establishment of Lake Malawi as a popular
ducreyi) and donovanosis (Calymmatobacterium in- tourist destination.
guinale). The potential for emergence of new infectious diseases
The incidence of STDs in some countries has increased and re-emergence of old ones has increased in recent
signicantly in recent years. Of particular concern is the years. Many factors have contributed to this threat, of
rise in syphilis, which has been observed in eastern which the rapid increase in international travel is one.
Europe and countries of the former USSR. The expand- Other factors are the globalisation of the food industry,
ing HIV epidemic (see below) has also increased the risks and social and environmental changes such as deforesta-
to the sexually active traveller. STDs in returning travel- tion and rapid urbanisation. In addition, the widespread
lers are likely to become an increasing problem in the and inappropriate use of antibiotics has led to the emerg-
future. ence of many resistant infectious diseases. At the same
time, successful vaccination programmes and other con-
trol measures have brought some diseases close to eradi-
cation.
Accidents
While travel has contributed to disease emergence,
Most of the burden of less severe illness in travellers is health problems in travellers can also be a highly sensitive
sentinel for changing global disease epidemiology. Illness
diarrhoea and other infectious diseases. In contrast, acci-
dents are the cause of more serious morbidity and mortal- in a traveller returning to an industrialised country is
ity in travellers. Accidents account for less than 2% of all more likely to be thoroughly investigated than in the
country where the illness was acquired, and indeed new
travel-related morbidity (Steen et al., 1987); however,
they are responsible for about 20% of travel-related infectious agents are often rst identied in travellers.
deaths (Hargarten et al., 1991; Paixo et al., 1991) (Table This was the case for Lassa fever, which was rst identi-
ed in 1969 among American missionaries in Nigeria.
5.1); worldwide there are several thousand deaths a year
in travellers. The most common cause of death is motor Similarly, the most sensitive method for monitoring the
vehicle accidents (accounting for a quarter of all deaths); spread of resistant malaria worldwide is through surveil-
lance of travel-associated disease; for example, chloro-
other causes of accidental deaths in travellers include
drowning, air crash, murder, suicide and poisoning (Table quine-resistant Plasmodium vivax was rst detected in US
5.1). For nonfatal accidents, the most common causes are Army troops returning from Somalia.
motor vehicle accidents, falls and recreational injuries.
The age and sex distribution of travel-associated acci-
dents is similar to accidents that occur at home, i.e. with Viral Haemorrhagic Fevers
the highest rates in young adult men.
A number of viral haemorrhagic fevers have re-emerged
or emerged in recent years. Dengue haemorrhagic fever
Other Health Problems in Travellers was almost eradicated in the Americas prior to 1981. The
incidence has increased dramatically since then, with epi-
Cardiovascular disease is common in travellers; indeed, it demics of dengue in Central and South America, the
is the commonest cause of death abroad (Table 5.1), al- Caribbean and more recently in Southeast Asia. The
though this is usually because of pre-existing disease and rising incidence of dengue fever over the past 20 years is
not due to travel. The exception is the risk of venous mirrored by increasing reports in travellers (for example
thrombosis that sometimes accompanies long-haul air in the UK) (Table 5.2).
travel (Sarvesvaran, 1986), the so-called economy-class During the last decade there has also been a large
syndrome. increase in the incidence of yellow fever in West Africa,
EPIDEMIOLOGY AND SURVEILLANCE OF TRAVEL-RELATED DISEASES 35
Table 5.2 Reported cases of dengue fever in UK travellers, epidemic in the former USSR has been brought under
19751995 control.
Year Number of reports
Meningococcal Disease
19751981 0
1982 6 Meningococcal disease is usually rare in travellers, with
1983 11 one notable exceptionvisitors to the annual pilgrimage
1984 11 to Mecca, the Hajj. A large outbreak of serogroup A
1985 1
disease occurred in Mecca in 1987, prompting the re-
1986 6
quirement by the Saudi authorities for pilgrims to be
1987 1
1988 6
vaccinated. Another epidemic occurred in the Hajj in
1989 2 2000, this time due to serogroup W135 infections. Cases
1990 34 were reported in pilgrims returning to the UK, France,
1991 12 The Netherlands, Onman and the USA (WHO, 2000b).
1992 30 This has implications for future vaccination recommen-
1993 17 dations for travellers. The risk to travellers in sub-Sa-
1994 22 haran Africa has also increased during the late 1990s,
1995 42 with large epidemics (serogroup A) reported in many
countries inside the meningitis belt.
Source: PHLS CDSC.
Cholera
and recent fatal cases in Swiss, American and German
Successive cholera pandemics have spread around the
travellers are a reminder of the potential risk in this part
globe as a result of international travel. The seventh
of the world. The Aedes mosquito is a vector for both
pandemic started in 1961, and by the early 1990s it had
dengue and yellow fever. Although yellow fever is con-
reached South America for the rst time in almost a
ned to South America and Africa, there is concern the
century. It rapidly spread throughout the continent, with
infection could spread, via infected travellers, to other
devastating consequences: for example, in Peru it caused
continents such as India, where the Aedes mosquito is
over 3000 deaths, and the estimated loss to the economy
also present. There have also been several outbreaks of
was about 500 million. The eighth pandemic started in
Ebola fever in central Africa since the large epidemic in
Bangladesh in 1992, and was due to an entirely new strain
Kiwit, Zaire in 1995, although travellers have not so far
(Vibrio cholerae 0139). This new strain has now spread to
been aected.
Africa, where it has caused outbreaks, especially among
refugees, in which the case fatality has been as high as
50%.
Nipah virus
Virus Infections
Arie J. Zuckerman
Royal Free and University College Medical School, London, UK
VIRAL HEPATITIS
Introduction and Denitions functions for propagation in hepatocytes, and is an
important cause of acute and severe chronic liver damage
The last three decades have witnessed an explosion in in some regions of the world. The modes of transmission
knowledge of viral hepatitis, a major public health prob- are similar to the parenteral transmission of HBV.
lem throughout the world aecting several hundreds of Hepatitis E virus (HEV) is an enterically transmitted,
millions of people. Viral hepatitis is an important cause of nonenveloped, single-stranded RNA virus, which shares
morbidity and mortality, both from acute infection and many biophysical and biochemical features with cal-
chronic sequelae which include, with hepatitis B, hepatitis iciviruses. It has caused large epidemics of acute hepatitis
C and hepatitis D (delta) infection, chronic active hepati- in the Indian subcontinent, Central and Southeast Asia,
tis and cirrhosis, and primary liver cancer with hepatitis B the Middle East, parts of Africa and elsewhere; it is re-
and hepatitis C. The hepatitis viruses include a range of sponsible for high mortality during the third trimester
unrelated human pathogens. of pregnancy. The number of infections with this virus,
Hepatitis A virus (HAV) is a small unenveloped sym- particularly in developed countries, may be under-
metrical RNA virus which shares many of the charac- estimated.
teristics of the family Picornaviridae. It is the cause of GB viruses and Hepatitis G virus. In 1995 two indepen-
infectious or epidemic hepatitis transmitted by the dent viruses, GBV-A and GBV-B, were identied in infec-
faecaloral route. The virus is classied within the genus tious plasma of tamarin monkeys inoculated with serum
Hepatovirus. from a surgeon (GB) with jaundice. A third virus, GBV-C,
Hepatitis B virus (HBV) is a large double-shelled virus was later isolated from a human specimen that was im-
of the hepadnavirus group of double-stranded DNA vi- munoreactive with a GBV-B protein. GBV-C RNA was
ruses which replicate by reverse transcription. The virus is found in several patients with clinical hepatitis. GBV-A/
endemic in the human population and hyperendemic in C, GBV-B and the hepatitis C viruses are members of
many parts of the world; it is estimated to have infected a distinct viral groups whose genomes show regions of
third of the worlds population. It is transmitted by sequence identity with aviviruses. A virus described in
blood-to-blood contact and by the sexual route. 1996 as Hepatitis G virus (HGV) is an independent isolate
Hepatitis C virus (HCV) is an enveloped single- of GBV-C. The role of this virus in viral hepatitis is not
stranded RNA virus, distantly related to aviviruses, but established.
not transmitted by arthropod vectors. Seroprevalence TT virus. TT virus stands for the initials of a patient in
studies conrm its wide dissemination in all parts of the Japan with post-transfusion hepatitis. TT virus DNA has
world and the importance of the parenteral route of been detected in up to 97% of the healthy population in
transmission, and transmission by blood and blood prod- some countries. Preliminary evidence indicates that this
ucts, but in as many as 50% of patients the origin of the virus is similar to members of the family Circoviridae,
infection remains unknown. Several genotypes have been viruses which infect plants and farm animals. The
described. Infection is common; it is associated with chro- pathogenic role, if any, of this virus in human disease
nic liver disease and with primary liver cancer. remains to be established.
Hepatitis delta virus (D) (HDV) is an unusual single-
stranded circular RNA virus resembling plant viral satel-
lites and viroids. This virus requires hepadnavirus helper
Figure 6.1 Hepatitis A virus: faecal extract from a patient during the incubation period showing the large number of viral particles.
; 200 000
Figure 6.2 Hepatitis B virus: (a) small spherical particles representing excess viral coat protein; (b) tubular structures; (c) double-
shelled complete virus. ; 400 000
require universal immunisation of infants and will common cancers worldwide and 80% of such cancers are
become possible when HAV vaccine is combined in a ascribed to persistent infection with HBV.
polyvalent form with other childhood vaccines such as
diphtheria, pertussis, tetanus, measles, rubella, mumps
and hepatitis B. Nature of the Virus
Humans are the principal reservoir of infection. A virus General protective measures are based on strict hygienic
similar to HEV has been detected in herds of swine in the precautions and those outlined for hepatitis A in relation
USA and Taiwan. It is not known yet whether this virus to drinking water and consumption of uncooked food.
crosses the species barrier. Passive immunisation with immunoglobulin derived
from plasma collected in endemic areas does not oer
protection against infection with HEV. This reects the
Pathology fact that adult populations in endemic regions, who are
very likely to have been exposed to HEV in early life, are
Histopathological features in the liver are similar to those susceptible to infection with this virus, with high attack
of other forms of hepatitis, although cholestasis may be rates during epidemics. Vaccines against HEV are under
more prominent. Ultrastructural changes in the liver, development.
after experimental transmission to nonhuman primates,
include the nding of 2734 nm virus particles during the
acute phase of the infection. It is not known whether the HEPATITIS C
virus causes cell injury directly or whether the changes in
the liver reect immune-mediated damage. Introduction and Denitions
year 2000. More recently, the pandemic of HIV has evol- Retroviruses contain RNA genomes and replication
ved into essentially an infection transmitted heterosexual- involves transcription of the RNA genome into a double-
ly in the developing and poor countries of the world, stranded DNA intermediate by a viral enzyme referred to
accounting now for over 75% of all cases of AIDS, and as reverse transcriptase.
infection of groups dened as at high risk in the indus- HIV was isolated in 1983. The HIV particle is an
trialised communities. These include young adult homo- icosahedral sphere which is enveloped and has 72 projec-
sexual and bisexual males in major cities and their part- tions consisting of two glycoproteins, gp120 and gp41.
ners, intravenous drug abusers and their sexual partners, Glycoprotein 41 traverses the lipid bilayer. The matrix
and persons who change their sexual partners frequently. protein (p17) covers the internal surface of the virus, and
It should be noted that the risk to travellers depends to p24 constitutes the core shell, which encloses the two
a large extent on their own behaviour and exposure to copies of the single-stranded HIV RNA (Figure 6.4).
risk, and that the epidemic of HIV is not conned by HIV uses the CD4 molecule on the surface of both
geographical boundaries or to particular regions. There is immature T lymphocytes and mature CD4; T-helper
no evidence of transmission of HIV by purely social and lymphocytes for initial attachment to cells. This receptor
household contact or by leisure activities such as swim- is also present in lower amounts on monocytes, macro-
ming, and there is no evidence of transmission by insects. phages and antigen-presenting dendritic cells. Other
coreceptors are also present to promote the entry of the
virus into susceptible cells, where, after uncoating of the
Nature of the Infectious Agent virus, reverse transcription, integration and expression of
the viral genome occur, followed by viral assembly and
Human retroviruses, as is the case in other vertebrates, release of virus. Infected cells are ultimately destroyed by
exist in two forms: as genetic elements in chromosomal a direct cytopathic eect, but most of the cells are not
DNA (endogenous retroviruses) and as horizontally- killed and may therefore form an important resevoir for
transmitted infectious RNA viruses (exogenous retro- persistent infection with virus shedding. There are two
viruses). Endogenous retroviruses probably evolved from major antigenic types of HIV, HIV-1 and HIV-2, which
transposable elements; they are present in most verte- share approximately 40% of genetic homology. While
brates and some other life forms as DNA proviruses in the both types cause AIDS, it appears that HIV-2 is less
germ line, and most of these are silent or have become pathogenic; it occurs mainly in West Africa and sporadi-
pseudogenes. cally elsewhere. Phylogenetic analysis of HIV-1 has re-
Exogenous retroviruses are transmissible and three are vealed at least 10 subtypes, but the more recent identica-
associated with human disease: Human T-cell leukaemia tion of highly divergent HIV-1 strains, principally from
virus 1 (HTLV-1) is associated with adult T-cell leukae- patients in Cameroon, led to classication of HIV-1 into
mia and tropical spastic paraparesis, HTLV-2 is asso- two groups. The major (M) group corresponds to HIV-1
ciated with hairy cell leukaemia and HIV is the cause of strains disseminated widely throughout the world, and an
AIDS. outlier group (O) corresponding to the highly divergent
54 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
HIV-1 strain, identied originally in Cameroon but Pathology
found subsequently in Gabon, Europe and the USA.
Antigen-presenting cells which prime naive T lym-
phocytes form a complex system of cells referred to as
dendritic cells. These cells express class I and class II
Epidemiology and Geographical Distribution molecules of the major histocompatibility complex
(MHC) and specic chemokines, which act as coreceptors
The global dissemination of HIV was referred to in the with CD4 molecules. CD4 permits binding of HIV-1
introduction to this section. In industrialised countries gp120 to cells, but the chemokine coreceptors allow
most reported cases of AIDS occur in one or more of the
fusion and penetration of the virus into the host cell.
following groups: Dendritic cells are readily infected by HIV-1 and support
Sexually active homosexual or bisexual men (genital viral replication in the presence of activated lymphocytes,
oral, genitalanal and genitalgenital sex) and 95% of HIV-1 variants transmitted are macrophage-
Intravenous drug abusers tropic. The Langerhans cells are either infected by the
Patients with haemophilia and others with severe co- virus or pick up the virus and then migrate to regional
agulation disorders who received unheated blood fac- lymph nodes. The virus is disseminated rapidly through-
tor concentrates out the lymphoid system and later enters the bloodstream
Recipients of unscreened blood transfusions (in the and further replication occurs. After transition to the
past) chronic phase of the disease, virus particles trapped in the
Sexual partners of the above groups follicular dendritic cell network become the dominant
Children born to mothers infected with HIV. form of HIV-1, and the number of circulating virus par-
ticles falls. Latent infection of CD4; T lymphocytes
Since the late 1980s there has been a substantial decrease results in the establishment of replication-competent
in HIV prevalence among men who have sex with men, HIV-1 proviral DNA, a reservoir for the virus.
but an increase in heterosexual transmission, with the
The intrinsic ability of HIV-1 to mutate rapidly allows
highest rates in women. the virus to escape immune surveillance and specic im-
Another epidemiological pattern is emerging in coun- mune responses so that it is able to continue to infect cells
tries of eastern Europe and the former Soviet Union,
and replicate, representing, together with a stable reser-
where infection with HIV has increased dramatically, voir of virus, a continuous source for infection of CD4;
mainly in association with intravenous drug abuse and T lymphocytes. CD4; T cells are damaged in several
unprotected sexual transmission. Nosocomial trans-
dierent ways: virus replication can destroy the cell as a
mission of HIV accounts for over 50% of children with result of damage of the cell membrane; viral genetic ma-
AIDS in Romania and the Russian Federation. The epi- terial may interfere with the metabolism of the cell; and
demic in sub-Saharan Africa involves well over 20 million
the virus may infect and destroy progenetior lymphoid
people, and an estimated 45 million children. The preva- cells. CD4; T cells may also be destroyed by autoim-
lence rate in the population ranges from 115 to 20% or mune reactions that kill uninfected cells, and is likely that
more. About 7500 people are infected daily. Infection is
anti-HIV immune eector cells kill many cells infected
typically the result of heterosexual and perinatal trans- with the virus.
mission. HIV-2 is found principally in West Africa, with a The number of circulating CD4; lymphocytes corre-
prevalence of about 10%. The prevalence of HIV and
lates signicantly with the development of bacterial, fun-
AIDS is increasing dramatically in Asia, with most cases gal, parasitic and viral opportunistic infections, including
(approaching 90%) occuring in India, Burma and Thai- Mycobacterium tuberculosis, M. avium complex and
land. Initially most infections were in intravenous drug
Streptococcus pneumoniae infections, candidiasis, crypto-
abusers, spilling rapidly into prostitutes and their clients coccosis, histoplasmosis, coccidioidomycosis, toxoplas-
and into the general population. The predominant mode mosis, enteric helminthic infections, Pneumocystis carinii
of spread of HIV in Asia is by heterosexual transmission.
pneumonia, herpes zoster, mucocutaneous herpes, poly-
The prevalence of infection among pregnant women is omavirus and others. Various tumours are also found in
increasing rapidly. The pattern of the prevalence of HIV patients with AIDS including non-Hodgkin lymphomas,
infection and AIDS in the Caribbean and Latin America
Kaposi sarcoma, cancer of the central nervous system,
is similar to that described initially in North America, but invasive cervical cancer and others.
with an apparently rapid increase in heterosexual trans-
mission since the late 1980s.
Clinical Features and Diagnosis
VIRAL GASTROENTERITIS
Introduction and Denitions relates of protection from rotavirus infection (which can
be without symptoms) and disease are not fully under-
Human gastroenteritis can be caused by bacteria, viruses stood.
and parasites, and diarrhoeal illness is second only to
respiratory diseases in terms of morbidity and mortality,
with very high mortality in children in the developing Adenoviruses
countries.
Viruses that cause human gastroenteritis belong to Adenoviruses are large icosohedral viruses measuring
dierent virus families: rotaviruses account for about 7080 nm in diameter, with a linear double-stranded
70% of gastroenteritis in children; enteric adenoviruses DNA. There are more than 100 antigenic types, of which
approximately 12%; caliciviruses, including small round 49 distinct serotypes in six dierent subgroups, AF, in-
structured viruses (SRSVs), 8%; and astroviruses are re- fect humans, causing mainly acute respiratory disease,
sponsible for 8% of all cases of gastroenteritis in children. follicular conjunctivitis, epidemic keratoconjunctivitis,
Other viruses can also infect the gastrointestinal tract in cystitis and, less frequently, gastroenteritis. Adenoviruses
conditions of immunosuppression but these are not con- associated with gastroenteritis belong to subgroup F,
sidered in this section. serotypes 40 and 41.
There are two epidemiological patterns. During child-
hood, viral diarrhoea occurs as an endemic disease,
caused mainly by group A rotaviruses, subgroup F aden- Small Round Structured Viruses (SRSVs)
oviruses, classical human caliciviruses and astroviruses.
The principal mode of transmission is by the faecaloral The rst member of this group was recognised by immune
route, by close contact and fomites. The second pattern is electron microscopy, during a large outbreak of acute
epidemic, aecting all ages, and caused mainly by SRSVs gastroenteritis in a school in Norwalk in the USA, as a
and at times by group B and C rotaviruses and by as- 2735 nm particle. After cloning and sequencing of Nor-
troviruses. Infection is transmitted frequently by con- walk virus it was classied as a calicivirus. The genome
taminated food or water. consists of a single-stranded RNA, and the name cal-
icivirus describes a particle with cup-shaped depressions
on its surface. The subsequent identication of other
Nature of the Infectious Agent viruses causing gastroenteritis led to a classication
based on the morphology of SRSVs comprising Norwalk
Rotaviruses virus and Norwalk-like viruses with a diameter of
2735 nm, so-called classical caliciviruses with a diameter
These viruses have a genome of 11 segments of double- of 3040 nm and astroviruses with a diameter of
stranded RNA encoding six structural proteins and ve 2830 nm. Picornaviruses with a 27 nm diameter and par-
nonstructural proteins within a wheel-like structure, as voviruses with a diameter of 1820 nm are included
seen by electron microscopy. Group A rotaviruses, of among the featureless small round viruses (SRVs).
which there are 10 serotypes, are major pathogens in
humans and animals; groups B and C are not important
causes of illness in infants and young children. Epidemiology, Clinical Features and Geographical
After neonatal or primary infection a specic serotype Distribution
humoral immune response develops, but there is also
partial protection against subsequent infections by other Viral gastroenteritis occurs throughout the world.
rotavirus serotypes. Second, third and fourth infections The incubation period of rotavirus gastroenteritis is
confer progressively greater protection. The immune cor- 12 days with a sudden onset of illness with watery diar-
VIRUS INFECTIONS 57
rhoea lasting 47 days, vomiting and rapid dehydration. scopy. Laboratory diagnosis of SRSVs and astroviruses is
The spectrum of illness ranges from mild to severe. Vir- by electron microscopy or immune electron microscopy,
tually all children become infected during the rst 35 ELISA and RT-PCR.
years of life, but severe diarrhoea and dehydration occur
primarily in children under the age of 3 years.
Rotavirus is also an important cause of nosocomial
gastroenteritis. Rotavirus infection in adults occurs
among those caring for children with diarrhoea, in travel-
lers and in the elderly. The virus is transmitted mainly by Management and Treatment
the faecaloral route.
The incubation period of SRSVs ranges from 10 to Oral rehydration with uids containing sugar and elec-
48 h; diarrhoea, vomiting or both last for 12 days. The trolytes is most important, and in severe cases, particular-
ly in children, rapid uid replacement intravenously is a
illness occurs typically in older children and adults, and is
uncommon in preschool children. Outbreaks occur in life-saving measure. If the ability to drink is lost, parent-
schools, camps and holiday centres, hospitals, cruise ships eral administration of uid is a medical emergency. Oral
bismuth subsalicylate has been found to be benecial in
and so on, and are associated with ingestion of con-
taminated drinking or recreational water (swimming children with acute watery diarrhoea.
pools), uncooked shellsh, eggs, cold foods and salads. Antibiotics have no place in the treatment of viral
gastroenteritis and specic antiviral therapy is not avail-
The faecaloral route alone does not, however, explain
the explosive outbreaks that have been documented. Very able.
large numbers of virus particles are present in vomit and In general, travellers diarrhoea does not require inten-
sive treatment apart from general supportive measures,
vomiting is often projectile, so aerosol transmission, par-
ticularly in enclosed spaces, is likely. but blood in the stools and persistent diarrhoea longer
Human astrovirus infections occur in childhood, often than a few days requires urgent medical attention and
laboratory investigation.
without symptoms, and in the elderly, and occasionally as
the cause of foodborne outbreaks of diarrhoea. Trans-
mission is by the faecaloral route, person-to-person con-
tact and possibly fomites. The seasonal incidence is high-
est during the winter.
Protective Measures and Prevention
Pathology General food and water hygiene measures and strict per-
sonal hygiene are important, as are sensible precautions
with the consumption of food and water. Viruses causing
The pathogenesis of rotavirus infection is based on in-
creasing necrosis of the gut epithelium, leading to loss of gastroenteritis are highly contagious and spread can be
villi, loss of digestive enzymes, reduction of absorption rapid. Careful handwashing, personal hygiene, disinfec-
tion, and safe disposal of contaminated material and
and increased osmotic pressure, resulting in diarrhoea.
These changes are followed by increased uid secretion. faeces are important. Outbreaks in hospitals, nurseries,
The onset of dehydration may be rapid. Pathological holiday centres and cruise ships require meticulous appli-
cation of these measures.
changes in the ileum resulting from infection with SRSVs
include blunting of intestinal villi, crypt hyperplasia and A rotavirus vaccine, a rhesus-based rotavirus vaccine-
cytoplasmic vacuolation and lymphocytic inltration of tetravelent (RRV-TV), has been licensed in the USA and
elsewhere. RRV-TV is a live attenuated oral vaccine
the lamina propria.
Pathological changes observed in animals infected with which incorporates a rhesus monkey rotavirus strain
species-specic astroviruses reveal infection of mature (with human serotype G3 specicity) and three single-
gene humanrhesus reassortants. Immunisation early in
enterocytes at the tip of the villi of the small intestine.
life, which mimics the childs rst natural infection, will
not prevent all subsequent disease but should prevent
most cases of severe rotavirus diarrhoea including hospi-
Diagnosis tal admission for treatment. The US Advisory Committee
on Immunization Practices (1999a) recommends routine
Specic diagnosis of viral gastroenteritis is relatively easy immunisation with three oral doses of RRV-TV for in-
by electron microscopy and immune electron microscopy fants at the age of 2, 4 and 6 months. This vaccine can be
of faecal extracts. The principal routine techniques for administered together with DPT, Hib vaccine, oral polio
rotavirus include ELISA and passive particle agglutinat- vaccine, inactivated polio vaccine and hepatitis B vaccine.
ion. Molecular techniques are also available. Enteric ad- RRV-TV is eective but has now been withdrawn owing
enoviruses are detected in faecal extracts mainly by to a number of adverse events.
ELISA using subgroup F-specic monoclonal antibodies, Vaccines against other viruses causing gastroenteritis
and by electron microscopy and immune electron micro- are not available.
58 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
POLIOMYELITIS AND OTHER ENTEROVIRUS INFECTIONS
Introduction and Denitions Poliomyelitis can aect all age groups. In areas with
poor sanitation most infants were infected early in life and
The enteroviruses belong to the family Picornaviridae acquired active immunity while still protected by ma-
(small RNA viruses) comprising ve genera: en- ternal antibodies. The infection occurred worldwide be-
teroviruses, rhinoviruses, hepatoviruses, cardioviruses fore the introduction of large-scale immunisation, and the
and aphthoviruses. Most infections with enteroviruses highest incidence of clinical disease was in temperate
are inapparent, but some may cause serious infection of zones and in the more developed countries, most
the central nervous sytem, heart, skeletal muscles, liver commonly during summer and autumn. It was expected
and pancreas. that poliomyelitis caused by wild-type virus would be
Sixty-six serotypes of enterovirus have been isolated eradicated from most (if not all) countries at the begin-
from humans and can replicate in the epithelium of the ning of the third millenium, and it is likely that po-
nasopharynx, gastrointestinal tract, lymphoid tissue, re- lioviruses found in nature will probably be derived from
ticuloendothelial system, and, in the case of HAV the oral poliovirus vaccine strains.
liver. The virus may spread to other organs and may The incubation period is commonly 714 days for
cause severe diseasefor example, the central nervous paralytic cases, with a reported range of 335 days. Cases
system (polioviruses), the myocardium, causing myocar- are most infectious 710 days before and after the onset of
ditis (coxsackie viruses), and others. Prevention by im- symptoms, and virus may be shed in the faeces for 6 weeks
munisation is limited so far to poliomyelitis and hepatitis or longer.
A. From the point of view of the traveller, poliovirus and
HAV are considered to be the most important of the
enteroviruses. This section considers, therefore, only Reservoir of Infection
poliomyelitis; hepatitis A infection has been discussed
earlier in this chapter. It should be noted that two genera The reservoir of infection is human, most frequently per-
of the Picornaviridae cause diseases of animals: the car- sons with inapparent infection, especially children.
dioviruses cause disease in mice, and the aphthoviruses
cause foot-and-mouth disease of cattle.
Clinical Features and Diagnosis
INFLUENZA
Introduction and Denitions and variants are described by the geographical site of
isolation, the culture number and year of isolation, e.g.
Inuenza is a highly infectious acute respiratory disease A/Japan/305/57(H2N2), A/Hong Kong/1/68(H3N2), A/
causing epidemics and pandemics throughout the world. Sydney/5/97(H3N2), and, in the case of inuenza B, B/
While it is usually a self-limiting disease, it can be compli- USSR/2/87, B/Beijing/184/93, and so on. Various inu-
cated by bronchitis and secondary bacterial pnuemonia, enza A subtypes have been isolated from wild and domes-
and in children by otitis media. Primary inuenza virus tic aquatic birds, from pigs, horses, mink, seals and
pneumonia is rare but carries a high case fatality rate. whales. Animal reservoirs are believed to be the sources of
Epidemics are generally associated with a large number new human subtypes, probably by genetic reassortment
of excess deaths among the elderly and among those with with human strains facilitated by the segmented viral
underlying chronic respiratory and cardiac diseases, renal genome. The emergence of completely new subtypes (re-
or metabolic diseases and immunosuppression. Epi- ferred to as antigenic shift) occurs at irregular and un-
demics and pandemics occur at unpredictable intervals. predictable intervals and only with inuenza A viruses.
There are three types of inuenza virus, A, B and C. Completely new subtypes are responsible for pandemics.
Type A causes widespread epidemics and pandemics, type Minor antigenic variations (antigenic drift) are associated
B is associated with regional and widespread epidemics, with annual epidemics and regional outbreaks.
and type C is associated with sporadic cases and minor
local outbreaks.
Epidemiology and Geographical Distribution
GENITAL HERPES
Introduction and Denitions vidual shedding the virus. Transfer of the virus occurs by
infection of a mucosal surface or by entry through skin
Herpesviruses are disseminated widely in nature and in- abrasions and lesions such as cuts. Replication of the
fect most animal species. Eight herpesviruses have been virus occurs at the site of infection, followed by a short
isolated from humans so far: Human herpesvirus 1 (HHV- period of viraemia. The primary infection is usually
1; Herpes simplex 1, HSV-1); HHV-2 (Herpes simplex 2, asymptomatic.
HSV-2); HHV-3 (Varicella-zoster virus, VZV); HHV-4 The site of primary infection for HSV-1 is most fre-
(EpsteinBarr Virus, EBV); HHV-5 (Human cytomega- quently the oral cavity and oropharynx, often by kissing,
lovirus); and HHV-6, -7 and -8. and by early adult life infection rates are in the order of
Herpesviruses share a number of biological properties, 9095%. The site of infection for HSV-2 is the genital
including the ability to code for a large number of en- mucosa and transmission is by intimate sexual contact.
zymes involved in nucleic acid metabolism, synthesis of However HSV-1 and HSV-2 may infect at either of these
viral DNA and capsid assembly take place in the nucleus, sites (between 10 and 40% of primary genital infections
and the viral envelope is acquired during migration from may be caused by HSV-1). It should be noted that al-
the nucleus, production of infectious virus is accom- though infection with HSV-2 is transmitted sexually,
panied by cell destruction, and the herpesviruses establish seroprevalence rates of about 3060%, which increase
latent infection in the host. with sexual maturity, do not attain the levels of infection
The herpesviruses aecting humans are probably the with HSV-1. Seroprevalence of HSV-2 is related to
viruses that have been studied most extensively. Genital socioeconomic factors but particularly to the number of
herpes, caused most frequently by HSV-2 but also by sexual partners.
HSV-1, is the most relevant to the traveller. Previous infection with HSV-1 does not protect against
HSV-2, but those who had been infected with HSV-1
usually experience milder symptoms with HSV-2 com-
Nature of the Infectious Agent pared with those who had not experienced either form of
the virus.
The herpes simplex viruses belong to a family of large Transmission is by direct contact with infected secre-
enveloped DNA viruses, measuring 120300 nm, contain- tions, obviously when genital lesions are present; how-
ing linear double-stranded DNA. HSV-1 and HSV-2 are ever, the virus can be excreted asymptomatically and this
closely related, with approximately 70% genomic homol- may occur in 2% of women. The presence of viral DNA,
ogy. detected by PCR in genital swabs, in the absence of virus
HSV-1, HSV-2 and VZV form a subfamily named the from women with a history of recurrent genital herpes
Alpha herpesvirinae, characterised by a very rapid repro- suggests persistent viral infection (chronicity) rather than
ductive cycle, rapid destruction of the host cell and ability recurrent infection. Nevertheless, about 60% of those
to multiply in a variety of host tissues. These viruses infected with HSV-2 will report recurrent infection.
establish latent infection in the dorsal root ganglia. Reac- The incubation period is 220 days, with an average of
tivation of latent virus is associated with stimuli such as about 1 week.
stress, menstruation, and ultraviolet light, in the presence
of a fully developed immune response, the production of
recurrent infection and virus shedding. Reactivation may Pathology
occur at intervals throughout life.
Pathological changes in the skin include ballooning of
infected cells, cell degeneration, formation of multinuc-
Epidemiology and Geographical Distribution leated giant cells, inammatory changes and the accumu-
lation of vesicular uid between the layers of the epider-
HSV is disseminated throughout the world and is en- mis and dermis. The vesicular uid contains large
demic in all the human populations examined. Humans quantities of virus. Scarring after healing is uncommon.
are the only natural host. Transmission of the virus is by Vesicles are less prominent, in general, when mucous
direct contact between a susceptible person and an indi- membranes are infected. Shallow ulcers are more
62 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
common as the vesicles rupture rapidly because of the Diagnosis in the laboratory is by viral isolation by
thin layer of protective stratied epithelium. The intensity culture, direct or indirect immunouorescence, im-
of the inammatory response is signicantly less marked munoperoxidase techniques, enzyme- and radioim-
with recurrent disease. munoassays and nucleic acid detection.
RABIES
Introduction and Denitions members of the Lyssavirus group which include the
serologically related Lagos bat virus, Mokola virus and
Rabies is a viral infection which is transmitted in the Duvenhage virus in Africa, and Duvenhage virus in Europe
saliva of infected mammals; it causes an acute encepha- (European bat virus) should be noted.
lomyelitis that is almost always fatal. Human pathogens Rabies virus is a negative-sense, non-segmented, single-
of medical importance are members of the genus Lys- stranded RNA virus measuring about 75 ; 180 nm. The
savirus and Vesiculovirus. Almost all cases of human ra- helical nucleocapsid of 3035 coils is surrounded by an
bies, a lyssavirus infection, are caused by a bite of a rabid outer lipid bilayer membrane with surface projections
animal. Although the risk of rabies is highest in countries about 8 nm in length. The viral genome encodes ve
of most of Asia, Africa and South America and it is rare as proteins, three of which are associated with the ribonuc-
a human infection in Western Europe and North Amer- leoprotein complex, which, together with the viral RNA,
ica, every year, for example, up to 40 000 people receive aggregate in the cytoplasm of infected neurons to form
postexposure prophylaxis in the USA. the characteristic Negri bodies. The matrix protein (M)
and the glycoprotein (G) are associated with the viral
envelope. The glycoprotein is required for virus infectivity
Nature of the Infectious Agent and recognises specic cell receptors. It is also the only
rabies virus protein known to induce neutralising anti-
Rabies virus is a member of the family Rhabdoviridae, with body.
a characteristic bullet shape. There are some 80 other The eect of chemical agents on rabies virus is under-
bullet-shaped viruses which infect animals (including lined by the importance of thorough cleansing of the
sh), plants, invertebrates and insects. For practical pur- wound with soap or detergent. The virus is destroyed by
poses, only Rabies virus is considered below, but other quaternary ammonium disinfectants, 1% soap solutions,
VIRUS INFECTIONS 63
ionic and nonionic detergents, 5% iodine, common or- Clinical Features and Diagnosis
ganic solvents such as 45% alcohol, ether and chloro-
form, formalin and -propriolactone. The incubation period is variable, ranging from a few
Isolates of rabies virus from naturally infected animals, days to several years, but in most cases the range is 3090
i.e. wild-type virus, are referred to as street virus, and days. The development of the infection depends on the
viruses adapted by laboratory passage in animals or cell severity of the exposure, the site of the bite and whether
culture are referred to as xed virus. the wounds were inicted through bare skin, and other
factors.
Prodromal symptoms are nonspecic, although behav-
Epidemiology, Geographical Distribution and
iour disturbances are often present, including anxiety,
Reservoir of Infection depression, hyperactivity, aggression, intolerance to tac-
tile, auditory and visual stimuli, or delirium. Later symp-
Human rabies is almost always caused by a bite or con-
toms of acute encephalitis appear, and clinical features
tamination of surface wounds by virus in saliva, but may be confused with tetanus or cerebral malaria, polio-
infection through intact mucosa, for example of the myelitis, botulism, or others. Clinical neurological nd-
mouth or the conjunctiva, can occur. Aerosol trans-
ings have been classied as either furious or paralytic.
mission has been implicated in human infection in bat- Furious rabies is the most common form; it is character-
infested caves and in laboratory accidents. Human-to- ised by spasms in response to external stimuli, which may
human transmission has been reported rarely, for
be tactile, visual, auditory or olfactory and include hydro-
example, by transplantation of infected corneas, and in phobia and aerophobia. Spasms alternate with periods of
the older literature. Rabies has not been reported in nurs- calm and lucidity, agitation and confusion and dysfunc-
ing and medical sta, but nevertheless there is a risk of
tion of the autonomic nervous system. Paralytic rabies
exposure by bite or by contaminated saliva during airway involves clinical features ranging from paralysis of one
care, and appropriate precautions should be exercised. It limb to quadriplegia. The disease progresses to severe
should also be noted that denitive animal exposure or
neurological complications, coma and death. Clinical dif-
incident cannot be identied in a signicant number of ferential diagnosis of rabies should be considered in every
human cases. patient with unexplained encephalitits or with neurologi-
Rabies is primarily a disease of animals and most hu-
cal signs, particularly where there is a history of animal
man cases occur in the developing world. The only areas bite or possible exposure in a country where rabies is
free of animal rabies include Australia and New Zealand endemic.
and islands such as the UK and Ireland, and the Pacic
Diagnosis in the laboratory is established by the detec-
Islands. Rabies is most prevalent among wild foxes, tion of rabies antigen, antibody, rabies viral RNA or the
wolves and jackals, followed by domestic dogs, skunks, isolation of the virus. Rapid diagnosis antemortem is by
cats, farm animals, bats and others. The principal reser-
detection of rabies antigen by direct immunouorescence
voir in Africa, Central America (including Mexico), South in a skin biopsy from the nape of the neck. Other freshly
America and Asia is the unvaccinated domestic dog. obtained tissues may be used. The virus can be isolated in
There is little information about rabies in wildlife in
tissue culture by inoculation of a murine neuroblastoma
tropical areas. The major reservoir of infection in Europe cell line (NAC 1300) or by inoculation of laboratory
is the red fox, and rabies has been identied in Central rodents. PCR and other molecular tests can be employed.
European deer. The major sources in the USA include
Detection of rabies virus neutralising antibody by a rapid
skunks, bats and racoons. uorescence focus inhibition test in the serum of unvac-
cinated persons is also diagnostic, and the presence of
Pathology antibody in the cerebrospinal uid conrms the diag-
nosis. In vaccinated individuals dierentiation between
Although rabies virus receptors appear to coincide with antibody due to vaccination or disease is not possible, but
the distribution of acetylcholine receptors, the virus can vaccination does not produce typically CSF antibody.
enter the cell independently of these receptors. The virus
may access the peripheral nerves directly or it may repli-
cate in the muscle tissue, remaining at or near the site of
introduction into the host for most of the incubation
period, essentially at motor endplates, replicating in Management, Treatment and Prevention
monocytes and later involving the peripheral nerves via
the neuromuscular junctions. The virus then moves cen- The basic approach to the control of rabies is control of
tripetally to the central nervous system for replication. infection of animals where possible, prevention of expo-
Subsequently it moves centrifugally to many tissues, in- sure and immunisation. Treatment of human rabies is
cluding the salivary glands. Pathological changes in the based on postexposure management of the wound and
brain are not profound, apart from the pathognomonic prophylaxis.
Negri bodies. Few neurons are involved, there is limited Methods for the control of rabies in animals are des-
tissue necrosis and some perivascular cung. cribed in a compedium prepared by the National Associ-
64 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
ation of State Public Health Veterinarians of the USA In the case of a patient who has been vaccinated previous-
(Compendium of Animal Rabies Control, 1999). ly with any of the above vaccines or with any other type of
Note that an unprovoked attack by an animal is more rabies vaccine, and a documented history of antibody
likely than a provoked attack to indicate that an animal is response to the prior vaccination, the following regimen
rabid and great care must be exercised to avoid contact applies after immediate wound cleansing:
with stray or unvaccinated dogs, cats and ferrets, particu-
Antirabies immunoglobulin should not be given.
larly in countries where rabies is endemic and vaccination
Human diploid cell vaccine, rabies vaccine adsorbed or
of domestic animals is unlikely.
puried chick embryo cell vaccine should be given
intramuscularly into the deltoid muscle immediately
(day 0) and on day 3 in a dose of 1.0 ml. The gluteal
Treatment of Wounds and Postexposure muscles should never be used because the resulting
Immunisation antibody titres are lower than those achieved by ad-
ministration into the deltoid muscle.
Attack by a rabid animal constitutes a medical emerg-
ency. Immediate and thorough washing of all bite
wounds and scratches with soap and water and, if avail-
able, a virucidal solution as described above, such as Primary Vaccination or Pre-exposure Vaccination
quaternary ammonium disinfectants, ionic and nonionic
detergents or 5% iodine, are most important. Avoid clo- Pre-exposure immunisation should be oered to high-
sure of the wound surgically unless suture of a large risk groups, which include veterinary surgeons and vet-
wound is essential because of the size of the wound, the erinary nurses and assistants, animal handlers, wildlife
potential for bacterial infection and cosmetic reasons. keepers and handlers, and certain laboratory workers.
Postexposure antirabies immunisation should include Pre-exposure immunisation should be considered for
the administration of both passive antibody in the form of other persons who may come into frequent contact with
specic antirabies immunoglobulin and active vaccina- animals potentially infected with rabies or who travel to
tion with a cell culture vaccine. A desirable postexposure or reside in areas where animal rabies, particularly dog
prophylaxis regimen is described in the recommendations rabies, is enzootic and immediate access to appropriate
of the US Advisory Committee on Immunization Practi- medical care is or may be limited.
ces (1999b). Briey, in those not previously vaccinated Primary intramuscular vaccination involves three
against rabies, immediate wound cleansing must be fol- 1.0 ml injections of one of the vaccines listed above given
lowed by: intramuscularly into the deltoid muscle on days 0, 7, and
21 or 28. Intradermal primary vaccination of three 0.1 ml
Administration of 20 IU kg\ body weight of anti-
doses of human diploid cell vaccine, one each on days 0, 7,
rabies immunoglobulin. If feasible anatomically, the
and 21 or 28 is an alternative schedule.
full dose should be inltrated around the wound(s), and
Note that malaria prophylaxis with chloroquine phos-
any remaining amount should be given intramuscular-
phate (and possibly structurally related compounds,
ly but at a distant site from the site of vaccine adminis-
which have not yet been investigated for this eect) de-
tration.
creases the antibody response to antirabies human di-
Human diploid cell vaccine, rabies vaccine adsorbed or
ploid cell vaccine given concomitantly.
puried chick embryo cell vaccine should be given
Pre-exposure booster doses of vaccine must be given to
intramuscularly into the deltoid muscle1.0 ml im-
laboratory research workers working with rabies virus or
mediately and on days 3, 7, 14 and 28.
those in vaccine production units. Rabies antibody
should be measured every 6 months and a booster dose
given according to the neutralisation antibody titre.
YELLOW FEVER
Introduction and Denitions America (apart from the rare imported case, e.g. Germany
in 1999). Urban yellow fever is an epidemic viral infection
Yellow fever is a disease of antiquity which originated of humans transmitted by the Aedes aegypti mosquito in
most probably in equatorial Africa and was brought by the Americas and Africa from infected to susceptible per-
the slave trade to the great cities of the New World late in sons. Although Ae. aegypti is the important vector in
the seventeenth century (New York in 1668, Boston in Africa, several other species of mosquito are involved.
1691), although it did not reach Europe until the eight- Jungle yellow fever is an enzootic viral disease transmit-
eenth century, with extensive epidemics associated with a ted among nonhuman primates (and occasionally hu-
high mortality of more than 60%. Urban and jungle mans, e.g. forest workers) by various mosquito vectors.
yellow fever now occur only in parts of Africa and South Yellow fever virus (YFV) is a member of the family
VIRUS INFECTIONS 65
fever. Jungle yellow fever is maintained among canopy-
dwelling monkeys and tree-hole breeding mosquitoes
(Aedes species in Africa and Haemagogus species in South
America). The monkey is a transient host because of the
short period of viraemia, and the major amplication
host is the mosquito, which is infected for life and which is
also able to pass the infection transovarially. Human
disease occurs sporadically or in small outbreaks and
initially only in persons exposed to forest mosquitoes (the
enzootic forest cycle).
The jungle yellow fever cycle now represents the most
important epidemiological form of yellow fever in rela-
Figure 6.5 Geographical distribution of Yellow fever virus tion to human infection. Outbreaks are frequent when
forest mosquitoes invade adjacent plantations, forest
clearings and villages on the fringes of rain forests and
Flaviviridae, genus Flavivirus, classied in the past in the riverine gallery forests. Human-to-human transmission
togaviruses. The other two genera in this family are Hepa- by the highly ecient urban Ae. aegypti mosquitoes sus-
civirus and Pestivirus, which include important animal tains the epidemics. The expansion of Ae. aegypti habitat,
pathogens such as Bovine diarrhoea virus and Hog cholera particularly in the Americas, raises the possibility of ma-
virus. The medically important aviviruses are often asso- jor epidemics, similar to those described in tropical Afri-
ciated with three major clinical syndromes: haemorrhagic ca. Note that species other than Ae. aegypti may be
fever with hepatitis (Yellow fever virus); encephalitis (St involved, e.g. Ae. simpsoni, Ae. africanus and others.
Louis encephalitis, Japanese encephalitis, Powassan and The urban yellow fever cycle is generally maintained by
Tick-borne encephalitis viruses); febrile illness with rash Ae. aegypti and reinfestations in towns and villages in
(Dengue virus); and haemorrhagic fever (Kyasanur Forest South America raise concerns about a resurgence of ur-
disease virus and sometimes Dengue virus). ban yellow fever, as is the case in towns and rural villages
in tropical Africa.
The incubation period of yellow fever is usually 36
Nature of the Infectious Agent days but may be longer. Death occurs 710 days after the
onset of illness, with a fatality rate in indigenous popula-
Yellow fever virus is the type species of the genus tions in endemic areas generally 5% (but may be con-
Flavivirus. The virus particles are spherical and enveloped siderably higher) and 50% or more in nonindigenous
with a diameter of 4050 nm. The nucleic acid consists of nonimmunised adults.
a single molecule of positive-sense single-stranded RNA.
The virus replicates in the cytoplasm of the cell in associ-
ation with the rough and smooth endoplasmic reticulum. Reservoir of Infection
Viral particles accumulate within lamellae and vesicles
and replication is associated with the proliferation of The reservoirs of infection in forests are vertebrates,
intracellular membranes. The high lipid content of the mainly monkeys and possibly marsupials and forest mos-
viral envelope is derived from the host cell membrane. quitoes. Transovarian transmission in mosquitoes may
contribute to the maintenance of infection. In urban
areas, humans and Ae. aegypti mosquitoes are the reser-
Epidemiology and Geographical Distribution voirs.
DENGUE FEVER
reactivities and strain variation. After infection, protec-
Introduction and Denitions
tive immunity is homotypic so that individuals can be
infected simultaneously or serially by more than one
Dengue virus is at present the most important arboviral
serotype.
cause of illness and death in humans. The four serotypes
of Dengue virus, a subgroup of the genus Flavivirus, are
distributed widely throughout the tropics and warm cli-
mate regions of Africa, Asia, Australia, the Pacic Islands, Epidemiology and Geographical Distribution
India, the Caribbean Islands, and the Americas, involving
several million people each year. The incidence of the Reference has been made to the extensive geographical
disease corresponds to the distribution of the principal distribution of dengue throughout the tropics and warm
vector, the Ae. aegypti mosquito, which maintains the climate regions of Africa, Asia, Australia, Oceania, India,
virus in a humanmosquitohuman cycle. The incidence the Caribbean Islands and the Americas. Extension to
of dengue is increasing, with more frequent epidemics and new areas is the result of uncontrolled poor housing
greater severity, and spread to new areas. settlements, slums and squatter camps on the peripheries
of cities, resurgence of infestation with Aedes mosquitoes
and failure of vector control.
Nature of the Infectious Agent The principal vector is Ae. aegypti. Other Aedes species
of the subgenus Stegomyia are also implicated as vectors
Dengue virus is a distinct antigenic subgroup of the genus in Asia and in the Pacic region. Although there are many
Flavivirus. There are four serotypes with extensive cross- similarities with the epidemiology of yellow fever, the
68 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
urban cycle involving domesticated Aedes mosquitoes is larly serotype 2; however, there is no consistent relation-
the most common and most important for both endemic ship between strain variation and increased virulence or
and epidemic dengue. The incubation period is 314 days. infectivity.
Humans together with the mosquito. Dengue fever is characterised by sudden fever, headache,
vomiting and severe muscle and bone pain of increasing
severity. The fever is biphasic, remitting on day 35 of the
Pathology illness, followed by a maculopapular or morbilliform
rash, which spreads from the trunk to the limbs and face.
All four dengue virus serotypes cause three distinct syn- This second phase of the illness, which is often accom-
dromes: dengue fever, dengue haemorrhagic fever and panied by recurrence of fever, is associated with lym-
dengue shock syndrome. The virus replicates in macro- phadenopathy, granulocytopenia and thrombocyto-
phages at the site of the mosquito bite, in the regional penia. Minor mucocutaneous bleeding may occur. The
lymph nodes and subsequently the reticuloendothelial fever lasts for 39 days and is self-limiting.
system. Viraemia is associated with circulating mono- The clinical features of dengue haemorrhagic fever are
cytes, and there is often severe leucopenia. A maculo- characterised by fever, rash and anorexia lasting 35
papular rash on the trunk appears on day 35 of the days, followed by hepatomegaly, hypotension and a
illness and spreads to the face and limbs, accompanied haemorrhagic diathesis. The dengue shock syndrome is
frequently by lymphadenopathy, granulocytopenia and due to decreased plasma volume following increased vas-
thrombocytopenia. Minor mucocutaneous bleeding may cular permeability, and is associated with a signicant
occur. mortality of up to 10%, but which can be as high as
Dengue haemorrhagic fever is the result of increased 4050% if untreated. Diagnosis in returning travellers
vascular permeability, unusual bleeding manifestations may be dicult. Serological diagnosis is based on haema-
and involvement of the gut and the liver, with or without gglutination-inhibition and IgM antibody-capture
encephalopathy, and disseminated intravascular coagu- ELISA. Denitive diagnosis is by way of virus isolation
lation. In dengue shock syndrome, increased vascular and PCR-based techniques.
permeability causes decreased plasma volume and clini- Treatment is symptomatic and, in case of complica-
cal shock, which, if uncorrected, may lead to acidosis, tions, careful management of clinical shock.
hyperkalaemia and death. Most cases of dengue haemor-
rhagic fever and dengue shock syndrome occur in
children and adolescents under the age of 15 years, with a Protective Measures and Prevention
fatality rate of 310%.
Dengue haemorrhagic fever and dengue shock syn- Live attenuated dengue vaccines are undergoing clinical
drome are believed to be the result of immune enhance- trials. There is no licensed dengue vaccine.
ment, whereby homologous and heterologous antibodies Epidemiological monitoring is important and also pro-
binding to the virus, including subprotective levels of vides means of education and control. Vector control is
maternal dengue antibodies in infants, enhance infection essential, with the aim of eliminating the domesticated
of macrophages via cellular Fc receptors. Another poss- Aedes mosquitoes. It appears that the results of insecti-
ible explanation is that T cells exacerbate the antibody- cide and larvicide treatment of stagnant water are tem-
enhanced cascade by concomitant release of cytokines by porary, and indeed reinfestations are inevitable. Never-
both T cells and damaged macrophages. The alternative theless, these are essential tools for control. The traveller
hypothesis is that the severe complications of dengue are should employ the usual measures for the prevention of
caused by unusually virulent strains of dengue, particu- insect bites.
The target cells for JEV are T cells and peripheral blood
mononuclear cells. Strains of virus which invade the cen-
tral nervous system cause oedema and small haemor-
rhages in the brain, and lesions include destruction of
cerebellar Purkinje cells, neuronal degeneration and nec-
rosis, glial nodules and perivascular inammation. Path-
ological lesions in other tissues include hyperplasia of
germinal centres of lymph nodes, changes in the spleen,
interstitial myocarditis and focal haemorrhages in the
kidney. The severity of the lesions varies considerably.
TICK-BORNE ENCEPHALITIS
Figure 6.9 Geographical distribution of Central European en- Figure 6.10 Geographical distribution of Russian SpringSum-
cephalitis virus. Reproduced from Zuckerman et al., 2000 mer encephalitis virus. Reproduced from Zuckerman et al., 2000
such as sheep, goats and cows, excrete virus in their milk, illness may follow after a short remission, with fever and
and ingestion of unpasteurised milk or unpasteurised signs of meningoencephalitis. Extrapyramidal and cere-
milk products may transmit the infection. bellar syndromes may persist for months, and residual
The infection is endemic, with increased incidence in paralysis involving the upper limbs and the shoulder
the summer months in relation to temperature and hu- girdle is common. Mortality in dierent outbreaks varies
midity which aect tick activity. The infection is common from 1 to 5%.
in rural populations, especially in farmers and forest Serological diagnosis is based on an IgM antibody-
workers, with seroprevalence of 520% or even greater. capture ELISA on serum or cerebrospinal uid. Haem-
The incubation period is 814 days. agglutination-inhibition or neutralisation tests are useful.
Virus can be isolated early after the onset of symptoms.
Pathology
Prevention and Protective Measures
The virus replicates in the liver before a signicant vir-
aemia occurs. Vascular permeability is altered and the Forests in some areas of the former Soviet Union are
virus crosses the bloodbrain barrier. Severe neuronal closed to visitors.
damage may occur, aecting the cervical segments of the Tick repellents are useful on outer clothes and socks,
spinal cord, medulla, midbrain and pons. There is glial and the arms, legs and ankles must be covered. Travellers
proliferation and lymphoid proliferation around vessels. who plan to walk, camp or work in late spring and
summer in the heavily forested areas listed above, es-
pecially where there is heavy undergrowth, should be
Clinical Features and Diagnosis immunised with a formalin-inactivated vaccine. Two
doses of 0.5 ml given intramuscularly 412 weeks apart
The onset of illness is sudden with a nonspecic febrile will provide protection for 1 year. An immunoglobulin
illness including headache and lassitude. Visual disturb- preparation is also available for postexposure prophylax-
ances may occur such as blurring of vision and diplopia. is.
In the majority the illness lasts 47 days. A biphasic
Yellow fever, which is endemic in Africa and in parts of haemorrhagic fever it is considered separately. The term
the Americas, has a long history and is well recognised, exotic viruses is applied to haemorrhagic viral infections
and although it may present in severe infections as a which have been recognised more recently, Marburg vi-
72 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Figure 6.11 Ebola virus (Zaire strain). This electron micrograph illustrates a single viral particle with many branches and a torus
conguration. Negative stain, ; 100 000. (Courtesy of Dr David Ellis, reproduced from Principles and Practice of Clinical Virology, 1st
edition, 1987)
rus disease (1967), Lassa fever (1969) and Ebola fever slavia were traced to direct contact with blood, organs or
(1976). Two other haemorrhagic fevers are discussed in tissue cell cultures from a batch of African green monkeys
this section, Rift Valley fever and CrimeanCongo haem- (Cercopithicus aethiops) that had been trapped in
orrhagic fever; the former because of extensive outbreaks Uganda. Several secondary cases occurred in hospital
in parts of Africa, including the Nile delta, and the latter personnel by contact with the blood of patients. One
because of its sporadic appearance in the Middle East further case was apparently transmitted by sexual inter-
and Pakistan. course 83 days after the initial illness, and virus was
isolated from the semen. The case fatality rate was 29%
for the primary cases, but no deaths occurred in the six
Natural Reservoir and Source secondary cases. This previously unrecognised disease
was caused by an infectious agent probably new to medi-
Those for Marburg virus and Ebola virus remain un- cal science. Three more cases were reported in Johannes-
known. Lassa virus and other arenaviruses are normally burg in 1975, in two young Australians who crossed
transmitted to humans from infected rodents in Africa central Africa, and a nurse treating them. One of the
and South America. Rift Valley fever virus is transmitted primary cases died. There have been two other detected
by mosquitoes. CrimeanCongo haemorrhagic fever vi- recurrences of Marburg virus disease in 1980 and in 1987,
ruses, common in Africa, Western Asia and parts of the all in travellers in rural Africa, and none has led to exten-
Middle East and in Russia and Republics in the former sive transmission.
Soviet Union, are transmitted by tick-bite; human-to-
human transmission has only been shown to result from
contact with infected blood. Nature of the Infectious Agent
Figure 6.12 (a) Surface spikes on Marburg virus. Negative stain, ; 200 000. (b) A torus form of Marburg virus showing the RNA core.
Negative stain, ; 200 000. (c) A lamentous form of Marburg virus curling up into a torus. The nal infective particle is believed to be
the torus form. ; 200 000. (Courtesy of Dr David Ellis, reproduced from Principles and Practice of Clinical Virology, 1st edition, 1987)
and have a diameter of 85 nm. Spikes are present on the primary infection appears to be limited to Central Africa.
surface (Figure 6.12a) and there is an axial channel within The incubation period is 416 days. Transmission is by
the ribonucleoprotein (Figure 6.12c). The genome con- contact with infected blood or tissue and transmission by
sists of a single negative-stranded RNA. Molecular analy- the sexual route has been described.
sis of the genome indicates that the loviruses are the
closest relatives to rhabdoviruses and paramyxoviruses.
Reservoir of the Infection
Figure 6.14 (a) Rift Valley Fever virus maturing within host cell vacuoles. ; 37 500. (b) Negatively stained Rift Valley Fever virus
particles from a patients serum during the 1977 outbreak in Egypt. ; 225 000. (Courtesy of Dr David Ellis, reproduced from Principles
and Practice of Clinical Virology, 1st edition, 1987).
HAEMORRHAGIC FEVERS OF SOUTH breaks of severe illness in between 100 and 3500 cases in
AMERICA agricultural workers in the wet pampas, with mortality
ranging from 315% or more. Outbreaks coincide with
These are described briey as they do not generally pres- the maize harvest between April and July, when the ro-
ent a hazard to travellers. dent populations reach a peak.
Argentinian haemorrhagic fever is caused by Junin Bolivian haemorrhagic fever is caused by Machupo
virus, rst isolated in 1958. The virus causes annual out- virus, with localised epidemics, which have waned con-
78 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
siderably since the 1970s; human infections are now rare. It seems probable that animals such as domestic goats
Control of Machupo-infected rodents in households, re- and cattle, together with their ticks, may be a reservoir,
ducing the opportunity for human contact with con- particularly in the Middle East, and that humans are
taminated food and soil, accounts for the reduction of infected by contact with these ticks. Infections have also
reported human infections. been acquired by sta from contact with the blood of
patients in hospitals in Pakistan, Baghdad and Dubai,
and there is evidence that infection acquired in this way
may carry higher mortality, increasing from 20 to 70%.
RIFT VALLEY FEVER The incubation period is about 7 days, followed by a
sudden fever, with nausea and vomiting. Like the other
Rift Valley fever virus is a member of the family haemorrhagic viruses described above, it can cause very
Bunyaviridae, genus Phlebovirus, and causes an enzootic extensive bleeding around the mouth, teeth and nose and
infection of sheep, cattle, camels and goats in Africa and
may sometimes mimic an acute surgical emergency.
Madagascar. The virus (Figure 6.14) is transmitted by These, and other severe haemorrhages that can occur into
mosquitoes and the disease is characterised by necrotic the skin of the upper parts of the body, appear during the
hepatitis and a haemorrhagic state, although infections
following week, when the patient suers from throm-
are frequently inapparent or mild. Humans become infec- bocytopenia, a reduced white cell count and widespread
ted from contact with blood and tissues of domestic live- impairment of liver function, without evidence of any
stock or mosquito bite, and the infection is a mild to
cellular inammation. There may also be neurological
severe febrile illness with encephalitis, involvement of the complications. Diagnosis may be conrmed by uor-
eye, and/or haemorrhagic fever in about 1% of cases. escence antibody techniques and by direct examination
Human cases are usually restricted to veterinary sur-
electron microscopy of serum or by infection of suckling
geons, butchers and others in close contact with the blood mice or BHK cells. Specic treatment is not yet available.
of domestic livestock, and there is a potential risk with
ritual slaughter. Dugbe, Ganjam, Hazara and Nairobi sheep disease viruses,
Specic tests are undertaken in maximum security lab- the other members of the genus Nairovirus, have all been
oratories and include serology, virus isolation and inocu- reported as having caused human infections, although
lation of susceptible mice. There is no specic treatment none has proved fatal. There is some evidence of cross-
and management is symptomatic. protection among the group.
Prevention and control is based on avoiding contact
between a susceptible human or animal and the source of
virus, either the infected arthropod or vertebrate. A hu- REFERENCES
man formalin-inactivated Rift Valley fever vaccine has
been produced in primary green monkey cells and diploid Advisory Committee on Immunization Practices (ACIP) (1999a)
fetal rhesus lung cells for use by veterinary ocers, lab- Rotavirus vacine for the prevention of rotavirus gastroenteri-
oratory workers, military personnel and others at risk. tis among children. Morbidity and Mortality Weekly Report,
When given in three doses it was immunogenic in over 48, RR-2, 123.
95% of recipients, and Rift Valley fever infection has not Advisory Committee on Immunization Practices (ACIP) (1999b)
been reported in vaccinated persons. Human rabies prevention: United States 1999. Morbidity and
Inactivated tissue culture veterinary vaccines are avail- Mortality Weekly Report, 48, RR-2, 123.
Compendium of Animal Rabies Control (1999) Morbidity and
able for immunization of sheep and cattle. A live at- Mortality Weekly Epidemiological Report, 48, RR-3, 19.
tenuated veterinary vaccine has been developed but it is
not recommended for use in unaected enzootic zones.
FURTHER READING
Hepatitis A
CRIMEANCONGO HAEMORRHAGIC
FEVER Catton MG and Locarnini SA (1998) Epidemiology of hepatitis
A. In Viral Hepatitis (eds AJ Zuckerman and HC Thomas),
A tick-borne haemorrhagic disease was described at the 2nd edn, pp 2941. Churchill Livingstone, London.
end of World War II in southern Russian and became Ko RS (1998) Hepatitis A. Lancet, 351, 16431649.
known as Crimean haemorrhagic fever. Similar diseases Lemon SM and Thomas DL (1997) Vaccines to prevent viral
were subsequently found in Africa, Pakistan and in the hepatitis. New England Journal of Medicine, 336, 196204.
Middle East. Steen R and Gyurech D (1994) Advances in hepatitis A preven-
CrimeanCongo haemorrhagic fever virus is a member tion in Travellers. Journal of Medical Virology, 44, 460462.
of the family Bunyaviridae, genus Nairovirus; like Rift
Valley fever virus, it is a single-stranded RNA enveloped Hepatitis B
particle, with an overall diameter of 115125 nm, which
includes a covering of prominent hollow surface spikes Chang M-H, Chen C-J, Lai M-S et al. (1997) Universal hepatitis
that pass out through the viral membrane. B vaccination in Taiwan and the incidence of hepatocellular
VIRUS INFECTIONS 79
carcinoma in children. New England Journal of Medicine, 336, Con JM (1996) HIV population dynamics in vivo: implications
18551859. for genetic variation, pathogenesis and therapy. Science, 271,
Harrison TJ, Dusheiko GM and Zuckerman AJ (2000) Hepatitis 15821586.
Viruses. In Principles and Practice of Clinical Virology (eds AJ Starkie J and Dale R (1988) Understanding AIDS. Consumers
Zuckerman, J Banatvala and JR Pattison, 4th edn, pp. Association and Hodder and Stoughton, London.
187223. Wiley, Chichester. Weiss RA, Dalgleish AG and Loveday C (2000) Human retro-
Van Damme P, Kane M and Mehens A (1997) Integration of viruses. In Principles and Practice of Clinical Virology (eds AJ
hepatitis B vaccination into national immunisation pro- Zuckerman, JE Banatvala and JR Pattison), 4th edn, pp
grammes. BMJ, 314, 10331036. 659693. Wiley, Chichester.
Wright TL and Lau JYN (1993) Clinical aspects of hepatitis B UNAIDS and WHO (1988) Report on the Global HIV/AIDS
virus infection. Lancet, 342, 13401344. Epidemic. UNAIDS and WHO, Geneva.
Zuckerman JN (1996) Nonresponse to hepatitis B vaccines and
the kinetics of anti-HBs production. Journal of Medical Virol-
ogy, 50, 283288. Viral Gastroenteritis
Zuckerman AJ and Zuckerman JN (1999). Molecular epidemiol-
ogy of hepatitis B virus mutants. Journal of Medical Virology, Cook SM, Glass RI, LeBaron CW et al. (1990) Global seasonal-
58, 193195. ity ofrotavirus infections. Bulletin of the World Health Organ-
ization, 68, 171177.
Desselberger U (1998) Viral gastroenteritis. Current Opinion in
Hepatitis C Infectious Diseases, 11, 565575.
Desselberger U (2000) Viruses associated with acute diarrhoeal
Alter MJ (1997) The epidemiology of acute and chronic hepatitis disease. In Principles and Practice of Clinical Virology (eds AJ
C. Clinics in Liver Disease, 1, 559568. Zuckerman, JE Banatvala and JR Pattison), 4th edn, pp
Houghton M (1966) Hepatitis C virus. In Fields Virology (eds 235252. Wiley, Chichester.
BN Fields, DM Knipe and PM Howley), 3rd edn, pp Vipond IB, Caul EO, Lambden PR et al. (1999) Hyperemesis
10351058. Lippincott-Raven, Philadelphia. hiemis: new light on an old syndrome. Microbiology Today,
National Institutes of Health Consensus Development Confer- 26, 110112.
ence (1997) Management of hepatitis C. Hepatology, 26 (suppl.
1), 1155.
Recommendations for Prevention and Control of Hepatitis C Polyomyelitis and other Enterovirus Infections
Virus (HCV) Infection and HCV-Related Chronic Disease
(1998) Morbidity and Mortality Weekly Report (suppl.), 47, Minor PD, Morgan-Capner M and Muir P (2000) En-
139. teroviruses. In Principles and Practice of Clinical Virology, (eds
AJ Zuckerman, JE Banatvala and JR Pattison), 4th edn, pp
427449. Wiley, Chichester.
Hepatitis D Salisbury DM and Begg NT (eds) (1996) Poliomyelitis. In Im-
munisation against Infectious Disease, pp 173182. Stationery
Oce, London.
Di Bisceglie AM (1998) Hepatitis D virus. Epidemiology and
diagnosis. In Viral Hepatitis (eds AJ Zuckerman and HC
Thomas), 2nd edn, pp 371378. Churchill Livingstone, Lon-
don. Inuenza
Hadziyannis SJ (1999) Hepatitis D. Clinics in Liver Disease, 3,
309325. Centers for Disease Control (1997) Update: inuenza activity
United States, 19971998 season. Morbidity and Mortality
Weekly Report, 46, 10941098.
Centers for Disease Control (1998) Update: outbreak of inu-
Hepatitis E enza A infectionAlaska and the Yukon Territory, JulyAu-
gust 1998. Morbidity and Mortality Weekly Report, 47,
Bradley DW (1992) Hepatitis E: epidemiology, aetiology and 685688.
molecular biology. Reviews in Medical Virology, 2, 1928. Centers for Disease Control (1998) Prevention and control in
Jameel S, Durgapal H, Habibullah CM et al. (1992) Enteric inuenza: recommendations of the Advisory Committee on
non-A, non-B hepatitis: epidemics, animal transmission and Immunisation Practices (ACIP). Morbidity and Mortality
hepatitis E detection by the polymerase chain reaction. Jour- Weekly Report, no. RR-6.
nal of Medical Virology, 37, 263270. Cox NJ and Subbarao K (1999) Inuenza. Lancet, 354,
Mushahwar IK and Dawson GJ (1997) Hepatitis E virus: epi- 12771282.
demiology, molecular biology and diagnosis. In The Molecu-
lar Medicine of Viral Hepatitis (eds TJ Harrison and AJ
Zuckerman), pp 3343. Wiley, Chichester. Genital Herpes
?Values in parentheses are the number of cases currently identied in average years in England and Wales.
L. pneumophila is a Gram-negative, strictly aerobic bacil- In most cases of Legionnaires disease pathological
lus that stains poorly or not at all with standard methods changes are conned to the lung and consist of an acute
and will not grow on usual bacteriological media. These inammatory exudate into the alveoli. In severe cases
unusual features explain why it remained unrecognised as inammation is generalised and both lungs are involved,
a human pathogen until the exceptionally thorough in- but more often part of a single lobe bears the brunt.
vestigation of an outbreak of pneumonia in Philadelphia Panlobar pneumonia is unusual. Organisms are usually
in 1976. found within macrophages in the alveoli but not the
bronchi. In severe cases there may be generalised pul-
monary oedema and the systemic changes of septic shock.
Epidemiology
The illness begins insidiously, after an incubation period Nature of the Infectious Agent
of between 1 and 3 weeks, with malaise, fever and head-
ache. In most cases the fever gradually increases through Rickettsiae are small pleomorphic bacteria that are obli-
the rst week and the patient is rarely afebrile. Children, gate intracellular parasites and therefore do not grow on
however, often have a swinging fever. At the end of the standard bacteriological media. Their inability to survive
rst week bloodborne spread of the organism may lead to outside the cytoplasm of their host cell results from their
focal symptoms such as cough (and chest X-ray may show dependence on the host for ATP. Outside the host cell
areas of consolidation), meningism (occasionally with they rapidly lose energy and, as a result, their infectivity.
BACTERIAL INFECTIONS IN TRAVELLERS 85
Table 7.3 Rickettsial infection in travellers
Vector
(from
Disease Geographic rodent
(symptoms) Organism distribution reservoir) Clinical
The rickettsiae that cause disease in travellers are Scrub and Tick Typhus
zoonoses in the ecology of which humans play an acci-
dental and incidental role, unlike louse-borne typhus,
which causes epidemics when people crowd together in
refugee camps. Infections in travellers are sporadic and Case History 3
are largely conned to those who wander in woods in A 24-year-old female backpacker presented on her
North America, bush in Africa and scrub in Southeast return from a 4 week visit to Thailand with a
Asia. (In Central and North America domestic dogs may u-like illness associated with macular rash. On
act as a reservoir for Rocky Mountain spotted fever examination, there was an eschar on her upper
(RMSF) rickettsiae so that, in theory, dog ticks could bite arm, with regional lymphadenopathy. She was
people in their homes and thus transmit infection in- treated with oral doxycycline and made a good
doors.) recovery. The diagnosis of scrub typhus was subse-
Tick typhus is regularly seen by practitioners working quently conrmed serologically.
in southern Africa in people who walk in game reserves
and similar terrain, and is likely to be seen increasingly in Headache, myalgia and feverishnessa nondescript u-
tourists attracted by easier travel between the Republic of like illnessare the rst, and often the only, symptoms of
South Africa and Zimbabwe. Scrub typhus is found in tick and scrub typhus and typically start quite abruptly
pockets through much of Southeast Asia and causes spor- between 5 and 7 days after the arthropod bite. Examin-
adic illness in the native population engaged in slash-and- ation will reveal an eschar at the site of a tick bite in most
burn subsistence farming. It is comparatively common in cases. This typically has a black necrotic centre, resemb-
the Sylhet region of Bangladesh, the origin of Britains ling a black scab, up to 1 cm in diameter surrounded by
earliest Indian restauranteurs. On returning to their eth- an area of acute inammation about 3 cm across. It is
nic homeland, they may help their relatives and become often dismissed as a secondarily infected insect bite. A
infected in the process. dull maculopapular rash, usually involving palms and
soles, appears about 5 days after the onset of illness.
Cough with radiographic evidence of a patchy pneumoni-
tis is common in scrub typhus. Untreated, symptoms
usually settle spontaneously after about 10 days, but with
Pathology appropriate treatment recovery is usually apparent after
2 days.
The intracellular multiplication of rickettsiae gives rise to
a diuse lymphocytic vasculitis with endothelial damage.
Increased permeability and foci of haemorrhage are the
result. Platelet aggregation at sites of vascular injury Rocky Mountain Spotted Fever
commonly gives rise to thrombocytopenia, but full-scale
disseminated intravascular coagulation is rare in the The illness ranges from a mild u-like illness to the
nonepidemic typhus fevers. picture of overwhelming sepsis with multiorgan failure
86 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
and a generalised maculopapular rash, which typically from inapparent to a life-threatening illness with multi-
appears on the third day. Purpura are common and the system involvement. Infection is usually acquired as a
picture then resembles meningococcaemia, except that in result of exposure to fresh water contaminated with the
the latter condition the purpuric rash typically appears urine of domestic or wild animals.
within hours of the onset of symptoms and a
maculopapular element is absent. The incubation period
ranges from 2 to 10 days but as the ticks responsible for Epidemiology
transmission are tiny, and their bites are seldom noticed,
this is usually of little help in establishing the diagnosis in A zoonosis with a worldwide distribution, the polar re-
endemic areas. Outside these, the fact of having walked or gions excepted. Infected reservoir animals excrete
camped in rural North America, especially in the spirochaetes in their urine and humans are infected either
Carolinas, Virginia, Maryland, Georgia, Tennessee and by direct exposure (chiey in farm workers, for example in
Oklahoma between June and September, is enough to milking parlours in the case of serovar Hardjo) or via
justify empirical treatment in an individual who is ill with contact with contaminated water during activities such as
compatible symptoms (reviewed in Silber, 1996). wading through streams or in paddy elds or while wash-
ing, etc. The contact may not, however, have been obvi-
ous to the subject (see case history 4). The incubation
Diagnosis period is about 10 days, with a range of between 4 and 19
days.
Empirical therapy of patients ill with suspected rickett-
sioses is vital because there is no reliable early diagnostic
test (reviewed in La Scola and Raoult, 1997). In practice, Reservoir of Infection
patients with u-like symptoms, a normal white cell
count and thrombocytopenia in some cases, are likely to Serovars pathogenic to humans are harboured by domes-
receive antimalarials if they have travelled in a malarious tic animals, including dogs, and livestock including cattle,
area, but such patients should always be inspected care- pigs and horses. A variety of wild animals may harbour
fully for an eschar and, if a compatible lesion is seen, they pathogenic serovars but rats are the most important
should also be treated for possible typhus. The diagnosis natural reservoir.
can be conrmed later by a rise in antibody titre.
Pathology
Treatment
In severe cases with multisystem involvement (Weils dis-
Tetracyclines have been used most extensively in rickett- ease) there is extensive vasculitis with focal haemorrhage
sial infection and remain the treatment of choice. in many organs. The kidneys are swollen, with evidence of
Doxycycline 100 mg daily is eective in tick and scrub interstitial ephritis, and there may be necrosis of proximal
typhus, whereas double this dose is advised in Rocky tubular epithelium. Spirochaetes have been seen between
Mountain spotted fever. As with most infections, there is the necrotic cells. Meningeal involvement suggests viral
no good evidence on optimal duration of treatment: con- meningitis, in that lymphocytes usually predominate, but
tinuing for 2 days after defervescence is conventional. a polymorphonuclear leucocytosis is usual in the blood.
Multisystem infection may be immunologically mediated.
Prevention
Clinical Features
When walking in endemic areas, travellers should try to
minimise pushing through dense vegetation and stay in
Most infections are subclinical but clinical illness usually
relatively open areas as far as possible. Inspecting the
consists of a u-like illness with headache and muscle
body for ticks every few hours, and removing them by
pain. This may progress seamlessly to a multisystem dis-
steady traction, will help to protect travellers but the best,
ease (see case history 4) or the patient may recover before
ultimate protection is the preparedness of physicians to
apparently relapsing with recurrence of fever, and in some
administer tetracyclines promptly on the rst reasonable
cases aseptic meningitis, hepatitis, renal failure and a
suspicion of rickettsial infection.
haemorrhagic rash.
Treatment
Nature of the Infectious Agent
Best results have been obtained with doxycycline 100 mg
The genus Brucella includes three species pathogenic to twice daily with rifampicin 15 mg kg\, both for 45 days.
man: B. melitensis (enzootic in sheep and goats), B. abor- This length of treatment is necessary to prevent relapse
88 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
because of the intracellular persistence and low growth cally reveals a grey membrane adherent to the tonsils.
rate of brucellae. Within a few days there may be swelling of the neck and
evidence of myocarditis or peripheral neuropathy.
DIPHTHERIA
Diagnosis
Denition
The diagnosis is usually a presumptive one, based on the
An acute infection of tonsils and pharynx, less often of
clinical features. The organism can occasionally be identi-
larynx or nose, or of skin. In individuals immunised
ed on throat swab or smears of the membrane, but
against the exotoxin produced by Corynebacterium diph-
denitive identication is based on culture of C. diph-
theriae, infection may still occur but gives rise to no more
theriae from such samples. Selective media are required
than moderate inammation of the infected site. In the
for optimal growth, and thus the laboratory must be
unimmunised, the production of toxin leads to the char-
alerted if there is clinical suspicion of diphtheria.
acteristic leathery pharyngeal exudate, swelling of the
neck, cranial and peripheral demyelinating neuropathy
and myocarditis. In toxaemic cases, early administration
of antitoxin is vital. Treatment
For distribution, see Denition. Louse-borne strains of B. A single dose of a tetracycline or erythromycin is usually
recurrentis are spread by lice from person to person, but, curative. Antibiotic treatment typically triggers a Jar-
as human carriage has not been documented, it is possible ishHerxheimer reaction, with pyrexia, hypotension and
that in some cases epidemics may originate from endemic leucopenia. This is thought to represent an extreme form
tick-borne disease in circumstances in which lice are of the febrile response associated with clearance of organ-
prevalent, i.e. where populations are displaced and isms from the blood stream in the untreated host, and is
crowded as a result of war or national disaster. Endemic not prevented by prior administration of steroids.
cases are zoonoses with a reservoir in small rodents and
other mammals. The vectors are soft ticks of the genus
Ornithodoros, which also act as a reservoir because Bor- Prevention
relia are passed transovarially to the next generation.
These ticks abound in dwellings with mud walls and earth Travellers to endemic areas should be warned of the
oors; they feed at night, engorging rapidly before drop- danger of sleeping in mud huts. Those working with
ping o so that the host is usually unaware of having been refugees should ensure that they remain louse-free by
bitten. regular dusting of clothing with insecticides.
REFERENCES
Pathology
Bonnet JM and Begg NT (1999) Control of diphtheria: guidance
Disappearance of spirochaetes from the blood coincides for consultants in communicable disease control. Communi-
cable Disease and Public Health, 2, 242249.
with a rise in temperature and pulse rate, with neu- Dedicoat M and Venkatesan P (1999) The treatment of Legion-
tropenia and thrombocytopenia. This is thought to repre- naires disease. Journal of Antimicrobial Chemotherapy, 43,
sent a JarischHerxheimer reaction triggered by the re- 747752.
lapse of cellular pyrogens. Eventual recovery is usual in Gad El-Rab MO and Kambal AM (1998) Evaluation of a
endemic disease but widespread haemorrhage in the skin Brucella enzyme immunoassay (ELISA) in comparison with
and viscera is seen in fatal cases of the epidemic form. bacteriological culture and agglutination. Journal of Infection,
36, 197201.
Gedikoglu S, Helvaci S, Ozakin C et al. (1996) Detection of
Brucella melitensis by BACTEC NR730 and BACTEC 9120
systems. European Journal of Epidemiology, 12, 649650.
Clinical Features Joseph CA, Harrison TG, Ilijic-Car D et al. (1999) Legionnaires
disease in residents of England and Wales: 1998. Communi-
After a mean incubation period of 7 days, the onset of cable Disease Public Health, 2, 280284.
spirochetaemia coincides with fever, rigors, headache and La Scola B and Raoult D (1997) Laboratory diagnosis of rickett-
muscle pains. The subsequent relapsing pattern of disease sioses: current approaches to diagnosis of old and new rickett-
is very characteristic (see Denition). Neutropenia and sial diseases. Journal of Clinical Microbiology, 35, 27152727.
thrombycotopenia are usual and there may be slight elev- Ploue JF, File TM, Breiman RF et al. (1995) Reevaluation of
ation of liver enzymes. The diagnosis is established by the denition of Legionnaires disease: use of the urinary anti-
gen assay. Clinical Infectious Diseases, 20, 12861291.
seeing extracellular spirochaetes in Giemsa- or Wright- Silber JL (1996) Rocky Mountain spotted fever. Clinics in Derma-
stained blood smears taken during febrile relapses. tology, 14, 245258.
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
Figure 8.1 Global malaria status. (From WHO, 1998b, by permission of the World Health Organization)
variation, as each of the dierent malaria species infects a 1983), glycophorins (Pasvol et al., 1982) and band 3
dierent subpopulation of red cells. P. vivax can only (Okoye and Bennett, 1985), and is hence able to develop
infect reticulocytes, as attachment to a reticulocyte-speci- very high parasitaemias, with the inevitable serious path-
c receptor and a specic interaction between a ological consequences.
135140 kDa P. vivax protein and the Duy (FyFy) blood The merozoite surface exhibits considerable antigenic
group glycoprotein are also required for cell invasion to variation, and contains several proteins that have a role
occur (Wertheimer and Barnwell, 1989). P. ovale also in erythrocyte attachment and invasion. Five merozoite
exhibits a reticulocyte preference. As this subpopulation surface proteins (MSP-15) have been found on the sur-
only accounts for approximately 1% of the total red cell face of P. falciparum, all of which cooperate in erythrocyte
number, P. vivax and P. ovale parasitaemias are limited to invasion. MSP-1 varies in antigenicity among parasites;
approximately 1%. P. malariae is only capable of infect- only the C-terminal 19 kDa fragment, which is carried
ing senescent red cells and this also limits the maximum with the merozoite during invasion, is relatively conser-
parasitaemia that can be achieved. P. falciparum is able to ved. The rest of MSP-1, which is shed during invasion,
infect red cells of all ages using receptors that vary be- exhibits antigenic variation. Erythrocyte membrane-
tween merozoite isolates, and include sialic acid (Facer, binding protein (EBA-175), another merozoite surface
VECTOR-BORNE PARASITIC DISEASES 93
Sporogony in
mosquito
Fertilisation in mosquito
Sporozoites injected into humans
Merozoites infect
erythrocytes
Erythrocytic
schizogony
Erythrocytic cycle
polypeptide, also plays a role in merozoite attachment to Within the red cells, the parasites dierentiate, passing
glycophorin of human erythrocytes; it, too, varies among through the trophozoite stages, and multiply asexually to
isolates (Sim et al., 1994). Another group of antigens that develop into an erythrocytic schizont (Figure 8.3). Even-
are almost certainly involved in erythrocyte attachment/ tually the schizont ruptures, releasing free merozoites into
invasion are the Pf60 antigens, which are located in the the bloodstream, completing the erythrocytic cycle. It is
rhoptry in the merozoite apex and are deposited on the the release of merozoites that is associated with spikes of
erythrocyte surface during invasion (Carcy et al., 1994). fever. The time that the erythrocytic cycle takes varies
This polypeptide is encoded by the Pf60 multigene family, between species, being fastest for P. falciparum, P. vivax
each haploid genome having about 140 gene copies; there and P. ovale (48 h) and slowest for P. malariae (72 h). At
is evidence that genetic rearrangement or modication rst, the erythrocytic cycle is asynchronous but, with
occurs in the parasite genome (Bonnefoy et al., 1997). prolonged infections, the cycle becomes synchronised,
While the number of these genes that are expressed by a resulting in sudden increases in the numbers of parasites
single merozoite remains unknown, the capacity for anti- present in the blood. Once synchronised schizont rupture
genic variation is obviously vast. is established, peaks of fever occur every 48 h in P. fal-
94 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Table 8.1 Some characteristics of the four species of human Plasmodium (modied from Gilles, 1993)
Merozoite invades
erythrocyte
Merozoite release
Schizont
Ring trophozoite
in erythrocyte
Mature trophozoite
in erythrocyte (now
expressing knobs)
ciparum, P. vivax and P. ovale malaria and every 72 h in enon termed rosetting) and vascular endothelium
P. malariae infection. However, it should be noted that in (cytoadherence). Several parasite-derived polypeptides,
P. falciparum infection in immunologically naive subjects, including PfEMP1, rosettins/rins, sequestrins and
very high parasitaemia will occur before synchronisation modied band 3 are inserted into the erythrocyte mem-
develops and thus this form of malaria rarely exhibits the brane, resulting in considerable loss of deformability of
classical periodic fever (see below). the erythrocyte. PfEMP1 is a 200400 kDa variable
Upon invasion of the erythrocyte, malaria parasites multidomain polypeptide which is encoded by the
extensively remodel the cell, both externally and inter- multiple var gene family (Smith et al., 1995; Su et al.,
nally, making structural modications necessary for their 1995). It is likely that the dierent domains function
survival and proliferation. The most obvious ultrastruc- independently; hence, PfEMP1 would appear to be a
tural alteration to the parasitised erythrocyte (pRBC) highly antigenically variable ligand with multiadhesive
membrane is the appearance of electron-dense protru- properties, allowing binding of pRBCs to a wide range of
sions or knobs (in P. falciparum and P. malariae) about receptors, including intercellular adhesion molecule 1
100 m in diameter (Luse and Miller, 1971). These knobs (ICAM-1), chondroitin sulphate A (CSA) and CD36 on
are thought to consist of several parasite polypeptides, endothelia and heparan sulphate-like glycosaminog-
including P. falciparum erythrocyte membrane protein 1 lycans (HS-like GAGs), complement receptor 1 (CR1,
(PfEMP1), and are the sites where pRBCs bind to other CD35) and CD36 on erythrocytes (Baruch et al., 1996,
cells, particularly erythrocytes (producing the phenom- Barragan et al., 1999). There are several other receptors
VECTOR-BORNE PARASITIC DISEASES 95
Infected Bites
Asymptomatic parasitaemia
Uncomplicated Malaria
Complicated Malaria
Death
for which the PfEMP1 is the likely (but not denite) Epidemiology
parasite ligand, such as blood group antigens A and B on
erythrocytes and thrombospondin and CD31 on en- Malaria was once widespread in the world but the spon-
dothelia. Rosettins or rins are parasite-derived low mol- sored malaria eradication campaign of the 19601970s,
ecular weight polypeptides encoded by the large rif multi- sponsored by the World Health Organization (WHO),
gene family (Fernandez et al., 1999). Their abundance on resulted in its eradication from most parts of central
the pRBC surface suggests that they contribute signi- America. Europe was declared malaria-free in 1976. In
cantly to antigenic variation; other possible roles for these many countries of Asia, malaria became an uncommon
proteins are still being investigated. Special channels or disease but in recent years has begun to return. The risk of
pores are created by the parasite in the erythrocyte mem- malaria is highest in sub-Saharan Africa where there
brane to enable the acquisition of nutrients. remain many areas of intense transmission.
A proportion of the multiplying parasites develop into The term endemic malaria is used to describe an area
the sexual form, the gametocytes. The male and female where there has been a constant incidence both of cases
gametocytes are taken up by mosquitoes, in which fer- and of transmission of malaria over a number of years.
tilisation occurs. The zygote develops into an oocyst, Endemicity is said to have ceased if there has been no
which ruptures to release about 1000 sporozoites into the evidence of transmission in the area over at least 3 years.
mosquito body cavity. These sporozoites migrate to the If the vector is still present in the area, malaria remains
salivary glands, and a further bite allows the life cycle to potentially endemic. The malariogenic potential of the
be completed (Figure 8.2). area then depends on its receptivity (i.e. number of new
cases of malaria that could theoretically originate from
96 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
one single imported case) and vulnerability (i.e. rate of in falciparum diseasethe diagnosis has been missed in
entry of imported cases). Levels of endemicity may be many patients by doctors who have assumed this fever
classied as follows: pattern is essential for the diagnosis of malaria. The cold
stage lasts 1560 min, and is characterised by an inappro-
Holoendemicity. Perennial transmission of high degree.
priate feeling of cold and apprehension. The patient is
Considerable immunity in all age groups, particularly
usually shivering, has a rapid low-volume pulse and ex-
adults.
hibits intense peripheral vasoconstriction despite a high
Hyperendemicity. Intense but seasonal transmission.
core temperature. The hot stage lasts 26 h, during which
Immunity insucient to prevent clinical malaria.
the patient suers unbearable heat, running temperatures
Mesoendemicity. Varying intensity of transmission de-
of 4041 C. Other characteristics include confusion, de-
pending on local circumstances.
lirium, severe headache, nausea, prostration and postural
Hypoendemicity. Little transmission with minimal ef-
syncope. Vomiting and diarrhoea may also feature,
fects on population.
adding confusion to the clinical picture. The patient has a
Not all female mosquitoes carry malaria parasites. The rapid, bounding pulse and dry, ushed, burning skin.
proportion of infected mosquitoes inuences the en- Febrile convulsions are particularly common in children.
demicity of infection. Once sporozoites are injected into a This is followed by defervescence over 24 h, accom-
human host, infection is not inevitable; indeed, only ap- panied by profuse sweating, whereupon the exhausted
proximately half of infective bites will result in infection. patient sleeps. P. vivax, P. ovale and P. malariae infection
Of these, only a proportion will result in clinical disease, may progress but the severity of symptoms is limited by
and an even smaller amount will be serious and result in parasitaemia. In contrast, P. falciparum infection may
death if untreated (Figure 8.4). The risk of malaria is also progress rapidly, and patients may develop the serious
inuenced by other vector factors. Mosquitoes bite be- complications set out below in a matter of hours.
tween dusk and dawn and thus travellers who protect
themselves during this period are at much lower risk of
acquiring infection. Mosquitoes are positively attracted Complications of P. falciparum Malaria
to heat and smells emitted by the human body. Also,
mosquitoes have a limited ight range of approximately The most serious complication of P. falciparum infection
500 metres; hence, siting of housing estates away from is cerebral malaria, which is most common among
breeding areas, the use of larvicides and environmental children aged 34 years. This is caused by massive seques-
control where mosquito breeding habitats are destroyed tration of pRBCs, often accompanied by uninfected red
can do much to reduce the risk of malaria. In endemic cells in the cerebral vasculaturea phenomenon unique
countries most serious disease is found in children under to P. falciparum. This massive sequestration is the result
the age of 5 years. Since recurrent bouts of infection result of upregulation of endothelial cytoadherence receptor
in partial immunity, adults living in endemic areas are expression by a variety of cytokines, including tumour
able to control the degree of parasitaemia and minimise necrosis factor (TNF ) and interferon (IFN) (Jakob-
the pathological consequences. Travellers who travel to sen et al., 1995). These cytokines also upregulate nitric
endemic areas are immunologically naive and are thus at oxide production, which causes local damage at sites of
risk of severe disease. sequestration (Green et al., 1994). In cerebral malaria,
Malaria appears some time after travel to an endemic overproduction of these cytokines and nitric oxide is
area. The incubation period is shortest for P. falciparum stimulated by the glycophosphatidylinositol (GPI) an-
(914 days) and longest for P. malariae (1840 days or chor of several transmembrane toxins (Gowda and
longer). Clinical disease is unlikely to occur in less than 9 Davidson, 1999). Patients with cerebral malaria present
days. The majority of cases occur within 3 months and with fever, a disordered level of consciousness, confusion
almost all within 1 year of return from an endemic area. or inappropriate behaviour, which progresses rapidly to
There are reports of malaria occurring many years after generalised convulsions, coma and death. Retinal haem-
this time but this is very unusual. orrhages are seen in 15% and these are associated with a
bad prognosis. The typical neurological pattern in adults
is that of a symmetrical upper neuron lesion and absent
Clinical Features abdominal reexes; however, patients, particularly child-
ren, may be hypotonic. The cerebrospinal uid (CSF)
The incubation period of malaria varies from 9 days to opening pressure is often raised in children, with cerebral
more than 1 year. Clinical infection commences with a herniation sometimes occurring (Newton et al., 1991).
prodromal illness characterised by fever, myalgia and Cerebral malaria carries a mortality of 1520% in areas
weakness. Patients then develop a u-like illness with where good standards of management are available, most
high temperature, weakness and prostration, often ac- deaths occurring within 24 h of admission. Patients who
companied by a cough. Some patients may develop diar- recover become rousable after being comatose for
rhoea due to parasites in mesenteric vessels. Periodic 3040 h. Neurological sequelae, such as focal epilepsy,
fevers, with the classical cold and hot stage, may develop mononeuritis multiplex, cranial nerve palsies, mental
in patients with vivax or ovale malaria but is often absent decit, behavioural disturbances and generalised spastic-
VECTOR-BORNE PARASITIC DISEASES 97
ity, occur in more than 10% of children but are much less
common in adults (Molyneux et al., 1989).
Sequestration also occurs in several other organs, with
parasitisation being greatest in the brain, heart, liver, lung
and kidney.
The intense haemolysis that may occur in severe ma-
laria may be associated with haemoglobinuria, resulting
in the syndrome known as blackwater fever. This used to
be a common manifestation of severe malaria, but hae-
moglobinuria is now usually the result of intravascular
haemolysis brought on by oxidant antimalarial drugs in
patients with glucose-6-phosphate dehydrogenase
(G6PD) deciency.
A rare but severe form of malaria, termed algid ma-
laria, is characterised by cardiovascular collapse. In some Figure 8.5 Giemsa-stained thick lm showing malarial para-
patients with algid malaria, Gram-negative bacteraemia sites. ;1000
has been documented.
Other complications of malaria include anaemia, hepa-
tic and renal dysfunction (failure is rare), hypoglycaemia
(5% of children with severe malaria), metabolic (largely
lactic) acidosis, haemostatic disturbances and adult re-
spiratory distress syndrome (ARDS) which carries a mor-
tality in excess of 50%.
Malaria should form part of the dierential diagnosis
of any patient presenting with fever following travel to a
malaria-endemic country. Because the parasites may ad-
here to microvasculature throughout the body, it has the
capacity to mimic almost any infectious disease. Patients
frequently have a mild cough and this may be mistaken
for pneumonia, especially when travel occurs during the
winter months in temperate countries or during inuenza
epidemics, where the clinical symptoms and signs may
resemble a lower respiratory tract infection. Intestinal Figure 8.6 Giemsa-stained thin lm showing several ring
symptoms, which are common, may result in a false diag- trophozoites. ;1000
nosis of enteric infection. Symptoms of cerebral malaria
may be mistaken for CNS infection and behavioural ab-
normalities or confusion may be blamed on alcohol mis- sensitivity of the tests. A satisfactorily prepared thick lm,
use. In surveys of fatal cases of malaria, in almost all examined by a competent microscopist, has a sensitivity
instances fatal outcome is associated with delayed diag- of about 0.0004% (Bruce-Chwatt, 1984). It is most suit-
nosis. able for returning travellers in whom parasitaemias may
be low. However, thick lm examination is technically
demanding, as parasites may be dicult to identify; only
Diagnosis experienced technologists should perform the test. The
thin lm is useful in speciating the parasite and dening
Diagnosis of malaria is made simply by taking samples of the degree of parasitaemia (Figure 8.6).
capillary blood for morphological diagnosis. Parasites Conventional blood lm examination has been modi-
are found in the blood when the patient is febrile and for ed in attempts to improve rapidity of diagnosis, particu-
more than 4 h afterwards. A malaria examination must be larly when parasitaemias are low. The renements intro-
undertaken on any patient complaining of fever who has duced have sought to concentrate pRBCs by
recently travelled to a malaria-endemic area. Further centrifugation of heparinised blood, density gradient cen-
samples should be taken in the presence of fever and the trifugation and selective magnetic separation, and facili-
diagnosis should not be excluded unless three satisfactor- tate identication by the use of uorochrome stains. One
ily taken negative blood lms are obtained. In the labora- such commercially available centrifugation/uoroch-
tory, capillary blood is examined by a Romanowsky- rome technique is the quantied buy coat (QBC) tech-
stained thick and thin lm. The thick lm is a 1 l blood nique (Spielman et al., 1988). This technique is easy to
spot which places many red cells together, the lysis of perform and rapid, but requires specialised equipment (a
these cells that occurs during the staining process making microcentifuge and uorescence microscope) and a
the parasites apparent (Figure 8.5). This technique has the supply of costly QBC tubes. The sensitivity of the QBC
eect of concentrating the blood and hence increasing the technique is similar or slightly better than that of conven-
98 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
tional microscopy. Table 8.2 Antimalarial chemotherapy for uncomplicated
Rapid immunological antigen detection methods for falciparum malaria (modied from Hommel and Gilles, 1998)
falciparum malaria are now available using dipstick tech-
nology. In the Parasight-F test, a monoclonal antibody Chloroquine-resistant
Chloroquine-sensitive areas or sensitivity
captures the falciparum antigen P. falciparum histidine- areas unknown
rich protein II (Pf HRPII). A positive result is indicated
by a visible line on the dipstick produced by a second, Chloroquine Quinine?
labelled, anti-HRPII antibody (Shi et al., 1993). One Adults: 600 mg base on Adults: 600 mg of the salt t.d.s. for 7
problem with tests based on HRPII detection is the per- days 1 and 2 days
sistence of HRPII antigenaemia after eective treatment; 300 mg base on day 3 Children: 10 mg kg\ of the salt t.d.s.
Children: 10 mg for 7 days
this makes the test unreliable for the identication of base kg\ on days 1 and OR
treatment failures. There are newer tests based on the 2 Sulfonamide-pyrimethamine
detection of parasite-specic lactate dehydrogenase 5 mg base kg\ on day 3 Sulfadoxine or sulfalene (500 mg) plus
these have the advantages of being able to diagnose infec- pyrimethamine (25 mg)
tion with any of the malarial parasites, and of becoming Adults: 3 tablets as a single dose
negative with eective treatment (Makler et al., 1998). Children: 56 kg0.25 tablet
710 kg0.5 tablet
Although commercially available, these tests have not 1114 kg0.75 tablet
been evaluated as thoroughly as the Parasight-F test in 1518 kg1 tablet
the eld. These methods approach the sensitivity and 1929 kg1.5 tablets
specicity of conventional blood lm examination but 3039 kg2 tablets
have the advantage that they are much less time-consum- 4049 kg 2.5 tablets
50 kg3 tablets
ing (the Parasight-F test takes only 10 min) and do not OR
require an experienced parasitologist or any additional Amodiaquine
equipment for their use. They may be of particular value 2535 mg kg\ over 3 days
in hospitals which have a low throughput of samples for OR
malaria diagnosis. Meoquine
Adults: 1525 mg base kg\ given as
two doses 6 h apart
Children: 25 mg base kg\ given as two
Treatment doses 6 h apart
OR
The treatment of malaria depends on the species of para- Atovaquone-proguanil@
site identied, its drug susceptibility prole, the level of Atovaquone (250 mg) plus proguanil
(100 mg)
parasitaemia and severity, and any factors pertinent to Adults: 4 tablets o.d. for 3 days
the patient in question. Patients infected with P. vivax, P. Children: 1120 kg1 tablet o.d. for 3
ovale, P. malariae and chloroquine-susceptible P. fal- days
ciparum should be treated with chloroquine, which may 2130 kg2 tablets o.d. for 3 days
be administered either orally, in uncomplicated malaria, 3140 kg3 tablets o.d. for 3 days
or parenterally (by intravenous, intramuscular or subcu- 40 kgdose as for adults
OR
taneous routes) in severe disease (Tables 8.28.5). Chloro- Qinghaosu derivatives
quine is a 4-aminoquinoline which has marked, rapid Loading dose: Artesunate or
blood schizontocidal and gametocytocidal activity. artemetherA 3.2 mg kg\ orally (day 1)
Against sensitive parasites, chloroquine is more potent Maintenance dose: Artesunate or
than quinine, usually requiring fewer doses to clear para- artemetherA 1.5 mg kg\ orally (days
sitaemia (White et al., 1989). Chloroquine is also better 27)
OR
tolerated; however, rapid intravenous administration Loading dose: Artesunate or
causes life-threatening arrythmias, hypotension, seizures artemetherA 3.2 mg kg\ orally (day 1)
and cerebral oedema. Hence, oral administration is pre- Maintenance dose: Artesunate or
ferred. Haemolysis occurs in patients with hereditary de- artemetherA 2.0 mg kg\ orally (days
fects of the pentose phosphate shunt, most commonly 25)
plus
G6PD-deciency. Methaemoglobinaemia may also oc- Meoquine 25 mg kg\ in two divided
cur. The most common side-eect of chloroquine in dark- doses
skinned people is pruritus, which can aect compliance.
Other adverse eects include dizziness, rash and blurring
?In areas where a 7 day course of quinine is not curative (e.g. the Mekong
of vision. In susceptible patients, severe attacks of acute region), therapy should be supplemented with an oral course of tetracyc-
intermittent porphyria and of psoriasis may be precipi- line 4 mg kg\ q.d.s. or doxycycline 3 mg kg\ o.d. for 37 days once the
tated. patient can swallow. This is contraindicated in children below the age of 8
Since P. vivax and P. ovale have a latent hypnozoite years and pregnant and lactating women, who should receive clindamycin
10 mg kg\ b.d. for 37 days instead.
stage in the liver (see above) against which chloroquine is @Safety in pregnancy unknown.
inactive, radical cure can only be achieved by the addition AContraindicated in rst trimester of pregnancy.
VECTOR-BORNE PARASITIC DISEASES 99
Table 8.3 Management of severe chloroquine-sensitive should dier depending on disease severity and presence
malaria (modied from WHO, 2000a) of complications (WHO, 2000b). For severe disease, quin-
ine remains the drug of rst choice. Quinine is an al-
Chloroquine kaloid, derived from the bark of the cinchona tree, with
10 mg kg\ base in isotonic uid over 8 h by controlled i.v. blood schizontocidal activity. It should be administered
infusion by slow, rate-controlled intravenous infusions (never in-
followed by:
jections). Where this is not possible, intramuscular ad-
15 mg kg\ given over the next 24 h
ministration is an eective alternative. Oral medication
OR
25 mg kg\ base in isotonic uid over 30 h by controlled i.v.
should be substituted as soon as the patient has improved
infusion suciently and can swallow: this can take the form of
OR quinine tablets (to complete a 7 day course) or a single
3.5 mg kg\ base every 6 h I.M. or S.C. up to a total dose of dose of sulphadoxine-pyrimethamine (details of treat-
25 mg kg\ ment regimens are shown in Table 8.6 (WHO, 2000a)).
Quinine is a relatively toxic drug with a poor therapeutic
Oral therapy should be substituted once the patient can index. Its principal adverse eect is hypoglycaemia; both
swallow the disease itself and quinine may promote insulin secre-
tion, hence reducing blood sugar (White et al., 1983). This
is particularly common in children and pregnant women,
Table 8.4 Management of P. vivax and P. ovale malaria occurring in 50% of the latter, and blood glucose should
(modied from Hommel and Gilles, 1998) therefore be monitored regularly. Quinine is a Vaughan-
Williams class 1a antiarrhythmic agent, i.e. it has the
Chloroquine eect of lengthening the duration of cardiac action poten-
10 mg base kg\ on days 1 and 2 tials and refractory periods. Toxicity is manifest by pro-
5 mg base kg\ on day 3 longation of the QT interval and widening of the QRS
plus (for radical cure)
complex. However, very high drug concentrations need
Primaquine?
to be achieved before cardiac function is seriously af-
0.250.33@ mg base kg\ o.d. (days 417)
fected, and electrocardiographic monitoring is necessary
only in patients with pre-existing heart disease. Seizures
?Contraindicated in pregnant and lactating women. Daily doses also may also occur at high drug levels. A troublesome but
contraindicated in G6PD-decient patients but radical cure may be ob- considerably less serious side-eect of quinine is cinchon-
tained with an 8 week course of 0.75 mg kg\ once weekly.
@For Oceania and Southeast Asia strains.
ism (tinnitus, headache, blurred vision, altered hearing,
nausea and diarrhoea), which is often seen in recovering
Table 8.5 Management of P. malariae malaria (modied from patients after about 3 days of treatment. Hypersensitivity
Hommel and Gilles, 1998) reactions, including haemolytic uraemic syndrome, bron-
chospasm and pancytopenia, occur rarely.
Chloroquine In some countries, notably the USA, quinine is not
10 mg base kg\ on days 1 and 2 available. In these situations, quinidine, its dextrorota-
5 mg base kg\ on days 3 and 4 tory diastereomer, may be used instead. Quinidine is four
times more cardiotoxic than quinine, making electrocar-
diographic monitoring mandatory in all patients.
In uncomplicated falciparum malaria acquired in areas
of primaquine, an 8-aminoquinoline derivative with po- where the parasite is resistant only to chloroquine, the
tent hypnozoitocidal activity and gametocytocidal activ- treatment recommended by WHO is either sulfadoxine-
ity (Table 8.4). This is unnecessary for P. malariae and P. pyrimethamine or amodiaquine (WHO, 2000b; Table
falciparum as they lack a hypnozoite stage. Primaquine is 8.2). Sulfadoxine-pyrimethamine is a combination prod-
an oxidant drug, causing intravascular haemolysis in pa- uct that contains a dihydrofolate reductase inhibitor (py-
tients with hereditary defects of the pentose phosphate rimethamine) and a dihydropteroate synthase inhibitor
shunt, most commonly G6PD deciency. It may be ad- (sulfadoxine), which synergise to inhibit folate metab-
ministered at a reduced dose (0.75 mg kg\ per week for 6 olism. The combination is an eective blood schizontoc-
weeks) to patients with mild variants but is contraindi- ide against P. falciparum and P. vivax, a single dose being
cated in patients with with severe variants of the disease. sucient treatment. The major contraindication to its use
Methaemoglobinaemia is common, particularly in is sulphonamide hypersensitivity, which is manifest by
G6PD deciency, and may be severe, resulting in cyano- cutaneous reactions that may be life-threatening (e.g.
sis and shock. StevensJohnson syndrome, toxic epidermal necrolysis),
For patients with potentially chloroquine-resistant erythema multiforme and myelotoxicity. Haemolysis may
malaria (dened as malaria acquired in an area in which occur in patients with G6PD deciency. Amodiaquine is
chloroquine resistance exceeds 5%, as shown in Figure a 4-aminoquinoline that has been shown to be more
8.7), the drug most commonly used is quinine. However, eective than quinine and is more palatable than chloro-
WHO guidelines suggest that antimalarial therapy quine (White, 1996). It is more eective than chloroquine
100 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Figure 8.7 Reported P. falciparum drug resistance. (From WHO, 1998, by permission of the World Health Organization)
in areas of low-grade chloroquine resistance (such as pyrimethamine and amodiaquine, the WHO recommend
Africa). Following reports of agranulocytosis and serious meoquine (WHO, 2000b). Meoquine is a 4-amino-
hepatotoxicity, WHO recommended that it should cease quinoline methanol with blood schizontocidal activity.
to be used in 1990. However, a recent overview of 40 Owing to its long elimination half-life, meoquine is eec-
randomised trials concluded that the likelihood of toxic- tive as single-dose treatment. The principal problem with
ity associated with amodiaquine treatment is not signi- meoquine is that it can cause virtually immediate vomit-
cantly dierent from that with chloroquine or sul- ing, which is a major concern in a single-dose regimen.
fadoxine-pyrimethamine, and the twentieth report of the Hence, patients need to be observed for 1 h post-treat-
WHO Expert Committee on Malaria recommends its use ment, and retreatment with either full-dose or half-dose
(Olliarro et al., 1996; WHO, 2000b). Clinicians using administered if vomiting occurs within 30 and 60 min of
amodiaquine should, however, be wary of its partial the initial dose, respectively. Meoquine also causes seri-
crossresistance with chloroquine. ous but reversible neuropsychiatric disturbances, and is
In the face of resistance to chloroquine, sulfadoxine- therefore contraindicated in patients with a pre-existent
VECTOR-BORNE PARASITIC DISEASES 101
Table 8.6 Antimalarial chemotherapy of severe falciparum (i.e. the region including Thailand, Vietnam, Laos PDR,
malaria that is chloroquine-resistant or of unknown sensitivity Cambodia and Myanmar, see Figure 8.7), multidrug re-
(modied from WHO, 2000a) sistance has begun to emerge: strains of P. falciparum with
resistance to all the drugs mentioned have been
Quinine? documented. The treatment of choice in this situation is
Loading dose@: 20 mg kg\ salt in 10 ml kg\ isotonic uid by with qinghaosu and its analogues, given orally in combi-
i.v. infusion over 4 h
nation with meoquine in uncomplicated disease and
Then, 8 hB after the loading dose began:
either intravenously or intramuscularly in complicated
Maintenance regimen: 10 mg kg\ saltC by i.v. infusionA over
4 hD, given 8-hourlyB, calculated from the beginning of the
disease. The artemisinin derivatives remain over 90%
previous infusion, until the patient can swallow eective even in the face of multidrug resistance, and
This is followed by: might also reduce transmission by their gametocytocidal
Quinine tablets 10 mg kg\ 8-hourly to complete a 7 day action (Looareesuwan et al., 1992; Price et al., 1996). An
course of treatment alternative approach, in areas where the qinghaosu de-
OR rivatives are unavailable, such as Europe, the USA and
Sulfadoxine 25 mg kg\ and pyrimethamine 1.25 mg kg\ as a Australasia, is to supplement quinine therapy with a
single dose (max. 1500 mg sulfadoxine and 75 mg course of tetracycline or doxycycline, except in children
pyrimethamine) below the age of 8 years and pregnant or lactating
?In areas where a 7 day course of quinine is not curative (e.g. the
women, in whom clindamycin should be considered.
Mekong region), therapy should be supplemented with an oral course of Malarone, a formulation combining 250 mg ato-
tetracycline 4 mg kg\ q.d.s. or doxycycline 3 mg kg\ o.d. for 37 days vaquone and 100 mg proguanil, has recently been shown
once the patient can swallow. This is contraindicated in children below to be another safe and highly eective alternative
the age of 8 years and pregnant and lactating women, who should
receive clindamycin 10 mg kg\ b.d. for 37 days instead.
(Looareesuwan et al., 1999). Atovaquone is a hy-
@Should not be given if patient has received quinine, quinidine or droxynaphthoquinone which acts by inhibiting the
meoquine in preceding 12 h. cytochrome bc complex, resulting in inhibition of
AIf intravenous infusion is not possible, quinine can be given at the same dihydro-orotate dehydrogenase and disruption of py-
dose intramuscularly with half the dose being given into the anterior of
each thigh, diluted in normal saline to a concentration of
rimidine biosynthesis. Whereas monotherapy with
60100 mg ml\. atovaquone has been shown to have an unacceptably
B12 h in children. high failure rate (30% recrudescence rate), combination
CIf parenteral therapy exceeds 48 h, maintenance doses should be therapy with proguanil, an arylbiguanide inhibitor of
reduced by one-third to one-half.
D2 h in children.
dihydrofolate reductase, produces synergistic blood
schizontocidal activity against all species of malarial
OR parasite. However, atovaquone-proguanil remains un-
Artenusate evaluated in the management of complicated falciparum
Loading dose: 2.4 mg kg\ i.v.E
malaria, and the combination lacks activity against the
Maintenance regimen: 1.2 mg kg\ at 12 and 24 hE
1.2 mg kg\ o.d. for 6 daysF hypnozoites of P. vivax. Atovaquone-proguanil has a
favourable safety prole and is well tolerated. Although
EDissolved in 0.6 ml of 5% sodium bicarbonate diluted to 35 ml with data from animal studies are encouraging, the safety of
5% dextrose and given as an i.v. bolus.
FMay be given orally if patient can swallow. atovaquone-proguanil in human pregnancy is unproven,
and mothers receiving the agent should not breast-feed.
OR
ArtemetherG
Loading dose: 3.2 mg kg\ i.m.
Maintenance regimen: 1.6 mg kg\ o.d. for 6 daysH Treating Malaria in Pregnancy
GContraindicated in rst trimester of pregnancy.
HMay be given orally if patient can swallow.
Pregnant women with malaria should always be
managed as inpatients. Long-acting sulphonamides near
If parenteral administration is not possible, artemisinin or term, the oral artemisinin derivatives in the rst trimester,
artenesunate suppositories can be given tetracyclines, primaquine and halofantrine are contrain-
Artemisinin dicated. Chloroquine, pyrimethamine, proguanil and
Loading dose: 40 mg kg\ P.R. quinine are safe in pregnancy, but quinine-induced hypo-
Maintenance regimen: 20 mg kg at 24, 48 and 72 h P.R. glycaemia is a greater concern (see above). There is inad-
This is followed by: equate data on atovaquone-proguanil or meoquine to
An oral antimalarial drug such as meoquine 25 mg kg\ in recommend their use, but animal studies on the former
two divided doses (10 and 15 mg kg\24 h apart are encouraging and meoquine seems safe in the second
and third trimesters. Tetracyclines, sulfonamide-py-
rimethamine, atovaquone-proguanil and primaquine
history. The alternative to meoquine is quinine, possibly should be avoided in lactating women.
in combination with tetracycline or doxycycline to ensure The management of severe malaria goes far beyond the
cure (see below). administration of antimalarial chemotherapy. The pa-
In some areas, particularly the greater Mekong region tient may have any combination of the complications
102 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
mentioned above. The following measures form an essen- special risk situations; in some countries, where the
tial component of correct management: Anopheles mosquito is still susceptible, DDT continues to
be used for this purpose. The targeted application of
Admission to intensive therapy unit if available.
insecticides to indoor walls serves to interrupt trans-
Frequent monitoring of vital signs to facilitate early
mission, with little dispersion into the environment. Re-
detection of complications.
sistance of the malarial vector to insecticides is a growing
Careful attention to uid balance and urine output. If
concern. Resistance to dieldrin, which became wide-
indicated, rehydration should be done cautiously with
spread in the 1960s, is still prevalent amongst Anopheles
0.9% saline, as overhydration may precipitate fatal
populations despite the agent having been abandoned.
acute pulmonary oedema. Haemoglobinuria or
Moreover, the resistance mechanism also confers cross-
oliguria may indicate incipient renal failure, and renal
resistance to a new class of insecticides called the phenyl-
replacement therapy may need to be instituted.
pyrazoles. In contrast, DDT resistance developed more
Frequent blood glucose monitoring. Hypoglycaemia is
slowly and was never as widespread. Of greater concern is
particularly problematic in patients with severe disease,
a novel resistance mechanism called kdr (knock-down
especially children, patients treated with quinine or
resistance), which has emerged in West Africa. Kdr results
quinidine, and pregnant women. It should be corrected
from a mutation in sodium channels, and confers cross-
with an infusion of 50 ml of 50% dextrose (1.0 ml kg\
resistance to DDT and a wide range of pyrethroids.
of body weight in children) followed with a continuous
For the traveller, prevention of malaria is the most
intravenous infusion of 5 or 10% dextrose.
important aim and depends on risk awareness, bite avoid-
Other treatable causes of coma need to be excluded.
ance and chemoprophylaxis. If these measures fail and
Meningitis due to other causes should be excluded by
the traveller is unfortunate enough to get malaria, early
lumbar puncture (if there is no evidence of papil-
diagnosis and treatment are of paramount importance.
loedema) or covered empirically.
Temperature control by tepid sponging, fanning and
antipyretic therapy.
Bite Avoidance
Empirical broad-spectrum antibacterial therapy (fol-
lowing blood cultures) if shock supervenes.
Regular monitoring of clinical and parasitological re- Several means are available for avoiding mosquito bites.
Besides malaria, these measures protect against a wide
sponse, together with haematological and biochemical
parameters. variety of mosquito-borne diseases such as dengue fever,
Specic complications may require particular interven- yellow fever and arboviral encephalitis.
The risk of mosquito bites can be reduced signicantly
tions, e.g. convulsions may require anticonvulsant ther-
apy, anaemia (haemoglobin 7 g dl\) may require by avoiding outdoor areas between dusk and dawn,
packed cell transfusion and hyperparasitaemia covering the skin as much as possible and using mosquito
repellents on exposed areas. Eucalyptus oil has been used
( 10%) may require exchange transfusion.
successfully on the skin, but its eect only lasts 1520 min.
Successful synthetic mosquito repellents include in-
dalone, Rutgers 612, dimethyl phthalate (DMP) and
Prevention dibutyl phthalate (DBP), which oer protection for 24 h.
The best repellent currently available is N,N-diethyl-m-
WHO has brought together a new initiative called Roll toluamide (DEET), a synthetic organic chemical which
Back Malaria, which is intended to halve the suering remains active for at least 10 h. Repellents should be
caused by this disease by 2010 (Nabarro, 1999). Roll Back applied to exposed areas of skin, avoiding the mouth,
Malaria consists of a worldwide partnership, in which all nose, eyes and broken skin. Cream-based preparations
partners contribute their skills and resources to maximise are generally preferred, and oer protection for longer
impact. Hence, high-quality, consistent technical advice periods than liquid formulations. Synthetic repellents are
regarding the various aspects of malaria is made available solvents of plastic materials, and direct contact with spec-
to national authorities by networks of experts based in tacles, pens, sleeping-bags, etc. must be avoided. How-
research, academic and disease control institutions. The ever, repellents may be applied to clothing or mosquito
initiative also supports research and development in the nets for greater protection.
ght against malaria. The technical basis of this project is Houses should be screened with mosquito netting that
the Global Malaria Control Strategy. prevents the ingress of mosquitoes. In order to be eec-
The Global Malaria Control Strategy emphasises the tive, not only the screen but also the building itself has to
selective use of preventive measures wherever this will be in an adequate state of repair so that mosquitoes do
produce sustainable results. Selective vector control con- not nd an alternative means of entry. Once in place, it is
tributes signicantly to reducing the morbidity associated then possible to use knock-down sprays containing per-
with malaria. Nonselective coverage, as was performed methrin to kill any mosquitoes already present. Addition-
using DDT and other insecticides previously, is no longer ally, mosquito coils containing pyrethrum, or, electrical
recommended because of its environmental risks. Indoor devices which vaporise a pyrethroid compound, can re-
residual spraying should be reserved for well-dened, duce the risk of bites.
VECTOR-BORNE PARASITIC DISEASES 103
Mosquito nets, the nal line of defence at night, should Table 8.7 Antimalarial prophylactic regimens (modied from
be in good repair and put in position before dusk. When Bradley and Warhurst, 1995; WHO, 1998b)
travelling, travellers should carry a repair kit to enable
unexpected holes in the net to be repaired. Nets that have Drug Dosage
been impregnated with pyrethrum are much more eec-
Chloroquine (100 or 150 mg 5 mg base kg\ weekly
tive and should be used where possible (Alonso et al.,
base tablets)
1991). Proguanil? (100 mg tablets) 3 mg kg\ daily
Meoquine@ (250 mg tablets) 5 mg kg\ weekly
DoxycyclineA (100 mg tablets) 1.5 mg salt kg\ daily
Antimalarial prophylaxis Pyrimethamine (12.5 mg) and 1019 kg: tablet weekly
dapsone (100 mg) 2039 kg: tablet weekly
Antimalarial prophylaxis is a controversial subject, with
(Maloprim)? 40 kg: 1 tablet weekly
varying opinions on the correct prophylactic agents for
each area. The use of prophylaxis has also been compli-
?Folate supplementation required in pregnancy. Maloprim is not recom-
cated by the rising tide of resistance. WHO recommenda- mended in the rst trimester of pregnancy and in children below 6 weeks
tions for malaria prophylaxis are shown in Figure 8.8 of age.
(WHO, 1998a; see Table 8.7 for dosage schedules). For @Contraindicated in the rst trimester of pregnancy, during lactation and
areas with chloroquine-susceptible P. falciparum (such as in children below 2 years of age. Pregnancy should be avoided for 3
months following cessation of prophylaxis.
North Africa, the Middle East and Central America north AContraindicated in pregnancy, lactation and children below 8 years of
of the Panama Canal), P. ovale or P. malariae, chloro- age. Pregnancy should be avoided for 1 week following cessation of
quine is recommended. Chloroquine is still the recom- prophylaxis.
mended prophylactic agent for areas with P. vivax, but
this advice may need to be re-evaluated in the light of
reports of chloroquine-resistant P. vivax in Papua New ded in the rst trimester of pregnancy and, as the drug is
Guinea, Irian Jaya, Myanmar and Vanuatu (WHO, excreted slowly, pregnancy should be avoided for 3
1998a). Chloroquine-resistant P. falciparum is now so months after stopping prophylactic meoquine.
widespread, however, that most travellers require an ad- Combination therapy comprising chloroquine and
ditional or alternative agent. In countries where there is proguanil provides substantial protection in areas with
chloroquine resistance but where meoquine resistance chloroquine-resistant malaria, but less so than mef-
has not emerged, meoquine is the drug of choice. Alter- loquine.
natively, chloroquine/proguanil may be used. In areas Pyrimethamine/dapsone has been largely superseded
where multidrug-resistant P. falciparum is also mef- by meoquine. However, used as a xed dose combina-
loquine-resistant (on the eastern and western borders of tion of pyrimethamine 12.5 mg and dapsone 100 mg (Mal-
Thailand, Cambodia and Burma), and for patients unable oprim) together with chloroquine, it remains a second-
to take chloroquine or meoquine, doxycycline is the line prophylactic agent for Oceania and elsewhere when
drug of rst choice. Prophylaxis should be commenced 1 the other drugs are not usable (Bradley and Warhurst,
week before travel (1 day for proguanil or doxycycline 1995). A maximum adult dose of 1 tablet weekly must be
and 2 weeks for meoquine) and continued for 4 weeks adhered to because of the risk of agranulocytosis.
after leaving an endemic area. Atovaquone-proguanil has been shown recently to
The choice of antimalarial prophylaxis is always a have an excellent safety/ecacy prole for the chemo-
balance between the risk of disease and the complications prophylaxis of falciparum malaria (Shanks et al., 1998;
of prophylaxis. None of the agents used are without risk van der Berg et al., 1999). In addition to the blood
of adverse events and over the last many years several schizontocidal activity of atovaquone and the eryth-
agents (e.g. sulfadoxine-pyrimethamine and amodia- rocytic schizogony-inhibiting action of proguanil, both
quine) have had to be withdrawn as a result of unaccept- agents inhibit development of the primary exoeryth-
able toxic events. Doxycycline may cause skin photo- rocytic liver forms and hence have causal as well as
sensitivity; people likely to be exposed to prolonged di- suppressive prophylactic activity. They also inhibit devel-
rect sunlight should use a highly protective sunscreen. opment of the mosquito stages of the parasite, an activity
The rate of (neuropsychiatric) adverse events attributable which could have signicant impact on transmission.
to meoquine is controversial, and how it compares with
that of chloroquine/proguanil remains unclear. A survey
indicated serious side-eects in 1: 10000 recipients but Vaccine
British data suggest a higher incidence (Bradley and War-
hurst, 1995). As it would clearly be dangerous to discon- Although malaria vaccination still appears a distant
tinue antimalarial prophylaxis while in an endemic area, hope, prospects for malaria vaccine look to be favourable
meoquine should be started at least 2 weeks before in the long run. Several approaches have been identied.
travel so that these eects can be identied (70% of Antigens present in the sporozoite could be used to pre-
disturbances occur within the rst three doses) and a vent infection of liver cells and thus provide sterile im-
suitable alternative given. Meoquine is not recommen- munity. Irradiated sporozoites do provide good protec-
104 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Figure 8.8 WHO recommendations for malaria drug prophylaxis. (From WHO, 1998b, by permission of the World Health
Organization)
VECTOR-BORNE PARASITIC DISEASES 105
Table 8.8 Choice of stand-by treatment (modied from WHO, T-cell immunity, is currently under trial. Vaccines based
1998b) on the merozoite surface proteins would not protect
against infection but could provide protection against
Prophylactic regimen Stand-by treatment severe disease. Vaccines directed against adhesion mol-
ecules, similarly, would not prevent disease but could
None Chloroquine (zone A in
reduce the severity of the most dangerous complications.
Figure 8.8)
Another vaccine approach has been to target antigens on
25 mg kg\ over 3 days
Sulfadoxine or sulfalene
the gametocyte. This would neither protect against infec-
(500 mg) and pyrimethamine tion nor reduce the severity of disease but would reduce
(25 mg) (zone B in Figure 8.8 transmission in the community.
and sub-Saharan Africa) A recent attempt to produce a malaria vaccine using a
Single-dose therapy combination of CS protein and synthesised peptides
Adults: 3 tablets based on merozoite antigens (the Spf66 vaccine) was
Children: 56 kg0.25 tablets shown to produce a strong immunological response and
710 kg0.5 tablets signicant protection in studies in South America (Valero
1114 kg0.75 tablets et al., 1996); however, studies in sub-Saharan Africa found
1518 kg1 tablet protective ecacy to be inadequate (Metzger et al., 1999).
1929 kg1.5 tablets These apparently disappointing studies do, however,
3039 kg2 tablets prove the principle that a malaria vaccine can be eective.
4049 kg2.5 tablets New vaccine candidates are being identied, and DNA
50 kg3 tablets vaccines are being investigated.
Meoquine
15 mg kg\ (single dose)
Quinine
8 mg base kg\ t.d.s. for 7 Stand-by Emergency Treatment
days
Supplement with doxycycline For the minority of travellers unable to obtain prompt
100 mg salt o.d. or medical attention when malaria is suspected, WHO ad-
tetracycline 250 mg o.d. for 7 vise the issue of antimalarial drugs for self-administra-
days in areas of high levels of tion. It must be emphasised that stand-by emergency
quinine resistance, except in treatment is a rst-aid measure, and not a substitute for
pregnancy, lactation and medical help, which should be sought urgently. The
children below the age of 8 choice of stand-by treatment is inuenced by the resis-
years tance pattern of the parasites in the area being visited, the
Chloroquine ; / 9 Proguanil Sulfadoxine or sulfalene prophylactic regimen taken and factors pertinent to the
(500 mg) and pyrimethamine individual patient (Table 8.8).
(25 mg) (see above) (zone B in
Figure 8.8 and sub-Saharan
Africa)
Meoquine The Pregnant Traveller
15 mg kg\
Quinine (see above) Pregnant women are advised not travel to malarious
Meoquine Sulfadoxine or sulfalene areas. Malaria poses serious hazards to both mother and
(500 mg) and pyrimethamine fetus, increasing the risks of both maternal and neonatal
(25 mg) (see above) (zone B in death, miscarriage and stillbirth. Chloroquine and
Figure 8.8 and sub-Saharan proguanil are considered safe, as is meoquine after the
Africa) rst trimester. Doxycycline is contraindicated through-
Quinine (see above) out pregnancy and lactation; hence, areas of mutidrug
Doxycycline Meoquine resistance should be avoided if at all possible. In the event
25 mg kg\ in two doses (10 of unplanned pregnancy, malaria chemoprophylaxis is
and 15 mg kg\ 624 h apart) not regarded as an indication for termination.
Quinine ; tetracycline (see
above)
LEISHMANIASIS
tion but this is not practical for a mass vaccine. Early
studies with CS protein, the major surface antigen of this Leishmania are trypanosomatid parasites that produce a
stage of the parasite, did not prove successful due to a chronic granulomatous disease. This may be limited to
failure to induce strong T-cell immunity (Nussenzweig the skin (cutaneous leishmaniasis or oriental sore) or can
and Nussenzweig, 1989). A new vaccine candidate, using be widespread (visceral leishmaniasis or kala-azar).
CS protein linked to hepatitis B surface antigen to induce Leishmania are members of the trypanosomatid fam-
106 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
ily, characterised by possession of a kinetoplast. Leish- respond to bacterial and viral infections, and death can
maniasis can be classied in several ways, either clinically result from pneumonia, dysentery, measles or tuberculo-
or taxonomically. It is conveniently divided into Old and sis. Once symptoms have developed, the patient declines
New World leishmaniasis, or clinically into visceral and progressively and dies within 2 years in the absence of
cutaneous disease (Tables 8.9, 8.10). Leishmaniasis occurs eective treatment. The course of the disease can be quite
sporadically throughout tropical and temporal countries. variable, depending on the health and nutritional state of
It is endemic in parts of southern Ethiopia, Sudan, north- the patient; there may be acute onset of symptoms with
ern Kenya and central Asia, and large epidemics can rapid progression to life-threatening disease within a fort-
occur (as reported amongst refugees in southern Sudan) night, or the disease may follow a far more insidious
(Zijlstra et al., 1994). It can be acquired in various parts of course (Badaro et al., 1986).
the Mediterranean littoral as well as in Africa, Central Laboratory ndings include leucopenia, normo-
and South America and India and other parts of Asia. It is chromic normocytic anaemia and hypergammag-
transmitted to humans by the bite of the female sandy. lobulinaemia. Circulating immune complexes and rheu-
In the Old World these belong to the Phlebotomus genus matoid factors are usually present (Pearson et al., 1983).
and in the New World to the Lutzomyia genus.
Cutaneous Leishmaniasis
Life cycle
Cutaneous leishmaniasis is a chronic but self-limiting
Leishmaniasis is mainly a zoonotic disease with a varied cutaneous infection, characterised by a circular
animal reservoir including rodents, dogs and wild foxes; granulomatous lesion that heals leaving a ne cigarette
humans are accidentally infected and also serve as a paper scar and brings about solid immunity to that
reservoir, particularly during epidemics. The life cycle is particular species of parasite. It is typically caused by L.
dimorphic. The insect stage consists of promastigotes tropica, L. major, L. aethiopica, certain strains of L. infan-
that are injected into humans (and other susceptible tum and, rarely, L. donovani in the Old World (where the
mammals) when the insect bites. The promastigotes are disease is also called oriental sore) and 12 of the 14
rapidly taken up by macrophages and transform into neotropical species of Leishmania in Latin America
amastogotes, which are able to survive inside the macro- (where it has been assigned various names, depending on
phage phagolysosome. The amastigotes multiply, infect- its presentation and location, such as bush yaws, uta or
ing new macrophages and setting up a chronic Chiclero ulcer). Infection is complicated by secondary
granulomatous infection, which can last from months to bacterial infection or by cosmetic consequences at the site
years. In cutaneous leishmaniasis the amastigotes remain of the lesion.
conned to the skin. In visceral disease there may be an
initial skin lesion, but infection is spread throughout the
reticuloendothelial system. The life cycle is complete
when the host is bitten and the female sandy takes up a Mucocutaneous Leishmaniasis (Espundia)
blood meal. For transmission of cutaneous disease to
occur, the sandy must bite a cutaneous lesion. South American leishmaniasis may be complicated by
chronic destructive disease at the mucocutaneous junc-
tions. This may occur many years after the original infec-
Clinical Features tion, causing severe destruction of the nose and face.
Blockage of the nasal passages by developing lesions
Visceral Leishmaniasis or Kala-azar usually results in respiratory distress, mouth breathing
and pneumonia that may be fatal. The vast majority of
Visceral leishmaniasis is the most serious form of this infections are caused by L. (Viannia) braziliensis.
infection. It is typically caused by Leishmania donovani, L.
infantum (which mainly aects young children) or L.
chagasi. The disease has a typical incubation period of Disseminated Cutaneous Leishmaniasis
26 months and is accompanied by a low-grade fever;
however, onset may be delayed for many years. Cells of This may occur in primary L. aethiopica infection or when
the reticuloendothelial system are invaded and the pa- other cutaneous leishmaniasis infection (L. (L.) pifanoi,
tient presents with weight loss, malaise, anorexia, left L. (L.) mexicana, L. (L.) amazonensis) occurs in individ-
hypochondrial discomfort, shivering and chills. On clini- uals with little cell-mediated immunity. Uncontrolled
cal examination the patient is cachectic and anaemic; multiplication occurs over much of the surface of the skin,
hepatosplenomegaly and lymphadenopathy may be pres- producing large, swollen plaques and nodules that do no
ent. The symptoms and signs are due to the eects of ulcerate. There is immunological anergy, neither arm of
chronic cytokine release; TNF is known to have anorec- the immune system being activated. This is a protracted
tic and catabolic eects (Pearson et al., 1992). Uncontrol- illness which can cause serious morbidity for the patients
led activation of the immune system results in inability to lifetime.
VECTOR-BORNE PARASITIC DISEASES 107
Table 8.9 Leishmaniasis in the Old World (modied from Ashford and Bates, 1998)
L. major Rural, zoonotic, cutaneous North Africa, Sahel of Africa, Great gerbil, fat sand rat
leishmaniasis Central and West Asia
L. tropica Urban, anthroponotic Central and West Asia Humans
cutaneous leishmaniasis
L. aethiopica Cutaneous and diuse Ethiopia, Kenya Rock hyraxes
cutaneous leishmaniasis
L. donovani Visceral leishmaniasis, PKDL India, East Africa Humans
L. infantum Infantile visceral leishmaniasis Mediterranean basin, Central Domestic dog
and West Asia
Table 8.10 Leishmaniasis in the New World (modied from Pearson et al., 2000)
Leishmaniasis Recidivans with leprosy, tuberculosis, basal cell carcinoma and fun-
gal infection.
This relapsing, tuberculoid form of cutaneous leish- The clinical diagnosis of visceral leishmaniasis depends
maniasis is caused by L. tropica. It is seen in central Asia largely on awareness, as none of the signs or symptoms
and Iran, and is characterised by lesions, usually facial, are diagnostic.
which heal centrally and spread outwards. It is a chronic In the laboratory, leishmaniasis can be diagnosed by
illness that can last 2030 years. demonstration of amastigotes in tissue or isolation of
promastigotes in culture. Serodiagnosis is also possible in
visceral leishmaniasis.
Diagnosis
Migration to
salivary glands
Trypomastigotes Epimastigotes
(Long slender forms (Multiplication)
Divide by binary fission
VSG coat) Vector salivary gland
epithelium
Vertebrate bloodstream
Inoculative transmission
Metacyclic trypomastigotes
(Short stumpy, highly motile
Synthesise VSG coat
Infectious
Nondividing)
Figure 8.11 Giemsa-stained peripheral blood smear demonstrating African trypanosomes. ;1000
the most sensitive of the blood concentration tech- tion of antibodies, antigens or nucleic acids often need to
niques, with a detection limit of 34 parasites ml\ be employed.
(WHO, 1998a).
Density gradients and dierential haemolytic agents Antibody tests. Various antibody detection tests have
can be employed to enable separation of trypanosomes been developed, including ELISA, immunouorescence,
from erythrocytes by centrifugation. immune trypanolysis, direct agglutination, indirect
haemagglutination, latex agglutination, Western blot and
In early illness, lymph node aspiration is carried out
dot blot. The card agglutination test for trypanosomiasis
easily and microscopic examination of a wet preparation
(CATT) uses a reagent made of xed, stained intact
of aspirates often enables visualisation of trypanosomes.
trypanosomes of variable antigen type LiTat 1.3 (Buscher
Examination of CSF is of particular use in demonstrating
et al., 1999). This test has the advantages of high sensitiv-
cerebral involvement. The double centrifugation tech-
ity and specicity, low cost, simplicity and speed, results
nique substantially enhances sensitivity to a detection
being obtained within 5 min in the eld; however, the
limit of 1 parasite ml\. In the absence of trypanosomes
LiTat 1.3 gene is not present in a small proportion of
in CSF, a raised leucocyte count ( 5000 ml\), the pres-
isolates, and nonexpression of this gene could also pro-
ence of morula cells and raised protein are all indicators
duce a false-negative result. CATT is not equally eective
of possible cerebral trypanosomiasis. In late disease, elev-
in all geographical areas and is only currently available
ated IgM titres are also of diagnostic value, and can now
for T.b. var. gambiense infection. Preliminary studies
be determined through a latex agglutination test (latex/
show that the trypanosomiasis agglutination card test
IgM) which is sensitive, simple and stable (Lejon et al.,
(TACT) could be a promising development in the
1998). CSF examination should not be undertaken until
serological diagnosis of T.b. var. rhodesiense infection
haemolymphatic system infection is treated, to avoid ac-
(Akol et al., 1999).
cidental inoculation of trypanosomes.
In vivo and in vitro culture systems may be used for the
isolation of trypanosomes, but neither technique is cur- Antigen tests. Several direct, indirect and sandwich
rently practical for routine diagnosis. ELISA antigen detection systems are being developed.
The card indirect agglutination test for trypanosomiasis
(TrypTect CIATT) uses specic antibodies coupled to
latex beads to detect circulating trypanosomal antigens in
Indirect Diagnosis patients blood (Asonganyi et al., 1998). The antigens are
invariant antigens expressed on the surface of procyclic
As the density of trypanosomes in body uids is often forms of T. brucei, and are common to all T.b. var. gam-
beyond the limits of even the most sensitive detection biense and T.b. var. rhodesiense stocks. TrypTect CIATT
systems, indirect diagnostic techniques employing detec- has been shown to have high sensitivity and specicity
VECTOR-BORNE PARASITIC DISEASES 113
(both 99%), and is simple and quick to perform. It is rate achieved with the current treatment regimen is 98%;
applicable for both T.b. var. gambiense and T.b. var. rho- relapse rates of 716% have been reported.
desiense infection.
PCR techniques have been developed for trypanosome
detection both in CSF and in blood, and sensitivity Meningoencephalitic Stage
thresholds of 1 parasite ml\ have been reported; how-
ever, further evaluation is required before they are used Eornithine (--diuoromethylornithine) is now the
for routine diagnosis. treatment of choice for T.b. var. gambiense meningoen-
cephalitis. T.b. var. rhodesiense is not susceptible to the
drug (Bacchi et al., 1990). It acts by irreversibly inhibiting
Treatment the enzyme ornithine decarboxylase, which is involved in
trypanosomal polyamine synthesis (Haegele et al., 1981).
The clinical course of trypanosomiasis divides into two Eornithine readily crosses the bloodbrain barrier. Ad-
stages, an earlier haemolymphatic stage and a later men- verse eects include myelosuppression, diarrhoea, con-
ingoencephalitic stage. Management of the two stages is vulsions, vomiting and fever. The current recommended
dierent, and determination of the stage by examination dosage regimen is 400 mg kg\ intravenously in four
of CSF must therefore always be performed once para- divided doses for 14 days; however, comparative studies
sites have been detected in other body uids. The criteria with a view to reducing the duration of treatment are
for diagnosing the meningoencephalitic stage are an elev- underway. Treatment regimens based on oral administra-
ated CSF leucocyte count ( 5 mm\) or protein con- tion of the drug have resulted in a failure rate, and are
centration ( 37 mg 100 ml\). Detection of trypano- hence not recommended. Eornithine is a much less toxic
somes in the CSF is not essential. drug than suramin, pentamidine or melarsoprol and is
likely eventually to replace them as the treatment of
choice for T.b. var. gambiense infection. It is not currently
Haemolymphatic Stage used as a rst-line agent in West Africa for economic and
logistic reasons (Pecoul and Gastellu, 1999).
Suramin, a polysulphonated naphthylamine derivative of Melarsoprol, an arsenical compound, used to be the
trypan red, is usually successful in treating patients with most eective drug for trypanosomal meningoencephali-
trypanosomiasis not involving the central nervous sys- tis before the introduction of eornithine, and remains so
tem. It is eective against both T.b. var. gambiense and for T.b. var. rhodesiense meningoencephalitis. Melarsop-
T.b. var. rhodesiense, but cannot be used in the menin- rol is a highly toxic drug, its most serious complication
goencephalitic stage as it does not cross the bloodbrain being a reactive encephalopathy which aects 510% of
barrier. Suramin is a relatively toxic drug. Immediate patients in the rst four days of therapy and carries a 6%
side-eects include nausea, vomiting, shock, loss of con- mortality (Arroz, 1987). Other adverse eects include a
sciousness, fever, urticaria and occasionally death. Later GuillainBarre-like syndrome, hepatotoxicity, agranu-
side-eects that may occur include optic atrophy, neph- locytosis, exfoliative dermatitis, myocardial damage, gas-
rotoxicity, adrenal insuciency, chronic diarrhoea and trointestinal disturbances, polyneuropathy and allergic
prostration. Agranulocytosis and haemolytic anaemia reactions. Patients with G6PD deciency can develop
occur rarely. Pre-existing renal or hepatic disease are severe haemolysis on treatment with melarsoprol. Vari-
relative contraindications to suramin administration. ous treatment regimens are used in dierent areas. In
Suramin is suitable only for intravenous administration. general, three series of three or four daily injections are
All doses are given by slow intravenous infusion of a 10% given for 34 days, separated by a weeks rest period; the
aqueous infusion; a test dose of 5 mg kg\ is given on the dosage is increased from 1.2 to 3.6 mg kg\ within each
rst day, followed by doses of 20 mg kg\ (maximum series, to a total dose of 2627 mg kg\; however, a recent
dose 1 g) on days 3, 10, 17, 24 and 31. trial suggests that a shorter treatment schedule compris-
Pentamidine isethionate was identied as a try- ing 10 daily injections of 2.2 mg kg\ is equally ecacious
panocidal agent in the 1930s. Like suramin, it is highly (Burri et al., 2000). Melarsoprol treatment is usually pre-
protein bound, and therefore does not cross the blood ceded by one or two injections of either pentamidine or
brainbarrier and is not eective in meningoencephalitic suramin to eliminate parasites from the blood and lymph.
disease. Pentamidine has a lower cure rate than suramin There is evidence that the incidence and severity of
in T.b. var. gambiense infection, and some cases of T.b. adverse reactions to melarsoprol may be reduced by sim-
var. rhodesiense infection do not respond to this agent. ultaneous administration of corticosteroids. The recom-
Toxicity is a serious concern with pentamidine (see sec- mended regimen is prednisolone 1 mg kg\ day\ up to a
tion on leishmaniasis for details on administration and maximum of 40 mg day\. Corticosteroid treatment
adverse eects). The recommended dosage regimen is should be commenced 1 day before the rst dose of
4 mg kg\ daily or on alternate days to a total of 710 melarsoprol and continued throughout therapy.
injections; however, recent pharmacokinetic data and in Patients should be followed up at 3-month intervals for
vitro experiments suggest that cure may be achieved with the rst 6 months and at 6-month intervals for the next 18
lower dosages and shorter durations of therapy. The cure months. At each session, blood and CSF examination
114 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
should be carried out in addition to clinical assessment. relative insensitivity of parasitological techniques. The
CSF cell counts and protein levels usually take several development of simple, cheap serodiagnostic techniques
months to return to normal; preliminary work shows that has greatly facilitated case detection, and the approach
PCR may a useful technique for staging African that has been adopted is that of initial serological screen-
trypanosomiasis. ing and subsequent parasitological conrmation of posi-
tive cases. The main problems with serological screening
are that the sensitivity of these techniques varies between
Prevention areas and a signicant proportion of cases are seroposi-
tive but parasite-negative; this proportion also exhibits
Travellers should be cautious in known endemic areas considerable interregional variation. Whereas these cases
and try to avoid being bitten by the tsetse y. could represent serological false positives, it is possible
On a national scale, strategies for the prevention and that some of them are infected patients with para-
control of trypanosomiasis are based on reducing infec- sitaemias too low to be detected; hence, these patients
tion by vector control and suppression of disease in infec- require 36-monthly follow-up for 12 years unless they
ted people by early treatment. become seronegative. Treatment is not usually com-
menced unless trypanosomiasis is conrmed para-
sitologically.
Vector Control
Figure 8.12 Distribution of schistosomiasis (from WHO, 1985, by permission of the World Health Organization)
matobium) and are characterised by bloody diarrhoea or transverse myelitis (S. mansoni and S. haematobium)
haematuria, respectively. The serious and long-term com- (Ariizumi, 1963).
plications of schistosomiasis are associated with the re- The severity of disease depends on the infecting dose.
tention or ectopic deposition of eggs in viscera and the Thus, travellers rarely suer from the long-term compli-
granulomatous reaction they induce. Eggs retained in the cations of schistosomiasis unless they are resident and
bladder can lead to bladder wall thickening and eventual- exposed to the infection extensively over a period of years.
ly to obstructive uropathy, and those in the gut wall cause More commonly travellers present with undiagnosed fe-
dysentery, colicky pain and polyps (Siongok et al., 1976). vers 6 weeks to 3 months after exposure. Because the
Some eggs are swept backwards in the portal circulation burden of infection is low, the symptoms and signs may
to lodge in the liver, where they produce hepatic brosis, be subtle and dicult to diagnose; the patient might even
or are swept onwards to the lungs, where they produce be asymptomatic.
lung brosis (and eventually portal and pulmonary hy-
pertension, respectively) (von Lichtenberg et al., 1971). Diagnosis
Rarely ectopic eggs may be found in the brain, causing
epilepsy (S. japonicum), or in the spinal cord, producing a The classical means of making a diagnosis of schis-
118 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
tosomiasis is to detect the presence of eggs in urine (S. Table 8.11 Oxamniquine dosage schedule
haematobium) or stool (other species). Since travellers are
not heavily infected, egg counts are often very low and Region Dosage
beyond the limit of detection. Sensitivity (for all species)
can be enhanced by taking rectal biopsies (Harries et al., West Africa, South America, Adults: 15 mg kg\ single
Carribean dose
1986).
Children: 20 mg kg\ in two
For S. haematobium infection, urine should be concen- divided doses
trated using a lter. The maximum concentration of eggs East and Central Africa, Adults/children: 30 mg kg\
occurs in urine passed between 10.00 and 14.00, and such Arabian Peninsula in two divided doses
a specimen should ideally be obtained (Marshall, 1995). Egypt, southern Africa Adults/children: 60 mg kg\
The total volume passed, as opposed to the terminal few over 23 days?
drops, should be collected. Examination of a single speci-
men is not adequate to exclude the diagnosis, and up to
four specimens passed on dierent days may be necessary. ?Maximum single dose must not exceed 20 mg kg\.
It is important to distinguish opaque, black, empty eggs,
which are dead and do not by themselves merit treatment, successful. This agent is not as well tolerated as
from translucent, pale yellow/colourless, miracidium- praziquantel: dizziness and drowsiness occur in about
containing, live eggs, which do. one-third of patients, levels of serum transaminases may
In intestinal schistosomiasis, 35 stool specimens be transiently raised, and many patients in the eastern
passed on dierent days should be examined before the Mediterranean region develop the Loeer syndrome
diagnosis is excluded. after treatment. Hallucinations and convulsions have also
For many travellers, these techniques fail to make a been reported rarely. Patients should be warned that their
diagnosis. A variety of serodiagnostic techniques are urine may be discoloured orange-red. Oxamniquine has
available and all travellers should have serum tested for not been shown to be teratogenic.
the presence of schistosoma antibodies at least 3 months Whereas oxamniquine has no activity against S. hae-
after a potential exposure. ELISA is widely used in diag- matobium, metrifonate, an organophosphorous cholines-
nosis. ELISAs for the detection of circulating anodic terase inhibitor, has been used extensively in large-scale
antigen (CAA) and circulating cathodic antigen (CCA) in control programmes. This agent is administered at a dose
serum and urine have been developed, and have been of 7.510 mg kg\ at fortnightly intervals, and cures
shown to have substantially higher sensitivities than 4080% of cases (WHO, 1995a). Metrifonate is well toler-
single egg counts (Polman et al., 1995). ated and is not teratogenic.
Animal studies suggest that artemether is eective in
the treatment of schistosomiasis; the results of eld trials
Treatment are awaited (Xiao et al., 1995).
Wuchereria bancrofti Mosquito (Culex, Anopheles Lymphatic and lung Africa, Asia, Australia, Pacic,
and Aedes) Latin America
Brugia malayi Mosquito Lymphatic and lung Southeast Asia
B. timori Mosquito Lymphatic and lung Indonesia
Loa loa Tabanid y (Chrysops) Allergic (calabar) cutaneous Africa
swellings
Onchocerca volvulus Black y (Simulium spp) Skin and eyes Sub-Saharan Africa, Yemen,
Central and South America
in irrigation schemes should be avoided, human settle- nological hyperresponsiveness to larial antigens, and is
ments should be sited well away from canals and proper characterised by dry cough, wheezing and dyspnoea. Pa-
drainage is essential so that new snail habitats are not tients may be systemically unwell, with scattered lym-
created. phadenopathy, weight loss, malaise and anorexia. Aus-
Water bodies around villages can act as transmission cultation reveals crackles and wheeze, and chest
sites, and should be lled, drained or made less accessible. radiography shows scattered reticulonodular shadowing.
Aquatic vegetation should be cleared. Eosinophilia is invariably present. Microlaraemia is ab-
sent, often confounding diagnosis; however, larial serol-
ogy is positive, and the diagnosis is ultimately conrmed
FILARIASIS by an appropriate response to treatment.
The primary features are the consequence of the hosts The adult onchocerca are found within subcutaneous
immune response to adult laria in the lymphatic chan- nodules: these are usually of cosmetic signicance only,
nels. Acute disease is characterised by recurrent intermit- although pressure symptoms can occur. Most of the dam-
tent fever and eosinophilia, accompanied by systemic age that occurs in onchocerciasis is due to the hosts
symptoms, such as headache, malaise and acute lym- immune response to dead/dying microlaria, released
phadenitis and lymphangitis of the groin and axillae. from these nodules, that invade the skin and eyes. Both
Each attack lasts 315 days, and there may be several granulomatous and nongranulomatous inammation oc-
attacks each year. Eventually, after 1015 years, the lym- cur.
phatic channels are permanently damaged, and chronic The commonest symptom is pruritus, which may be
disease supervenes. The incompetent lymphatics become very severe. A variety of other acute reactive skin manifes-
brosed, and the nodes calcify. Lymph accumulates in tations may occur, including papular eruptions (reecting
tissues, producing lymphoedema and eventually elephan- intraepithelial abscesses) and transient oedema. Subse-
tiasis. Secondary bacterial and fungal infection is quent cutaneous changes resemble those of ageing
common. Hydrocele, orchitis and epididymitis occur in (wrinkling, atrophy and hyper/hypopigmentation). Lym-
men. Rarely an abnormal connection between ureter and phadenopathy may also occur.
thoracic duct results in chyluria. Ocular damage is the most devastating consequence of
The presence of microlaria in the tissues, especially onchocerciasis. It only occurs in patients with moderate/
the lungs, produces the disease syndrome termed tropical high worm loads. Both anterior uveitis and chorioretini-
pulmonary eosinophilia. This disorder reects immu- tis may occur.
120 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Diagnosis Table 8.13 Dosage schedule for diethylcarbamazine
REFERENCES
treatment with ivermectin (WHO, 1995b). A total dose of
4.0 g is administered intravenously, as shown in Table Addiss DG, Beach MJ, Streit TG et al. (1997) Randomised
8.14. placebo-controlled comparison of ivermectin and albendazole
alone and in combination for Wuchereria bancrofti micro-
laraemia in Haitian children Lancet, 350, 480484.
Addy M and Nandy A (1992) Ten years of kala-azar in West
Prevention and Control Bengal Part 1. Did post kala-azar dermal leishmaniasis initi-
ate the outbreak in 24 Parganas? Bulletin of the World Health
Lymphatic lariasis is prevented by avoiding mosquito Organization, 70, 341346.
bites and mosquito control measures. It has recently been Agostoni C, Dorigoni N, Maltano A et al. (1998) Mediterra-
identied as a potentially eradicable disease and WHO is nean leishmaniasis in HIV-infected patients: epidemiology,
coordinating eorts towards this end. These eorts entail clinical and diagnostic features of 22 cases. Infection, 26, 9399.
both environmental vector control (e.g. adequate mainte- Akol MN, Olaho-Mukani W, Odiit, M et al. (1999) Try-
nance of open drains and septic tanks, spraying a lm of panosomiasis agglutination card test for Trypanosoma brucei
rhodesiense sleeping sickness. East African Medical Journal,
oil over water surfaces, the addition of larvivorous sh to 76, 3841.
ponds and the use of larval insecticides) and mass chemo- Alonso PL, Lindsay SW, Armstrong JR et al. (1991) The eect of
therapy. It has recently been shown that single annual insecticide-treated bed nets on mortality of Gambian children.
doses of diethylcarbamazine and/or ivermectin have po- Lancet, 337, 14991502.
tent, sustained activity in reducing microlaraemia and Ariizumi M (1963) Cerebral schistosomiasis japonica. Report of
that additional treatment with albendazole has macro- one operated case and fty clinical cases. American Journal of
laricidal activity (WHO, 1992; Ottesen and Ramachan- Tropical Medicine and Hygiene,12, 4055.
dran, 1995). These ndings lay the foundations for a Arroz JO (1987) Melarsoprol and reactive encephalopathy in
successful international eradication campaign. Trypanosoma brucei rhodesiense. Transactions of the Royal
Society of Tropical Medicine and Hygiene, 81, 192.
The prevention of loiasis is based on the avoidance of Ashford RW and Bates PA (1998) Leishmanasis in the Old
tabanid y bites. This involves the avoidance of places World. In Topley and Wilsons Microbiology and Microbial
where ies are numerous and the use of insect repellents Infections (eds FEG Cox, JP Kreier and D Wakelin), 9th edn,
and protective clothing. Prophylactic diethylcar- vol. 5, pp 215240. Arnold, London.
bamazine administered to travellers at a dose of 300 mg Asonganyi T, Doua F, Kibona SN et al. (1998) A multi-centre
once weekly is eective in preventing loiasis (Nutman et evaluation of the card indirect agglutination test for
al., 1988). Transmission has been successfully interrupted trypanosomiasis (TrypTect CIATT). Annals of Tropical Medi-
by the mass treatment of villages with diethylcar- cine and Parasitology, 92, 837844.
bamazine 5 mg kg\ day\ for 3 consecutive days each Bacchi CJ, Nathan HC and Livingston T (1990) Dierential
susceptibility to DL-alpha-diuoromethylornithine in clinical
month or quarterly doses of ivermectin (Ranque et al., isolates of Trypanosoma brucei rhodesiense. Antimicrobial
1996). Agents and Chemotherapy, 34, 11831188.
For the traveller, onchocerciasis is best prevented by Badaro R, Jones TC, Lorenco R et al. (1986) New perspectives on
the avoidance of endemic areas and the use of protective a subclinical form of visceral leishmaniasis. Journal of Infec-
clothing and insect repellents. Onchocerciasis is an im- tious Diseases, 154, 639649.
portant public health problem in West Africa and, as Barragan A, Spillmann D, Carlson J et al. (1999) The role of
such, several intensive eorts to control this devastating glycans in Plasmodium falciparum infection. Biochemical So-
disease using dierent approaches are ongoing. Success- ciety Transactions, 27, 487493.
ful vector control was rst achieved in 1951 by removal of Baruch DI, Gormley JA, Ma C et al. (1996) Plasmodium fal-
ciparum membrane protein 1 is a parasitized erythrocyte re-
all the riverside shade trees from a small area in Kenya. ceptor for adherence to CD36, thrombospondin and intercel-
Subsequent eorts at vector control have focused on the lular adhesion molecule 1. Proceedings of the National
larval stage. The Onchocerciasis Control Programme Academy of Sciences of the USA, 93, 34973502.
(OCP) began in 1974, and has successfully reduced trans- Bonnefoy S, Bischo E, Guillotte, M et al. (1997) Evidence for
mission over approximately 1.3 million km in 11 coun- distinct prototype sequences with the Plasmodium falciparum
tries. The basis of the OCP is the aerial spraying of ve Pf60 multigene family. Molecular Biochemical Parasitology,
insecticides (temephos, phoxim, pyraclofos, permethrin 87, 111.
122 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Bradley DJ and Warhurst DC (1995) Malaria prophylaxis: Gowda DC and Davidson EA (1999) Protein glycosylation in
guidelines for travellers from Britain. Malaria Reference Lab- the malaria parasite. Parasitology Today, 15, 147152.
oratory of the Public Health Laboratory Service, London. Green SJ, Scheller LF, Marletta MA et al. (1994) Nitric oxide:
BMJ, 310, 709714. cytokine-regulation of nitric oxide in host resistance to in-
Bruce-Chwatt LJ (1984) DNA probes for malaria diagnosis. tracellular pathogens. Immunology Letters, 43, 8794.
Lancet, i, 795. Guan L-R (1991) Current status of kala-azar and vector control
Burri C, Nkunku S, Merolle A et al. (2000) Ecacy of new, in China. Bulletin of the World Health Organization, 69,
concise schedule for melarsoprol in treatment of sleeping sick- 595601.
ness caused by Trypanosoma brucei gambiense: a randomised Haegele KD, Alken RG, Grove J et al. (1981) Kinetics of alpha-
trial. Lancet, 355, 14191425. diuoromethylornithine: an irreversible inhibitor of ornithine
Buscher P, Lejon V, Magnus E et al. (1999) Improved latex decarboxylase. Clinical Pharmacology and Therapeutics, 30,
agglutination test for detection of antibodies in serum and 210217.
cerbrospinal uid of Trypanosoma brucei gambiense infected Hagar JM and Rahimtoola SH (1995) Chagas heart disease.
patients. Acta Tropica, 73, 1120. Current Problems in Cardiology, 20, 825924.
Carcy B, Bonnefog S, Guillotte M et al. (1994) A large multigene Harries AD, Fryatt R, Walker J et al. (1986) Schistosomiasis in
family expressed during the erythrocytic schizogony of Plas- expatriates returning to Britain from the tropics: a controlled
modium falciparum. Molecular Biochemical Parasitology, 68, study. Lancet, i, 8688.
221233. Hommel M and Gilles HM (1998) Malaria. In Topley and Wil-
Carvalho MR, Krieger MA, Almeida E et al. (1993) Chagas sons Microbiology and Microbial Infections (eds FEG Cox, JP
disease diagnosis: evaluation of several tests in blood bank Kreier and D Wakelin), 9th edn, vol. 5, pp 361409. Arnold,
screening. Transfusion, 33, 830834. London.
Chiari E, Dias JCP, Lana M et al. (1989) Hemocultures for the Ismail M, Metwally A, Farghaly A et al. (1996) Characterisation
parasitological diagnosis of human chronic Chagas disease. of isolates of Schistosoma mansoni from Egyptian villagers that
Revista Da Sociedade Brasileira de Medicina Tropical, 22, tolerate high doses of praziquantel. American Journal of Tropi-
1923. cal Medicine and Hygiene, 55, 214218.
Chulay JD and Bryceson AD (1983) Quantitation of amastigotes Jakobsen PH, Bate CA, Taverne J et al. (1995) Malaria: toxins,
of Leishmania donovani in smears of splenic aspirates from cytokines and disease. Parasite Immunology, 17, 223231.
patients with visceral leishmaniasis. American Journal of Kalil J and Kunha-Neto E (1996) Autoimmunity in Chagas
Tropical Medicine and Hygiene, 32, 475479. disease cardiomyopathy: fullling the criteria at last. Para-
Croft A (2000) Extracts from Clinical Evidence. Malaria: pre- sitology Today, 12, 396399.
vention in travellers. BMJ, 321, 154160. Kar K (1995) Serodiagnosis of leishmaniasis. Critical Reviews in
Dennis DT and Kean BH (1971) Isolation of microlariae: re- Microbiology, 21, 123152.
port of a new method. Journal of Parasitology, 57, 11461147. Kirchho LV (1990) Trypanosoma species (American
Desowitz RS, Southgate BA and Mataika JU (1973) Studies on trypanosomiasis, Chagas disease): biology of trypanosomes.
lariasis in the Pacic. 3. Comparative ecacy of the stained In Principles and Practice of Infectious Diseases (eds GL Man-
blood-lm, counting-chamber and membrane-ltration tech- dell, RG Douglas and JE Bennett), 4th edn, pp 20772084.
niques for the diagnosis of Wuchereria bancrofti micro- Churchill Livingstone, New York.
laraemia in untreated patients in areas of low endemicity. Kirchho LV (2000) Trypanosoma species (American
Southeast Asian Journal of Tropical Medicine and Public trypanosomiasis, Chagas disease): biology of trypanosomes.
Health, 4, 329335. In Mandell, Douglas and Bennetts Principles and Practice of
Doherty JF, Moody AH and Wright SG (1996) Katayama fever: Infectious Diseases (eds GL Mandell, JE Bennett and R Dolin),
an acute manifestation of schistosomiasis. BMJ, 313, 1071 5th edn, vol. 2, pp 28452853. Churchill Livingstone, Philadel-
1072. phia.
Facer CA (1983) Erythrocyte Sialoglycoproteins and Plas- Kobayasi S, Mendes EF, Rodrigues MAM et al. (1992) Toxic
modium falciparum invasion. Transactions of the Royal Society dilatation of the colon in Chagas disease. British Journal of
of Tropical Medicine and Hygiene, 77, 524530. Surgery, 79, 12021203.
Fallon PG, Sturrock RF, Niang, AC et al. (1995) Short report: Leiby DA, Read EJ, Lenes BA et al. (1997) Seroepidemiology of
diminished susceptibility to praziquantel in a Senegal isolate T. cruzi, etiologic agent of Chagas disease, in US blood do-
of Schistosoma mansoni. American Journal of Tropical Medi- nors. Journal of Infectious Diseases, 176, 10471052.
cine and Hygiene, 53, 6162. Lejon V, Buscher P, Sema NH et al. (1998) Human African
Fernandez V, Hommel M, Chen Q et al. (1999) Small clonally trypanosomiasis: a latex agglutination eld test for quantify-
variant antigens on the surface of the Plasmodium falciparum- ing IgM in cerebrospinal uid. Bulletin of the World Health
infected erythrocyte are encoded by the rif gene family and are Organization, 76, 553558.
the target of human immune responses. Journal of Experimen- Looareesuwan S, Viravan C, Vanijanonta S et al. (1992) Ran-
tal Medicine, 190, 13931403. domised trial of artesunate and meoquine alone and in se-
Gardon J, Kamgno J, Folefack G et al. (1997) Marked decrease quence for acute uncomplicated falciparum malaria. Lancet,
in Loa loa microlaraemia six and twelve months after a single 339, 821824.
dose of ivermectin. Transactions of the Royal Society of Tropi- Looareesuwan S, Chulay JD, Caneld CJ et al. (1999) Malarone
cal Medicine and Hygiene, 91, 593594. (atovaquone and proguanil hydrochloride): a review of its
Gilles HM (1993) The malaria parasites. In Bruce-Chwatts Es- clinical development for treatment of malaria Malarone Clini-
sential Malariology (eds HM Gilles and DA Warrell), 3rd edn, cal Trials Study Group. American Journal of Tropical Medi-
pp 1234. Arnold, London. cine and Hygiene, 60, 533541.
Golino A, Duncan JM, Zelu B et al. (1992) Leishmaniasis in a Luse SA and Miller LH (1971) Plasmodium falciparum malaria:
heart transplant patient. Journal of Heart and Lung Transplan- ultrastructure of parasitised erythrocytes in cardiac vessels.
tation, 11, 820823. American Journal of Tropical Medicine and Hygiene, 20,
VECTOR-BORNE PARASITIC DISEASES 123
655660. ciples and Practice of Infectious Diseases (eds GL Mandell, JE
Makler MT, Palmer CJ and Ager AL (1998) A review of practical Bennett and R Dolin), 5th edn, vol. 2, pp 28312845. Churchill
techniques for the diagnosis of malaria. Annals of Tropical Livingstone, Philadelphia.
Medicine and Parasitology, 92, 419433. Pecoul B and Gastellu M (1999) Production of sleeping-sickness
Maroli M and Majori G (1991) Permethrin impregnated cur- treatment. Lancet, 354, 955956.
tains against phlebotomine sandies: laboratory studies. Polman K, Stelma FF, Gryseels B et al. (1995) Epidemiologic
Parassitologia, 33(suppl.), 399404. application of circulating antigen detection in a recent Schis-
Marsden PD, Barreto AC, Cuba CC et al. (1979) Improvements tosoma mansoni focus in northern Senegal. American Journal of
in routine xenodiagnosis with rst instar Dipetalogaster maxi- Tropical Medicine and Hygiene, 53, 152157.
mus (Uhler 1894) (Triatominae). American Journal of Tropical Pratlong F, Dedet JP and Marty P (1995) Leishmania-human
Medicine and Hygiene, 28, 649652. immunodeciency virus co-infection in the Mediterranean
Marshall I (1995) Schistosomiasis. In Medical Parasitology: A basin: iso-enzymatic characterisation of 100 isolates of the
Practical Approach (eds SH Gillespie and PM Hawkey), pp Leishmania infantum complex. Journal of Infectious Diseases,
191208. Oxford University Press, Oxford. 172, 323327.
Menard R (2000) The journey of the malaria sporozoite through Price RN, Nosten F, Luxemburger C et al. (1996) Eects of
its hosts: two parasite proteins lead the way. Microbes and artemisinin derivatives on malaria transmissability. Lancet,
Infection, 2, 633642. 347, 16541658.
Metzger WG, Haywood M, DAlessandro U et al. (1999) Ranque S, Garcia A, Boussinesq M et al. (1996) Decreased
Serological responses of Gambian children to immunization prevalence and intensity of Loa loa infection in a community
with the malaria vaccine SPf66. Parasite Immunology, 21, treated with ivermectin every three months for two years.
335340. Transactions of the Royal Society of Tropical Medicine and
Molyneux ME, Taylor TE, Wirima JJ et al. (1989) Clinical Hygiene, 90, 429430.
features and prognostic indicators in paediatric cerebral ma- Schreck CE, Kline DL, Chaniotis BN et al. (1982) Evaluation of
laria: a study of 131 comatose Malawian children. Quarterly personal protection methods against phlebotomine sand ies
Journal of Medicine, 71, 441459. including vectors of leishmaniasis in Panama. American Jour-
Muller R, Wakelin D (1998) Lymphatic lariasis. In Topley and nal of Tropical Medicine and Hygiene, 31, 10461053.
Wilsons Microbiology and Microbial Infections, 9th edn, vol. Seaman J, Boer C, Wilkinson R et al. (1995) Liposomal am-
5, pp 609619. Arnold, London. photericin B (AmBisome) in the treatment of complicated
Nabarro D (1999) Roll back malaria. Parassitologia, 41, kala-azar under eld conditions. Clinical Infectious Diseases,
501504. 21, 188193.
Newton CR, Kirkham FJ, Winstanley PA et al (1991) Intrac- Seed JR (1998) African trypanosomiasis. In Topley and Wilsons
ranial pressure in African children with cerebral malaria. Lan- Microbiology and Microbial Infection (eds F Cox, J Kreier and
cet, 338, 573576. D Wakelin), 9th edn, vol. 5, pp 267282. Arnold, London.
Nussenzweig RS and Nussenzweig V (1989) Antisporozoite vac- Shanks GD, Gordon DM, Klotz FW et al. (1998) Ecacy and
cine for malaria: experimental basis and current status. Re- safety of atovaquone-proguanil as suppressive prophylaxis for
views of Infectious Diseases, 11(suppl. 3), S579585. Plasmodium falciparum malaria. Clinical Infectious Diseases,
Nutman TB, Miller KB, Mulligan M et al. (1988) Diethylcar- 27, 494499.
bamazine prophylaxis for human loiasis Results of a double- Shi CJ, Premij Z and Minjas JN (1993) The rapid ParaSight2+-
blind study. New England Journal of Medicine, 319, 752756. F. A new diagnostic tool for Plasmodium falciparum infection.
Ochs DE, Hnilica V, Moser DR et al. (1996) Postmortem diag- Transactions of the Royal Society of Tropical Medicine and
nosis of autochthonous acute chagasic myocarditis by poly- Hygiene, 87, 2931.
merase chain reaction amplication of a species-specic DNA Sim BKL, Chinis CE, Wasniowska K et al. (1994) Receptor and
sequence of Trypanosoma cruzi. American Journal of Tropical ligand domains for invasion of erythrocytes by Plasmodium
Medicine and Hygiene, 34, 526259. falciparum. Science, 264, 19411944.
Okoye VC, Bennett V (1985) Plasmodium falciparum malaria: Siongkok TKA, Mahmoud AAF, Ouma JH et al. (1976) Morbid-
band 3 as a possible receptor during invasion of human eryth- ity in schistosomiasis mansoni in relation to intensity of infec-
rocytes. Science, 227, 169171. tion: study of a community in Machakos, Kenya. American
Olliaro P, Nevill C, LeBras J et al. (1996) Systematic review of Journal of Tropical Medicine and Hygiene, 25, 273.
amodiaquine treatment in uncomplicated malaria. Lancet, Smith JD, Chitnis CE, Craig AG et al. (1995) Switches in expres-
348, 11961201. sion of Plasmodium falciparum var genes correlate with
Ottesen EA and Ramachandran CP (1995) Lymphatic lariasis changes in antigenic and cytoadherent phenotypes of infected
and disease: control strategies. Parasitology Today, 11, erythrocytes. Cell, 82, 101110.
129131. Spielman A, Perrone JB, Teklehaimanot A et al. (1988) Malaria
Pasvol G, Jungery M, Weatherall DJ et al. (1982) Glycophorin as diagnosis by direct observation of centrifuged samples of
a possible receptor for Plasmodium falciparum. Lancet, 2, blood. American Journal of Tropical Medicine and Hygiene, 39,
947950. 337.
Pearson RD, de Alencar JE, Romito R et al. (1983) Circulating Su X-Z, Heatwole VM, Wertheimer F et al. (1995) The large
immune complexes and rheumatoid factors in visceral leish- diverse gene family var encodes proteins involved in cytoad-
maniasis. Journal of Infectious Diseases, 147, 1102. herence and antigenic variation of Plasmodium falciparum-
Pearson RD, Cox G, Jeronimo SM et al. (1992) Visceral leish- infected erythrocytes. Cell, 82, 8999.
maniasis: a model for infection-induced cachexia. American Sultan AA (1999) Molecular mechanisms of malaria sporozoite
Journal of Tropical Medicine and Hygiene, 47, 815. motility and invasion of host cells. International Microbiology,
Pearson RD, De Queiroz Sousa A and Jeronima SMB (2000) 2, 155160.
Leishmania species: visceral (kala-azar), cutaneous and mu- Valero MV, Amador R, Aponte JJ et al. (1996) Evaluation of
cosal leishmaniasis. In Mandell, Douglas and Bennetts Prin- SPf66 malaria vaccine during a 22-month follow-up eld trial
124 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
in the Pacic coast of Colombia. Vaccine, 14, 14661470. WHO (1992) Lymphatic lariasis: The Disease and Its Control.
van der Berg JD, Duvenage CS, Roskell NS et al. (1999) Safety Fifth Report of a WHO Expert Committee on Lymphatic
and ecacy of atovaquone and proguanil hydrochloride for Filariasis. World Health Organization Technical Report Series,
the prophylaxis of Plasmodium falciparum malaria in South 821, ivi, 171.
Africa. Clinical Therapeutics, 21, 714749. WHO (1995a) WHO Model Prescribing Information. Drugs used
Van Laetham Y and Lopes C (1996) Treatment of onchocer- in Parasitic Diseases, 2nd edn. World Health Organization,
ciasis. Drugs, 52, 861869. Geneva.
Villanueva MS (1993) Trypanosomiasis of the central nervous WHO (1995b) Onchocerciasis and its control: report of a WHO
system. Seminars in Neurology, 13, 209218. expert committee on onchocerciasis control. World Health
von Lichtenberg F, Sadun EH, Cheever AW et al. (1971) Experi- Organization Technical Report Series, 852, iviii, 1103.
mental infection with Schistosoma japonicum in chimpanzees. WHO (1998a) Control and surveillance of African try-
Parasitologic, clinical, serologic, and pathological observa- panosomiasis: report of a WHO expert committee. World
tions. American Journal of Tropical Medicine and Hygiene, 20, Health Organisation Technical Report Series, 881, IVI, 1114.
850893. WHO (1998b) International Travel and Health. Vaccination Re-
Wanderley DM (1993) Control of Triatoma infestans in the State quirements and Health Advice: Situation as on 1 January 1998.
of Sao Paulo. Revista Da Sociedade Brasileira de Medicina World Health Organization, Geneva.
Tropical, 26(Suppl. 3), 1725. WHO (2000a) Management of Severe Malaria: A Practical Hand-
Wertheimer SP and Barnwell JW (1989) Plasmodium vivax inter- book, 2nd edn. World Health Organization, Geneva.
action with the human Duy blood group glycoprotein: WHO (2000b) WHO expert committee on malaria (20th report).
identication of a parasite receptor-like protein. Experimental World Health Organization Technical Report Series, 892, iv,
Parasitology, 69, 340350. 174.
White NJ (1996) Can amodiaquine be resurrected? (letter: com- Xiao SH, You JQ, Yang YQ et al. (1995) Experimental studies on
ment). Lancet, 348, 11841185. early treatment of schistosomal infection with artemether.
White NJ, Warrell DA, Chanthavanich P et al. (1983) Severe Southeast Asian Journal of Tropical Medicine and Public
hypoglycemia and hyperinsulinemia in falciparum malaria. Health, 26, 306318.
New England Journal of Medicine, 309, 6166. Zheng HJ, Tao ZH, Cheng WF et al. (1990) Comparison of
White NJ, Krishna S, Waller D et al. (1989) Open comparison of Dot-ELISA with Sandwich-ELISA for the detection of circu-
intramuscular chloroquine and quinine in children with severe lating antigens in patients with bancroftian lariasis. American
chloroquine-sensitive falciparum malaria. Lancet, ii, Journal of Tropical Medicine and Hygiene, 42, 546549.
13131316. Zijlstra EE, Hassan AM, Ismael A et al. (1994) Emdemic kala-
WHO (1985) The control of schistosomiasis: report of a WHO azar in eastern Sudan: a longitudinal study on the incidence of
expert committee. World Health Organization Technical Re- clinical and subclinical infection and post kala-azar dermal
port Series, 728, 1113. leishmaniasis. American Journal of Tropical Medicine and Hy-
WHO (1991) Control of Chagas disease. World Health Organiz- giene, 51, 826836.
ation Technical Report Series, 811, ivi, 195.
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
MMMM
Section III
Figure 9.4 New World cutaneous leishmaniasis from Central Figure 9.5 Onchocerciasis from Central Africa. Erythematous
America. Ulcerated lesion with nodular violaceous border on the and pruriginous papules and nodules on the buttocks
external aspect of the wrist
The clinical picture of cutaneous leishmaniasis and the tries in Central and South America. Fast owing brooks
history of exposure in an endemic region of the world and small rivers provide breeding sites for the blacky
strongly suggest the diagnosis. Complementary tests in- vectors and only the female individuals are haema-
clude histology of lesional skin, slit-skin smears stained tophagous. They can bite potential hosts throughout the
with Giemsa for direct microscopy, and tissue samples for day, principally those pursuing outdoors activities. Holi-
culture in NNN medium, and for genetic analysis by day-makers as well as those travelling for professional
polymerase chain reaction (PCR) techniques. reasons risk acquiring this parasitic disease, but it is the
local population that suers the highest toll from both
clinical disease and subsequent disability.
Management and Treatment Following an approximate incubation period of 1 year,
the adult worms live freely in the skin or within brotic
The general public and health personnel easily establish nodules or cysts named onchocercomas. The female adult
the diagnosis of cutaneous leishmaniasis in endemic areas worm releases microlaria into the dermis, and they are
of the world and, following referral to a physician, one or disseminated by the lymphatic system. Adult worms may
more treatment options are available. However, in live and reproduce for up to 15 years in the human host.
nonendemic regions, and particularly in nontropical
countries, the returning traveller requires attention by an
experienced doctor in tropical medicine, infectious dis-
eases, or dermatology. Several drugs are eective against
Leishmania parasites and these include pentavalent anti- Clinical Findings and Diagnosis
monials, amphotericin B, triazole and alylamine antifun-
gal compounds; however, the only treatment of choice for The main clinical manifestations include pruritus and
a number of species is the intravenous administration of skin lesions, consisting of lichenied plaques, papular or
antimonials carefully monitored in hospital and adminis- prurigo eruptions, nodules, atrophic changes, and pig-
tered only by experienced personnel. In our experience, a mentary abnormalities. Early symptoms include fever,
dose of 20 mg kg\ body weight daily for 3 weeks has arthralgia, and transient urticaria aecting face and
been eective in curing most of our patients with New trunk. Pruritus and scratching lead to eczematization,
World cutaneous leishmaniasis caused by L. braziliensis. revealed as patches of lichenied and excoriated skin on
Patients require long-term follow up as leishmaniasis the trunk and lower limbs. The buttocks are commonly
may relapse in some cases. involved (Figure 9.5) and oedematous plaques are charac-
teristic in Latin American cases, named locally mal
morado. Late skin lesions show atrophy and hyper- and
Onchocerciasis hypopigmented patches, giving the appearance of leopard
skin described in African cases. The presence of laria in
Aetiology and Pathogenesis the ocular anterior chamber causes acute symptoms and
late ocular lesions lead to blindness.
This larial disease is acquired through the inoculation The parasitological diagnosis includes the identica-
into the skin of Onchocerca volvulus by blackies of the tion of microlaria in samples taken from skin snips from
genus Simulium. This infection, also named river blind- the back, hips, and thighs, specimens for histopathologi-
ness and Robles disease, is highly prevalent in Africa cal investigation and serology. Most patients develop
within latitudes 15N and 15S, and aects tropical coun- peripheral hypereosinophilia.
TROPICAL SKIN INFECTIONS 131
Management and Treatment After taking nourishment for several days, eggs are laid to
the exterior and the ea dies.
The treatment of choice for onchocerciasis is a single dose
of systemic ivermectin every 6 months. The surgical ex-
cision of nodules is indicated and all patients require Clinical Findings and Diagnosis
specialised attention in tertiary medical centres, including
a comprehensive ophthalmological assessment. An active These eas commonly aect one foot, penetrating the soft
programme of mass therapy for individuals living in en- skin on the toe web spaces, but other areas of toes and
demic regions of the world has been in place for more plantar aspects on the foot can be aected (Douglas-
than a decade. Jones et al., 1995). The initial burrow and the ea body
can be evident in early lesions but within 34 weeks a
crateriform single nodule develops, with a central
Gnathostomiasis haemorhagic point. Superimposed bacterial infections
may be responsible for impetigo, ecthyma, cellulitis, and
Aetiology and Pathogenesis gangrenous lesions.
The diagnosis is clinical but skin specimens for direct
A number of Gnathostoma species live as adult worms in microscopy and histopathology with H&E stain reveal
the intestine of domestic cats. Travellers can acquire the the structures of the ea and eggs.
disease by eating contaminated sh that have ingested
small crustaceans, acting as intermediary hosts in this
condition. The larval stages do not reach maturation in Management and Treatment
the human body and can cause disease in several internal
organs as well as in the skin. The disease is prevalent in Curettage, cryotherapy, surgical excision, or else careful
Southeast Asia, China, Japan, Indonesia, and Mexico. removal of the ea and eggs are the curative therapeutic
choices. Early treatment and avoidance of secondary in-
fection are of the utmost importance in all infested travel-
Clinical Findings and Diagnosis lers, and particularly in individuals with diabetes mellitus,
leprosy, or other debilitating conditions of the feet. A
Episodes of migrating intermittent subcutaneous oedema haemorrhagic nodule caused by T. penetrans may pose
with pruritus constitute the main clinical picture and dierential diagnostic diculty with an inamed
cases can adopt a chronic protracted course for years. common wart or a malignant melanoma but the short
The episodes of oedema can be quite inammatory and duration of the lesion and the history of exposure indicate
painful and the larvae can erupt out from the aected the acute nature of this parasitic disease.
skin. The feet are not aected commonly.
Myasis
Management and Treatment
Aetiology and Pathogenesis
The surgical extraction of the larva from the skin repre-
sents the curative therapeutic approach (Taniguchi et al., A number of diptera species in larval stages (maggots)
1992). may colonize the human skin. The infestation mechan-
isms include direct deposition of eggs, contamination by
soil or dirty clothes, other insects acting as vectors, or else
Tungiasis by actual penetration into the skin by larvae. Species of
Dermatobia and Cordylobia are the commonest found in
Aetiology and Pathogenesis the tropics, respectively in the Americas and Africa,
whereas European cases originate from Hypoderma spp.
Tungiasis is a localised skin disease commonly aecting (Lui and Buck, 1992). A local inammatory reaction to
one foot and caused by the burrowing ea Tunga penet- the larvae, with secondary infection, is responsible for the
rans. This is also known as chigoe infestation, jigger, signs and symptoms of disease.
sandea, chigoe, and puce chique (Fr.). It has been re-
ported that this ea originated in Central and South
America (Ibanez-Bernal and Velasco-Castrejon, 1996) Clinical Findings and Diagnosis
and was subsequently distributed in Africa, Madagascar,
India, and Pakistan. It is a very small organism, : 1 mm Elderly and debilitated individuals of both sexes with
in length, and lives in the soil near pigsties and cattle exposed chronic wounds or ulcers are at a higher risk of
sheds. Fecundated females require blood and their head suering from this infestation. Furunculoid and subcu-
and mouthparts penetrate the epidermis to reach the taneous forms may aect any part of the body, but in
blood and other nutrients from the supercial dermis. children the scalp is a commonly aected site. Chronic
132 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
ulcers of the lower legs and feet represent a predisposing from chronic crusted scabies may present with eczem-
factor and myasis often complicates severe infections by atisation, impetiginised plaques, and hyperkeratosis,
bacteria or fungi. Larvae feed on tissue debris and may masking the typical clinical signs of this infestation. Large
not cause discomfort or symptoms at all. Cases are ob- crusts covering inammatory papular lesions contain a
served throughout the year in tropical regions where the large number of parasites and a careful examination is
standards of hygiene, nutrition, and general health are required to prevent health personnel from acquiring the
poor. The diagnosis is based on clinical suspicion and infestation.
physical ndings. This problem is rarely seen in the re- The clinical ndings and intense pruritus support the
turning traveller. diagnosis. Conrmation is obtained by direct microscopy
of skin scrapings from a burrow, revealing the structures
or faecal pellets of the mite. This test is carried out on a
Management and Treatment glass slide in 1015% KOH solution under low power; it
has a low sensitivity if carried out by inexperienced hands.
The treatment of choice is the mechanical removal or
surgical excision of the larvae (Lui and Buck, 1992). Single
furunculoid lesions can be covered by thick petroleum
jelly or paste to suocate the larvae, which can then be
Management and Treatment
extracted. Supercial infestations respond to repeated
topical soaks or baths in potassium permanganate, at a
Topical treatment overnight with benzyl benzoate,
1: 10 000 dilution in water, carried out for a few days.
malathion, lindane, or permethrine, lotion or cream, is
Cases with secondary pyogenic infection require a full
usually eective. A second course is recommended 1014
course of -lactam or macrolide antibiotics.
days after the original application, and all the aected
members of a household or travelling party require treat-
ment at the same time to prevent cyclical reinfestations.
Scabies
Severe cases or individuals in particular community set-
tings, such as those living in homes for the elderly, or-
Aetiology and Pathogenesis
phanages, prisons, or psychiatry wards, require oral treat-
ment with a single dose of ivermectin, as originally
Scabies is a cosmopolitan problem but individuals in
described by E. Macotela in 1991 (personal communica-
poor tropical countries with low standards of hygiene,
tion). Severe outbreaks often require a second dose of
and particularly overcrowding, suer from cyclical out-
ivermectin after a 2 week interval (150200 g kg\ of
breaks of severe and chronic forms. Travellers often ac-
body weight). This drug can only be prescribed by a
quire this infestation by personal contact. The human
qualied physician. Other therapeutic measures are di-
scabies mite Sarcoptes scabiei commonly aects the skin
rected to controlling the symptoms, inammation, and
of both feet of infants and children. Adults rarely manifest
infection. Clothes and bedlinen require washing at high
scabies on the lower limbs below the knees (Hebra lines),
temperature to kill all young fecundated females but a
but exceptional cases of crusted or Norwegian scabies
number of authors have demonstrated that this is not
may present with lesions on both feet. The scabies mite
necessary. In the right epidemiological context, scabies
burrows a tunnel of up to 4 mm into the supercial layer
may represent a venereal disease. Pruritus may last for
of the epidermis, where eggs are laid. The eggs hatch and
several weeks after cure.
reach the stage of nymph and subsequently become an
adult male or female mite. Female individuals live up to 6
weeks and lay up to 50 eggs. A new generation of fecund-
ated females penetrates the skin in regions adjacent to the
nesting burrow, but the mite infestation can also be per- Ticks
petuated by clothes, or by reinfestation from another host
in the family. Aetiology and Pathogenesis
Figure 9.6 Tick bite from Western Africa. Erythema and char- Figure 9.7 Bites by Pulex irritans in a traveller. Clusters of
acteristic eschar in a patient who subsequently developed typhus erythematous and pruriginous papules on the lower limbs
Figure 9.8 Folliculitis on lower limbs. Erythematous and ex- Figure 9.11 Ecthyma on the chest of a backpacker. Pyogenic
coriated follicular papules ulcer following a friction blister caused by the strap of a rucksack
Mycobacterial Infections
Figure 9.14 Mycobacterium marinum infection of the hand in a
Aetiology and Pathogenesis patient from Hong Kong. Fish-tank granuloma with violaceous
nodules showing proximal lymphangitic dissemination
Several mycobacterial species can cause primary or sec-
ondary infection in the traveller. The swimming or sh- gers or dorsum of the hand but it has also been described
tank granuloma is an infection caused by Mycobacterium on the foot and other anatomical sites. M. marinum fre-
marinum. Other common chronic mycobacterial tropical quently infects freshwater sh and, hence, individuals
infections include leprosy, tuberculosis, and Buruli ulcer, handling sh tanks represent the main population at risk
but these conditions are not relevant for travellers. They (Gray et al., 1990). Direct inoculation into the foot pres-
are caused by M. leprae, M. tuberculosis, and M. ulcerans, ents with similar clinical ndings to those found in infec-
respectively. Mycobacterial skin diseases can be acquired tions of the upper limb. The disease manifests as a local-
by direct skin contact with a patient, by direct accidental ised, progressing swelling with variable pain, and the
or occupational inoculation, and by inhalation of the appearance, within a few weeks, of nodular or verrucous
infective organisms. Particular clinical forms of skin lesions on the aected area. These lesions can show
cutaneous tuberculosis result following haematogenous ulceration and bleeding from the disease process itself but
dissemination from a primary infection elsewhere. The also from mechanical trauma. The nodular lesions,
respiratory route is particularly important for leprosy measuring a few millimetres up to 23 cm, may resolve
and diverse forms of pulmonary tuberculosis. In the case spontaneously after a few months, but they can also
of Buruli ulcer it has been suggested recently that contact disseminate proximally by haematogenous or lymphatic
with infected water in rural areas of Africa may represent spread (Figure 9.14). The dorsal aspects of the hand, foot,
the main source of infection. A toxin called mycolactone and the malleolar regions are exposed to trauma and
seems to be responsible for the severe tissue destruction therefore direct inoculation commonly takes place on
and ulceration seen in patients with Buruli ulcer (Than- these regions. Once the condition is suspected, microbi-
garaj et al., 1999). In general, however, it is accepted that ological and histopathological investigations are the
agents causing mycobacterial skin diseases have a low most sensitive tests to conrm the clinical diagnosis.
pathogenic potential, as most infected individuals in en- Leprosy is a chronic disease that aects not only the
demic regions do not develop clinical mycobacterial dis- skin but particularly the peripheral nerves bilaterally. The
eases. hands and feet are the anatomical sites where inamma-
Mycobacteria are very complex organisms, most of tion, characteristic skin lesions, and nerve damage occur
them ubiquitous in nature as saprophytes, but a number in the course of leprosy. The commonest skin lesions are
of species cause disease in other animals. A very thick wall nodules, erythematous plaques, or hypopigmented
surrounds the cytoplasmic membrane of mycobacteria patches. Symptoms like hypo- or dysaesthesia, together
and contains virulence factors, such as proteins and with motor/sensory nerve abnormalities and obvious
glycolipids. Mycobacteria can inhibit an ecient phago- thickening of peripheral nerve branches, suggest the char-
cytosis and intracellular killing by macrophages and also acteristic demyelinating neuropathy of leprosy. Ad-
interact with the hosts immune cells. This interaction vanced disease manifests with skin atrophy, pigmentary
results in chronic inammation, tissue damage, and im- changes, and in severe cases chronic ulceration leading to
munopathology, all of which account for the signs and mutilation and disability (Figure 9.15). Mutilating lesions
symptoms observed in the wide range of mycobacterial of the hands and feet result from bone resorption, mech-
diseases. anical trauma, and secondary bacterial infection.
The clinical diagnosis of leprosy can be easily estab-
lished in most cases that occur in endemic regions of the
Clinical Findings and Diagnosis world (Bryceson and Pfaltzgra, 1990). Epidemiological,
clinical, histopathological, bacteriological, and immu-
The sh-tank granuloma aects more commonly the n- nological criteria have been used for many years to
TROPICAL SKIN INFECTIONS 137
a consequent degree of local skin insuciency. The clini-
cal diagnosis can be conrmed by histopathology, bac-
teriology, and PCR investigations.
Buruli ulcer aects mainly young individuals in rural
Africa, and particularly in West Africa, where an increase
in incidence has been reported (Thangaraj et al., 1999).
More than two-thirds of the total of cases present in
children below age 15. The initial lesions present as
papules or small nodules that slowly increase in size to the
point of causing an area of inammation and subsequent-
ly ulceration of the skin. The ulcer characteristically pres-
ents with undermined edges and manifests active indolent
phagedenism, often involving large areas of the aected
limb. A single ulcer or smaller, coalescing ulcers present
Figure 9.15 Hand neuropathy in a Mexican patient with lep- more frequently on the lower leg above the ankles but
rosy. Atrophic and dysautonomic skin with ulceration and distal other regions of the foot can be involved as well.
mutilation in a patient with bilateral ulnar, radial, and median Oedematous forms may progress rapidly and cause a
nerve damage panniculitis, with destruction of underlying tissues such
as fascia and bone. In cases where a large ulceration is
followed by healing, contractures of the aected limb
diagnose and classify the cases of leprosy within a disease result from scarring. Severe scarring and contractures
spectrum. This spectrum considers two polar groups or have been identied as a high morbidity factor for disabil-
forms, called tuberculoid and lepromatous, as well as ity and up to 10% of these cases require amputation of
intermediate forms of the disease dened as borderline. the deformed limb (Josse et al., 1994).
Early disease may not present characteristics of any of the
above groups and such cases are called indeterminate.
The evolution of leprosy is a dynamic process and a Management and Treatment of Mycobacterial
signicant number of cases cannot be classied easily at Infections
the time of diagnosis. All patients require long-term fol-
low-up as their place within the spectrum involves not All mycobacterial diseases require highly specialised di-
only therapeutic, but most importantly, prognostic impli- agnostic investigations that in many cases can only be
cations. Patients with early disease, and particularly carried out in a tertiary hospital setting. Most mycobac-
those presenting to the travel specialist in countries terial diseases aecting the skin represent public health
nonendemic for leprosy, often pose diagnostic diculties. priorities, not only for the endemic countries where they
The delay in establishing an accurate diagnosis and treat- occur but also at an international level, as established by
ment inevitably results in irreversible nerve damage and the World Health Organization (WHO). Following the
chronic complications with variable degrees of disability. diagnosis of individual cases, a long-term multidrug
Skin tuberculosis aects individuals of all ages and both therapeutic regimen can be prescribed only by specialised
sexes, presenting with a wide variety of clinical pictures physicians. Mycobacteria are known to develop resis-
that frequently aect the lower limbs and particularly one tance to antibiotics and it is imperative that all cases are
or both feet (Chopra and Vega-Lopez, 1999); however, treated with combinations of at least two drugs. The main
lupus vulgaris and papulonecrotic tuberculide are more drugs with antimycobacterial activity are rifampicin,
common in females, whereas tuberculosis verrucosa cutis ethambutol, pyrazinamide, clofazimine, sulfone,
is rare in children. By far the main clinical presentation of isoniazid, macrolide antibiotics, tetracyclines, and
cutaneous tuberculosis aecting the adult foot is called quinolones. The management of all mycobacterial dis-
tuberculosis verrucosa cutis, whereas cases of lupus vul- eases must include not only the medical treatment but
garis are commonly observed on the face. The tubercu- also a full range of educational initiatives aimed at the
lous bacilli cause disease following direct inoculation into patient, the community, and health personnel. Early
the skin but clinical disease can also result from haema- lesions of sh-tank granuloma, skin tuberculosis, and
togenous dissemination. Unilateral and asymmetrical in- particularly those caused by Buruli ulcer require surgical
volvement is the rule in almost all cases of skin tuberculo- excision.
sis. Commonly observed asymptomatic lesions include
dry patches of atrophic skin, pigmentary changes, nod-
ules, and plaques of verrucous lesions. The typical plaque Bacterial Mycetoma
of tuberculosis can measure between 2 and 12 cm in diam-
eter, but chronic and larger lesions can involve most of Aetiology and Pathogenesis
the foot dorsum and lateral aspects. The course of
cutaneous tuberculosis is indolent and chronic, but deter- Nocardia, Actinomadura, and Streptomyces species are
mines skin atrophy and variable degrees of scarring with the common aetiological agents of Madura foot or
138 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
tuberculosis, and sarcoidosis are the main conditions to
consider. Direct microscopy to disclose the grains dis-
charged from sinus tracts conrms the diagnosis and the
culture of this material also provides a denite diagnosis
of actinomycetoma.
African tick typhus Rickettsia conorii Ixodid tick Rodents, dogs Africa, Mediterranean
(boutonneuse
fever/Mediterranean
spotted fever)
Siberian tick typhus R. sibirica Ixodid tick Rodents Russia, Central Asia
Queensland tick typhus R. australis Ixodid tick Marsupials, rodents Australia
Solar Urticaria
Sunburn
This is a rare disorder in which UVA, UVB and visible
This is an acute delayed transient response to UV radi- light may produce itchy wheals after a few minutes expo-
ation and the clinical features are easily identied by sure. Tingling sensation and erythema precede the devel-
travellers. These include erythema and tenderness, but opment of whitish wheals which fade within a few hours.
severe cases manifest with blistering, oedema and pain. It is more common in female individuals, who become
Systemic symptoms of headache and malaise are aected between 10 and 50 years of age. It may rarely be
common. Prevention with adequate sunscreens is most associated with lupus erythematosus and the treatment
important. The acute treatment consists of topical cor- includes avoidance of exposure, use of adequate sun-
ticosteroids, cool wet dressings, systemic aspirin, and bed screens, and antihistamines.
rest away from direct, reected, or refracted sunlight.
Figure 9.29 Actinic keratoses on the forehead. Erythematous Figure 9.31 Squamous cell carcinoma of the scalp. Hyper-
lesions with supercial ulceration in a patient with severe sun keratotic and verrucous ulcer with tissue destruction and fast
damage growth
Figure 9.32 Malignant melanoma of the upper chest in a pa- Figure 9.33 Acute urticaria from drugs, showing large
tient with a history of sun exposure in the tropics erythematous wheals lasting for a few hours in a recurring pat-
tern
trunk in males (Figure 9.32) and lower leg in females. The
main clinical variants are:
Supercial spreading: most common form; irregularly
pigmented macule.
Nodular: less common, presents as pigmented nodule
and may ulcerate.
Acral lentiginous: most common form in black-skinned
and Asian individuals; presents as pigmented macule
on palms or soles or nail bed.
Lentigo maligna melanoma: presents as irregular pig-
mented macule or chronically photodamaged skin, of-
ten on the face of elderly patients.
Amelanotic melanoma: nonpigmented friable nodule;
clinically may be confused with other benign skin
lesions such as pyogenic granuloma.
Figure 9.34 BrocqLyell syndrome in a patient from
The treatment of melanoma must be managed by ex- Bangladesh. Severe toxic epidermal necrolysis from car-
perienced physicians and includes excision with adequate bamazepine
margins, evaluation for metastases, chemotherapy and
immunotherapy, as appropriate.
10
Travelers Diarrhea
Luis Ostrosky-Zeichner
University of Texas Houston Medical School, Houston, Texas, USA
Charles D. Ericsson
University of Texas Houston Medical School, Houston, Texas, USA
Travelers diarrhea, also known as Montezumas revenge, The frequency with which specic microorganisms cause
Aztec two-step, Delhi belly, Gyppy tummy, Turkey trots disease varies somewhat around the world (Table 10.1),
and turista, is usually dened as the passage of 34 un- but the majority of the identied causal organisms are
formed stools in a 24 h period plus at least one symptom bacterial (Petola and Gorbach, 1997). The most common
of enteric disease, such as abdominal pain, cramps, cause of travelers diarrhea is enterotoxigenic Escherichia
nausea, vomiting, fever, or tenesmus (DuPont and Erics- coli (ETEC). In some regions of the world Campylobacter
son, 1993; Ericsson and DuPont, 1993). Less severe forms jejuni is a relatively common cause of travelers diarrhea,
of the syndrome (e.g. 12 loose stools per day) are fre- especially during the winter season. Aeromonas species
quently caused by the same enteropathogens but prob- are a frequent cause of diarrhea in parts of Southeast
ably do not need to be treated symptomatically or speci- Asia. Invasive bacterial pathogens (Shigella, Salmonella
cally because they are mild and short-lived (Ericsson et and Campylobacter) on average cause more severe, lon-
al., 1994). Some denitions of diarrhea consider the vol- ger-lasting disease than that caused by ETEC. Salmonella
Trimethoprim-sulfamethoxazole Two DS? tablets as a single dose The loading dose regimen led to a statistical
One DS tablet b.i.d. for 3 days benet that is not clinically relevant. Rising
Two DS tablets (loading dose), then one DS resistance worldwide has limited its usefulness
b.i.d. for 3 days
Fluoroquinolones
Noroxacin 400 mg b.i.d. for 3 days Double doses can be used for single-dose
Ciprooxacin 500 mg b.i.d. for 3 days therapy. Other uoroquinolones like
Ooxacin 200 mg b.i.d. for 3 days eroxacin and peoxacin should be eective
Levooxacin 500 mg q.d. for 3 days
Azithromycin 500 mg (loading dose) then 250 mg q.d. for 4 Optimal dosing is under investigation. Highly
days eective agent in recent studies
1000 mg as a single dose
Rifaximin 200400 mg t.i.d. for 3 days Not absorbed
Aztreonam Not absorbed. Eective in studies but not
available
and DuPont, 1993). Choice of a specic antimicrobial Many studies have veried the ecacy of antimicrobial
agent has been determined, in part, by a growing under- agents in both the prevention and the treatment of the
standing of the many causes of travelers diarrhea and syndrome. Antibiotics can limit the course of diarrhea to
increasing antimicrobial resistance among some of the approximately 1 day. Untreated diarrhea lasts over 3
enteropathogens (Petola and Gorbach, 1997). days. The benets of antibiotic therapy include signicant
reductions in the total duration of diarrhea, earlier relief
of accompanying symptoms like cramps, and a decrease
Oral Rehydration Therapy and Feeding in the amounts of time spent in bed and missing or
altering planned activities. Some experts still consider
Oral rehydration solution is a cost-eective, elegantly that antibiotics have little role in the empiric treatment of
simple treatment for dehydrating diarrhea. The addition travelers diarrhea (Petrucelli et al., 1997). While it is true
of glucose to electrolyte-containing solutions facilitates that travelers diarrhea is a self-limited disease, in the
absorption of electrolytes. The output of uid is increased authors opinion the considerable relief aorded by anti-
by as much as 50% by aggressive uid replacement with biotic treatment argues against therapeutic nihilism.
traditional oral rehydration solutions. Furthermore, A number of antibiotics have been shown to be useful
travelers diarrhea is not usually a dehydrating disease. in the treatment of travelers diarrhea. For years
The addition of oral rehydration solution to therapy with trimethoprim-sulfamethoxazole (TMP-SMX) was an ex-
loperamide makes no dierence to the recovery of the cellent choice for treatment of travelers diarrhea, and
patient with the usual travelers diarrhea. The use of oral trimethoprim alone could be substituted for patients who
rehydration solutions that contain complex sugars de- were allergic to sulfa preparations. TMP-SMX resistance
rived from rice or cereal can lower the output of diarrhea, around the world has increased so much that it is no
and such solutions should be studied in the treatment of longer a preferred empiric treatment choice.
travelers diarrhea. Currently, the most readily available of the active anti-
Early refeeding is recommended in children with diar- biotics for treatment are uoroquinolones such as nor-
rhea. In adults, dietary adjustment is often not necessary oxacin, ciprooxacin, ooxacin, enoxacin, eroxacin
because diarrhea abates so quickly with modern therapy. and others (Table 10.2). All appear to be highly eective,
When symptoms linger despite treatment, common sense so the choice of one should probably be based solely on
suggests that milk, fruits, vegetables, red meat, caeine the price.
and alcohol should be added to the diet only when diar- Nonabsorbed antibiotics (e.g. bicozamycin, aztreonam,
rhea has abated. Persisting or recurring symptoms should and rifaximin) were predicted to be less eective for the
prompt consideration of parasitic disease. treatment of diarrhea because antibiotic absorption and
high mucosal levels were thought to be necessary. How-
ever, these agents have been proven to be ecacious in
Antimicrobial Therapy treating diarrhea due to the full range of causal bacterial
agents, including those like Salmonella that cause in-
Kean rst demonstrated the successful prevention of tracellular infection. The theoretic reason for preferring
travelers diarrhea with antimicrobial agents in 1963. nonabsorbed agents is that they should engender fewer
158 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
side-eects and should be safer to use in children and Antibiotic resistance has developed during treatment
pregnant women, in whom the currently preferred of Campylobacter disease with the quinolones. Symptoms
quinolones are contraindicated. With the exception of have relapsed despite having responded initially. When
rifaximin, which is available in some countries but not quinolones are used as agents of choice for self-therapy in
worldwide, companies have been slow to develop such areas where Campylobacter are common causes of
agents further, presumably because the market is not travelers diarrhea, the patient might need to be armed
large enough to satisfy their economic motivations. with a course of azithromycin to take in the event that
Erythromycin is eective in Campylobacter disease and quinolone-treated disease relapses. Alternatively,
has been shown to be eective in the prevention of rifaximin could be prescribed in place of a
travelers diarrhea, probably owing to its activity against uoroquinolone if it is available. Azithromycin needs
Gram-negative enteric organisms in the alkaline milieu of more study before it can be advocated as front-line ther-
the gut. Erythromycin, however, has not been studied for apy.
the treatment of travelers diarrhea. The azalide, azi- We provide clients with 3 day courses of a quinolone
thromycin, has been studied in Campylobacter disease, for self-therapy. We ask them to re-evaluate themselves
and it is also ecacious (Kuschner et al., 1995). In vitro when the next dose of antibiotic would be due. If they are
studies predict that azithromycin should be active in still passing unformed stools, or fever or passage of
treating travelers diarrhea. bloody stools was a feature of their disease, we recom-
Certain antibiotics are available over the counter in mend that they nish the full 3 days of antibiotic. Other-
many developing countries and local physicians might wise, we feel that single-dose antibiotic therapy usually
recommend them. These include ampicillin, which is sim- suces.
ply not active enough around the world to be an eective
choice. Furazolidone is active not only against bacterial
causes of travelers diarrhea but also against Giardia. This Symptom Management
feature can be a benet in some regions of the world like
Russia, where the risk of acquisition of Giardia appears to Less severe disease can be treated with a variety of nonan-
be exceptionally high. The problem is that furazolidone is tibiotic agents (Table 10.3). Bismuth subsalicylate (BSS)-
only about one-half as eective as the preferred containing compounds decrease the number of unformed
quinolones in the treatment of the common bacterial stools passed after beginning treatment by almost 50%.
causes of travelers diarrhea. The antisecretory and antimotility agent, loperamide, is
Increasing resistance around the world has limited the more ecacious than BSS. Neither is as eective as an
usefulness of doxycycline. Chloramphenicol is cheap and antibiotic.
readily available over the counter in many countries, but Some studies with antimotility agents such as
its rare but devastating bone marrow toxicity limits its diphenoxylate suggested that the agents might prolong
widespread recommendation. Clioquinol was studied the course of disease caused by invasive enteropathogens.
many years ago with variable results. It was taken o the In a small number of prisoners, shigellosis was treated
market in many countries because of serious ophthal- with an antibiotic and diphenoxylate. Shedding of
mologic adverse eects. Doxycycline, chloramphenicol Shigella and fever where prolonged. Patients with bloody
and clioquinol cannot be recommended. diarrhea treated with diphenoxylate alone had a longer
The duration of treatment with antibiotics has steadily course of disease than did placebo-treated subjects. The
decreased with ongoing study. Now a single dose of anti- use of antimotility agents should be avoided in the treat-
biotic can be recommended for most patients (DuPont ment of Clostridium dicile disease. Conversely, current
and Ericsson, 1993; Ericsson and Rey, 1997). The invasive research indicates disease is not prolonged when patients
pathogens and severe disease are the causes and clinical are able to take an antibiotic when they feel they are not
state that might require lengthier therapy than a single getting enough relief from loperamide. Also, cipro-
dose. As a rule Shigella responds to single dose therapy, oxacin plus loperamide treats Shigella dysentery more
but disease caused by S. dysenteriae appears best treated eectively than ciprooxacin alone (Murphy et al., 1993).
with a 3-day course of antibiotic. Fortunately, S. dysen- Loperamide is absorbed rapidly and acts more quickly
teriae is an uncommon cause of travelers diarrhea. More than BSS preparations, which take nearly 4 h to begin
study is needed before single-dose therapy can be recom- having their eect. Loperamide is a safe drug that is
mended condently for Campylobacter disease. In areas available over the counter. It is approved for use in
of the world where C. jejuni is especially prevalent (e.g. children as young as 3 years old.
Southeast Asia), at least a 3 day course of antibiotic is The prescription product diphenoxylate plus atropine
recommended. Probably 3 day therapy should be prefer- (Lomotil) is popular, but the drug is not as ecacious as
red over single-dose therapy to treat winter-time diar- loperamide in the treatment of diarrhea and has a rela-
rhea, because Campylobacter is a relatively more tively unfavorable side-eect prole. Elderly men can
common cause of winter-time diarrhea in regions where it suer urinary retention due to the atropine. Lomotil is
is otherwise not a common cause of travelers diarrhea habit forming and central nervous system side-eects are
during peak summer-time travel (e.g. Morocco and possible.
Mexico). Other symptomatic drugs that have been advocated in
TRAVELERS DIARRHEA 159
Table 10.3 Symptomatic treatment of travelers diarrhea
Attapulgite 3 g initially and after each loose stool for a Safe in pregnancy but only marginally
total of 9 g per day eective
Bismuth subsalicylate 30 ml (1 ounce) every half hour for a total of Rinse mouth carefully. Brush teeth and
preparations 240 ml (8 ounces) tongue after evening dose
Loperamide 4 mg loading dose, then 2 mg after each loose Over-the-counter directions limit total daily
stool, not to exceed 16 mg per day dose to 8 mg. Oral hydration does not add to
symptomatic relief aorded by loperamide
Zaldaride maleate Not yet marketed. Calmodulin antagonist
SP 303 Mechanism of action not known. Not yet
approved but alternatively available as a
natural preparation
the past include the anticholinergic agents, activated predicted to become more severe or last many days. We
charcoal, Lactobacillus preparations, polycarbophil, advise longer-term travelers such as expatriates to with-
methylcellulose, psyllium, and kaolin/pectin preparations hold antibiotic treatment for travelers diarrhea unless
(Petrucelli et al., 1997). All of these are not eective for the more than two loose stools are passed. Some disease
treatment of travelers diarrhea with the exception of begins so explosively that therapy should logically be
attapulgite (a hydrated aluminum silicate clay prepara- begun before passage of a third loose stool. Figure 10.1
tion), which performed well enough in trials to recom- outlines our approach to the treatment of travelers diar-
mend it for mild diarrhea. Attapulgite is a safe product rhea.
that can be recommended for use in pregnant women. It
causes a more formed stool; however, net losses of water
and electrolytes persist unabated.
Recent studies have shown that a new and novel cal- HEALTH ADVICE AND PROTECTIVE
modulin inhibitor, zaldaride, is useful in decreasing the MEASURES
duration of diarrhea from an average of 42 h in untreated
subjects to an average of 20 h (DuPont et al., 1993; Ok- As shown in Figure 10.2, options for the prevention of
huysen et al., 1995). The drug worked both in ETEC travelers diarrhea include education, vaccination and
disease as well as in other bacterial diseases, suggesting a chemoprophylaxis with either BSS-containing com-
common role for calmodulin for the pathogenesis of diar- pounds or antibiotics (Ericsson and Rey, 1997). Although
rhea. A loading dose will likely be necessary for optimal vaccination is a promising option, vaccines against all
use. Zaldaride is not yet marketed worldwide. Still an- enteropathogens that cause travelers diarrhea will prob-
other agent, the antisecretory drug SP303, shows promise ably never be possible or cost-eective owing to the large
in the symptomatic relief of travelers diarrhea. number of strains that cause disease. Promising vaccines
The combination of an antibiotic and loperamide has against ETEC and Shigella are not available for routine
been studied with the usual dose of each agent. In one use (Ericsson and Rey, 1997).
study more than half of the patients passed no further
unformed stools once combination therapy was begun.
The average duration of diarrhea was only a few hours, Education
even when patients had blood in stools at enrollment.
This result was superior to treatment with either agent The problem with education as an approach to preven-
alone and was conrmed in subsequent studies (Ericsson tion is achieving and maintaining behavior modication
et al., 1997). Some studies have not veried such remark- among tourists. The tourist too often has a carefree atti-
able results, either when Campylobacter was a common tude, wants intentionally to sample new culture and food
cause of disease or when disease among placebo controls and has consumed alcohol, which disinhibits all travelers.
was relatively mild. Catchy phrases like boil it, cook it, peel itor forget it
are simply not practiced. Business travelers appear to
have fewer episodes of diarrhea than do most tourist
Algorithmic Approach to Treatment travelers. The business traveler faces occasionally meals
of exotic and risky foods that cannot be refused easily.
Among all travelers developing diarrhea, approximately While not studied, a single dose of an eective antimi-
40% will have mild self-limiting disease that ceases within crobial should be eective in preventing most causes of
a day or two, with passage of no more than two unformed diarrhea after such a risky meal.
stools per day (Ericsson and DuPont, 1993). Once a third Many travel experts have given up trying to educate
loose stool is passed within a 24 h period, diarrhea can be travelers about safe culinary practices. The problem is
160 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Figure 10.1 Algorithmic approach to the treatment of travelers diarrhea. (a) Long-term travelers are encouraged to endure mild
diarrhea to develop some immunity. (b) Business travelers on short, critical trips might consider earlier addition of a single dose of
antibiotic. (c) Reassess symptoms when second dose of uoroquinolone is due. Discontinue therapy if diarrhea has abated. A single dose
of antibiotic usually suces
A 1985 Consensus Development Conference in age immunity to develop against some enteropathogens.
Washington concluded that travelers diarrhea was self- Might tourists using preventative antibiotics in a devel-
limiting and did not cause mortality; therefore, antibiotic oping country promote the emergence of antibiotic resis-
prophylaxis should not be used owing to rare but severe tance? Subtherapeutic doses of antibiotic used by in-
side-eects. Further, the consensus was that BSS should digenous persons in a developing country are probably
not be used because patients might abuse an over-the- much more important to the development of resistance
counter preparation. than antibiotic use by a relatively small number of tour-
In our clinic we do not oer prophylaxis routinely, but ists.
are willing to discuss the issue with any traveler who The bivalent cation in BSS interferes with the absorp-
expresses an interest in using prophylaxis. We discourage tion of doxycycline. This interaction might jeopardize
prophylaxis of travelers diarrhea with antibiotics except malaria prevention by lowering serum doxycycline con-
in certain high-risk hosts. We recommend BSS to most centrations below eective levels. Since the interaction
travelers who desire prophylaxis. We educate the traveler occurs when the two drugs are taken concomitantly, and
wanting prophylaxis about the pros and cons of chemo- since prophylactic BSS is taken four times a day, plenty of
prophylactic agents and let the traveler make the nal opportunity exists for drugdrug interaction. The combi-
decision. nation of BSS and doxycycline should be avoided.
Chemoprophylaxis, however, is not so straightforward. Finally, parasites, viruses and Clostridium dicile be-
In addition to possible adverse reactions, the cost of come relatively more likely causes of diarrhea when a
chemoprophylactic agents must be considered. Prophy- short-term traveler takes a prophylactic antibiotic and
laxis was found to be more cost-eective than treatment still develops diarrhea. These causes are ideally evaluated
for many travelers, when treatment with an antibiotic in conjunction with a visit to a physician, who can order
took, on average, longer than a day to cure the patient. stool studies in order to prescribe logical treatment. How-
Expensive vacation time was often lost. Treatment with ever, empiric treatment with metronidazole (followed by
an antibiotic plus loperamide has so shortened the course trimethoprim-sulfamethoxazole to treat Cyclospora if di-
of disease that vacation time is not often lost when diar- arrhea persists) is an option for the trekker or others
rhea is treated empirically and quickly. Treatment is when they are far removed from reliable medical care.
more cost-eective than prevention, with the exception of
trips that last only a few days. Chemoprophylaxis may
lead to complacency in food and beverage selection, thus Immunization
adding additional behavioral risks for acquiring parasitic
or viral disease against which an antibiotic has no or little Vaccination to prevent travelers diarrhea is limited by
activity. the number of available vaccines against the etiologic
The use of antibiotics can cause overgrowth of Can- agents and their ecacy.
dida, resulting in vaginitis. Overgrowth of Clostridium An oral vaccine for prevention of cholera (cholera
dicile can cause diarrhea. Some antibiotics seem to whole cell/recombinant B subunit) is available in some
promote infection with certain organisms such as parts of the world, and it appears to crossprotect some-
Salmonella and Campylobacter. what against ETEC disease. Cholera vaccination is not
Early, eective antibiotic treatment can obviate the necessary for most tourists, because they are simply not at
immune response to an enteropathogen. Expatriates risk unless they insist on eating raw seafood or are forced
probably should not take chemoprophylaxis to prevent to live under deplorable conditions (e.g. some Peace
diarrhea and should not treat mild disease with an anti- Corps volunteers and refugee workers). Vaccination
biotic (Ericsson et al., 1994). This approach might encour- against typhoid with the preferred oral Ty21a (or parent-
TRAVELERS DIARRHEA 163
eral Vi) vaccine is easy and devoid of bothersome side- Medicine and Health (eds HL DuPont and R Steen), pp
eects. However, risk of typhoid is very low among tour- 8691. Decker, Hamilton, Ontario.
ists, and vaccination is generally limited to travelers who Ericsson CD, DuPont HL and Mathewson JJ (1994) Epi-
demiologic observations on diarrhea developing in US and
plan to stay longer than 3 weeks in a developing country
Mexican students living in Guadalajara, Mexico. Journal of
or who avowedly are adventurous eaters. Vaccination Travel Medicine, 2, 610.
against Shigella and other enteric agents is currently un- Ericsson CD, DuPont HL and Mathewson JJ (1997) Single dose
der investigation. New so-called DNA vaccine technol- ooxacin plus loperamide compared with single dose or three
ogy and novel vaccine delivery systems (e.g. fruit and days of ooxacin in the treatment of travelers diarrhea. Jour-
vegetables) promise to revolutionize the eld of vaccines nal of Travel Medicine, 4, 37.
and might have an important impact on risks for Kuschner R, Trofa AF, Thomas RJ et al. (1995) Use of azi-
travelers diarrhea in the future. thromycin for the treatment of Campylobacter enteritis in
Milk immunoglobulins against ETEC have provided travelers to Thailand, an area where ciprooxacin resistance is
prevalent. Clinical Infectious Diseases, 21, 536541.
passive protection for a particular strain. Perhaps due to
Mattila L (1994) Clinical features and duration of travelers
high development costs, further development of this ap- diarrhea in relation to its etiology. Clinical Infectious Diseases,
proach has faltered. 19, 728734.
Murphy GS, Bodhidatta L, Echeverria P et al. (1993) Cipro-
oxacin and loperamide in the treatment of bacillary dysen-
REFERENCES tery. Annals of Internal Medicine, 118, 582586.
Okhuysen PC, DuPont HL, Ericsson CD et al. (1995) Zaldaride
DuPont HL and Ericsson CD (1993) Prevention and treatment malaete (a new calmodulin antagonist) versus loperamide in
of travelers diarrhea. New England Journal of Medicine, 328, the treatment of travelers diarrhea: randomized, placebo-con-
18211827. trolled trial. Clinical Infectious Diseases, 21, 341344.
DuPont HL, Ericsson CD, Mathewson JJ et al. (1993) Zaldaride Petola H and Gorbach SL (1997) Travelers diarrhea: epidemiol-
maleate, an intestinal calmodulin inhibitor, in the therapy of ogy and clinical aspects. In Textbook of Travel Medicine and
travelers diarrhea. Gastroenterology, 104, 709715. Health (eds HL DuPont and R Steen), pp 7886. Decker,
Ericsson CD and DuPont HL (1993) Travelers diarrhea: ap- Hamilton, Ontario.
proaches to prevention and treatment. Clinical Infection Dis- Petrucelli BP, Kollaritsch H and Taylor DN (1997) Treatment of
eases, 16, 616624. travelers diarrhea. In Textbook of Travel Medicine and Health
Ericsson CD and Rey M (1997) Prevention of travelers diarrhea: (eds HL DuPont and R Steen), pp 92100. Decker, Hamilton,
risk avoidance and chemoprophylaxis. In Textbook of Travel Ontario.
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
11
Vaccine-preventable Disease
Jane N. Zuckerman
Royal Free and University College Medical School, London, UK
Diphtheria (infants) 0.5 ml i.m. (as DTP) 3 doses at 4-weekly School entry and
intervals leaving
Diphtheria (adults) 0.5 ml i.m. 10 years
Tetanus (infants) 0.5 ml i.m. (as DTP) 3 doses at 4-weekly School entry and
intervals leaving
Tetanus (adults) 0.5 ml i.m. (or as Td) 10 years
Poliomyelitis (infants) Oral/i.m. 3 doses at 4-weekly School entry and Human normal
intervals leaving immunoglobulin, live
Poliomyelitis (adults) Single dose 10 years viral vaccines,
tuberculin skin test
Haemophilus inuenzae 0.5 ml i.m. 3 doses at 4-weekly NA
intervals
Measles, mumps, rubella 0.5 ml i.m. Single dose School entry Human normal
immunoglobulin, live
viral vaccines,
tuberculin skin test
BCG (at birth for high 0.1 ml i.d. Single dose NA Live viral vaccines
risk or between 10 and
14 years)
Hepatitis B (universal) 0.51.0 ml i.m. 3 doses; 0,1 and 6 NA
months
Inuenza 0.5 ml i.m. Single dose; 2 doses at Annually
0, 46 weeks for 13
years old
Pneumococcal 0.5 ml i.m. Single dose 510 years
?Based upon schedules of immunisation applicable to the United Kingdom. Individual countries may follow dierent schedules.
i.d. : intradermal; i.m. : intramuscular; NA : not applicable.
?Based upon schedules of immunisation applicable to the United Kingdom. Individual countries may follow dierent schedules.
i.d. : intradermal; i.m. : intramuscular; NA : not applicable; s.c. : subcutaneous.
VACCINE-PREVENTABLE DISEASE 173
parenteral vaccine is administered in order to satisfy the swelling at the site of injection.
entry requirements of some countries. This is accom-
panied by a valid International Certicate of Vaccination
against cholera, which is valid for a period of 6 months. Haemophilus Inuenza
Such procedures avoid travellers being subjected to quar-
antine rules or vaccination at a border, with its inherent Immunisation with Hib vaccine has now become a com-
risks. ponent of the routine childhood immunisation pro-
gramme in industrialised countries, where it is adminis-
tered simultaneously with the combination vaccine DTP.
Diphtheria As a conjugate polysaccharide vaccine, it provides en-
hanced immunogenicity which is of particular import-
Routine childhood immunisation against diphtheria has ance in providing protection for infants under the age of 4
been instigated for many years throughout the indus- years, the highest risk group. It is also recommended for
trialised countries of the world. In the United Kingdom, use in asplenic or immunosuppressed children and adults,
diphtheria vaccine has been administered routinely as in whom a single dose of vaccine will protect against
part of the national childhood immunisation programme serious respiratory disease. This may well be relevant for
since 1940, with a schedule of administration of 0.1 ml such individuals travelling where the risk of exposure
vaccine at 2, 3 and 4 months of age by the intramuscular may be high in developing countries. Booster doses are
route, now combined with tetanus and pertussis, (DTP). not recommended.
Booster doses of diphtheria and tetanus (DT) are given at
school entry, followed by a dose of tetanus and low-dose
diphtheria (Td) when leaving school. Consequently, Hepatitis A
travellers born before 1940 should be considered as either
naturally immune or they might not have received a Vaccination against hepatitis A is recommended for all
primary course of immunisation. travellers visiting areas outside northwestern Europe,
Although diphtheria has been eliminated in indus- North America, Australia and New Zealand, where the
trialised countries, travellers may continue to be exposed risks of infection from contaminated food and water and
to a risk of diphtheria throughout the world, with disease close contact with the local population may be high.
being imported from Africa and the Indian subcontinent, Those at risk include a wide group of travellers, e.g. short-
as well as from the Russian Republic and Independent and long-term travellers, expatriates, aid/health care
Federations, where there has been an epidemic for several workers, missionaries and military personnel, and those
years, since 1991. Therefore, adult travellers to endemic travellers with underlying medical conditions such as
areas and expatriates and aid/health care workers de- chronic liver disease, where infection with another hepa-
ployed to such countries, who have previously received a tic virus may result in an increased burden on the liver,
primary course of diphtheria vaccine, should receive a leading to morbidity and mortality in this group. The
low-dose booster, 0.5 ml at 10-yearly intervals. For risks of infection with hepatitis A have been estimated as
children over the age of 10 years and adults who may not three cases per 1000 travellers per month of travel in a
have been previously immunised against diphtheria, a tourist resort, which rises to 20 cases per 1000 travellers
primary course of three doses of low-dose monovalent per month of travel outside tourist resorts. As the preva-
diphtheria vaccine should be administered at monthly lence of infection with hepatitis A has been estimated as
intervals in order to minimise any local or systemic side- 1.4 million cases per annum worldwide, this supports the
eects or the possibility of a reaction, if naturally immune. fact that hepatitis A is the most frequent vaccine-prevent-
A low-dose booster of diphtheria (d) alone or in combina- able disease in travellers.
tion with tetanus (Td), where appropriate, may then be The available vaccines are both highly immunogenic
given at 10-yearly intervals. It is strongly advised that and protective when administered intramuscularly at day
infants receive a complete course of immunisation before 0 with a booster at 612 months, which confers long-term
travelling to developing countries. protection of between 10 and 20 years. Protective levels of
An alternative for those who require protection against hepatitis A antibody are reached within 710 days of the
both diphtheria and tetanus is a combination vaccine primary dose, and immunisation with a single dose of
using a full dose of diphtheria and tetanus toxoid vaccine hepatitis vaccine only confers protection for up to 1 year.
(TD) intramuscularly, which is available as a paediatric It is well known that compliance with the rst booster at
preparation. It is also licensed for use in children over 10 612 months is often poor and so, in terms of practical-
years old and for adults, with this formulation containing ities, this rst booster dose may be administered safely
low-dose diphtheria and a full dose of tetanus (Td). This is and eectively at any time after the rst dose, which
of value to those travellers who may require either a represents the primary course for this vaccine. At present,
primary or a booster dose of both vaccines at the time of further booster doses are recommended at 10-yearly in-
travel (see below, Tetanus). Neither the monovalent nor tervals but, as this is a highly immunogenic vaccine, fur-
the combination vaccines are associated with serious ther experience is likely to indicate that this may be
side-eects, the most common of which are pain and unnecessary. Recent research has demonstrated the pres-
174 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
ence of protective antibody levels for up to 20 years by (1.0 ml; over 16 years) use by the intramuscular route,
using a model of statistical extrapolation determining the with the primary course being administered at day 0, 1
kinetics of antibody decay. month and 6 months. The corresponding levels of anti-
As a result of the paradoxical shift in seroprevalence, body protection achieved at each of these time points are
adults over the age of 40 years, including those who may 94%, 99% and 100% for hepatitis A, and 34%, 97% and
have a history of jaundice or have lived in an endemic 99% for hepatitis B. Booster doses of the monovalent
area for several years, may be naturally immune to hepa- hepatitis A vaccine should be administered at 10-yearly
titis A. In such circumstances, vaccination may not be intervals, with that of the monovalent hepatitis B recom-
necessary and natural immunity may be determined by mended at 5-yearly intervals at present for those travel-
serological testing of the presence of hepatitis A antibo- lers at continued high risk. No serious side-eects have
dies (IgG). been reported using this combination vaccine. Recent
Both adult (0.1 ml) and paediatric (0.5 ml licensed for clinical trial data have demonstrated that the hepatitis A
those over the age of 1 year) vaccine formulations are now and B vaccine may be administered at an accelerated
available. Minor side-eects, such as swelling and pain at schedule on days 0, 7 and 21, with a booster at month 12,
the site of injection, may be experienced, with systemic with eective levels of protection at 1 month of 99%, 96%
eects, such as nausea and fever, occurring infrequently. at 12 months and 100% at 13 months for hepatitis A, and
The availability of this immunogenic vaccine should dis- 82%, 94% and 100%, respectively, for hepatitis B.
pense with the use of the hepatitis A immunoglobulin Travellers, especially those travelling at short notice, will
preparation whose immunological properties are much certainly benet from the availability of this schedule
inferior to those of the active vaccine (see below, Im- once licensure has been obtained.
munoglobulins). Hepatitis A vaccine induces an adequate
level of seroprotection within 710 days of vaccination
and will provide some degree of protection to an individ- Combined Hepatitis A and Typhoid Vaccine
ual travelling at short notice, depending upon their risk of
exposure. Some travellers may not reach the high-risk Another combination vaccine recently licensed in the
destination for several days after immunisation. How- United Kingdom is that of hepatitis A and typhoid. Li-
ever, for those travellers who may be exposed more quick- censed currently for those aged 15 years and over, 1.0 ml
ly, the human normal immunoglobulin preparation may of vaccine administered intramuscularly will confer pro-
be used simultaneously, but at a dierent anatomical site, tection against hepatitis A and typhoid within 14 days.
with the vaccine in order to provide more immediate Booster doses of the monovalent typhoid vaccine must be
protection. Recent studies have demonstrated that hepa- administered at 3-yearly intervals, while that of the
titis A vaccine is able successfully to prevent outbreaks of monovalent hepatitis A vaccine must be given at 612
disease when used without the immunoglobulin prepara- months initially, followed by 10-yearly intervals. Again,
tion, by providing either protection or attenuation of no serious side-eects have been reported with the use of
infection with hepatitis A, which is aorded by use of the this vaccine.
vaccine following exposure. This may therefore have im- The future development of routine universal im-
plications for the use of hepatitis A vaccine for those munisation programmes against hepatitis A, such as
travelling at short notice. those being introduced in the United States and several
A recent communication from the Public Health Lab- southern Mediterranean countries, will be of benet to
oratory Service in the United Kingdom has recommen- future generations of travellers, who will be protected well
ded that, due to the lack of availability of human normal in advance of their travels. It could also be surmised that
immunoglobulin, active vaccination using the licensed future universal immunisation programmes will include
hepatitis A vaccines is the preferred option for the protec- the use of the combination hepatitis A and B vaccine,
tion of travellers. Human normal immunoglobulin will therefore providing concurrent dual long-term protection
only be made available for the protection of household against both types of viral hepatitis.
contacts of conrmed cases of hepatitis A and to control
outbreaks.
Hepatitis B
Combined Hepatitis A and B Vaccine Protection against hepatitis B has gained greater import-
ance for all types of travellers who may be exposed to
Recent advances in combination vaccines have resulted in hepatitis B by virtue of many risk activities as well as
the availability of two dierent multivalent vaccines, one destination. It has been estimated that there are 2 billion
containing hepatitis A and hepatitis B antigen (see below, people infected with hepatitis B and more than 350 mil-
Hepatitis B) and the other being hepatitis A and typhoid lion carriers of disease throughout the world. The risks of
antigen (see below and Typhoid). These vaccines may be infection to travellers has been estimated to be 80240
suitable for those travellers at dual risk of exposure to cases per 100 000 travellers per month of stay for long-
these diseases. The combined hepatitis A and B vaccine is term travellers and 210 times lower among short-term
licensed for both paediatric (0.1 ml; 115 years) and adult travellers. Therefore, hepatitis B is the second most
VACCINE-PREVENTABLE DISEASE 175
common vaccine-preventable disease in travellers. The below, Immunoglobulins).
risk factors which may lead to subsequent infection with Universal immunisation against hepatitis B has been
hepatitis B include sexual behaviour, medical or dental successfully implemented in more than 100 countries
intervention, which may follow an accident or an adven- throughout the world, with the objective of eliminating
ture sports activity, acupuncture, tattooing, body pierc- this disease. Introduction of such programmes will ensure
ing, haircuts, sharing razors and toothbrushes; all of these protection against infection for all high-risk groups, in-
may result in transmission of bloodborne viruses. Travel cluding those of travellers, both present and future. Dual
health care professionals should consider vaccination and concurrent protection against both hepatitis A and B
against hepatitis B for those travelling outside north- by use of the combination vaccine may be recognised in
western Europe, North America, Australia and New Zea- future universal immunisation programmes.
land, including long- and short-term travellers, those at
occupational risk, e.g. aid/health care workers including
expatriates, missionaries and the military, those with pre-
existing medical conditions who may require medical Immunoglobulins
attention while abroad, and young children who may be
in contact with other young children in an endemic area. The administration of immunoglobulins has been mostly
Hepatitis B vaccine is licensed for administration by superseded by the advent of improved methods of im-
the intramuscular route by several dierent schedules and munisation with new and improved active vaccines.
is also available following the use of the combination Human normal immunoglobulin provides immediate
hepatitis A and B vaccine (see above, Hepatitis A). Mono- protection against infection with hepatitis A, measles,
valent hepatitis B vaccine may be administered by the mumps, rubella and varicella in particular, as high titres
following schedules: of these circulating antibodies are found in the popula-
tion from whom pooled plasma donations are sought.
0, 1 and 6 months with a booster at 5-yearly intervals
This preparation may, in theory, cause interference with
for those at continued high risk.
the immune response to live virus vaccines by competitive
0, 1 and 2 months with a booster at 12 months.
inhibition. It is therefore recommended that live vaccines
0, 12 and 24 months (licensed schedule in the United
are administered a minimum of 3 weeks before or 3
States).
months after human normal immunoglobulin in order to
Days 0, 7 and 21, with a booster at 12 months only for
reduce this possibility. In practice, this may be dicult to
those over 18 years of age. The levels of seroprotection
achieve when a traveller is travelling at short notice. For
achieved are 65% within 1 week of the course and 98%
those travellers who may be exposed to an immediate risk
1 month after the booster dose. This schedule of im-
of disease, both an active live vaccine and human normal
munisation is ideal for those travelling at short notice.
immunoglobulin may be administered simultaneously at
It is currently only licensed for use in Europe.
dierent sites in order to confer immediate protection.
The combined hepatitis A and B vaccine may be adminis- This does not apply to the use of yellow fever vaccine as
tered as follows: antibodies to yellow fever are not present in a signicant
quantity, in the human normal immunoglobulin prepara-
0, 1 and 6 months.
tions available from European countries, to cause any
Nonresponse to hepatitis B vaccine occurs in approxi- inhibition. Also, the potential of interference with the
mately 1015% of adult vaccinees and is associated with immune response to OPV and simultaneous administra-
several factors, including incorrect administration, male tion of human normal immunoglobulin is negligible, par-
sex, increasing age ( 40 years), body mass index and ticularly when OPV is given as a booster dose.
haplotype. Hepatitis B vaccine must be administered in- Inactivated and toxoid vaccines may be given simulta-
tramuscularly in the deltoid muscle or anterolateral as- neously or at any time with human normal immuno-
pect of the thigh (see above, Route of Administration). globulin but at dierent anatomical sites. Concurrent
Consequently, it is advisable to check the hepatitis B administration of human normal immunoglobulin and
antibody response following vaccination with the pri- the rst dose of hepatitis A vaccine may result in the
mary course as well as boosters in the older traveller to production of lower hepatitis A antibody levels initially,
ensure that adequate levels of protection have been which has little clinical signicance owing to the subse-
achieved. The use of booster doses remains controversial, quent synergistic eect, which provides a high hepatitis A
but for those at continued high risk, e.g. aid/health care antibody level overall.
professionals and expatriates deployed to areas of high Other immunoglobulin preparations include those
endemicity, the administration of booster doses of hepati- which are specic for hepatitis B, tetanus, rabies and
tis B vaccine is recommended at 5-yearly intervals. varicella-zoster. All these preparations are highly specic
Travellers who have been exposed to a risk of infection with greater antibody titres than those present in human
with hepatitis B and are nonresponders or poor respon- normal immunoglobulin, as they are prepared from the
ders to hepatitis B vaccine should receive hepatitis B pooled plasma of individuals who have recovered from
specic hyperimmune globulin as well as a booster dose infection or have been immunised (see under relevant
of hepatitis B vaccine under specic medical guidance (see headings).
176 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Inuenza more rapid schedule may be considered for use, with two
doses given at 12 weeks apart, and the last dose must be
Infection with inuenza virus has been considered in the administered at least 10 days prior to travel to enable
context of travel-related diseases more recently, with adequate levels of protection to develop. This schedule
travellers contracting infection and international travel will confer immunity in 80% of vaccine recipients for
also encouraging the spread of the virus. In general, vacci- between 3 and 12 months. In the United States the vac-
nation is recommended for those aged 65 years and over, cine is also licensed for use in a schedule of days 0, 7 and
including those at high risk with chronic medical condi- 14. Booster doses are recommended at 2-yearly intervals
tions, e.g. diabetes mellitus, chronic respiratory disease or and an additional 1 ml dose of vaccine is recommended a
cardiovascular disease. In temperate climates during the month after completion of the primary course for travel-
winter, the same population may be at risk of exposure to lers over the age of 60 years. All travellers should also
inuenza after travel to tropical climates, where inuenza observe other methods of protection against mosquito
can occur throughout the year, or to temperate climates bites.
of the southern hemisphere when inuenza activity is at Japanese encephalitis is a reactogenic vaccine with an
its peak between April to October. Apart from the envi- incidence rate of severe reactions occurring following
ronmental considerations, such as season and destination administration of 510 per 10 000 doses and within 2
of travel, such individuals may be exposed to a greater weeks of the vaccination. Adverse reactions include ur-
than expected risk of infection by virtue of travelling with ticaria and angiooedema; vaccination is therefore recom-
a group of people and contact with air conditioning, mended at least 2 weeks prior to travel. The vaccine is
mechanisms by which respiratory-borne disease may be unlicensed in the United Kingdom, where it must be
easily transmitted. given on a named-patient basis.
Identical or very similar strains of the inuenza virus
circulate in the dierent hemispheres, and travellers at
high risk should be vaccinated with the current strain Lyme Disease
specic vaccine for that year. Although dierent strains of
the inuenza virus may circulate in tropical countries, the Lyme disease is a tick-borne disease endemic in the for-
same advice applies to travellers as mentioned previously. ested areas of northeast and north-central regions of the
Inuenza vaccines are administered intramuscularly and United States and Canada, as well as in parts of Asia and
are licensed for use for paediatrics and adults. Children northern European countries, e.g. Scandinavia, where dif-
under the age of 13 years should receive two doses of ferent strains of Borrelia burgdorferi, the causal organism,
vaccine administered 46 weeks apart for the primary exist. Travellers hiking, trekking or camping in these
course. Adults require a single dose as the primary course areas may be exposed to a risk of infection, particularly in
and, as with children, a booster dose is administered the spring and autumn.
annually. Inuenza vaccine is a well-tolerated vaccine, Until recently, the only methods of prevention of expo-
occasionally associated with fever and general malaise sure included the avoidance of walking through infested
which resolves within 48 h. Use of the vaccine is contrain- areas, the use of long-sleeved clothing and the use of
dicated in those with a severe egg allergy. It may also be insect repellent, i.e. N,N-dimethyl-m-toluamide (DEET),
advisable for travellers at high risk of the complications of on clothes and exposed skin to reduce the risk of the tick
inuenza infection to take antiviral agents for use as attaching itself. These presently remain the mainstay of
either prophylaxis or treatment of infection, as appropri- reducing exposure, except for people living in the United
ate. States where, recently, an eective recombinant inac-
tivated vaccine against Lyme disease has been licensed: it
provides protection against the specic strains of the
Japanese Encephalitis disease prevalent in the USA.
The vaccine is administered intramuscularly, with
Vaccination against Japanese encephalitis is recommen- three 0.5 ml doses at day 0, 1 month and 12 months with a
ded for travellers to Southeast Asia and the Indian Sub- level of seroprotection of 76% after three doses, which
continent who will be visiting an endemic rural area, falls to 49% after two doses, clearly indicating that the use
particularly for longer than 1 month during the appropri- of the vaccine should be supplemented by the other
ate season, which varies between countries within the methods of personal protection previously mentioned.
Asian subcontinent. The risk of infection is extremely low The vaccine is licensed for use in those aged between 15
and is estimated at approximately O 1 per million travel- and 70 years of age and is well tolerated with local side-
lers, which increases to 1 per 5000 for travellers visiting a eects being most commonly reported. Alternative sched-
rural endemic area. This risk depends upon the season, ules of administration are currently being evaluated and
location and duration of travel as well as the actual it is uncertain whether this vaccine will provide protec-
activities of the traveller. tion against infection with other strains of B. burgdorferi.
The vaccine is administered by deep subcutaneous in- Available data indicate that a booster dose of vaccine will
jection at days 0, 714 and 28 and is licensed for paediat- probably be necessary a year after completion of the
ric (0.5 ml for those 3 years) and adult (1.0 ml) use. A primary course. For detailed recommendations for the
VACCINE-PREVENTABLE DISEASE 177
use of Lyme disease vaccine, see Further Reading. administered rst and protection is required against
serogroup A, a 2 week interval should be observed before
the administration of the polysaccharide A and C vaccine.
Meningococcal Meningitis All other vaccines may be administered simultaneously
with the C conjugate vaccine, although those vaccines
Travellers are at risk of exposure to a specic strain of containing diphtheria or tetanus should be administered
Neisseria meningitides, serogroup A, which is found pre- at a 1 month interval in order to avoid enhanced reac-
dominately in sub-Saharan Africa (the meningitis belt), togenicity, as the carrier protein used in the conjugation
particularly during the dry season. Other countries where process includes the use of diphtheria toxin or tetanus
outbreaks of meningococcal meningitis group A occur toxoid.
include those within the Indian subcontinent. Travellers
at particular risk of infection include aid/health care
workers and expatriates visiting and living for extended Mumps, Measles and Rubella
periods within the indigenous population, backpackers,
asplenic children and adults, who are at particular risk The risk of travellers exposure to measles, mumps and
when visiting endemic areas. In recent years, following rubella is greatest from visits to tropical countries where
outbreaks of meningococcal disease in those attending these diseases remain endemic and routine vaccination
the Hajj, a certicate of immunisation against menin- programmes are not established, unlike those in indus-
gococcal meningitis has become mandatory for those trialised countries. Infants and young children born in
travelling to Mecca at the time of the Hajj; the certicate industrialised countries, who are going to live for pro-
must have been issued less than 3 years, and not less than longed periods in such areas, should receive their routine
10 days, before arrival in the country. childhood immunisations, including MMR, before travel,
Protection is aorded by the administration of a single which may necessitate immunisation at an earlier age
0.5 ml dose of polysaccharide serogroup A and C vaccine than recommended for the national immunisation pro-
administered intramuscularly, with booster doses recom- gramme. For those that have defaulted or have not re-
mended between 3 and 5 years. The polysaccharide A and ceived a complete course of immunisation, the risks of
C vaccine is a T-cell independent vaccine with poor im- infection should be clearly explained and immunisation
munogenicity in children under the age of 18 months, so a strongly recommended and administered before depar-
booster 1 year later is recommended for this age group. In ture. Susceptible adolescents, adults and women of child-
2000, a specic strain of Neisseria meningitides, serogroup bearing age should also be vaccinated with MMR before
W135, was identied as the cause of an outbreak of travel or living abroad. Individuals born before 1957 are
disease during the Hajj. Consequently, a quadrivalent generally considered to have natural immunity and are
polysaccharide, ACW135Y meningococcal meningitis therefore not susceptible to infection.
vaccine has been developed and is now the required men- MMR vaccine is administered as a single 0.5 ml dose at
ingococcal meningitis vaccine for travellers specically 1215 months of age, with a booster given at 35 years of
visiting Saudi Arabia for the Hajj. age in the United Kingdom and during infancy and pre-
Recently, a new conjugate serogroup C meningococcal school in other industrialised countries. The safety of
meningitis vaccine has been licensed in the United King- these vaccines should not be questioned, as the causal
dom for use in all high-risk groups, including infants, relationship between MMR and autism and Crohn dis-
children and adolescents. The introduction of this conju- ease remains unproven.
gate vaccine has been very eective, resulting in a 75%
decrease in the incidence of disease in a period of 1 year. Pertussis
Infants receive three doses of 0.5 ml vaccine at 2, 3 and 4
months, with children receiving two doses and adoles- As with other infectious diseases of childhood, pertussis
cents and adults receiving a single dose of vaccine. This immunisation is a well-established component of routine
vaccine does not provide crossprotection against the
childhood immunisation programmes throughout the in-
other serogroups; therefore, those individuals who have dustrialised world. Administered as part of the triple
received the new conjugate C vaccine must be immunised combination vaccines against diphtheria and tetanus as
with the polysaccharide A and C vaccine if travelling to
three doses at monthly intervals, the whole cell pertussis
an endemic area. vaccine has now been mostly superseded by the availabil-
Current available data indicate that an interval of 6 ity of the acellular formulation, the use of which is asso-
months should be observed between the administration
ciated with less adverse events. It is strongly advisable
of the polysaccharide A and C and the subsequent admin- that infants receive a complete course of immunisation
istration of conjugate C vaccine in young children in before travelling to developing countries.
order to provide enhanced protection. It is advisable for
those children who may be exposed to a high risk of
exposure to serogroup C to receive immunisation with Plague
the C conjugate vaccine within 2 weeks of the polysac-
charide vaccine. If the C conjugate vaccine has been Regions of the world where the potential for a plague
178 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
epidemic to occur include the Indian Subcontinent, South munosupression is present. A primary course of the live
America and Africa, but the risk to travellers is generally trivalent OPV consists of 0.5 ml of vaccine given at 1-, 2-
very low. If an epidemic were to occur, clearly travellers and 3-monthly intervals, and a booster dose is adminis-
would be advised to avoid travel to such areas. Aid or tered initially at 5 years and thereafter at 10-yearly inter-
health care workers deployed to an epidemic area may be vals throughout adulthood. Unimmunised adults should
vaccinated with an inactivated vaccine, which is not wide- receive the same schedule of immunisation. The oral
ly available. Three doses are administered intramuscular- preparation provides protection against wild virus polio-
ly at day 0, 13 months and 69 months and must be myelitis and contributes to the provision of herd immun-
supplemented by methods of personal protection includ- ity. However, faecal excretion of the vaccine strain of
ing the use of insect repellent, i.e. DEET, and appropriate poliomyelitis virus occurs up to 6 weeks following im-
clothing, as well as prophylactic antibiotics, e.g. tetracyc- munisation. Consequently, oral administration of vaccine
line if there is a high risk of exposure. If vaccine is unavail- may be rarely associated with vaccine-associated polio-
able, it may be prudent to administer prophylactic anti- myelitis in individuals who are susceptible to infection,
biotics and advice regarding methods of personal the incidence of which ranges from 1: 520 000 after the
protection if travel is absolutely unavoidable. rst dose to 1: 12 300 000 after subsequent doses. As this is
a disease of faecaloral transmission, individuals im-
munised with OPV must observe good methods of hy-
Pneumococcal Infection giene and sanitation in order to avoid transmission of the
vaccine strain. In the United Kingdom, the incidence of
Pneumoccocal infection may occur anywhere in the transmission of the vaccine strain has been estimated as
world but is of particular concern to those at high risk of two contact or recipient cases per 2 million doses of
infection in whom invasive disease may be a serious cause OPV administered. Therefore close and susceptible con-
of morbidity and mortality. This group includes those tacts of those who receive OPV should also be immunised
who are over the age of 65 years, are immunocom- or, if appropriate, receive a booster dose. Asymptomatic
promised, have an underlying chronic medical condition, HIV individuals may be given live OPV but consider-
e.g. diabetes mellitus or chronic respiratory or cardiovas- ation must be given to the fact that there is likely to be
cular disease or have asplenia or have undergone a sple- increased faecal excretion of the vaccine virus strain. It
nectomy. Asplenic individuals, travelling or otherwise, may be also be administered to HIV symptomatic indi-
are advised to receive inuenza, meningococcal and Hib viduals, but only at the discretion of a medical practi-
vaccine as well as pneumococcal vaccine. tioner.
Immunisation consists of a single 0.5 ml dose of an Oral polio vaccine may be given simultaneously with
inactivated polysaccharide vaccine administered intra- other live vaccines. If this is not feasible, then a period of 3
muscularly with a booster dose at 510 years, which is weeks should elapse before administration of another live
only recommended for those at signicant risk of serious vaccine in order to avoid inhibition of the immune re-
illness. It should be noted that there is an association with sponse to other live vaccines. Concurrent administration
rapid decay of antibody levels with polysaccharide vac- of oral polio and oral typhoid vaccines should be avoided
cines as they are not T-cell dependent, resulting in a poor because of the shared site of absorption and subsequent
amnestic response. immune response. OPV should also be administered 3
weeks before or 3 months after human normal immuno-
globulin to allow for a full immune response to develop. It
Poliomyelitis also contains penicillin, neomycin and streptomycin and
so its administration is contraindicated if there is extreme
Although the objective of WHO and the Expanded Im- hypersensitivity to these constituents.
munisation Programme is to achieve the eradication of Inactivated polio vaccine, including the enhanced po-
polio throughout the world, the disease remains endemic tency formulation, is administered intramuscularly for
in many countries in Africa and the Indian subcontinent. those in whom OPV is contraindicated, including the
Although industrialised countries worldwide introduced immunosuppressed, the pregnant and adults who have
national childhood immunisation programmes against not previously been immunised, including siblings and
polio between 1956 and 1962, polio remains endemic in other household contacts of immunosupressed individ-
some developing countries. Consequently, travellers, in- uals. Several countries recommend the use of the inac-
cluding aid/health care workers, are advised to receive tivated preparation in order to avoid any cases of vac-
booster doses to ensure maximum protection, particular- cine-associated poliomyelitis. The schedule of adminis-
ly when visiting endemic countries. It should also be tration is identical to that of the oral preparation.
remembered that individuals born before 1958 may never In the United States, enhanced inactivated polio vac-
have been immunised against poliomyelitis and so remain cine (eIPV) is administered routinely as part of the child-
susceptible to infection and its consequences. hood immunisation programme at 2, 4 and 618 months,
Immunisation against polio may be administered with a booster at 46 years. Unvaccinated adult travellers
either orally or by injection, the latter being given when should receive eIPV at day 0, 48 weeks and 612
the oral formulation is contraindicated, e.g. if im- months. If rapid protection is required, three doses of
VACCINE-PREVENTABLE DISEASE 179
vaccine may be given at 4-weekly intervals. If an unim- of doses of vaccine. In practical terms, preexposure pro-
munised adult is travelling and there may be insucient phylaxis provides a signicant level of protection in situ-
time to administer a course of eIPV, it would be advisable ations where postexposure treatment may be delayed.
to provide immunisation using the oral preparation, as Postexposure immunisation with ve doses of human
the risk of infection with wild virus poliomyelitis may be diploid cell vaccine, at days 0, 3, 7, 14 and 30, is recom-
greater than that of the vaccine strain. A single adult mended within 24 h for those who are susceptible to
booster at 10-yearly intervals is recommended. The oral infection, i.e. unimmunised or incompletely immunised
and inactivated preparations may be used interchange- individuals, and includes the administration of rabies-
ably; the latter does not contain penicillin. specic immunoglobulin. This must be given immediately
and within 7 days, with at least half being injected directly
into the site of the wound and the remainder given intra-
Rabies muscularly at a dierent anatomical site to that of the
vaccine. Rabies-specic immunoglobulin is obtained
Although rabies is present throughout the world, the risk from the plasma of immunised human donors and is
to travellers is minimal as this depends upon their chosen administered for rapid postexposure protection simulta-
destination and activities, i.e. potential contact with ani- neously with active vaccine. For those previously im-
mals where rabies is enzootic. Those specic groups of munised, two booster doses are recommended as soon as
travellers at particular risk include those travelling to an exposure has occurred and within 5 days to ensure maxi-
endemic country where they will be more than 24 h away mum protection, e.g. day 0 and 35 days. There is no
from medical assistance and the availability of rabies indication for the use of the immunoglobulin preparation
vaccine and immunoglobulin is poor, those staying for in this situation.
long periods in remote areas, and those at occupational Travellers who are immunosuppressed should be
risk while travelling, e.g. veterinarians, health and labora- strongly advised to avoid travel to situations where they
tory workers. may be placing themselves at risk of exposure to rabies
Pre-exposure immunisation includes the intramuscular infection, as immunisation with rabies vaccine may not
administration of 1 ml doses of inactivated human diploid confer signicant levels of protection.
cell rabies vaccine at days 0, 7 and 21 or 28. Boosters are
recommended at 23-yearly intervals for those at con-
tinued risk and may be associated with pain at the site of Rubella
injection. An alternative schedule of intramuscular ad-
ministration of rabies vaccine includes two doses of 1.0 ml Rubella immunisation is administered as the MMR vac-
of vaccine given 4 weeks apart, which confers 98% pro- cine (see previously). It is strongly advisable for infants to
tection but is recommended for use as long as postex- receive a complete course of immunisation prior to travel-
posure treatment is available. A further dose should be ling to developing countries. Susceptible adolescents,
administered 612 months later for those at continued adults and women of childbearing age should also be
risk. Intradermal administration of rabies vaccine is li- vaccinated against rubella prior to travel or living
censed in the United States according to the 0, 7 and 21 or abroad.
28 day schedule and, if administered correctly, serop- Immigrants may be susceptible to rubella infection as a
rotection may be achieved within 1 month of completion result of the dierent epidemiological prole of disease in
of the course. However, the antibody response following tropical climates. Individuals who immigrate after the age
intradermal administration is less vigorous than that of of completion of school immunisation programmes
intramuscular injection, which is the preferred method of should therefore receive rubella vaccine as a single 0.5 ml
immunisation. The intramuscular route is also preferred injection to avoid infection and the possibility of subse-
if antimalarial chemoprophylaxis is given concurrently quent transmission.
because of the inhibitory eects of chloroquine or mef-
loquine on the rabies vaccine antibody response. The
intradermal route may be used if it is completed in ad- Tetanus
vance of antimalarial chemoprophylaxis, i.e. at least 1
month before travel; the intramuscular route should be Vaccination against tetanus is recommended for all
used if this is not feasible. A rapid schedule of administra- travellers visiting any destination throughout the world
tion of rabies vaccine, presently unlicensed, may be used where the risk of infection remains high. Routine im-
for both rapid pre-exposure immunisation and postex- munisation against tetanus as part of the childhood im-
posure prophylaxis, with four single doses being adminis- munisation programme was introduced throughout the
tered into each limb. United Kingdom in 1961. Consequently, people born
If bites or scratches are sustained, pre-exposure vacci- before this may not have received a primary course of
nation does not circumvent the need for postexposure vaccination and may be at risk of infection.
treatment nor the application of rst-aid treatment; how- A primary course of inactivated tetanus vaccine is ad-
ever, it does both eliminate the need for administration of ministered intramuscularly as three doses of 0.5 ml of
rabies-specic immunoglobulin and reduce the number vaccine at monthly intervals. Infants receive a combina-
180 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
tion DTP vaccine as part of their routine immunisations, sider immunisation only for those at high risk, including
with booster doses of tetanus when entering and leaving aid/health care workers and travellers undertaking a long
school. Where appropriate, the combination vaccine of stay in an endemic area. In the United States, for example,
tetanus and low-dose diphtheria may be administered, it has been determined that the overall risk for acquiring
either as a primary course or as a booster for adults and milliary tuberculosis by the total United States popula-
children over the age of 10 years. In the United Kingdom, tion is low, and therefore a national immunisation pro-
it is felt that an adult who has received ve doses of gramme against tuberculosis has not been implemented.
tetanus vaccine does not require any reinforcing doses, Alternative methods of prevention are used, including the
except if a tetanus-prone injury has been sustained, at interruption of transmission through the use of tuberculin
which time human tetanus immunoglobulin should also skin testing for identication of cases and the subsequent
be administered. However, booster doses are recommen- appropriate administration of chemoprophylaxis. This
ded at 10-yearly intervals for travellers who may be inad- policy was introduced following consideration that BCG
vertently exposed to a risk and for whom the benets of is not immunogenic and it is associated with side-eects
vaccination with tetanus vaccine clearly outweigh the and loss of tuberculin skin test reactivity, so making
risks of infection with both tetanus and possible blood- interpretation of the test dicult if infection has truly
borne viruses as a result of the use of contaminated occurred.
medical equipment in a foreign country. In the United Kingdom and other European countries,
immunisation against tuberculosis is administered
routinely following a negative tuberculin skin test, for
Tick-borne Encephalitis children aged 14 years. The vaccine is given intradermally
in the deltoid as a 0.1 ml dose, which provides protection
Travellers, specically ramblers and those camping, are against the milliary and meningeal forms of tuberculosis
exposed to a risk of infection with tick-borne encephalitis for approximately 1015 years. This primary course pro-
when visiting the forested areas of central and eastern vides protection within 68 weeks.
Europe and Scandinavia, particularly during the summer Immunisation with BCG should be administered with
months. care as inadvertent subcutaneous administration may re-
The vaccine is administered intramuscularly as a pri- sult rarely in the formation of an injection site abscess.
mary course of two 0.5 ml injections given 412 weeks Keloid scars are also not unusual and can be avoided by
apart, which will provide protection for 1 year. A third immunisation using both the correct site and technique.
dose is given 912 months after the second dose and As BCG is a live vaccine, it may be given concurrently
confers immunity for 3 years. Booster doses are subse- with other live vaccines or after a 3 week interval. Admin-
quently recommended at 3-yearly intervals for those at istration of simultaneous vaccines should be avoided in
continued risk. Serious side-eects are uncommon. A spe- the same arm as BCG, so reducing the risk of regional
cic immunoglobulin preparation is available for both lymphadenitis.
preexposure and post-exposure use where appropriate. Tuberculin skin testing, used to determine the presence
The vaccine is available in the United Kingdom on a of immunity or active infection, should be performed
named-patient basis only, and additional methods of per- prior to immunisation with BCG in order to avoid unnec-
sonal protection should be aorded by the use of insect essary repeat BCG immunisation and the subsequent
repellents and appropriate clothing. development of a reaction if the individual is already
immune. Reimmunisation with BCG should only be con-
sidered if the tuberculin skin test is negative and a BCG
Tuberculosis scar is not evident.
The reaction to tuberculin testing must be interpreted
The worldwide risk of tuberculosis has gained increased with caution because glandular fever, viral infections, live
signicance with the emergence of drug-resistant tubercu- viral vaccines, immunosuppressive disease or treatment,
losis associated with the prevalence of HIV throughout and sarcoidosis may suppress it. If one of these is present
the world. Such areas include Africa and the Indian sub- at the time of the tuberculin test, the result of which is
continent, Southeast Asia, Central and South America. negative, the test should be repeated 3 weeks after recov-
Consequently, groups of travellers, including aid/health ery (using the other arm) before the administration of
workers and expatriates living in close contact with the BCG, in order to avoid a hypersensitivity reaction. Other
indigenous population in these areas for longer than a contraindications to the use of BCG include the presence
month, are at increased risk of exposure to tuberculosis. A of HIV infection, immunosuppression, pregnancy, fever
recent study estimated the risk of acquiring infection as and the presence of skin disease.
7.9 per 1000 person-months of travel for health care Several studies have demonstrated that booster doses
professionals and 2.8 per 1000 person-months for all of BCG do not provide additional protection and their
other long-term travellers. protective ecacy for travel to endemic areas remains
There is no worldwide consensus regarding the recom- unknown; however, the risks of infection associated with
mendations for use of the BCG vaccine. Although given travel to endemic countries have recently been demon-
as a routine immunisation in some countries, others con- strated to be signicant. This warrants a review of the
VACCINE-PREVENTABLE DISEASE 181
most appropriate strategy of prevention for travellers, Kingdom there are approximately 200 notied cases per
which will need to be country specic as national im- annum, of which 80% are associated with travel in the
munisation policies against tuberculosis dier. There has Indian Subcontinent. In comparison with the United
been considerable discussion regarding the administra- States, 464 patients with typhoid were reported between
tion of BCG vaccine and/or booster doses, or alternative- 1975 and 1984, of whom 62% had travelled abroad. It can
ly, the use of skin testing for travellers at risk of infection therefore be concluded that the incidence of typhoid in-
with Mycobacterium tuberculosis. fection in travellers is declining, due mostly to improve-
There are disadvantages associated with either ap- ments in hygiene and sanitation in many countries
proach. BCG vaccine may produce a false-positive skin throughout the world.
test, thus interfering with the ability of the skin test to Typhoid vaccine is currently available in two formula-
detect infection following travel. If booster doses of BCG tions, oral and by injection. Immunisation with a single
are given, interpretation of the puried protein derivative 0.5 ml dose for both children over the age of 18 months
(PPD) skin test must therefore be made with care. An and adults, administered intramuscularly, provides 70%
alternative approach, followed in the United States, is protection against infection, indicating that adjunct
that of undertaking skin testing both before and after methods of protection, including strict observance of food
travel. The pretravel skin test is used to establish the and water precautions, are necessary. The vaccine is asso-
baseline immunological status of the traveller, and this ciated with a suboptimal response in infants under the age
may be supported by the use of two-step testing in which of 18 months as the polysaccharide vaccine is not T-cell
the skin test may be repeated in order to conrm the dependent. A booster dose is required at 3-yearly inter-
presence of a baseline negative result. The post-travel skin vals in the United Kingdom (2-yearly for the United
test should also be interpreted with caution as false- States) for those at continued risk. The availability of
positives may occur owing to reactivation of previous polysaccharide vaccines has resulted in a decline in the
infection with tuberculosis, to previous BCG vaccination reactogenicity of typhoid vaccine, although some vac-
or to the presence of active infection, which then necessi- cinees do experience pain at the site of injection, a slight
tates active treatment. Two-step testing is therefore a fever and headache lasting for 24 h.
valuable tool in assessing the post-travel skin test result; The live oral typhoid vaccine is administered as one
however, the disadvantage of this strategy is that of con- capsule taken on 3 alternate days, i.e. days 1, 3 and 5,
siderable inconvenience for travellers, in whom compli- providing 62% protection against infection. The com-
ance may be dicult to achieve. plete course of three capsules must be taken to provide a
Another group of travellers to consider are immigrants, booster dose, at 3-yearly intervals; however, for those
including infants, children and adults, to industrialised travellers at continued high risk of exposure to infection
countries, who should receive a tuberculin skin test unless with typhoid, an annual booster course is recommended.
there is evidence of a BCG scar. Those whose response is The oral vaccine is well tolerated, with less reactogenicity,
positive should undergo further investigation to deter- and is rarely associated with diarrhoea or vomiting. Its
mine the presence of disease; those whose response is usefulness is complicated by the fact that it is licensed for
negative should be immunised with BCG as soon as use in children over the age of 6 years and adults, and
possible. Infants born subsequently should receive BCG there are theoretical concerns regarding its use when
immunisation within a few days of birth. Such protocols administered concurrently with antimalarial chemo-
should be followed because tuberculosis is once more prophylaxis or viral vaccines. Oral typhoid vaccine
becoming a public health concern, as demonstrated by an should not be given with meoquine or antibiotics: the
80% increase in notied cases of tuberculosis in the vaccine should be taken 12 h before or after meoquine
United Kingdom during the past 10 years, mostly at- and more than 24 h after a dose of antibiotics. The stan-
tributed to importation of disease. dard contraindications to the use of live vaccines apply
and the administration of live polio vaccine and oral
typhoid vaccine should be separated by at least 3 weeks
Typhoid unless travel is to be undertaken at short notice, at which
time oral typhoid may be administered before, simulta-
Typhoid aects an estimated 30 million people per an- neously or after live polio vaccine. This is to avoid the
num worldwide, resulting in approximately 600 000 potential of antibody response competition between the
deaths. The risk of infection to travellers is present two oral vaccines, whose site of action within the intesti-
throughout the world but particularly following travel to nal mucosa is similar. The schedule of administration of
the Indian subcontinent, Asia, South and Central Amer- the oral typhoid vaccine diers in the United States,
ica and Africa where hygiene and sanitation is limited. where the vaccine is licensed for use as one capsule given
The risk of infection to unprotected travellers residing in as four doses every 2 days, with a booster given every 5
industrialised countries, and who visit India and North years by way of repeating the full course.
Africa, has been estimated as 300 per 100 000 per month Overall, the currently available monovalent vaccines
of stay. However, for unprotected travellers visiting devel- provide 6080% protection against infection within 7
oping countries other than those previously mentioned, days of immunisation and travellers must therefore be
the incidence of infection declines tenfold. In the United advised about the observance of strict methods of per-
182 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
sonal, food and water hygiene as well. issued from designated yellow fever centres. It is valid for
The availability of a combination vaccine which pro- 10 years, beginning 10 days after the date of vaccination.
vides dual protection against both hepatitis A and ty- There are circumstances in which administration of yel-
phoid is of value to travellers to destinations where there low fever vaccine is contraindicated for medical reasons,
is a risk of exposure to both food- and water-borne dis- at which time an exemption certicate should be issued,
eases (see above, Hepatitis A). which will then be accepted by the authorities.
Yellow fever vaccine, a live attenuated vaccine, is ad-
ministered subcutaneously as a single 0.5 ml dose for
Varicella children aged 9 months and over and adults. The risk of
encephalitis following administration of yellow fever vac-
Protection against varicella-zoster virus (VZV) infection cine is greatest for those under 4 months old; if absolutely
through immunisation has been available since 1995 and necessary, infants aged 49 months old who may be ex-
this live attenuated vaccine is currently licensed for use in posed to a high risk of infection can be vaccinated. Al-
several countries, including the United States, although it though a highly immunogenic vaccine which probably
is available on a named-patient basis only in the United confers life-long immunity, a booster dose is required
Kingdom. The vaccine is administered subcutaneously as every 10 years for those at continued risk of exposure. As
a single 0.5 ml dose to healthy children aged between 12 a live vaccine, its use is contraindicated in the im-
months and 12 years. It may also be administered as two munosupressed, pregnancy and for those with a serious
0.5 ml doses given 48 weeks apart to children over the egg allergy or hypersensitivity to polymyxin and neo-
age of 13 years and to adults. Seroconversion rates of mycin. It may be administered simultaneously with hu-
97% have been demonstrated in infants receiving one man normal immunoglobulin and the same guidance
dose of vaccine, with consistently high levels of antibody applies to the administration with other live vaccines.
present for up to 10 years following completion of the The safety of immunisation with yellow fever vaccine
course. In those recipients over the age of 13 years, 78% has yet to be fully determined in asymptomatic HIV
seroconverted after the rst dose, rising to 99% after individuals. There are occasions when the risk of infection
completion of the course. would appear to be unavoidable, at which time an exemp-
The vaccine is recommended routinely for all children tion certicate may be provided, or, if absolutely necess-
aged 1218 months, susceptible adolescents and adults, ary, vaccination may be given for those individuals with a
including high-risk occupational groups, e.g. health care CD4 count 400 cells mm\. In these circumstances,
workers, and nonpregnant women of childbearing age immunisation may be less eective and protection should
following determination of their immune status to VZV. be aorded by other means, for example the use of insect
Immunisation with varicella vaccine should also be con- repellent and appropriate clothing.
sidered for susceptible travellers, as conrmed by
serological testing where appropriate. This applies par-
ticularly to those travelling to tropical countries, especial-
ly when close contact with the indigenous population is FURTHER READING
likely as varicella infection occurs predominantly in ado-
Ambrosch F, Wiedermann G, Andre FE et al. (1994) Clinical and
lescents and adults, with signicant morbidity and mor- immunological investigation of a new combined hepatitis A
tality in endemic countries. Recent immigrants from and hepatitis B vaccine. Journal of Medical Virology, 44,
tropical to temperate climates may also be at risk of 452456.
infection from the indigenous population to which they Anonymous (1998) World Health Organizations global pro-
migrate. Consequently, if the same group return to their gramme for vaccines and immunisation: recommendations
country of origin for a visit, they may inadvertently trans- from the Scientic Advisory Group of Experts. Weekly Epi-
mit varicella infection to those that they visit. demiological Record, 37(73), 281288.
Anonymous (2000) Inuenza vaccine. Weekly Epidemiological
record, 35, 281288.
Anonymous (2000) Hepatitis A vaccines. Weekly Epidemiological
Yellow Fever Record, 5, 3844.
Anonymous (2000) Human normal immunoglobulin: lack of
Areas of endemicity for yellow fever include sub-Saharan availability for travellers. Communicable Disease Report
Africa and Central and South America, with yellow fever Weekly, 10(34), 301.
vaccination recommended for travel to these destina- Anonymous (2000) Typhoid vaccines. Weekly Epidemiological
tions. Many countries require evidence of vaccination by Record, 32(75), 257264.
way of a certicate of vaccination from travellers arriving Bedford H and Elliman D (2000) Concerns about immunisation.
from, or who have been in transit through, endemic coun- BMJ, 320, 240243.
Bock HL, Loscher T, Scheiermann et al. (1995) Accelerated
tries in order to restrict the potential of infection being schedule for hepatitis B immunisation. Journal of Travel
imported into that country. The International Certicate Medicine, 2, 213217.
of Vaccination for Yellow Fever is a requirement of the Brown F, Dougan G, Hoey EM et al. (1993) Vaccine Design.
International Health Regulations of WHO and, as such, Wiley, Chichester.
the vaccine can only be administered and the certicate Centers for Disease Control (1988) Cholera vaccine: recommen-
VACCINE-PREVENTABLE DISEASE 183
dations of the Advisory Committee on Immunisation Practi- lers: tuberculosis comes home. Lancet, 356, 442443.
ces. Morbidity and Mortality Weekly Report, 37(40), 617618, Pervikov Y (ed.) (2000) Dengue and Japanese encephalitis vac-
623624. cines. Vaccine, 18 (suppl. 2).
Centers for Disease Control (1993) Inactivated Japanese en- Ryan CA, Hargett-Bean NT and Blake PA (1989) Salmonella
cephalitis virus vaccine: recommendations of the Advisoty typhi infections in the US 197584: increasing role of foreign
Committee on Immunisation. Morbidity and Mortality travel. Reviews in Infectious Disease, 11, 18.
Weekly Report 42 (RR-1), 115. Sagliocca L, Amoroso P, Stroolini P et al. (1999) Ecacy of
Centers for Disease Control (1996) Prevention of varicella: rec- hepatitis A vaccine in prevention of secondary hepatitis A
ommendations of the Advisory Committee on Immunisation infection: a randomised trial. Lancet, 353, 11361139.
Practices. Morbidity and Mortality Weekly Report, 45 (RR- Salisbury DM and Begg NT (1996) Immunisation against Infec-
11). tious Disease. Stationery Oce, London.
Centers for Disease Control (1996) Prevention of plague: recom- Sanchez JL and Taylor DN (1997) Cholera. Lancet, 349,
mendations of the Advisory Committee on Immunisation 18251830.
Practices. Morbidity and Mortality Weekly Report, 45 (RR- Scholtz M and Duclos P (2000) Immunisation safety: a global
14). priority. Bulletin of the World Health Organization, 78,
Centers for Disease Control (1999) Human Rabies Prevention 153154.
USA: recommendations of the Advisory Committee on Im- Scottish Centre for Infection and Environmental Health (1999)
munisation Practices. Morbidity and Mortality Weekly Re- Recommendations on hepatitisA immunisation for travel-
port, 48 (RR-1), 121. lers. SCIEH Weekly Report, 33, 173.
Centers for Disease Control (1999) Prevention of varicella: up- Steen R (1993) Hepatitis A and hepatitis B: risks compared with
dated recommendations of the Advisory Committee on Im- other vaccine-preventable diseases and immunisation recom-
munisation Practices. Morbidity and Mortality Weekly Re- mendations. Vaccines, 11, 518520.
port, 48 (RR-06), 15. WHO (2000) International Travel and Health. World Health
Centers for Disease Control (1999) Recommendations for the use Organisation, Geneva.
of Lyme disease vaccine: Advisory Committee on Immunisa- Zuckerman JN (1996) Non-respnse to hepatitis B vaccines and
tion Practices. Morbidity and Mortality Weekly Report, 48 the kinetics of anti-HBs production. Journal of Medical Vi-
(RR-07), 117. rology, 50, 283288.
Centers for Disease Control (2000) Poliomyelitis prevention in Zuckerman JN and Steen R (2000) Risks of hepatitis B in
the US: updated recommendations of the Advisory Commit- travellers as compared to immunisation status. Journal of
tee on Immunisation Practices. Morbidity and Mortality Travel Medicine, 7, 170174.
Weekly Report, 48 (RR-5). Zuckerman JN, Dietrich M, Nothdurft HD et al. (2000) Rapid
Cobelens FGJ, van Deutekom H, Draayer-Jansen IWE et al. protection against hepatitis A and hepatitis B following an
(2000) Risk of infection with Mycobacterium tuberculosis in accelerated schedule of a combined hepatitis A/B vaccine.
travellers to areas of high tuberculosis endemicity. Lancet, Antiviral Therapy, 5 (suppl. 1), 8.
356, 461465.
Department of Health et al. (1995) Health Information for Over-
seas Travel. Stationery Oce, London. ADDITIONAL RESOURCES
Hutin YJF and Chen RT (1999) Injection safety: a global chal-
lenge. Bulletin of the World Health Organization, 77, 787788. Centres for Disease Control and Prevention. Travellers Health.
Kane M, Banatvala J, Da Villa G et al. (2000) Lifelong protection
Health information for international travel. www.cdc.gov
against hepatitis B and the need for boosters. Lancet, 355,
561565. World Health Organisation. International Travel and Health:
Lifson AR (2000) Mycobacterium tuberculosis infection in travel- Vaccination requirements and Health Advice. www.who.int
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
12
Returned Travellers
Nicholas J. Beeching and Sharon B. Welby
Liverpool School of Tropical Medicine, Liverpool, UK
Why Did They Travel and What Did They Do? malaria prevention, the latter advice may not be heeded
in dicult eld conditions. Their activities may result in
Some occupational groups are inevitably at greater risk considerable exposure to a wide variety of soil-borne
of exposure to vectors and illness. Health care personnel pathogens, for example hookworms and Strongyloides
are particularly prone to the risk of needlesticks and spp, as well as to arthropod-borne and food- and water-
similar accidents, as well as dealing with patients with borne illnesses. Sexually transmitted diseases also con-
pathogens that can be spread by airborne droplets or by tinue to be a particular problem in military personnel and
direct contact with body uids and faeces. The diculties merchant seamen.
in preserving high levels of risk avoidance in a rural Table 12.3 summarises some of the typical risks asso-
hospital setting are all too common and emphasised by ciated with dierent patterns of exposure behaviour.
the tragic deaths of health care workers assisting patients
with Ebola infection in Uganda or CongoCrimean
haemorrhagic fever in South Africa, the Middle East Sexual History
(Suleiman et al., 1980) and Pakistan (Burney et al., 1980).
Tuberculosis has always been a problem for health care The importance of taking an appropriate sexual history
sta and remains a hazard for those working overseas in from travellers cannot be overemphasised. This poses
areas of high endemicity (Harries et al., 1997). problems in the busy practice, clinic or hospital setting
Other groups, such as veterinarians and agricultural but it is essential to include such enquiries as a matter of
workers, will be at increased risk of zoonotic infections routine. A suitable excuse needs to be found to exclude
such as brucellosis, Q fever and anthrax through contact parents, partners or friends who accompany the patient
with animals. Forestry workers, construction workers while this part of the history is taken. People go on
and other project workers may venture into forested or holiday to have fun, and for many this includes new
other rural ecosystems and be at risk of arthropod-borne sexual experiences, often associated with high-risk part-
diseases such as trypanosomiasis, onchocerciasis, loiasis, ners. This is particularly true for young adults. In one
lariasis, rickettsial infection, leishmaniasis and yellow British study, 74% of male migrant tourism workers in a
fever. popular coastal resort had sex with tourists, almost half
Aid workers and others in refugee or school settings are with more than four tourists, and only 40% of respon-
at risk of acquiring diseases of overcrowding such as dents had used a condom (Ford and Inman, 1992). Teen-
respiratory infections and meningococcal disease. Mili- agers are just as busy when visiting other European
tary personnel constitute a special group. Although they destinations, particularly those associated with the
may have received adequate immunisation and advice on dance-music scene. In a recent study performed in Ibiza,
190 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
over a third of 846 young adults attending music venues In-ight medical emergencies aect about 1/11 000
had taken recreational drugs, and 58% of males and 50% passengers and comprise a full range of medical problems,
of females had at least one new sexual partner during some of which need further attention when the patient
their 12 week stay. Twenty-six per cent did not use arrives, including the eects of overindulgence in alcohol
condoms and 23% had more than one sexual partner (Beighton, 1967; Dowdall, 2000; Goodwin, 2000). Recir-
(Bellis et al., 2000). We have observed similar risk behav- culation of air leads to sharing of pathogens, and the
iour in expeditioners and in long-term expatriates, often transmission of inuenza (Klontz et al., 1989) and tuber-
associated with high levels of alcohol use. culosis between air passengers is recorded (Driver et al.,
The risk of acquiring sexually transmitted infection 1994; Kenyon et al., 1996). Although the risk of tuberculo-
abroad is very high and includes traditional infections sis transmission is low and is limited to passengers near to
such as gonorrhoea (often multidrug resistant), syphilis, the index case, it generates considerable concern (Or-
chancroid and lymphogranuloma venereum (Adler, 1997; merod, 2000).
Wang and Celum, 1999). The prevalence of HIV in sex Passengers and crew on cruise ships are also exposed to
workers in many cities and towns in India, Thailand and conditions of crowding, and respiratory symptoms are
much of Africa exceeds 60% and is rapidly increasing in the most common reason for consultation (29%) during
many other parts of the world, including the Eastern bloc cruises. Although tuberculosis transmission has not been
countries, where syphilis is also reaching epidemic pro- reported in this setting, inuenza A outbreaks are well
portions (Tichonova et al., 1997). described and in the last decade several serious outbreaks
Rates of HIV infection in 2000 returning Dutch travel- of Legionnaires disease have been reported on cruise
lers were low (0.2%) in the late 1980s, despite consider- ships (Minooee and Rickman, 1999). Outbreaks of
able risk activity while overseas (Houweling and gastroenteritis are also commonly recorded, including
Coutinho, 1991) and compared with more than 1% in bacterial infections caused by pathogens such as Shigella
returning Belgian expatriate workers (Bonneux et al., spp, Salmonella spp and Vibrio spp. More devastating are
1988) and 1.2% of heterosexual male travellers seen in the frequently recorded explosive outbreaks of small
London (Hawkes et al., 1994). The improved recent round structured viruses, Norwalk and similar agents,
Dutch gures may reect improved attitudes to safe sex, particularly in an elderly population, although the major-
with an increase in condom use to 67% of occasions by ity of passengers so aected will be treated on ship and
the 23% of Dutch expatriates who had sex with casual recover before returning to shore.
local partners while on overseas assignments (de Graaf et Expedition travel is less hazardous than one might
al., 1997). In the UK, new heterosexual HIV infections expect. A recent questionnaire survey of 246 expedition
have outnumbered those in homosexuals in both 1998 leaders revealed only 835 medical incidents in 130 000
and 1999 and many of these infections are imported from person-days of travel, of which 33% were gastrointestinal
overseas, either directly or indirectly. and 21% were general medical, including 23 cases of
HIV is the single most common imported lethal infec- proven or suspected malaria, most of which were dealt
tion but modern management approaches are improving with by local doctors (Anderson and Johnson, 2000). Of
the prognosis. Patients who have been at risk of infection 206 expedition participants treated by a doctor, only 10
need appropriate counselling with a view to testing for saw their general practitioner and only ve needed to see
HIV and sexually transmitted infections. This usually a hospital doctor after their return to the UK.
implies referral to a genitourinary medicine clinic for a
full screen because sexually transmitted diseases may be
asymptomatic in both men and women. The Patient Who Has Not Travelled
Malaria
vivax 1 10
This unfortunate history also emphasises that it is not
falciparum 3 3 just expatriates who fail to recognise that they are at risk
Respiratory infection of catching malaria when they travel to endemic zones.
lower 1 7 The majority of patients who present with imported ma-
upper 1 7 laria have failed to take adequate chemoprophylaxis.
Diarrhoea Poor outcome is usually associated with delays in presen-
travellers 0 6 tation by the patient, failure of the attending physician to
bacterial 3 3 consider the diagnosis, and delays in arranging for diag-
Hepatitis 1 6 nostic tests and treatment (Kain et al., 1998).
Dengue 2 0 The fever is of abrupt onset and is often mistaken for
Typhoid 2 1 inuenza, with headache, sweating, myalgia and in some
No diagnosis 14 3 cases paroxysms or rigors. Around 15% of malaria pa-
tients are afebrile at presentation or other symptoms may
?Klein and Millman (1998). predominate, so that the diagnosis is not considered by
@Riordan and Tarlow (1998). Some children in this study had more than the attending health care worker. In a recent audit in
one cause of fever. Liverpool, 31% of patients with falciparum malaria had
diarrhoea as a prominent clinical feature, and in 16% of
such cases malaria was not included in the admission
particularly as patients with falciparum malaria can de- dierential diagnosis. Seventeen per cent had jaundice,
teriorate and develop severe complications within a few which was sometimes ascribed to hepatitis rather than to
hours of presentation. In Britain, approximately malaria. Similar errors are commonly reported (Svenson
20002500 cases of malaria and 1014 deaths are re- et al., 1995; Kain et al., 1998) and emphasise the protean
ported each year, a fatality rate of 12% in patients with nature of malaria presentations (Table 12.7).
falciparum malaria. Higher mortality rates have been The timing of presentation of cases helps in the dier-
reported in other countries (Kain et al., 1998). The numb- ential diagnosis of malaria. The majority of patients with
er of tourists and expatriates who die overseas is not falciparum malaria present within 6 weeks of leaving an
known. The majority of cases are imported by visitors endemic area, and over 90% present within 2 months
and resident immigrants returning from a visit to their (Kain et al., 1998). Patients taking chemoprophylaxis
country of origin (Behrens and Curtis, 1993) and this may have partial suppression of their parasitaemia, which
pattern now predominates in other parts of Europe (Wet- both increases the clinical incubation period and hampers
steyn et al., 1997) and North America (Kain et al., 1998). the laboratory diagnosis, as the lower degree of para-
Table 12.6 summarises the geographical origin of malaria sitaemia is more dicult to detect. Nevertheless, partial
reported in the UK in 1999; 16% of the patients were chemosuppression is better than none and probably re-
children, similar to earlier reports (Brabin and Ganley, duces mortality in such patients (Lewis et al., 1992).
1997). An increasing proportion of cases in both adults The benign malarias have a dierent spectrum of incu-
RETURNED TRAVELLERS 193
Table 12.6 Geographical source and type of malaria imported into the UK in 1999
Reproduced by permission of the PHLS Malaria Reference Laboratory, London School of Hygiene & Tropical Medicine.
Table 12.7 Common errors in diagnosis and management of tioned. Rashes suggest other illnesses except in very rare
malaria cases of petechiae due to disseminated intravascular co-
agulopathy complicating falciparum malaria. The fever
Delayed presentation by patient pattern of malaria, when present, is usually continuously
Failure of health care worker to take a travel history elevated in falciparum infection. Parasite populations do
Failure of health care worker to consider malaria in not become synchronised (Chapter 8) until at least the
symptomatic patient
second week of clinical illness in the benign malarias, so
Belief that chemoprophylaxis prevents all malaria
that it is unusual to see the classical 48 or 72 h pattern of
Belief that malaria is unlikely to be present if patient does not
remember being bitten by mosquitoes
fever produced by simultaneous lysis of erythrocytes and
Belief that absence of splenomegaly excludes malaria release of merozoites. Patients with malaria may have an
Belief that absence of regular fever pattern excludes malaria enlarged liver, and splenomegaly is present in only a
Failure to recognise nonspecic clinical presentations of minority at presentation and has little positive or nega-
malaria tive predictive diagnostic value.
Failure to obtain good quality blood lm diagnosis The diagnosis of malaria can only be made by perform-
immediately (with species diagnosis) ing the appropriate laboratory tests.
Failure to obtain repeat lms or use ancillary diagnostic tests if
rst lms are negative
Failure to prescribe adequate and appropriate chemotherapy Case History
immediately A 55-year-old businessman consulted his general
Failure to anticipate complications practitioner with fever 2 weeks after returning from
Failure to treat complications a holiday in coastal Kenya. He took no prophylax-
Failure to follow patient up after treatment is as his daughter, an air stewardess, had told him
that it would make him ill. The general practitioner
sent a blood lm to a local laboratory and did not
receive their negative blood lm report until 36 h
later. The patient continued to be unwell and was
bation and must always be considered in a patient who sent into hospital after a further 3 days, by which
has been to an endemic region within the last 2 years. time he had 2% parasitaemia with falciparum ma-
Approximately a third of patients with vivax malaria laria. Expert review of the original blood lms later
present within 2 months of arrival, and another third do conrmed the presence of falciparum malaria.
not develop symptoms until 612 months after leaving a
malarious area. Ovale malaria, usually from West Africa,
presents with similar delays. Late presentations of vivax In this case the general practitioner had done well to
or ovale malaria should not be overlooked in a febrile consider malaria, but there was a failure to obtain results
patient who has been successfully treated for falciparum within a few hours and the diagnosis was missed by an
malaria several months earlier, as chemosuppression will inexperienced laboratory. In all cases in which malaria is
have been discontinued and the treatment for falciparum a possibility, results of good quality blood tests must be
malaria will not have treated the hypnozoites (quiescent obtained within half a working day at the most. In every-
liver stages) of the benign malarias. Plasmodium malariae day practice, most family practitioners should refer such
has the potential to relapse for years but is only found in a patients immediately to hospital for diagnosis, or to their
small proportion of imported cases. It is rare for patients regional specialist clinic if one is available.
with recurring fevers years after return from the tropics
to have malaria: other diagnoses should be sought for
such patients. Laboratory Diagnosis of Malaria
The physical ndings in malaria are nonspecic and
malaria cannot be distinguished clinically from other ill- Malaria is conventionally diagnosed by examination of
nesses. Jaundice and diarrhoea have already been men- blood lms for characteristic parasites within the eryth-
194 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
rocytes. Thin blood lms are routinely processed in most OptiMAL and similar tests are now well validated for the
hospitals, but are not usually stained at the optimum pH diagnosis of falciparum and vivax malaria and are being
for malaria diagnostics. Thin lms are most valuable for improved for the diagnosis of other species (Iqbal et al.,
conrming the species of parasite, especially in mixed 1999). LDH-based tests can be used to monitor the suc-
infections, and for determining the degree of para- cess of treatment, as they become negative at the same
sitaemia, but have low diagnostic sensitivity. In the time as parasites disappear from blood lms. They may
tropics and in expert laboratories, examination of thick also suer from false positivity in the presence of rheuma-
blood lms is the preferred method because a larger toid factor (Grobusch et al., 1999). The dipstick methods
volume of blood is examined in the lm and sensitivity is have the great advantage that they are less prone to
improved. Few laboratories in western countries are pro- observer error than lm interpretation in less experienced
cient at this and numerous studies conrm that many laboratories, but they are not yet simple enough for
diagnostic laboratories either cannot identify the species travellers to use for self-diagnosis in remote situations
correctly (the usual problem) or fail to see parasites at all (Jelinek et al., 1999). The measurement of antibodies has
(Malaria Working Party, 1997; Kain et al., 1998). In no place in the routine diagnosis of patients with fever,
imported malaria cases, the rst blood lms are positive but is used to make a retrospective diagnosis of recent
in more than 95% of cases examined by experts (Kain et malaria in previously nonimmune subjects, particularly
al., 1998) but may genuinely be negative, especially if the in the context of detecting subclinical malaria infection in
patient is taking partially eective chemosuppression and clinical trials or epidemiological studies. Polymerase
parasitaemia is very scanty. Patients with negative lms chain reaction (PCR)-based tests are increasingly being
should have a second lm examined 12 h later, and poss- used to monitor the quality of diagnostic laboratories
ibly a third one 12 h after that if clinical suspicion con- (Kain et al., 1998; Iqbal et al., 1999; Rubio et al., 1999) or
tinues. The timing of taking the specimen in relation to for epidemiological investigations of unusual situations
fever is not clinically important. such as the nosocomial transmission of malaria (Rubio et
Thus the conventional management approach to a pa- al., 1999), but are not yet generally used for clinical diag-
tient with fever ?malaria is to admit to hospital for nosis or for monitoring therapy (Tham et al., 1999). New
2448 h for observation, syndromic management and for techniques, such as the use of automated counters to
blood lms to rule out malaria as well as other investiga- detect malaria pigment in whole blood specimens, may
tions. Recent improvements in laboratory technology are produce new methods for diagnosis in the future (Han-
revolutionising this approach and can be expected to scheid et al., 2000). Table 12.8 summarises the use of these
improve diagnostic sensitivity and specicity of the rst tests.
blood test. One approach has been to stain the buy coat
of centrifuged blood with acridine orange and to examine Other Causes of Fever
this for uorescence in capillary tubes (quantitative buy
coat; QBC method). This is similar in sensitivity to thin- The emphasis so far has been on malaria and its labora-
lm examination but parasites cannot be speciated. tory diagnosis. Other causes of fever can be determined
Special equipment is needed and the method is techni- by a combination of history, examination and laboratory
cally demanding. More useful are the tests that are cur- investigations. In practice the most useful aid is a precise
rently being developed for detection of malaria antigens history of exposure or risk behaviour, together with rec-
(Chiodini, 1998). The rst generation of tests have been ognition of the overall clinical pattern of presentation, as
based on detection of histidine-rich protein 2 (HRP-2) many features of febrile illness overlap. Risk activities
derived from Plasmodium falciparum (but not from other such as those in Table 12.3 suggest the diagnosis and can
species). These tests (ParaSight F, ICT, malaria Pf) have be combined with the incubation periods (Table 12.2) and
approximately the same or lower sensitivity compared groups of physical signs in Tables 12.912.11, and routine
with a thick blood lm that is read by an expert, and can laboratory tests may yield further clues.
be used in eld or clinic situations or in less expert labora-
tories as an ancillary to routine blood lm diagnosis Case History
(Cropley et al., 2000). Problems include occasional false A 23-year-old woman developed high fever, head-
positivity, for example in patients with rheumatoid factor ache, back pain and a generalised blanching
(Laferi et al., 1997), and the persistence of antigen for 12 erythematous rash 3 days after returning from ru-
weeks after successful treatment. This is useful for making ral Thailand. The clinical diagnosis of dengue was
a recent retrospective diagnosis but means the test cannot conrmed by detection of antibodies 2 weeks later.
be used to monitor the success of treatment. Occasional
false negative tests have been reported in patients with
high parasitaemia rates (Risch et al., 2000), so blood lms This typical presentation of fever and rash with a short
must always be examined as well. incubation period is highly suggestive of dengue fever,
Species of malaria other than falciparum are not detec- which is now widespread throughout Asia and South and
ted by HRP-2-based tests, but alternative methods use Central America and the Caribbean, and is rapidly
the secretion of parasite species-specic lactic dehyd- spreading through Africa (Gubler, 1999; Jelinek, 2000).
rogenase (LDH) as a marker of active parasitaemia. The Diagnosis is by PCR in the rst week of illness and by
RETURNED TRAVELLERS 195
Table 12.8 Laboratory diagnosis of malaria
version illness, during which conventional HIV antibody exposure to freshwater is typical, particularly in Asia,
detection tests are usually negative. The importance of where large epidemics aect the local population each
the exposure history is self-evident. year. In the absence of other focal features and specic
Focal lymphadenopathy is usually associated with re- exposure history, viral hepatitis should be considered as
gional sepsis, most commonly infected skin wounds and the cause of jaundice. Hepatitis A is still a hazard for
arthropod bites, but rarities such a plague (exquisitely nonimmunised travellers; hepatitis B and C are both
tender unilateral nodes or buboes) should also be con- transmitted by unsterile injections and infusions; and
sidered, as well as more common illnesses such as tuber- hepatitis B is a risk after unprotected sexual exposure.
culosis. Water-borne hepatitis E is endemic and also causes spor-
Jaundice is a feature of many illnesses, including ma- adic epidemics in the Indian subcontinent, in much of
laria, viral hepatitis, leptospirosis, the glandular fever adjacent Asia and in Mexico and is probably underrecog-
group and arbovirus infections such as yellow fever. nised in most other parts of the tropics. It should be
suspected in jaundiced travellers to Asia who are immune
to hepatitis A and have not been immersed in fresh water.
Case History Serological tests are essential to dierentiate the causes of
A 33-year-old man developed headache, fever, viral hepatitis, which are indistinguishable clinically
myalgia and jaundice 10 days after white-water (Chapter 6).
rafting in Thailand. He had meningism, jaundice, After malaria, respiratory infections are the most
tender muscles, splenomegaly and mild renal fail- common causes of imported fever, with or without local-
ure. He had been immunised against hepatitis A ising signs. Most are due to cosmopolitan infections, such
and B before travel and serological tests subse- as inuenza and other respiratory viruses, or community-
quently conrmed infection with leptospirosis. acquired pneumonia. Rare but important causes of phar-
yngitis include diphtheria (look for membrane) and Lassa
fever (exposure in rural West Africa). It is impossible to
Leptospirosis is found worldwide and the history of distinguish the dierent causes of community-acquired
198 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
pneumonia at the bedside, and the usual conventional Case History
diagnostic tests should be employed, including convales- A 47-year-old Indian seaman was admitted with
cent serological tests several weeks after the onset of fever and rigors for 4 days, accompanied by head-
illness. ache and mild diarrhoea. He had a high fever and
Of particular importance to travellers is the increasing developed right shoulder-tip pain the next day,
prevalence of multi-drug resistant Streptococcus pneu- when he was observed to have a tender enlarged
moniae in many countries, including most of the Far East, liver with a right basal pleural eusion. His blood
Papua New Guinea, South Africa and Spain, so that count showed neutrophilia, and ultrasound con-
therapy with penicillin is inappropriate for travellers from rmed the presence of a large abscess in the right
these areas. Legionella infection imported to the UK is lobe of the liver. Liver function tests were normal
typically associated with travel to Mediterranean resorts and amoebic serology was strongly positive. He
and with cruises, or contaminated air conditioners or responded rapidly to metronidazole.
showers in hotels. Surveillance suggests that approxi-
mately a quarter of legionella infections are associated
with recent travel (Anonymous, 1997). The older patient
who smokes and drinks alcohol to excess is most likely to This typical history emphasises the need to re-examine
develop severe disease; he or she is also most likely to patients carefully and to consider amoebic liver abscess in
have delayed antibody seroconversion, so that serological occult fever. The presence or absence of diarrhoea or of
tests may not become positive until 68 weeks after onset trophozoites or cysts of Entamoeba histolytica in the
of illness. Other clues to atypical pneumonia pathogens faeces is of no diagnostic value, but neutrophilia is sup-
include contact with animals for Q fever (splenomegaly, portive and serology is usually positive at presentation.
thrombocytopenia) and tularaemia (lymphadenopathy) In the absence of the above syndromes, physical exam-
and with psittacine birds (psittacosis). ination should exclude other organ-based infections, in-
Hantavirus infections transmitted by rodent contact, cluding mundane sinusitis and ear infections. Focal signs
such as sin nombre virus, are increasingly being recog- may be diagnostic.
nised as causes of severe atypical pneumonia in visitors to Diarrhoeal illness is common while travelling (von
rural areas of the USA or South America (Doyle et al., Sonnenburg et al., 2000) but is self-limiting in the majority
1998). of cases (Chapter 10). The usual bacterial and viral causes
A nonproductive cough is found in typhoid fever and in are implicated and enterotoxigenic Escherichia coli is
brucellosis, often without radiographic abnormality. Fe- overrepresented in travellers with diarrhoea on their re-
ver with wheezy cough or asthmatic presentation is a turn home (Svenungsson et al., 2000). Cholera is rarely
feature of larial tropical pulmonary eosinophilia (TPE) imported by travellers, partly because of the lack of risk
and of the migratory phase of immature stages of many to travellers while overseas and mainly because the incu-
nematode and trematode infections, including the hook- bation period is so short that most patients need medical
worms, roundworms and schistosomes. In these situ- treatment before repatriation. Diarrhoea is a feature of
ations, eosinophilia will suggest the diagnosis (see below, many of the febrile infections already described and is
Eosinophilia). more likely to cause fever in children than in adults.
Haemoptysis suggests tuberculosis (or tumour) but Children with enteric fever are also more likely to have
travellers who have eaten raw crustacea in the Far East, diarrhoea than adults. Diarrhoea with blood, fever and
West Africa or South America may have paragonimiasis, systemic illness is usually due to Campylobacter, Shigella
which can be mistaken radiologically for tuberculosis and or Salmonella spp, but the recent traveller with bloody
is diagnosed by looking for characteristic ova in sputum. diarrhoea (dysentery) and without much general illness
Imported infections may produce a variety of neur- may have amoebiasis. This is conrmed by examination
ological or psychiatric syndromes. In addition to the of unpreserved faeces (the hot stool) or rectal scrapings
usual bacterial pathogens causing meningitis, infections within 2030 min for active trophozoites of Entamoeba
such as brucellosis, leptospirosis, rickettsial illness and histolytica containing ingested erythrocytes. If these infec-
arboviruses frequently have a meningoencephalitic el- tions are excluded, the patient will need a further work-up
ement. Drowsiness, meningism, focal neurological signs including lower bowel endoscopy to exclude underlying
or progression to coma are all features of malaria, which gastrointestinal disease or chronic tropical conditions
must always be excluded, as must trypanosomiasis in such as schistosomiasis. Watery diarrhoea caused by
travellers who have visited Africa. Transient psychologi- Cyclospora infections is also diagnosed by faecal micro-
cal problems are common in travellers and are often scopy, and is suggested by a history of travel to known
associated with alcohol or drug misuse or rapid translo- endemic areas such as Nepal or Peru. Co-trimoxazole is
cation between cultures. Rabies should be considered in eective treatment, with ciprooxacin as an alternative.
patients who behave abnormally and may have had expo- In about 3% of cases, travel-related diarrhoea lasts for
sure to animals in the tropics, even if they do not remem- more than 14 days (DuPont and Capsuto, 1996). Patients
ber the bite or lick. need a full work-up to exclude underlying immunosup-
pression, especially HIV, and adequate faecal tests for
bacterial and parasitic (protozoan) parasites. Giardia lam-
RETURNED TRAVELLERS 199
blia is the most common culprit, typically causing explos- borreliosis, lariasis, babesiosis and African try-
ive steatorrhoic diarrhoea in the mornings and often panosomiasis. Neutropenia is an inconsistent nding in
associated with eggy burps. Untreated, the patient can malaria, in viral infections and in typhoid and must be
develop signicant malabsorption. Parasitological diag- interpreted with caution, as the normal neutrophil and
nosis may be dicult and many physicians opt for empiri- platelet counts are lower in patients of African ethnic
cal therapy with agents such as tinidazole or metro- origin than Caucasians (Bain, 1996). Neutrophilia usually
nidazole. Failure to respond to therapy may represent suggests a pyogenic bacterial infection but is also seen in
drug resistance (Zaat et al., 1997) but is more likely to be malaria, and eosinophilia suggests a helminth infection or
due to failure to take the medication (ask the patient), or atopy. Thrombocytopenia is present in the majority of
to transient lactase deciency (exclude all lactose-con- both benign and falciparum malaria infections and may
taining food and drink for 1 week) or to reinfection by alert the microscopist to the presence of parasitaemia, but
other family members. If all the above have been ex- it is also found with dengue, brucellosis and many viral
cluded, second-line drugs such as mepacrine or infections. A combination of thrombocytopenia (
paromomycin may be needed. 150 ; 10 l\) and raised bilirubin ( 18 mol l\) was
Apart from the exclusion of underlying gastrointestinal found to have a positive predictive value of 95% and
disease, schistosomiasis or postinfectious irritable bowel specicity of 98%, but a low sensitivity in diagnosing
syndrome, tropical sprue must be considered. The aetiol- malaria in one study in London (Doherty et al., 1995).
ogy of tropical sprue is unknown and it causes persistent However, this combination was only found in 36 of the 82
small bowel diarrhoea and malabsorption and requires a patients with malaria, limiting the diagnostic usefulness
full expert diagnostic work-up. Treatment with tetracyc- to a small proportion of patients. Hypoglycaemia may
lines, folic acid and vitamin B is eective (DuPont and also suggest malaria or African trypanosomiasis. Liver
Capsuto, 1996). function abnormalities are rarely of specic diagnostic
value but are helpful in assessing disease severity.
Investigation of fever
Treatment
Baseline investigations include full blood count, includ-
ing dierential white count and platelet count, serum A sequential approach to the diagnosis and treatment of
electrolytes and liver function tests, blood cultures and the patient with imported fever is summarised in Figure
malaria lms. Urinalysis and cultures of urine and stool 12.1. For details of specic treatment of most infections,
should be sent and a sample of serum stored for possible the relevant chapters in this book should be consulted.
serological testing. The need for chest X-ray and other The pharmacological management of malaria and its
focal imaging, such as ultrasound of the liver, may be complications are described in full in Chapter 8 and in a
suggested by clinical ndings. As indicated in the cases recent useful publication (World Health Organization,
already presented, the potential list of serological tests 2000).
and other investigations can be extensive but practi- A few principles guide malaria treatment, once the
tioners should resist the temptation to order everything diagnosis has been conrmed. Treatment should cover
just because the patient has travelled to an exotic country. falciparum malaria unless there is a condent expert lab-
Special examinations include microscopy of cerebros- oratory diagnosis of another Plasmodium species. Pa-
pinal uid for trypanosomiasis, bone marrow culture for tients with falciparum malaria should usually be treated
partially treated typhoid or brucellosis, or bone marrow as inpatients for at least the rst 2448 h in western set-
for microscopical examination for visceral leishmaniasis. tings, unless they are recent immigrants (with partial
The initial emphasis should be on excluding malaria immunity) with very mild infections. Therapy is usually
and infections of chest, urine or gastrointestinal tract initiated via the parenteral route in severe or complicated
before focusing on the most likely exotic diagnosis if these falciparum malaria, one of the denitions of which in-
investigations prove negative. Convalescent serology cludes hyperparasitaemia, and the level of parasitaemia
taken at least 2 weeks later is often needed to make a must always be measured. Although the World Health
retrospective diagnosis if this is thought to be important Organization denes hyperparasitaemia as a parasite
after the patient has recovered. rate 5%, the majority of tropical specialists use a prag-
The small risk of transmission of infection to health matic cut-o level of 2% parasitaemia to indicate in-
care workers should always be kept in mind and appro- creased clinical risk in nonimmune travellers with im-
priate infection control precautions should be taken. For ported malaria. Children and pregnant women are
patients with suspected diphtheria or with a possible viral particularly likely to experience hypoglycaemia as a com-
haemorrhagic fever, more stringent isolation is needed plication of falciparum malaria. This may be exacerbated
and immediate advice should be obtained from public by quinine therapy, and blood glucose levels should be
health specialists as well as from infectious disease experts monitored before and during treatment. Parenteral quin-
(Centers for Disease Control, 1995; Advisory Committee ine remains the mainstay of British treatment regimens
on Dangerous Pathogens, 1996). and it is essential that this (or quinidine) is available in
Blood lms for malaria can also be used to exclude western hospitals. Parasite rates should be estimated at
200 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Admit
Quinine
First Oral treatment
Is malaria Yes Yes P. falciparum Yes unless any of
Urgent blood films film
possible? positive? or uncertain vomiting
parasitaemia
> 2%
complications
No No
No Usually
outpatient
treatment
Chloroquine
Consider other Continue to consider Primaquine
diagnosis malaria for P. vivax
and P. ovale
Early clinic
appointment
Syndromic
approach to Yes Localising Yes
Seriously
differential symptoms
ill?
diagnosis or signs?
Life-
Consider threatening
malaria Yes Low Repeat No
illness of
dengue platelets? blood films unknown
viral cause?
No Yes
Figure 12.1 Algorithm for diagnosis of fever in the returned traveller. (Modied from Jacobs, Journal of Royal Society of Medicine,
2000, 93: 1248, and reproduced with permission)
RETURNED TRAVELLERS 201
least daily until negative and the patient must be followed the sunlounger) or by choosing the part of the beach that
up early after discharge to detect recrudescence due to is regularly cleaned by tidal action (Bouchaud et al., 2000;
resistance or inadequate treatment. Concurrent infec- Caumes, 2000). Treatment of single lesions can be per-
tions, particularly bacteraemia (Berkley et al., 1999), formed by applying a topical paste of tiabendazole but
should be considered in severe malaria, with a low thresh- this is rarely available and a short course of albendazole
old for introducing broad-spectrum antibiotics pending or ivermectin is very eective.
the results of blood cultures. Careful attention should be Other invasive parasitic skin diseases are described in
paid to uid balance and monitoring renal, hepatic, neur- the section on eosinophilia, below. The most frequent
ological and respiratory function, and ill patients should delayed skin lesion seen in travellers is cutaneous leish-
be managed in a high dependency or intensive care set- maniasis, particularly in people who have travelled in
ting. The role of exchange transfusion or eryth- rural or forested areas of South and Central America or in
rocytapheresis in reducing morbidity or mortality re- the Indian subcontinent, although the cutaneous leish-
mains controversial in the absence of any controlled maniases have a widespread geographical distribution
trials, and is favoured in some centres but not in Liver- (Chapter 8). The rash typically starts as a papule that
pool (Macallan et al., 1999; Pasvol and Jacobs, 1999). enlarges and ulcerates with indurated edges. The lesion
Less severe cases of falciparum malaria can be slowly expands over weeks and is usually relatively pain-
managed with oral quinine, meoquine, co-artemether or less unless there is bacterial superinfection. Lesions are
atovaquone plus proguanil (Malarone) (Anonymous, usually on the face or peripheral parts of the limbs that
2000). Patients with benign malarias can be managed, have been exposed to sandy bites, and may be single or
often as outpatients, with chloroquine (the above agents multiple. There is often local lymphadenopathy and care-
are also eective), which is followed by primaquine to ful examination may reveal smaller nodules proximal to
eradicate the hypnozoite stages of vivax and ovale ma- the main lesion. Most patients present within 6 months of
laria to prevent late relapse. Resistance to both agents is exposure. There is no systemic upset and patients are
present in the Pacic Chesson strain of vivax (Murphy et often treated unsuccessfully for suspected staphylococcal
al., 1993) and is increasingly seen in vivax malaria im- infection before referral to a specialist clinic for investiga-
ported from other areas, including India (Whitby, 1997); tion. Diagnosis is made by aspirating material from the
however, treatment should be started with chloroquine active edge of the lesion or by making an impression
even if resistant vivax is suspected, and can be switched smear from the lesion and staining with Giemsa for amas-
later if there is no response. tigotes. Special culture media are needed to grow the
organism and species-specic PCR is a quicker and more
sensitive method of conrming the diagnosis (Noyes et
SKIN DISEASE al., 1998). Infections with Leishmania tropica from India
and the Middle East do not usually need specic treat-
The most common dermatological problems in travellers ment, but L. braziliense lesions should be treated by
are caused by overexposure to sun and insect bites (Hay, specialists with parenteral antimonial agents because of
1993; Caumes et al., 1995). A variety of hypersensitivity the small risk of mucocutaneous dissemination (Hepburn
reactions can follow arthropod bites and these, together et al., 1993; Aronson et al., 1998). L. braziliense lesions
with complicating staphylococcal and streptococcal in- cannot be distinguished clinically from those caused by L.
fections, are common reasons for travellers to consult mexicana and other Central and South American species.
their family doctor after return. Suntans will also make Myiasis is a frequent problem in travellers to Africa.
dermatophyte infections such as pityriasis versicolor The tumbu y, Cordylobia anthropophaga, lays its eggs on
more obvious to the patient. clothes and the larvae from these directly invade the skin,
Cutaneous larva migrans is frequently seen in the cli- producing lesions resembling a staphylococcal boil. At
nic. the centre of these the tip of the larva can be seen to
wriggle. Treatment is by suocating the larva with topical
petroleum jelly, then careful removal with forceps as it
Case History extrudes itself to obtain air. Travellers to South and
A young British couple had been for their honey- Central America may acquire more invasive cutaneous
moon in the Caribbean. One week after their re- myiasis due to larvae of Cochliomyia homnivorax or Der-
turn, both developed multiple red serpiginous matobia hominis. These larvae have lateral spines that
raised lesions on their legs and abdomen. Both had make removal more dicult, often requiring minor sur-
been lying on the sand to sunbathe. The rash per- gery under local or even general anaesthetic. The jiggers
sisted for a week until treatment with albendazole. ea, Tunga penetrans, frequently infects the feet of people
who walk barefoot in the tropics. The female ea, full of
eggs, grows to cause a nodule, from which it can be
The tracks are caused by animal hookworms that in- carefully shelled out with a toothpick or needle. Care
vade skin in contact with sand or soil contaminated by should be taken not to rupture the ea, which could lead
cat or dog faeces. This common problem can be avoided to local bacterial infection.
by wearing shoes and not lying directly on the sand (use
202 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Table 12.12 Selected parasitic infections and eosinophilia in cause of eosinophilia: a history of immersion in fresh
travellers water in Africa, the Middle East or in much of the Far
East or South America should always be sought. Only a
Parasite/disease Clinical clues minority of patients recall having swimmers itch
2448 h after bathing in infected water, caused by the
Nematodes
initial penetration of skin by the schistosomule. As the
Ascaris lumbricoides Visible worms in faeces;
Loeer
earlier case report illustrated, acute schistosomiasis may
Hookworms Anaemia; Loeer cause symptoms in nonimmune travellers 38 weeks later
Strongyloides spp Diarrhoea; larva currens rash as the larvae begin to mature and to excrete eggs, which
Trichuris trichiura Diarrhoea (bloody) elicit an eosinophilic response. Patients experience fever,
Loa loa Travel history; visible worm in transient urticarial rashes, headache, a dry cough and
eye; Calabar swelling malaise (Katayama fever) (Colebunders et al., 1998).
Mansonella perstans Travel history Hepatosplenomegaly is occasionally found and transi-
Onchocerca volvulus Travel history; eye symptoms; tory nonspecic inltrates may be seen on chest X-ray
rash; nodules (Cooke et al., 1999). High levels of eosinophilia
Wuchereria bancrofti Travel history; sometimes ( 1 ; 10 l\) are common at this stage but specic
Brugia malayi tropical pulmonary diagnostic tests are usually negative. The condition settles
eosinophilia; rarely chyluria, and the patient may then remain asymptomatic or subse-
elephantiasis, etc. quently develop haematuria, alteration in colour and/or
Nonhuman hookworms Rash of cutaneous larva consistency of semen (McKenna et al., 1997), or blood in
migrans the faeces. By this stage, serological tests and microscopy
Trematodes of terminal urine specimens, ltered urine collections
Schistosoma spp Travel history and freshwater (Schistosoma haematobium) and stool or rectal snips (S.
exposure; Katayama fever; japonicum, S. mansoni) should be positive (Whitty et al.,
haematuria or blood in faeces 2000a). Treatment with praziquantel during the acute
Fasciola hepatica Travel history; tender enlarged state has no eect on migrating schistosomules and we
liver repeat the treatment 3 months later. The role of a short
Clonorchis spp course of steroids in Katayama fever is unproven but they
Travel history; cholangitis-like
Opisthorcis spp are often used for patients who are ill enough to merit
presentation treatment in hospital (Harries and Cook, 1987). Haema-
Paragonimus spp Travel history and food history; turia requires further investigation and follow-up for
haemoptysis possible complications. Patients with schistosomiasis can
be treated as outpatients and should be followed up to
conrm parasitological cure. This is important as ectopic
EOSINOPHILIA egg deposition may cause crippling transverse myelitis
later on if the patient is not cured (Blanchard et al., 1993).
A raised eosinophilia count usually suggests a helminth The enzyme-linked immunosorbent assay (ELISA) titre
infection in returned travellers. Although the traditional often rises initially and can take several years to become
denition of eosinophilia is an absolute count negative. This reduces its usefulness for diagnosis of new
0.44 ; 10 l\ (Wolfe, 1999), many clinicians use a infection after repeated exposures during subsequent
cut-o level of 0.5 ; 10 l\ in working practice travels.
(Gyawali and Whitty, 2000). This level of eosinophilia is Schistosomiasis is the most common cause of
used for travellers returning from the tropics, but no eosinophilia in travellers from Africa seen in our clinic or
normal ranges have been published for those who live in in London. The next most common systemic cause is
the tropics long-term. larial infections. Onchocerciasis is still a major problem
Up to 10% of the travelling population have atopic in West Africa, the Yemen and in Central and South
conditions, such as eczema or asthma, which cause a America (Chapter 8). Patients are often asymptomatic or
raised eosinophil count, and some medications such as present years after exposure with itchy skin. Occasionally
nonsteroidal anti-inammatory agents also cause a nodules containing adult worms can be found, and fun-
raised count. A wide variety of nematode and trematode doscopy should always be performed to detect
infections produce eosinophilia, particularly during the choroidoretinitis, which leads to blindness. Diagnosis is
migratory phases of larvae through the body (Table usually conrmed by examining skin snips for motile
12.12). Some of these, such as hookworms, roundworms larvae. Treatment with diethylcarbamazine (DEC) is in-
and Strongyloides spp are universally distributed in the variably followed by an allergic reaction (the Mazzotti
tropics, while other parasitic infections will be suggested reaction) which can be severe enough to cause hypoten-
by the specic travel history of the patient and by the sive collapse in heavily infected patients. It can be used to
symptoms and physical ndings. conrm the diagnosis in skin-snip negative patients by
Asymptomatic schistosomiasis is a common imported giving a small dose of DEC. This reaction is much less
common following the current treatment of choice which
RETURNED TRAVELLERS 203
is ivermectin, but expatriates should still be treated under man hookworm larvae or the transient rash (ground itch)
hospital supervision. that is occasionally seen in nonimmune travellers follow-
Loa loa infection is relatively common in people who ing skin penetration by larvae of human hookworms.
have visited West Africa, some of whom may complain of These rashes should be distinguished from the larva cur-
transient oedematous swellings of the limbs (Calabar rens rash of Strongyloides stercoralis infection, which can
swelling). Patients occasionally notice the larvae migra- persist for decades by autoreinfection.
ting under the conjunctiva of the eye, where they are Intestinal nematodes can usually be identied by stool
readily visible to the health care worker. Patients with L. microscopy but this is often negative in Strongyloides
loa should always be investigated with skin snips to ex- infections, for which special culture methods are needed,
clude coexistent onchocerciasis, especially if they are to be together with specic ELISA tests on serum. Stron-
treated with DEC, when pretreatment with steroids is gyloidiasis should be excluded in patients who are about
used by some (Churchill et al., 1996). Ivermectin or poss- to undergo chemosuppressive therapy, and who have
ibly albendazole are now the treatments of choice and travelled or were born in the tropics or subtropics, be-
heavy larial loads may need to be reduced by plas- cause of the risk of fatal hyperinfection syndrome.
mapharesis prior to chemotherapy.
Other blood and lymphatic lariases have a more
widespread distribution in the tropics and are common Case History
causes of eosinophilia in Asia and the Pacic region, as A 45-year-old Nigerian presented to our clinic 10
well as in Africa and South and Central America. Infec- years after leaving West Africa with chronic non-
tions are usually asymptomatic but the early phase of bloody diarrhoea and weight loss. On direct ques-
infection is characterised by wheezing, dyspnoea, cough, tioning he admitted to occasional rashes that con-
fever and fatigue, with widespread shadowing on the sisted of a linear urticarial track moving rapidly
chest X-ray (tropical pulmonary eosinophilia). across his abdomen for 2448 h. He had high
Eosinophil levels are very high ( 3 ; 10 l\) but eosinophilia, a positive serum ELISA for Stron-
microlariae are not found in the blood. Serological tests gyloides, and positive charcoal culture of faeces for
(ELISA) for lariasis are positive. Symptoms may require the characteristic larvae of S. stercoralis. His symp-
relief with a short course of steroids. This condition is less toms resolved after treatment with ivermectin.
commonly seen in travellers after their return, when
lariasis is usually asymptomatic. Emergence of the
microlariae of Wuchereria bancrofti into the blood- Patients in whom the above infections have been ex-
stream is nocturnal and they are most easily found in cluded as causes of eosinophilia may harbour uke infec-
blood taken at midnight. Daytime blood samples are tions from ingestion of raw foods and a careful history
positive if the patient is given a single dose of DEC 1 h should be sought about dietary habits while travelling.
beforehand. Other larial infections do not usually have Consumption of contaminated salads or cress is asso-
nocturnal periodicity and can routinely be detected in ciated with fascioliasis, particularly in the Middle East.
daytime blood lms. Treatment is with DEC, ivermectin Patients experience painful hepatomegaly and fever dur-
or albendazole. ing the migratory phase, with alarming ndings on ultra-
After excluding schistosomiasis and larial infections, sound of holes in the liver resembling peliosis hepatis.
the most common imported causes of eosinophilia are Serological tests may be helpful, as the characteristic ova
intestinal nematode infections such as hookworm infec- may be dicult to nd in stools. Patients who have eaten
tion, trichuriasis and strongyloidiasis. Trichuris trichuria raw sh, crabs or other freshwater crustacea in the Far
is often asymptomatic but heavy infections can cause East may acquire clonorchiasis or paragonimiasis,
bloody diarrhoea and even rectal prolapse in young producing cholangitis and haemoptysis, respectively. In-
children. Patients with hookworm may have abdominal gestion of frogs in the Far East can transmit gnathos-
pain but anaemia is only caused by heavy infections, tomiasis, characterised by solitary swellings, often on the
especially in malnourished children. face, which persist for days to weeks. Ingestion of slugs or
Tapeworm infections of the gut are often associated snails (usually inadvertently in salads) in much of the
with moderate eosinophilia but are not common in re- Pacic region can result in eosinophilic meningitis. This
turned travellers. They are diagnosed by nding proglot- presents acutely with uctuating focal neurological signs
tids in stool which are visible to the naked eye. Treatment and meningitis, with eosinophils in peripheral blood and
is with praziquantel. Hydatid cysts rarely cause a raised cerebrospinal uid. Eosinophils are occasionally seen in
eosinophil count unless they have ruptured or leaked. the cerebrospinal uid of patients with neurocysticerco-
Ascaris and hookworms can also cause transient parasitic sis, which may cause epilepsy years after acquiring Taenia
pneumonitis (Loeer syndrome) during the pulmonary solium after ingestion of pork. Subcutaneous nodules may
larval migration phase. This is less severe than tropical be present and calcied cysts can be visualised in plain
pulmonary eosinophilia, from which it can be distin- X-ray lms of the thighs. Computed tomography or mag-
guished by negative larial ELISA tests, and blood lms netic resonance imaging of the head conrm the diag-
for microlariae are also negative. Eosinophilia can also nosis. Trichinosis and visceral larva migrans (toxo-
accompany cutaneous larva migrans caused by nonhu- cariasis) are cosmopolitan infections that should be con-
204 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
POST-TRAVEL CHECK
Filaria ELISA Positive Skin snips
(if appropriate) Day/night bloods for Post-travel checks are frequently requested by travellers,
microfilariae
although their usefulness remains controversial. These
If negative Negative travellers usually fall into three groups: those concerned
Negative about specic risk exposures; those who have had unex-
If symptoms or
exposure suggest,
Mazzotti test plained illness in the tropics; and those who have been
consider: abroad but are otherwise well. The rst two groups have
Positive had a risk exposure or an illness for which diagnosis and
treatment could prevent possible future health problems,
Repeat stool Treat and
and further investigation is usually recommended. This
Strongyloides Positive
culture follow up includes patients at risk of relapse or late complications of
ELISA String test incompletely treated malaria, borreliosis, amoebiasis,
schistosomiasis, giardiasis and the lariases. The import-
Review history ance of sexually transmitted diseases has already been
}
Hydatid discussed. The third group may have unknowingly had a
Positive Imaging of chest/
Fasciola serology risk exposure while living under local conditions for a
Toxocara abdomen
Treat appropriately prolonged period of time, and it may be worthwhile
If negative screening them for subclinical tropical infections; how-
ever, there is no evidence that screening asymptomatic
Evidence of an Yes Appropriate long-term (usually considered more than 6 months)
allergic disorder? treatment travellers is cost-eective.
Another category of asymptomatic patients who might
No benet from screening include specic occupational
groups such as food handlers or nursery workers who
Consider empirical anthelmintic treatment, may have acquired infections that could be transmitted to
e.g. albendazole 400 mg i.d. 3 days others. The principles of screening individual travellers
are somewhat dierent from instituting a public health-
Eosinophilia persists?
oriented screening programme for specic groups of
people such as immigrants, refugees or other displaced
Consider other causes
of eosinophilia
persons, or for children arriving from overseas for adop-
tion (Okereke and Gelletlie, 1999). In these groups the
Figure 12.2 Approach to diagnosis of eosinophilia in returned spectrum of illnesses that are screened for are dierent
travellers. (Modied from Churchill et al., 1993, with permission) and focused more on transmissible diseases such as tuber-
culosis and hepatitis B, for which specic prevention
sidered in the dierential diagnosis of eosinophilia but are measures are available.
not specically associated with travel. Some studies have described the prevalence of tropical
The investigation of eosinophilia may be a protracted infections in asymptomatic travellers and one study has
process, a useful scheme for which is summarised in Fig- compared the cost-eectiveness of using dierent diag-
ure 12.2. Simple investigations, including examination of nostic screening strategies on asymptomatic travellers.
at least two faecal specimens for ova and larvae, and
blood for microlariae, should precede more focused
serological and parasitological tests of skin snips, sputum Prevalence of Tropical Diseases in Asymptomatic
and duodenal samples. The exposure history or clinical Returning Travellers
picture may also suggest the need for specic tests such as
imaging of the liver. If these fail to provide a diagnosis, In 1029 British travellers (age range 8 months to 74 years)
treatment with a broad-spectrum agent, such as alben- who had recently returned from the tropics (staying for 3
dazole, with follow-up to establish resolution of months to 45 years) and requested screening in London,
RETURNED TRAVELLERS 205
one in four had an abnormality. Stool microscopy was Table 12.13 Some travel-related infections which may exclude
positive for ova and cysts in 186/995 (19%); 67/852 (8%) the traveller from donating blood, either because of
had eosinophilia and in this group a parasitological cause geographical exposure or past infection
was found in 26 (39%). Schistosomal serology was posi-
tive in 72/676 (11%) (Carroll et al., 1993). In a Dutch African trypanosomiasis
study, tropical diseases were diagnosed in 99/253 (39%) American trypanosomiasis
Hepatitis B
asymptomatic children returning from the tropics, of
Hepatitis C
whom 58 (23%) had giardiasis and 19 (8%) had schis-
HIV
tosomiasis (Brouwer et al., 1999). In Montreal, 1605 HTLV-I/II
asymptomatic expatriates were screened and a para- Malaria
sitological diagnosis was found in 225 (17%) (Libman et New variant CreutzfeldtJakob disease
al., 1993). An Australian study found that, of 221 travel- Visceral leishmaniasis
lers who visited East Africa, 117 (53%) considered them-
selves at risk for schistosomiasis and 10 (9%) were posi-
tive on subsequent testing (Hipgrave et al., 1997).
tive of a parasitic infection in 4050% of cases.
Patients who may have been exposed to schis-
Consequences of Not Detecting and Treating tosomiasis should be screened at least 3 months after
Parasites departure. This is also a convenient time for discussion of
HIV testing, as HIV seroconversion is likely to have
The potential of untreated schistosomiasis or stron- occurred by then. If the tests are negative but there is
gyloidiasis to cause serious problems has already been strong concern, repeat screening at 6 months may be
discussed. If HIV infection remains undetected the travel- required for either of these infections. Other serological
ler will not benet from chemoprophylaxis against op- tests are of variable availability and cost, and we try to
portunistic infections, or from specic antiretroviral ther- keep these to a minimum. However, adequate stool exam-
apy, and will be at risk of passing infection on to others. ination requires at least two, and ideally three, faecal
The consequences of untreated lariasis in the ordinary specimens taken on dierent occasions (patients need
traveller is unclear and probably not signicant. The specic instructions not to split one specimen three ways).
majority of other intestinal parasites will eventually die This is time-consuming and expensive, but a study of
without causing any harm to the host, and many feel that 1605 asymptomatic travellers showed that, in a Canadian
routine comprehensive travel screens of the asympto- setting, a combination of serological tests and up to three
matic patient are inappropriate for these reasons (Conlon faecal examinations was more eective and cheaper than
and Peto, 1993). Moreover, screening will not reliably the combination of faecal microscopy and an eosinophil
detect signicant infections such as malaria and may lull count for diagnosing schistosomiasis, lariasis and stron-
the patient into a false sense of security. Some have sug- gyloidiasis (89% versus 61%, respectively) (Libman et al.,
gested that the main value of screening asymptomatic 1993).
travellers is to inform the travel specialist about the Whatever the specic combination of tests used, pa-
health problems prevailing in dierent destinations, so tients who test negative need to be warned about the
that preventive advice for future travellers can be im- possibility of late appearance of malaria if they have been
proved (Ellis, 1993). Meanwhile, the cost-eectiveness of to a malarious area. They may need to be warned that
routine post-travel screening has not been proven (Gen- travel to or residence in some parts of the world may be
ton and Gehri, 1999). sucient to bar them from being blood donors, even if
they have no signs of past or current infection (Table
12.13).
Screening Methods Finally, screening should explore noninfectious and
situational problems, particularly in the worried well or
Nevertheless, it is common practice to oer screening to anxious patient. Reverse culture shock is a genuine prob-
travellers that request it and a structured approach is lem for many travellers returning to their former western
required. A full travel and risk history should be taken. environment, and the health care worker should be at-
The extra information gained from a thorough physical tuned to the possibility of signicant social or psychiatric
examination is limited (Whitty et al., 2000b). A full blood problems (Lankester, 2000). This should be an integral
count should be examined, looking particularly for part of the post-travel check, which, if it is to be per-
eosinophilia, together with stool microscopy for ova, formed at all, should not just be reduced to a couple of
cysts and parasites and specic culture for Strongyloides laboratory tests. In this context, family practice-based
spp (but not for bacterial pathogens). The predictive diag- screening is likely to provide a more suitable environment
nostic value of eosinophilia is reduced by its nonspecic than many busy hospital clinics. If for nothing else, the
nature, so that a large number of investigations may be post-travel check-up should be seen as an opportunity for
required. In our own experience and that of others (Lib- promoting healthy, safe behaviour next time the traveller
man, 1993), an eosinophil count 1 ; 10 l\ is predic- ventures overseas.
206 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Treatment versus Screening demiology and prevention. British Medical Bulletin, 49,
363381.
Alternative strategies are now being used to treat immi- Beighton PH (1967) Medical hazards of air travel. Practitioner,
198, 668672.
grant populations in some settings, based on the total
Bellis MA, Hale G, Bennett A et al. (2000) Ibiza uncovered:
costs (actual and projected) to the health care system. A changes in substance use and sexual behaviour amongst
study of refugees in New York concluded that presump- young people visiting an international night-life resort. Inter-
tive treatment of all immigrants at risk for parasitosis national Journal of Drug Policy, 11, 235244.
with a broad-spectrum anthelmintic, such as albendazole, Berkley J, Mwarumba S, Bramham K et al. (1999) Bacteraemia
was cheaper and more eective than screening and treat- complicating severe malaria in children. Transactions of the
ing, or waiting until clinical symptoms developed before Royal Society of Tropical Medicine and Hygiene, 93, 283296.
treating. This policy prevented death and hospitalisation Blanchard TJ, Milne LM, Pollock R et al. (1993) Early chemo-
as well as saving money in the model used (Muennig et al., therapy of imported neuroschistosomiasis. Lancet, 341, 959.
Bonneux L, van der Stuyft P, Taelman H et al. (1988) Risk factors
1999). Similar considerations have now been extended to
for infection with human immunodeciency virus among
justify routine treatment of refugees for undiagnosed ma- European expatriates in Africa. BMJ, 297, 581584.
laria as well as for intestinal parasites (Miller et al., 2000). Bouchaud O, Houze S, Schiemann R et al. (2000) Cutaneous
This approach has not been widely adopted in the UK or larva migrans in travellers: a prospective study, with assess-
other countries and is not generally suitable for individ- ment of therapy with ivermectin. Clinical Infectious Diseases,
ual returning travellers. It may have a role in special 31, 493498.
situations, for example empirical treatment of groups of Brabin BJ and Ganley Y (1997) Imported malaria in children in
travellers exposed to schistosomiasis by freshwater bath- the UK. Archives of Diseases in Childhood, 77, 7681.
ing in Africa, but the balance of risks and costs in this type Brouwer M, Tolboom JJM and Hardeman JHJ (1999) Routine
screening of children returning home from the tropics: retro-
of setting has not been modelled.
spective study. BMJ, 318, 568569.
Bryceson ADM (1987) Imported fevers. Advanced Medicine, 23,
336343.
ACKNOWLEDGEMENTS Burnett A and Peel M (2001) Health needs of asylum seekers and
refugees. BMJ, 322, 544547.
We thank our colleagues Mike Beadsworth, David Lal- Burney MI, Ghafoor A, Saleen M et al. (1980) Nosocomial
loo and George Wyatt for comments on earlier manu- outbreak of viral hemorrhagic fever caused by Crimean hem-
scripts for this chapter. orrhagic feverCongo virus in Pakistan, January 1976.
American Journal of Tropical Medicine and Hygiene, 29,
941947.
Carroll B, Dow C, Snashall D et al. (1993) Post-tropical screen-
REFERENCES ing; how useful is it? BMJ, 307, 541542.
Caumes E (2000) Treatment of cutaneous larva migrans. Clinical
Adler MW (1997) Sun, sex and responsibility. Journal of the Infectious Diseases, 30, 811814.
Royal College of Physicians, London, 31, 425433. Caumes E, Carrie`re J, Guermonprez G et al. (1995) Dermatoses
Advisory Committee on Dangerous Pathogens for Department associated with travel to tropical countries: a prospective
of Health (1996) Management and Control of Viral Haemor- study of the diagnosis and management of patients presenting
rhagic Fevers. Stationery Oce, London. to a tropical disease unit. Clinical Infectious Diseases, 20,
Anderson SR and Johnson CJH (2000) Expedition health and 542548.
safety: a risk assessment. Journal of the Royal Society of Medi- Centers for Disease Control (1995) Update: management of pa-
cine, 93, 557562. tients with suspected viral hemorrhagic feverUnited States.
Anonymous (1997) Legionnaires disease in Europe, 1997. Week- MMWR , 44(25), 475479.
ly Epidemiological Record, 73, 257261. Chiodini PL (1998) Non-microscopic methods for diagnosing
Anonymous (2000) Malarone2+ for malaria treatment and pro- malaria. Lancet, 351, 8081.
phylaxis. Churchill DR, Chiodini PL and McAdam KPWJ (1993) Screen-
http//www.cdc.gov/travel/disease/malaria/malarone.htm ing the returned traveller. British Medical Bulletin, 49,
Archibald LK, Beeching NJ, Gill GV et al. (1993) Albendazole is 465474.
eective treatment for chronic strongyloidiasis. Quarterly Churchill DR, Morris C, Fakoya A et al. (1996) Clinical and
Journal of Medicine, 86, 191195. laboratory features of patients with loiasis (Loa loa lariasis)
Arishi H, Ageel A, Rahman MA et al. (2000) Outbreak of Rift in the UK. Journal of Infection, 33, 103109.
Valley feverSaudi Arabia, AugustOctober, 2000. Morbidity Colebunders R, Verstraeten T, van Gompel A et al. (1998) Acute
and Mortality Weekly Report, 49(40), 905908. schistosomiasis in travellers returning from Mali. Journal of
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4940a1.htm Travel Medicine, 2, 235238.
Aronson NE, Wortmann GW, Johnson SC et al. (1998) Safety Communicable Disease Report (1997) Needlestick malaria with
and ecacy of intravenous sodium stibogluconate in the treat- tragic consequences. Communicable Disease Report Weekly,
ment of leishmaniasis: recent US military experience. Clinical 7(28).
Infectious Diseases, 27, 14571464. Conlon CP and Peto T (1993) Post-tropical screening (letter).
Bain BJ (1996) Ethnic and sex dierences in the total and dier- BMJ, 307, 1008.
ential white cell count and platelet count. Journal of Clinical Cooke GS, Lalvani A, Gleeson FV et al. (1999) Acute pulmonary
Pathology, 49, 664666. scchistosomiasis in travelers returning from Lake Malawi,
Behrens RH and Curtis CF (1993) Malaria in travellers: epi- sub-Saharan Africa. Clinical Infectious Diseases, 29, 836839.
RETURNED TRAVELLERS 207
Cropley IM, Lockwood DNJ, Mack D et al. (2000) Rapid diag- among Dutch expatriates in sub-Saharan Africa. International
nosis of falciparum malaria by using the ParaSight F test in Journal of STD and AIDS, 2, 252257.
travellers returning to the United Kingdom: prospective Humar A and Keystone J (1996) Evaluating fever in travellers
study. BMJ, 321, 484485. returning from tropical countries. BMJ, 312, 953956.
de Graaf R, van Zessen G, Houweling H et al. (1997) Sexual risk Iqbal J, Sher A, Hira PR et al. (1999) Comparison of the Opti-
of HIV infection among expatriates posted in AIDS endemic MAL test with PCR for diagnosis of malaria in immigrants.
areas. AIDS, 11, 11731181. Journal of Clinical Microbiology, 37, 36443646.
Doherty JF, Grant AD and Bryceson ADM (1995) Fever as the Jelinek T (2000) Dengue fever in international travellers. Clinical
presenting complaint of travellers returning from the tropics. Infectious Diseases, 31, 144147.
Quarterly Journal of Medicine, 88, 277281. Jelinek T, Amsler L, Grobusch MP et al. (1999) Self-use of rapid
Dowdall N (2000) Is there a doctor in the aircraft? Top 10 tests for malaria diagnosis by tourists. Lancet, 354, 1609.
in-ight medical emergencies. BMJ, 321, 13361337. Kain KC, Harrington MA, Tennyson S et al. (1998) Imported
Doyle TJ, Bryan RT and Peters CT (1998) Viral hemorrhagic malaria: prospective analysis of problems in diagnosis and
fevers and hantavirus infections in the Americas. Infectious management. Clinical Infectious Diseases, 27, 142149.
Disease Clinics of North America, 12, 95110. Kenyon TA, Valway SE, Ihle WW et al. (1996) Transmission of
Driver CR, Valway SE, Morgan WM et al. (1994) Transmission multi-drug resistant Mycobacterium tuberculosis during a long
of Mycobacterium tuberculosis associated with air travel. airplane ight. New England Journal of Medicine, 334,
JAMA, 272, 10311035. 933938.
DuPont HL and Capsuto EG (1996) Persistent diarrhea in Kesteven PLJ (2000) Travellers thrombosis. Thorax, 55 (suppl.
travellers. Clinical Infectious Diseases, 22, 124128. 1), S32S36.
Ellis CJ (1993) Post-tropical screening (letter). BMJ, 307, 1008. Klein JL and Millman GC (1998) Prospective, hospital based
Ford N and Inman M (1992) Safer sex in tourist resorts. World study of fever in children in the United Kingdom who had
Health Forum, 13, 7780. recently spent time in the tropics. BMJ, 316, 14251426.
Genton B and Gehri M (1999) Routine screening of children Klontz KC, Hynes NA, Gunn RA et al. (1989) An outbreak of
returning home from the tropics (letter). BMJ, 319, 121. inuenza A/Taiwan/1/89 (H1N1) infections at a naval base
Geroulakos G (2001) The risk of venous thromboembolism from and its association with airplane travel. American Journal of
air travel. BMJ, 322, 188. Epidemiology, 129, 341348.
Gill GV and Bell DR (1979) Strongyloides stercoralis infection in Laferi H, Kandel K and Pichler H (1997) False positive dipstick
former Far East prisoners of war. BMJ, 12, 572574. test for malaria. New England Journal of Medicine, 337,
Goodwin T (2000) In-ight medical emergencies: an over-view. 16351636.
BMJ, 321, 13381341. Lankester T (2000) Health screening and psychological consider-
Gratz NG, Steen R and Cocksedge W (2000) Why aircraft ations in the returned traveller. In Travel Medicine and Mi-
disinfection? Bulletin of the World Health Organization, 78, grant Health (eds C Lockie, E Walker, L Calver et al.), pp
9951003. 443452. Churchill Livingstone, Edinburgh.
Grobusch MP, Alpermann U, Schwenke S et al. (1999) False- Lettau LA (1991). Nosocomial transmission and infection con-
positive rapid tests for malaria in patients with rheumatoid trol aspects of parasitic and ectoparasitic diseases Part II.
factor. Lancet, 353, 297. Blood tissue parasites. Infection Control and Hospital Epi-
Gubler D (1999) Dengue and dengue hemorrhagic fever. Clinical demiology, 12, 111121.
Microbiological Reviews, 11, 480496. Lewis SJ, Davidson RN, Ross EJ et al. (1992) Severity of im-
Gyawali P and Whitty CJM (2000) Investigating eosinophilia in ported falciparum malaria: eect of taking antimalarial pro-
patients returned from the tropics. Hospital Medicine, 62, phylaxis. BMJ, 305, 741743.
2528. Libman MD, MacLean JD and Gyorkos TW (1993) Screening
Hanscheid T, Valadas E and Grobusch MP (2000) Automated for schistosomiasis, lariasis and strongyloidiasis among ex-
malaria diagnosis using pigment detection. Parasitology To- patriates returning from the tropics. Clinical Infectious Dis-
day, 16, 549551. eases, 17, 353359.
Harries AD and Cook GC (1987) Acute schistosomiasis Luzzi GA, Brindle R, Sockett PN et al. (1993) Brucellosis: im-
(Katayama fever): clinical deterioration after chemotherapy. ported and laboratory-acquired cases, and an overview of
Journal of Infection, 14, 159161. treatment trials. Transactions of the Royal Society of Tropical
Harries AD, Maher D and Nunn P (1997) Practical and aord- Medicine and Hygiene, 87, 138141.
able measures for the protection of health care workers from Macallan DC, Pocock M, Bishop E et al. (1999) Automated
tuberculosis in low-income countries. Bulletin of the World erythrocytapheresis in the treatment of severe falciparum ma-
Health Organisation, 35, 477489. laria. Journal of Infection, 39, 233236.
Hart CA and Kariuki S (1998) Antimicrobial resistance in devel- McKenna G, Shousboe M and Paltridge G (1997) Subjective
oping countries. BMJ, 317, 647650. change in ejaculate as symptom of infection with Schistosoma
Hawkes S, Hart GJ, Johnson AM et al. (1994) Risk behaviour haematobium in travellers. BMJ, 315, 10001001.
and HIV prevalence in international travellers. AIDS, 8, MacLean JD, Lalonde RG and Ward R (1994) Fever from the
247252. tropics. Travel Medicine Advisor, 5, 27.127.14.
Hay RJ (1993) Skin disease. British Medical Bulletin, 49, 440453. Malaria Working Party of the General Haematology Task
Hepburn NC, Tidman MJ and Hunter JAA (1993) Cutaneous Force of the British Committee for Standards in Haematology
leishmaniasis in British troops from Belize. British Journal of (1997) The laboratory diagnosis of malaria. Clinical Labora-
Dermatology, 128, 6368. tory Haematology, 19, 165170.
Hipgrave DB, Leydon JA, Walker J and Biggs IBA (1997) Schis- Miller JM, Boyd HA, Ostrowski SR et al. (2000) Malaria, intesti-
tosomiasis in Australian travellers to Africa. Medical Journal nal parasites and schistosomiasis among Barawan Somali
of Australia, 166, 294297. refugees resettling to the United States: a strategy to reduce
Houweling H and Coutinho RA (1991) Risk of HIV infection morbidity and decrease the risk of imported infections. Ameri-
208 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
can Journal of Tropical Medicine and Hygiene, 62, 115121. control subjects: a 1-year prospective study in a Swedish clinic
Minooee A and Rickman LS (1999) Infectious diseases on cruise for infectious diseases. Clinical Infectious Diseases, 30,
ships. Clinical Infectious Diseases, 29, 737744. 770778.
Molyneux M and Fox R (1993) Diagnosis and treatment of Tham JM, Hee Lee S, Tan TMC et al. (1999) Detection and
malaria in Britain. BMJ, 155, 861868. species determination of malaria parasites by PCR: compari-
Muennig P, Pallin D, Sell RL et al. (1999) The cost eectiveness son with microscopy and with Parasight-F and ICT malaria
of strategies for the treatment of intestinal parasites in immi- Pf tests in a clinical environment. Journal of Clinical Microbi-
grants. New England Journal of Medicine, 340, 773779. ology, 37, 12691273.
Murphy GS, Purnomo HB, Andersen EM et al. (1993) Vivax Tichonova L, Borisenko K, Ward H et al. (1997) Epidemics of
malaria resistant to treatment and prophylaxis with chloro- syphilis in the Russian Federation: trends, origins, and priori-
quine. Lancet, 341, 96100. ties for control. Lancet, 350, 210213.
Nichols GL (2000) Food-borne protozoa. British Medical Bulle- Trees A and Shaw S (1999) Imported disease in small animals. In
tin, 56, 209235. Practice (Journal of Veterinary Postgraduate Clinical Study),
Nosten F and van Vugt M (1999) Neuropsychiatric adverse October, 482491.
eects of meoquine. What do we know and what should we von Sonnenburg F, Turnieporth N, Waiyaki P et al. (2000) Risk
do? CNS Drugs, 1, 18. of aetiology of diarrhoea at various tourist destinations. Lan-
Noyes HA, Reyburn H, Bailey JW et al. (1998) A nested-PCR- cet, 356, 133134.
based schizodeme method for identifying Leishmania kineto- Wang CC and Celum CL (1999) Global risk of sexually transmit-
plast minicircle classes directly from clinical samples and its ted diseases. Medical Clinics of North America, 83, 975995.
application to the study of the epidemiology of Leishmania Wetsteyn JCFM, Kaer PA and van Gool T (1997) The changing
tropica in Pakistan. Journal of Clinical Microbiology, 36, pattern of imported malaria in the Academic Medical Centre,
28772881. Amsterdam. Journal of Travel Medicine, 4, 171175.
Okereke E and Gelletlie R (1999) Routine screening of children Whitby M (1997) Drug resistant Plasmodium vivax malaria.
returning home from the tropics (letter). BMJ, 319, 121122. Journal of Antimicrobial Chemotherapy, 40, 749752.
Ormerod P (2000) Tuberculosis and travel. Hospital Medicine, Whitty CJM, Mabey DC, Armstrong M et al. (2000a). Presenta-
61, 171173. tion and outcome of 1107 cases of schistosomiasis from Afri-
Paget Staneld J and Reid D (1980) Imported infections in can diagnosed in a non-endemic country. Transactions of the
children. Journal of the Royal College of Physicians of London, Royal Society of Tropical Medicine and Hygiene, 94, 531534.
14, 232237. Whitty CJM, Carroll B, Armstrong M et al. (2000b) Utility of
Pasvol G and Jacobs M (1999) What is the future for exchange history, examination and laboratory tests in screening those
transfusion for falciparum malaria? Journal of Infection, 39, returning to Europe from the tropics for parasitic infection.
183184. Tropical Medicine and International Health, 5, 818823.
Phillips-Howard PA, Radalowicz A, Mitchell J et al. (1990) Risk Wolfe MS (1999) Eosinophilia in the returned traveller. Medical
of malaria in British residents returning from malarious areas. Clinics of North America, 83, 10191032.
BMJ, 300, 499504. World Health Organization (2000) Severe falciparum malaria.
Pike RM (1978) Past and present hazards of working with infec- Transactions of the Royal Society of Tropical Medicine and
tious agents. Archives of Pathology and Laboratory Medicine, Hygiene, 94 (suppl. 1), 190.
102, 333336. Zaat JOM, Mark TG and Assendelft WJJ (1997) A systematic
Riordan FAI and Tarlow MJ (1998) Imported infections in East review on the treatment of giardiasis. Tropical Medicine and
Birmingham children. Postgraduate Medical Journal, 74, International Health, 2, 6382.
3637.
Risch L, Bader M, Huber AR (2000) Self-use of rapid tests for
malaria diagnosis. Lancet, 355, 237. FURTHER READING
Rubio JM, Benito A, Berzosa PJ et al. (1999) Usefulness of
seminested multiplex PCR in surveillance of imported malaria Armstrong D and Cohen J (1999) Infectious Diseases, Mosby,
in Spain. Journal of Clinical Microbiology, 37, 32603264. London.
Schmetzer O (1999) Hemorraghic fever ? Germany ex Cote Cook GC (1996) Mansons Tropical Diseases, 20th edn. WB
DIvoire. ProMED Mail, 6 Aug. http://www.healthnet.org/ Saunders, London.
programs/promed.html DuPont HL and Steen R (1997) Textbook of Travel Medicine
Schwartz E, Jenks NP, van Damme P et al. (1999) Hepatitis E and Health. Decker, Hamilton.
virus infection in travellers. Clinical Infectious Diseases, 29, Feigin RD and Cherry JD (1998) Textbook of Pediatric Infectious
13121314. Diseases, 4th edn. WB Saunders, Philadephia.
Steen R, Kane MA, Shapiro CN et al. (1994) Epdemiology and Gilles HM and Wallace P (1995) Colour Atlas of Tropical Medi-
prevention of hepatitis A in travellers. JAMA, 272, 885889. cine and Parasitology, 4th edn. Mosby-Wolfe, London.
Suh KN, Kozarsky PE and Keystone JS (1999) Evaluation of Guerrant RL, Walker DH and Weller PF (1999) Tropical Infec-
fever in the returned traveller. Medical Clinics of North Amer- tious Diseases: Principles, Pathogens and Practice. Churchill
ica, 83, 9971017. Livingstone, Philadelphia.
Suleiman MN, Muscat-Baron JM, Harries JR et al. (1980) Hunter GW and Strickland GT (2000) Hunters Tropical Medi-
CongoCrimean haemorrhagic fever in Dubai. Lancet, ii, cine and Emerging Infectious Diseases, 8th edn. WB Saunders,
939941. Philadelphia.
Svenson JE, MacLean JD, Gyorkos TW et al. (1995) Imported Lockie C, Walker E, Calvert L et al. (2000) Travel Medicine and
malaria: clinical presentation and examination of sympto- Migrant Health. Churchill Livingstone, Edinburgh.
matic travellers. Archives of Internal Medicine, 155, 861868. Mandell GL, Bennett JE and Dolin R (2000) Mandell, Douglas
Svenungsson B, Lagergren A , Ekwall E et al. (2000) En- and Bennetts Principles and Practice of Infectious Diseases,
teropathogens in adult patients with diarrhoea and healthy 5th edn. Churchill Livingstone, Philadelphia.
RETURNED TRAVELLERS 209
Wilson ME (1991) A World Guide to Infections: Disease, Distribu- Outbreak Information (WHO).
tion Diagnosis. Oxford University Press, New York. http://www.who.int/disease-outbreak-news/
Regular reports on WHO-conrmed outbreaks of international
importance.
MMMM
Section IV
13
Aviation Medicine
Michael Bagshaw
British Airways Health Services, Harmondsworth, UK
Aviation medicine is a branch of occupational medicine Since air is a mixture of gases which exert pressure, have
which has developed from human needs to adapt to the measurable mass and can be compressed, it is subject to
inherently hostile environment of the air. It is a wide- certain established laws governing reaction to changes in
ranging discipline, encompassing physiological and psy- pressure, temperature, volume and density. A basic
chological aspects of tness to y, and the human factors knowledge of these gas laws helps in understanding how
facets of ight safety are recognised as an important the human body reacts to the aviation environment.
component of ight crew training. The normal physiol- Boyles law states that:
ogy of the human body when in ight can be inuenced
by altitude, changes in pressure, temperature, acceler- providing the temperature is constant, the volume of a gas is
ation and sensory perception. This chapter is concerned inversely proportional to its pressure.
only with those areas of aviation medicine applicable to This means that when the pressure increases, the volume
travel medicine. For fuller consideration of the wider decreases and, conversely, when the pressure decreases,
discipline, the reader is referred to more comprehensive the volume increases. Boyles law explains some of the
texts (Campbell and Bagshaw, 1999; Ernsting et al., 1999). eects of altitude on the gas-containing cavities of the
Commercial air travel is a comfortable, speedy and safe human body during ight. For example, as altitude in-
means of transport and is now accepted as a part of creases, gas contained within the middle ear, sinuses and
everyday life for many people in the developed world. It is gut will expand, sometimes with painful results.
aordable and accessible to almost all sectors of the Charless law states that:
population, and it is easy to forget that the individual is
travelling in a potentially physiologically hostile environ- the volume of a xed mass of gas held at a constant pressure varies
ment. directly with absolute temperature.
A feature of gas expansion is that equal volumes of dier-
ent gases expand by the same amount when heated to the
THE ATMOSPHERE same temperature, so another way of stating Charless
law is that volume of a xed mass of gas at constant
Composition pressure is directly proportional to its absolute tempera-
ture.
The atmosphere surrounds the earth and forms an elastic The gas laws of Boyle and Charles can be summarised
layer of air composed of a mixture of gases and water in the equation:
vapour. The most abundant gases are nitrogen (78%) and
oxygen (21%), with the remaining 1% being argon, car- pv/T : constant,
bon dioxide, neon, hydrogen and ozone. The proportions
remain constant up to the tropopause (approximately where p : pressure, v : volume, T : absolute tempera-
36 000 feet (11 000 m)). The pressure at sea level in the ture. This is known as the gas equation, or general gas
standard atmosphere is 760 mmHg and this falls to half law, and it applies even when there is a change in all three
(380 mmHg) at 18 000 feet (5500 m), where the ambient variablespressure, volume and temperature.
temperature is about 920C.
Above 10 000 feet (3000 m), however, the oxygen tension which is the atmospheric pressure at 40 000 feet
falls below a critical level and deterioration in perform- (12 000 m). Therefore, 40 000 feet (12 000 m) is clearly the
ance becomes obvious. maximum altitude that can be considered acceptable for
216 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Summary of Oxygen Requirements
Hypoxia
Symptoms
Hyperventilation
The symptoms of hyperventilation are classical and may
be summarised as follows:
Hyperventilation may be dened as breathing in excess of
the metabolic needs of the body. As a consequence the Dizziness. Shortly after the onset of hyperventilation it
level of carbon dioxide in the blood is lowered, while by is common for most people to experience a giddy or
denition it is not being replaced by carbon dioxide pro- dizzy sensation.
duced as a result of metabolic processes. Tingling. Tingling of the extremities (hands, feet) or face
It can be seen from this denition that a man breathing may be felt.
heavily following exertion has increased his metabolism. Visual disturbances. Many people experience a cloud-
He needs more oxygen and has produced more carbon ing or dimming of vision, perhaps accompanied by
dioxide. Consequently the rate and depth of breathing is palpitations and hot ushes, which in turn generates
not in excess of his needs. Conversely an individual further anxiety.
breathing in excess without accompanying activity can- Disturbed consciousness. It is possible in a severe attack
not take in extra oxygen, and does not produce extra for the symptoms to progress to clouding of conscious-
carbon dioxide. The excessive breathing will remove car- ness and ultimately loss of consciousness; however, this
bon dioxide from the bloodstream faster than metabolic is followed by immediate recovery as the respiratory
production, thereby lowering blood carbon dioxide level, rate returns to normal.
218 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
EFFECTS OF REDUCED ATMOSPHERIC eyes, in the cheeks and at the back of the nose. Like the
PRESSURE middle ear, no problems are usually encountered on as-
cent, but on descent, if their openings into the nose be-
By Boyles law the pressure of any gas is inversely related come blocked by a cold or catarrh preventing air entry,
to its volume, providing the temperature remains con- the relative vacuum created in the cavities will cause
stant. Hence, in aviation, where the body temperature damage to their lining membranes. This leads to inam-
remains essentially constant, when we ascend to altitude mation and bleeding within the sinus cavities, which may
gas trapped anywhere in the body will tend to expand as produce pain, often severe, and frequently nose bleeding.
altitude increases and atmospheric pressure decreases. This condition of pressure eect on the sinuses is known
The problems thus produced are known as trapped gas as sinus barotrauma.
dysbarism.
In addition, gas which is dissolved in the tissues and Gut. Ascent to 18 000 feet (5500 m) from ground level
body uids at sea-level pressures may come out of solu- halves the atmospheric pressure and therefore doubles
tion in the form of bubbles as the pressure reduces with the volume of gas trapped in the stomach and in the
altitude, in accordance with Henrys law. The problems intestines. Normally this is voided quite easily but occa-
associated with this phenomenon are known as evolved sionally, when ascent is fairly rapid, it can cause discom-
gas dysbarism and the gas of concern is nitrogen. When fort or pain. Avoidance of gas-forming foods, such as
these nitrogen bubbles form in the tissues they give rise to curries, beans, etc., can minimise these eects.
a condition known as decompression sickness.
Teeth. Any tooth that has been lled recently has a
small quantity of air trapped underneath the lling.
Usually, this air escapes around the edge of the lling
Trapped Gas Dysbarism when its owner goes to altitude. Occasionally, however,
the air does not escape and, on ascent, it causes pressure
The body cavities that contain gas are as follows: on the nerve of the tooth, resulting in pain. Similar pain
can be caused by gas produced in dental decay. This is
Middle ear. Many air travellers are familiar with what known as aerodontalgia.
happens when they cannot clear their ears as a result of a
common cold. The mechanism of this disturbance, known Lungs. If a sudden decompression is rapid enough and
as otic barotrauma, may be explained as follows. over a big enough pressure range, damage to the lungs is
The eustachian tube connects the middle-ear cavity theoretically possible. Such high rates of pressure change
with the nose. It permits the passage of air in and out of could occur when a large defect is suddenly produced in a
the middle-ear cavity, thus preventing distortion of the high-dierential pressure cabin. However, in an aircraft
eardrum during changes in ambient pressure. The normal with a cabin altitude of 8000 feet (2400 m), decompression
state of the tube is collapsed, similar to a bicycle tyre inner resulting from the loss of a window, even at very high
tube which is not inated, where the lower half of the tube altitude, has not been known to cause lung damage.
passes through the soft tissues behind the nose. During
ascent, the expanding air in the middle-ear cavity escapes
easily down the tube. On descent, however, the increasing Decompression Sickness
pressure may cause diculty with re-entry of air to the
middle ear due to swollen mucous membranes and con- Decompression sickness is a condition that can arise as a
gestion around the opening of the tube behind the nose. result of exposure of the body to reduced atmospheric
Normally, the tube can be opened voluntarily by certain pressure either in an aircraft or in a decompression cham-
manoeuvres such as yawning or swallowing. In the event ber. It is rare below 25 000 feet (7600 m), but the incidence
of congestion of membranes lining the nose and throat, and onset increases rapidly above this altitude.
the lining of the tube becomes swollen and may not open.
The unequal pressures so produced cause the eardrum to
be drawn inwards, resulting in pain, deafness and possible Causes
dizziness and disorientation. In the worst case, the ear-
drum may perforate. Ideally one should not y with a The human body is saturated with nitrogen, which is in
cold or other forms of upper respiratory congestion, such solution in tissues and body uids, at a partial pressure of
as hay fever. If travel is essential, frequent steam inhala- gas equal to that of the surrounding atmosphere. When
tion on the days preceding travel plus the judicious use of the ambient pressure is lowered, the nitrogen tends to
a nasal decongestant spray (e.g. oxymetazoline or come out of solution. The formation of nitrogen bubbles
xylometazoline) may prevent the development of baro- thus released from solution is generally accepted as the
trauma. cause of decompression sickness.
The following factors increase susceptibility to decom-
pression sickness:
Sinuses. The sinuses are cavities in the bones of the face
which open into the nose. They are situated above the Altitude. Decompression sickness rarely occurs below
AVIATION MEDICINE 219
18 000 feet (5500 m) cabin altitude, is unlikely below condition worse. On descent, symptoms usually pass o
25 000 feet (7600 m), and the incidence increases with but will recur immediately on reascent.
altitude above this level.
Duration of exposure. The longer the exposure, the
Creeps. This is a transient, mild, itching or tingling
greater the number of individuals aected by decom-
feeling, usually of the thigh and trunk. A blotchy red rash
pression sickness.
may sometimes accompany the condition. In itself it is
Re-exposure. Re-exposure to altitude, within 48 h, in-
not a serious condition, but it indicates the presence of
creases susceptibility to decompression sickness.
decompression sickness.
Exercise. Exercise while at altitude is one of the most
important factors inuencing susceptibility to this con-
dition. There is also evidence that preight exercise Chokes. This is a name used to describe respiratory
may increase the incidence of decompression sickness. symptoms, which may be preceded by bends pain. It is
Temperature. Cold may increase the incidence of de- characterised by a burning feeling in the chest with pain
compression sickness. on breathing in, often accompanied by severe bouts of dry
Age. There is an increased incidence of decompression coughing. In spite of the name, there is no respiratory
sickness with age: each decade roughly doubles the obstruction and no danger, therefore, of choking. Al-
susceptibility. though rare, the condition must be treated seriously and
Obesity. Fat, having a relatively high nitrogen content, descent should be initiated immediately, to avoid serious
predisposes obese individuals to decompression sick- complications. The individual should receive expert
ness. medical care as soon as possible.
Individual susceptibility. Certain individuals are more
susceptible than others in comparable circumstances,
Nervous system symptoms. Symptoms of decom-
and this susceptibility varies from day to day.
pression sickness arising from the central nervous system
Subaqua swimming. Swimming underwater exposes the
are very varied and may take the form of a temporary loss
body to an increased ambient pressure (atmospheric
of areas in the visual eld, inability to concentrate or
pressure plus the pressure of water, which varies with
weakness and paralysis of a limb. The last symptom is the
depth). If air is breathed underwater, nitrogen will enter
origin of the divers name of staggers.
the body until the partial pressure of nitrogen equals
the ambient pressure. Flying, even at low cabin alti-
tudes, after subaqua swimming is very likely to result in Decompression collapse. This is a serious condition
decompression sickness. This increased susceptibility which may be primary, secondary or postdecompression.
lasts for up to 48 h, and it is recommended that ying Primary collapse occurs with little or no warning. There
should be avoided for at least 12 h following exposure is a feeling of apprehension, pallor of the skin and a cold
to a pressure of up to 2 atmospheres absolute (33 feet sweat, which may be followed by a faint. Secondary col-
(10 m) of sea water), as in subaqua swimming, and at lapse is similar, but is preceded by some other form of
least 24 h when exposure exceeds 2 atmospheres. decompression sickness, usually chokes or severe bends.
Hypoxia. Coexistent hypoxia makes an individual This is the commonest form of collapse. Postdecompres-
more prone to the symptoms of decompression sick- sion collapse occurs after return to ground level, usually
ness. within 4 h, but it can occur after many hours. It may be
Fatigue. preceded by headache, nausea or a feeling of malaise.
Ill health. Decompression collapse is uncommon but, should it oc-
Recent alcohol intake. This can increase signicantly cur, it must be treated as a medical emergency. If it occurs
the likelihood of decompression sickness. in ight, land as quickly as possible and seek urgent
specialist assistance and immediate transfer to a hyper-
baric chamber facility.
Symptoms
The sections on hypoxia and decompression sickness A pressure cabin is built strong enough to withstand its
have shown the need for protection from these hazards. In maximum intended pressure dierential, plus an element
passenger-carrying aircraft these problems are overcome for safety, and is sealed to meet regulatory standards for
by pressurising the aircraft cabin. leak rates. Pressurisation is then achieved by tapping air
from a suitable stage of the engine compressor, cooling it
and ducting it into the cabin. In some aircraft, a separate
engine-driven compressor is used. The dierential press-
Environmental Requirements of a Pressure Cabin ure level is then set by controlling the inow of compres-
sor air together with a ne control for regulating the rate
The physiological ideal for a pressure cabin would be to of escape of air from the cabin by means of a barometri-
pressurise it to sea level, but this would require an ex- cally operated outow valve. The cabin altitude is usually
tremely strong, and consequently very heavy and com- allowed to increase with aircraft altitude until a cabin
plex, cabin or fuselage structure. This is incompatible altitude of between 5000 and 8000 feet (1500 and 2000 m)
with the need to carry a large number of passengers, is reached. Barometric control of the outow valve then
baggage and freight over long distances. Aircraft are maintains the cabin at that altitude until the maximum
therefore designed with cabin dierential pressures that dierential pressure for that aircraft cabin is achieved. If
are a compromise between the physiological ideal and the the aircraft continues to climb, the maximum dierential
economic realities of the aircrafts role and performance. bleed valve control takes over; the maximum dierential
In general, pressure cabins fall into two broad catego- pressure is maintained and the cabin altitude increases,
ries, low- and high-dierential cabins. The advantage of a maintaining that dierential over ambient atmospheric
high cabin dierential is that it protects the occupants of pressure. In reality, it is rare for a commercial airliner to
the cabin from any serious eects of hypoxia without exceed a cabin altitude of 8000 feet (2400 m) during nor-
having to use personal breathing equipment, and there is mal operation.
no risk of decompression sickness at the cabin altitudes There are other methods of pressurising cabins. For
maintained [commonly 60008000 feet (18002400 m)]. example, space vehicles carry their own source of pressur-
Passenger-carrying aircraft normally have high-dieren- isation, which may be 100% oxygen (stored in liquid
tial cabins. These aircraft must be able to operate at high form) or a mixture of oxygen and an inert gas. It is
altitudes for long periods and they are able to carry the advantageous to use an oxygeninert gas mixture for
weight of pressurisation equipment which is necessary. A reasons of safety. Because a space vehicle is a closed
low-dierential cabin is usually found in military aircraft environment, there has to be a system for absorbing
in which the crew use personal oxygen equipment carbon dioxide, something that is not necessary in a
routinely. When pressurising aircraft cabins the following passenger airliner.
factors must be controlled:
Pressure
Loss of Cabin Pressure
Relative humidity
Mass ow
Loss of cabin pressure can vary from a slow leak, due to
Volume ow
some minor mechanical problem such as a faulty door
Temperature.
seal, to a rapid or even explosive decompression due to a
If these factors are adequately controlled, the problems of rupture of the cabin wall or loss of one or more windows.
cabin conditioning, i.e. temperature and ventilation, are The occurrence of a rapid decompression is readily in-
also taken care of. dicated by a loud noise due to the sudden release of
In modern passenger aircraft, it is normal for 50% of pressure. The compressed air within the cabin roars out
the cabin air to be recirculated. This recirculated air is of the defect at a velocity near the speed of sound until the
passed through high-eciency particulate lters (HEPA cabin pressure reaches that of the surrounding atmos-
lters), which remove bacteria and viral particles. The phere. As this air leaves the cabin, so the remaining gas
benets of recirculating air are an increase in relative expands, causing the temperature of the air within the
humidity and a reduction in ozone levels, as well as cabin to drop to its dewpoint and water condenses out as
reduction in uncomfortable drafts of fresh air. Flow rates a mist, which can be so dense that it interferes with the
of fresh air in passenger aircraft cabins are designed to occupants vision. The loud noise plus misting has led
exceed the minima laid down for indoor rooms by the crews to believe that their aircraft is severely damaged
American Society of Heating, Refrigeration and Air-con- and on re. In the case of a slow leak, there is no such
ditioning Engineers (ASHRAE). This rate is 5 cubic feet dramatic indication. The rst sign is likely to be the sound
(142 litres) per minute per person, which ensures that of a cabin pressurisation failure warning device, the il-
carbon dioxide levels remain below 5000 parts per million lumination of the appropriate warning light or a cabin
by volume. Most modern airliners achieve ow rates of altimeter indication, depending upon the aircraft instru-
approximately double this value. mentation.
AVIATION MEDICINE 221
Possible causes of loss of cabin pressure are: and position of the defect there may be considerable
wind noise, which interferes with communication be-
Compressor failure
tween crew members.
Malfunction of the control system
Pressure leakage; especially around doors The pressure cabin is an essential part of the modern
Window blowout high-performance aircraft, without which it would not
Structural failure. have any useful high-altitude capability. Without press-
urisation, aircrew and passengers would only be able to
carry out high-altitude ying by the continuous use of
personal oxygen equipment, which of course would not
Aerodynamic Suck be acceptable for the transport of fare-paying passengers.
In the case of a rapid decompression resulting from a
defect in the cabin wall rather than a failure of the press-
urisation system, the nal cabin altitude may exceed the SLEEP AND FATIGUE
actual pressure altitude of the aircraft. This is due to the
Sleep is essential for restoring the normal balance be-
ow of air over the defect, which tends to suck the resid-
ual air out of the cabin (aerodynamic suction eect), tween the dierent parts of the central nervous system.
except in cases where the defect faces directly into the During sleep, the bodys physical functions are rested and
some renewal takes place; sympathetic nervous activity
airstream. The magnitude of this eect varies with the
aircraft type, the position of the defect in relation to the decreases and the muscular tone becomes almost nil; the
atmospheric airstream, and the aircrafts altitude and arterial blood pressure falls, the pulse rate decreases, the
blood vessels in the skin dilate and the overall basal
speed. In the worst case the height discrepancy could be
such that the cabin altitude is many thousands of feet metabolic rate of the body falls by up to 20%. On aver-
above the aircraft pressure altitude. This can, therefore, age, most humans need physiologically about 8 h of sleep
per night; however, in modern society most adults report
be an important phenomenon because of the eect it can
have on the aircraft occupants and whether or not their an average of 77.5 h sleep per night, with 75% reporting
personal emergency oxygen equipment has the perform- daytime sleepiness (Rosekind et al., 1994).
Sleep loss can be acute or cumulative. In an acute
ance necessary to prevent hypoxia at the resulting cabin
altitude. situation, sleep loss can occur either totally or as a partial
loss. It can accumulate over time into what is referred to
as sleep debt. As little as 2 h of sleep loss can result in
impairment of performance and levels of alertness. Sleep
Eects of Rapid Decompression loss leads to increased reaction time, reduced vigilance,
cognitive slowing, memory problems, time-on-task decre-
The eects of loss of cabin pressure are dependent upon: ments and optimum response decrements. It has also
The altitude at which the decompression takes place been shown that performance variability increases with
and the presence or absence of aerodynamic suck sleep loss.
The pressure dierential at the time of failure
The size of the hole permitting loss of pressure and
therefore the duration of the decompression Physiology of Sleep
The volume of the pressurised compartment.
Sleep can be divided into ve stages: stages 1 to 4 and
The possible physiological eects, dependent on the
rapid eye movement (REM) sleep. Stage 1 is a transitional
factors above, are:
phase between waking and sleeping and this normally
Pressure change eects on ears, sinuses, lungs and gut. lasts around 10 min as an individual falls asleep. Sleep
Of these, only rapid expansion of trapped gas in the gut then becomes deeper, with 15 min in stage 2 sleep and a
is usually of any signicance, as in the other sites the further 15 min in stage 3 sleep before moving into stage 4.
expansion is normally counterbalanced by the rate of Approximately 90 min after sleep onset, REM sleep will
leakage from the body. Rapid distension of the gut can occur. The cycle of REM sleep and stages 14 sleep
lead to a faint as a result of vagal inhibition. repeats during the course of the night in 90 min cycles,
Hypoxia, particularly in high-dierential cabins where each succeeding cycle containing greater amounts of
the crew and passengers are not wearing oxygen equip- REM sleep. An 8 h sleep period will typically contain
ment at the time of decompression. about 45 bouts of REM sleep. Most stage 4 sleep hap-
Decompression sickness, if there is any need to con- pens early in the night. It is thought that stages 14 sleep
tinue the ight at cabin altitudes above 25 000 feet is related to body restoration, whereas REM sleep may be
(7600 m). related to strengthening and organising memory. When
Cold, depending upon the size and position of the learning new tasks, an increased proportion of REM
defect in the cabin. sleep is seen.
Diculty in communication: depending upon the size The need to operate commercial airliners worldwide
222 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
for 24 h each day inevitably leads to the problems of considered to be better tolerated than eastward, possibly
unsocial and irregular hours, time zone (transmeridian), because the endogenous system, with a natural periodic-
climatic and cultural changes, sleep disturbances, and ity in most individuals of about 25 h, is more able to adapt
alterations to circadian rhythms. Fatigue is the main to the longer day encountered during westward ight.
danger for ight crew, as a decline in performance is likely The aetiology of the eects of jet lagsleep disturban-
to accompany it. The economic and operational require- ces, disruption of the other body functions such as feeding
ments of an airline must be balanced against these unde- and bowel habit, general discomfort, and reduced
sirable factors, but good aircrew scheduling has been psychomotor eciencyhas been the subject of much
developed to minimise the eects on health, morale and investigation. This has largely concentrated on underly-
safety. ing hormonal variations, but for aircrew and business
For passengers travelling by air, the eects of sleep loss travellers the important changes are those associated
and fatigue are likely to be less critical than for aircrew. with performance levels. Ability at many mental skills,
However, when important business decisions have to be including vigilance, choice reaction time, and simulator
taken after a long journey it is essential that the traveller performance, rises to a peak during the day between 12.00
has some understanding of the nature of sleep and fatigue and 21.00, with a dip during the afternoon, and then falls
so that the eects of sleep loss and circadian disruption to a minimum between 0300 and 0600. Results of memory
can be minimised. tests peak in the morning and then fall steadily.
For ight crew, there are statutory constraints on sched- There are two principal components of sleepiness or fa-
uling. These constraints include limitations on the maxi- tigue:
mum ying duty period, minimum rest periods, maxi-
mum scheduled duty hours, and minimum cumulative Physiological sleepiness or fatiguethis is a require-
o-duty periods. In the United Kingdom proposed ight ment like hunger or thirst and can only be reversed by
schedules have to be submitted by the airline manage- sleep.
ment to the Flight Times Limitation Board of the Civil Subjective sleepiness or fatiguethis is an individuals
Aviation Authority before their introduction. Other perception of his or her sleepiness but it may be aected
countries have similar limitations, and within such frame- by other factors. It may be dicult for an individual to
works airlines operate schedules that are further restric- subjectively assess his or her own alertness, with a
ted by the need to meet the needs of passengers and to tendency to report a greater level of alertness than is
comply with night ying bans, peak hour saturation, and actually the case.
political inuences on route planning. In addition, ight Factors aecting sleepiness include:
time limitations usually reect conditions acceptable to
industrial bodies rather than to medical advisers. The Prior sleep and wakefulness
commercial need to keep aircraft ying, and so earning Circadian phase leading to:
revenue, and the requirements of engineering schedules increased sleepiness in the early hours of the morning
for airframe and engine inspection and checks are also and during the afternoon
relevant considerations. decreased performance in the early hours of the
morning
Age (the amount of nocturnal sleep required reduces
Transmeridian Travel after the age of 50)
Alcohol (reduces the quality of sleep)
The endogenous circadian system, in which over 50 Work and environmental conditions.
physiological and psychological rhythms have now been
identied, is known to be aected by many environmental
factors. These include local clock hour, light and dark, Prevention and Management of Fatigue
and temperature, although many of the rhythms continue
in the absence of such cues, albeit usually with a slightly Individuals have dierent needs and react dierently to
prolonged periodicity. The environmental factors facili- sleep loss. Therefore each individual must apply recom-
tate entertainment or phasing of the rhythms and are mendations to suit his or her particular circumstances.
known as synchronisers or Zeitgebers (time givers).
Travel across time zones outstrips the ability of syn-
chronisers to entrain rhythms and desynchronisation oc-
Sleep Scheduling
curs. This is responsible for the syndrome known as jet
lag, as circadian rhythms need a nite period to become
re-entrained to local time (usually estimated at about 1 At home the best possible sleep should be obtained
day per time zone crossed). Westward travel is generally before a trip.
AVIATION MEDICINE 223
On a trip, as much sleep per 24 h should be obtained as her, and evolve the appropriate strategies to suit his or
would be at home. her particular needs.
Feelings should be trusted: if the individual feels sleepy
and circumstances permit, then he or she should sleep;
however, if the individual wakes spontaneously and
cannot get back to sleep in about 1530 min, then he or MOTION SICKNESS
she should get up out of bed.
Motion sickness is a condition characterised primarily by
nausea, vomiting, pallor and sweating, which occurs
when humans are exposed to real or apparent motion
stimuli with which they are unfamiliar and hence unadap-
Good Sleep Habits
ted. It is a generic term that embraces sea sickness, air
sickness, car sickness, swing sickness, simulator sickness,
A regular presleep routine should be developed. ski sickness, camel sickness, space sickness, etc.all vari-
Sleep time should be kept protected. ous forms of the same malady named after the provoca-
The individual should avoid going to bed hungry, but tive environment or vehicle. Despite the diversity of the
should not eat or drink heavily before going to bed. causal environment, the essential characteristics of a pro-
Alcohol or caeine should be avoided before bedtime. vocative stimulus and the response of the aicted indi-
vidual are common to all these conditions, hence the use
An optimum dark, quiet and comfortable sleep environ-
of the general term motion sickness. Nevertheless, it must
ment is important. A healthy lifestyle with regular exer-
be acknowledged that the term motion sickness is, in
cise should be maintained, which seems to help with the
certain respects, a misnomer. First, because symptoms
rst stages of sleep. Caeine consumption may be used to
characteristic of the condition can be evoked as much by
increase alertness. A cup of coee usually takes about
the absence of expected motion as by the presence of
1530 min to become eective, and the eect lasts for
unfamiliar motion, such as in simulator sickness and
between 3 and 4 h. A balanced diet, including drinking
Cinerama sickness. Secondly, the word sickness carries
plenty of uids, can also prevent the onset of fatigue.
the connotation of being aected with disease and tends
Bright light (more than 2500 lux), used at the appropri-
to obscure the fact that motion sickness is a quite normal
ate time in the circadian cycle, can help to reset the
response of the healthy individual, without organic or
circadian clock. After ying east, the traveller should be
functional disorder, when exposed for sucient length of
exposed to evening light with respect to body time, but
time to unfamiliar motion of sucient severity. Indeed,
morning light avoided. Conversely, when travelling west,
under severe stimulus conditions, it is the absence rather
morning light should be sought and evening light avoid-
than the presence of symptoms that is indicative of true
ed. This makes the best use of the natural Zeitgebers in
pathology, for only those individuals who lack a func-
resetting the body clock.
tional vestibular system are truly immune (Miller and
When used appropriately, certain drugs can help in the
Graybiel, 1970).
short term to resynchronise the sleep cycle after time zone
crossing. Temazepam is a short-acting benzodiazepine
that is rapidly cleared from the body. Many people nd
this drug helpful in promoting sleep and, used for 23 Symptoms and Signs
days after travel, it can assist in resetting the sleep cycle.
Melatonin is a substance secreted by the pineal gland Typically, the development of motion sickness follows an
with a rhythm linked to the lightdark cycle through the orderly sequence, the time scale being determined by the
suprachiasmatic nucleus. It is available in tablet form and intensity of the stimulus and the susceptibility of the
has been used by many people in an attempt to assist individual. The earliest symptom is usually epigastric
sleep; however, the timing of administration to match the discomfort, which is normally described as stomach
late evening part of the pineal circadian cycle is critical. awareness. Should the provocative motion continue,
Also, despite being a natural substance, the long-term well-being usually deteriorates quite quickly, with the
side-eects are not fully understood, particularly those appearance of nausea of increasing severity. At the same
aecting reproductive function and cardiac activity. It time, facial pallor may be observed and the individual
therefore does not have a pharmaceutical licence for gen- begins to sweat, the sweating usually being conned to
eral use. Although alcohol is widely used as an aid to those areas of skin where thermal sweating rather than
sleep, it is a nonselective nervous system depressant and is emotional sweating occurs. This is followed by the so-
eectively a drug. Although alcohol may induce sleep, called avalanche phenomenon, with increased salivation,
REM sleep is considerably reduced and early waking is feelings of bodily warmth, light-headedness and, not in-
likely. It is therefore not appropriate to use alcohol in this frequently, quite severe depression and apathy. By this
manner. stage vomiting is usually not far away, although there are
It should be remembered that there is no simple or some individuals who remain severely nauseated for long
single solution for combating the eects of sleep loss and periods and do not obtain the transitory relief that many
jet lag. The individual has to discover what helps him or people report following the act of vomiting.
224 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Apart from these characteristic features of motion sick- angular accelerations but also by purely visual stimuli
ness, other signs and symptoms are frequently, although without a changing force environment (as in simulators
more variably, reported. In the early stages, increased or Cinerama). Furthermore, it must account for the phe-
salivation, belching and atulence are commonly asso- nomenon of adaptation to the provocative motion, as
ciated with the development of nausea, and hyperventila- well as the sickness that can occur when the individual
tion is frequently observed. Headache is another variable returns to a normal motion environment after having
prodromal symptom and complaints of tightness round adapted to an atypical one (an example being land sick-
the forehead or of a buzzing in the head are not uncom- ness on disembarking after a few days at sea).
mon. Another symptom commonly associated with expo- Undoubtedly the vestibular apparatus plays a signi-
sure to unfamiliar motion is drowsiness, and, typically, cant role in the condition because, as has been known for
feelings of lethargy and somnolence persist for many more than half a century, individuals without vestibular
hours after withdrawal of the provocative stimulus and function do not get motion sickness. Nonetheless, the
nausea has abated. The soporic eect of repeated theory that motion sickness is due to vestibular over-
motion stimulus on infants has long been recognised and stimulation alone does not account for the fact that sick-
it may be that the drowsiness observed in the adult when ness may not be induced at quite strong motion stimuli
exposed to appropriate motion is a manifestation of the (for example, vertical oscillation at frequencies above
same mechanism, although this is conjecture. 0.51.0 Hz), yet weaker stimuli (for example head move-
ment during turns) are highly provocative. Nor does it
account for the visually induced forms of motion sickness
Incidence or the characteristic adaptive phenomenon (Benson,
1988).
Motion sickness is a normal response to an abnormal The most satisfactory explanation is still provided by
environment. Thus, individuals who are unadapted to a Reasons neural mismatch theory which views motion
particular type of motion are all likely to suer from the sickness not as an isolated vestibular phenomenon but as
disability if the motion is of sucient intensity and the the response of the body to discordant motion cues (Rea-
period of exposure is suciently prolonged. Of course son, 1978). In all the situations where motion sickness is
there are wide dierences in individual susceptibility, al- provoked, the information transmitted by the eyes, the
though in severe sea states, sickness rates as high as 99% vestibular system and other sensory receptors is at vari-
have been recorded (Bles et al., 1984). Nonetheless, in less ance with the information the individual expects, from
provocative environments a proportion of the population past experience, to receive. It is postulated that within the
at risk do not succumb. Although many of the factors that central nervous system there is some form of store or
determine individual susceptibility have been identied, memory and with it a comparator, where signals from the
and the nature of evocative motions recognised, it is still sensory receptors and neural store are correlated. If the
not yet possible to predict with certainty the incidence of signals to the sense organs stimulated by the motion
sickness in a given population, even when exposed to a agree with the stored association, there is no mismatch
motion stimulus that can be dened. This has caused and all is well. However, when the input signals do not
severe problems with the space programme, where the agree with the expected (stored) information, then a mis-
incidence of sickness is in excess of 50%, despite very match signal is generated. This has two eects. One is to
careful screening of the astronaut population (Homick et modify the store so that a new association of cues is
al., 1984). Similarly, it has proved dicult to predict elaborated (the store is rearranged); the other is to initiate
susceptibility in applicants for military aircrew training the sequence of neurovegetative responses which charac-
and an absence of sea sickness or swing sickness does not terise the motion sickness syndrome. Both these re-
confer immunity from air sickness. Conversely, a suscep- sponses depend on the duration and intensity of the
tibility to these stimuli does not imply that an individual mismatch signal. A sustained strong mismatch signal is
will in turn necessarily suer from air sickness. likely to provoke sickness and concurrently a signicant
Air sickness in passenger transport aircraft is now- rearrangement of the store. Conversely, a weak mismatch
adays a relatively rare occurrence, the incidence being of signal, provided it is sustained, can allow rearrangement
the order of 0.41.0% (Benson, 1988). This is largely due or adaptation to occur without engendering nausea.
to the fact that large jet transports are able to y above In the humans normal typical environment, usually
the turbulent weather and a smooth ride is the norm. The natural movement on the ground, the inputs from the
incidence is higher in small light aircraft, particularly sensory receptors accord with the expected signals. On
among passengers unfamiliar with this form of travel. transfer to a new or atypical motion environment, such as
riding a camel or ying in an aeroplane, the comparator
signals dier appreciably from those coming from the
Aetiology visual and/or vestibular receptors, because the stored
information remains appropriate to the typical condi-
An explanation of the causation of motion sickness must tions. With continued exposure, the contents of the neural
include the fact that it can be induced not only by motion store are slowly modied so that the intensity of the
in which the individual experiences changing linear and mismatch signal decreases as the expected signal comes to
AVIATION MEDICINE 225
agree with the sensory input appropriate to the new Individual Susceptibility
atypical environment. Thus there is no longer any mis-
match. At this stage, the individual may be considered to There are wide dierences between individuals in their
have adapted to the atypical motion environment, and susceptibility. It used to be thought that a person who is
the symptoms of motion sickness will disappear. prone to sickness in one motion environment is also likely
On return to the normal or typical motion environ- to suer when exposed to other types of provocative
ment a mismatch again occurs and this may provoke motion, but, as already indicated, experience shows this
symptoms similar to those experienced on initial transfer not to be so. However, susceptibility does appear to be a
to the atypical environment. This mismatch arises be- relatively stable and enduring characteristic of the indi-
cause the expected signals are still appropriate to the vidual, even though it can be modied by environmental
atypical environment. The store has now to be rearranged and experimental factors.
to make it compatible once again with the sensory input. An attempt was made to correlate for the Spacelab 1
In general this phase of adaptation proceeds more quick- astronauts their preight motion sickness susceptibility
ly than the initial adaptation to the atypical environment, test scores with their inight susceptibility (Homick et al.,
because the correlations established by long experience 1984). Little correlation was apparent, although an im-
are more easily retrieved than new ones can be acquired. portant nding from Spacelab 1 was that motion sickness
By the same argument, should the individual return to the was not experienced after return to earth. Therefore the
atypical environment, adaptation is likely to be a more astronauts seemed less susceptible postight than pre-
rapid process than on rst exposure, because the store ight to several forms of provocative vestibular stimula-
can be rearranged with the aid of retained stimulus pat- tion.
terns acquired during previous exposures to the atypical
environment. If transfer from one specic motion envi-
ronment to another is frequent, than a stage is reached Eect of Age
where the neural store can be modied quite rapidly, so
that the mismatch signal is short-lived or of insucient Susceptibility changes with age, sickness rarely occurring
strength to engender motion sickness. before the age of 2. In childhood, the incidence of sickness
Unfortunately, this neural mismatch theory does not increases markedly to reach a peak at puberty (1013
explain why motion sickness should take the particular years) and thereafter susceptibility declines rapidly be-
form that it does, nor indeed why motion sickness should tween the 12th and 21st years. Motion sickness is not a
occur at all. However, the theory is a unifying concept geriatric problem, being quite rare above the age of 50
and gives us a basis from which to begin to try and years (Benson, 1988). The mechanism underlying the
explain it. large changes in age susceptibility is not understood,
although it is tempting to ascribe the phenomenon to
long-term adaptation. It may also be due to a reduction in
Provocative Stimulus general neural sensitivity, which is part of the normal
ageing process.
The neural mismatch theory implies that there is disson-
ance between the incoming sensory signals and those
expected by the neural store. Basically, two sensory sys- Alcohol
tems are involved: the visual system and the vestibular
system. The vestibular system is further divided into the It is known that alcohol induces nystagmus. Positional
angular acceleration receptor system, which is the ampul- alcohol nystagmus appears in two phases. The rst ap-
lary receptors of the semicircular canals, and the linear pears within 30 min of alcohol intake and shows nystag-
acceleration or force environment receptor system of the mus, with the fast component beating to the right if the
utricular and saccular maculae, usually referred to as the subject is in the right lateral position and vice versa. This
otolith organs. Other mechanoreceptors are also stimu- phase lasts about 34 h and is followed by an intermedi-
lated by the changes in the force environment, but in ate period in which no nystagmus is observed. The second
general they act synergistically with the macula receptors phase begins 56 h after the consumption of alcohol and
and need not be considered separately. The motion cue the direction of movement is reversed, in that the fast
mismatch can be specied according to the sensory sys- component beats to the left when the subject is on the
tem involved: right side. The duration of the second phase and the
intensity of both phases are related to the maximal blood
Visualvestibular mismatch
alcohol concentration, and hence to the amount of alco-
Canalotolith mismatch.
hol consumed. This second phase always persists for sev-
These can be further subdivided into type 1 conict, when eral hours after all alcohol has disappeared from the
both systems concurrently signal contradicting or uncor- blood.
related information, and type 2, when one system signals It is thought that when alcohol diuses from the blood
information in the absence of the expected signal from the into the endolymph of the semicircular canals it does not
other system (Benson, 1988). become evenly distributed. It is less dense than water and
226 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
so creates a light spot at the ampulla, because the concen- by sickness in those environments where motion sickness
tration of blood vessels there means that most of the occurs. In the airborne environment, anxiety does not
diusion occurs in this region. If the canal is then orien- produce motion sickness, but it can be the prime cause of
tated appropriately to gravity, this light spot will tend to sickness in the air, which is a separate condition often
rise, causing the uid to move as it would if the head were associated with phobic anxiety.
turning. This leads to nystagmus. The second phase can
be explained as follows. When alcohol starts to diuse
back out of the endolymph, the area around the ampulla Prevention and Treatment
becomes free of alcohol fastest and this creates a relatively
heavy spot, which in turn causes a reversal of the direc- As always, prevention is better than cure. Having under-
tion of the nystagmus fast beat. This eect on the en- stood some of the aetiology it is now fairly obvious that
dolymph causes an increased vestibular sensitivity and the head movements should be reduced to a minimum
hence the nding of motion sickness in susceptible indi- and discordant visual cues (such as reading during the
viduals following minimal alcohol intake. journey with the head down) should be minimised. Alco-
hol should be avoided in the 24 h prior to ight and
during the ight itself, particularly if there is any sugges-
Receptivity, Adaptability and Retentivity tion that the individual may be susceptible to motion
sickness.
Receptivity refers to the way in which the individual
processes a stimulus within the nervous system. It is
suggested that a person who has high receptivity transdu- Drugs
ces the sensory stimulus more eectively, and that it
evokes a more powerful subjective experience than in a A number of drugs have been shown to be of value in
person of low receptivity. Hence, according to the mis- reducing the incidence of motion sickness, or attenuating
match theory, the receptive has a more intense mismatch symptoms of those suering from the disability. However,
signal and is therefore more likely to suer from motion as ever, no pharmacologically active agent is entirely
sickness than the nonreceptive when exposed to provoca- specic and they all have side-eects. No drug can pre-
tive motion. vent the occurrence of motion sickness in every member
Adaptability describes the rate at which the individual of a population at risk. Drugs currently available for the
adapts to an atypical motion environment or, in more treatment of motion sickness include antihistamines,
general terms, adjusts to the conditions of sensory rear- phenothiazines or atropine derivatives. The exact mode
rangement. Those who adapt slowly suer more severe of action of many of these drugs is not fully understood,
symptoms and require a longer period for adjustment to other than a so-called vestibular sedative action.
the motion than the fast adaptors. It follows that slow Receptors for some antimotion sickness drugs are un-
adaptors are more susceptible to motion sickness than evenly distributed in the vestibular nuclei, where they
the fast adaptors, but this does not mean that slow apparently modulate, but do not relay, primary sensory
adapters are also receptives, and it has been shown that inputs. It is thought that a dynamic balance exists be-
these two factors are in fact unrelated. tween muscarinic cholinergic-activated brainstem neur-
One factor remains. This is the manner in which adap- ons, which initiate motion sickness, and noradrenaline
tation is retained between exposures to the provocative (norepinephrine)-activated brainstem neurons, which act
motion. Poor retention of adaptation is illustrated by the against motion sickness development. The action of
ying individual who is troubled by motion sickness dopamine and its function in sensory switching in the
when ights are separated by several days, but is symp- basal ganglia is thought to be the most likely mechanism
tom-free when able to y regularly with not more than a of action.
few days between ights. The individual with the better Hyoscine hydrobromide (available in the UK as
retention is not so aicted, such that, once having Kwells) is still the most eective drug in most of the
adapted to the provocative motion of a particular ight population and has the advantage of a relatively short
environment, he or she remains free even when ights are duration of action. This is an advantage in aviation, but in
quite spasmodic. the marine world it can be a disadvantage. At sea the
favoured drug is cinnarizine (sold in the UK as Stugeron)
because it has a long half-life and is eective for a days
Anxiety and Neurotic Reactions sailing. It has calcium antagonistic properties and ap-
pears to exert a signicant depressant eect on the vesti-
Nausea and vomiting are not common symptoms of fear bular nuclei, possibly by antagonising the stimulated in-
and anxiety, although it is often assumed that anxiety ux of calcium ions from the endolymph into the
coexisting with provocative motion increases susceptibil- vestibular sensory cells. Unfortunately it can cause drow-
ity to motion sickness. However, there is little rm evi- siness, due to its antihistamine activity.
dence to support this assumption, although it is import- Calcium antagonists are potent blockers of neurotran-
ant to recognise that neurotic reactions may be manifest smitter release in the brain and it has been a chance
AVIATION MEDICINE 227
nding that nifedipine (Adalat) has reduced motion sick- Preight Assessment and Medical Clearance
ness, possibly by antagonising the inux of calcium ions
into vestibular cells. However, this nding has failed to be The objectives of medical clearance are to provide advice
reliably repeated under experimental conditions (J.R.R. to passengers and their medical attendants on tness to
Stott, personal communication, 1990). y, and to prevent delays and diversions to the ight as a
result of deterioration in the passengers well-being. It
depends upon self-declaration by the passenger, and
upon the attending physician having an awareness of the
ight environment and how this might aect the patients
Adaptation
condition. Most major airlines provide services for those
passengers requiring extra help, and most have a medical
The most potent therapeutic measure, at least in the long
adviser to assess the tness for travel of those with medi-
term, is adaptation to the provocative motion through
cal needs (Bagshaw and Byrne, 1999). Individual airlines
repeated exposure. This is natures own cure and is obvi-
work to their own guidelines, but these are generally
ously the preferred method of preventing sickness, par-
based on those published by the Aerospace Medical As-
ticularly for aircrew who cannot y when under the inu-
sociation (Air Transport Medicine Committee, 1996) on
ence of antimotion sickness drugs.
tness for travel. The International Air Transport Associ-
Since 1966, the Royal Air Force has run a programme
ation (IATA) publishes a recommended Medical Infor-
for the treatment and desensitisation of military aircrew
mation Form (MEDIF) for use by member airlines. The
suering from motion sickness. The programme involves
MEDIF should be completed by the passengers medical
graduated exposure to provocative motion, both on the
attendant and passed to the airline at the time of booking
ground and in the air. The success rate measured by the
to ensure timely medical clearance.
number of treated aircrew who successfully complete y-
Medical clearance is required when:
ing training is in excess of 85% (Bagshaw and Stott, 1985),
and similar desensitisation programmes are now in rou- Fitness to travel is in doubt as a result of recent illness,
tine use for military aircrew throughout the world. hospitalisation, injury, surgery or instability of an acute
or chronic medical condition.
Special services are required, e.g. oxygen, stretcher or
authority to carry or use accompanying medical equip-
ment such as a ventilator or a nebuliser.
PASSENGER HEALTH
Medical clearance is not required for carriage of an inva-
With an understanding of the basic principles of aviation lid passenger outside these categories, although special
medicine, it can be seen that ying as a passenger should needs (such as a wheelchair) must be notied to the airline
be no problem for the t, healthy and mobile individual. at the time of booking. Cabin crew members are unable to
But for the passenger with certain pre-existing conditions provide individual special assistance to invalid passen-
or developing an acute medical problem in ight, the gers beyond the provision of normal inight service. Pas-
cabin environment may exacerbate the situation. We sengers who are unable to look after their own personal
have seen that modern commercial airliners y with a needs during ight (such as toiletting or feeding) will be
cabin altitude of between 4000 and 8000 feet (1200 and asked to travel with an accompanying adult who can
2400 m) when at cruising altitude, which means a reduc- assist. It is vital that passengers remember to carry with
tion in ambient pressure of the order of 20% compared them any essential medication, and not pack it in the
with sea level and a consequent reduction in blood oxy- baggage checked in for the hold.
gen saturation of about 10%. The cabin air is relatively Deterioration on holiday or on a business trip of a
dry, and the limited room available in the nonpremium previously stable condition, such as asthma, diabetes or
cabin may be a factor to be considered. epilepsy, or accidental trauma can often give rise to the
Inight medical problems can result from the exacerba- need for medical clearance for the return journey. A
tion of a pre-existing medical condition, or can be an stretcher may be required, together with medical support,
acute event occurring in a previously t individual. Al- and this can incur considerable cost. It is thus important
though the main problems relate to the physiological for all travellers to have adequate travel insurance, which
eects of hypoxia and expansion of trapped gases, it includes provision for the use of a specialist repatriation
should be remembered that the complex airport environ- company to provide the necessary medical support where
ment can be stressful and challenging to the passenger, necessary.
leading to problems before even getting airborne.
Although passengers with medical needs require medi-
cal clearance from the airline, passengers with disabilities Assessment Criteria
do not. However, disabled passengers do need to notify
the requirement for special needs, such as wheelchair In determining the passengers tness to y, a basic
assistance or assignment of seats with lifting armrests, knowledge of aviation physiology and physics can be
and this should be done at the time of booking. applied to the pathology. Any trapped gas will expand in
228 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
volume by up to 30% during ight, and consideration disability must not impede the free egress of the cabin
must be given to the eects of the relative hypoxia en- occupants in case of emergency evacuation. There is
countered at a cabin altitude of 8000 feet (2400 m) above limited leg space in an economy class seat and a passenger
mean sea level. The altitude of the destination airport with an above-knee leg plaster or an ankylosed knee or
may also need to be taken into account in deciding the hip may simply not t in the available space. The long
tness of an individual to undertake a particular journey. period of immobility in an uncomfortable position must
Particular evaluation may be necessary for cardiovas- be taken into account, and it is imperative to ensure
cular disease (e.g. angina pectoris, congestive heart fail- adequate pain control for the duration of the journey,
ure, myocardial infarction), deep venous thrombosis, re- particularly following surgery or trauma. Even in the
spiratory disease (e.g. asthma, chronic obstructive premium class cabins with more available leg room, there
airways disease, emphysema), surgical conditions, cere- are limits on space. To avoid impeding emergency egress,
brovascular accident, epilepsy, psychiatric illness, dia- immobilised or disabled passengers cannot be seated ad-
betes and infectious disease. jacent to emergency exits, despite the availability of in-
The passengers exercise tolerance can provide a useful creased leg room at many of these positions. Similarly, a
guide on tness to y; if unable to walk a distance greater plastered leg cannot be stretched into the aisle because of
than about 50 metres without developing dyspnoea, there the conict with safety regulations. There is limited space
is a risk that the passenger will be unable to tolerate the in aircraft toilet compartments and, if assistance is necess-
relative hypoxia of the pressurised cabin. More specic ary, a travelling companion is required.
guidance can be gained from knowledge of the passen- The complexities of the airport environment should
gers blood gas levels and haemoglobin value. not be underestimated, and must be considered during
Table 13.1 shows the guidelines recommended by one the assessment of tness to y. The formalities of check-in
international carrier. This list is not exhaustive, and it and departure procedures are demanding and can be
should be remembered that individual cases might re- stressful, and this can be compounded by illness and
quire individual assessment by the attending physician. disability as well as by language diculties or jet lag. The
The prolonged period of immobility associated with operational eect of the use of equipment such as wheel-
long haul ying can be a risk for those individuals predis- chairs, ambulances and stretchers must be taken into
posed to develop deep venous thrombosis (DVT). Al- account, and the possibility of aircraft delays or diversion
though many airlines promote lower limb exercise via the to another airport must be considered. It may be necess-
inight magazine and encourage mobility within the ary to change aircraft and transit between terminals dur-
cabin, those passengers known to be vulnerable to DVT ing the course of a long journey, and landside medical
should seek guidance from their attending physician on facilities will not be available to a transiting passenger. At
the use of compression stockings and/or anticoagulants. Londons Heathrow Airport, for example, transfer trac
There is currently no evidence that ying, per se, is a risk accounts for more than 40% of all passengers.
factor for the development of DVT. There is often a long distance between the check-in
As well as the eect of the condition upon the sick desk and the boarding gate. Not all ights depart from or
passenger, account must be taken of the eect or potential arrive to jetties, and it may be necessary to climb up or
eect on other passengers or crew members. It is obvious down stairs and board transfer coaches. It is thus import-
that an individual should not y during the infectious ant for the passenger to specify the level of assistance
stage of a contagious disease, although any risk of trans- required when booking facilities such as wheelchairs.
mission of infection in the cabin is usually conned to
those passengers seated near to the infected passenger
(the index case). Recirculated cabin air is passed through Stretchers
HEPA lters that remove bacteria and viral particles,
reducing the risk of infection via air circulation. Any risk All equipment used on board a commercial aircraft must
is due to person-to-person droplet spread, as in any situ- comply with the safety and compatibility requirements of
ation where people sit in close proximity. The determina- both the regulatory authority and the airline. This applies
tion of infective periods is dened by the American Public to a stretcher, which must be securely xed in the cabin,
Health Association (Benenson, 1990). Most states have must not impede normal or emergency egress, and must
strict rules with respect to infectious passengers entering provide adequate restraint for the sick passenger. There is
the country; in the UK, the port health authority have an assessment and approval system for all aircraft equip-
strict disembarkation rules for an aircraft which is carry- ment and the airline itself will normally provide a suitably
ing a passenger suspected of having an infectious disease. approved stretcher.
A qualied attendant, whether nurse or doctor, must be
responsible for all care and attention to the passenger
Considerations of Physical Disability or Immobility throughout the journey. Any supporting equipment such
as a ventilator must be approved by the airline. Consider-
As well as the reduction in ambient pressure and the ation must be given to factors such as disposal of bio-
relative hypoxia, it is important to consider the physical hazardous waste, and the eect on other passengers and
constraints of the passenger cabin. A passenger with a crew members of carrying the sick passenger. Pre- and
AVIATION MEDICINE 229
Table 13.1 Guidelines for medical clearance
Cardiovascular disorders Uncomplicated myocardial infarction within 7 days Myocardial infarction less than 21 days requires
MEDIF assessment
Uncontrolled heart failure
Open heart surgery within 10 days This includes CABG and valve surgery
MEDIF assessment required up to 21 days
postoperatively
Transpositions, ASD/VSD, transplants etc. will
require discussion with airline medical advisor
Angioplasty:
no stenting 3 days
with stenting 5 days
Circulatory disorders Active thrombophlebitis of lower limbs
Bleeding/clotting conditions Recently commenced anticoagulation therapy requires
assessment
Blood disorders Hb less than 7.5 g dl\ MEDIF assessment required for Hb less than
10 g dl\
History of sickling crisis within 10 days
Respiratory disorders Pneumothorax which is not fully inated, or within 14
days after full ination
Major chest surgery within 10 days MEDIF assessment required up to 21 days
postsurgery
If breathless after walking 50 metres on ground, or on Consider mobility and all aspects of total journey,
continuous oxygen therapy on ground interlining, etc.
Gastrointestinal disorders General surgery within 10 days Laparoscopic investigation may travel after 24 h if all
gas absorbed. Laparoscopic surgery requires MEDIF
up to 10 days
GI tract bleeding within 24 h MEDIF required up to 10 days
CNS disorders Stroke, including subarachnoid haemorrhage, within 3 Consider mobility/oxygenation aspects. MEDIF up to
days 10 days
Epileptic t (grand mal) within 24 h Petit mal or minor twitchingcommon sense prevails
Brain surgery within 10 days Cranium must be free from air
ENT disorders Otitis media and sinusitis
Middle-ear surgery within 10 days
Tonsillectomy within 1 week
Wired jaw, unless escorted and with wire cutters If tted with self quick-release wiring may be
acceptable without escort
Eye disorders Penetrating eye injury/intraocular surgery within 1 If gas in globe, total absorption necessarymay be up
week to 6 weeks, specialist check necessary
Psychiatric disorders Unless escorted, with appropriate medication carried MEDIF required. Medical, nursing or highly
by escort, competent to administer such competent companion/relative escort
Pregnancy After end of 36th week for single uncomplicated Passenger advised to carry medical certicate
After end of 32nd week for multiple uncomplicated
Neonates Within 48 h Accept after 48 h if no complications present
Infectious disease If in infective stage As dened by American Public Health Association
(Benenson, 1990)
Terminal illness Until individual case assessed by airline medical Individual case assessment
advisor
Decompression Symptomatic cases (bends, staggers, etc.) within 10 May need diving or aviation physician advice
days
Scuba diving Within 24 h
Fractures in plaster Within 48 h unless splint bivalved Extent, site and type of plaster may allow relaxation of
guidelines. Exercise caution with breglass casts
Burns Consult airline medical advisor
230 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Table 13.2 Supplementary oxygen product of one airline Table 13.3 Inight medical incidents reported in 1 year by a
major airline (total 2522 incidents in 34 million passengers)
Oxygen can be delivered via various systems: cylinders,
aircraft portable oxygen units or, on B747-400/B777, Incident type No. %
therapeutic ring main
Cylinders can be present at ow rates of 2 or 4 l min\. Ring Gastrointestinal system 563 22.3
main 4 or 8 l min\. (A passenger requiring 8 l min\ would Cardiovascular system 551 21.8
not generally be considered t to y) Central nervous system 392 15.5
2 l min\ provides approximately 23%; 4 l min\ provides Musculoskeletal system/skin 337 13.4
approximately 40% Respiratory system 256 10.2
Urogenital system 82 3.3
Cylinders Metabolic system 64 2.5
Dumpy 530 litres Medium :2 l min\ lasts Otorhinolaryngology (ENT) 34 1.4
4.24 h Miscellaneous 243 9.6
High :4 l min\ lasts
2.12 h
Invalid set ; 2 340 litres Medium :2 l min\ lasts equipment used on board must meet regulatory stan-
cylinders, each 2.50 h dards; the specication for aviation oxygen is higher than
170 litres High :4 l min\ lasts that for normal medical oxygen in terms of permissible
1.25 h
water content (to prevent freezing of valves and regula-
Invalid set ; 2 240 litres Medium :2 l min\ lasts
tors at high altitude). The supplementary or scheduled
cylinders, each 2.00 h
120 litres High :4 l min\lasts
oxygen provided for use by the sick passenger may be
1.00 h delivered from gaseous bottles, or it may be delivered on
some aircraft by tapping into the ring-main system. Some
Masks carriers provide molecular sieve concentrators, although
Adult Hudson mask and tubing is supplied. Any alternative these can be expensive to service and maintain. Those
mask must be provided by the passenger airlines that do provide oxygen usually do so only in
ight; if oxygen is required on the ground, e.g. at an
airport of transit, the passenger is probably unt to y.
postight ground handling of the stretcher requires ar- Table 13.2 describes the supplementary (scheduled)
rangement in advance of the ight. oxygen product available from one international carrier.
Airlines generally prefer stretcher cases to be arranged
by a specialist medical assistance or repatriation com-
pany because of the potential practical and organisa-
tional diculties inherent in the operation. There are Inight Medical Emergencies
cases when it is more appropriate for the sick passenger to
be carried in a specialist air ambulance. An inight medical emergency is dened as a medical
occurrence requiring the assistance of the cabin crew. It
may or may not involve the use of medical equipment or
Oxygen drugs, and may or may not involve a request for assist-
ance from a medical professional travelling as a passenger
In addition to the main gaseous system, all commercial on the ight. Thus it can be something as simple as a
aircraft carry an emergency oxygen supply for use in the headache, or a vasovagal episode, or something major
event of failure of the pressurisation system or during such as a myocardial infarction or impending childbirth.
emergencies such as re or smoke in the cabin. The pas- The incidence is comparatively low, although the me-
senger supply is delivered via drop-down masks from dia impact of an event can be signicant. One major
chemical generators or an emergency reservoir, and the international airline recently reported 3022 incidents oc-
crew supply is from oxygen bottles strategically located curring in something over 34 million passengers carried
within the cabin. This emergency supply has a limited in 1 year (Bagshaw, 1996). The breakdown of these inci-
duration. Sucient rst-aid oxygen bottles are carried to dents into generalised causes is shown in Table 13.3. The
allow the delivery of oxygen to a passenger in case of a top six inight emergency medical conditions reported by
medical emergency inight, but there is insucient to the same airline are shown in Table 13.4.
provide a premeditated supply for a passenger requiring Any acute medical condition occurring during the
it continuously throughout a journey. If a passenger has a course of a ight can be alarming for the passenger and
condition requiring continuous (scheduled) oxygen for a crew due to the remoteness of the environment. The cabin
journey, this needs prenotication to the airline at the crew receive training in advanced rst aid and basic life
time of booking the ticket. Most airlines make a charge to support and the use of the emergency medical equipment
contribute to the cost of its provision. carried on board the aircraft. Many airlines give training
It is not permissible for the passenger to use his or her in excess of the regulatory requirement, particularly when
own oxygen system in ight. As we have already seen, all an extended range of medical equipment is carried.
AVIATION MEDICINE 231
Table 13.4 Six most common inight medical incidents and follow up the particular case, and the Good Samari-
reported in 1 year by a major airline (total 2522 incidents in 34 tan indemnity provision no longer applies.
million passengers) Airlines are always grateful for assistance willingly of-
fered by medical professionals travelling as passengers,
Incident No. % particularly when the costs and inconvenience of an un-
scheduled diversion are avoided. There is no standard
Faint 377 14.9 industry response, but the expression of gratitude can
Diarrhoea 291 11.5
vary from a quick word of thanks from the cabin crew to a
Head injury 158 6.3
free rst-class ticket sent from the oce of the airline chief
Vomiting 153 6.1
Collapse 136 5.4
executive. In practice, most airlines provide an immediate
Asthma 124 4.9 reward, such as a bottle of champagne, followed up with a
letter of thanks. As already discussed, for reasons of in-
demnity it is inappropriate to pay a full professional fee to
the Good Samaritan.
Good Samaritans Follow-up of the passenger after disembarkation is
frequently dicult, because he or she is no longer in the
Although the crew are trained to handle common medical care of the airline and becomes the responsibility of the
emergencies, in serious cases they may request assistance receiving hospital or medical practitioner.
from a medical professional travelling as a passenger.
Such assisting professionals are referred to as Good Sa-
maritans. Cabin crew members attempt to establish the Aircraft Medical Diversion
bona des of medical professionals oering to assist, but
much has to be taken on trust. Responsibility for the conduct of the ight rests with the
The international nature of air travel can lead to com- aircraft captain, who makes the nal decision as to
plications in terms of professional qualication and certi- whether or not an immediate unscheduled landing or
cation, specialist knowledge and professional liability. diversion is required for the well-being of a sick passen-
An aircraft in ight is subject to the laws of the state in ger. The captain has to take into account operational
which it is registered, although when not moving under its factors as well as the medical condition of such a passen-
own power (i.e. stationary at the airport) it is subject to ger. In practice, it is rarely possible to land immediately
the local law. In some countries it is a statutory require- because, even if a suitable airport is in the immediate
ment for a medical professional to oer assistance to a vicinity, the aircraft has to descend from cruising altitude,
sick or injured person (e.g. France), whereas in other possibly jettison fuel to reduce to landing weight, and
states no such law exists (e.g. UK or USA). Some coun- then y the approach procedure to land. Consideration
tries (e.g. USA) have enacted a Good Samaritan law, has to be given to the availability of appropriate medical
whereby an assisting professional delivering emergency facilities, and in many cases, it is of greater benet for the
medical care within the bounds of his or her competence sick passenger to continue to the scheduled destination
is not liable for prosecution for negligence. In the UK, the where the advantage of appropriate facilities will out-
major medical defence insurance companies provide in- weigh the risks of continuing the ight.
demnity for their members acting as Good Samaritans. Operational factors to be considered include the suit-
Some airlines provide full indemnity for medical profes- ability of an airport to receive the particular aircraft type.
sionals assisting in response to a request from the crew, The runway must be of sucient length and load-bearing
whereas other airlines take the view that a professional capacity, the terminal must be able to accommodate the
relationship is established between the sick passenger and number of passengers on the ight, and if the crew go out
the Good Samaritan and any liability lies within that of duty time, there must be sucient hotel accommoda-
relationship. To the end of 1999, there is no record of any tion to allow an overnight stay of crew and passengers.
action for negligence or professional malpractice arising The cost to the airline may be substantial, including the
out of a Good Samaritan act on board a commercial knock-on eects of aircraft and crew unavailability for
airliner. the next scheduled sector, as well as the direct airport and
Recognition by the airline of the assistance given by the fuel costs of the diversion. In making the decision whether
Good Samaritan is complicated by the special nature of or not to divert, the captain will take advice from all
the relationship between the professional, the patient and sources. If a Good Samaritan is assisting, he or she has an
the airline. Indemnity, whether provided by the airline or important role to play, perhaps in radio consultation with
the professionals defence organisation, depends upon the the airline medical adviser.
fact that a Good Samaritan act is performed. If a profes-
sional fee is claimed or oered, the relationship moves
away from being that of a Good Samaritan act to one of a Telemedicine
professional interaction with an acceptance of clinical
responsibility. This implies that the professional is suit- Many airlines use an air-to-ground link which allows the
ably trained, qualied and experienced to diagnose, treat captain and/or the Good Samaritan to confer with the
232 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
airline medical adviser on the diagnosis, treatment and In determining the type and quantity of equipment and
prognosis for the sick passenger (Bagshaw, 1996). The drugs to include in the medical kits, the airline must
airline operations department is also involved in the deci- obviously full the statutory requirements laid down by
sion-making process. Some airlines maintain a worldwide the regulatory authority. Other factors to be considered
database of medical facilities available at or near the are:
major airports; others subscribe to a third-party provider
Route structure and stage lengths own. Dierent coun-
giving access to immediate medical advice and assistance
tries of the world vary in their regulations on what
with arranging emergency medical care for the sick pas-
might be imported and exported, particularly in terms
senger at the diversion airport.
of drugs. For example, it is illegal to import morphine
The link from the aircraft is made using either high-
derivatives into the USA, even if securely locked in a
frequency radio communication (HF) or a satellite com-
medical kit.
munication system (satcom). Satcom is installed in newer
Passenger expectations. Premier class business passen-
long-range aircraft, and is gradually replacing HF as the
gers from the developed world expect a higher standard
industry norm for long-range communication. HF
of care and medical provision than passengers travel-
utilises the Heavyside-Appleton layer of the upper atmos-
ling on a relatively inexpensive package holiday ight.
phere to skip radio waves around the curvature of the
Training of cabin crew. The crew must have a know-
globe. This layer moves diurnally and HF propagation is
ledge and understanding of the kit contents, for use by
also sensitive to atmospheric conditions. There are areas
themselves or in assisting a Good Samaritan. They
of the world where HF contact cannot be established, and
must be procient in rst aid, resuscitation and basic
these vary from day to day or hour by hour. This means
life support.
that occasionally it is not possible to establish an air-to-
Dierences in medical cultures. Ideally, the kit contents
ground voice link, or, if it is established, contact can be
should be familiar to any Good Samaritan irrespective
lost for several minutes. Satcom does not suer from these
of nationality or training. Some authorities require
limitations and usually provides clear and unbroken
information and drug names to be given in more than
communication links.
one language.
Digitisation and telephone transmission of physiologi-
Equipment and drugs appropriate for likely medical
cal parameters is a well-established practice; for example,
emergencies. It is important to audit the incidence and
in the remote highlands and islands of Scotland, a consul-
outcome of inight medical emergencies and maintain
tant obstetrician in a main hospital is able to monitor the
a review of the kit content. This review should also take
antenatal progress of pregnant patients by the digital
account of changes in medical practice.
transmission of routine tocograms from outlying clinics
Space and weight. The medical equipment must be ac-
to the hospital. In many parts of the world, ECG data can
cessible, but securely stowed. Some airlines divide the
be digitised and transmitted via a telephone modem for
equipment and drugs between basic rst-aid kits, which
interpretation by a consultant cardiologist at a specialist
are readily accessible on the catering trolleys, and a
centre. An aircraft cabin at 37 000 feet (11 250 m) can be
more comprehensive emergency medical kit that is
considered a remote location in terms of availability of
sealed and stowed with other emergency equipment.
medical support, and the digital technology used in
Space and weight are always at a premium within the
satcom is similar to that used in modern ground-to-
cabin, and the medical kits must be as light and com-
ground communication. The advent of satcom has en-
pact as possible.
abled the development of air-to-ground transmission of
Shelf life and replenishment. A tracking system for each
physiological parameters to assist in diagnosis. Pulse
kit must be in place to ensure that contents have not
oximetry and ECG are examples of data that can assist
exceeded their designated shelf life. Similarly, after use
the medical adviser to give appropriate advice to the
of a kit, there has to be a procedure for replenishment.
aircraft captain, although the costbenet analysis has to
In practice, the aircraft can depart if the kit contents
be weighed very carefully.
meet the statutory minimum, even though drugs or
equipment have been used from the nonstatutory part
of the kit. Many airlines subcontract the tracking and
Aircraft Emergency Medical Equipment replenishment to a specialist medical supply company.
National regulatory authorities stipulate the minimum
scale and standard of all equipment to be carried on
aircraft operating under their jurisdiction. This includes Resuscitation Equipment
emergency medical equipment. Although these standards
stipulate the minimum requirement, in practice many Although basic cardiopulmonary resuscitation (CPR)
airlines carry considerably more equipment. Table 13.5 techniques are an essential part of cabin crew training, the
gives the minimum standard of equipment to be carried outcome of an inight cardiac event may be improved if
by aircraft registered in the USA, while Table 13.6 gives appropriate resuscitation equipment is available. This
the standard determined by the European Joint Aviation can range from a simple mouth-to-mouth face guard, to a
Authorities for aircraft registered in European states. resuscitation bag and mask and airway, to an endo-
AVIATION MEDICINE 233
Table 13.5 Federal Aviation Regulations (USA) part 121
First-aid kits
Approved rst-aid kits required by 121.309 must meet the following specications and requirements:
(1) Each rst-aid kit must be dust and moisture proof, and contain only materials that either meet Federal Specication GG-K-291a,
as revised, or are approved
(2) Required rst-aid kits must be distributed as evenly as practicable throughout the aircraft and be readily accessible to the cabin
ight attendants
(3) The minimum number of rst-aid kits required is set forth in the following table
No. of rst-aid
No. of passenger seats kits
050 1
51150 2
151250 3
More than 250 4
(4) Except as provided in paragraph (5), each rst-aid kit must contain at least the following or other approved contents:
Contents Quantity Burn compound, -ounce or an 6
Adhesive bandage compresses, 16 equivalent of other burn remedy
10-inch Arm splint, noninatable 1
Antiseptic swabs 20 Leg splint, noninatable 1
Ammonia inhalants 16 Roller bandage, 4-inch 4
Bandage compresses, 4-inch 8 Adhesive tape, 1-inch standard roll 2
Triangular bandage compresses,
10-inch 5 Bandage scissors 1
(5) Arm and leg splints which do not t within a rst-aid kit may be stowed in a readily accessible location that is as near as
practicable to the kit
Emergency medical kits
The approved emergency medical kit required by 121.309 for passenger ights must meet the following specications and
requirements:
(1) Approved emergency medical equipment shall be stored securely as as to keep it free from dust, moisture, and damaging
temperatures
(2) One approved emergency medical kit shall be provided for each aircraft during each passenger ight and shall be located so as to
be readily accessible to crew members
(3) The approved emergency medical kit must contain, as a minimum, the following appropriately maintained contents in the
specied quantities
Contents Quantity Nitroglycerin tablets 10
Sphygmomanometer 1 Basic instructions for use of the
Stethoscope 1 drugs in the kit
Airways, oropharyngeal (3 sizes) 3 Oral antihistamine
Syringes (sizes necessary to 4 Non-narcotic analgesic
administer required drugs) Aspirin
Needles (sizes necessary to 6 Atropine
administer required drugs) Bronchodilator inhaler
50 percent Dextrose injection, 1 Lidocaine and saline
50 ml IV administration kit with
Epinephrine (Noradrenaline) 2 connectors
1: 1000, single dose ampoule or AMBU bag (to assist respiration
equivalent following debrillation)
Diphenhydramine HCl injection, 2 CPR masks
single-dose ampoule or equivalent Latex gloves
234 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Table 13.6 European Joint Aviation Requirements: JAR-OPS 1, subpart L
First-aid kits
The following should be included in the rst-aid kits:
Bandages (unspecied)
Burns dressings (unspecied)
Wound dressings, large and small
Adhesive tape, safety pins and scissors
Small adhesive dressings
Antiseptic wound cleaner
Adhesive wound closures
Adhesive tape
Disposable resuscitation aid
Simple analgesic e.g. paracetamol
Antiemetic e.g. cinnarizine
Nasal decongestant
First-aid handbook
Splints, suitable for upper and lower limbs
Gastrointestinal antacid
Antidiarrhoeal medication, e.g. Loperamide
Ground/air visual signal code for use by survivors
Disposable gloves
A list of contents in at least two languages (English and one other). This should include information on the eects and side-eects of
drugs carried
Note: An eye irrigator while not required to be carried in the rst-aid kit should, where possible, be available for use on the ground
In addition, for aeroplanes with more than nine passenger seats installed, an emergency medical kit must be carried
Emergency medical kit (additional, for aircraft with more than nine passenger seats)
The following should be included in the emergency medical kit:
Sphygmomanometernonmercury
Stethoscope
Syringes and needles
Oropharyngeal airways (2 sizes)
Tourniquet
Coronary vasodilator, e.g. nitroglycerine
Antispasmodic, e.g. hyoscine
Noradrenaline (epinephrine) 1: 1000
Adrenocortical steroid, e.g. hydrocortisone
Major analgesic, e.g. nalbuphine
Diuretic, e.g. frusemide
Antihistamine, e.g. diphenhydramine hydrochloride
Sedative/anticonvulsant, e.g. diazepam
Medication for hypoglycaemia, e.g. hypertonic glucose
Antiemetic, e.g. metoclopramide
Atropine
Digoxin
Uterine contractant, e.g. ergometrine/oxytocin
Disposable gloves
Bronchial dilatorincluding an injectable form
Needle disposal box
Catheter
A list of contents in at least two languages (English and one other). This should include information on the eects and side-eects of
drugs carried
tracheal tube and laryngoscope, to an automatic advisory analysis has to balance the cost of acquisition, mainte-
external debrillator (AED). The decision on the scale of nance and training against the probability of need and the
equipment to be carried has to take account of the same expectation of the travelling public. Indeed, the decision
parameters used in determining the content of the emerg- will often be inuenced by commercial considerations as
ency medical kits (see above). In addition, a costbenet much as medical, as seen in the debate on carriage of
AVIATION MEDICINE 235
AEDs on commercial aircraft. even weeks, and so it may be advisable to avoid the
The European Resuscitation Committee and the suggestion that the passenger has died during the ight.
American Heart Association endorse the concept of early In the UK, the police must be notied and the event will
debrillation as the standard of care for a cardiac event be reported to the Civil Aviation Authority and to the
both in and out of the hospital setting. However, the coroner.
protocol includes early transfer to an intensive care facil- The storage and disposition of the body in the aircraft
ity for continuing monitoring and treatment, which is not for the remainder of the ight can cause diculties. There
always possible in the ight environment. Despite this is inevitable distress for the cabin crew, the accompanying
inability to complete the resuscitation chain, it is becom- relatives and for fellow passengers. In some cases, it is
ing increasingly common for commercial aircraft to be appropriate to leave the body in the seat covered with a
equipped with AEDs and for the cabin crew to be trained blanket. In other cases, it may be more appropriate to
in their use. This is partly driven by public expectation. leave the body on the oor of a galley covered with a
Experience of those airlines which carry AEDs indicates blanket, particularly if there have been resuscitation at-
that there may be benets to the airline operation as well tempts. It may not be appropriate to store the body in a
as to the passenger. Some types of AED have a cardiac toilet compartment, despite the apparent attraction of
monitoring facility, and this can be of benet in reaching this option. The cubicle is small, and there may be dicul-
the decision on whether or not to divert. For example, ties in removing the body at the end of the ight, particu-
there is no point in initiating a diversion if the monitor larly if rigor mortis has occurred. Each case must be
shows asystole, or if it conrms that the chest pain is considered individually.
unlikely to be cardiac in origin. Lives have been saved by Many airlines have in place a procedure for the follow-
the use of AEDs on aircraft and diversions have been up of crew members involved in a distressing event, such
avoided, so it could be argued that the costbenet analy- as an on-board death. This can be valuable in avoiding
sis is weighted in favour of carrying AEDs as part of the long-term post-traumatic stress disorder, and also in rein-
aircraft medical equipment. Nonetheless, it is important forcing the training which the crew member has under-
that unrealistic expectations are not raised. An aircraft gone.
cabin is not an intensive care unit and the AED forms
only a part of the rst-aid and resuscitation equipment.
Birth in Flight
Death in Flight This is a happier event for all concerned, but not without
risks to the mother and baby. For this reason, many
Death in ight is a cause of distress to everybody con- airlines refuse to carry women in the later stages of preg-
cerned. The number of people who travel on domestic nancy, typically after the 36th week for a single uncom-
and foreign airlines each year is approximately 1 billion, plicated pregnancy or the 32nd week for a multiple preg-
so the laws of chance suggest that there is a risk that some nancy. One major airline reports an average of one
of those travellers may reach the end of their natural life inight births per year, out of a total of more than 34
during the course of a ight. One major airline reported million passengers carried (Bagshaw, 1996).
10 deaths in ight during a year in which it carried over 34 Cabin crew receive training in assisting childbirth, and
million passengers (Bagshaw, 1996). A major aim of pref- in most countries a delivery pack is a statutory compo-
light medical clearance is to reduce the chance of an acute nent of the inight emergency medical equipment.
medical event and the risk of death in ight.
Death can legally be conrmed only by a registered
medical practitioner. If a doctor is not present on board
the aircraft, and in the absence of an AED or monitor, or CONCLUSION
of the telemetry of an ECG, cabin crew may continue
resuscitation attempts until the aircraft lands. Death can The passenger cabin of a commercial airliner is designed
then be conrmed by the receiving physician. If a doctor to carry the maximum number of passengers in safety and
is in attendance on board, or conrmation of asystole is comfort, within the constraints of cost-eectiveness. It is
given by an AED or telemetry, the captain is required to incompatible with providing the facilities of an ambu-
record the event, including details of time of death and the lance, an emergency room, an intensive care unit, a deliv-
geographical coordinates where death occurred. Medical ery suite or a mortuary. The ease and accessibility of air
diversion is not appropriate once death has been con- travel to a population of changing demographics inevi-
rmed, and may only complicate matters for the next of tably means that there are those who wish to y who may
kin. not cope with the hostile physical environment of the
The regulations for the procedure to be followed on airport, or the hostile physiological environment of the
landing vary greatly between countries. Indeed, when pressurised passenger cabin. It is important for medical
landing in certain states police may detain the cabin crew professionals to be aware of the relevant factors, and for
while investigations into the circumstances of the death unrealistic public expectations to be avoided.
on board are investigated. This can take several days, or Most airlines have a medical adviser who may be con-
236 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
sulted prior to ight to discuss the implications for a Man. American Public Health Association, Washington DC.
particular passenger. Such preight notication can pre- Benson AJ (1988) Aetiology of motion sickness. In Aviation
vent the development of an inight medical emergency, Medicine, (eds J. Ernsting and PF King), 2nd edn, pp. 323329.
Butterworths, London.
which is hazardous to the passenger concerned, incon-
Bles W, de Jong HAA and Oosterveld WJ (1984) Prediction of
venient to fellow passengers and expensive for the airline. seasickness susceptibility. In Motion Sickness: Mechanisms,
For those with disability, but not a medical problem, Prediction, Prevention and Treatment. Conference Proceedings
preight notication of special needs and assistance will 372, 27, 16. AGARD/NATO, Neuilly sur Seine.
reduce the stress of the journey and enhance the standard Campbell RD and Bagshaw M (1999) Human Performance and
of service delivered by the airline. The importance of Limitations in Aviation, 2nd edn. Blackwell Science, Oxford.
adequate medical insurance cover for all travellers cannot Ernsting J, Nicholson AN and Rainford DJ (1999). Aviation
be overemphasised. Medicine, 3rd edn. Butterworth-Heinemann, London.
Finally, as with all things in commercial aviation, there Homick JL, Reschke MF and Vanderploeg JM (1984) Space
adaptation syndrome: incidence and operational implications
is a continuing audit of activity and an ongoing risk
for the Space Transportation System programme. In Motion
benet analysis. The industry is under constant evolution, Sickness: Mechanisms, Prediction, Prevention and Treatment.
and is now truly global in its activity. Application of basic Conference Proceedings 372, 36, 1-6. AGARD/NATO,
physics and physiology, and an understanding of how Neuilly sur Seine.
this may aect underlying pathology, will minimise the Miller AD and Graybiel A (1970). The semicircular canals as a
medical risks to the travelling public. primary etiological factor in motion sickness. In 4th Sympo-
sium on the Role of the Vestibular Organs in Space Exploration,
SP-187, pp 6982. NASA, Washington.
REFERENCES Reason JT (1978) Motion sickness adaptation: a neural mis-
match model. Journal of the Royal Society of Medicine, 71,
Air Transport Medicine Committee, Aerospace Medical Associ- 819829.
Rosekind MR, Gander PH, Connell LJ et al. (1994) Alertness
ation (1996) Medical guidelines for air travel. Aviation Space
and Environmental Medicine, 67, B1B16. management in ight operations. NASA Technical Memoran-
dum, DOT/FAA/RD-93/18.
Bagshaw M (1996) Telemedicine in British Airways. Journal of
Telemedicine and Telecare, 2, 3638.
Bagshaw M and Byrne NJ (1999). La sante des passagers. Ur-
gence Pratique, 36, 3743. FURTHER READING
Bagshaw M and Stott JRR (1985) The desensitisation of chroni-
cally motion sick aircrew in the Royal Air Force. Aviation McNeill EL (1983) Airborne Care of the Ill or Injured. Springer-
Space and Environmental Medicine, 56, 11441151. Verlag, New York.
Benenson AS (ed.) (1990) Control of Communicable Diseases in Martin T and Rodenberg HD (1996) Aeromedical Transporta-
tion: A Clinical Guide. Avebury, London.
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
14
Aviation Psychology
Robert Bor, Justin Parker and Linda Papadopoulos
London Guildhall University, London, UK
15
ALTITUDE ILLNESS
Figure 15.2 A schema of the pathophysiology of AMS and HACE. The primary mechanism of AMS/HACE is vasogenic oedema, but
increased blood volume and intracellular uid volume will contribute to the altered brain compliance and increase in intracranial
pressure as illness progresses. Mild oedema remains asymptomatic if CSF volumetric buering is successful. Once AMS develops, uid
retention aggravates oedema formation. CBF : cerebral blood ow; CBV : cerebral blood volume; ICF : intracellular uid.
(Adapted from Hackett, 1999, by permission of the Wilderness Medical Society)
adults (Yaron et al., 1998). Exertion may be a risk factor apathetic, uninterested facial expression. Other signs are
for AMS, but lack of physical tness is not. Whether generally lacking. Localised crackles may be heard in the
dehydration increases the risk of AMS is unclear. lung elds and uid accumulation may be evident as
peripheral and periorbital oedema. The latter is more
common in women and may occur at high altitude in the
Clinical Features absence of AMS. Blood pressure and heart rate are
usually within normal limits. Body temperature may be
The diagnosis of AMS relies on a recent ascent to high elevated, especially with more severe AMS.
altitude, and the presence of characteristic symptoms. A The nonspecic nature of symptoms and paucity of
typical scenario is the development of headache following physical ndings may make it dicult to dierentiate
rapid ascent to a new altitude, accompanied by some or AMS from other conditions such as migraine, alcoholic
all of nausea, vomiting, anorexia, lassitude, and dizziness. hangover, and some acute viral infections. If symptoms
Symptoms of AMS typically start a few hours (often accompany a recent gain in altitude it is usually safer to
16 h) after arrival, but are frequently rst noticed the assume the person has AMS, as the consequences of
next morning. Headache is the cardinal symptom, but misdiagnosing this condition are serious.
lacks specic features. It can be bifrontal, or occipital, is
often made worse by bending and the Valsalva ma-
noeuvre, and may be severe. Although most AMS case Pathophysiology
denitions require the presence of headache, a minority of
people with AMS describe an unusual feeling or tightness The aetiology of AMS is incompletely understood. The
in the head rather than true pain. People with AMS are most likely hypothesis is that AMS is due to mild cerebral
frequently irritable and uninterested in ongoing activities. oedema, and that AMS and HACE share a common
Although often accompanied by tiredness, many people pathophysiology, each representing a dierent end of a
complain of diculty sleeping, which may be at least spectrum of severity (Figure 15.2). Support for this theory
partly due to the headache. comes from several quarters. Symptoms of AMS are con-
The most common physical nding in AMS is a rather sistent with a pathological process involving the central
250 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
nervous system, namely headache, dizziness, gastrointes- time for acclimatisation after arrival by avoiding exer-
tinal upset (nausea, vomiting, and anorexia), and sleep tion and ascending no higher for several days. Drug
disturbance. AMS/HACE-like syndromes in a sheep prophylaxis may also be appropriate in this situation
model are associated with brain swelling and raised in- (see below).
tracranial pressure. Neuroimaging studies in humans 4. If there is an established safe ascent itinerary recom-
have also demonstrated brain swelling in AMS, although mended for a given destination, this should be fol-
this also occurs on ascent to high altitude in the absence lowed. Ideally, there should be sucient time in the
of AMS. An interesting hypothesis is that susceptibility to itinerary to permit an ascent rate of 300400 m day\
AMS may relate to the tightness of the brain within the above 3000 m.
cranial vault (Hackett, 1999). Variations in cranial anat- 5. Travellers who know from previous experience that
omy may make some people less able to accommodate they are susceptible to AMS may need to ascend at a
brain swelling through cerebrospinal uid (CSF) dyna- rate slower than that recommended.
mics, and thus more susceptible to AMS. 6. Spare days should always be built into the itinerary so
that unplanned rest days can be taken as needed.
7. Travellers should be familiar with the symptoms of
AMS, and should observe closely for the development
Prevention of AMS in themselves and their companions. Ascent
to a higher sleeping altitude should not occur while
Graded Ascent experiencing symptoms of AMS.
The best way to avoid AMS is to ascend slowly to allow
sucient time for acclimatisation to occur. Unfortunate-
Drug Prophylaxis
ly, no single ascent schedule is suitable for all people and
settings. One recommendation that has been used along
Individuals who are susceptible to AMS or who are to
the major trekking routes in Nepal advises that, when
undertake a large rapid ascent may benet from drug
above 3000 m, each night should be spent on average no
prophylaxis. Outside this setting, the use of drugs is dis-
higher than 300 m above the previous, and compulsory
cretionary and controversial.
rest days should be incorporated every 1000 m or every
Acetazolamide is the drug of choice for the prevention
23 days. Several comments need to be made about this
of AMS. The drug inhibits the enzyme carbonic anhyd-
recommendation. First, a reduction in the incidence of
rase, reducing renal reabsorption of bicarbonate. This
AMS and death rate among trekkers was observed in the
causes a bicarbonate diuresis and metabolic acidosis,
Mount Everest region following introduction of this re-
thereby stimulating ventilation and mimicking the pro-
commendation. Second, even among those who follow
cess of ventilatory acclimatisation. In addition, the drugs
this recommendation, approximately 50% still develop
diuretic action counteracts the uid retention of AMS.
AMS. Comparable gures for HACE and HAPE are
Several placebo-controlled trials have demonstrated the
lacking, and it is possible that the impact of this guideline
eectiveness of acetazolamide for the prevention of AMS
is greater for these serious conditions. A moderate risk of
(Reid et al., 1994). As acetazolamide genuinely aids ac-
AMS may be tolerated if the incidence of HACE and
climatisation, concerns about masking serious illness are
HAPE (and death) is low. Third, this formula emphasises
unwarranted. The standard dosage recommendation is
sleeping altitudes. Hypoxic stress is greatest during the
250 mg twice daily, although many anecdotal reports sug-
night because of lower ventilation during sleep, which
gest that 125 mg twice daily is also eective. Alternatively,
may be made worse by periodic breathing which is
a single daily dose of the 500 mg slow-release formulation
common above 2500 m. Finally, this schedule works well
can be used. For prophylaxis, acetazolamide should be
in Nepal where satisfying itineraries can be built around
started at least 1 day before ascent, and continued until
it. In many other areas of the world a daily ascent rate of
about 2 days after maximum ascent is reached.
300 m is painfully slow, such that few people would ad-
Anyone prescribed acetazolamide should be warned
here to it.
about potential side-eects, which are common, but gen-
For most people a daily average ascent rate of 400 m is
erally mild in nature. Mild diuresis and paraesthesiae
likely to be sucient to allow acclimatisation, while mini-
tend to diminish with continued use, and carbonated
mising the risk of HACE and HAPE, and some people
beverages may taste at. Other side-eects include
will be able to safely ascend at a rate of 600 m day\.
nausea, drowsiness and headache. Most of these side-
The following should serve as a guideline for advising
eects result from the uptake of the drug in the central
travellers about ascent rates at high altitude:
nervous system (CNS); related drugs with little CNS
1. Abrupt ascent to sleeping elevations 9 3000 m should penetration, such as benzolamide, prevent AMS and have
be avoided, if possible. fewer side-eects, but are not generally available. Acet-
2. At least one night spent at an intermediate elevation azolamide is a sulfa drug and carries the usual pre-
(15002500 m) will aid acclimatisation. cautions about hypersensitivity.
3. If rapid ascent to 9 3000 m is unavoidable (e.g. ying Dexamethasone is an alternative to acetazolamide for
to La Paz or Lhasa), travellers should allow sucient AMS chemoprophylaxis, but is less eective (Reid et al.,
ALTITUDE AND EXPEDITION MEDICINE 251
1994), and is generally reserved for situations when acet- probably shares the same underlying pathophysiology
azolamide is contraindicated. The mechanism of action is with AMS, and most people with HACE have had pre-
unknown but, unlike acetazolamide, dexamethasone ceding symptoms of AMS. HACE occurs at altitudes
does not aid acclimatisation. Doses of 4 mg every 812 h above 2500 m, but is much more common above 4000 m.
are usually recommended, starting the day prior to as- The incidence of HACE is dicult to estimate amongst
cent. Aspirin has also been used prophylactically to pre- high-altitude travellers because the number of exposed
vent high-altitude headache. individuals is ill dened. An epidemiological study among
the Indian military found that as many as 12% of those
ascending to an altitude of 4500 m developed HACE
Treatment (Singh et al., 1969) and a study of trekkers in Nepal found
an incidence of 1.8% (Hackett et al., 1976).
The presence of AMS symptoms indicate that additional Risk factors for HACE are probably the same as for
time is required for acclimatisation. They also serve as a AMS. Some individuals may be susceptible to HACE and
warning that more serious, potentially life-threatening, will develop recurrent symptoms on reascent to altitude;
complications may occur if ascent continues before ad- however, previous episodes of HACE do not necessarily
equate acclimatisation has been achieved. imply that a further episode will develop on reascent.
The principles of treatment of AMS are as follows:
1. Stop further ascent.
Pathophysiology
2. Descend if there is no improvement or if symptoms
worsen.
3. Descend immediately if any signs or symptoms of The precise mechanism of HACE remains unknown.
However, increased cerebral blood ow and capillary
cerebral or pulmonary oedema develop.
leakage of uid occur, resulting in an increase in cerebral
For mild AMS, rest at the same altitude may be all that is blood volume and parenchymal volume (interstitial
required to ameliorate symptoms. Symptomatic treat- oedema), respectively (Hackett, 1999; Hackett et al., 1998)
ment with analgesics (paracetamol, aspirin, or other non- (Figure 15.2). Neural cell swelling may also occur. The
steroidal anti-inammatory agents) and antiemetics may swelling and subsequent compression within the cranial
be benecial. Preliminary evidence suggests that suma- vault result in the clinical features of HACE. The develop-
triptan may relieve high-altitude headache, but this needs ment and severity of HACE probably relates to individ-
to be studied further. Acetazolamide (250 mg every ual factors such as the relative tightness of the brain in the
812 h) relieves symptoms and improves arterial oxygen- vault, pressure buering capacity of the CSF spaces and
ation in established AMS (Grissom et al., 1992). Dexa- cerebral vascular responses to hypoxia. Cerebral oedema
methasone (4 mg every 6 h) relieves symptoms of AMS is likely to be initially vasogenic (leakage of uid and
eectively, but symptoms can recur with abrupt discon- protein from capillaries across the bloodbrain barrier) in
tinuation of the drug (Ferrazzini et al., 1987; Hackett et origin as it aects primarily white matter and rapidly
al., 1988). It is usually reserved for the treatment of mod- resolves following treatment of early HACE (Hackett et
erate to severe AMS. al., 1998). The mechanism of this capillary leakiness re-
Descent is the only denitive treatment for all forms of mains unknown but may be linked to high capillary
altitude illness. If symptoms of AMS persist or worsen, or pressures causing vessel wall stress, or various substances,
if there is any doubt, descent is indicated. Descent should released in response to hypoxia, that are active on the
be immediate if there is any suggestion of cerebral or endothelium, including histamine, arachidonic acid,
pulmonary oedema, as deterioration can occur rapidly. bradykinin, nitric oxide and vascular endothelial growth
Descent of 5001000 m can be very eective at ameliorat- factor (VEGF) (Severinghaus, 1995). Neural cell swelling
ing symptoms. Oxygen relieves eectively symptoms of probably also occurs either as a primary phenomenon or
AMS, but is rarely available in the eld. The combination secondary to vasogenic oedema.
of descent and oxygen is the optimal therapy.
Portable hyperbaric chambers are fabric bags that can
be pressurised using a hand or foot pump to simulate Clinical and Pathological Features
descent. When available, these devices may be used to
facilitate descent or for treatment when descent is impos- HACE is usually, but not always, preceded by AMS and
sible. In controlled studies, portable hyperbaric chambers is frequently associated with signs of HAPE. Unsteadi-
relieve symptoms of AMS and improve arterial oxygena- ness of gait and altered mental status are clear warning
tion, but the benecial eects usually disappear within signs. Ataxia is often the rst sign to appear and can be
12 h (Bartsch et al., 1993). tested for by asking the person to walk heel-to-toe in a
straight line. Unless there is a good alternative explana-
tion, anyone who performs poorly in this test at high
HIGH-ALTITUDE CEREBRAL OEDEMA altitude should be regarded as having HACE. Mental
status changes can be subtle at rst, with altered behav-
HACE is a rare, life-threatening form of altitude illness. It iour and/or confusion, but will progress to loss of con-
252 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
sciousness and coma. Other signs that may be present status by improving oxygenation and facilitate descent.
include nuchal rigidity, extensor plantar responses, cran- Some have also recommended the use of acetazolamide
ial nerve palsies, hemiparesis, hyperreexia and clonus. as a treatment for HACE but there are no data on its
Retinal haemorrhages are apparent on fundoscopy in eectiveness. Others have advocated the use of frusemide,
many patients, but this may also be a normal nding in but concerns over excessive diuresis and plasma volume
up to one-third of individuals at 5000 m. Papilloedema is contraction have limited its use.
common.
If lumbar puncture can be performed, it will typically
demonstrate raised CSF pressure and normal biochemi- HIGH-ALTITUDE PULMONARY OEDEMA
cal and cellular ndings. Cerebral oedema may be dem-
onstrated on both computed tomography and magnetic HAPE is a potentially life-threatening form of noncar-
resonance imaging (Hackett et al., 1998). In the latter, diogenic pulmonary oedema which occurs at altitudes
white matter oedema particularly aecting the corpus above 2500 m. It is uncommon compared to AMS. The
callosum has been noted. Postmortem examination of the prevalence depends mainly on individual susceptibility
brain reveals cerebral oedema, thromboses in the cerebral and on the rate of ascent. HAPE-prone individuals fall
venous sinuses, subarachnoid haemorrhage and paren- into ve groups:
chymal petechial haemorrhages (Dickinson et al., 1983).
Spongiosis is prominent in the white matter. 1. Susceptible individuals who are apparently healthy and
Progression to coma and death occurs over a few hours who have a past history of one or more episodes of
but may take as long as several days in untreated cases. HAPE. Episodes are precipitated by rapid ascent,
After descent, symptoms often resolve rapidly, but may strenuous exercise and cold. In these subjects, episodes
persist for days or weeks. Ataxia persists longer than tend to recur at about the same altitude. The rate of
other symptoms of HACE and may still be evident recurrence for each individual is about 6070%. The
months after apparent recovery. Neurological sequelae severity of recurrent attacks is unpredictable.
are rare in survivors, but may occur particularly after 2. Idiosyncratically in those with a recent inammatory
prolonged coma or delayed treatment. illness such as a viral infection. This occurs especially
in children during and following upper respiratory
tract infections.
Prevention 3. Anybody who ascends rapidly and high enough is prone.
For example, unacclimatised individuals who use air
As HACE and AMS probably share a common transportation to reach very high altitude and im-
pathophysiology, the previous discussion about AMS mediately start a rapid ascent without hope of ac-
prevention applies to HACE as well. In individuals with climatisation may achieve this. Vigorous young men
recurrent HACE, reascent to the altitude where illness are at most risk possibly because they climb fastest.
occurred should only be undertaken with extreme cau- 4. Individuals with obstruction, congenital hypoplasia or
tion, if at all. absence of a pulmonary artery. They are very likely to
develop HAPE.
5. High-altitude residents are not immune. They may
develop re-entry HAPE on return to high altitude
Treatment
after a sojourn of 3 or more days at low altitude. They
are not considered further here.
Descent should always begin as soon as HACE is recog-
nised. The immediate practical diculty in a remote
mountain area is how to evacuate physically the individ-
ual with HACE. The use of adjunctive measures de- Pathophysiology
scribed below may improve the clinical condition of the
patient so that they can walk and facilitate descent. When The mechanism of HAPE is uncertain. It is clear that
possible an individual should be carried by his compan- pulmonary hypertension precedes the formation of pul-
ions, porters, animals or preferably by motorised trans- monary oedema (Bartsch et al., 1991) and appears to be
port. In most remote areas, motorised land or air trans- crucial for its pathogenesis. Compared with control sub-
port are not immediately available, but descent should jects at sea level, HAPE-susceptible subjects have a high-
not be delayed while awaiting a vehicle. Evacuation er pulmonary artery pressure (although still within nor-
should continue to as low an altitude as is possible and mal limits) due to increased pulmonary vascular
symptoms have resolved. Individuals with severe HACE resistance and a marked pulmonary hypertensive re-
should ideally be evacuated to hospital at low altitude. sponse to exercise. At altitude the pulmonary hyperten-
Dexamethasone and oxygen (if available) should be sion is caused by a brisk hypoxic pulmonary vasocon-
used to treat HACE as an adjunct to descent. Dexa- strictor response in HAPE-susceptible subjects.
methasone (8 mg followed by 4 mg 6-hourly) probably Vasodilators which lower pulmonary artery pressure
improves HACE. Treatment in a portable hyperbaric have been shown to prevent (Bartsch et al., 1991) and
chamber may bring a temporary improvement in clinical attenuate the formation of oedema (Oelz et al., 1989), with
ALTITUDE AND EXPEDITION MEDICINE 253
associated improvement in symptoms and gas exchange. Physical signs include sinus tachycardia, pyrexia (not
Since vasoconstriction of the pulmonary circulation usually exceeding 38.5 C), tachypnoea, central cyanosis,
ought to reduce capillary pressure and prevent pulmon- and inspiratory crackles in the chest that may be highly
ary oedema, Hultgren (1978) proposed that pulmonary localised despite the widespread oedema. In severe cases
vasoconstriction might be uneven throughout the vascu- the patient may develop concomitant cerebral oedema
lar bed. Evidence for this came from animal studies and with signs as described above.
the chest radiographic appearance of patchy nonuniform Where medical facilities are available, a chest radio-
oedema at high altitude. In humans there is wide vari- graph should be performed to conrm the diagnosis. This
ation in the amount of pulmonary vasoconstriction and may show patchy pulmonary oedema, although as the
this may be determined by the amount of muscle in the disease progresses this becomes conuent. Arterial blood
distal arteries. Hultgren (1978) described this as the con- gases reveal pronounced hypoxia with little abnormality
cept of overperfusion: the patchy vasoconstriction of the of the P .
small pulmonary arteries causes underperfusion of some
areas of the lungs and overperfusion of others. Pulmon-
ary oedema develops in the overperfused areas as a result Dierential Diagnosis
of high pulmonary capillary pressure, which may result in
uid and red cells leaking between capillary endothelial In its early stage HAPE may be mistaken for AMS. As
cells into the alveolar space (stress capillary failure) (West symptoms develop, chest infection is a common misdiag-
and Mathieu-Costello, 1995) or through cells via transcel- nosis. In addition the dierential diagnosis includes high-
lular channels. altitude cough (a benign but irritating dry cough), pul-
This mechanism of hydrostatic pulmonary oedema is monary embolism or infarction, acute myocardial infarc-
corroborated by the predisposition of patients with con- tion and heart failure.
genital anomalies of the pulmonary arteries and those
with acquired obstruction of the pulmonary circulation
to HAPE. These patients share a markedly reduced ca- Prognosis and Mortality
pacity of their pulmonary circulation which may cause
capillary overperfusion more readily. Following recovery clinical sequelae are rare. Untreated
Studies of subjects suering from pulmonary oedema the mortality is up to 50%, although this can be consider-
have also suggested a further mechanism. Bronchoalveo- ably reduced by recognition of the illness early in its
lar lavage uid taken during HAPE has shown evidence course and provision of prompt treatment.
of an inammatory response (Schoene et al., 1986), al-
though these data cannot determine whether this is cause
or eect. Studies of children with HAPE in the Rockies Prevention
have also shown evidence for intercurrent respiratory
tract infections, and animal studies have demonstrated Individuals susceptible to HAPE cannot be reliably
that respiratory syncytial virus infection leads to pulmon- identied prospectively at sea level, either clinically or by
ary oedema in hypoxia. Thus inammation in the pres- routine clinical investigations. Exposure to high altitude
ence of hypoxia may be the cause of pulmonary capillary simulated in a barochamber or hypoxia chamber for
leak in some cases. several days is limited to research laboratories. Neverthe-
One further factor in the pathogenesis of HAPE may less, HAPE is preventable. Subjects with known suscepti-
be a failure of uid clearance from the alveoli. Hypoxia bility to HAPE should understand that high-altitude as-
inhibits transepithelial salt and water reabsorption in cent may expose them to a life-threatening situation.
vitro but its clinical signicance is yet to be established. Avoidance of a hasty ascent and gaining altitude slowly
are the cornerstone of prevention. This may even be
eective in subjects known to be susceptible. Above
Clinical Features 2500 m subjects may ascend up to 350 m per day in sleep-
ing altitude provided they have no symptoms of AMS.
The onset of HAPE is usually after one or two nights at a Subjects must be advised never ascend to a higher sleep-
new altitude on ascent, but can very occasionally occur ing altitude with symptoms. If symptoms of AMS persist
within a few hours of arrival. HAPE rarely occurs after 5 for more than a day they should descend. During ac-
days at the same altitude. climatisation vigorous exercise should be avoided.
HAPE is frequently preceded by symptoms of AMS Nifedipine MR 20 mg orally t.d.s. is eective when the
(see above). The main symptoms of HAPE are breathless- rate of ascent must be faster than is desirable in subjects
ness and cough. Breathlessness rst becomes noticeable known to be susceptible (Bartsch et al., 1991). Side-eects
on exercise and progresses to orthopnoea and breathless- are not normally a signicant problem at this dose.
ness at rest. Cough is initially dry and may progress to the Nifedipine should be continued until the subject descends
production of white then pink frothy sputum associated to an altitude to which they are well acclimatised or
with gurgling in the chest. Subjects may also describe below 3000 m. Nifedipine will not prevent symptoms of
chest tightness or pain. AMS. The role of acetazolamide in preventing HAPE is
254 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
unclear at present. Subjects should also be advised to OTHER ALTITUDE-RELATED
avoid alcohol and sleeping tablets, which may potentially CONDITIONS
worsen hypoxia and exacerbate dehydration.
The risk of an individual developing HAPE associated Peripheral Oedema
with an inammatory illness is unknown. At the very
least attention should be paid to the recommended rate of Swelling of the extremities and face is common at high
ascent. Patients known to have congenital absence or altitude, and is more common in females than males.
hypoplasia of a pulmonary artery, or acquired obstruc- Although the presence of peripheral oedema should raise
tion of a pulmonary artery, are at high risk of developing suspicion of altitude illness, it does occur in the absence of
HAPE, sometimes at relatively low altitude. It is not clear AMS. Treatment is usually unnecessary.
whether any of the preventive measures described above
will be eective and these patients should be advised not
to go to high altitude. Sleep Disturbance
Where doubt exists about the management of HAPE-
susceptible individuals an opinion should be sought from Sleep disturbance is very common at high altitude. There
a physician experienced in high-altitude medicine. is a decrease in both deep and rapid eye movement
(REM) sleep, with frequent arousals. Some of these
arousals are due to periodic breathing (CheyneStokes
respirations), which is surprisingly common at high alti-
Treatment tude, and does not appear to be related to AMS. Some
people are unaware that they have periodic breathing,
The treatment of HAPE is urgent as delay may result in while others wake in a panicked state following an ap-
further deterioration. The aim of treatment is to improve noeic episode, thinking that they are being suocated. A
oxygenation and hence reduce pulmonary artery press- low dose of acetazolamide (125250 mg) taken before
ure. Exactly how this achieved depends on the local facili- bedtime is eective in relieving periodic breathing and
ties. maintaining arterial oxygen saturation during sleep. The
The sick patient should be sat up, kept warm and given use of benzodiazepines to facilitate sleep at high altitude
oxygen. In remote places the patient should descend at has been generally discouraged because of the theoretical
least 1000 m in altitude immediately. In severe cases risks of respiratory depression. However, recent prelimi-
evacuation by air to low altitude should be undertaken if nary data suggest that short-acting benzodiazepines are
possible but the logistics of organising evacuation should actually associated with improved nocturnal oxygen
not result in a delay in descent. Where the patient cannot saturation, although this needs to be conrmed.
descend or is signicantly unwell they should be given
nifedipine MR 20 mg orally q.d.s. in an attempt to relieve
symptoms and facilitate urgent descent. Sublingual Retinopathy
nifedipine 510 mg may be administered where a rapid
eect is needed or the patient is vomiting, but is prone to High-altitude retinopathy (HAR) is characterised by disc
cause hypotension. If nifedipine is not available then a hyperaemia, tortuosity and dilatation of retinal veins, and
portable hyperbaric bag may be used to improve oxygen- retinal hemorrhages. These changes are seen in about
ation temporarily and facilitate descent. The patient 3050% of people at 5000 m, and are even more common
should not be placed supine in the portable hyperbaric at higher elevations. Retinal haemorrhages are usually
bag as this may compromise oxygenation further. asymptomatic, unless involving the macula, and resolve
Where proper medical facilities are available, oxygen spontaneously in 1014 days. Whether the presence of
should be administered to maintain arterial oxygen satu- HAR is a warning sign for altitude illness is unclear.
ration 9 90% and the patient encouraged to rest. They
should be reviewed regularly but may require several
days treatment. If an oxygen saturation 9 90% can be Other Neurological Disorders
achieved with no more than 4 litres oxygen per minute
then descent may be avoided and no further treatment In addition to AMS, HACE, and high-altitude re-
may be required. tinopathy, several other syndromes have been described
Expiratory positive airway pressure achieved using a at high altitude in the absence of concomitant altitude
special mask is theoretically useful but the increased work illness. The sudden appearance of focal neurological de-
of breathing and the diculty of using the device do not cits in previously healthy high-altitude travellers has been
recommend it as eective therapy. described on many occasions. The aetiology in most cases
Unlike cardiogenic pulmonary oedema, HAPE is asso- remains obscure. Cerebral thromboembolism has been
ciated with relative intravascular volume depletion, and clearly documented in a few cases, and others appear
diuretics, nitrates, opiates and alcohol should be avoided. migrainous in origin. Regardless of aetiology, immediate
descent, administration of oxygen and dexamethasone (if
available), and evacuation to a hospital are indicated. A
ALTITUDE AND EXPEDITION MEDICINE 255
thorough neurological examination should also be per- Heart Disease
formed before further ascent to high altitude.
Ascent to high altitude is associated with activation of the
sympathetic nervous system and an increase in heart rate,
Thrombosis cardiac output and blood pressure, which return to sea-
level values by 3 months. In addition, hypoxic pulmonary
Cerebral and peripheral venous thrombosis and pulmon- vasoconstriction results in pulmonary hypertension. The
ary embolism have been reported in high-altitude travel- physiological stress of hypoxia and cold has important
lers, but usually after exposure to extreme altitudes implications for patients with coronary artery disease,
( 9 5500 m). Polycythaemia, increased blood viscosity, who may experience new or worse angina, hypertension
dehydration, cold, and inactivity (e.g. tent-bound in bad which may be harder to control, and heart failure and
weather) are thought to be risk factors. pulmonary vascular disease which may deteriorate. Risks
can be minimised with appropriate medical advice.
Heart Failure
Asthma
Normal myocardial performance is not aected by alti-
tudes up to the summit of Mount Everest. Patients with Although theoretically the cold, dry, hypoxic mountain
coronary artery disease with mild to moderately impaired environment should worsen bronchoconstriction, there is
left ventricular function without residual ischaemia have little evidence of deterioration in practice. Asthmatics
good tolerance to exposure to an altitude of 2500 m (Erd- often nd that they have less trouble at high altitude and
mann et al., 1998). Acute or decompensated heart failure this is likely to be related to the absence of allergens in the
is a contraindication to ascent. Patients in New York air and the reduced air density. They may also be helped
Heart Association (NYHA) class I and II may travel by the increased sympathetic drive and production of
provided they are medically stable and their baseline corticosteroids at altitude.
Pa is 9 70 mm Hg. Patients in NYHA class III or IV Patients should not ascend to altitude unless their
must be medically stable and should be discouraged from asthma is stable. Travellers to remote places should take
ascent above 2500 m. an emergency supply of steroids with them in case of
deterioration.
Arrhythmias
Chronic Obstructive Pulmonary Disease
Arrhythmias may be precipitated by sympathetic activa-
tion, and respiratory alkalosis which may reduce serum A small fall in Pa results in a large fall in arterial oxygen
potassium. No change has been detected in arrhythmic saturation in thesepatients because their Pa falls on the
substrate in hypoxia as detected by signal averaged ECGs steep slope of the oxygen dissociation curve. These pa-
(Levine et al., 1997). Single premature ventricular com- tients will notice signicant deterioration in their breath-
plexes during exercise do increase modestly with acute lessness on ascent to altitude. AMS prophylaxis with
exposure to 2500 m without an increase in repetitive acetazolamide may worsen breathlessness by increasing
forms and it is unlikely that moderate altitude exposure ventilation.
substantially alters the risk of life-threatening arrhyth- Lung function should be optimised and stable prior to
mias in patients with coronary disease. ascent to altitude. Administration of gas mixtures con-
Patients with uncontrolled ventricular or supraven- taining oxygen levels the patient will encounter in the
tricular arrhythmias should not ascend to high altitude. eld may be used to assess gas exchange and risk in the
Frequent or high-grade ventricular ectopy is also a lung function laboratory. A chest infection is more seri-
contraindication to ascent above 2500 m. ous at high altitude than at sea level and patients should
carry an emergency supply of steroids and antibiotics.
16
Diving Medicine
Peter J. Benton
Institute of Naval Medicine, Gosport, UK
The human animal, unlike marine mammals such as the In common with the eye, the human ear is designed to
whale, has evolved to live and work on land and as such is operate in air. The middle ear is designed to compensate
poorly adapted to life in water. Water and air are very for the impedance mismatch that exists between the low-
dierent media. Water, a uid, is dense (1000 kg m\) density, low-impedance medium that usually surrounds
whereas air, a gas, has a density of only 1.29 kg m\. This the head, air, and the head itself, which is a high-density,
vast dierence in densities aects the performance of the high-impedance medium. The diver, by ooding the outer
human diver in many ways. ear, eectively cuts out the middle ear, with hearing in
water being primarily by bone conduction. The middle
ear not only operates as an impedance matching device
Vision but also as an amplier, the result being that by bypassing
this amplier hearing acuity in water is reduced by be-
The human eye is designed to operate with a low-density tween 20 and 30 dB. Even if the outer ear is kept dry, as
medium, air, in contact with the cornea. If this is replaced the diver descends the pressure and hence the density of
by water then refraction of light at the watercornea the breathing gas increases. The function of the middle
boundary occurs, with resultant distortion. Use of a ear is aected by this increase in gas density, which acts as
divers facemask, by placing a pocket of air in front of the a damper to the middle-ear amplier, the result being that
Figure 16.1 Change in lung volume of breath-hold diver, P and P with increasing depth
change in tone of voice or a tight feeling in the neck. that of the arterial blood, and hence air breathed, and so
Specic treatment is rarely required, although adminis- the tissues become saturated with nitrogen. Tissues with a
tration of oxygen will speed the resorption of the gas. good blood supply, such as the brain and spinal cord, will
Rarely precordial gas may be palpable, which may be rapidly become saturated with nitrogen, while tissues
associated with crepitus synchronous with the pulse, the with a relatively poor blood supply (cartilage and bone)
Hamman sign. may take 24 h or more to become fully saturated with
3. Pulmonary vasculature. Extra-alveolar gas entering the nitrogen. If the diver breaths a heliumoxygen mixture,
pulmonary vasculature will result in arterial gas emboli. the same principles apply with the inert gas, in this case
Not only may such arterial gas emboli obstruct blood helium, equilibrating with the body tissues. The dynamics
vessels but also the very presence of these bubbles in of tissue gas exchange are highly complex and beyond the
contact with the vessel walls may damage the delicate scope of this text. Further details of this complicated, and
endothelial lining, with subsequent leakage of uid into as yet not fully understood process, can be found in the
the surrounding tissues. Symptoms following such an specialist texts listed under Further Reading.
insult range from minor neurological changes to rapid As the diver ascends, the inert gas absorbed during the
loss of consciousness and death. dive will move in the opposite direction, from the tissues
into the blood, where it is carried to the lungs and ex-
haled. If the ascent, and hence decompression, is in ac-
Inert Gas Absorption cordance with recognised diving tables this process of
o-gassing will occur in a controlled manner, and the
The concentration of the inert gas nitrogen in arterial inert tension gas within the tissues will not reach a su-
blood is approximately the same as the concentration of cient level of supersaturation for bubbles to form. How-
nitrogen in the air we breathe. At sea level, where the ever, if the rate of decompression is such that supersatura-
partial pressure of the nitrogen (Pi ) in the air we tion does occur, then bubbles will form within both blood
breathe is 79 kPa, the P in arterial blood will also be and body tissues. Even when such bubbles form, the
approximately 79 kPa. During a dive, the ambient press- human body is capable of tolerating a certain bubble
ure surrounding the diver increases, and so too will the load. Bubbles in venous blood, for example, are eciently
partial pressures of the component gases of the gas removed from the circulation by the lungs, with numer-
breathed by the diver (Figure 16.1). If the diver is breath- ous studies demonstrating the presence of such venous
ing air, then as the Pi of the air breathed increases so gas emboli in asymptomatic divers. Although the lungs
will the alveolar P and hence pulmonary capillary P . are excellent lters of gas bubbles, this capacity is nite
This nitrogen-loaded blood will travel throughout the and if the bubble burden is such that this is exceeded,
body and the nitrogen will pass down the concentration bubbles may transit the lungs and enter the arterial circu-
gradient from the arterial blood to the surrounding tis- lation, where they form arterial gas emboli.
sues. In time the P of the tissues will equilibrate with
264 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Patent Foramen Ovale Table 16.1 Eects of nitrogen narcosis with depth when
breathing air
In approximately 2530% of the normal adult popula-
tion this relic of the fetal circulation remains patent and Depth (m) Symptoms
usually results in no ill eects. However, it does oer a
3060 Light headedness, euphoria, loss of ne
possible route for venous gas bubbles to bypass the pul-
discrimination
monary lter and consequently, along with other right- 6090 Poor judgement and reasoning, slowed reexes,
to-left shunts, has the potential to promote the arterialisa- peripheral paraesthesiae, overcondence
tion of otherwise relatively harmless venous bubbles. Al- 90120 Progressive depression of the sensoria,
though routine screening of divers for patent foramen hallucinations, amnesia
ovale is not performed, if an individual should be found to 9120 Loss of consciousness
have a patent foramen ovale with signicant right-to-left
shunting during the normal cardiac cycle, he or she
should be advised not to dive. Consequently, it is now recognised that, for practical
purposes, the distinction between the conditions that
used to be known as decompression sickness and arterial
Decompression Illness gas embolism was articial. As a result, the term decom-
pression illness, which encompasses both mechanisms, is
As well as forming in blood, bubbles may form in any being increasingly used.
tissue within the body. In some tissues (such as adipose
tissue) they may form without causing overt disease; how-
ever, other tissues, particularly nervous tissue, are much
GAS TOXICITY
more sensitive and the presence of even a small number of
gas bubbles may result in abnormal tissue function. The
With increased depth, and hence ambient pressure, the
precise mechanisms by which bubbles provoke tissue dys-
partial pressures of the component gases breathed by the
function is not fully understood but possibly include the
diver increase. This section will discuss briey the prob-
physical disruption of tissue architecture, interruption of
lems associated with exposure to nitrogen, oxygen, car-
tissue microcirculation and derangement of tissue bio-
bon dioxide and helium at increased partial pressures.
chemical activity at the tissuebubble interface.
One obvious mechanism is that they physically ob-
struct small blood vessels and thereby cause tissue is-
chaemia. The behaviour of bubbles in the cerebral circu- Nitrogen Narcosis
lation has been studied extensively and, although the
obstruction of blood vessels occurs as soon as bubbles Nitrogen, when breathed at raised partial pressure, has an
arrive in the brain, this eect appears to be short-lived. anaesthetic eect and produces narcosis. The symptoms
Cerebral blood vessels respond to the presence of bubbles and signs of nitrogen narcosis are similar to those of
by dilating and thus allowing the bubbles to move on drunkenness, except that there is no hangover. With
(Francis and Gorman, 1993). increased narcosis comes a demonstrable decrease in
It is now thought that much of the illness that results diver performance and hence ability to respond to any
from bubble embolism of the brain is due to the conse- emergency situation. On ascent and reduction in P the
quences of traumatic injury to the delicate endothelial eects rapidly wear o, the danger of nitrogen narcosis
lining of cerebral blood vessels, which in places may be being not from the narcotic eect itself but that the nar-
stripped away from the vessel wall. This results not only cosed diver may act inappropriately and hence sustain an
in a breakdown of the bloodbrain barrier, and the conse- injury or drown while so impaired. Although there is
quential leaking of potentially harmful blood constitu- variation in individual susceptibility to nitrogen narcosis
ents into the brain, but also, by exposing blood compo- and some degree of habituation to the eects of narcosis
nents such as white blood cells and platelets to the from frequent exposure, all divers will be impaired to
damaged blood vessel wall, promotion of a tissue reaction some degree. Some drugs, particularly alcohol and seda-
to the injury. Ironically, it is the physical and biochemical tives, may have an eect additive to the narcosis and
consequences of this process that may actually result in a should not be taken prior to diving. The degree of impair-
further deterioration of cerebral blood ow and function. ment with increasing depth is illustrated in Table 16.1.
Although it is recognised that tissue bubbles may arise Because of the eects of nitrogen narcosis, professional
from two fundamentally dierent processes (pulmonary divers in the UK are limited to a maximum depth of 50 m
barotrauma and/or inert gas release), it is often dicult, breathing air. Most recreational dive organisations rec-
in individual cases, to be certain of the origins of the ommend a similar, or shallower, depth limit. Other gases
disease-provoking gas. Indeed, with respect to some or- also have a narcotic eect, the narcotic potency being
gan systems, such as the ear and lungs, it may occa- proportional to their lipid solubility. Of the gases which
sionally be dicult to distinguish between a bubble-in- are used in diving, the order of potency is: nitrogen 9 hy-
duced condition and the results of barotrauma. drogen 9 helium.
DIVING MEDICINE 265
Oxygen Toxicity high partial pressure of oxygen, the patient may become
hypoxic as a result of the thickened alveolar walls and
Although essential for life, oxygen is an extremely reactive reduction in diusing capacity.
element that is controlled within well-dened limits in the
body. Exposure to raised partial pressures of oxygen will
Carbon Dioxide
result in toxicity, the type and severity of which will be
determined by both duration of exposure and partial
The compressed air, or other gas, breathed by a diver
pressure. For divers, the two most important toxic eects
should contain little if any carbon dioxide. However, due
of oxygen are its eects on the lungs and on the central
to a combination of increased work of breathing asso-
nervous system (CNS).
ciated with immersion, the dead space of the breathing
CNS oxygen toxicity. Exposure to a raised partial apparatus and the increased density of the gas, the end-
pressure of oxygen may result in a variety of symptoms, tidal carbon dioxide of a diver breathing air, may exceed
including lip twitching, dizziness, anxiety, nausea, tin- 8.5 kPa. Indeed, at depths in excess of 40 m, even with the
nitus, tunnel vision, a choking sensation, diculty most ecient breathing apparatus, a diver breathing a
breathing, tremor and convulsion. There is no xed oxy- dense gas such as air and who is working hard may easily
gen exposure at which CNS oxygen toxicity becomes exceed this level. Divers using rebreathers may also en-
apparent, with susceptibility varying both between indi- counter a high level of carbon dioxide. These rebreathers
viduals and within the same person from day to day. utilise a carbon dioxide absorbent, such as sodium or
However, CNS oxygen toxicity is uncommon if the Pi lithium hydroxide, which if exhausted or incorrectly
of the breathing gas is kept below 140 kPa. This equates packed will result in the diver being exposed to high levels
to the Pi of air when breathed at 60 m or of 100% of carbon dioxide.
oxygen breathed at a depth of 4 m. The danger to the Symptoms of hypercapnia include dyspnoea, dizziness,
diver who breathes a gas mixture with a high Pi is that nausea, headache, anxiety, sweating, palpitations, neur-
the rst sign of CNS oxygen toxicity may be a convulsion, omuscular twitching, convulsions and loss of conscious-
which, when it occurs underwater, often results in drown- ness. When the Pi exceeds 50 kPa, which equates to
dyspnoea associated with hyper-
15 m breathing air, the
ing as the diver releases the mouthpiece.
Pulmonary oxygen toxicity. Prolonged exposure to capnia may not be as severe. If the diver is breathing hard
over 50% oxygen at the surface (50 kPa) has long been due to heavy exertion, he or she might receive little warn-
known to aect adversely pulmonary function. Divers ing of hypercapnia, become confused and even slightly
may be exposed to a Pi signicantly in excess of this euphoric, before losing consciousness. Without doubt,
and in some individuals the rst symptoms of pulmonary some of the fatalities associated with deep air dives in
oxygen toxicity may develop within 3 h of breathing oxy- recent years have been due in part to hypercapnia. Symp-
gen at a Pi of 200 kPa. Symptoms and signs often start toms, with the exception of a severe throbbing headache,
sensation in the throat, which is worse on
with a tickling rapidly resolve once the diver reaches fresh air on the
inspiration and which may provoke coughing. After a few surface.
hours of continued oxygen exposure, the tickle is gradual-
ly replaced by a sensation of substernal burning, and Helium
coughing becomes uncontrollable. Shortness of breath
eventually prevents even mild exertion. There are often Gas mixtures containing helium are used for deep dives
few physical signs associated with pulmonary oxygen (below 50 m) as helium does not have the narcotic eect of
toxicity in its early stages; however, progress of the condi- nitrogen. For such deep dives the divers use either heliox
tion can be monitored by measurement of the vital capac- (a heliumoxygen mixture) or trimix (a heliumnitro-
ity, which decreases with oxygen exposure, a 10% de- genoxygen mixture). The precise proportions of gas used
crease in vital capacity occurring after about 10 h will depend upon the depth dived to, and will be chosen to
exposure to a Pi of 200 kPa.
keep the P at maximum depth below 141 kPa, and, in
The pathological changes noted in the human lung the case of trimix, the P at a level that does not incur an
unacceptable level of narcosis.
exposed to raised partial pressures of oxygen comprise
two phases, an early exudative phase followed by a prolif-
erative phase. During the exudative phase there is al-
veolar oedema, intra-alveolar haemorrhage, brinous ex- FITNESS TO DIVE
udate and generalised congestion of the lung. This phase
merges into the proliferative phase, which is characterised To enter the underwater environment, which by its nature
by marked thickening of alveolar and interlobular septa, is hostile to air-breathing humans, it is essential that the
with marked proliferation of broblasts, early brosis diver is both physically and medically t. Professional
and alveolar cell hyperplasia. Such extreme changes are divers within the UK are required to undergo regular
highly unlikely to occur during conventional diving expo- medical examinations by doctors who have specialist
sures but may occur during prolonged hyperbaric oxygen knowledge of diving medicine and physiology. This is not
therapy. In extreme cases, despite breathing gas with a so for many recreational divers who, unless they wish to
266 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
join the British Sub-Aqua Club, which requires a medical gas embolism. Experience of such situations is the reason
examination, may have to do nothing more than com- why even well-controlled asthmatics are considered un-
plete a simple medical screening questionnaire. In view of t to dive, both by the United Kingdom Health and
the fact that the underwater environment does not distin- Safety Executive (HSE) and the Royal Navy.
guish between those who dive for pleasure and those who Within the recreational diving community certain dive
dive for employment, it is dicult to justify the total lack organisations will permit well-controlled asthmatics to
of competent medical screening for recreational divers. dive, well-controlled being dened as follows:
Physical tness is important, especially for the diver
Mild symptoms
who plans to dive in northern European waters where the
Stable with only infrequent and predictable episodes
combination of tidal ow, cold, and the heavy equipment
No requirement for regular use of bronchodilators
and thermal protection required to survive in such an
Normal exercise capacity
environment makes such diving physically demanding. In
No exercise-induced symptoms
tropical waters, although diving may appear to be less
Inhaled prophylactic steroid or cromoglycate therapy
demanding physically, the divers may still be required to
only
exert themselves entering and exiting the water carrying
Can tolerate use of breathing apparatus.
heavy equipment and also if required to rescue another
diver. However, it must be remembered that lung function can
Medical conditions that often create problems include decline slowly over a period of time without the asthmatic
asthma, chest trauma, diabetes mellitus, head injury, epi- being aware of this; in such cases an asthmatic diver may
lepsy, cardiovascular disease and decompression illness. decide, especially when subject to peer pressure, that he or
Each of these conditions and their implications with re- she is t when in fact that is not the case. In view of this,
gard to diving will be discussed. plus the divers exposure to provocative factors and the
diculty in ensuring that an individual is well controlled
and genuinely asymptomatic at the commencement of a
Asthma dive, many diving medicine specialists nd this a dicult
policy to accept (Elliott, 1995).
Normal lung function is required by all divers, both to
enable them to achieve adequate work capacity and to
ensure that their lungs can accommodate the pressure Chest Trauma
and volume changes that occur during diving. Failure to
accommodate these changes in pressure and volume can Major chest trauma may result in scarring of the lung
result in lung rupture, which may manifest as interstitial parenchyma and/or pleura. In extreme cases the chest
emphysema, pneumothorax or arterial gas embolism. wall itself may be so deformed as to prevent normal
Whereas interstitial emphysema may be no more than inspiration and expiration. Less severe trauma may be
uncomfortable, the development of a pneumothorax or manifest only as a traumatic pneumothorax that may or
arterial gas embolism in a diver can be life threatening. may not require formal aspiration or drainage. A history
Individuals with asthma are known to be at increased risk of a pneumothorax, be it spontaneous or traumatic, used
of lung rupture (Light, 1994), even under normobaric to be considered to be an absolute contraindication to
conditions: 5.4% of a group of 479 children admitted diving, the logic being that the lung had, in the case of a
during an asthmatic episode were noted to have pneu- spontaneous pneumothorax, demonstrated a weakness
momediastinum on chest X-ray (Eggleston et al., 1974). and, in the case of a traumatic pneumothorax, been
Asthmatics also frequently have impaired exercise tol- weakened by the injury. The weakened lung being at
erance and it is important to note that many of the factors greater risk of subsequent rupture, the consequences
that are known to precipitate asthma in susceptible indi- should this occur underwater would be catastrophic, with
viduals are to be found in the underwater environment. any pneumothorax occurring at depth rapidly expanding
The most important factors include breathing cold dry as the diver ascended.
air, extreme exercise, increased inspiratory eort, anxiety With the development of ever more sophisticated in-
and saline inhalation. Although many people perceive vestigative techniques it has, however, become apparent
diving to involve gently drifting eortlessly in clear blue that many individuals who have suered a pneu-
water, the reality, especially in northern European waters mothorax, be it spontaneous or traumatic, have no de-
and where commercial or military diving is concerned, is tectable evidence of lung abnormality or function. In the
very dierent. Each year the Duty Diving Medical O- absence of any weakness it would appear that these
cers at the Institute of Naval Medicine receive calls de- individuals should be at no more risk of recurrence than a
scribing well-controlled asthmatics who, when diving in member of the general population. Furthermore, epi-
cold water, have become disorientated, anxious, short of demiological studies reveal that the risk of recurrence
breath and nally developed frank bronchospasm at following a spontaneous pneumothorax, although be-
depth, resulting in a rapid panic ascent to the surface. tween 20 and 40% (Light, 1994; Lippert et al., 1991; Voge
Upon arrival at the surface some of these individuals are and Anthracite, 1986) in the rst 12 years, drops to a rate
unconscious, having suered lung rupture and arterial similar to that of the general population by 45 years. In
DIVING MEDICINE 267
the case of a traumatic pneumothorax, recurrence is ex- in poor response to recompression therapy. Sensory and
tremely uncommon provided that there is no residual motor neuropathies are not uncommon among diabetics
pathology. This knowledge has lead to a revision in the and, if not known to the examining doctor, could lead to
advice given to divers who experience pneumothorax. confusion following a diving incident. Finally, many dia-
Current advice, which is based upon a study of a group of betics have subclinical small vessel disease. This may not
257 divers and submariners who have experienced both only increase the probability of an ischaemic event occur-
traumatic and spontaneous pneumothoraces (Denison ring during in-water exertion, but could also theoretically
and Francis, 1999), is that, provided there is no evidence result in impaired inert gas exchange with a possible
of lung pathology, individuals who have suered a spon- altered risk of DCI.
taneous pneumothorax may return to diving after 4 re- Research is ongoing, especially within the recreational
currence-free years. diving organisations, to identify and develop techniques
In the case of traumatic pneumothorax the individual by which diabetic divers can dive safely, with certain
may return to diving after 3 months, once again provided recreational diving organisations permitting well-con-
that there is no evidence of pathology. To determine trolled diabetics to dive. Techniques include ensuring
whether or not there is any residual pathology all such that diabetic divers start the dive with slightly elevated
individuals require full pulmonary function testing, in- blood sugar levels and that they carry glucose (contained
cluding measurement of maximum inspiratory and expir- within a squeezy tube) throughout the dive. This enables
atory owvolume loops, absolute lung volumes by divers to correct any hypoglycaemic episode they might
whole body plethysmography and transfer factor, as well notice during the dive, or if they should be called upon to
as high resolution computed tomography (CT) of their perform any unplanned hard work. Such techniques, al-
lungs. CT subjects the individual to a signicant exposure though possibly acceptable in the recreational environ-
to ionising radiation and should only be contemplated if ment where the individual can freely choose whether or
he or she wishes to return to diving. Ongoing review of not to dive, do not translate well to either the military or
the 257 cases who have returned to diving supports the commercial environment. Furthermore, these techniques
view that the risk of recurrence is extremely low, with only make no allowance for the chronic problems that face the
one case suering a recurrence of lung rupture. diabetic diver. Diving is a very strenuous task, often
performed in cold, demanding conditions, and so even in
diabetics who have never experienced symptomatic hy-
Diabetes Mellitus poglycaemia there can be no guarantee that they will not
become hypoglycaemic while diving. Current Royal
Diabetes mellitus is a complex condition that may lead to Navy and HSE medical standards prohibit diabetic
the development of a wide variety of both acute and divers who require medication to control their diabetes,
chronic complications. Of the acute complications, hy- be it insulin or an oral hypoglycaemic, from diving.
poglycaemia, with the possibility of sudden loss of con-
sciousness underwater, is of greatest concern. Loss of
consciousness underwater, from whatever cause, often
Head Injury
leads to the death of the unconscious diver and, not
infrequently, that of the divers buddy, who is faced with
Head injuries account for 5% of the referrals to the
the dicult task of attempting a rescue. Hypoglycaemia
Undersea Medicine Division at the Institute of Naval
can also lead to the development of an acute confusional
Medicine for an opinion regarding tness to dive. The
state, which has led to diabetic drivers driving the wrong
concerns with head injuries are twofold: rst, to ensure
way down motorways and causing serious accidents.
that the individual has recovered fully, with normal cog-
Such a confusional state in the diabetic diver could con-
nitive function and no residual neurological decit; and,
ceivably, especially if accentuated by nitrogen narcosis,
second, to determine the risk of post-traumatic epilepsy.
result in the diver making decisions that could have fatal
Epilepsy, whether idiopathic or post-traumatic, is an ab-
consequences to both diver and buddy. Few fatalities
solute contraindication to diving as sudden loss of con-
involving diabetic divers have been reported, perhaps the
sciousness while diving can have catastrophic eects.
most well known example being that of a diver who died
Formal assessment of return to normal cognitive function
only a few feet from safety while exploring the Huautla
is usually only required following very severe head inju-
Cave system, Mexico in 1994. Although this incident
ries, in which case formal neuropsychological testing is
occurred during that which many may consider an ex-
required. In the majority of cases simple testing of mental
treme dive, the diver was vastly experienced and presum-
function is sucient, with the primary focus being the
ably a well-controlled diabetic.
assessment of risk of post-traumatic epilepsy.
As well as the acute problems facing the diabetic diver,
A head injury is considered to be severe if any of the
there is also the question of possible diagnostic confusion.
following are or have been present:
Cases are known of diabetic divers being treated for
diabetic comas, then subsequently being discovered to 1. Loss of consciousness for more than 30 min
be suering from acute neurological decompression ill- 2. Evidence of residual focal neurological sequelae
ness (DCI). The resultant delay in treatment often results 3. A period of post-traumatic amnesia of more than 1 h
268 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
4. Any period of prograde amnesia on leaving the recompression chamber is When can I
5. Depressed skull fracture with or without loss of con- dive again?. For those divers with major residual prob-
sciousness. lems the appropriate advice is probably never (Elliott,
1990).
Some 5% of patients admitted to hospital after a severe
The majority of divers who appear to have made a full
head injury have a seizure within the rst week, with an
clinical recovery may, however, return to diving once
additional 5% suering seizures at a later date. With
their body has fully recovered from the insult. The di-
time, the risk of seizure after a head injury appears to
culty is that, although the diver may have recovered to the
decrease, eventually reaching a level not dissimilar to that
extent that no decit is detectable on clinical examin-
of a member of the general population (91% per annum)
ation, postmortem studies of divers with a history of DCI
(Marsden, 1988). The Medical Commission on Accident
who died from nondive-related causes (Palmer et al.,
Prevention, in providing advice on return to driving after
1987) have revealed silent central nervous system dam-
head injury, permit group II drivers to recommence driv-
age. Neuropsychological screening (Elliott and Moon,
ing if specialist assessment has determined the risk of
1993) of divers with a history of DCI has also revealed
post-traumatic epilepsy to have fallen below 2%. For
evidence suggestive of abnormal cognitive function in
divers, where there is the additional factor of exposure to
some groups of divers who, on careful clinical examin-
raised partial pressures of oxygen, which may increase the
ation, appeared to have made a full recovery. In one study
risk of seizure, return to diving can be considered once the
(Sutherland et al., 1993), this abnormal function persisted
risk of post-traumatic epilepsy has fallen below 1%.
in some divers in excess of 12 months postincident. This
evidence suggests it may be wise for all divers who suer
DCI, including those who have made a full clinical recov-
Cardiovascular Disease ery, to consider never diving again.
For those who do wish to return to diving and who
Diving is a very strenuous activity and, as such, any have made a complete recovery, current recommenda-
cardiovascular disorder that results in impairment of ex- tions are that a period of at least 4 weeks (DMAC, 1994)
ercise capacity should be considered as a contraindi- should elapse before diving. However, the development of
cation to diving. This includes ischaemic heart disease, increasingly sophisticated examination techniques, in-
cardiomyopathies and valvular stenosis, all of which may cluding magnetic resonance imaging, electrophysiologi-
impair exercise tolerance. Conduction disorders such as cal studies, and postmortem studies in the very small
the WolParkinsonWhite syndrome may predispose number of cases where the diver has died due to a non-
an individual to dysrrythmias, which may in turn precipi- dive-related course shortly after treatment for DCI, raise
tate in-water loss of consciousness, already discussed as the suspicion that subtle changes are present in the cen-
an absolute contraindication to diving. tral nervous systems of divers who appear to have fully
An unusual condition that has been noted among recovered. This knowledge has led to some hyperbaric
divers is that of immersion pulmonary oedema. The pre- medicine centres advising individuals not to dive for at
cise mechanism of causation of this condition, in which least 23 months and to consider giving up diving alto-
the diver develops pulmonary oedema while immersed, is gether.
unknown, although mild hypertension, cold immersion,
exercise, raised Pi and beta blockers have all been
suggested as possible provocative agents. Whatever the
precise mechanism, once a diver has experienced immer- Medication
sion pulmonary oedema the condition usually recurs on
subsequent dives, often with increasing severity. Because When considering whether or not a particular drug is
of the possible connection with hypertension, it is prob- compatible with diving it is rst essential to ask why the
ably unwise for an individual with hypertension, unless drug is being taken, as in most cases the condition for
very mild and only requiring diuretics, to dive. The use of which the drug is being taken will disqualify the individ-
beta blockers by divers is certainly to be discouraged. ual from diving. Where this is not the case, consideration
must be given to the mechanism by which the drug works
and any possible side-eects. Drugs that impair exercise
Decompression Illness tolerance or produce drowsiness are obviously incompat-
ible with diving, while drugs that may have side-eects
Each year some 200250 divers are treated for decom- such as neuropathies and arthropathy should probably
pression illness in the UK. Of these, 75% make a full be avoided because of possible diagnostic confusion with
recovery following treatment but some 25%, despite DCI if such symptoms should rst occur after a dive.
treatment, are left with a residual decit, which may range Finally, it must be remembered that many drugs have
from a minor area of sensory loss to a full-blown paraple- very complex structures that might be aected, and hence
gia. Just as the rst question asked by most injured have altered function, by exposure to raised ambient
motorcyclists admitted to an orthopaedic ward is When pressure and partial pressures of oxygen. In summary, few
can I ride again?, the rst question asked by most divers drugs are compatible with diving.
DIVING MEDICINE 269
Malarial Prophylaxis fullness, followed by pain of increasing intensity up until
the point where the drum ruptures and allows water to
In the case of malarial prohylaxis it is essential that the enter. To prevent this from occurring, the diver must
individual is both protected from malaria and also that ensure that the pressure dierence between the pharynx
the drug, or drug combination, taken does not impair and the eustachian tube never reaches the point where the
tness to dive. Some of the reported side-eects of mef- cartilaginous portion of the tube collapses. This is
loquine (Larium), which include motor and sensory neur- achieved by performing frequent swallowing, yawning,
opathies, ataxia, anxiety and panic attacks, are without jaw movements or gentle Valsalva manoeuvres against a
question incompatible with safe diving. The current ad- closed nose and mouth, but not glottis, during descent.
vice of the Diving Medical Advisory Committee (DMAC, Middle ear barotrauma of descent is classied into six
1998) is that, if meoquine is the drug of choice for a grades:
particular area, at least three doses, over a period of 23
weeks, should be taken prior to diving. If side-eects have Grade 0: Symptoms without signs
not developed within this time, it is highly unlikely that Grade 1: Injection of the tympanic membrane, especially
they will, and so it is safe to dive. An individual who has along the handle of the malleus
previously taken meoquine without side-eects may Grade 2: Injection plus slight haemorrhage within the
dive immediately. substance of the tympanic membrane
Grade 3: Gross haemorrhage within the substance of the
tympanic membrane
Grade 4: Free blood in the middle ear as evidenced by
CLINICAL FEATURES
blueness and bulging
Grade 5: Perforation of the tympanic membrane.
The bends, more correctly termed decompression illness,
are just one of a variety of diving-related disorders. Divers Barotrauma resulting simply in rupture of the tympa-
may also drown or suer hypothermia, despite using nic membrane usually results in no permanent loss of
breathing apparatus and wearing very eective thermal hearing, as in most cases the tympanic membrane heals
protection. Drowning and hypothermia are, however, rapidly with minimal scarring. More extensive scarring
hazards common to all water sports and as such will not may lead to some slight conductive hearing loss but this is
be dealt with in this section. Diving-related disorders can quite uncommon. Less common than simple rupture of
be divided into two major categories: conditions that do the tympanic membrane is dislocation of the ossicles,
not require recompression therapy, and those that do. which can occur if attempts are made forcibly to equalise
pressure between middle- and outer-ear cavities during
the divers descent. Such dislocation will result in a con-
Conditions that do not require recompression ductive hearing loss as the middle-ear amplier can no
therapy longer function. Prompt surgical reduction will result in
almost complete restoration of function in most cases.
Middle ear barotrauma. Middle ear barotrauma may Middle-ear barotrauma, grades 02, will usually re-
occur during descent if the diver is unable to equalise the solve rapidly within a few days. Grades 3 and 4 baro-
air pressure within the middle-ear cavity with that of the trauma may take 710 days to resolve, while the diver
water pressure in the external auditory meatus. For press- with grade 5 barotrauma should not dive until the tympa-
ure equalisation to occur the eustachian tube must be nic membrane has healed fully, a process that may take
patent. However, the pharyngeal two-thirds of the eusta- 46 weeks. Active intervention is rarely required, al-
chian tube is formed from cartilage and is buried within though simple analgesics and decongestants may ease the
the mucosal folds of the pharynx. This acts as a very discomfort. Middle-ear barotrauma is often accompanied
eective ap valve that prevents reux of food and saliva by slight conductive hearing loss: this is temporary and
into the middle ear on swallowing. Unfortunately, as the rarely more than 20 dB. If the hearing loss persists, is
pressure of the air in the pharynx increases during the greater than 20 dB or is accompanied by tinnitus and/or
divers descent, this ap valve can be forced shut, making vertigo, the possibility of ossicular chain disruption or
it impossible to equalise the pressure in the middle ear inner-ear barotrauma must be considered. In all such
even with the most forceful Valsalva manoeuvre. This cases the diver must be referred to an ENT specialist as a
results in the tympanic membrane bulging inwards due to matter of urgency, as prompt surgical intervention is
the excess water pressure in the external auditory meatus, essential if permanent hearing loss is not to occur.
when compared to the air pressure in the middle ear.
The tympanic membrane can only withstand a relative-
ly small pressure imbalance before becoming traumatised Inner-ear barotrauma. Inner-ear barotrauma may occur
and eventually rupturing. The mucosal lining of the during descent if a diver tries to equalise middle-ear press-
middle-ear cavity is also traumatised by exposure to this ure by a forcible Valsalva manoeuvre. This has the eect
relative vacuum and becomes oedematous and haemor- of raising intracranial pressure, the increased pressure
rhagic. As the drum bulges inwards and the mucosal being transmitted via a patent cochlea aqueduct to the
lining swells, the diver will rst experience a feeling of inner ear. Animal studies have revealed that this pressure
270 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
wave may reach 120 mmHg (16 kPa), which is sucient to diving course or holiday, can promote the condition.
rupture the round window. The resulting leak of Swimmers ear can be prevented by use of 8% aluminium
perilymph will produce a range of symptoms, including acetate solution applied after each wet dive. This solution
tinnitus, sensorineural deafness and vertigo. Symptoms is bacteriostatic and astringent. Three or four drops of the
may become apparent while the diver is still in the water solution should be poured into each ear in turn and left
but, if the leak is small, may not present until some time for a minimum of 5 min.
after the diver has left the water. Inner-ear barotrauma
requires urgent referral to an ENT department for assess- Sinus barotrauma. Sinus squeeze may occur when the
ment, and possible exploration and repair of the ruptured ostia that vent the sinuses are obstructed. It may be
round window. It is essential to consider inner-ear baro- experienced during descent, presenting as increasing pain
trauma in any diver who presents complaining of having in the sinus(es) involved. Since the pressure in aected
diculty clearing the ears and who has deafness and a sinuses decreases relative to ambient, oedema of the mu-
normal-looking drum. Inner-ear barotrauma or even os- cosa and haemorrhage into the sinus cavity may occur. If
sicular dislocation, both of which require an urgent ENT an ostium becomes blocked during a dive, which can
referral, may be the cause. Of interest is the fact that the occur as a result of breathing cold gas, barotrauma dur-
round windows of many diving marine mammals are ing descent, etc., sinus barotrauma may occur during the
protected by a layer of brous tissue that strengthens the ascent phase of a dive. In such cases, the sinus pain is
membrane and hence reduces the risk of rupture. caused by a relatively increased pressure within the sinus
and this may persist for some hours after the dive. Quite
Alternobaric vertigo. Alternobaric vertigo occurs when commonly, relief is accompanied by a squeaking sound,
the pressure, usually during ascent but occasionally dur- as gas, often accompanied by a discharge, escapes from
ing descent, in one middle-ear cavity diers from that in the sinus.
the opposite ear due to unequal rates of middle-ear press-
ure equalisation. This can result in unequal stimulation of External ear squeeze (reversed ears). If the external
the inner ear via the round and oval windows and marked auditory meatus is blocked by an obstruction, such as
vertigo. The vertigo is short-lived and resolves sponta- wax, a tight-tting hood, ear plugs or otitis externa, the
neously. pressure in the outer ear can not equalise with the ambi-
ent pressure. During descent, a relative vacuum develops
Caloric vertigo. Caloric vertigo occurs when cold water in both the outer and middle ear. When the ears are
enters one ear canal while the other is still full of relatively cleared, which returns the middle-ear pressure to ambi-
warm air, or water trapped by the divers hood or by ear ent, the tympanic membrane balloons outwards, in the
wax. This condition usually occurs during descent and opposite direction to that which occurs in more conven-
can produce a marked, but transient, vertigo. tional middle-ear barotraumahence reversed ears. If
this persists for more than a few minutes, injury to the
Middle-ear oxygen absorption syndrome. During a long epithelial lining of the external auditory meatus and the
dive using either oxygen, or a nitrox mix with a high tympanum may occur; this consists of oedema and
percentage of oxygen, gas with a high percentage of oxy- petechial haemorrhages. Occasionally haemorrhagic
gen will enter the middle-ear cavity. Following such a grape-like blisters form and may burst to produce sub-
dive the oxygen is slowly absorbed and metabolised by stantial haemorrhage into the ear canal.
the tissues of the middle ear, and if the eustachian tube
does not open spontaneously a negative pressure relative Barotraumatic facial palsy. In a small number of indi-
to ambient may develop. Symptoms, which include a mild viduals the facial nerve is exposed to middle-ear pressure
discomfort and hearing loss in one or both ears plus, as it traverses the temporal bone. If the middle ear is
occasionally, a sense of pressure and a moist, crackling pressurised during ascent, due to failure of the eustachian
sensation, may not become apparent for some hours after tube to vent, the vascular supply of the facial nerve may
completion of the dive. A uid level (serous otitis media) be compromised, resulting in an ischaemic neuropraxia.
may be seen in the middle ear on otoscopy. Middle-ear Generally, 1030 min of overpressure are necessary for
oxygen absorption syndrome is dicult to avoid but does symptoms to appear. During this period there may be
not usually pose a signicant problem because the symp- nausea and vertigo. The syndrome is characterised by a
toms are generally minor. Attempts at equalising the unilateral facial palsy of the lower motor neuron type.
pressure in the middle ear using a Valsalva manoeuvre When the syndrome presents shortly after surfacing, it
are usually successful, although occasionally a decongest- may be dicult to distinguish the condition from DCI.
ant may be required. Once the middle ear vents, full facial function generally
returns in between 10 min and 2 h.
Otitis externa (swimmers ear). Repeated immersion
breaks down the skin that lines the external ear canal, Gastrointestinal barotrauma. Gas within the intestine
allowing the bacteria and fungi that are normally present expands during decompression and may result in eructa-
to multiply. This is a condition that most commonly tion, atus or abdominal discomfort. Rarely, colicky ab-
occurs during saturation diving, although frequent im- dominal pain, abdominal distension and tinkling bowel
mersion of the ears for any reason, such as an intensive sounds occur, which may resemble bowel obstruction. As
DIVING MEDICINE 271
a preventative measure, heavy meals and carbonated MANAGEMENT OF DECOMPRESSION
drinks should be avoided before a dive. Swallowing gas ILLNESS
(aerophagia) when under pressure is dangerous because
serious gastrointestinal barotrauma, possibly resulting in The denitive treatment of DCI is recompression and
rupture of the bowel, may occur during ascent. Gastric administration of hyperbaric oxygen. However, the re-
rupture has been reported following very rapid ascents, as compression chamber may be some distance from the
well as in individuals who have undergone fundoplication dive site, and thus it may be necessary to support the diver
for repair of hiatus hernia. Individuals with para- for some hours while awaiting, and during, transport to
oesophageal hiatus hernia should not dive, as any gas the recompression facility. The initial treatment of the
trapped in the gastric remnant within the chest will ex- injured diver should not dier from that of any casualty
pand during ascent and may cause gastric rupture. but should, in addition, include administration of 100%
oxygen and uids. The theoretical justication for oxygen
administration is that it both promotes the reabsorption
Pulmonary barotrauma. Pulmonary barotrauma is a
of gas bubbles by providing a favourable tissuebubble
serious and potentially life-threatening complication of gas diusion gradient, and, by increasing the tissue oxy-
diving that has already been discussed. gen levels, the eect of tissue damage resulting from
bubble formation is minimised.
Practical experience has revealed that oxygen adminis-
Conditions that require recompression therapy tration does indeed slow the progression of DCI and may
in some cases result in the complete resolution of symp-
Decompression Illness toms. This should not be taken as an indication that
recompression therapy is no longer required, as almost
Because bubbles can form in any tissue, or travel to any invariably symptoms recur when oxygen administration
tissue in the case of arterial gas emboli, any part of the ceases. Oxygen should thus be administered from initial
body can be aected. DCI is thus a multisystem disease diagnosis of DCI to arrival at a recompression chamber.
that can manifest in a wide variety of forms. Furthermore, Intravascular bubbles may result in activation of plate-
as, with time, more bubbles may come out of solution, or lets, leucocytes and certain biochemical pathways (Fran-
existing bubbles may grow in size, DCI is a dynamic cis and Gorman, 1993), the end-result of which will be an
process with changing symptoms and progression of increase in vascular resistance and decreased tissue blood
symptoms. ow. This may be exacerbated by relative dehydration,
Although DCI is a multisystem disease, there are cer- common in divers, due to a combination of immersion
tain systems that are aected more frequently than others. and cold diuresis. Furthermore, some divers deliberately
The British Hyperbaric Associations Diving Accident restrict their uid intake before a dive as it is impracti-
Database contains data on more than 1200 cases of DCI, cable to urinate while wearing a diving dry suit. The
over 75% of the cases presenting with neurological mani- conscious diver can be given any nonalcoholic uid
festations. These manifestations include muscle weakness, orally, aiming at about 1 litre in the rst hour, while the
objective and subjective sensory changes, altered balance unconscious diver should be given either normal saline or
and coordination and, more rarely, visual and auditory Hartmanns solution, once again aiming for 1 litre in the
disturbances and impairment of higher mental function. rst hour. When administering such quantities of uid it
Although neurological dysfunction is the most common should be noted that urinary catheterisation may be re-
presentation of DCI, limb pain is present in approximate- quired, as bladder dysfunction and urinary retention may
ly 50% of cases. This limb pain is a deep, aching, boring be a symptom of decompression illness.
pain that is poorly localised to the area around a joint. Although divers with limb pain or girdle pain may be in
The intensity of the pain is not aected by position or quite severe pain, it is essential that unless there is likely
movement of the joint and the joint is not tender on to be a long delay in transferring the diver to a recompres-
palpation. In a small proportion of cases (5%) the diver sion facility, analgesics are not given. Analgesics may
will present complaining of a dull aching pain in the back, cause diagnostic and management diculties by masking
often radiating anteriorly in a girdle-like distribution. certain DCI symptoms, such as pain and altered higher
Such girdle pain is an ominous manifestation usually mental function. If it is necessary to administer an anal-
implying involvement of the spinal cord and frequently gesic, the drug of choice is paracetamol. Under no cir-
precedes the onset of objective motor and sensory loss. cumstances should a 50: 50 mixture of nitrous oxide and
Other manifestations of DCI include constitutional oxygen (Entonox) be administered to a diver, as not only
symptoms (general malaise, lethargy, fatigue, headache will it mask symptoms but also, because of its solubility,
and nausea), pulmonary symptoms and cutaneous mani- the nitrous oxide may diuse into existing bubbles, caus-
festations, which include itching and skin rashes (an ing them to enlarge and thus exacerbate the divers symp-
erythematous rash which may progress to cyanotic toms.
mottling or marbling of the skin.) Although very rare,
DCI may present with lymphatic obstruction. In most
cases of DCI the diver will present with two, three or
more manifestations.
272 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Recompression Therapy
Once the diagnosis of DCI has been made, the aim should
be to transport the diver to a recompression chamber as
rapidly as possible. The method of transport will depend
upon what is available but the priority should always be
to transfer the diver speedily and at as low an altitude as
possible. Speed is essential as the shorter the time from
onset of symptoms to commencement of recompression
the better the prognosis (Moon and Gorman, 1993). If a
helicopter is used to transport the diver, it should not
exceed an altitude of 300 m, thereby avoiding a signicant
decrease in atmospheric pressure, which would result in
the enlargement of any bubbles and exacerbation of Figure 16.2 Royal Navy Table 62/US Navy Table 6 (standard
symptoms. oxygen recompression therapy)
Recompression therapy has three prime actions:
action to take in the event of a recurrence of symptoms.
The reduction in volume (Boyles law) of any gas bubbles.
The resorption of gas bubbles by providing a favourable
tissuebubble gas diusion gradient.
The provision of oxygen to tissues damaged by bubble
formation. Outcome
Recompression chambers come in a wide variety of Unfortunately, not all cases of DCI are cured by recom-
shapes and sizes, ranging from small monoplace cham- pression therapy, only 55% of divers making a complete
bers, which only accommodate the injured diver, to large recovery after the initial recompression therapy. Fortu-
multiplace chambers in which a suitably qualied attend- nately this gure rises to 75% after retreatment but still
ant accompanies the diver. Some multiplace chambers leaves 25% of divers who do not fully recover. Although
are capable of providing all the facilities to be found in an in most cases the residual symptoms are relatively minor,
intensive care unit. This is essential in the management of each year a small number of divers (12% of cases of DCI)
the seriously injured diver or a patient receiving hyper- are left with severe and disabling residual symptoms fol-
baric oxygen therapy for a nondiving-related clinical in- lowing recompression therapy and require extensive and
dication, such as carbon monoxide poisoning or necrotis- long-term rehabilitation.
ing fasciitis.
Once the diver has arrived at the recompression cham-
ber, standard treatment protocols are followed and, de- Flying after Recompression Therapy
pending upon the divers presenting symptoms and re-
sponse to recompression therapy, one of a range of Flying after therapeutic recompression therapy should be
dierent therapeutic recompression tables may be avoided for at least 7 days as it may precipitate a recur-
utilised. These tables range in duration from 135 min rence of symptoms. This is because, even following rec-
(Royal Navy Table 61/ US Navy Table 5), which is used ompression therapy in which there has been complete
for limb pain-only DCI rapidly resolving on recompres- symptomatic relief, small microbubbles may still remain
sion, to 4; days for severe cases (Royal Navy Table 65/ in tissues; these may expand and produce symptoms in
US Navy 7). The therapeutic table most frequently used is response to the reduction in cabin pressure. Symptoms
the Royal Navy Table 62/US Navy Table 6 (Figure 16.2). may also be caused by damaged tissues, especially those
This table is 285 min long, during which time the diver of the central nervous system, becoming hypoxic when
breathes 100% oxygen at both 18 m chamber depth (Pi exposed to the reduced P of the aircraft cabin at alti-
280 kPa) and also at 9 m chamber depth (Pi 190 kPa). tude.
The oxygen-breathing periods are interspersed by short If it is impossible to delay ying for 7 days then ar-
breaks during which the diver breaths chamber air. These rangements should be made for oxygen to be available for
air-breaks reduce the probability of both pulmonary and the full duration of the ight. Even if oxygen is available,
CNS oxygen toxicity. divers with limb pain or lymphatic or cutaneous DCI
Following recompression therapy the diver must be who have had complete resolution of all symptoms must
admitted to a hospital for a period of at least 12 h, and not y for 24 h after completing the therapeutic table.
preferably 24 h, for observation. The diver should be as- Patients with neurological, pulmonary or multisystem
sessed regularly during this period of observation as, DCI who have had a complete resolution must not y for
although uncommon, there may be a recurrence of signs a minimum of 48 h. Divers with residual symptoms
and symptoms. In such cases it is essential that recogni- should not y for at least 72 h after completion of their
tion is prompt and the diver is recompressed. Before nal recompression table, and then only after consulta-
being discharged, all patients should be briefed on what tion with a diving medicine specialist.
DIVING MEDICINE 273
Drugs Medical Advisory Committee, London.
Eggleston PA, Ward BH, Pierson WE et al. (1974) Radiographic
Although recompression therapy is the denitive treat- abnormalities in acute asthma in children. Pediatrics, 54,
442449.
ment of DCI, various drugs have been suggested as being
Elliott DH (1990) Residual eects and the return to diving. In
of possible benet as an adjuvant in treatment. The role of Diving Accident Management, 41st Undersea and Hyperbaric
steroids is currently under review, while lignocaine, which Medical Workshop (eds PB Bennett and RE Moon), pp
presumably provides benet by virtue of membrane 235243. Undersea Hyperbaric Medical Society, Bethesda
stabilisation, is currently being assessed in a large trial in MD.
Australasia, from where preliminary results appear en- Elliott DH (ed.) (1995) Pulmonary tness. In Medical Assessment
couraging. of Fitness to Dive, pp 109153. Biomedical Seminars, Ewall.
Elliott DH and Moon RE (1993) Long term health eects of
diving. In The Physiology and Medicine of Diving (eds PB
Bennett and DH Elliott), 4th edn, pp 585604. Baillie`re, Tin-
HEALTH ADVICE AND PROTECTIVE dall and Cassell, London.
MEASURES Francis TJR and Gorman DF (1993) Pathogenesis of the decom-
pression disorders. In The Physiology and Medicine of Diving
(eds PB Bennett and DH Elliott DH), pp 454480. Baillie`re,
Perhaps the most important advice with regard to dive Tindall and Cassell, London.
safety is to ensure that the diver receives adequate and Light RW (1994) Pneumothorax. In Textbook of Respiratory
appropriate training. Accidents are far more common Medicine (eds JF Murray and JA Nadel), 2nd edn, pp
with inexperienced divers, as shown by a study of 747 21932210. WB Saunders, Philadelphia.
diving fatalities that occurred in the United States be- Lippert HL, Lund O, Blegvad S et al. (1991) Independent risk
tween 1989 and 1996 (Caruso et al., 1998). This study factors for cumulative recurrence rate after rst spontaneous
revealed that 8.1% of fatalities involved divers who had pneumothorax. European Respiratory Journal, 4, 324331.
completed ve or fewer dives, and 18.7% of fatalities Malhotra MS and Wright HC (1961) The eects of a raised
involved divers who had completed between 6 and 20 intrapulmonary pressure on the lungs of fresh unchilled ca-
davers. Journal of Pathology and Bacteriology, 82, 198202.
dives. Within the UK and worldwide there are a number Marsden CD (1988) Neurology. In Oxford Textbook of Medicine
of recreational dive training organisations, all of which (eds DJ Weatherall, JGG Ledingham and DA Warrell), 2nd
oer comprehensive training. The largest training or- edn, p. 21.1. Oxford University Press, Oxford.
ganisations active within the UK are the British Sub- Moon RE and Gorman DF (1993) Treatment of the decom-
Aqua Club (BSAC) and the Professional Association of pression disorders. In The Physiology and Medicine of Diving
Diving Instructors (PADI) (see Additional Resources). (eds PB Bennett and DH Elliott, pp 454480. Baillie`re, Tindall
When travelling abroad to dive it is essential that travel and Cassell, London.
insurance is purchased and that this insurance covers the Palmer AC, Calder IM and Hughes JT (1987) Spinal cord degen-
costs associated with the treatment of diving accidents. eration in divers. Lancet, ii, 13651366.
Sutherland AFN, Veale AG and Gorman DF (1993) The neuro-
Although, increasingly, travel policies do cover recre- psychological problems prevalent in a population of recre-
ational diving, they often contain limits as to the maxi- ational divers one year after treatment for decompression
mum depth of dive or only apply when diving with a illness. Journal of the South Pacic Undersea Medical Society,
qualied instructor. Furthermore, some policies will only 23, 711.
cover the cost of recompression therapy and not the cost Voge VM and Anthracite R (1986) Spontaneous pneumothorax
of air evacuation, which may be many thousands of in the USAF aircrew population: a retrospective study. Avi-
pounds, to the nearest recompression chamber. ation, Space and Environmental Medicine, 57, 939949.
REFERENCES
FURTHER READING
Benton PJ, Woodne JD and Westwood PR (1996) Arterial gas
embolism following a one metre ascent during helicopter es- Bennett PB and Elliott DH (eds) (1993) The Physiology and
cape training. Aviation, Space and Environmental Medicine, 67,
Medicine of Diving, 4th edn. Baillie`re, Tindall and Cassell, Lon-
6364. don.
Caruso JL, Hobgood JA, Uguccioni DM et al. (1998) Inexperi-
Bove AA and Davis JC (eds) (1997) Diving Medicine, 3rd edn. WB
ence kills: the relationship between lack of diving experience Saunders, Philadelphia.
and fatal diving mishaps. Undersea and Hyperbaric Medicine,
Edmonds C, Lowry C and Pennefather J (1992) Diving and
25 (suppl), 32. Subaquatic Medicine, 3rd edn. Butterworth-Heinemann, Oxford.
Denison DM and Francis TJRF (1999) Lung rupture, diving and
Elliott DH (ed.) (1995) Medical Assessment of Fitness to Dive.
submarine escape. In The Lung at Depth (eds CEG Lundgren, Proceedings of an International Conference at the Edinburgh
JN Miller), pp 295374. Marcel Dekker, New York.
Conference Centre 811 March 1994. Biomedical Seminars,
DMAC (1994) Guidance on assessing tness to return to diving Ewell.
after decompression illness. DMAC 013. Diving Medical Ad-
visory Committee, London.
DMAC (1998) Problems relating to the potential side eects
from using meoquine. DMAC information note 01. Diving
274 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
ADDITIONAL RESOURCES Professional Association of Diving Instructors
PADI International
UK Training Organisations Unit 7, Albert Road
St Phillips Central
Bristol BS2 0PD, UK
British Sub-Aqua Club
BSAC headquarters
Telfords Quay
Ellesmere Port Diving Emergency Helpline (24 hours)
South Wirral
Cheshire CH65 4FL, UK Undersea Medicine Division, Institute of Naval Medicine
Tel (within the UK): 07831 151523
Tel (outside the UK): ; 44 7831 151523
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
17
A serious illness or injury while traveling can result in A small ashlight is very Eyeglass repair kit
signicant nancial liability for the unfortunate tourist. handy if there is a power Spare eyeglasses, contacts
Not only can out-of-pocket expenses be signicant but outage or if the kit is needed and sunglasses
emergency air medical evacuation can run into tens of out of doors Antihistamine/decongestant
Pen and notepad to keep medications for allergic
thousands of dollars. Medical insurance for these events
track of supplies and make symptoms and congestion.
can be provided by a traditional health insurer or by one
notations about important Eye drops
specializing in health insurance for the traveler. Many incidents Cough medicine and throat
people with health insurance at home will be covered for Aspirin, acetaminophen or lozenges
medical services in another country; however, medical ibuprofen are eective for the Lip balm, canker gel, dental
providers and facilities outside of the travelers home treatment of pain and fever. oss
country may not have the capacity to invoice the Acetaminophen is the Hydrocortisone cream for
travelers insurer for services rendered and may expect preferred medication for insect bites and itch
direct payment from them at the time of service. It is children with fever. Antifungal cream for athletes
important for travelers to review their insurance policy Oil of cloves for toothache foot and yeast infections
regarding specic coverage for services outside their local A pair of round-tipped Antacid and heartburn relief
area and reimbursement for direct payment for services. scissors is useful for cutting tablets
United States Medicare typically does not cover medical bandages and other items Laxative and antidiarrheal
services outside US territories. A telephone call to the Tweezers, safety pins and a medication
travelers health insurer prior to leaving on the trip can Swiss Army-type knife are all Sunscreen, factor 15 or
provide additional information on health care benets tools that have multiple uses greater
while traveling. It is important to discuss precisely what Tape, bandages, cutton swabs Sea/motion sickness tablets
medical services are covered and whether emergency air and antibiotic ointment are Insect repellent when
evacuation is included in the policy. If the benets from used to treat scrapes, cuts and traveling to insect-prone
the primary health insurance are insucient, the traveler burns. Blister dressings destinations
Elastic wraps and triangular Personal medications and
should consider purchasing supplemental coverage,
bandages can help immobilize prescriptions
either from the same provider or from a travel insurance injured limbs Personal medical information
company. The medical illness and injury benet should Instant ice pack (or form
be at least $US20 000. The emergency medical evacuation disposable freezer bag)
portion of the policy (for North American cruise ship Rubber gloves protect your
passengers) should provide up to $US15 000 of coverage hands and reduce the risk of
for trips to Alaska, Bermuda, Canada, the Caribbean and infection when treating open
Central America; $US60 000 for travel to Europe, South wounds
America and other readily accessible locations; and up to Thermometer with case
$US100 000 for trips to Africa, Antarctica, Asia, Australia
and other remote or exotic areas. The traveler should also
All medications should be stored out of reach of children; only products
be sure that any pre-existing medical conditions are with child safety caps should be used.
covered by the policy. First-aid kits should be in a carry-on bag, not in checked luggage.
In addition to medical and evacuation policies, various
other types of travel-related insurance are available.
These include trip cancellation/delay/interruption, lost not life threatening; however, if travelers are not prepared
luggage, tour operator default/failure, accidental death/ to treat them they can easily disrupt an otherwise enjoy-
repatriation of remains, and travel assistance coverage. able trip. A personal rst-aid kit is an ecient way to
Home and business insurance policies, credit card pro- prepare for these unexpected emergencies, both while
grams or transportation providers may oer limited traveling and at home. A standard kit can be purchased at
coverage for some of these potential losses. These types of most pharmacies and sporting goods stores or travelers
coverage are often bundled into a comprehensive insur- may wish to design a specialized rst-aid kit that meets
ance package along with the medical and evacuation their own particular needs (Table 17.2).
insurance. The premium for a comprehensive insurance A small tote bag is a convenient way to store all of the
plan, good for the duration of the cruise or air/land tour, supplies in the kit. It allows enough room for the essential
is typically 57% of the total cost of the travel package. If items and it ensures easy portability for travel. Certain
travelers need only supplemental medical and evacuation items should be included in any rst-aid kit. A small
insurance, it can cost as little as $US50 per person for a ashlight is very handy if there is a power cut or if the kit
years coverage. is needed out of doors. A pen and notepad help to keep
track of supplies and make notations about important
Travelers First-aid Kit incidents. A pair of rounded-tip scissors is useful for
cutting bandages and other items. Tweezers, safety pins
Most illnesses and injuries incurred while traveling are and a Swiss Army-type knife are all tools that have
278 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
multiple uses. Tape, bandages, cotton swabs, antibiotic the total number of passengers and crew members.
ointment and blister dressings are used to treat cuts, the average age of the passengers, their baseline health
scrapes and blisters. Elastic wraps and triangular ban- status, and their planned activities. Industry-wide, the
dages can help immobilize injured limbs. Rubber gloves average cruise line passenger is 4550 years of age. Cer-
provide a protective barrier to reduce the risk of infection tain cruise lines attract a senior clientele, while others
when treating open wounds. Acetaminophen, aspirin and cater to the younger crowd. An older age group will tend
ibuprofen are eective for the treatment of pain or fever. to have more chronic medical problems, such as heart
Nonprescription medications for colds, allergies, motion and lung disease, which may act up while they are travel-
sickness, heartburn and diarrhea are commonly needed ing. A younger age group may have more injuries due to
when traveling. Sunscreen and insect repellent are im- alcohol use and sports activities.
portant for trips to sunny and insect-prone destinations. The destination and length of the cruise. Longer per-
It is important for the cruise traveler to include an ad- iods away from the home port, especially days at sea,
equate supply of any prescription medications, including necessitate stocking up on more frequently used supplies.
eyeglasses and/or contact lenses, to last the entire trip. Common ailments, such as respiratory infections, may
They should also enclose a written list or copies of their increase in frequency on longer cruises. Knowledge of the
medication and eyeglass prescriptions in the kit. types and quality of medical facilities along the itinerary
The nal component of the rst-aid kit should be a is important to determine whether passenters or crew
personal medical information form (Figure 17.1). This is a members can be sent shore side for additional care or
convenient way of ensuring that essential medical infor- whether they need to be evacuated by air back to the
mation will be available to traveling companions and home port.
medical personnel when needed. The form identies the
next of kin, doctors, hospital and insurance carrier. It lists
any past and present illnesses, medications, allergies, A well-designed cruise ship medical department re-
blood type and immunization status. People with a his- quires careful planning. Adequate space must be assigned
tory of heart disease may want to attach a copy of their in the architectural plans of the ship to allow for the
most recent electrocardiogram. The form indicates who is delivery of necessary medical services for passengers and
to be notied in an emergency. That person should have a crew members. The medical facility must be equipped
copy of the form outlining the travelers entire medical with essential diagnostic and therapeutic supplies and
history. equipment. An ecient medical care delivery system is
needed in order to meet the needs of passengers and crew
members despite limitations in equipment and sta when
MEDICAL CARE AT SEA compared with a shore-side hospital. There should be a
contingency plan in place to provide emergency medical
Many people think of a cruise as the trip of a lifetime. For services in designated locations in the event of an on-
others it is the only way to travel. A modern cruise ship board disaster and the primary medical facility becoming
oers one of the most luxurious and safe ways of explor- inaccessible due to re, smoke or water damage. Most
ing international destinations. From the smaller ships of importantly, the medical department must be staed by
less than 100 m in length which carry fewer than 100 qualied doctors and nurses who are capable of working
passengers, to the truly titanic 300 m vessels sailing with in an isolated environment. The nal plan for any par-
more than 3000 passengers and 1000 crew members, ticular medical department will also be inuenced by the
cruise ships provide their guests with amenities that rival, ships size and design, total number of passengers and
and even exceed, those experienced at renowned shore- crew members, guest demographics, expected number of
side resorts. A beautiful vessel, luxurious accommoda- medical facility patient visits, and the ships itineraries.
tions, great food, the leisurely life at sea and exotic ports Until recently, most cruise lines worked independently
of call all add up to a fabulous holiday. But what if the to address these shipboard medical facility issues. In 1990,
unexpected happens and the cruise traveler suddenly be- however, the American College of Emergency Physicians
comes ill or injured? They are far away from home on the (ACEP) Cruise Ship and Maritime Medicine Section was
high seas and in need of prompt evaluation and treat- founded and created a forum for cruise ship medicine
ment. It is comforting to both passengers and crew mem- practitioners and others in the cruise industry to discuss
bers to know that the ships medical sta is just a few these topics.
decks away. The Cruise Ship and Maritime Medicine Section was
organized by members of the ACEP experienced in the
practice of cruise ship medicine. The objectives of the
Cruise Ship Medical Facility Section are to:
Several factors inuence the specic requirements for 1. Serve as a resource to the cruise industry, their medical
medical sta and equipment onboard a cruise ship. These departments, and physicians interested in cruise ship
include: medicine.
2. Develop guidelines for quality and consistent medical
the size of the ship. care aboard cruise ships.
TRAVEL HEALTH AT SEA: CRUISE SHIP MEDICINE 279
Section V
18
Travel-related Injury
Robert Grenfell
Grenfell Health Consulting Pty Ltd, Horsham, Australia
INTRODUCTION reason for admission was for injury and poisoning (38%).
The other reasons were cardiovascular (12%), gastroin-
Inherent in the desire to travel is the desire for new testinal (10%) and genitourinary (9%).
experience. The exposure to dierent surroundings and These studies present a tantalising glimpse of the mag-
the excitement of the change itself yield the traveller to nitude of travel-related injury, but unfortunately they are
risks of unfamiliar proportion. All too often a journey at best fragmented. There are many surveys of health
ends prematurely as the result of injury. This chapter service utilisation that indicate that injury is a common
provides an overview of current knowledge concerning event while travelling (Bewes, 1993); however the infor-
travel-related injury, and provides a broad framework mation is of an uncontrolled nature, and as such only
that can be used to minimise actively the occurrence and oers snapshot views of morbidity and mortality. We
impact of injury. await the larger scale controlled studies that will take into
account the various exposure indices, such as length of
stay or activities undertaken, and individual indices, such
as age or sex. These types of studies, when combined with
EPIDEMIOLOGY
available population statistics, will allow injury rate cal-
culation and a more in-depth account of injury mechan-
To analyse the epidemiology of travel-related injury one
ism.
looks at morbidity and mortality studies to dene the
As a consequence of the diversity of exposure and
overall population status.
accident types, the epidemiology is poorly dened. This is
In the formative study by Hargarten (Hargarten et al.,
not too dissimilar to all other areas of injury research, and
1991) of the deaths of 2463 American travellers over a 10
indeed many areas of public health. There are diculties
year period, it was found that 24% were caused by injury.
in the denitions of both cases and injury types. Surveil-
Of these, motor vehicle crashes were the most common
lance is fragmented, or even absent. Interventional studies
(27%), followed by drowning (16%). In an analysis of
are rare indeed.
cases transported back to the USA by emergency medical
In order to attempt to analyse travel-related injury it is
air transport over a 3 year period (Hargarten and Bouc,
necessary to utilise a risk-based approach. This involves
1993), 44% were due to injury. Over half of these were the
risk identication and risk management. Risk can be
result of motor vehicle accidents. Studies from other
sourced from the environment that the travellers are in,
countries echo these data. The deaths of Scottish citizens
through to the individuals themselves. An individual has
abroad from associated injury have been measured at
many variables, such as age and sex, activities planned,
21% (Paixo et al., 1991). The deaths of Australians over-
behaviours adopted, precautions taken and, most im-
seas have been quantied (Prociv, 1995): 35% cardiovas-
portantly, what their particular perception of risk is. The
cular, 18% injury and 2% infection. The deaths due to
environment poses an innite array of risks.
injury were mainly the result of motor vehicle accidents.
Within Australia, the deaths of visitors to the state of
Victoria were found to be due to cardiovascular disease CASE-BASED APPROACH
(47%) and injury (19%) (Grenfell et al., 1997). The injuries
were mainly motor vehicle accidents; other causes were As with other areas of public health where the data are
drowning, suicide or multitraumatic. Of overseas visitors limited, it is desirable to review issues on a case study
admitted to a hospital in the Australian state of Queens- format. To illustrate the case-by-case nature of injury, let
land over a 12 month period (Nicol et al., 1996), the main us consider the following actual cases:
Insurance Industry
Travel Health Physician
Travel insurance packages must provide broader cover.
The basic provision of structured injury prevention and The small print needs to be large, so that travellers know
risk minimisation advice is paramount; this includes the what is and is not covered, and can then make an in-
determination of the risks apparent from a detailed ac- formed decision about purchasing the appropriate policy.
count of the travellers proposed itinerary and any par- Older travellers are increasing in number and, more
ticular health conditions that he or she may have: than any other group, need insurance cover. The habit of
not covering existing medical conditions is nonsensical.
Highlight the consequences of risk exposure. For example, an 80-year-old man with ischaemic heart
Strengthen the advice with brief, to the point, written disease is likely to experience a cardiac event, so he should
material. be encouraged to cover such an event and should be able
Advise pertinent preventative actions: for example, to obtain a reasonably priced policy to do so.
travel with an organised tour group if undertaking The adventure traveller needs specialised cover that
adventure activities (with a reputable organisation, includes the activities to be undertaken. It is all too easy
standards would be expected to be higher, and risks to say rock climbing not included but, when that is the
correspondingly reduced); hire a car and a driver; wear purpose of the trip, the insurance broker must be able to
protective equipment; do not mix alcohol with physical provide an adjusted policy that does cover rock climbing.
activities; seek local safety information, e.g. re escapes, The exclusion of motor cycle riding (either in dened
safe areas to swim. areas or as a blanket clause) by a number of policies may
Explain the value of travel insurance, as medical evacu- act as a deterrent for many travellersthat is, if they are
ations are expensive and access to high-quality health aware of the exclusion. But what of the traveller who has
services is often limited, due to language, knowledge, no other option to a motorcycle as a means of transport?
distance from centres, and infrastructure deciency. There should be a policy variation to cover this situation.
Travel health physicians are in an ideal position to
continue research into specic travel injury risks. Much
information is needed on the incidence, rate and causa- Governments
tion of travel-related injury, as is more information on
eective proven strategies to reduce the injury caseload. Many countries rely heavily on tourism for revenue; in
296 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Australia, for example, tourism is a major industry em- Edmonds C and Walker D (1999) Snorkelling deaths in Austra-
ploying over 6.9% of the workforce and generating over lia, 19871996. Medical Journal of Australia, 171, 591594.
$A46.9 billion (Department of Industry, Science and Grenfell R (1996) Beach related injuries. Medical Journal of
Australia, 166, 390.
Tourism, 1996). It would therefore seem obvious that it is
Grenfell RD and Ranson D (1997) Tourism and recreational
very important to protect the industry by the provision of injuries. Journal of Law and Medicine, 4.
adequate health and safety management. This is not the Grenfell R and Ross K (1992) How dangerous is that visit to the
case. It seems absurd that health and safety in tourism beach? A pilot study of beach injuries. Australian Family Phys-
settings are not regarded with as much importance as ician, 23, 11451148.
they are in the mining industry. Government depart- Grenfell R, Ranson D and Hargarten S (1997) Mortality of
ments need to focus on health and safety management in visitors to Victoria Australia. In Proceedings of an ISTM
tourism, with legislation providing a backbone for oper- conference, Geneva.
ation. This would include the enforcement of codes of Hargarten SW (1991) International travel and motor vehicle
crash deaths: the problem, risks, and prevention. Travel Medi-
conduct and the prosecution of unsafe practices. Plann-
cine International, 106110.
ing is necessary for the designation of specied activity Hargarten S and Bouc G (1993) Emergency air medical transport
zones. With each new tourist area developed, consider- of US citizen tourists: 1988 to 1990. Air Medicine Journal, 12,
ation of the safety implications is required. Placing a 398402.
resort in an isolated area next to a serious hazard, for Hargarten S, Baker T and Guptill K (1991) Overseas fatalities of
example a beach that is unsafe for swimming, is a reason United States citizen travellers: an analysis of deaths related to
for concern, raising questions about adequate monitoring international travel. Annals of Emergency Medicine, 20,
of water activities and how serious mishaps are to be 622626.
managed. The service infrastructure is vital in such cases. Manolios N and Mackie I (1988) Drowning and near-drowning
on Australian beaches patrolled by life-savers: a 10 year study,
Not only does this cover the provision of adequate trans-
197383. Medical Journal of Australia, 148, 165171.
port but it should also provide for appropriate rescue Nicol J, Wilks J and Wood M (1996) Tourists as inpatients in
services, evacuation services, primary treatment facilities, queensland regional hospitals. Australian Health Review,
and so on. 19(4), 5572.
Paixao M, Dewar R, Cossar J et al. (1991) What do Scots die
from abroad? Scottish Medical Journal, 36, 114116.
SUMMARY Petridou E, Askitopoulou H, Vourvahakis D et al. (1997) Epi-
demiology of road trac accidents during pleasure travelling:
the evidence from the island of Crete. Accident Analysis and
Injuries associated with travel are very common but the Prevention, 29, 687693.
exact nature and incidence is not precisely known; how- Petridou E, Dessypris N, Skalidou A et al. (1999) Are trac
ever, in order to appreciate the risks of a specic activity, injuries disproportionately more common among tourists in
it is possible to analyse it with a generic framework. Greece? Struggling with incomplete data. Accident Analysis
Injury prevention requires a systems approach, attempt- and Prevention, 31, 611615.
ing to identify process errors, as there are usually a multi- Prociv P (1995) Deaths of Australian travellers overseas. Medical
tude of causative factors for each particular injury. It Journal of Australia, 163, 2730.
must be remembered that in cases of injury it is all too Short A, May A and Hogan C (1991) A three year study into the
circumstances behind surf based rescues. NSW Beach Safety
easy to blame the individual, when very often it is not the
Program Report 91. Sydney Coastal Studies Unit, University
individuals fault. of Sydney.
Wilks J (1999) International tourists, motor vehicles and road
safety. Journal of Travel Medicine, 6, 115121.
REFERENCES Wilks J and Watson B (1998) Road safety and international
visitors in Australia: looking beyond the tip of the iceberg.
Bewes P (1993) Trauma and accidents: practical aspects of the Travel Medicine International, 16, 194198.
prevention and management of trauma associated with travel. Wilks J and Watson B (1999a) International drivers in unfamiliar
British Medical Bulletin, 49, 454464. surroundings: the problem of disorientation. Travel Medicine
Carey M and Aitken M (1996) Motorbike injuries in Bermuda: a International, 17.
risk for tourists. Annals of Emergency Medicine, 28, 424429. Wilks J, Watson B and Hansen R (1999b) International Visitors
Department of Industry, Science and Tourism (1996) Impact: and Road Safety in Australia: A Status Report. Australian
Tourism Facts. DIST, Canberra. Transport Safety Bureau, Canberra.
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
19
Aeromedical Repatriation
Alex T. Dewhurst and John C. Goldstone
Middlesex Hospital, London, UK
INTRODUCTION occurs once the patient has been fully stabilised and all
urgent therapy initiated. However, these patients may
The increase in foreign travel, the rise in holidays to exotic still require a high degree of supportive therapy, including
locations and the enthusiasm for adventure holidays has intensive care. In countries where the health care re-
led to an increase in the requirements for medical repatri- sources are felt to be inadequate, the patient may be
ation services in the last decade. An ageing population transferred back to the UK at an earlier stage of the
with increased disposable income is expected to lead to a illness. In some cases the air ambulance team may need to
rise in the number of air ambulance transfers each year. institute resuscitative and supportive procedures before
People who fall ill or have an accident abroad can be the patient is deemed t to y. In the rare situation where
repatriated to the UK by a number of methods: medical care is completely inadequate or unavailable, a
They may organise their own transport, either alone or primary rescue ight may need to be undertaken. Occa-
with an escort. sionally the patient may be transferred locally to a region
They may travel on a scheduled ight with a doctor or or country that can provide the required resources. If
nurse escort. communications are dicult and the clinical situation is
They may require an air ambulance on a scheduled not clear, a doctor may be own out to assess the patient
ight or chartered aircraft. and decide if transfer is required.
All transfers place the patient at some risk, and poorly
In the region of 3000 patients a year are repatriated on conducted transfers have been shown to be detrimental to
scheduled airline services with a nurse escort and there outcome (Waddell, 1975; Gentleman and Jennett, 1981;
are approximately 9001000 air ambulance transfers into Bion et al., 1988). The risk of transfer should be balanced
the UK per annum (Morton et al., 1997). In Europe, the against the risk of deterioration in a suboptimal environ-
German Air Rescue service has shown a steady increase ment. For an escorted scheduled ight, the patients con-
in the number of ights, from 322 in 1976, 704 in 1983 to dition should be unlikely to deteriorate, not contagious,
1468 in 1993 (Kramer et al., 1996). This chapter will focus not disturbing to other passengers, require minimum
on the logistics and problems associated with air ambu- nursing or medical care and the patient should be able to
lance transfers. travel seated. If the patient requires high-dependency or
intensive care or needs to be transported on a stretcher,
an air ambulance transfer should be performed either via
MEDICAL TRANSFERS a scheduled carrier or in a chartered jet. The use of a
scheduled ight or chartered aircraft will depend on the
The medical transfer of a patient can be designated as clinical condition, the distance to travel, the availability
primary or secondary: primary transfer is from the scene of ights and the conditions stipulated by the carrier.
of injury or illness to the initial treating hospital; second- Approximately 90% of stretcher cases are transported on
ary transfer is the movement of a patient from one hospi- small chartered aircraft (Kramer et al., 1996).
tal to another for medical or social reasons. All cases of
medical repatriation should be deemed secondary trans-
fers, although some may be undertaken with a degree of Organisation of Repatriation Services
urgency and without denitive treatment having been
performed. In the majority of cases, patients will have Air ambulance ights are expensive. Prices quoted vary
been treated in countries in which the health care facilities from 5000 to 19 000 to return from Mediterranean
are of a good standard. In these situations transfer usually countries, 35 000 to 50 000 from Africa and 60 000
P
Gas breathing
Altitude Pressure volume air
(feet) (kPa) (litres) (kPa)
0 101 1 14
5 000 (1 500) 84 1.2 10
8 000 (2 400) 75 1.35 8.5
10 000 (3 000) 70 1.44 8.4
20 000 (6 000) 46 2 5
38 000 (11 600) 21 5 NA
The eects of G on the body depend on duration and DETRIMENTAL EFFECTS OF TRANSPORT
direction. Short or intermediate duration forces are those
associated with an abrupt deceleration, such as vehicle The majority of medical transfers are simple escorted
crashes. Long duration accelerations of more than 2 s cases that pass o with the minimum of problems. Trans-
occur mainly in military aircraft. In commercial aircraft, porting critically ill patients is more dicult, requiring
linear acceleration seldom reach magnitudes of any sig- continuation of organ support and invasive monitoring.
AEROMEDICAL REPATRIATION 301
Table 19.4 Dening a detrimental eect of transportation Gas expansion will increase the volume of pneu-
mothoracies, which may lead to respiratory compro-
Deterioration in vital signs mise. All pneumothoracies, or even suspected pneu-
Change in vital signs by more than 20% from baseline mothoracies, should be drained via an intercostal drain
Change outside normal range for patient before ascent to altitude or the aircraft should maintain
Mechanical, equipment or human error leading to an adverse a sea-level cabin pressure. In trauma patients with
eect on patient
fractured ribs there should be a low threshold for plac-
Airway, ventilator problems
ing an intercostal drain. The use of a Heimlich valve
Handling, loading problems
Loss of I.V. access, failure of infusion system
rather than an underwater seal makes transfer simpler.
Power failure Patients who are stable on mechanical ventilation are
Failure of oxygen supply safe to transfer. However, caution is required if the
Aircraft incidents inspired oxygen concentration is greater than 60%,
lung ination pressures are higher than 35 cmH O, or
more than 10 cmH O of positive end-expiratorypress-
In some cases a more sophisti-
ure (PEEP) is in use.
It has been shown that critical incidents, which have a cated ventilator than the standard transport ventilator
detrimental eect on outcome, occur while moving these may be required. Consideration should be made to
patients (Venkataraman and Orr, 1992). The environ- sedating and formally ventilating patients who are on a
mental factors of ight mentioned in the previous section, weaning mode of ventilation. Transferring a patient is
factors associated with road transport and the logistics thought to set weaning back by 1 day.
involved in moving the intensive care patient can all lead Gas-lled endotrachael cus increase in volume with
to adverse eects. These can be divided into major, re- altitude and may cause tracheal mucosal ischaemia.
quiring immediate intervention, and minor, leading to They should be lled with saline or their pressures
little disturbance to the patient. The causes can be dened monitored regularly.
as changes in physiology in response to transfer, leading Drugs and equipment should be available for treating
to disturbed organ function and mechanical or equip- respiratory emergencies.
ment-related errors. It is dicult to stipulate when a
change to physiology becomes detrimental and even
harder to show a dierence in outcome as a result of such
a change. However, commonly used denitions of signi- Cardiovascular
cant change are either movement from baseline vital signs
by 20% or readings that fall outside the normal range for Cardiovascular events are the leading cause of death
the patient (Table 19.4). during air travel (Gong, 1992).
Any movement and stimulation of critically ill patients
may cause hypertensive or hypotensive episodes (Wad-
dell, 1975). There are haemodynamic changes asso-
SPECIFIC HAZARDS AND THEIR
ciated with air ambulance transport, possibly due to
MANAGEMENT DURING TRANSPORT
the eects of gravitational forces and hypoxia
(Malagon et al., 1996). The force of acceleration on take
Respiratory
o may cause a reduction in cardiac output, especially
in patients who are volume depleted, vasodilated and
The reduced oxygen tension at altitude may lead to have poor myocardial function. Adequate monitoring,
symptoms of hypobaric hypoxia. Arterial oxygen satu- including invasive arterial and central venous press-
ration should be monitored and supplementary oxygen ures, with institution of therapy to maintain
administrated if indicated. If gas exchange is critical, haemodynamic stability may reduce such complica-
the aircraft may have to y at a lower altitude to tions.
maintain a sea-level cabin pressure. Reduced inspired oxygen concentration may precipi-
The dry atmosphere of the cabin may lead to thicken- tate angina or heart failure. Oxygen should be adminis-
ing of bronchial secretion and paralysis of respiratory trated to these patients during ight.
cilia. This can cause a deterioration in respiratory func- Despite the risks, unstable angina patients have been
tion, especially in patients whose natural humidica- transferred over long distances by air. However they
tion processes are bypassed by an articial airway. The require intensive therapy unit level care, adequate
end-result maybe a spontaneously ventilating patient monitoring and sedation (Castillo and Lyons, 1999).
requiring mechanical ventilation (Armitage et al., Any collections of mediastinal air will enlarge, poten-
1990). Eorts should be made to humidify inspired tially causing cardiovascular compromise.
gases using heat moisture exchange lters and Patients on inotropic infusions are at risk of inadver-
nebulisers. Patients should receive regular chest tent changes in the rate of infusions. Pumps with
physiotherapy, manual bagging and suction to clear alarms and short, sti infusion lines should be used.
secretions during transport. Lines should be labelled and not used for boluses.
302 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Noninvasive blood pressure readings have been shown All critically ill patients need to be catheterised to allow
to underread systolic and overread diastolic pressures monitoring of their urine output.
during transport. Direct methods of blood pressure
readings should be used in critically ill patients (Runcie
et al., 1990). The pressure transducer should be re- Neurological
zeroed at altitude.
There is an increased risk of thromboembolic events
during ight because of dehydration and immobility Head-injured patients should be managed to maintain
(Cruickshank et al., 1988). Support stockings may be cerebral perfusion pressures within a safe range: the
considered and heparin prophylaxis administrated un- ultimate aim being to prevent secondary brain injury.
less contraindicated. Standard guidelines for the management of head-in-
jured patients during transport are followed (Gentle-
man et al., 1993).
Patients with air in the skull or fractures through sinus
Gastrointestinal cavities are at risk of gas expansion. This may lead to a
tension pneumocephalus or the risk of bacterial menin-
Motion sickness can be treated with prophylactic anti- gitis. Following neurosurgery, ying other than at sea
emetics. Escorting sta should not suer unduly from level should be delayed until CT shows no evidence of
motion sickness. intracranial air.
In the normal subject, gas expansion within the bowel Patients with recent subarachnoid haemorrhages
causes little problem unless ascent is to altitudes should preferably have had denitive surgery if the
greater than 25 00028 000 feet (76008500 m). How- cause of bleeding is amenable to operative intervention
ever, in patients with cardiorespiratory compromise and if expertise is available. If surgery has not been
and intestinal distension, even ascent up to moderate performed, the blood pressure must be adequately
altitudes of 8000 feet (2400 m) can cause distress. Con- monitored and controlled. Infusions of nimodipine
sideration should be given to restricting cabin altitude need to be continued. If an extraventricular drain is in
to less than 6000 feet (1800 m) in those patients with situ it should be closely monitored during ight and
severe abdominal distension. turned o while the patient is moved.
Gastric distension and intestinal obstruction lead to an Patients with a spinal cord injury must be treated as if
increased risk of aspiration of gastric contents. During the injury is unstable, unless cleared by an orthopaedic
transport, restricted access to the patient means that in or neurosurgeon. They are at increased risk of requir-
the event of vomiting the oropharynx cannot be easily ing ventilatory assistance and need to be transferred by
cleared. A nasogastric tube should be placed, aspirated a doctor able to institute mechanical ventilation (Ar-
and left on free drainage. Patients who have reduced mitage et al., 1990). Spinal shock and autonomic hyper-
airway protective reexes should be considered for in- reexia should have been adequately treated.
tubation.
Gas expansion in the small and large bowel increases
the risk of perforation in cases of severe bowel disten- TRANSFERRING PATIENTS WITH
sion. There is a theoretical risk to surgical anastomoses. SPECIAL NEEDS
Air in the peritoneal cavity may expand and it is recom-
mended that 10 days be allowed between abdominal Paediatric/Neonatal Patients
surgery and transport in an aircraft not pressured to
sea level. Neonatal, infant and paediatric transfers require special
Ileus may be prolonged. consideration. These transfers are complicated by the
Patients with abdominal or chest trauma should have smaller size of the patient, dierent physiology and pa-
no evidence of continuing intra-abdominal haemor- thology. Specialist equipment such as a transport incuba-
rhage before transfer. tor and neonatal ventilator are required. Personnel
Limited cleaning facilities make severe diarrhoea a ma- should be skilled in neonatal and paediatric intensive
jor problem. Laxatives and suppositories should be care. The medical crew should include at least one doctor,
avoided before travel. either a neonatal paediatrician or paediatric anaesthetist,
and a nurse with neonatal experience. Many neonates are
transferred to specialist units for management of congeni-
Renal tal disorders; specic protocols for management are avail-
able.
Information received by the air ambulance company ambulance team must assume the worst case scenario and
on the patients condition varies widely in content and prepare for all eventualities. The most important infor-
accuracy, depending on the referring hospital and numb- mation the retrieval team require is whether the patient is
er of parties involved in the communication chain. Stan- cardiovascularly stable, on inotropes, what the ventilator
dard information requested is the history of the presenti- parameters are and what the patients gas exchange is
ng illness, past medical history, progress of disease and like. With this information it is usually possible to estab-
results of investigations or tests. Often very little is re- lish with some accuracy whether it is safe to transfer the
ceived other than a diagnosis and statement that the patient. It is useful to have a form that can be faxed to the
patient is felt to be t for transfer. In this situation the air referring hospital requesting this information (Figure
AEROMEDICAL REPATRIATION 305
Table 19.5 Equipment and drugs taken on air ambulance
19.5). This should be simple and easy to understand, using extra drugs, equipment, uids or blood products not
internationally recognised terms and translated to the normally carried should be ordered.
relevant language.
Arrival at Hospital
Planning Prior to Repatriation
It is important to establish a rapport with the referring
This involves planning the transfer, brieng crew, check- medical team caring for the patient. They must be given
ing equipment and organising aircraft. The duration of time adequately to hand over the patient, and undue
ground transfer and ight time should be estimated. Any criticism should not be made of any perceived deciencies
306 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
AEROMEDICAL REPATRIATION 307
Table 19.6 Checklist for pretransfer assessment suggested:
Before transfer 1. Administer oxygen and establish monitoring
Sta prepared-fully briefed 2. Secure intravenous access and infuse intravenous
ICU bed available uids
Drugs and equipment checked 3. Insert arterial line under local anaesthesia
Any extra equipment needed 4. Rapid sequence induction, intubation and ventilation
5. Central access
Patient safe to transfer
6. Inotropes if necessary
Respiratory 7. Urinary catheter
Airway secure, is intubation required? 8. Review patient, check arterial blood gases, chest X-ray
Ventilation adequate Pa 9 13 kPa if possible
Sp 9 95% 9. Transfer if stable.
Pa 45 kPa
If invasive procedures are to be performed, this should
Chest drain needed?
Cardiovascular be explained to the referring medical sta as being necess-
Heart rate/blood pressure controlled and stable ary for a safe transfer. Cases have been reported of the
Circulating volume adequate transferring medical sta being forcibly removed from the
Intravenous access established and secure patients side by hospital security sta after having in-
Inotrope infusions moderate and stable itiated an invasive procedure without clear communica-
Renal tion to referring medical sta. It may become necessary to
Catheterised delay the transfer to stabilise and review the patient.
Adequate urine output During transfer the patient will be moved four times
from various beds, trolleys and stretchers. To simplify
Neurological
Glasgow coma scale stable
these movements the patient is placed on a vacuum mat-
No air in skull tress, which is then secured to a scoop stretcher (Figure
Spine stabilised 19.6). The scoop stretcher can now be used to lift the
patient and can also be secured to the ambulance and
Abdominal
aircraft stretchers.
Nasogastric tube free drainage
Major intra-abdominal haemorrhage excluded
Any further investigations or treatment required?
Established and stable on monitors and transport ventilator Ground Transfer to Aircraft
GUIDELINES
20
200 000
No. of enquiries
150 000
100 000
50 000
1980
1964
1966
1968
1970
1972
1974
1976
1978
1982
1984
1986
1988
1990
1992
1994
1996
1998
2000
Figure 20.1 Number of emergency case enquiries received by the National Poisons Information Service (London), 19642000
Not known 2%
Malicious 2% Land 3%
Leak 29%
Figure 20.3 Chemical incidents reported to the Chemical Incident Response Service, by type, 1999
the unknown chemical within minutes. Groups of com- dies resulting in adverse health eects. Some of these
pounds that can be detected include volatile solvents, remedies are potentially harmful if used inappropriately
alcohols, glycol ethers, pesticides and drugs. For toxic without adequate medical supervision. The following
metals, inductively coupled plasma mass spectrometry case report by Seng and Anderson (1999) documents the
(IPC-MS) is the best technique and can screen for elev- concern raised about a recent case.
ated levels of over 30 elements in less than an hour.
No amount of investment in these expensive analytical
instruments will bear fruit without having a team of fully Case History
trained and experienced analytical toxicologists available Recently a 48-year-old woman resident of Harrow
to undertake the assays. By using the experience gained with multiple sclerosis was investigated following
from the work of the two services, the following data are complaints of fatigue, loss of appetite, constipation
provided on poisons and travel. and myalgia. She was found to have severe anae-
From the NPIS, London database: mia caused by lead poisoning. For several weeks
she had been taking various remedies given to her
Traditional and alternative remedies by an Ayurvedic practitioner who had visited her
Exposure to potentially harmful plants at home. These remedies were analysed at the
Use of domestic products MTU laboratory, Guys and St Thomas Hospital
Individual risks from toxicity to the traveller. Trust and two were found to have very high levels
Several cases reported to NPIS, London are not pres- of lead and arsenic. These were Guggul (lead
ented but are mentioned for completeness only. These 29 000 p.p.m.) and Pulsineuron (lead 12 000 p.p.m.
include cases or health concerns occurring after exposure and arsenic 46 000 p.p.m.).
to imported venomous and nonvenomous animals into
the UK (usually found in personal luggage) and use of
pharmaceuticals purchased overseas.
From the CIRS database: Comment. The Department of Health and the Medi-
cines Control Agency (MCA) were notied immediately.
Food-related issues The MCA found that the remedies had been unocially
Water contamination introduced into the country from India by a relative of the
Air contamination practitioner. The extent of the distribution of these two
Pesticide exposure medicines is unknown. The authors found that there was
Travelling incidents. no protocol for rapid dissemination of information for
Where appropriate, additional information from incident such incidents:
reports is included to give a view of the complexity of For contaminated food there is health hazard system in
drawing together data from sources to show risks to the UK which can be triggered rapidly. Within hours of
travellers from poisoning. the issue of a warning, the environmental health de-
partments can be alerted and the suspected products
removed from the shelves.
NPIS, LONDON DATABASE A similar mechanism exists for licensed drugs. Health
Authorities are sent urgent messages via a dedicated
Traditional and Alternative Remedies electronic network (EPINET). The hospitals and gen-
eral practitioners of that district are then sent the mess-
NPIS, London and the MTU has received a series of case age by fax or, to those without fax, by rst-class mail.
reports about the use of traditional and alternative reme- It is worrying that with the increasing use of alternative
314 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
medicines in the UK, there is no established national ain and Ireland (Dauncey, 2000) and its sister publication
mechanism for ensuring the safety of these medicines in German, covering the ora of northern Europe, were
and also no rapid system of warning the public against published in September 2000.
taking those remedies identied as dangerous. An example of one of the frequently found and fre-
quently documented harmful plant is the Brugmansia
Concern must exist as to mechanisms of alert in other
species. A detailed report by Bates (2000b) on this plant
countries, although some, such as Australia, are develop-
has been prepared and can be found on the CD-Rom. The
ing sophisticated networks.
Brugmansia species, also known as angels trumpets,
brugmansia or tree datura, is known for its dramatic,
fragrant hanging ower heads, often up to 1015 cm long.
Lead In summary, poisoning from Brugmansia species causes
anticholinergic eects, with dry mouth, blurred vision
Lead is also toxic by ingestion of contaminated water and dilated pupils, tachycardia, warm and dry skin, re-
from lead pipes, lead-lined tanks and cooking utensils; it duced bowel sounds, urinary retention and hallucina-
is also present in a few Asian cosmetics and as a constitu- tions. Its main toxins are the tropane alkaloids, hyo-
ent or contaminant of traditional medicines from other scyamine (-atropine), atropine (-hyoscyamine) and
developing countries. scopolamine (hyoscine). Deaths have occurred from
Lead and lead salts (Bates, 2000a) are ubiquitous in our abuse of Brugmansia (Mendelson, 1976a, 1976b, 1976c;
environment. Acute clinical eects include commonly McHenry and Hall, 1978), but are rare. Fatalities may be
gastrointestinal colic with nausea, vomiting, anorexia and due to the toxic eects of the alkaloids or from inappro-
abdominal pain, leading to malaise, convulsions, coma, priate behaviour secondary to altered mental state, e.g.
encephalopathy, hepatic and renal damage, anaemia, hy- from drowning (Hall et al., 1977) or exposure. Abuse of
pertension and bradycardia may occur (Khan et al., 1983; Brugmansia appears to occur in periodic epidemics and is
Carton et al., 1987; Parras et al., 1989). particularly prevalent among adolescents and young
Chronic clinical eects from exposure to inorganic lead adults.
are summarised as follows: clinical eects from chronic Two examples of case reports are given to show the
exposures include severe gastrointestinal disturbances toxicity of the plant.
with constipation, abdominal pain tenderness. Other ef-
fects include anaemia, weakness, pallor, anorexia, insom-
nia, renal hypertension and mental fatigue. Rarely there Case History : Accidental Ingestion
may be a bluish lead line on the gums. Lead may also be A 76-year-old male made moon ower wine from
drawn to areas of the skeleton that grow most rapidly and Brugmansia suaveolens and ingested 5 ml to test the
in some cases hypermineralisation of the radius, tibia and nal product. Some days later he drank 1520 ml
femur can be seen on X-ray with the development of over a 1 h period. Shortly afterwards, he experi-
metaphyseal lines (Davies, 1984). Neuromuscular dys- enced loss of coordination of his hands and feet,
function may result in signs of motor weakness and para- followed by sensory loss. Ninety minutes later he
lysis of the extensor muscles of the wrist and ankles. was rushed to hospital with respiratory diculty,
Encephalopathy can occur in patients with previously partial body paralysis and muscle weakness. He
mild symptoms. Eects include vomiting, confusion, was fully conscious on arrival but unable to com-
ataxia, apathy, bizarre behaviour and coma and convul- municate. He left hospital several hours later after
sions due to cerebral oedema. Nephropathy may occur refusing to stay. Analysis of his wine revealed a
and is characterised by albuminuria, glycosuria and renal scopolamine concentration of 29 mg ml\. No
tubular acidosis. Gout has also been reported. atropine was detected. This patient had ingested
Early diagnosis and management are essential to mini- 435580 mg of scopolamine (Smith et al., 1991).
mise harm, with removal from exposure and institution of
control of source. Children are particularly at risk. Infor-
mation and advice are available from local Poisons Infor-
mation Centres. Case History : Intentional Abuse
Two 15-year-old boys were found by police wan-
dering naked and delirious in a eld. One of them
Exposure to Potentially Harmful Plants was holding a ower later identied as Brugmansia
suaveolens. Within 5 min of admission one of them
Many plants are potentially harmful to humans and our developed profound muscular weakness and suf-
knowledge of those found abroad can be limited. Much fered a convulsion which was treated with dia-
work has been undertaken on this aspect of the toxicol- zepam. He had tachycardia, tachypnoeia, pyrexia,
ogy at the MTU and the NPIS, London. This work has dry ushed skin, dry mouth, xed dilated pupils
been undertaken in collaboration with the Royal Botanic and a positive Babinski sign. Muscular weakness
Gardens, Kew. As a result of the current work pro- was so marked that he was unable to stand. He was
gramme the CD-Rom Poisonous Plants and Fungi in Brit- confused, disorientated in time, place and person
POISONS AND TRAVEL 315
and had terrifying visual hallucinations. He was have been reported. These include hypocalaemia and hy-
given physostigmine and improved but continued pomagnesaemia, which may lead to cardiac arrhythmias,
to complain of intermittent hallucinations for 4 and metabolic acidosis (Hathaway et al., 1996). Although
days after treatment and had persistently dilated chronic eects are reported, these are less likely to be of
pupils. He had recent memory loss and diminished concern to families living abroad.
ability to imprint new short-term memories for 1 Early management is the removal of any contaminated
week. Analysis of his urine revealed a mixture of clothing, placing it in double, sealed, clear bags, labelling
alkaloids, with scopolamine predominating. Both it and storing it in a secure area away from patients and
boys had eaten Brugmansia owers before becom- sta. The aected area should be irrigated immediately
ing delirious. The other boy, who was only mildly with copious amounts of water. Specic treatment with
intoxicated, having eaten less of the owers, re- calcium gluconate gel massaged into the aected area for
ported that his friend had eaten 5 or 6 owers (Hall a minimum of 30 min or injected, as appropriate, is re-
et al., 1977; McHenry and Hall, 1978). quired. Information and advice are available from local
Poisons Information Centres.
21
Specic Signs
Diagnosis
Figure 21.7 Schematic representation of the IgG molecule highlighting both F(ab) , Fab and Fc regions
whose venom causes brinogen consumption. On admis- the clinical response does not help in deciding whether
sion to hospital such patients often have incoagulable further antivenom is needed.
blood, measured by the 20 min whole blood clotting test Enzyme immunoassay can be used as a research tool to
(20WBCT; Sano-Martins et al., 1994). Six hours after look at the rate of permanent venom clearance. Circula-
antivenom, the 20WBCT should be repeated. Resolution ting venom and antivenom levels can be assessed quanti-
of coagulation is evidence that the antivenom is eective; tatively on retrospective samples and may help to deter-
if the blood is still nonclotting, then a further dose of mine the optimum dose of a particular antivenom (Figure
antivenom is indicated. As incoagulable blood can reoc- 21.8). The time taken by the antivenom to clear venom
cur after apparent successful treatment with antivenom, permanently from the circulation correlates well with
the whole blood clotting test should be repeated at 6- correction of venom-induced systemic eects, such as the
hourly intervals for the rst 2 days. restoration of blood coagulability.
It is generally more dicult to judge the need for
further antivenom when the predominant problem is
neurotoxicity. In envenoming by some species (e.g. the Antivenom Reactions
Australasian death adder or the Philippine cobra) an
eective antivenom will reverse neurotoxic signs such as Prediction and Prevention
ptosis, external ophthalmoplegia and respiratory para-
lysis. For these species, if there is no improvement in All patients given antivenom treatment should be re-
neuromuscular function, then further doses of antivenom garded as likely to have a reaction, although the incidence
should be given; however, for other species of elapid, of reaction varies widely between dierent antivenoms
especially those with neurotoxins that bind presynapti- (180%; Cardoso et al., 1993). Skin sensitivity tests have
cally, neurotoxic signs are more dicult to reverse even no predictive value for reactions (Warrell, 1983). They
with adequate doses of antivenom. This appears to be should not be used; they delay treatment and can them-
because toxin binding is poorly reversible. In such cases, selves be sensitising. A history of a signicant allergic
VENOMOUS BITES AND STINGS 331
200 adrenaline (epinephrine), especially in patients with co-
6
)
agulopathies. While the ecacy of prophylaxis with ad-
-1
)
-1
0 0
Early Reactions
(a) Av Time after bite (h)
The majority of early antivenom reactions appear to be
due to complement activation, often by the presence of
F(ab) , or Fab, aggregates in the antivenom. The inci-
200 dence of antivenom reactions is closely related to the
quality of purication of antivenoms. Both immediate
)
)
-1
6
-1
Tachypnoea
Excessive salivation
Nausea and vomiting
Lacrimation
Sweating
Abdominal pain
Muscle twitches and spasms
Hypertension
Pulmonary oedema
Cardiac arrhythmias
Hypotension
Respiratory failure
Figure 21.9 Scorpion, with young, showing the terminal seg-
ment or telson, which contains two venom glands. The sting is
always brought forward over the abdomen Treatment
Avoiding Scorpion Sting First aid consists of reassuring the victim, immobilising
the limb and getting the victim to hospital. If local pain is
The traveller in areas where scorpions are common can severe, the area should be inltrated through the punc-
take certain simple precautions to avoid being stung: ture wound with 25 ml 1% lidocaine (lignocaine) hydro-
chloride. Alternatively, opiates may be used, but care
Shoes should be worn when walking in the dark.
must be taken not to cause respiratory depression. Local
Clothes, socks and footwear should be checked careful-
injection of emetine hydrochloride has been used to con-
ly for scorpions by shaking them in the morning before
trol pain, but is not generally recommended because it
dressing.
sometimes causes local necrosis. Specic scorpion anti-
A torch should be used when searching in dark areas
venom is available in many parts of the tropics, although
such as cupboards.
supplies are variable. It is indicated, especially in children,
Storing domestic rubbish near the house should be
for systemic envenoming (ideally, by intravenous infusion
avoided.
as in snake bite, but intramuscular administration may be
Travellers, especially children, should be actively dis-
eective). When antivenom is not available, supportive
couraged from handling scorpions.
treatment is indicated. Prazosin appears to be eective in
treating hypertension and cardiac failure; it may block
the action of scorpion venom peripherally. Nifedipine has
also been used to manage hypertension; opinion is
Clinical Features divided on its ecacy and it should probably only be used
in combination with prazosin. Pulmonary oedema
These are partly dependent on the amount of venom should be treated by conventional means; intravenous
injected relative to the weight of the victim. Pain around vasodilators, such as sodium nitroprusside, may be
the bite site is the commonest feature; this can be severe needed in severe cases. Subcutaneous atropine and intra-
and last for several hours, even 12 days. Local erythema venous calcium gluconate have been advocated to allevi-
and swelling are unusual, but itching and paraesthesia ate systemic symptoms, but evidence of their ecacy is
may be prominent and last for many days. Only a small lacking and they could theoretically be harmful.
proportion of victims develop systemic envenoming; this
is more common in children and may occur within several
minutes of the bite in severe cases. Symptoms and signs
are caused primarily by activation of the autonomic nerv- SPIDER BITES
ous system by venom components, leading to an auton-
omic storm (Table 21.7). As with scorpions and many snakes, the harmfulness of a
In severe envenoming, the cardiovascular manifesta- spider cannot be judged from its appearance: many of the
tions of severe hypertension, acute pulmonary oedema large brown fearsome tarantula-like spiders are harmless
and myocardial failure are particularly prominant. Re- to humans. Perhaps the most dangerous are the black
spiratory failure may also occur, due to pulmonary widow spiders of the genus Latrodectus, which are found
oedema, bronchial hypersecretion and paralysis of respir- in most tropical and subtropical countries including
atory muscles. Both tachycardias and bradycardias are North America, Argentina, the Mediterranean region,
common. Acute pancreatitis has been reported to occur Middle East, southern Russia, Arabia, Ethiopia, southern
in Tityus stings and, in India, necropsy evidence of intra- and eastern Africa, Madagascar, south and Southeast
vascular coagulation has been reported in Buthus stings. Asia and New Zealand. The bodies of these spiders
VENOMOUS BITES AND STINGS 335
Table 21.8 Symptoms and signs of latrodectism
Sweating
Hypersalivation
Rhinitis and lacrimation
Nausea and vomiting
Intense cramp-like muscle pain
Generalised weakness
Tachycardia or badycardia
Hypertension
Breathing diculties
Insomnia and mental agitation
Restlessness and feeling of impending doom
Generalised rash (late)
22
Lens
Cataract, ?presbyopia
Pterygium (Figure 22.3) is the growth of a membrane, Sunlight exposure, diabetes, diarrhoea, alcohol and ciga-
consisting of blood vessels and degenerative bres, that rette smoking are all strongly associated with cataracts.
extends across the cornea. The nasal side of the cornea is
aected more frequently than the temporal. It is more Sunlight exposure. The lens absorbs both UVB and
common with exposure to sunlight and proximity to the UVA light, and with increasing age the lens absorbs more
equator. It is also more common in windy countries, short wave visible spectrum light, i.e. blue light. Experi-
suggesting that mechanical abrasion is a factor in devel- mentally, short bursts of UVB cause cataract but UVA
346 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
the case of glass there is a chemical reaction of conversion
of silver ion to elemental silver. The reaction is reversible
when the glass is returned to the dark. At its most dark,
about 80% of the light is absorbed, and at its most light
about 20% of light is absorbed. It takes longer for the
glass to lighten than it does for it to darken.
Plastic photochromic lenses depend for their property
on a chemical coating that lightens and darkens with
exposure to short wavelength light. The chemical coating
is more easily damaged than that of the glass lenses.
Almost all dark glasses absorb most ultraviolet light.
Even toy sunglasses can absorb over 90%; however, there
is no guarantee. Children should wear British Standard
approved (kite marked) sunglasses. Blue lenses are much
Figure 22.4 Cataract
less eective at absorbing short wavelength light than are
lenses of other colours and should not be used. Dark
sunglasses should be worn; blue tints should be avoided.
and blue light do not. Human lenses are exposed to
chronic low levels of UVA and visible light. Epi-
demiolocal studies have shown a greater instance of cata- AIRCRAFT TRAVEL AND THE EYE
racts with increasing levels of ultraviolet and visible light.
Calculating an individuals exposure to light, however, is The atmosphere of an aircraft is drier and is under lower
complicated and depends on factors such as how much pressure than normal. In addition there are often blowers
time is spent indoors and whether a hat is worn, etc. The above seats that cause increased evaporation of tears.
Maryland waterman study took these factors into con- Travellers often cannot sleep on long haul ights and will
sideration and compared ambient ocular exposure be- attempt to while away time by reading, using their com-
tween dierent shermen and found as much as a 20-fold puters and watching triple movie screenings. When
increase of exposure to ultraviolet and visible light in people are overtired their rate of blinking also decreases.
some shermen compared with others. Increased occur- These conditions can aggravate existing eye problems as
rence of some types of cataract was found in those ex- well as giving rise to symptoms in people who do not
posed to most visible light and ultraviolet light. ordinarily suer from dry eyes.
This study and others have denitely linked exposure
to sunshine to cataracts. This has enormous signicance
both for personal behaviour and for economics world-
wide. Much concern has been raised over the depletion of The Dry Eye
the ozone layer and increasing levels of UVB radiation
and the likely increase of cataracts in future years. A People who have never experienced dry eyes may get
recent study of people living in Chile under the hole in the symptoms. Likely suerers are people with thyroid dis-
ozone layer did not demonstrate changes, but these ease, pregnant women, perimenopausal women, and
would not necessarily be expected as increased levels of rheumatoid arthritis suerers.
cataract would take many years to develop. Blepharitis is a very common condition caused by al-
terations of tear lm. These people suer already from
Protection from sunlight exposure. It is recommended gritty and sensitive red eyes, which may be aggravated by
that young people and children, in particular, wear hats air travel. It is advisable for susceptible travellers to take
and sunglasses during long periods of time in the sun- articial tears with them, which can easily be bought over
shine, especially at the beach and when engaged in water the counter at most good pharmacies. A range of prod-
sports. ucts is available: before travelling they can try dierent
preparations to see which suits them best. Drops should
Dark glasses. On a bright sunny day, the high light be instilled throughout the ight.
levels saturate the retina and reduce overall visual per-
formance, particularly distinguishing between ne levels
of contrast in objects of similar colour and shade. Most Management
sunglasses will absorb 7080% of incident light of all
wavelengths and will improve visual function. When on the aircraft, if eyes become red or gritty it will
Polaroid sunglasses reduce glare from reective light help if the blowers above the seats are turned o. Articial
from the road or water. Wide sunglasses that curve teardrops should be instilled when the eyes feel grittyup
around the eyes reduce glare from the side. to as often as every 15 min. Those with severe dry eye or
Photochromic lenses darken when exposed to short who are sensitive to preservatives can use preservative-
wavelength light; they may be made of glass or plastic. In free drops (also available over the counter).
OPHTHALMIC CONDITIONS IN TRAVELLERS 347
Corneal Abrasion and Recurrences the eye with a clean eye pad and plastic shield if available,
to avoid pressure on the eye. (If a shield is not available
Many people who have had previous corneal scratches or then fashion one out of a polystyrene coee cup, just
abrasion may experience a recurrence. This presents with cutting an oval in it and taping it over the eye, without
a sudden onset of pain, watering and photophobia, exerting any undue pressure.) Do not instil antibiotic
usually on waking or after minor trauma. Treatment is creams and drops as the intraocular contents need pre-
the same as for a corneal abrasion with chloramphenicol servative-free drops and some antibiotics, e.g. gentamicin,
ointment. To prevent the pain recurring, patients are are retinotoxic; however, oral ciprooxacin should be
advised to use ocular lubricants and simple eye ointment given and this has good ocular penetration. If patients
before sleeping. have a blood level, hyphaema, in the eye then it is prob-
ably best to keep them sitting upright in the aircraft seat
to assist resolution, but the position adopted is not very
Contact Lens Wear important.
Cornea taken, with dark goggles that protect from the side as
Gas well.
bubble
in
vitreous
Iris
Hyperbaric Oxygen
Lens
Hyperbaric oxygen used to treat frost bitten limbs often
causes temporary loss of vision due to constriction of
Anterior retinal arterioles. This is reversible.
chamber
Optic nerve
THE RED EYE
(a) Posterior segment The major problems facing a traveller are whether and
how to obtain treatment for a red eye and deciding what
is a serious red eye problem, needing repatriation and
what can be treated with simple measures. Nonophthal-
mologists often shy away from even thinking about how
to resolve red eye problems, but in fact a systematic
approach, a torch, a Snellen chart (or even simpler means
Cornea becomes hazy of checking vision) and uorescein strips will sort out
due to raised pressure
most problems and indicate what needs urgent attention.
Iris bowed
Symptoms
forward
Some symptoms are helpful as they point their way to the
Gas diagnosis; others need clarication to understand precise-
Lens bubble ly what the patient means:
Blurred vision. This may be the result of a reduction of
visual acuity or diplopia or simply a need for a change
Anterior in glasses, or even a bit of mucous that intermittently
chamber
smears across the vision and clears on blinking.
Optic nerve Double vision. This may indicate diplopia, in which case
try to work out if it is present in one eye only or in both
eyes. Often patients will refer to double vision, meaning
(b) Posterior segment
that their vision is blurred or that there is ghosting of
Figure 22.5 (a) The position of the gas bubble in the posterior objects around the edges.
segment following retinal detachment surgery. (b) As the air Haloes. These may refer to glare or dazzle seen in
cabin pressure falls, the air bubble expands within the eye, push- cataracts. Coloured or rainbow haloes suggest corneal
ing the lens forward and compressing the anterior chamber oedema, which is seen in acute angle closure glaucoma,
in which case it will be associated with pain and the
patient should be referred urgently.
routine, as well as jet lag. Blurring of vision can occur Photophobia. This may be due to corneal disease or
during hypoglycaemic attacks. uveitis, or the patient may be referring to the glare of
cataract, or to migraine or meningism.
Pain. This, as opposed to discomfort, suggests a serious
OCULAR CHANGES AT ALTITUDE cause, e.g. corneal disease, uveitis or acute glaucoma.
Urgent referral should be considered.
Examination of the retinas of people climbing on Everest Grittiness. This is usually the result of dry eyes and
expeditions have shown the common occurrence of small, occasionally blepharitis.
ame-shaped haemorrhages in the retina. These are not Foreign body sensation. This may be caused by the
sight threatening. Most visual problems at altitude are presence of an actual foreign body, or by a corneal
related to exposure of the corneas to wind, cold and abrasion, or dry eyes.
ultraviolet light. Wind and cold cause mechanical ab- Sticky discharge. This usually occurs as a result of
rasions and drying of the cornea. Ultraviolet light dam- bacterial infection -conjunctivitis, or occasionally
age causes snow blindness. Extreme precautions against blepharitis and sometimes accompanies an acute aller-
exposure to ultraviolet light and wind damage must be gic reaction.
OPHTHALMIC CONDITIONS IN TRAVELLERS 349
Itchy eyes. These are usually due to allergy, but are
sometimes due to blepharitis.
Examination
Visual Acuity
Subconjunctival Haemorrhage
Eyelids
Spontaneous subconjunctival haemorrhage (Figure 22.6)
Look at the eye and eyelids generally with a torch, look- involves an isolated patch of redness, no discomfort and
ing for lid swelling, red rims and redness of the eyes and normal vision.
for the presence of pus.
Treatment. Reassure the patient that it will go away in a
week or two.
Light Reection from the Eye
Shine a torch into the eye and look at the reection from Acute Bacterial Conjunctivitis
the cornea. If the reection is cloudy or hazy in the
presence of a painful eye, look for a serious cause such as Acute bacterial conjunctivitis involves an uncomfortable
corneal ulcer or acute glaucoma. but not painful sticky discharge, especially in the morn-
ing, with redness all over the conjunctiva and a normal
visual acuity. It is usually bilateral.
Redness Treatment. Clean the lids three times a day and use
drops of chloramphenicol 2-hourly for the rst day, then
Redness all over the conjunctiva associated with severe four times a day for 4 days. If it does not respond to
pain may be due to acute glaucoma. Redness associated chloramphenicol consider another diagnosis, as it is un-
with mild pain or discomfort may be due to conjuncti- likely to be bacterial conjunctivitis. Other useful anti-
vitis. Redness around the cornea only may be the result of biotics are fucidic acid, ooxacin and gentamicin.
corneal disease or uveitis. A patch of redness may be
episcleritis, scleritis or subconjunctival haemorrhage.
Chlamydial Conjunctivitis
Scleritis
Scleritis is rare. It produces a severely painful and photo- Figure 22.8 Chalazion
phobic eye, usually unilateral and usually with a history
of rheumatoid arthritis or other autoimmune condition.
tion. It is rare for travellers to grow a pterygium that
Examination. There should be a characteristic patch of extends across the visual axis.
redness and swelling about 6 mm behind the cornea, with
possible reduced vision. Treatment. Surgery is undertaken for cosmetic reasons.
There is a high recurrence rate. The currently favoured
Treatment. Refer urgently. surgical technique involves a free conjunctival graft.
Treatment. Regular, from 6-hourly to 1-hourly, instilla- Treatment. Hot compresses applied with a annel for
tion of articial teardrops, e.g. hypromellose, as required, 5 min twice a day sometimes help. If there is no resolution
depending on the severity of the symptoms. Other useful within 1 week refer routinely.
drops are Liquilm Tears, Viscotears and simple eye
ointment.
Stye
in 50% of cases. If the side of the nose is aected, then the Anterior Uveitis (acute iritis)
eye is usually aected because both are supplied by the
nasocillary branch of the ophthalmic division. If the eye is Anterior uveitis (Figure 22.17) involves (usually) unilat-
red, it is aected. There may be blepharitis, conjunctivitis, eral redness, pain, photophobia, watering and a possible
corneal ulcer, corneal anaesthesia, uveitis and other rarer history of ankylosing spondylitis, sarcoidosis, the Reiter
manifestations. Refer urgently if the eye is aected or the syndrome, inammatory bowel disease and previous at-
patient is concerned. tacks of uveitis.
OPHTHALMIC CONDITIONS IN TRAVELLERS 353
Figure 22.21 Corneal abrasion stained with uorescein in a Figure 22.22 Fungal corneal ulcer
child
Major Trauma
Penetrating Injuries
Hyphaema
Retention of Intraocular Foreign Body
Hyphaema (Figure 22.24) is a bleed into the anterior
Retention of an intraocular foreign body (Figure 22.23) chamber of the eye. Sometimes in a severe bleed all of the
occurs with high-velocity missiles, such as in drilling, anterior chamber lls with blood. This will soon settle
hammering, etc. Metal foreign bodies are toxic if retained down if the patient is kept in an upright position, and a
in the eye, quickly setting up a severe inammation, even blood level will form.
if sterile. It is important to have a high index of suspicion The blood originates usually from a tear in the iris or
as they can be easily missed. It is worthwhile to X-ray for iris root. The hyphaema usually settles quickly in 4872 h.
intraocular foreign bodies, but this will not always detect The problems associated with hyphaema are those of a
them. Glass does not always show up on X-ray. The best short-term rise in ocular pressure and long-term risk of
way of ruling out a foreign body is by history taking, glaucoma, due to damage to the drainage mechanism of
always recording Snellen visual acuity and conducting a the eye if the injury was at the iris root. There is an
OPHTHALMIC CONDITIONS IN TRAVELLERS 357
increased risk of development of cataract in those who
have had hyphaema.
Signs and symptoms of blow-out fractures. A blow-out and undisplaced fractures of the zygoma are stable and
fracture is diagnosed on history and examination; X-rays can be treated conservatively. Fractures of the roof of the
do not always easily show it. Patients who have vertical orbit are more complex and must be referred to a neuro-
diplopia following injury almost invariably have a blow- surgical unit. There is the risk of meningitis due to leak of
out fracture. Paraesthesia of the cheek below the eye cerebrospinal uid, for which broad-spectrum antibiotics
suggests damage to the infraorbital part of the maxillary are necessary. If a patient complains of a runny nose,
nerve as it travels through the oor of the orbit. Check eye check the uid for glucose using urinalysis sticks. The
movements using a torch. Watch the excursions of the eye presence of glucose indicates that the uid is cerebro-
in the vertical plane. You will notice that there is reduc- spinal.
tion in upgaze in the aected eye due to tethering of the
tissues around the inferior rectus.
Ask for an X-ray to show the oor of the orbit and Damage to the Adnexal Tissues: Eyelids, Muscles
maxillary sinuses. Usually blood can be seen in the an- and Canalicular Structures
trum as a level. But this is not always the case, sometimes
there is just entrapment of muscle; this is recognised by Road trac accidents, sports injuries and dog bites are
the teardrop sign. the commonest causes of ocular adnexal tissue injury. Lid
If the patient blows the nose, surgical emphysema oc- lacerations cause cosmetic and functional problems.
curs due to air from the nose entering the space beneath
the conjunctiva or lid (Figure 22.28). This is benign but Assessment. When obvious damage has occurred to
broad-spectrum systemic antibiotics are advised. these areas, be aware that there may be globe perforation.
(Check vision and look for iris prolapse.) If these can be
Management of blow-out fracture. Broad-spectrum ruled out, then proceed to assess the degree of damage.
antibiotics are given to prevent spread of infection from Full-thickness lacerations through the lid should be refer-
sinuses to orbit. Pain relief is not usually necessary. Refer- red to an ophthalmologist for repair. Minor skin lacer-
ral for further assessment of fracture is to both an oph- ations could be closed with sterile strips. Look for dam-
thalmologist and a maxillary facial unit (or in some units age to the medial side of the lower lid to see if canalicular
ENT). The best time and type of repair depends on the damage has occurred, as this may result in a watery eye
nature of the injury. Delays result in brosis, and out- (Figure 22.29). Check ocular movement for assessment of
come can be compromised. Again, repatriation is best, muscle damage, asking for symptoms of diplopia.
ensuring that the patient knows that delays beyond 10
days are best avoided. Management. Full-thickness lid lacerations should be
repaired by an experienced ophthalmologist. Poor sur-
Other orbital fractures. Fractures of the rim of the orbit gery can result in ectropion, entropion, ptosis and
OPHTHALMIC CONDITIONS IN TRAVELLERS 359
Figure 22.29 Lid laceration through lower canaliculusrisk of Figure 22.30 Chloroquine maculopathy
watering eye
If given the choice, it is better to keep the preparations
misalignment. If travelling abroad, surgery can be de- at too cold rather than too hot a temperature, as the
layed for up to 24 h if adequate facilities cannot be active ingredient is likely to remain stable, even if the
reached. The wounds should be covered with sterile carrier becomes denatured. On return to normal tem-
moistened dressings and the patient given a tetanus perature the bottle should be shaken thoroughly, par-
booster and broad-spectrum antibiotic. Reapposition of ticularly if the preparation is in a suspension, such as
full-thickness lid lacerations should be accurate and per- dexamethasone.
formed in layers with appropriate ne suture such as 6-0 All ocular preparations should be discarded 1 month
Prolene or silk to the skin and 5-0 absorbable to the tarsal after opening because the preservative becomes un-
plate and muscle layers. Care should be taken to realign stable. At higher temperatures the preservatives may
the lashes. Damage to the levator aponeurosis, which become unstable earlier than 1 month and consider-
attaches to the levator muscle of the lid, will cause a ation should be given to discarding the preparation
ptosis. Repair of this is very specialised, but it can be done after 2 weeks.
as a secondary procedure with reasonable success. Drops can be made up from intravenous preparations
Assessment of trauma around the eye requires examin- of the drug, given suitable dilutions mixed with normal
ation of the lacrimal system. Tears drain from the con- saline. These preparations, of course, are not preserved,
junctival sac via the lacrimal puncta into the canaliculus. but if kept refrigerated can safely be used for a few days.
If there is damage to this area then there is a 50% chance
of a chronic watery eye. Repair, even in the best hands, is
dicult.
Ocular Toxicity from Systemic Medication
Chloroquine/Hydroxychloroquine
DRUGS AND TOXINS
Retinal toxicity from chloroquine (Figure 22.30) used for
Ocular Preparations malarial prophylaxis at the recommended dosage does
not occur, even in those people such as pilots on routes to
Stability at Extremes of Temperature malaria-infested areas who are on continuous prophylax-
is. Massive overmedication with chloroquine by self-ad-
There is surprisingly little information about the stability ministration, when patients are feeling unwell and think-
of dierent ocular preparations at extremes of tempera- ing they have a recurrence of malaria, has resulted in
ture; however, the following general statements can be visual loss due to retinal toxicity. Hydroxychloroquine is
made: less toxic than chloroquine and is usually used for treat-
Eye drops should ideally be stored between 2 and 6 C. ment of rheumatoid arthritis and skin diseases. Treat-
Almost all preparations are stable up to 25 C. ment is at a much higher dosage than for malaria prophy-
The more simple the preparation, the more likely it is to laxis.
be stable at higher temperatures. For example, simple
antibiotics such as chloramphenicol or gentamicin are Screening of patients. Patients taking chloroquine for
more likely to be stable than those with a complex malaria prophylaxis must be advised not to take more
viscous carrier. than the prescribed amount and to seek expert attention
Ointments are more likely than drops to be stable at a if a malaria attack is suspected. Those taking high levels
higher temperature. of hydroxychloroquine for rheumatoid arthritis or
360 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
associated conditions will be on a screening regimen for a result of a closing of the drainage angle in the eye. On
retinal toxicity. Only those taking over 6 mg kg\ day\ examination the pupil will be nonreactive to light and
are considered to be at risk (usually 400 mg: two tablets a oval-shaped and the cornea hazy. Chronic glaucoma is
day or more in a person weighing 70 kg). symptomless. If in doubt check with an ophthalmologist.
The current recommendations of the Royal College of Common drugs that induce angle closure are antihista-
Ophthalmologists are that the prescriber should check mines (used in travel sickness), anticholingerics, tricyclic
the visual acuity and central eld with an Amsler chart if antidepressants and illegal drugs such as cocaine.
the patient is taking under the at-risk dose. An ophthal- Most people under the age of 60 are unlikely to develop
mologist should check those taking more than angle closure unless very hypermetropic. The risk in-
6 mg kg\ day\, by central elds, visual acuity and ret- creases with age. Angle closure glaucoma is more
inal examination every 6 months. common in Orientals (particularly people from Mon-
golia) and other Asians.
Acute glaucoma is an emergency and needs treatment
Ethambutol to be instituted within hours. It is a diagnosis that should
not be missed.
Ethambutol is used to treat drug-resistant tuberculosis, in
combination with rifampicin and isoniazid. Some travel-
lers returning from abroad having contracted TB may be Eye Medications: Side-eects
on ethambutol. The ocular side-eects of optic neuro-
pathy leading to irreversible loss of vision occur in a small Many patients forget to mention to their physician that
number of patients. The eects are idiosyncratic and topical eye medications are being used. The following
dose-related, 1% of patients on 15 mg kg\ develop optic drugs prescribed by ophthalmologists could have poten-
neuropathy, and this is more likely if there is poor renal tially serious side-eects or exacerbate existing health
function. conditions.
There are reports that Ethambutol toxicity is more
common in alcoholics and diabetics. Beta blockers, e.g. timolol, carteolol, betaxolol. These
drugs may exacerbate asthma and chronic obstructive
Screening of Patients. Patients need examination for airways disease and cause heart block. Some are sup-
baseline visual acuity, colour vision, check of pupil reac- posed to be cardioselective, but can still cause problems.
tions (for relative aerent defects) and ophthalmoscopy. If in doubt stop all drops. There is always a substitute
Sometimes baseline visual elds to a red target are per- possible and glaucoma is a slow process. It should not
formed. These need to be documented in notes so that if harm the patient to stop the drops for 23 weeks until an
side-eects are experienced by a patient the ophthalmol- ophthalmologist can be seen.
ogist can be sure that the eects are due to treatment and
not due to pre-existing pathology. The most important Pilocarpine. Pilocarpine is a treatment for glaucoma. It
part of the consultation is for the prescribing doctor to may result in headaches and blurred vision. The pupils
make the patient aware of the potential ocular eect of are constricted, which may cause problems in the assess-
the drug and when to stop the drug and seek advice. ment of head injury.
Follow-up by the ophthalmologist should be every 3
months if the patient remains on ethambutol. Chloramphenicol. Chloramphenicol is associated with
the rare idosyncratic side-eect of bone marrow sup-
pression, resulting in acute agranulocytosis. It is, how-
Acute Closed Angle Glaucoma Induced by Drugs ever, an excellent antibiotic with good stability and a
Likely to be Used by a Traveller broad spectrum of activity and good ocular penetration.
Any drug that causes the pupil to dilate could result in the Acetazolamide. Acetazolamide is a treatment for glau-
development of acute glaucoma (see Figure 22.18), but coma. Patients are rarely on this treatment for long per-
usually only in susceptible people. Patients who are lon- iods of time, as it has quite severe side-eects. The worst
gsighted (hypermetropic) and elderly are at greater risk of of these is StevensJohnson syndrome. Tingling of n-
angle closure. Most preparations carry warnings about gers, tiredness and depression are common. Renal stones
the use of a drug if the patient suers from glaucoma. and renal failure can also occur. Patients dehydrate as
These refer to acute closed angle glaucoma rather than acetazolamide is a diuretic. It is useful in treatment of
primary open angle glaucoma. altitude sickness.
Most patients who know they are at risk will have had
laser iridotomies which prevent an attack; such patients
are therefore no longer at risk. The warnings are useless Alcohol Poisoning and Reduction in Vision
to those who do not know they are at risk because the
condition is asymptomatic until the rst attack. Acute Travellers may be induced to imbibe some unusual alco-
glaucoma is characterised by pain and hazy vision and is holic drinks when on their journeys. This should be
OPHTHALMIC CONDITIONS IN TRAVELLERS 361
avoided unless the contents and ingredients of these SPECIFIC INFECTIONS AFFECTING THE
drinks can be ascertained. Travellers should avoid home- EYES IN TRAVELLERS
brewed alcoholic beverages, which could contain poten-
tially toxic substances, particularly methanol. Methanol Ocular symptoms following travel are often a cause for
is toxic to the optic nerve. great concern for both traveller and clinician alike. Some
Alcoholics develop vitamin B deciency due to poor of the more esoteric and visually devastating ocular dis-
diet; and smoking of high-tar cigarettes and pipe tobacco ease may well have been seen by travellers when visiting
can result in optic neuropathy (tobaccoalcohol am- far-o countries such as India and Africa and South
blyopia). This is a slow process and reversible in the early America. Travellers may then become anxious about
stages with hydroxocobalamin injections and a change of whether they could have caught these diseases.
habit.
Bee stings around the ocular tissue are common but Skin infestation always accompanies eye disease, with
rarely serious. Incidents of multiple stings from African pruritus, hyperkeratosis, depigmentation or hyperpig-
bees have been reported. Stings on the cornea have also mentation, as well as nodules. Skin snips are used
been reported. commonly to make the diagnosis.
Early stages of the ocular infection may not be ob-
served without a slit lamp to see the microlariae swim-
Management. Reassure the patient. The eye and lid may ming in the anterior chamber or in the cornea. The pa-
be grossly swollen and look alarming. This will resolve. tient is asked to bend over to increase the load of
Remove the sting and give antihistamines if there is a microlariae in the anterior chamber. When the micro-
large amount of swelling. A cold compress may also help. lariae die they become more obvious due to inamma-
If corneal sting has occurred, a whitish opacity will be tory reactions. The cornea can take on the appearance of
seen on the normally clear cornea associated with chemo- cracked ice, or have snowake opacities. The retina and
sis and congestion. Refer to an ophthalmologist for treat- optic nerve can also be aected, with mottling of the
ment with steroid drops. Cellulitis due to infection can retina and brosis. Optic nerve inammation causes
follow a bee sting. swelling and, in the later course of the disease, atrophy.
362 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Reducing Risk creased hygienic living conditions and disposal of waste.
In the developing world it is usually spread by eye-seek-
The traveller need not worry unnecessarily about con- ing ies that feed o the ocular discharge. It is a sad fact
tracting the disease unless going to endemic regions for a that the blinding disease is entirely preventable by simple
period of some years. Obviously it would be wise always hygiene measures, yet is still aecting millions. The infec-
to avoid being bitten by insects in areas of the world tion rate could easily be reduced by educating mothers to
where insect vectors are common; this can be achieved by keep eyes and hands clean, and the frequent removal of
the use of insect repellent, covering bare skin and sleeping waste from around living quarters, which could reduce
under nets. the number of ies that also carry the infection to the
Treatment should be managed by experienced clini- faces of small children. Regular treatment of infection as it
cians because violent reaction to drug treatments is occurs, with a tube of cheap antibiotic such as tetracyc-
common, as millions of parasites are killed simultaneous- line, could reduce reinfection and therefore prevent future
ly, often leading to more damage, such as optic atrophy. long-term damage.
Trachoma
MMMM
Section VI
23
Is DEET safe for use in young children? Millions of children who lick their hands and arms. The concentra-
children use DEET each year, and there have been just 13 tion of DEET relates to the duration of eective protec-
reports of adverse outcomes in children who were using tion but not to the risk of toxicity. Thus, DEET use by
DEET (Fischer and Christenson, 1998). One 6-year-old children can be encouraged with attention paid to using it
child with previously undiagnosed ornithine carbamoyl only on the few areas of skin that are exposed to insects.
transferase deciency had a fatal Reye-like syndrome Personal protective measures are critically important,
(Heick et al., 1980). Just before becoming encepha- but they are not universally practiced or completely pro-
lopathic, she had used 15% DEET on at least 10 occa- tective. Thus, chemoprophylaxis should be advised for
sions over extensive areas of skin. An 8-year-old girl had travelers to areas where malaria is endemic. Protective
seizures and encephalopathy after using copious immunity to malaria develops slowly over 25 years in
amounts of DEET (unspecied concentration) and re- children, so prophylactic medications can be necessary
covered after supportive care (Roland et al., 1985). Simi- for years despite ongoing exposure to malaria parasites.
larly, a 5-year-old boy with underlying developmental
delay seized after a total body application of 95% DEET
followed by a repeat application of another DEET-con- Malaria Chemoprophylaxis and Treatment
taining formulation (Lipscomb et al., 1992). In another
case, an 18-month-old girl used 20% DEET daily for 3 The geography of medication resistance by Plasmodium
months and was often noted to lick her skin following parasites is not age-dependent. Nonetheless, the delivery
application of the DEET; she then developed ataxia (Ed- of medication to children diers from that to adults.
wards and Johnson, 1987). In a report of two children Dosing details are noted in Table 23.1.
from Africa, a 5-year-old girl developed fatal encepha- Meoquine seems fully eective and safe in children.
lopathy and seizures after using 10% DEET nightly for 3 Despite hesitation during the earlier part of the past
months, and an 18-month-old girl developed encepha- decade to use meoquine in children, no signicant toxic
lopathy a day after incidentally using an unknown eects were reported. Its use is now accepted for children
amount of DEET (Zadiko, 1979). Details of exposure to of any age. As in adults, meoquine would not be given
DEET are less clear in the other reported cases (Osimitz routinely to a child with a history of cardiac dysrhythmia
and Murphy, 1997). or with a known psychiatric disorder. Attention decit
Studies of the percutaneous absorption of DEET have disorder and other behavioral problems have not been
not been undertaken in children. Nonetheless, studies associated with meoquine-induced toxicity. Children
with similar compounds suggest that absorption is in- with active seizure disorders, however, should not take
creased during the rst few weeks of life but that children meoquine. Since some children with simple febrile seiz-
otherwise do not have greater absorption than adults ures go on to develop recurrent epileptiform seizures, it is
(Osimitz and Murphy, 1997). probably best to be judicious about meoquine use in
Clearly, DEET has been associated very rarely with children less than 6 years old with a history of a previous
tragic outcomes, but there is no clear evidence of causal- febrile convulsion. However, since meoquine is by far
ity. In cases where details were available, the exposure the best prophylactic agent available for some areas, indi-
seemed to be either oral or over extensive skin surfaces in vidualized decisions should be made, weighing the known
frequent applications. How should travel medicine prac- risk of severe malaria with the unknown but probably
titioners interpret these data? Clearly, DEET is eective small risk of meoquine toxicity in a particular child.
and is safely used in millions of children each year. It Meoquine, however, does not taste good, and it is not
spares the inconvenience of insect bites and the risk of yet available in a liquid form. Weekly doses can be
insect-borne disease. The use of DEET should be encour- weighed and placed by a pharmacist into capsules; cap-
aged, but it should be used prudently. It should only be sules can then be opened each week to give the appropri-
applied on exposed skin, and most of the skin should be ate dose of powdered meoquine to the child. Alterna-
covered with clothes. DEET, travel medicine practi- tively, pills can be cut in quarters with doses rounded o
tioners should remind parents, should not be ingested to the nearest quarter pill to be given weekly. Anecdotal
orally. Thus, special attention should be placed on young reports suggest that the taste of meoquine is better
TRAVELING WITH CHILDREN 369
tolerated when mixed with chocolate or cola-containing single treatment dose or in two doses (15 mg kg\ rst,
soft drinks. then 10 mg kg\) separated by 6 h. Artemesin derivatives
Doxycycline is associated with discoloration of devel- would always be used in combination with a longer-
oping teeth and might adversely aect the growth of long acting antimalarial.
bones. It is, thus, generally not used in children less than 8
years of age.
Chloroquine is completely safe in children and is eec- Malaria Vaccines
tive against most of the malaria present in a few parts of
the world. Even with long-term weekly use, toxicity has The initial optimism for the usefulness of a South Ameri-
not been noted. Nonetheless, ocular damage has been can malaria vaccine has waned, as studies in other popu-
reported with large doses of chloroquine used over shor- lations showed very limited ecacy in children. New
ter periods of time. Thus, chloroquine use in a child for DNA vaccines oering a combination of antigens in a
more than 5 consecutive years should be undertaken only prime-boost technique now hold great promise. Vaccines
in careful consultation with an ophthalmologist who is could be ready for clinical trials in children during the
following the condition of the childs retinas. As in adults, rst few years of the twenty-rst century.
other rare but reversible adverse eects are possible. As
with meoquine, most children do not enjoy the taste of
chloroquine, but attempts to hide the taste may help. DIARRHEA
The combination of weekly chloroquine with daily
proguanil is also safe for children. Compliance is always Travelers diarrhea occurs in children as in adults. Treat-
an issue with children, so careful attention to regular daily ment, however, varies according to the age of the traveler.
administration is important.
The combination of atovaquone and proguanil has
Incidence
also been studied in children. This has recently been
recommended for use and its seems safe and eective for
A retrospective survey done in the late 1980s provided
children (Lell et al., 1998).
age-specic epidemiology of travelers diarrhea (Pitzinger
The combination of sulfadoxine and pyrimethamine,
et al., 1991). The survey involved 363 children who had
like other sulfa-containing products, carries about a 1 in
recently traveled to tropical developing areas of the world
5000 risk of life-threatening StevensJohnson syndrome.
after receiving pretravel advice from an established Swiss
Thus, this combination is not routinely used in children.
travel clinic. Diarrhea occurred in 40% of travelers aged
The artemesinin derivatives are short-acting anti-
zero to 2 years, in 9% of children from 3 to 6 years, in
malarials developed from a plant originally used in
22% of children 714 years of age, and in 36% of travelers
China. Even for malaria treatment, they are eective only
1520 years old. While the numbers of children included
as short-term agents so are not used alone. Similarly, they
in each age group were not large, it seems clear that the
are not eective as prophylactic agents.
incidence of travelers diarrhea is similar in children and
There is increasing interest in using primaquine as an
adults (Steen et al., 1999) but that the youngest children
agent of causal prophylaxis. As in adults, this product
carry the highest risk. In addition, infants seem to have
should not be used in children until glucose-6-phosphate
more severe diarrheal illness and had diarrhea for longer
dehydrogenase (G6PD) deciency is ruled out. Careful
than the other travelers (Pitzinger et al., 1991).
studies of the best dosing for long-term prophylaxis have
not yet been completed.
Presumptive treatment is sometimes recommended for Etiology
adults traveling beyond the reach of accessible medical
care. This sort of prediagnosis use of malaria treatment is There is no evidence that the microbiological causes of
not generally advised for traveling children due to the risk travelers diarrhea dier between adults and children.
of overtreatment of nonmalarial fevers as well as the risk Thus, the most common germ causing diarrhea in
of staying away from medical care when a child has travelers is enterotoxigenic Escherichia coli. With varying
malaria and could deteriorate rapidly. rates in diering regions of the world, Shigella,
When malaria treatment is needed in a traveler, the Salmonella, and Campylobacter are also important patho-
medication selection is the same as in adults. Chloroquine gens for travelers (Paredes et al., 2000). Other bacterial
is used orally with a total cure of 25 mg kg\ (10 mg kg\ causes occur less frequently, as do parasites and viruses.
once, 5 mg kg\ 8 h later, 5 mg kg\ 24 and 48 h after the In about a third of cases of travelers diarrhea, no
initial dose). Parenteral chloroquine has a narrow thera- pathogenic agent is identied (Peltola and Gorbach,
peutic window and is only used with intensive care unit 1997).
levels of monitoring. Quinine may be used in a dose of
10 mg kg\ three times daily for 7 days. The associated
use of tetracyclines for 1 week in treating life-threatening Prevention
infections is acceptable despite the slight risk of rapid
tooth staining. Meoquine is used either in a 15 mg kg\ The microbes causing travelers diarrhea typically follow
370 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
oral contamination. This is usually blamed on and eective when used for the treatment of travelers
contaminated food and water. The higher incidence of diarrhea in teenagers.
diarrhea in young children (Pitzinger et al., 1991), how- In adult travelers, the decision to initiate presumptive
ever, suggests that hand-to-mouth contamination is a antibiotic therapy is made, in part, based on the social
likely source of microbes. For children, preventive eorts impact of diarrhea on the travelers schedule and plans.
should include not only food and water hygiene but also Children usually have less time-sensitive itineraries, and
handwashing, promotion of clean living spaces, and the therapy is often limited to oral hydration for simple (non-
avoidance of manual contact with germ-laden materials. dysenteric) travelers diarrhea.
Paciers and bottles should be handled only with clean When judged necessary, however, traveling children
hands as they are prepared for children. Special attention may carry antibiotics to use presumptively in the event of
to handwashing around diaper changes is also important. severe travelers diarrhea. Of course, diarrheal illness with
Primum non nocere (First, do no harm) is a fundamental bloody stool or with fever should prompt the family to
principle guiding medical care. While it would be nice to seek medical attention. In the United States, ciproox-
prevent travelers diarrhea in children, potential preven- acin (10 mg kg\ twice daily) is not generally used for
tive medications carry signicant risks for adverse eects. children due to concerns about musculoskeletal toxicity.
Bismuth subsalicylate is usually avoided in asymptomatic In fact, this medication seems safe in children (Schaad et
children due to the association of salicylates with Reye al., 1995; Jick, 1997), but both the benet and the poten-
syndrome. Similarly, sulfa-containing antibiotics have tial risk would need to be considered in making individ-
been linked occasionally to StevensJohnson syndrome, ual decisions for prepubertal children. Co-trimoxazole
and tetracyclines can stain teeth. Fluoroquinolone anti- (dose calculated based on 5 mg of the trimethoprim com-
biotics carry a theoretical risk of damaging growing ponent per kilogram of body weight twice daily for 5
joints. Although readily used for ill children, these anti- days) is safe in children and may readily be used for
biotics are usually avoided in asymptomatic traveling travelers diarrhea; in many areas of the world, however,
children. the microorganisms causing diarrhea are increasingly re-
Prevention of travelers diarrhea in children is thus sistant to this product. Azithromycin has shown good
based on careful food, water, and hand hygiene. Cleanli- ecacy against some of the etiologic agents of travelers
ness is particularly important in young children who put diarrhea (Khan et al., 1997) and may be used orally in a
their hands and other objects frequently in their mouths. dose of 10 mg kg\ once followed by 5 mg kg\ on each
of 4 successive days. Though not studied in children with
travelers diarrhea, shorter courses of antibiotic therapy
Treatment are likely to be equally eective.
24
Choosing a Method
HIV Prophylaxis
The advantages and disadvantages of particular methods
Women should be educated about the availability of are reviewed in Table 24.3. Considerations when choos-
postexposure HIV prophylaxis for high-risk sexual expo- ing a contraceptive method should include length of
sures or sexual assault. If travel is to a remote area, the travel, ease of use considering the itinerary and style of
initial 2 weeks of treatment should be included in the travel (backpacking versus luxury hotels), possible envi-
travelers medical kit. Travelers should check with the ronmental eects on the reliability of the method, such as
Centers for Communicable Disease or similar source for extreme heat, immersion in water, etc., and accessibility.
the latest information on postexposure prophylaxis rec- A woman traveler should be instructed about the basic
ommendations. Home testing kits for HIV are available types of contraception and how they work (Table 24.3).
in many countries. The sensitivity and sensitivity of these This information will be helpful if she is trying to choose a
tests is not known and should be reviewed with a reliable new method in another country. For a more indepth
source (Pinkerton et al., 1998; Gerberding and Katz, review the reader is referred to one of the many excellent
1999). texts available (Hatcher et al., 1998; Guillebaud, 1999).
WOMENS HEALTH AND TRAVEL 385
Table 24.2 Resources on reproductive options
Resource Notes
Center for Reproductive Law and Policy Web site provides a list of countries where abortion is
http://www.crlp.org/abortion1icpd.html legal (and what restrictions are placed on abortion)
Contraceptive Research and Development (CONRAD) Program Primary objective is the development of new or improved
http://www.conrad.org/general.html contraceptives and methods for prevention of the
transmission of sexually transmitted infections that are
safe, eective, acceptable, and suitable for use in developed
and developing countries
Links to sites for general contraceptive information
International Planned Parenthood Federation (IPPF) Regents College
www.ippf.org Inner Circle
Regents Park
London W1 4NS, UK
Tel ; 44 0207 487 7900
Fax ; 44 0207 487 7950
E-mail info@ippf.org
Marie Stopes International Web site provides country information on the availability
http://www.mariestopes.org.uk/abortion.html of emergency contraception, contraceptive methods and
abortion, with help line numbers for advice and services
related to family planning and sexual health
Oce of Population Research Web site with information on emergency contraception
Emergency Contraception Click on country of destination to see options that are
http://ec.princeton.edu/worldwide/default.asp available in the country
Click on search EC type to nd out in which countries a
particular contraceptive is available
PATH (Program for Appropriate Technology in Health) Health information on emergency contraception for
Consortium for Emergency Contraception providers and patients. Available in many dierent
http://www.path.org/cec.htm languages
http://path.org/ PATH has been designated the WHO collaborating
center on research in human reproduction
WHO Gender and Health Technical Paper Excellent paper on the importance of gender with regards
http://www.who.int/frh-whd/GandH/GHreport/gendertech.htm to all aspects of health including tropical disease
Women should be advised to take adequate supplies of If a woman misses a pill she should take it as soon as she
their oral contraceptives with them, as the same formula- remembers and then take the next one at it its usual time.
tion may not be available in the country of destination. If she misses two or more pills and has intercourse she
An empty package should be retained in case the traveler should consider emergency contraception measures and/
needs help from a local pharmacist to nd an alternative. or using a back-up method for the rest of the month.
Many low-income countries have higher dose formula-
tions that are eective in preventing pregnancy but may
result in a higher incidence of side-eects. Pill Absorption
To maintain eectiveness of the oral contraceptive
method, women should be reminded about the factors Another issue is problems with pill absorption due to
outlined below. illness. Nausea, vomiting and/or diarrhea may decrease
absorption of the pill. If vomiting occurs within 3 h of
taking a pill, another should be taken. If a woman experi-
Changes in Time Zone ences nausea and vomiting or diarrhea and cannot keep a
replacement down (equivalent to missing a pill) she
Many of the low-dose formulations are time sensitive, so should use a back-up method for the rest of the month.
forgetting to take a pill because of time zone changes or a Elimination of the pill-free interval and starting the next
change in schedule could result in ovulation. It is advised package right away can also be considered if the missed
that a woman carry a special wristwatch alarm, dedicated pill was less than 7 days from the end of the package. For
to oral contraceptive dosing control for every 24 h. This is continued nausea and vomiting some clinicians recom-
important for both the low-dose combined and proges- mend inserting the oral contraceptive pill into the vagina
tin-only pills. for absorption. New contraceptives in the form of vaginal
386 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Table 24.3a Currently available contraceptive choices for travel
Barrier
Spermicides: creams, jellies, Surface-active agents that Chronic exposure may cause Easy to carry
foams, melting suppositories, damage the cell membranes of mucosal injury that increases risk Readily available
sponges, foaming tablets, lms sperm, bacteria and viruses of HIV transmission Bring own supplies
Female controlled
Cap Mechanical barrier Needs tting by clinician Easy to carry
Requires spermacide Can use for up to 48 h Rubber may deteriorate in heat
Needs practice to use and humidity
Sponge Polyurethane sponge One size Easy to carry, use
containing nonoxynol-9 Over the counter Use bottled water for
Protects for 24 h no matter how Moisten with water prior to use moistening in countries with
many times intercourse occurs and insert questionable water supply
Leave in place for 6 h after Loop for removal
intercourse Do not wear longer than 2430 h
due to risk of toxic shock
syndrome
Diaphragm Domed-shaped rubber cup Requires tting by clinician Carry in climate-resistant case
Must use with spermacide Insert extra spermacide with Spermacide may not be
Protection for 6 h repeated intercourse available in developing
After use leave in for 6 h countries
Condom
Female (Reality) Polyurethane pouch Can be inserted 8 h before Female controlled
Spermicide not required intercourse Bring supply from home
One use only Does not deteriorate in heat
and humidity
Male Latex Possible allergy Male controlled
Do not use oil-based lubricants Quality varies country to
Polyurethane Thinner/stronger, more resistant country
to deterioration Bring supply from home of
Can use oil-based lubricants latex and polyurethane types
Lambskin/natural Small pores permit passages of May break down in heat and
viruses-Hep B, HSV, HIV humidity. Carry in special case
Use only for contraception Use emergency contraception if
Brands and materials dier in condom breaks or slips and no
quality back-up method in place
(OCP/diaphragm/sponge/etc.)
Store in cool, dry place
Hormonal
Pills
Progestin only Inhibition of ovulation (may Use if can not take oestrogen Need to be prepared for
occasionally ovulate) Take same type of pill every day: irregular bleeding
Thickened and suppressed no pill-free week Must take pill at same time
cervical mucus Decreased menstrual cramps, less every dayset alarm watch to
Suppression of midcycle LH bleeding help with time zone changes
and FSH Can use when breast feeding, Must use additional method for
older women, smokers protection against STDs
(condoms, etc.)
Combined pill: Inhibition of ovulation Increased menstrual cycle Convenient, eective, easy to
oestrogen ; progesterone Many dierent types regularity carry
Monophasic (xed dose of Less blood loss Need to take every 24 h
hormones in every pill) Less cramping Must use additional method to
Triphasic (dosage of hormones Fewer ectopic pregnancies prevent STDs (condoms, etc.)
in pills varies week to week) Less pelvic inammatory disease May use to delay menses by
Fewer cysts starting next packet of active
Fewer broids pills following 3 weeks of
Less endometriosis previous packet
WOMENS HEALTH AND TRAVEL 387
Table 24.3a (cont.)
FSH : follicle-stimulating hormone; Hep B : Hepatitis B virus; HIV : Human immunodeciency virus; HSV : Herpes simplex virus; ITP : idiopathic
thrombocytopenic purpura; LH : luteinizing hormone; OCP : oral contraceptive pill; STD : sexually transmitted disease.
388 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Table 24.3b Methods of contraception currently in clinical trials and/or available in countries other than the USA
Barrier
Leas Shield Silicone rubber cap; one size ts all; oval bowl which looks like Easy to transport
(Available in Canada and a loose tting cervical cap Carry in climate-resistant
Europe) Recommended for use with spermicidal jelly case
Does not require tting by clinician Rubber may deteriorate in
Has a loop for easy removal heat
Should be left in place for at least 8 h after intercourse
Can be worn for 48 h
Replace once a year
Fem Cap Silicone rubber sailor hat-shaped cap; intended for use with or Easy to carry
without spermicide Use
Two sizes being tested; tting by clinician required Do not need spermacide
Can be worn up to 48 h
Phase III clinical trials involving 800 women at 10 university
health centers
5% failure rate
Gyneseal Unique two-part chamber designed in Australia as either a Could be used during
(Made in Australia) menstrual blood collection device (like a tampon) and/or a menstrual periods and for
contraceptive barrier contraception
Inner diaphragm-shaped chamber drains through a one-way Less to carry!
valve into an outer collection chamber, which clings by suction
to the vaginal vault. The inner part seals to the outer part so
that blood or secretions do not stay in contact with the cervix
and do not leak into the vaginal vault
Oves Shaped like the Prenti cervical cap Disposable
(Made in France) Disposable device made of thinner, softer silicone rubber Need enough for entire trip
designed for one-time use with spermicide May also be used to absorb
Dow Chemical recently acquired rights to product medicine such as an oral
May be developed as a vehicle to deliver medicines contraceptive pill if have
transvaginally rather then as a contraceptive device nausea and vomiting. Not
Vaginal mucosa provides a good adsorptive surface for FDA approved for this use?
administering medicines (used by women taking emergency
contraception or chemotherapy who experience so much
nausea they cannot take their oral medicines; can place pills
high in vagina and achieve good systemic levels)
Protectaid Sponge Soft polyurethane sponge impregnated with a F-5 gel Easy to use
(Available in Canada) dispersing agent and 3 spermicides Easy to carry in individual
Works as a physical barrier packets
Protecting the cervix Available without a
Chemical action of spermicides prescription
Reservoir of gel (continuous release)
Absorption of semen, no leakage
Leave in for at least 6 h after intercourse
Can be kept in for 12 h
May have repeated acts of intercourse during that period
Disposable diaphragms Two diaphragms which release spermicide are being tested in Easy to use
clinical safety trials No spermacide required
They may be used up to 24 h with multiple acts of intercourse
Hormonal
Transdermal patches Designed to deliver 1 weeks worth of hormone; used 3 weeks Good alternative method if
on 1 week o unable to take pills owing to
gastrointestinal illness
Table 24.3b (cont.) WOMENS HEALTH AND TRAVEL 389
Intravaginal rings Doughnut-shaped rings are composed of soft silastic, slightly Biggest advantage over the
(Tested in 19 centers smaller than a diaphragm and inserted into the upper vaginal other long-acting sustained
worldwide. May be produced vault release methods is the ease
by the UK) Presently being evaluated for use with a number of hormone with which woman can insert
formulations or remove the ring
Release progestin alone It can be removed for up to
Levonorgestrel 24 h without losing ecacy,
Desogestrel (Dutch rm Organon) so it can be taken out for
Release a combination of a progestin with an oestrogen for intercourse
absorption across the vaginal wall Disadvantage
Slightly lower ecacy rate
that with injectables, implants
or medicated IUDs
Increased vaginal discharge,
irritation, irregular bleeding
with progestin-only rings,
expulsion; and partner able to
feel it during coitus
IUDs
Levonorgestrel IUDLNg Available in 14 European and Asian countries May be option for traveler if
IUS Delivers 20 g of levonorgestrel directly on the inner wall of the she can nd a reliable clinic
uterus for 5 years
Dosage is equivalent to taking 23 minipills per week
Unlike copper IUD, which can increase blood loss by 50%, the
LNg IUS reduces blood ow by 90% after one year of use
Other health benets include a reduction in broids and
menstrual pain
Manufactured name Levonovas in Scandinavia and Mirena
in Europe and Hong Kong
Frameless IUD A frameless IUD would eliminate any pressure against the
uterus and thus minimize cramping
Polyurethane thread anchors the copper-releasing sleeves in the
myometrium at the fundus
Another version a biodegradable anchor cone allows insertion
immediately postpartum
?Not tested in women travellers in rapidly changing time zones and with hectic schedules.
Immunocontraceptives Status
For women Most advanced testing is on human chorionic gonadotropin (hCG)-based approaches either the
whole molecue or fragments
Both approaches are abortifacients; thus even if ecacy, safety and reproducibility could be
demonstrated it is unlikely a company will pursue hCG-based vaccines
Other antigens that prevent fertilization may be more promising from a political point of view,
and include sperm, ovum, zona pellucida antigens
For men Luteinizing hormone-releasing hormone (LHRH) or follicle-stimulating hormone (FSH) may be
used as potential vaccines for men. A vaccine using LHRH linked to a tetanus toxoid shuts down
the testes to eliminate testosterone as well as sperm production. To maintain libido and potency
one would have to supplement with testosterone
In contrast, FSH vaccines have eliminated sperm while maintaining normal testosterone levels in
monkeys. Initial studies are underway in India
?Research in progress. Travel health practitioners may, in the future, be able to give contraceptive vaccines.
390 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Table 24.3d Computerized natural family planning?
Persona Hand-held monitor. Computer reads, stores and analyzes hor- Available from UK
monal cycle data from urine tests to give feedback on safe sex $US185.00
times. Becomes more accurate with time as computer gets to
know the womens cycle
Uses urine test to monitor hormone level
Bioself Fertility Indicator Electronic fertility indicator $US100.00
Identies both period of maximum fertility (most favorable days
for conceiving a child) and the infertile period during which
contraception is not possible
Lady Comp Microcomputer equipped with a thermic sensor which allows the Available for $US700.00 from
user to measure the bodys basal body temperature in the mouth Germany
on rising in the morning
A sophisticated program takes charge to determine actual fertil-
ity of the day based on the measurement of the last 10 years
Provides an indication of current fertility, a prognosis for fertility
for the next 6 days, a prognosis for impregnation and prognosis
of menstruation
Baby Comp Microcomputer similar to above which can be used for contra- $US900.00 from Germany
ceptive purposes by assessing least fertile days or for help in
conceiving on most fertile days
Clear Plan Fertility Monitor Identies a womans fertile days, about 6 per month $US200.00
Allows women to avoid or maximize chance of pregnancy
PFT 1-2-3-KIT Combines a powerful compact microscope with multicolored
slides to distinguish fertile days from nonfertile days
Used to pinpoint ovulation, enabling the woman to avoid or
achieve pregnancy
?None of these options have been tested in women travelers in rapidly changing time zones and with hectic schedules.
rings and skin patches are presently being evaluated in Emergency Contraception
research trials. These options may be available in the
future for women who cannot absorb their pill from the The potential for becoming a pregnant traveler exists for
gastrointestinal tract due to illness. Estrogens are actually most women of reproductive age. Contraceptive failures
absorbed better through the vaginal mucosa than are common. Condoms break, diaphragms slip, contra-
through the gastrointestinal tract (Hatcher et al., 1998; ceptive jelly runs out, oral contraceptive pills may be
Fraser et al., 2000). missed due to changes in time zones, or malabsorption of
the pill may occur due to vomiting and diarrhea. Emerg-
ency contraceptive options should be taught to every
woman traveler of reproductive age.
Drug Interactions and Oral Contraceptive Ecacy Emergency contraception is dened as a method of
contraception that women can use to prevent pregnancy
A common question is whether antibiotics aect oral after unprotected intercourse or contraceptive failure
contraceptive ecacy. Antibiotics have been shown, in (Table 24.4). Emergency contraception should be used in
animal studies, to kill intestinal bacteria responsible for cases of unprotected intercourse, contraceptive failure or
the deconjugation of oral contraceptive steroids in the sexual assault. It should be included in every womans
colon. Without such deconjugation and subsequent reab- medical kit (Table 24.5). For an excellent review on this
sorption, decreased hormone levels result, leading to a topic see the articles by Glasier (Glasier, 1997, 1999) and
decrease in hormone ecacy. Despite numerous case re- the emergency contraception web site (see Table 24.2).
ports of penicillins, tetracyclines, metronidiazole and nit- The emergency contraception options available in
rofurantoin causing contraceptive failure in humans, no most countries include either two doses of
large studies have demonstrated that antibiotics, other estrogenprogestin combination contraceptive pills or
than rifampicin, lower steroid blood concentrations two doses of levonorgestrel pills taken 12 h apart. A var-
(Weaver and Glasier, 1999). iety of pills may be used. Women should be taught the
To date there are no known interactions between oral generic names of the formulations so they can obtain
contraceptive pills and malaria chemoprophylaxis. more if needed.
WOMENS HEALTH AND TRAVEL 391
Table 24.4 Emergency contraception options
Oestrogenprogestin See Table 24.5 Established safety and Nausea (up to 50%) and Available worldwide
combination pill Schering PC4 (UK) ecacy vomiting (up to 20%) Check web site for
Tetragynon Can continue as regular are common side eects availability at
(Switzerland) contraceptive 72 h window destination
Preven (USA) Availability over the
counter in many
countries
Progestin only Postinor: available Well tolerated 72 h window Worldwide
0.75 mg levonorgestrel from pharmacists in Fewer side-eects
given 12 h apart eastern Europe, Far compared with
East and many combined pill regimen
developing countries
NorLevo (France):
available from
pharmacists
Plan B (USA, Canada)
Oestrogen alone Netherlands Failure rate Nausea and vomiting Europe
Ethinyl estridiol (called 5 ; 5)
Antiprogestin RU-486 Highly ecacious and Menses can be delayed China
Mifepristone well tolerated; 100% France
eective in some studies USA
Can be used up to 5
days after unprotected
intercourse
Inhibits ovulation and
prevents implantation
IUD Can be inserted up to 5 IUD limitations? Worldwide
Copper days after uprotected Requires oce visit
intercourse Needs strict sterile
Can continue as technique, which may
long-term contraception not be available in some
Failure rate less than countries, and thus not
1% recommended due to
risk with insertion
?Include the following: should not be used in women with history of a pelvic infection, undiagnosed uterine bleeding, or at risk for sexually transmitted
disease.
Mifepristone is an antiprogesterone that is considered information in a variety of languages see the Consortium
to be as eective as the combined pill regimen with fewer for Emergency Contraception web site (see Table 24.2).
side-eects. Recent data demonstrate doses as low as
10 mg to be eective (compared to 600 mg for a medical
abortion). Unplanned Pregnancy
A copper-containing intrauterine device (IUD) is also
highly eective. Advantages include its high ecacy, 5 If a traveler becomes pregnant and wishes to terminate
day window for insertion, and ongoing contraceptive the pregnancy it may be best for her to return home,
benet if it is kept in place. This method is not recommen- depending on where she is and where she is going. Over
ded for women with more than one partner, at risk for half the countries listed by the International Planned
sexually transmitted diseases or who have never been Parenthood Federation prohibit abortion except in ex-
pregnant. Access to a health care facility that can safely treme cases such as rape and life-threatening illness.
insert the IUD is also important. Issues of safety and legality for terminating a preg-
Options available in other countries and how to access nancy vary. The Center for Reproductive Law and Policy
them should also be reviewed. Women can obtain infor- web site provides a list of countries where abortion is legal
mation on what options are available in various countries (and what restrictions are placed on abortion).Women
by checking the emergency contraception web site and travelers should be advised to obtain advice regarding the
typing in her country of destination (see Table 24.2). For options available. The Marie Stopes International web
392 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Table 24.5 Emergency contraceptive methods for the travel medicine kit
Combined
Preven Kit 2 light blue 100 0.5 Two doses 12 h apart
Ovral 2 white 100 0.5 Within 72 h of
unprotected intercourse
Lo-Ovral 4 white 120 0.6 May need antinausea
medication
Nordette 4 orange 120 0.6
Levelen 4 orange 120 0.6
Levora 4 white
TriLevelen 4 yellow 120 0.5
Triphasil 4 yellow 120 0.5
Trivora 4 pink
Alesse 5 pink 100 0.5
Progestin only?
Plan B 1 pill 0 0.75 Two doses 12 h apart
within 72 h
Ovrette 20 pills 0 0.75 Two doses 12 h apart
within 72 h
Levonorgestrel 1 pill 0 0.75 Two doses 12 h apart
(Postinor) within 72 h
Antiprogestins
RU-486@ 1 pill Within 72 h
IUD Copper Insert within 5 days
?Much lower incidence of nausea and vomiting compared with pill regimen (Lancet 1998, 352: 428433).
@Available in China, Europe and USA.
Women should know what is available in other countries if your medications are stolen or forgotten. They should consult: Emergency Contraception Web
site, http://not-2-late.com; US Emergency Contraception Hotline, 1-888-NOT-2-LATE; IPPF Directory of Hormonal Contraceptives 1996.
site gives a list of services available in dierent countries. risk and taught preventative measures such as exercise
This web site provides country-specic information on and hydration. They can also decrease their risk by avoid-
the availability of emergency contraception, contracep- ing smoking, maintaining a normal blood pressure and
tive methods and abortion, along with helpline numbers normal weight. A woman with a personal history of a
for advice and services related to family planning and venous thrombosis should not take oral contraceptives. A
sexual health (see Table 24.2). common scenario may involve a woman traveler with a
strong family history of venous thrombosis who wants to
take oral contraception for an expedition to a remote
RISK OF VENOUS THROMBOSIS area with no access to medical care. In this case she might
be screened for one of the biochemical or genetic defects
With Oral Contraceptives associated with an increased risk of venous thrombosis to
get a better idea of her actual risk; for example, factor V
Studies have shown a slight increase in the risk of deep Leiden mutation or protein C, protein S or antithrombin
vein thrombosis (DVT) for women on oral contracep- deciencies have been associated with venous thrombosis
tives. The absolute risk of venous thromboembolism is (Vandenbroucke et al., 2001).
small, ranging from 10 to 30 cases per 100 000 women per Some studies have found no dierence in risk for ve-
year in women using oral contraceptives, versus 4 per nous thrombosis between the low-dose second- and
100 000 in nonpregnant women not using oral contracep- third-generation oral contraceptive pill formulations
tives. The risk in pregnancy is much greater, estimated to containing less than 50 g ethinylestradiol (Farmer et al.,
be 60 per 100 000 pregnant women. Women travelers on 2000). Newer studies on the eects of the second- and
oral contraceptives should be advised about this small third-generation oral contraceptives show a net pro-
WOMENS HEALTH AND TRAVEL 393
thrombic eect. See the article by Vanderbroucke et al. Table 24.6 Checklist for pregnant travelers
(2001) for an excellent review of the recent data and
theories describing possible hemostatic mechanisms re- Pretravel risk assessment
lating to the risk of venous thrombosis associated with Stage of gestation
the use of oral contraceptives. These authors also discuss Obstetric risk factors
the pros and cons of screening for genetic defects asso- Medical risk factors
Destination risk considerations
ciated with an increased risk of clotting.
Due to infectious disease
For travel to altitude above 4000 m the riskbenet
Chloroquine-resistant Plasmodium falciaprium malaria
ratio should be discussed, as should the possibility of Outbreak of disease requiring a live virus vaccine
using another method. If a woman insists on continuing Outbreak of a disease for which no vaccine is available but
her pill and she has no known risk factors she should has a high risk of maternal and fetal morbidity and
maintain hydration and takes an aspirin a day. Of the mortality
thousands of woman students on oral contraceptives seen Due to food water exposure
over a period of 10 years in one advice center, and trekk- Due to insect exposure
ing to over 4000 m, not one case of DVT was seen. A Due to environment
well-designed study to address this issue needs to be Sports or exercise risk
undertaken. Altitude
Open water
Lack of access to care
With Emergency Contraception
Travel risk assessment
Mode of travel
The risk of venous thrombosis during pregnancy is of the
Medical services available during transit and at destination
order of 60 per 100 000 per year, which is much higher Medical insurance and evacuation coverage
than the risk for routine oral contraception. The risk of Review emergency signs and symptoms for which care should
DVT with emergency contraceptive use is thought to be be sought
insignicant due to the limited time frame (Glasier, 1997; Severe vaginal bleeding, abdominal pain, contractions,
Vasilakis et al., 1999). proteinuria, severe headache with visual change, severe
edema and/or accelerated weight gain
Rupture of membranes
With Pregnancy
Recommendations
Risk of DVT is of the order of 60 per 100 000, as stated Immunizations to reect actual risk of disease and probable
above. Risk is increased due to hormonal changes aect- benet
ing hemostatic coagulability factors and due to the press- Medicationsreview safety during pregnancy
Preventative measures to decrease:
ure of the uterus on the great vessels, decreasing venous
Gestation-related risks
return. Exercise and hydration help to decrease risk.
Typical problems
Mode of travel risks
With Estrogen Replacement Therapy Food-related risk
Water-related risk
Insect-related risk
Current use of estrogen replacement therapy has been Environment-related risk
associated with a 23-fold increase in venous throm- Sexual-behavior risk
boembolism but the absolute risk remains low (Daly et Medical kit adaptations
al., 1996; Oger and Scarabin, 1999). For women travelers Postpone travel if risks outweigh benet
on estrogen replacement therapy going on long airplane
ights, aspirin therapy might help decrease this small risk
(Grady et al., 2000).
should be reviewed carefully, with particular attention to
gestational age and evaluation for high-risk categories, as
PREGNANCY listed in Table 24.7.
Pretravel Evaluation
Relative Contraindications for Travel during
See Table 24.6. Pregnancy
Adapted from Samuel BU and Barry M (1998) The pregnant traveler. Infectious Disease Clinics of North America, 12, 325354.
ordered in advance (Bia, 1992). pregnant women beyond 3236 weeks of gestation. It is
Pregnancy predisposes pregnant travelers to a risk of important to check with the airline ahead of time. Preg-
supercial and deep vein thrombosis due to alterations in nant women should always carry a letter from their phys-
clotting factors and the pressure of the expanding uterus. ician documenting their gestational status and due date.
Preventative measures should include frequent stretch- The radiation exposure associated with a long ight
ing, walking up and down the aisle and isometric leg from London to Tokyo has been estimated to be the
exercises. An aisle seat would facilitate this activity. De- equivalent of one chest radiograph. For the infrequent
hydration is a risk for passengers due to the low humidity yer this is not of much concern. For pregnant travelers
on pressurized ights (Bia, 1992). Women should be en- who are aircrew or business frequent yers this may be a
couraged to drink nonalcoholic beverages to maintain consideration and should be discussed with their phys-
hydration and placental blood ow. ician. Airport security machines are magnetometers and
Most airlines have regulations that prevent travel by are not harmful to the fetus.
396 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Motor Vehicle Travel Englund, 2000). Advice to pregnant women regarding
recommended immunizations should balance the theor-
Motor vehicle accidents resulting in blunt trauma are a etical risk of the immunization against the potential for
common cause of maternal and fetal morbidity and mor- maternal and fetal illness. The basic questions are:
tality in pregnant women. Complications are obviously What is the real incidence of the vaccine-preventable
increased when the women is ejected from the vehicle. disease along the pregnant travelers itinerary?
Unfortunately, lap belts have been associated with pla- What is the real risk to the pregnant traveler or her
cental and fetal injury. A diagonal shoulder strap with a fetus of acquiring the disease?
lap belt provides the best protection, with the straps What would be the risk of treatment of the particular
carefully placed above and below the abdominal bulge disease during pregnancy or fetal development (if there
to distribute the impact energy over the anterior chest is a treatment)?
and pelvis. Safety restraints do not exist in most automo- What is the known eectiveness of the vaccine in pre-
biles in many parts of the world. Pregnant women on an venting the disease?
extended automobile or bus ride should take frequent What is the theoretical risk of the vaccine to the mother
exercise breaks and walk for at least 10 min every 2 h to or the fetus?
prevent venous stasis and risk of thromoboembolism.
The main health risk associated with sea voyages is the Vaccines based on inactive viruses, inactivated bacterial
exacerbation of the nausea and vomiting associated with toxins (toxoids), inactivated bacteria or bacterial compo-
pregnancy. Lack of access to medical care in case of an nents are thought to be of low risk for the pregnant
emergency is another issue, especially on sailboats oper- woman and her fetus (Fischer et al., 1997).
ated by smaller tour companies or in self-designed tours. Live attenuated viral vaccines and live bacterial vac-
On the larger cruise carriers pregnant women are allowed cines are not generally recommended to pregnant women
to travel until the seventh month. Medical facilities due to a theoretical concern secondary to the live com-
aboard are usually quite well equipped but this should be ponents. In general, pregnant women should avoid live
assessed in advance of travel. vaccines, and women generally should avoid becoming
pregnant within 3 months of having received a live vac-
cine. However, limited data from registries of live vaccines
Gestation-related Changes in Immune Status given inadvertently to pregnant women suggest that
many of these vaccines may be safe in pregnancy. Until
Data suggest that pregnancy results in a number of more data are available, live vaccines should be used
changes in the maternal immune system, although re- during pregnancy only if the risk of exposure to a vaccine-
search on the immune response during pregnancy is con- preventable disease outweighs a possible theoretical risk
tinually evolving. The evidence from a number of studies of the vaccine (Munoz and Englund, 2000). Ideally it is
suggests that there is a reduction in cell-mediated immun- best to avoid any form of immunization during the rst
ity during pregnancy. There is evidence to support this trimester of pregnancy.
hypothesis. Pregnancy has been found to result in in- Table 24.9 summarizes the latest data. All vaccines are
creased susceptibility and/or a predisposition to more listed as category C under the FDA pregnancy categories
severe disease in a number of infections in which the (Briggs et al., 1998; Anonymous, 2000a).
cell-mediated immune response is the most important. FDA has developed a set of guidelines to categorize
Examples of this type include malaria, amebiasis, coc- drugs, vaccines and toxoids with regard to developmental
cidiomycosis, leishmaniasis, leprosy, listeriosis and tuber- toxicity and adverse fetal outcome. The assessments are
culosis (Pedler, 2000). Thus, when the itinerary is being based on the degree to which available information has
reviewed, risk for these infections should be determined. ruled out a risk to the fetus, balanced against the potential
By contrast, infections in which the humoral response benets to the pregnant women (Table 24.10). Most medi-
is the most important show no increase in susceptibility cations in the US Physicians Desk Reference fall under the
to infection. B-cell numbers and functions do not appear FDA category C. Few double-blind studies have been
to be reduced during pregnancy. carried out in pregnant women to categorize drugs. Clini-
cians who want more information can obtain it from
teratogen reference systems available around the world
Immunizations (see Additional Resources).
High fevers occurring during the rst trimester have
Ideally all women have had their immunizations updated been associated with neural tube defects; such fevers may
prior to pregnancy. In fact there has been a recent empha- be vaccination-induced. Vaccinations which might cause
sis on encouraging maternal immunization to protect the a febrile response are not recommended during preg-
newborn against certain childhood diseases (Munoz and nancy.
WOMENS HEALTH AND TRAVEL 397
Live Vaccines or Live Attenuated Vaccines previously healthy mother, who was 56 weeks pregnant.
After an elective abortion, polymerase chain reaction test-
Measles/Mumps/Rubella (MMR) and Measles ing of fetal tissue did not reveal the virus. Varicella zoster
immune globulin should also be given to a nonimmune
Immunity to measles is essential for all travelers. Many woman with exposure to varicella within 96 hours of
young adults require immunization (or reimmunization) exposure.
for protection. The specic recommendations for the age
groups vary depending on the travelers country of origin
Poliomyelitis
and epidemiology of measles in that country. The measles
vaccine as well as the MMR (measles, mumps, rubella
It is important for all pregnant women to be protected
combination) are live vaccines and contraindicated in
against polio. Paralytic disease may occur with greater
pregnancy. Due to the increased incidence of measles in
frequency when infection develops during pregnancy.
children in developing countries, its communicability,
Anoxic fetal damage has been reported, with up to 50%
and its potential for causing serious consequences in
mortality in neonatal infection. If not previously immu-
pregnancy, some health providers would advise delaying
nized, a pregnant women should have at least two doses
travel of a nonimmune woman until after delivery, when
of the vaccine prior to travel (day 0 and 1 month). Despite
the vaccine can be given. If a documented exposure to
being a live vaccine, the oral polio vaccine is recommen-
measles occurs, immune globulin may be given within a 6
ded by some experts when immediate protection is
day period to a pregnant woman to prevent disease. It is
needed. The recommendation is for one dose prior to
important to remember that the immune globulin may
travel, followed by completion postdelivery.
not be available in many high-risk countries.
Mass immunization programs, prompted by polio vi-
rus epidemics in Finland and Israel, which included thou-
sands of pregnant women failed to show any association
Rubella
between maternal immunization with oral polio vaccine
and congenital malformations or adverse perinatal out-
The Centers for Disease Control and Prevention (CDC)
comes (Anonymous, 1994). For pregnant women travel-
established a registry for women who received the rubella
ing to endemic areas, it is recommended that the inac-
vaccine within 3 months before or after conception. Preg-
tivated poliovirus (eIPV) be used for routine boosting. If a
nancy outcomes collected from 1979 to 1998 have not
pregnant woman needs immediate protection for a high-
shown any fetal abnormalities or congenital rubella syn-
risk area, oral polio vaccine should be used.
drome. Guidelines still state that reasonable precautions
should be used to prevent administration during preg-
nancy. However, inadvertent administration of the ru- Tetanus and Diphtheria
bella vaccine is not considered a reason to terminate the
pregnancy because, in cases where rubella vaccine has To maintain immunity against diphtheria and tetanus a
been accidentally given, no complications have been re- booster dose of tetanusdiphtheria vaccine (Td for adult
ported. use) should be given every 10 years. Women traveling to
Routine prenatal screening for rubella immunity areas where they may deliver under unhygienic circum-
should be emphasized. The vaccine should be adminis- stances or surroundings should update their immunity to
tered to susceptible women who are not pregnant. prevent neonatal tetanus. The WHO, the Advisory Com-
mittee on Immunization Practices (ACIP) and the Ameri-
can College of Obstetricians and Gynecologists all en-
Varicella dorse tetanus toxoid administration during pregnancy.
Immunization of pregnant women with tetanus toxoid at
The vaccine manufacturer, in collaboration with the least 6 weeks before delivery eectively provides protec-
CDC, has established the Varivax Pregnancy Registry to tion of newborns against neonatal tetanus by stimulating
monitor maternal and fetal outcomes of women who are the production of specic IgG antibodies that cross the
inadvertently immunized with varicella vaccine 3 months placenta, while also protecting these women against puer-
or less before pregnancy or anytime during pregnancy peral tetanus. Maternal immunization with tetanus
(Centers for Disease Control and Prevention, 1996). The toxoid is practiced worldwide and has resulted in dra-
registry, which contains data from more than 300 delive- matic decreases in the incidence of neonatal tetanus in
ries, indicates no defects compatible with congenital many regions, with no evidence of adverse eects to
varicella syndrome. However, the small number of preg- mother or fetus (Munoz and Englund, 2000).
nancies followed up to date gives low power to detect a Nonimmunized or incompletely immunized pregnant
rare eect, and the serologic status of the majority of the women should receive one or two properly spaced doses
women was unknown, but the majority were likely to be of Td (for adult use) preferably in the last two trimesters.
immune. A 12-month-old infant who developed approxi- Pregnant women traveling to areas endemic for diph-
mately 30 vesicular lesions after receiving the currently theria should also be vaccinated. Contraindications to a
licensed varicella vaccine transmitted vaccine virus to his booster immunization would include a history of a high
398 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Table 24.9 Immunizations during pregnancy
Adapted from CDC Information for International Travel 19992000 and Samuel BU and Barry M (1998) The pregnant traveller. Infectious Disease Clinics
of North America, 12, 325354.
Table 24.10 FDA use-in-pregnancy categories morbidity from inuenza virus infection. The risk in-
creases in the third trimester of pregnancy in the presence
FDA of other underlying conditions. Inactivated inuenza vi-
Category/Rating Description rus vaccine is recommended by the CDC for all pregnant
women who will be in the second or third trimester of
A Adequate and well-controlled studies pregnancy during an inuenza season and for those with
in women show no risk to the fetus underlying risk factors, regardless of their stage of preg-
B No evidence of risk in humans. Either nancy, such as women with any immunosuppressive dis-
studies in animals show risk, but ease or pulmonary problems. Maternal immunization
human ndings do not, or, in the
with inactivated inuenza virus vaccine is considered safe
absence of human studies, animal
at any stage of pregnancy (Anonymous, 2000c).
ndings are negative
C Risk cannot be ruled out. No adequate
and well-controlled studies in humans,
or animal studies are either positive Bacterial Polysaccharide Vaccines
for fetal risk or lacking as well. Drugs
should be given only if the potential In general, polysaccharide vaccines have been given to
benet justies the potential risk to the pregnant women without adverse eects.
fetus
D There is positive evidence of human
fetal risk. Nevertheless, potential Pneumococcal Infection
benets may outweigh the potential
risks Vaccine should be given to all pregnant women who
X Contraindicated in pregnancy. Studies would otherwise qualify for special protection against
in animals or humans or these diseases, such as pregnant women with chronic
investigational or postmarketing diseases or pulmonary problems. Another reason to con-
reports have shown fetal risk that far sider is maternal immunization to protect infants under 3
outweighs any potential benet to the
years old who are at risk for severe pnemoncoccal disease.
patient
Meningoccal Meningitis
fever (over 39.4 C) or an Arthrus-type sensitivity reac-
tion, due to concern about the eect of a febrile reaction The bacterial polysaccharide polyvalent meningococcal
on the neurological system of a developing fetus. vaccine may be administered during pregnancy if the
woman is entering an area where the disease is epidemic
Inuenza or during an outbreak. The commonly available menin-
gococcal vaccine in the United States is a tetravalent
Pregnant women and infants are vulnerable to increased vaccine from groups A, C, Y and W135. In a number of
400 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
other countries only bivalent vaccine from group A and C increased risk of premature labor and fetal death. These
is commonly used. events did occur in women from developing countries and
The safety of the vaccine in pregnancy has not been may have been related to underlying malnutrition. The
conclusively demonstrated, although a small study pub- hepatitis A virus is rarely transmitted to the fetus but
lished in 1980 showed no birth defects in infants whose transfer can occur during delivery. Immune globulin is a
mothers were vaccinated during an epidemic in Brazil. safe and eective means of preventing hepatitis A but
immunization with one of the new hepatitis vaccines gives
a more complete and prolonged protection. The eect of
Haemophilus inuenzae Type b the new killed vaccines on fetal development is unknown
but the production methods for the vaccines is the same
Haemophilus inuenzae type b is an important cause of as eIPV, which is considered safe in pregnancy. Thus
meningitis and pneumonia in infants in areas of the world hepatitis A should be administered to pregnant women
where the vaccine is not available. For women traveling when indicated.
to endemic areas to live, the Haemophilus inuenzae type
b (Hib) vaccine could be considered. This vaccine has
been a model for the protection of infants from bacterial Hepatitis B
disease through maternal immunization (Glezen and
Alpers, 1999). The hepatitis B vaccine may be administered during preg-
In the 1980s Hib capsular polysaccharide vaccines nancy. Hepatitis B virus infection is a risk for short-term
given to women in the third trimester of pregnancy were and long-term travelers who may be exposed to blood or
shown to result in the transmission of vaccine-specic body uids. The risk is increased for travel to Asia, sub-
antibodies to the infant serum and maternal breast milk. Saharan Africa, the Amazon basin and parts of the
Newer conjugate vaccines (Hib-PRP covalently linked Middle East. The main risk factors for a pregnant woman
to a carrier protein) have been shown to induce the pro- include working in a health care setting, being sexually
duction of IgG antibodies, which are more eciently active with a new partner, planning delivery overseas, or
transmitted transplacentally than IgG and resulted in a planning extended travel.
higher level of total protective antibody than the polysac- Ideally, all pregnant women should be screened for
charide vaccines. Thus maternal immunization with Hib hepatitis B carriage. If a woman is positive for hepatitis B
conjugate vaccines should be considered in pregnant surface antigen (HBsAg) her infant should be given hepa-
women travelers planning to live in endemic areas. titis immune globulin and hepatitis B vaccine at birth.
The hepatitis B vaccine can be administered to pregnant
women. It is preferred that it is given after the rst trimes-
Typhoid ter (for theoretical reasons) to all women who are at high
risk and test negative by serology for past infection.
There are three vaccines available for prevention of ty- Immunization for hepatitis B will also prevent hepatitis
phoid; the intramuscularly administered V1 capsular D infection.
polysaccharide typhoid vaccine (ViCPS, Typhim Vi) is
recommended in high-risk exposure. Because it is a poly-
saccharide vaccine it is less likely to cause a febrile reac- Hepatitis C
tion. It is classied as FDA category C and should only be
used if clearly indicated. The live oral typhoid vaccine Hepatitis C infection is on the rise. Travel-associated
(enteric-coated, lyophilized, Ty21a strain of Salmonella risks include exposure to blood that has not been
typhi) is not recommended during pregnancy as it is a live screened, sexual transmission, tattooing and occupa-
vaccine. The old subcutaneously administered heat/phen- tional exposures of volunteer health care workers or
ol-activated typhoid vaccine should not be used as it missionaries to blood products or contaminated needles
causes a febrile reaction and a sore arm. used for administration of medications or intravenous
drug use. There is no evidence that pregnancy alters the
natural history of hepatitis C or that it interferes with
Hepatitis A normal pregnancy, unless the woman already has cirrho-
sis and its associated complications (Reinus and Leikin,
Pregnant women without immunity to hepatitis A need 1999). Vertical transmission is uncommon. Pregnant
protection prior to traveling to developing countries. The travelers should be advised of at-risk behaviors to de-
risk for nonimmune travelers is 36/1000 per month. crease risk of infection. Immune globulin is not thought
Rates as high as 20/1000 are seen in overland travelers to be eective postexposure.
living and eating under poor hygienic conditions. Hepati-
tis is no more severe during pregnancy then at other times
and does not aect the outcome of the pregnancy. There Hepatitis E
have been reports of acute fulminant disease in pregnant
women during the third trimester, when there is also an A new hepatitis E virus (HEV) vaccine is in clinical trials
WOMENS HEALTH AND TRAVEL 401
in Nepal (Shlim and Innis, 2000). HEV is a major cause of For pregnant women who are traveling or transiting
hepatitis in Nepal, India, Burma, Pakistan and China, the regions within a country where the disease is not a current
former Soviet Union and Africa (Ooi, Gawoski et al., threat but where policy requires a yellow fever certicate,
1999). Transmission of the virus occurs through a physician waiver should be carried along with docu-
fecaloral exposure. HEV acquired during pregnancy has mentation on the immunization record. In general, travel
a particularly high case fatality rate (1530%). HEV infec- to areas where yellow fever is a risk should be postponed
tion is most common in persons of childbearing age until after delivery, when the vaccine can be administered
(1540 years). Clinical illness can range from mild to without concern of fetal toxicity.
severe. In the non-pregnant, fulminant disease occurs in A nursing mother traveling to a yellow fever endemic
less than 1%. In pregnant women the disease may be area should also delay travel as a neonate cannot be
fulminant in 2030%. The overall fatality rate for non- immunized because of the risk of vaccine-associated en-
pregnant patients is 0.54.0%. During pregnancy the cephalitis. Breastfeeding is not a contraindication to the
fatality rate increases from 1.5% during the rst trimester, vaccine for the mother.
to 8.5% during the second trimester and 21% during the
third trimester (Reinus and Leikin, 1999). The reasons
why the infection is more severe in pregnancy are not Japanese Encephalitis
known. HEV infection acquired during the third trimes-
ter is also associated with fetal complications. Fetal mor- Japanese encephalitis vaccine is an inactivated vaccine
tality is much more common than with the other forms of but is reactogenic, especially in atopic individuals. To
hepatitis. Most outbreaks occur due to fecal contamina- determine whether a pregnant traveler should receive the
tion of drinking water. vaccine, the risk of exposure and infection versus the risk
Prevention of hepatitis E is dependent on strict food of the vaccine to the fetus or the mother must be weighed
and water precautions. Drinking only boiled water and carefully. Risk factors for the disease would include the
avoidance of local beverages, unpeeled fruit and un- particular location and duration of intended stay, hous-
cooked vegetables and ice is eective. Administration of ing conditions, nature of activities, and the possibility of
HEV-immune serum globulin to persons at risk did not travel to high-risk areas. The safety of this vaccine in
aect disease rates. Pregnant women should not travel to pregnancy has not been established and it should only be
areas where there are known outbreaks of HEV. given after weighing the risks and benets.
Yellow fever is increasing worldwide so appropriate im- Tick-borne encephalitis is a virus transmitted by a tick in
munization is important (Anonymous, 1999). Severe yel- endemic areas. A number of vaccines are available (De-
low fever has a case fatality rate of between 20 and 50% micheli et al., 2000). Inactivated tick-borne encephalitis
(Monath, 1999; Tomori, 1999; Anonymous 2000b). Yel- vaccine is highly immunogenic and reactive in most stu-
low fever vaccine should not be given to a pregnant dies. There have been no studies in, and it is not recom-
woman unless travel to an endemic or epidemic area is mended for, pregnant women. Strict tick-bite precautions
unavoidable. If travel to a high-risk area cannot be avoid- are recommended for women hiking or traveling through
ed, the benets of the vaccine far outweigh the small an endemic area.
theoretical risk to the fetus (Robert et al., 1999).
The rst systemic epidemiological study of yellow fever
vaccination in pregnancy found no evidence of congenital Lyme Disease
infection in 40 exposed infants in Nigeria. The yellow
fever vaccine (17d) was given to 101 pregnant women Lyme disease is a potentially serious infection that is
during a yellow fever outbreak in Nigeria. No untoward caused by the spirochete Borrelia burgdorferi and trans-
eects on the mother or infant were noted (Nasidi et al., mitted by the bite of infected Ixodes ticks. The infection is
1993). Antibody responses of pregnant women and endemic in certain areas of North America, Europe and
mothers who were vaccinated mainly during the last Asia. There was a concern about the possiblility of fetal
trimester were much lower than those of yellow fever- infection and teratogenicity from Lyme disease contrac-
vaccinated nonpregnant women in a comparable group. ted during pregnancy because of the similarities of disease
A recent study of women inadvertently immunized during caused by B. burgdorferi to syphilis. Although initial case
pregnancy found neonates who appeared well but had reports were alarming, more recent prospective data have
yellow fever virus-specic IgM antibody, indicating a been reassuring. A study of 2000 pregnant women in
vaccine-related congenital exposure (Tsai et al., 1993). A Weschester, New York, was carried out to determine if
small study has found a slight increase in spontaneous prenatal exposure to Lyme disease was associated with an
abortions during the rst trimester but other studies have increased risk of adverse pregnancy outcome. The results
not (Cobelens, 1998). It is better to give the vaccine during demonstrated that Lyme disease was not associated with
the second or third trimester if possible. fetal death, decreased birth weight, or length of gestation
402 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
at delivery. Tick bites or Lyme disease around the time of General Principles
conception was not associated with congenital malforma-
tions. Maternal exposure to Lyme disease before concep- The following questions should be considered before pre-
tion or during pregnancy was not associated with fetal scribing a medication to a pregnant woman:
death, prematurity, or congenital malformations. The
How does pregnancy aect the pharmacokinetics of the
possibility that exposure to Lyme disease increases the
medication?
risk of specic malformations or has an eect if a preg-
Are the side-eects of the medication more severe or
nant womens infection is not treated is not known. This
more common than in the nonpregnant woman?
study overall supports the benign nature of this infection
What is the potential risk to the developing fetus?
with respect to the fetus and the pregnant woman
(Strobino et al., 1993). There are a number of physiological changes during preg-
Lyme disease vaccine (LYMErix) is an adjuvanted for- nancy that might aect the pharmacokinetics of a par-
mulation of the outer surface protein A (OspA) of the ticular medication. The volume of distribution of drugs is
causative spirochete. It is eective against the Lyme dis- increased during pregnancy owing to an increase in ma-
ease spread by ticks in the USA only. It acts by inducing ternal weight and plasma volume. The result is less drug
high titres of anti-OspA antibodies (anti-OspA), which due to a reduced maternal serum concentration. Drugs
must be present in vaccinated individuals before exposure that are excreted mainly by the kidney may be inuenced
to B. burgdorferi to provide protection against Lyme by increased renal blood ow and glomerular ltration.
disease. Ecacy against Lyme disease was 80% for de- The increase in progesterone during pregnancy may lead
nite and asymptomatic cases and 76% for denite cases at to an induction of liver metabolism of some medications.
year 2 using the recommended dosage. A change in gastrointestinal motility may lead to variable
This is an example of a vaccine-preventable disease and reduced absorption of orally administered agents.
with a vaccine that is only moderately ecacious at 80%. Any of these factors could lead to a reduction in the
As studies have shown that Lyme disease is not asso- maternal serum level of the drug and failure of the clinical
ciated with fetal death, prematurity or fetal malformation response. The actual clinical signicance of these changes
if treated, the vaccine is not recommended for pregnant is not known.
women. Preventive measures should be emphasized, such Most drug transfer across the placenta occurs by
as avoiding heavily wooded areas in endemic areas, wear- simple diusion. Drugs with low molecular weight, high
ing protective clothing, and having body checks for ticks lipid solubility and low protein binding are most readily
to promote early removal and less likelihood of trans- transferred. Drug transfer increases with gestation due to
mission. reduced thickness of the placenta. To minimize risk to the
fetus, doses at the lower end of the therapeutic range
should be prescribed.
The typical problems of pregnant travelers are the
Rabies same as those experienced at home. Appropriate self-
management tools should be discussed to address issues
Pregnancy is not a contraindication for postexposure
such as morning sickness, heartburn, indigestion, consti-
prophylaxis. Pre-exposure prophylaxis with rabies vac- pation, hemorrhoids, frequent urination and leg cramps.
cine should be given if there is substantial risk of expo- Other medications for treating urinary tract infection,
sure.
vaginitis, diarrhea and malaria should be reviewed for
safety during pregnancy.
Use of Medications
Malaria and Pregnancy
All physicians advising pregnant women should have
ready access to a reference such as Drugs in Pregnancy and Malaria aects between 300 and 500 million people a
Lactation (Briggs et al., 1998), which includes reviews of year, resulting in over 3 million deaths. Morbidity and
the reproductive literature relevant to drugs and immu- mortality are the greatest in children and pregnant
nizations. Each medication is categorized by the risk women and travelers. There is increasing incidence of
classications outlined by the FDA. It is dicult to state chloroquine-resistant strains of Plasmodium faciparum
categorically that any medication used before or during (CRPF) and P. vivax worldwide. A greater eort needs to
pregnancy is completely safe. As most medications have be made to reach pregnant women who may be returning
not been tested in pregnant women, they are classied as to a malaria endemic area to see family and friends.
category C. For up-to-date information one can consult What is the incidence of malaria in pregnant travelers?
the teratogen web sites (see Additional Resources). Preliminary data from the CDC surveillance program
There are other classication systems (for example in during 19971999 demonstrates that 3810 cases of ma-
Sweden, Australia, Netherlands, Switzerland and Den- laria were reported to the CDC; of these, 2313 were men,
mark) that are based on a hierarchy of estimated fetal 1279 were women and the sex was not known in 218
risk. people. Sixty-three of the women were reported to be
WOMENS HEALTH AND TRAVEL 403
pregnant; 25 of the women were US residents; 36 were of pregnancy until delivery, and pregnancy outcome was
foreign residents; others of unknown status (M. Parise, recorded. The eect of P. vivax infection on anemia and
2000, personal communication). pregnancy outcome were compared with the eect of
These data suggest that the highest risk of malaria in either P. falciparum or the eect of no evidence of malaria
pregnant travelers is in those women returning to an infection during the pregnancy. P. vivax malaria was not
endemic area to see their family(18/25 US residents). associated with miscarriage, stillbirth or with a shortened
Travel medicine practitioners should promote duration of pregnancy but it was associated with ma-
chemophylaxis in this high-risk group. Most cases of ternal anemia and low birthweight. The eects of P. vivax
malaria were acquired in Africa and most cases were infection are less striking than those of P. falciparum
falciparum plasmodium. According to the data collected infection but antimalarial prophylaxis against P. vivax in
most of the pregnant travelers did not take, or took pregnancy is still justied (Nathwani et al., 1992; Nosten
inappropriate, prophylaxis for the area of destination et al., 1999).
(20/25 US residents); 47 of the women were hospitalized. For nonimmune pregnant travelers the risk of contact-
Complications during treatment included adult respir- ing any type of malaria during any pregnancy is signi-
atory distress syndrome, renal failure and anemia. None cant. Maternal malaria is a major cause of pregnancy-
of the cases was fatal. related complications, including premature delivery, in-
Malaria acquired during pregnancy has severe conse- trauterine growth retardation and perinatal mortality in
quences. If a woman is pregnant or plans to become the infant and anemia and maternal mortality for the
pregnant and cannot defer travel to a high-risk area, mother. Contraction of malaria by a nonimmune preg-
appropriate chemoprophylaxis is essential. Pregnancy is nant traveler greatly increases the risk of losing the fetus.
associated with an increased susceptibility to malaria
both during pregnancy and during the postpartum period
(Diagne et al., 2000). Pregnancy increases susceptibility Theories of Pathogenesis of the Malaria Parasite
and clinical severity of falciparum malaria in women both During Pregnancy
with and without existing immunity, i.e. women living in
and traveling to endemic areas. A pregnant traveler visit- Why are women more at risk for malaria during preg-
ing an endemic area is at signicant risk for malaria nancy? In endemic areas women have, with time, ac-
infection and its devastating consequences for her and her quired immunity to P. falciparum equivalent to their male
fetus. counterparts. It has been found, however, that pregnant
Most of the studies on malaria occurring during preg- women have a unique susceptibility to malaria, especially
nancy have been done on pregnant women living in en- with their rst pregnancy. This susceptibility to malaria
demic areas. These studies have demonstrated that has been found to decrease as the number of pregnancies
women living in such areas have an increased susceptibil- increases. One theory for an increased risk of malaria
ity to P. falciparum infection during pregnancy when during pregnancy has been thought to be due to the
compared with local women who are not pregnant. The immunosuppression of pregnancy necessary to inhibit
increase in susceptibility appears to be more during the maternalfetal placental unit rejection. This is believed to
rst pregnancy and to diminish, in some studies, with lead to a number of increased infections during preg-
subsequent pregnancies. For individuals living in en- nancy, including malaria. The fact that this susceptibility
demic areas protective immunity is acquired during child- is markedly lower in gravid women than it is in primi-
hood. The increased susceptibility to malaria for women gravid women in endemic countries suggests that im-
during pregnancy has been thought to be due to seques- munosuppression cannot entirely explain the phenon-
tration of the parasites in the placenta and suppression of menon.
selected components of the immune system, associated The placenta is a preferential site for sequestration of
with the increased production of several hormones and red blood cells and may have a high density of multiply-
other proteins (Fried and Duy, 1996; Diagne et al., 1997; ing parasites, while the peripheral circulation is free of
Duy and Fried, 1999; Nahlen, 2000). parasites. Thus the peripheral blood smear may be nega-
tive, making the diagnosis of malaria dicult. The para-
sites sequestered in the placenta might be the source of an
Plasmodium vivax Infection overwhelming maternal malarial infection if not treated
in time. The placental infection leads to fetal growth
Plasmodium vivax is more common than P. falciparum as retardation and may lead to intrauterine fetal death
a cause of malaria in many parts of the tropics outside (Matteelli et al., 1997; Steketee et al., 1996).
Africa. Most of the studies done on malaria in pregnancy
have concentrated on P. falciparum infection. The eects
of P. vivax have not been as well characterized. A study Guidelines for Prevention
investigated the eects of P. vivax infection during preg-
nancy on women living in camps for displaced people on As no antimalarial agent is 100% eective, it is of crucial
the western border of Thailand (Nosten et al., 1999a). The importance that pregnant women use personal protective
women were screened for malaria and anemia each week measures to avoid and/or minimize mosquito bites when
404 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
traveling through a malaria endemic area. weak mosquito repellent for 15 min and thus is clearly not
A recent study demonstrated that pregnant women indicated for malarial endemic areas.
might be more attractive to mosquitoes and therefore
more at risk for malaria, as well as other mosquito-borne
infections such as dengue and yellow fever (Lindsay et al., Chemoprophylaxis
2000). The mechanisms underlying an increased attract-
iveness to mosquitoes during pregnancy are likely to be A list of the available antimalarials and their uses and
related to at least two physiological factors. First, women contraindications during pregnancy can be found in
in the advanced stages of pregnancy were found to pro- Table 24.11. Any medication taken during pregnancy
duce 21% more exhaled breath than their nonpregnant carries some risk. In order to truly evaluate a medication
counterparts. There are several hundred dierent compo- during pregnancy large-scale studies involving hundreds
nents in human breath, some of which are likely to be of thousands of pregnant women would have to be under-
used by mosquitoes for detecting a host. At close range, taken. This has not been done.
body warmth, moist convection currents, host odors and Most travel health advisors recommend that pregnant
visual stimuli allow the insect to locate its target. During women do not travel to areas where cholorquine-resis-
pregnancy, blood ow to the skin increases, which helps tant faliciparum malaria occurs because of the potential
heat dissipation, particularly in the hands and feet. Thus, risk of acquiring the disease and the possible eects from
the second reason for increased attractiveness may be treatment or chemoprophylaxis. This is particularly im-
that these hotter pregnant women increase the release of portant in areas of conrmed meoquine resistance, such
volatile substances from the skin surface and produce a as the ThaiBurmese border. However, sometimes a
larger host signature that allows mosquitoes to detect woman must travel to an endemic area and it is important
them more readily at close range. Not only do pregnant for the travel medicine advisor to help a woman appreci-
women appear to be physiologically more attractive to ate the risk of such a decision and what she can do to
mosquitoes, but changes in their behavior can also in- decrease that risk if travel is unavoidable. A clinician
crease exposure to night-biting mosquitoes. In compari- involved with advising pregnant women will have to con-
son with the nonpregnant, pregnant women are likely to sult up-to-date web sites and research centers for the most
leave the protection of their bed net at night to urinate current data.
twice as frequently. This study demonstrates that preg-
nant women are at increased risk of malaria, and perhaps
other mosquito-borne diseases, and underlines the im- Chloroquine-sensitive P.falciparum Malaria
portance of protecting this vulnerable group against bit-
ing by vectors. Pregnant women should be encouraged to Although chloroquine crosses the placenta, it has been
use a combination of preventative measures including: found to be safe in pregnancy both for chemoprophylaxis
permethrin-treated clothing, topical insect repellents and and in therapeutic doses for established malaria. Preg-
bed nets. nant women have used chloroquine for decades without
any documented increase in birth defects. Thus travel by a
Topical insect repellentsDEET. N,N, diethyl-m-tol- pregnant woman to an area where chloroquine can be
umide (DEET)-containing preparations have been used used for prophylaxis can be considered relatively safe.
by millions of people worldwide for 40 years. DEET has a This includes endemic areas in Central America, the Cari-
remarkable safety prole. Studies of high doses of DEET bbean and the Middle East. In these areas, chloroquine
administered orally to mice and rats did not reveal any remains the drug of choice. It should be given as the
potential in humans for teratogenicity or oncogenicity. 300 mg base equivalent (equal to 500 mg of chloroquine
Because the reproductive eects of DEET in laboratory base salt), starting 1 week prior to travel in an endemic
animals are conicting and there are no human data, area, continuing weekly while traveling in an endemic
DEET is currently classied as category B. It has been area and for 4 weeks after.
shown to cross the placental barrier in some studies and
not in others; thus pregnant women should avoid the use
of highly concentrated DEET-containing repellents. P. vivax and P. ovale Malaria
Lower concentrations of DEET, from less than 10% to
35%, may be used sparingly (Fradin, 1998). There is also a It is usually recommended that the nonpregnant traveler
new slow-release formula (microcapsule) of DEET that take a drug called primaquine phosphate for causal pro-
may be safer for use in pregnancy. phylaxis to prevent relapse of malaria caused by the liver
stage of P. vivax or P. ovale. However, it is important that
Non-DEET topical insect repellents. The safety and e- primaquine is not given to a pregnant traveler owing to
cacy of non-DEET preparations has not been established the possibility of a life-threatening hemolytic anemia in
and cannot be relied upon to prevent malaria in highly the fetus if the fetus is glucose-6-phosphate dehyd-
endemic areas. For example, one of the brands recom- rogenase (G6PD) decient. Instead, weekly chloroquine
mended by the lay press as eective and safe in pregnancy or other appropriate antimalarial agent should be con-
has been shown to be neither safe nor eective; it may be a tinued until delivery to prevent a febrile episode caused
WOMENS HEALTH AND TRAVEL 405
Table 24.11 Malaria chemoprophylaxis in pregnant travelers
Chloroquine-sensitive areas
Chloroquine 300 mg base (equal to 500 mg of Safe
phosphate salt per week) Reactions rare
Cholorquine-resistant areas
Meoquine 250 mg weekly Neuropsychiatric reactions
Start 1 week before travel and continue 1: 15 00020 0000
for 4 weeks after travel to malarious zone Safety in rst trimester not fully
established although CDC approved
Possible trend in stillbirths noted in some
studies
Atovaquoneproguanil (Malarone) Atovaquone 500 mg ; proguanil 200 mg, Recommended for individuals who can
or Atovaquone 250 mg ; proguanil not take meoquine
100 mg Safety of atovaquone in pregnancy not
1 tablet daily for 12 days before travel established
and for 1 week after leaving malarious It is not known whether atovaquone is
area excreted into human milk
Proguanil is excreted into human milk in
small quantities
Based on experience with other
antimalarial drugs, the quantity of drug
transferred in breast milk is insucient to
provide adequate protection against
malaria for the infant
Because data are not yet available on
safety and ecacy, Malarone should not
be given to a woman who breast feeds an
infant who weighs less than 11 kg unless
the potential benet to the woman
outweighs the potential risk to the child
(for example, for a lactating woman who
had acquired P. falciparum malaria in an
area of multidrug resistance who could
not tolerate other treatment options)
Proguanil and chloroquine Proguanil 200 mg per day Anecdotally safe in pregnancy
Chloroquine 300 mg base per week Only 70% eective
Folate supplements recommended
Limited use due to increasing drug
resistence
Pyrimethaminedapsone (Maloprim) Pyrimethamine 12.5 mg and dapsone Pyrimethamine should be avoided in the
100 mg, 1 tablet once a week rst trimester
Folinic acid supplement needed
Side-eects of dapsone include
dose-related hemolytic anemia, more
severe in G6PD-decient individuals,
methemoglobinemia, agranulocytosis
1: 20 000
Restricted use only
Not FDA approved
Pyrimethaminesulfadoxine (Fansidar) Pyrimethamine 25 mg ; sulfadoxine Severe cutaneous reactions 1: 5000 to
500 mg, 1 tablet once a week 1: 10 000
Generally not recommended
Azithromycin (Zithromax) 250 mg daily More data needed
Eectiveness only 7080%
Not recommended
Adapted from Samuel BU and Barry M (1998) The pregnant traveler. Infectious Disesase Clinics of North America, 12, 325354.
406 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
by symptomatic malaria. After delivery the mother For women of reproductive age it is recommended that
should be tested for G6PD deciency and given they do not become pregnant while taking the drug and
primiquine if she is not G6PD decient. for 3 months afterwards.
Alternatives to meoquine include the following.
The main concern with travelers diarrhea during preg- GENDER-RELATED ISSUES IN TROPICAL
nancy is the prevention of dehydration, which can lead to DISEASE
decreased placental blood ow, premature labor and
shock. Pregnant women may be at greater risk of con- Gender-related issues in tropical medicine have not been
tracting diarrhea owing to decreased gastric acidity and addressed on a large scale until recently. WHO has for-
increased transit time of food through the intestine. med the Gender Task Force of the WHO Tropical Dis-
Treatment for uid loss should be started promptly. For ease Research Programme (TDR), which is evaluating the
travel to rural areas, pregnant travelers should carry oral gender-related biological, behavioral and cultural factors
rehydration packets. that might aect the epidemiology, diagnosis, treatment
Chemoprophylaxis for mild travelers diarrhea is not and/or outcome of a particular tropical disease (Vlasso,
recommended for pregnant travelers. To control fre- 1997).
quency of bowel movements, loperamide or
diphenoxylate are two antimotility drugs (category B)
that may be used with severe diarrhea. Antibiotics Parasitic Infection
commonly used to treat diarrhea, such as ciprooxacin
and tetracycline, are contraindicated in pregnancy; how- Parasitic infections are common throughout the world
ever, for severe diarrhea a few days of a quinolone anti- but until recently dierences between eects on women
biotic should be considered. Quniolones are category C and men have not been studied. Due to the increase in
drugs: adverse eects have been seen in animals but not in international travel and the immigration of people from
humans. A limited dose would be unlikely to aect the tropical areas to more developed countries, physicians
fetus. Although many enteric pathogens are resistant to are likely to see an increase in tropical disease with both
ampicillin/amoxicillin, they may be tried in pregnant common and uncommon presentations.
woman who are not allergic to penicillin. Erythromycin Pretravel advice for women should include a risk as-
and azithromycin are safe to take during pregnancy and sessment as to potential exposure to parasitic disease.
are especially eective in treating Campylobacter-induced Knowledge about how a particular disease might aect
WOMENS HEALTH AND TRAVEL 409
Table 24.12 Potential eects of parasitic infection on reproduction
Failure to
Parasites Impaired fertility carry to term Fetal infection
Protozoans
Entamoeba histolytica ; ;
Giardia lamblia x ;
Leishmania spp ; ; ;
Plasmodium spp ; ; ;
Trypanosoma spp ; ; ;
Toxoplasma gondii ; ;
Pneumocystis carinii ; ;
Intestinal nematodes
Ascaris lumbricoides ; ; ;
Enterobius vermicularis (pinworm) ;
Trichuris trichiura (whipworm) Hookworm ; ; ;
Extraintestinal nematodes
Strongyloides stercoralis ; ;
Trichinella spiralis ; ; ;
Filaria spp ; ; ;
Trematodes
Schistosoma spp ; ;
Clonhorchis sinensis ; ;
Paragonimus westermani ;
Cestodes
Echinococcus spp ; ;
Taenia spp ; ;
Adapted from Lee RV (1988) Medical Complications During Pregnancy (eds GN Burrow and TF Ferris). WB Saunders, Philadelphia; and Manuel, Elaine
C. Jong and Mcmullen Russel (eds) (1995) Travel and Tropical Medicine, p. 156. WB Saunders, Philadelphia.
her long-term fertility or pregnancy outcome might make uid during the in vitro fertilization procedure. The
a dierence to a travelers compliance with preventative woman was also found to have schistosomal infection.
measures or bring about a change in itinerary so as to Although the authors do not believe a case similar to this
avoid the risk of exposure (Table 24.12). has been reported, it is probably because microlariae
After travel, women should be asked about travel his- and other parasites have not been looked for routinely in
tory if they have recurrent gynecological symptoms or are the female genital tract.
in the process of an infertility workup or breast-mass Thus, physicians evaluating women immigrants or
evaluation. Parasitic worms such as Ascaris spp. amd world travelers for infertility and other gynecologic prob-
Enterobius vermicularis have been found on Pap smear lems should consider parasitic infections in the dieren-
results. Amebiasis can result in ulcerating lesions and tial diagnosis (Balasch et al., 1995). Clinicians evaluating
unusual vaginal disharge in some cases (Hammill, 1989). pregnant women should also review past travel history
Breast masses are not always malignant: they can be during their prenatal visit owing to the risk of an acceler-
parasitic in a woman with the appropriate travel history ated course of some tropical diseases during pregnancy
(Sloan et al., 1996; Perez et al., 1997). and/or congenital transmission.
Parasitic infection as the only or concomitant cause of Parasitic diseases in women may have eects on fertil-
infertility in Caucasian women is rare to date; however, ity, during pregnancy and throughout the life stages as a
with the burgeoning increase in travel for work and play, result of a variety of mechanisms (Stray-Pedersen, 2000).
parasitic causes of infertility will increase. Parasitic infec- The infecting parasite may cause anatomic or func-
tions may be found in unusual places if there is an index of tional changes in the genital tract so that conception or
suspicion. An interesting case of microlariae in follicular implantation does not occur, owing to scarring and in-
uid was recently described in a case report (Goverde et ammation of the fallopian tubes or inltration of the
al., 1996). The case involved an infertile woman undergo- uterine lining. The parasitic infection may be severe
ing in vitro fertilization. Her infertiliy was presumed to be enough to aect maternal health adversely during preg-
due to Chlamydia trachomatis but moving microlariae of nancy, to the point that pregnancy termination is
Mansonella perstans were found in the aspirated follicular required. The parasites may infect and cross the placenta
410 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Table 24.13 Tropical parasitic infections: issues specic to women
Intestinal nematodes
Ascariasis Adult worms can invade the female Food and water precautions Pyrantel pamoate
genital tract and cause tubo-ovarian Treat in pregnancy only if
abscess, pelvic pain and infertility severe infection
Mebendazole
Albendazole
Enterobiasis (pinworm) Pinworms can migrate and ascend the Good personal hygiene Mebendazole
genital tract causing vaginitis and Albendazole
pelvic inammatory disease Pyrantel pamote
Pregnancy can exacerbate the Treat only if severe infection
symptoms of vaginitis and pruritus
vulva
Hookworm Can cause severe anemia, causing Do not walk barefoot Mild cases treat with iron,
Ancylostoma duodenalis intrauterine growth retardation during vitamins, protein
Necator pregnancy Severe cases pyrantel
pamoate 11 mg\ kg\ daily
for 3 days
Strongylodiasis Hyperinfection can occur during Do not walk barefoot Postpone treatment in
pregnancy due to immunosuppression asymptomatic women until
Lactation is contraindicated until after after delivery
treatment as larvae may be passed in Severe infection
milk to infant thiabendazole, ivermectin
Tissue nematodes
Wucheria bancrofti Adult worms inhabit lymphatics and Avoid mosquito bites Treatment should be avoided
regional lymph nodes. Acute and until after delivery;
chronic inammation can lead to diethylcarbamazine
obstruction of the lymphatics and
edema of the breast, vulva and pelvic
organs
Brugia malayi Adverse eect on fertility and lactation Avoid mosquito bites Treatment should be avoiled
Elephantitis of vulva may obstruct until after delivery;
labor and necessitate C-section diethylcarbamazine
Pregnancy may exacerbate edema and
chyluria
May be associated with hydramnios
Microlaria can invade placenta and
fetus
Trichinella spiralis May disrupt menstrual cycle Avoid eating pork, boar or Pyrantel pamoate active
May cause abortion, premature labor, bear against ingested larve
stillbirth Once tissue invasion need
? Intrauterine infection thiabendazole
Trematodes
Schistosomiasis (Female The female genital may be infected with Avoid water, infested areas Praziquantel
genital schistosomiasis, FGS) eggs of S. mansoni and S. haematobium May treat if necessary during
Acute and chronic inammation of the pregnancy
fallopian tubes and ovaries can lead to
salpingitis, infertility, ectopic
pregnancies
Lesions of the cervix, vagina, vulva
may ulcerate and be painful with
intercourse
May facilitate transmission of HIV
from infected men to uninfected women
May need surgery prior to vaginal
delivery
Schistosomiasis may aect the placenta
and the fetus; however, there is no
evidence of growth retardation or
preterm delivery to date
No evidence that pregnancy accelerates
the development or increases the
severity in the mother
WOMENS HEALTH AND TRAVEL 411
Table 24.14 Indications for treatment of intestinal nematodes during pregnancy
Indications for
Mode of prescription in
Parasite Infective state transmission Adult habitat pregnancy
Adapted from Lee RV (1988) Medical Complications During Pregnancy (eds GN Burrow and TF Ferris). WB Saunders, Philadelphia.
and cause intrauterine growth restriction, miscarriage, Therapeutic Recommendations for Individual
stillbirth and fetal and congenital infection. The infection Conditions
may cause problems during the perimenopause and
menopausal era that have not been studied. Virtually all the important helminth infections in humans
If infection occurs during pregnancy or immediately can be treated with one of ve anthelmintics currently in
prior to pregnancy, the eect on maternal health and the use: albendazole, mebendazole, diethylcarbamazine, iver-
developing fetus depends on the type of parasitic infec- mectin and praziquantel (de Silva et al., 1997). These
tion, the natural immunity to the infection and the para- drugs are vital not only for the treatment of individual
sitic load. Diagnosis is often based on a high index of infections but are also useful in controlling transmission
suspicion due to the patient having traveled to or from an of the more common infections. This article reviews brie-
endemic area or to the presence of certain diseases in the y the pharmacology of these ve drugs, and then dis-
local community. cusses current issues in the use of anthelmintics in the
All travel health clinicians should develop an under- treatment and/or control of soil-transmitted nematode
standing of the most common parasitic diseases, their infections, lariasis, onchocerciasis, schistosomiasis (and
mode of transmission, clinical manifestations, diagnosis other trematode infections), neurocysticercosis and hy-
and how the infection might aect a pregnancy or lead to datidosis.
changes in the female genital tract. This information will Mebendazole and albendazole are most eective
be helpful for both pretravel and post-travel assessments against intestinal nematodes, but are contraindicated
(Tables 24.12 and 24.13). Most of the work on the eects during the rst trimester of pregnancy. The ecacy of
of tropical disease in women has been done on women prolonged therapy with these two drugs for treatment of
that live in developing countries. There may be a range of larval cestode infections has not yet been established.
eects, from asymptomatic to more devastating, due to Diethylcarbamazine is widely used to treat and control
dierences in immunity between women living in endemic lymphatic lariasis, but adverse eects related to death of
countries and women traveling to or working in them. microlariae or damage to adult worms may be marked.
Hopefully, by developing a better understanding of the While ivermectin has been used in the treatment of pa-
range of eects, all women can be helped. tients with onchocerciasis, it is also undergoing investiga-
tion for use against lymphatic lariae. Praziquantel, used
to treat schistosome infections, is also eective in other
When to Treat a Parasitic Disease in Pregnancy trematode infections and adult cestode infections (de
Silva et al., 1997).
The decision of when to treat a parasitic infection during Ivermectin is the drug of choice for onchocerciasis. A
a pregnancy is dicult but should be based on knowledge small study demonstrated no increased incidence of birth
of the maternal and fetal eects of the disease balanced defects when it was given inadvertently to pregnant
with the toxic eects of the antiparasitic drug on the women (Pacque et al., 1990).
developing fetus. Table 24.14 summarizes the use of anti- Intestinal protozoan disease diagnosed in pregnant
parasitic agents in pregnancy. women is mostly controlled by symptomatic treatment.
Specic therapy can be delayed until after delivery. Only
severe cases, i.e. continued diarrhea leading to malnutri-
tion of either mother or fetus, require an immediate speci-
412 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
c drug therapy, which might be harmful to the fetus due Pathophysiological Basis
to toxic and teratogenic potentials. Vertical transmission
of intestinal protozoa has not been described. Invasive Copulating adult worms have been found in histological
protozoan infections can be lethal to the mother, making sections of the vulva, cervix, uterus and fallopian tubes.
immediate drug therapy mandatory, even if the potentials The specic vasculature of the small pelvis allows the
of fetotoxicity or teratogenicity are known. Vertical adult worms to migrate and can cause schistosomal eggs
transmission occurs independent of maternal symptoms, to be transferred to the genital organs. Anastomoses be-
causing clinical disease in the child either directly after tween the dierent venous plexes of the small pelvis, the
birth or during the rst months of life. Knowledge of veins, which are almost without valves and allow blood to
endemic regions and of the maternal travel history is ow in either direction, as well as portosystemic anas-
essential for early diagnosis and treatment of protozoan tomoses present a network of routes for the migration of
disease in pregnancy and of congenital protozoan infec- worms and/or the embolization of eggs. Adaptive vascu-
tions (Bialek and Knobloch, 1999). lar changes at puberty and changes in the venous blood
Prevention is the key concept, owing to the potential ow during pregnancy can increase the risk of ectopic
adverse eects resulting from the parasite or its treatment. vascularization.
it requires a basic knowledge of the life cycle of the
parasite.
Parasitic infection during pregnancy is common. With Prevalence
most parasites, primary prevention is very eective in
avoiding infestation. With the exceptions of malaria, Until recently the occurrence of FGS was estimated from
toxoplasmosis and African trypanosomiasis, when infec- postmortem studies in endemic areas. Frequencies of any-
tion does occur treatment decisions should be based on where from 7 to 100% for lesions in the lower reproduc-
the impact of the infection on the patient and her fetus on tive tract, and 2 to 83% for lesions in the upper reproduc-
an individual basis. When treatment is indicated, selec- tive tract, were observed (Feldmeier et al., 1995). More
tion of medications with the least potential to harm the research needs to be done on the eects of and immune
mother, and more particularly the developing fetus, is reponse to schistosome infection in both women and
essential (Tietze and Jones, 1991). men.
Natural History
Female Genital Schistosomiasis
The natural history of egg-induced lesions remains un-
The recent explosion in the number of women exposed to clear. There are two distinct tissue patterns: a strong
schistosomiasis, either through adventure travel and/or inammatory reaction around viable eggs, and brous
from working for a relief organization in endemic areas, tissue reaction around nonviable eggs or fragments.
may increase the numbers of infections (Centron et al., FGS symptoms and signs are nonspecc and may be
1996). Thus it is important to review some of the recent confounded by those of other pelvic disease: irregular
studies describing the long-term eects on a womens menstruation, pelvic pain, vaginal discharge. Lesions can
reproductive tract. This information can be used to edu- grow for months and years. If in the vagina or vulva they
cate women before travel about the risks of exposure. may lead to hypertrophy and obstruction. They can be
Female genital schistosomiasis (FGS) is characterized painful or painless.
by the presence of schistosome eggs or worms in the
upper or lower genital tract (Poggensee et al., 2000). The
original description dates back to Egypt in 1899, when a Public Health
tumorous growth was observed in the vagina of a young
woman and was found to consist of numerous egg FGS may be an important factor in the spread of sexually
granulomas. Since then schistosoma ova and adult transmitted diseases, especially AIDS.
worms have been detected throughout the female genital Because lesions tend to bleed easily, HIV in semen would
tract, from the vulva to the ovaries, in many of the coun- have access to the blood circulation via ulcerative lesions,
tries where urinary schistosomiasis is endemic (Feldmeier and thence to regional lymph nodes.
et al., 1995). Clinically apparent vulvar, vaginal and cervi-
cal schistosomiasis has been reported from both endemic
and nonendemic areas due to the increase in travel and Infertility and Pregnancy-related Disorders
migration. This has lead the Gender Task Force of the
WHO-TDR to include FGS in a list of scientic areas Functional and anatomic disorders caused by ovarian,
that deserve a high research priority (Poggensee et al., tubal and uterine schistosomiasis include brosis of the
1999). ovaries and tubal occlusion, which can lead to ectopic
pregnancies and infertility. Infection of the placenta may
cause stillbirths.
WOMENS HEALTH AND TRAVEL 413
Table 24.15 Consequences of female genital schistosomiasis for severe disease and death (Li and Stanley, 1996). Preg-
nancy may predispose to the development of fulminant
Organ aected Possible consequences colitis in patients with amebic dysentery. One study re-
ported that two-thirds of the fatal cases of amebiasis
Vulva/vagina Destruction of clitoris/hymen occured in pregnant women (Abioye, 1973). Increased
Cervix Anemia due to chronic blood loss
circulating cholesterol during pregnancy may be a
Carcinoma, may be cofactor with
human papillomavirus
growth substrate for the amebae and is thought to be one
May increase risk for STD explanation for the fulminant course. The frequency of
Uterus Anemia due to blood loss liver abscesses is thought to be a consequence of a protec-
Metaplasia tive eect of estrogen (Ravdin, 1995). Other risk factors
Miscarriage for severe disease include treatment with corticosteroids,
Preterm delivery malignancy and malnutrition. There is no evidence that
Tubes Ectopic/tubal pregnancy E. histolytica is associated with an intrauterine infection;
Secondary infertility however, infection during delivery or during the neonatal
Ovaries Hypogonadism period, from mother to infant, does occur.
Infertility primary or secondary Treatment during pregnancy depends on the symp-
toms. There is currently no drug that is active against
amebic cysts. Antimicrobial therapy is directed against
Diagnosis the trophozoite stage. For asymptomatic cases the in-
traluminal stage can be treated with paromomycin, an
The gold standard is biopsy of the lower genital tract but oral aminoglycoside. Paromomycin is poorly absorbed
diagnostic means suitable for eldwork are still lacking. from the gastrointestinal tract and is thus considered safe
The aim is the development of assays for detection of in pregnancy. Metronidazole has broad activity against
indirect disease markers or schistosome antigen from amebiasis. It is also eective against giardiasis and
swab eluates that women can do themselves. Until recent- trichomoniasis. It passes freely through the placental bar-
ly, diagnosis of upper tract FGS was incidental. rier and animal studies to date indicate that it is non-
This is an example of how a tropical disease such as teratogenic. The drug, classied as FDA pregnancy cat-
schistosomiasis can have severe consequences in women egory B, is regarded as safe in pregnant women as no
(Table 24.15). Much more research is needed. There may teratogenic eect in humans has been documented (Bur-
be dierence in immune status between women who live tin, 1995). For amebic abscess the treatment of choice is
in endemic countries and women who travel to them. It is metronidazole followed by paromoycin.
not known what to do if there is positive serology in an
asymptomatic person. Treatment is recommended. If the
woman is treated, how will we measure the endpoint? Giardiasis
New preventative measures and methods for early diag-
nosis and treatment need to be developed. Although maternal giardiasis does not aect the fetus
directly, it may cause growth retardation and impair
fertility as a result of malabsorption and nutritional
Amebiasis deprivation. Pregnant women should only be treated if
they are symptomatic. The treatment of choice is metro-
It has been estimated that 500 million people are infected niadazole 400 mg t.i.d. for 7 days. Do not use a 2 g dose
with either Entamoeba histolytica or E. dispar, with E. during pregnancy. Paromomycin, a poorly absorbed
dispar infection probably 10-fold more common than E. aminoglycoside, could be used at a dose of 10 mg kg\
histolytica infection. Among individuals infected with E. three times a day for 510 days.
histolytica, 40 million people develop disabling colitis or
extraintestinal abscesses, resulting in 40 000 deaths an-
nually. Among parasitic diseases, only malaria and schis- Trypanosomiasis
tosomiasis result in more deaths than amebiasis. Al-
though amebiasis is found worldwide, the highest Chagas disease is a tropical disease now making its ap-
prevalence rates are in developing countries. High rates of pearance in the USA as immigration from Latin America
amebic infection (both E. histolytica and E. dispar) have increases. Pregnant women with chronic Trypanosoma
been reported from the Indian subcontinent and In- cruzi infection may present with cardiac or gastrointes-
donesia, the sub-Saharan and tropical regions of Africa, tinal symptoms and transmit the infection to their fetuses
and areas of Central and South America. (Gilson et al., 1995).
The prevalence of colonic disease is equal in men and African trypanosomiasis is a rare but well-documented
women, but amebic liver abscesses and other extraintes- cause of fever in US travelers returning from areas where
tinal disease is 310 times more common in men. it is endemic. Recently, two cases were diagnosed in tour-
Children, especially neonates, pregnant women and ists who went on safari in Tanzania (Sinha et al., 1999). A
women in the postpartum period have an increased risk comrehensive review of the cases occurring in the USA
414 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
suggests that disease in returning American travelers is years, grow up to 35 cm long and lay 200 000 eggs a year.
nearly always of the East African form, a fulminant illness Complications of ascariasis include bowel obstruction,
for which prompt diagnosis is necessary. Timely and appendicitis, peritonitis and pancreatitis. There are rare
appropriate therapy for this disease in the USA has re- reports of congentital infection, ascribed to placental
sulted in favorable outcomes for most patients. Chemo- transmission. Maternal ascariasis leads to a risk of in-
prophylaxis for East African trypanosomiasis is not rec- trauterine growth retardation. Mebendazole, pyrantel
ommended, but travelers visiting areas of endemicity and levamisole are all eective but are not recommended
should undertake appropriate measures to prevent tsetse during pregnancy. Piperazine may be given to gravidas
y bites. after the rst trimester.
Toxoplasmosis Enterobiasis
Toxoplasma gondii is an intracellular coccidian parasite Infection with pinworm is common in temperate climates.
found throughout the world. Infection is spread through There is frequently perianal and perineal itching. The
the ingestion of oocysts in undercooked meat, by expo- worms may migrate into the genital area, producing chro-
sure through handling cat litter, or by consumption of nic vaginitis and on occasion pelvic inammatory disease.
foodstus contaminated with oocysts. The most import-
ant factor is eating raw or undercooked meat. Cats ex-
crete up to 10 million oocysts a day for up to 2 weeks
postinfection. Oocysts become infective 15 days after Leishmaniasis
excretion, are spread by surface water and can survive for
more than 1 year. Thus contact with soil and water and Each year 500 000 new infections with visceral leish-
eating undercooked meat are greater risk factors than maniasis occur. According to WHO, the ratio of subclini-
exposure to cats. cal to clinical infections is 5: 1.14. A study from Kenya
Fetal infection occurs as a result of primary maternal suggested that asymptomatic persons can be a reservoir
infection. Infection acquired prior to conception is not of leishmaniasis for extended periods. People can develop
considered a risk. The risk during pregnancy is that the the disease even decades after traveling to endemic areas.
infection will cross the placenta and cause spontaneous Women become immunosupressed during pregnancy,
abortion, stillbirth, hydrops fetalis or congenital infec- with a shift from cell-mediated to humoral immunity,
tion. Risk of fetal infection increases with length of gesta- which has been described in mice as well as humans.
tion but severity of infection is decreased. Therefore, women may also have a higher susceptibility
Preventative measures are important: avoid contact to leishmanisis during pregnancy, as has been shown in
with cat feces, wear gloves when gardening, employ high mice. Pregnancy may trigger the (re)activation of disease.
standards of hygiene when preparing food, avoid eating A recent report describes a leishmaniasis infection of an
raw or undercooked meat, wash vegetables and salads infant determined to have been infected by his mother,
thoroughly. who had must have had a subclinical infection that was
reactivated by pregnancy (Meinecke et al., 1999). The
mother had traveled to the Mediterranean areas of Por-
tugal, Malta and Corsica years previously. Thus leish-
Helminth Infections maniasis can be transmitted congenitally from asympto-
matic mother to child. Women who have lived in endemic
Disease and morbidity are a function of the number of areas for extended periods of time should be evaluated for
worms in the body. In the pregnant woman, low worm asymptomatic disease. Asymptomatic leishmanaisis
loads can wait until after delivery for treatment. should be considered in the prenatal evaluation of women
who have lived in endemic countries and may not be
symptomatic.
Ascariasis Visceral leishmaniasis is endemic to several tropical
and subtropical countries, but also to the Mediterranean
Ascaris lumbricoides is the most common helminth infec- region. It is transmitted by the sand y (Phlebotomus and
tion of humans, with an estimated 1 billion cases world- Lutzomyia spp). Occasional nonvector transmissions
wide. Transmission usually occurs from hand to mouth. have also been reported, through blood transfusions, sex-
Ova are ingested from a contaminated environment; ual intercourse, organ transplants and dog excrements,
larva are released into stomach, penetrate the gut wall and sporadically outside endemic areas.
and enter the circulation, on reaching the lung, larva cross
the alveoli and are transported to the trachea by cough-
ing and muciliary function. They are swallowed and reach
the small bowel, where they stay, developing into sexually
active forms. Adult worms have an average lifespan of 12
WOMENS HEALTH AND TRAVEL 415
GENDER-RELATED ISSUES IN SPORTS Temperature control in important. A pregnant woman
AND ADVENTURE ACTIVITIES should avoid extreme exercise in a hot and humid climate
because of the possible eect of raising the maternal and
Exercise during Pregnancy and Travel fetal temperature. The concern is of an increase in neural
tube defects. Hot tubs and saunas should be avoided for
Exercise during pregnancy has become the norm for most the same reason.
women. Pregnant women may plan to trek at altitude, ski A womans previous level of exercise and endurance
or go on extended bicycle trips. The potential benets and should be considered when planning an adventure.
possible risks of particular exercises have been reviewed Common sense should be used. For example, a pregnant
in the literature (Clapp, 1994; Artal, 1996). There are both traveler who wants to go on a ski vacation should con-
benets and risks that must be weighed and discussed. sider the fact that changes in her bodys center of gravity
Pregnant women who take holidays and vacations expect and increased joint laxity may put her at risk of an
to take part in all the sports and activities that elective accident due to a change in balance. Even an expert skier
travel allows them. Women without any medical prob- could fall under these circumstances, resulting in trauma
lems can indulge in numerous recreational activities to the fetus and the mother. It is probably best not to ski
throughout their pregnancy. The usual cautions about or trek at high altitudes due to the lack of access to care if
exercise in pregnancy hold true an emergency should occur.
The physician and the pregnant woman should discuss Limitations and/or contraindications to an exercise
her history, overall tness, previous level of activity and program during pregnancy would include any of the fol-
signs that portend discontinuation of the activity. They lowing problems: a history of spontaneous abortion or
should develop a program that is acceptable and enjoy- miscarriage, premature labor, multiple gestation, incom-
able but not hazardous to the fetus or the mother. petent cervix, unusual bleeding, placenta previa or severe
cardiac or pulmonary disease.
Exercise and Activity Guidelines
Categories Options
Menstrual supplies
Calender to keep track of menses
Supplies/devices: pads, tampons, menstrual cups, Keeper
towelettes/plastic disposal bags
PMS medication
NSAIDS Ibuprofen, other
Dysfunctional uterine bleeding medication
Guidelines Premarin 2.5 mg tablets,
Premarin 1.25, estradiol 2 mg
Oral contraceptive pills
NSAIDSiboprofen, other
Urinary tract infections
Antibiotic Ciprooxacin 250 mg b.i.d. ; 3
Urinary analgesic Pyridium 200 mg t.i.d. for dysuria
Optional screening Urinary dipstick to check for leukocytes and nitrites
test
Pyelonephritisif fever, nausea and ank pain suspect upper
tract disease
Antibiotic Ciporooxacin 250 mg b.i.d. ; 14 days
Urinary voiding supplies
Toilet tissue, towelettes
Funnelspaper or plastic
Vaginitiscandidasis
Self-diagnosis tool pH paper: pH 4.5 acidophilic
Vaginal creamsCandida Monistat vaginal cream
Vaginal suppositories Nystatin
Oral medication Fluconazole 150 mg ; 1
Mild soaps
Pruritus Hydrocortisone cream for pruritus
Loosey airy clothes
Bacterial vaginosis
Self-diagnosis tool pH paper: Ph 4.7
Vaginal creams Metrogel, clindamycin
Oral antibiotics Metronidazole, clindamycin
Trichomoniasis
Metroniadazole
Contraception
Chartto keep track of pills if using them, menstrual periods
Timerspecial wrist watch alarm to use for oral
contraceptive pill dosing when changing time zones, traveling
Male/female condoms
Diaphragm/cap/sponge
Spermicidescontraceptive creams, jellies, lms
Review options in country of destination
Emergency contraception
Combined pill regimen or levonorgestrel regimen
Antinausea pillsphenergan 25 mg per rectum
New method of contraception to be used
Misopristone (RU-486) China, some European countries, USA
(just approved)
Emergency postexposure HIV prophylaxis for high-risk
unprotected sexual encounter
Check latest Zidovudine 200 mg t.i.d. for 4 weeks
recommendations Lamivudine 150 mg b.i.d. for 4 weeks
Add indinavir 800 mg t.i.d./nenavir for high-risk exposure or if
zidovudine-resistant HIV strains present or suspected
WOMENS HEALTH AND TRAVEL 417
Table 24.16 (cont.)
Categories Options
unchanged. Changes in fetal hemoglobin shift the oxygen exercise at altitude (skiing, running, mountain bicycling,
dissociation curve to the left, which improves cord blood trekking, etc.). The studies to date have been conducted at
oxygen saturation and reduces the risk to the fetus. Thus moderate altitudes for short periods and low intensities;
risk to the fetus should be insignicant during the short we need data on pregnant women who perform various
term and at moderate altitudes (Barry and Bia, 1989). recreational activities at altitudes over 2400 m. Fetal
It is reassuring that there have been no reports of injury bradycardia has been seen with exposure to extreme alti-
or pregnancy complications or losses associated with tudes. Thus, until more data are available, it is recommen-
418 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
ded that pregnant women avoid the hypoxic stress of Scuba Diving during Pregnancy
extreme altitude, but moderate altitude is not a signicant
risk if there is access to care. More women of reproductive age are scuba diving. Div-
Studies on pregnant women at altitude show that the ing vacations to exotic locales are becoming popular.
human fetus develops normally under low-oxygen condi- This raises the question of the safety of diving for women
tions. Exposure of a pregnant woman to the hypoxia of who are pregnant or who are planning to become preg-
high altitude results in acclimatization responses, which nant. Most international federations and the Undersea
act to preserve the fetal oxygen supply. The fetus also and Hyperbaric Medical Society advise against scuba
utilizes several compensatory mechanisms to survive diving for pregnant women or those planning a preg-
brief periods of hypoxia. While fetal heart rate monitor- nancy, but no randomized trials provide a solid scientic
ing during air travel suggests no compromise of fetal basis. The fetal circulation is characterized by the exclu-
oxygenation, exercise at high altitude may place further sion of the pulmonary circulation by two right-to-left
stress on oxygen delivery to the fetus. Thus a pregnant shunts. As the lung appears to act as a lter against the
woman who goes to altitude must take time to acclimat- progression of microbubbles to the main circulation, the
ize. Low oxygen tension and pressure changes result in fetus may be particularly exposed to gas emboli (Morales
intrauterine growth retardation and an increased risk of et al., 1999). The eects of scuba diving on pregnancy have
premature labor in women who spend most of their preg- been reviewed in detail (Camporesi, 1996). The review
nancy above 2400 m (Ali et al., 1996). summarizes physiological changes induced by immersion
The limited data on maternal exercise at high altitude diving and decompression eects on male and female
suggest good tolerance in most pregnancies; however, divers. The study concluded that there is no contraindi-
short-term abnormalities in fetal heart rate and subse- cation to diving for the nonpregnant woman; however,
quent pregnancy complications have been observed. A pregnant women should refrain from diving, owing to a
survey of Colorado obstetric care providers yielded the risk of fetal malformation and gas embolism following
consensus that preterm labor and bleeding complications possible decompression disease. The advice for a woman
of pregnancy are the most commonly encountered preg- who nds she was pregnant during the time she was
nancy complications among high-altitude pregnant visi- diving is not to terminate the pregnancy. There are case
tors (Clapp, 2000). The fact that pregnancy complications reports of normal pregnancies in spite of continued div-
are much higher and birth weights lower at altitudes ing.
above 3000 m suggests that exposure to the additional A few researchers have suggested that shallow diving,
physiological stress produced by exercising at high alti- not requiring decompression (less than 10 m, where risk
tudes may not be wise. of venous air embolism is low), is not associated with
Dehydration, engaging in strenuous exercise before ac- abnormal outcome unless frequent and occupationally
climatization, and participation in activities with high related. In women who dive regularly there is evidence of
risk of trauma are behaviors that may increase the risk of a 36-fold increase in incidence of spontaneous abortion
pregnancy complications. Medical and obstetric condi- and congenital malformation. Some recommend that
tions that impair oxygen transfer between the environ- pregnant women limit their dives to 10 m and, if they go
ment and fetal tissue at any point may compromise fetal deeper, extend their decompression times by a minimum
oxygenation. Knowledge of the medical, obstetric and of 50%. However, no safe depth/time proles have been
behavioral risk factors during pregnancy at high altitude established.
can help the pregnant visitor to high altitude to avoid Until more data are available, scuba diving should not
such complications. Short-term travel to a favorite moun- be recommended during pregnancy.
tain escape with adequate resources may be safe for a
pregnant adventurer. More research is needed to evaluate
the risks of intense exercise at altitude during pregnancy CULTURAL AND SAFETY ISSUES
(Artal et al., 1995).
The issue of global violence is not routinely addressed in
the travel medicine literature. Statistics are alarming.
WHO estimates that between 2050% of women in the
Water Sports during Pregnancy world have been physically or sexually assaulted by a
man at some point in their lives. What does this mean for
Swimming and snorkeling are safe during pregnancy, as the woman traveler? Be prepared! Women travelers
long as marine envenemation is avoided. Water skiing, jet should research as much as they can about the countries
skiing and other water sports that might force water up and the cultures along their itinerary.
into the vagina and through the cervix, causing a risk of It is particularly important to nd out as much as
miscarriage or peritonitis, are not recommended during possible about the roles of both women and men in the
pregnancy (MacLeod, 1992). places they plan to visit. Harassment exists everywhere.
Women should be prepared for the potential of sexual
harassment and intimidation. Women travelers should
avoid wearing provocative, form-tting clothing as a gen-
WOMENS HEALTH AND TRAVEL 419
eral rule. They should always travel with minimal luggage Artal R, Fortunato V et al. (1995) A comparison of cardiopul-
and have an arm free. In some male-dominated cultures, monary adaptations to exercise in pregnancy at sea level and
it is considered incorrect for a woman to travel alone. In altitude (see comments). American Journal of Obstetrics and
Gynecology, 172, 11701178; discussion 11781180.
some areas of the world, if a woman goes out at night on
Backer H (1997) Travel related emergencies. Emergency Medi-
her own it means that she is available. There is an cine Clinics of North America, 15(1).
excellent review of these issues in Her Own WayAdvice Balasch J, Martinez-Roman S et al. (1995). Schistosomiasis: an
for the Woman Traveler (see Additional Resources). unusual cause of tubal infertility. Human Reproduction, 10,
All women should learn basic self-defense techniques. 17251227.
Travel medicine advisers should stay abreast of new de- Barry M and Bia F (1989) Pregnancy and travel. Journal of the
velopments in the area of personal alarm and personal American Medical Association, 261, 728731.
security systems that could promote safety for women. Baumann H, Bung p et al. (1985) Reaction of mother and fetus to
physical activity at altitude. Geburtshilfe und Frauenheilkunde,
45, 869.
Bia FJ (1992) Medical considerations for the pregnant traveler.
MEDICAL KIT Infectious Disease Clinics of North America, 6, 371388.
Bialek R and Knobloch J (1999) Parasitic infections in preg-
See Table 24.16. nancy and congenital protozoan infections. Part I: Protozoan
infections. Zeitschrift fur Geburtshilfe und Neonatologie, 203(2),
5562.
Briggs GG, Freeman RK et al. (1998) Drugs in Pregnancy and
CONCLUSION Lactation. Williams and Wilkins, Baltimore.
Burtin PTA, Ariburnu O et al. (1995) Safety of metroniadazole in
Travel medicine advisors should be able to address the pregnancy. A meta-analysis. American Journal of Obstetrics
key travel health issues for women across the life span and Gynecology, 172, 525.
Camporesi EM (1996) Diving and pregnancy. Seminars in
during the pretravel assessment. Pretravel advice should
Perinatology, 20, 292302.
include information on contraception, emergency contra- Centers for Disease Control and Prevention (1996). Establish-
ception and prevention of sexually transmitted disease, if ment of VARAVAX pregnancy registry. Journal of the Ameri-
appropriate. The woman travelers itinerary should be can Medical Association, 275, 173.
carefully evaluated for exposure to any travel or tropical Cetron MS, Chitsulo L et al. (1996) Schistosomiasis in Lake
disease that might have long-term consequences. There is Malawi. Lancet, 348, 12741278.
a need for appreciation of gender-related issues in travel Clapp JF 3rd (1994) A clinical approach to exercise during
and tropical medicine and a need for further research. pregnancy. Clinics in Sports Medicine, 13, 443458.
Clapp JF 3rd (2000) Exercise during pregnancy. A clinical up-
date. Clinics in Sports Medicine, 19, 273286.
Cobelens FG (1998) Yellow fever vaccination and risk of sponta-
REFERENCES neous abortion (letter; comment). Tropical Medicine and Inter-
national Health, 3, 687.
Abioye AA (1973) Fatal amoebic colitis in pregnancy and the Daly E, Vessey MP et al. (1996) Risk of venous thromboembol-
puerperium: a new clinico-pathological entity. Journal of ism in users of hormone replacement therapy (see comments).
Tropical Medicine and Hygiene, 76, 97100. Lancet, 348, 977980.
ACOG (1994) Exercise during pregnancy and the postpartum Demicheli V, Graves P et al. (2000) Vaccines for preventing
period. American College of Obstetricians and Gynecologists tick-borne encephalitis. Cochrane Database System Review, 2,
technical bulletin no. 189. CD000977.
Agnostini R (1994) Medical and Orthopedic Issues of Active and de Silva N, Guyatt H et al. (1997). Anthelmintics: a comparative
Athletic Women. Hanley and Belfus, Philadelphia. review of their clinical pharmacology. Drugs, 53, 769788.
Ali KZ, Ali ME et al. (1996) High altitude and spontaneous Diagne N, Rogier C et al. (1997) Incidence of clinical malaria in
preterm birth. International Journal of Gynaecology and Ob- pregnant women exposed to intense perennial transmission
stetrics, 54, 1115. (see comments). Transactions of the Royal Society of Tropical
Anonymous (1994) From the Centers for Disease Control: prog- Medicine and Hygiene, 91, 166170.
ress toward global eradication of poliomylitis. Journal of the Diagne N, Rogier C et al. (2000). Increased susceptibility to
American Medical Association, 272, 345. malaria during the early postpartum period (see comments).
Anonymous (1999) Need for vaccination against yellow fever. New England Journal of Medicine, 343, 598603.
Communicable Disease Report Weekly, 9(33), 289, 292. Duy PE and Fried M (1999) Malaria during pregnancy: para-
Anonymous (2000a) Drug Facts and Comparisons. Wolters sites, antibodies and chondroitin sulphate A. Biochemical So-
Kluwer, St Louis. ciety Transactions, 27, 478482.
Anonymous (2000b) Fatal yellow fever in a traveler returning Farmer RD, Lawrenson RA et al. (2000) A comparison of the
from Venezuela, 1999. MMWR Morbidity and Mortality risks of venous thromboembolic disease in association with
Weekly Report, 49, 303305. dierent combined oral contraceptives. British Journal of Cli-
Anonymous (2000c) Statement on inuenza vaccination for the nical Pharmacology, 49, 580590.
20002001 season. An Advisory Committee Statement (ASC). Feldmeier H, Poggensee G et al. (1995) Female genital schis-
National Advisory Committee on Immunization (NACI). Ca- tosomiasis: new challenges from a gender perspective. Tropical
nadian Communicable Disease Report, 26, 116. and Geographical Medicine, 47(Suppl. 2), S215.
Artal R (1996) Exercise in pregnancy. Seminars in Perinatology, Fischer GW, Ottolini MG and Mond JJ (1997) Prospects for
20, 211.
420 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
vaccines during pregnancy and the perinatal period. Clinical laria. Transactions of the Royal Society of Tropical Medicine
Perinatology, 24, 231249. and Hygiene, 88, 321323.
Fradin M (1998) Mosquitoes and mosquito repellants: a clini- Nahlen BL (2000) Rolling back malaria in pregnancy (comment)
cians guide. Annals Internal Medicine, 128, 931940. (editorial). New England Journal of Medicine, 343, 651652.
Fraser IS, Lacarra M et al. (2000) Vaginal epithelial surface Nash HA, Alvarez-Sanchez F et al. (1999) Estradiol-delivering
appearances in women using vaginal rings for contraception. vaginal rings for hormone replacement therapy. American
Contraception, 61, 131138. Journal of Obstetrics and Gynecology, 181, 14001406.
Fried M and Duy PE (1996) Adherence of Plasmodium fal- Nasidi A, Monath TP et al. (1993) Yellow fever vaccination and
ciparum to chondroitin sulfate A in the human placenta (see pregnancy: a four-year prospective study. Transactions of the
comments). Science, 272, 15021504. Royal Society of Tropical Medicine and Hygiene, 87, 337339.
Gass M and Rebar R (2000) Hormone replacement for the new Nathwani D, Currie PF et al. (1992) Plasmodium falciparum
millennium. Obstetric and Gynecology Clinics of North Amer- malaria in pregnancy: a review. British Journal of Obstetrics
ica, 27, 611623. and Gynaecology, 99, 118121.
Gerberding JL and Katz MH (1999) Post-exposure prophylaxis Nelson AL (1998) Menstrual problems and common gynecologi-
for HIV. Advances in Experimental Medicine and Biology, 458, cal concerns. In Contraceptive Technology (eds RA Hatcher, J
213222. Trussell and F Stewart), pp 95140. Ardent Media, New York.
Gilson GJ, Harner KA et al. (1995) Chagas disease in pregnancy. Nosten F et al. (1990) Meoguine antimalarial prophylaxis in
Obstetrics and Gynecology, 86, 646647. pregnancy. Dose nding and pharmacokinetics study. British
Glasier A (1997) Emergency postcoital contraception (see com- Journal of Clinical Pharmacology, 30, 79.
ments). New England Journal of Medicine, 337, 10581064. Nosten F, McGready R et al. (1999a) Eects of Plasmodium vivax
Glasier A (1999) Emergency contraception in a travel context malaria in pregnancy. Lancet, 354, 546549.
(editorial; comment). Journal of Travel Medicine, 6, 12. Nosten F, Vincenti M et al. (1999) The eects of meoquine
Glezen WP and Alpers M (1999) Maternal immunization. Clini- treatment in pregnancy. Clinical Infectious Diseases, 28,
cal Infectious Diseases, 28, 219224. 808815.
Goverde AJ, Schats R et al. (1996) An unexpected guest in Oger E and Scarabin PY (1999) Assessment of the risk for venous
follicular uid. Human Reproduction, 11, 531532. thromboembolism among users of hormone replacement ther-
Grady D, Wenger NK et al. (2000) Postmenopausal hormone apy. Drugs and Aging, 14, 5561.
therapy increases risk for venous thromboembolic disease. Ooi WW, Gawoski JM et al. (1999) Hepatitis E seroconversion
The Heart and Estrogen/progestin Replacement Study. An- in United States travelers abroad. American Journal of Tropi-
nals of Internal Medicine, 132(9), 689696. cal Medicine and Hygiene, 61, 822824.
Guillebaud J (1999) Contraception: Your Questions Answered. Pacque M, Munoz B et al. (1990) Pregnancy outcome after
Churchill-Livinstone, Edinburgh. inadvertent ivermectin treatment during community-based
Guillebaud J (2000) Reducing withdrawal bleeds (letter). Lancet, distribution. Lancet, 336, 14861489.
355, 21682169. Pedler SJ (2000) Bacterial, fungal and parasitic infections. In
Hammill HA (1989) Unusual causes of vaginitis (excluding Medical Disorders During Pregnancy (ed. LM Barron), pp
trichomonas, bacterial vaginosis, and Candida albicans). Ob- 411465. Mosby, St Louis.
stetrics and Gynecology Clinics of North America, 16, 337345. Perez JA, Castillo P et al. (1997) Breast hydatid cyst. A case
Hatcher R, Trussell J et al. (1998). Contraceptive Technology. report. Revista Medica de Chile, 125, 6670.
Ardent Media, New York. Phillips-Howard PA, Steen R et al. (1998) Safety of meoquine
Hawkes S and Hart G (1998) The sexual health of travelers. and other antimalarial agents in the rst trimester of preg-
Infectious Disease Clinics of North America, 12, 413430. nancy. Journal of Travel Medicine, 5, 121126.
Huch R (1996) Physical activity at altitude in pregnancy. Sem- Pinkerton SD, Holtgrave DR et al. (1998) Cost-eectiveness of
inars in Perinatology, 20, 303314. post-exposure prophylaxis following sexual exposure to HIV.
Li E and Stanley SL Jr (1996) Protozoa. Amebiasis (Review; 154 AIDS, 12, 10671078.
references). Gastroenterology Clinics of North America, 25, Poggensee G, Feldmeier H et al. (1999) Schistosomiasis of the
471492. female genital tract: public health aspects. Parasitology Today,
Lindsay S, Ansell J et al. (2000) Eect of pregnancy on exposure 15, 378381.
to malaria mosquitoes (letter). Lancet, 355, 1972. Poggensee G, Krantz G et al. (2000) Screening of Tanzanian
MacLeod CL (1992) The pregnant traveler. Medical Clinics of women of childbearing age for urinary schistosomiasis: valid-
North America, 76, 13131326. ity of urine reagent strip readings and self-reported symptoms.
Matteeli A, Caligaris S et al. (1997) The placenta and malaria. Bulletin of the World Health Organization, 78, 542548.
Annals of Tropical Medicine and Parasitology, 91(7), 803810. Polaneczky M and OConnor K (1999) Pregnancy in the adoles-
Meinecke CK, Schottelius J et al. (1999) Congenital transmission cent patient:screening diagnosis, and Initial management.
of visceral leishmaniasis (kala azar) from an asymptomatic Pediatric Clinics of North America, 46, 649670.
mother to her child. Pediatrics, 104, e65. Ravdin J (1995) Amebiasis. Clinical Infectious Diseases, 20,
Monath TP (1999) Facing up to re-emergence of urban yellow 14531466.
fever (comment). Lancet, 353, 1541. Reinus J and Leikin E (1999) Pregnancy and liver disease: viral
Morales M, Dumps P et al. (1999) Pregnancy and scuba diving: hepatitis in pregnancy. Clinics in Liver Disease, 3, 116130.
what precautions? Journal of Gynecology, Obstetrics and Bio- Rioux JE, Devlin C et al. (2000) 17beta-estradiol vaginal tablet
logical Reproduction (Paris), 28, 118123. versus conjugated equine estrogen vaginal cream to relieve
Munoz FM and Englund JA (2000) A step ahead: infant protec- menopausal atrophic vaginitis (see comments). Menopause, 7,
tion through maternal immunization. Pediatric Clinics of 156161.
North America, 47, 449463. Robert E, Vial T et al. (1999) Exposure to yellow fever vaccine in
Na Bangchang K, Davis TM et al. (1994) Meoquine phar- early pregnancy. Vaccine, 17, 283285.
macokinetics in pregnant women with acute falciparum ma- Schlagenhauf P (1999) Meoquine for malaria chemo-
WOMENS HEALTH AND TRAVEL 421
prophylaxis 19921998: a review. Journal of Travel Medicine, Denmark Tetragynon Yuzpe regimen
6, 122133. Finland NeoPrimovlar Yuzpe regimen
Shlim DR and Innis BL (2000) Hepatitis E vaccine for travelers? France Tetragynon Yuzpe regimen
Journal of Travel Medicine, 7, 167169.
approved 1998
Sinha A, Grace C et al. (1999) African trypanosomiasis in two
travelers from the United States. Clinical Infectious Diseases, Levonorgestrel regimen
29, 840844. approved 1998
Sloan BS, Rickman LS et al. (1996) Schistosomiasis masquerad- Germany Tetragynon Yuzpe regimen
ing as carcinoma of the breast. Southern Medical Journal, 89, approved 1998
345347. Hong Kong Postinor 4 and Postinor 10
Smoak BL, Writer JV et al. (1997) The eects of inadvertent levonorgestrel regimens
exposure of meoquine chemoprophylaxis on pregnancy out- Hungary Postinor 4, Postinor 10 and
comes and infants of US Army servicewomen. Journal of Postinor 2 levonorgestrel
Infectious Diseases, 176, 831833.
regimens
Steketee RW, Wirima JJ et al. (1996) The problem of malaria and
malaria control in pregnancy in sub-Saharan Africa. American Jamaica Postinor 4 and Postinor 10
Journal of Tropical Medicine and Hygiene, 55(suppl. 1), 27. levonorgestrel regimens
Stray-Pedersen B (2000) Parasitic infections. In Cherry and Mer- Kenya Postinor 4 and Postinor 10
katzs Complications of Pregnancy (eds R Wayne, MD Cohen, levonorgestrel regimens
H Sheldon et al.), pp 693833. Lippincott Williams and Wil- Malaysia Postinor 4 and Postinor 10
kins, Philadelphia. levonorgestrel regimens
Strobino BA, Williams CL et al. (1993) Lyme disease and preg- Netherland Lynohigh-dose oestrogen
nancy outcome: a prospective study of two thousand prenatal regimens
patients. American Journal of Obstetrics and Gynecology, 169,
New Zealand PC-4 Yupze regimen marketed
367374.
Thomas SL and Ellertson C (2000) Nuisance or natural and but then withdrawn due to
healthy: should monthly menstruation be optional for legislative need for a physician
women? Lancet, 355, 922924. prescription
Tietze PE and Jones JE (1991) Parasites during pregnancy. Nigeria Postinor 4 and Postinor 10
Primary Care: Clinics in Oce Practice, 18, 7599. levonorgestrel regimens
Tomori O (1999) Impact of yellow fever on the developing world. Norway Tetragynon Yuzpe regimen
Advances in Virus Research, 53, 534. Pakistan Postinor 4 and Postinor 10
Tsai TF, Paul R et al. (1993) Congenital yellow fever virus levonorgestrel regimens
infection after immunization in pregnancy (see comments).
Poland Postinor 4 and Postinor 10
Journal of Infectious Diseases, 168, 15201523.
Vandenbroucke JP et al. (2001) Medical progress: oral contra- levonorgestrel regimens
ceptives and risk of venous thrombosis. New England Journal Singapore Postinor 4 and Postinor 10
of Medicine, 334(20), 15271535. levonorgestrel regimens
Vasilakis C, Jick SS et al. (1999) The risk of venous thromboem- Slovakia Postinor 4 and Postinor 10
bolism in users of postcoital contraceptive pills. Contraception, levonorgestrel regimens
59, 7983. South Africa E-Gen-C Yuzpe regimen
Vlasso C (1997) Gender and Tropical Disease Task Force of launched August 1997,
TDR: achievements and challenges. Acta Tropica, 67(3): Levonorgestrel regimen
173180.
expected early 1999
Weaver K and Glasier A (1999) Interaction between broad-
spectrum antibiotics and the combined oral contraceptive pill: Soviet Union Postinor 4 and Postinor 10
a literature review. Contraception, 59, 7178. (former) levonorgestrel regimens
Sei Lanka Postinor 2 levonorgestrel
regimen launched 1998
ADDITIONAL RESOURCES Sweden Tetragynon Yuzpe regimen
Thailand Tetragynon Yuzpe regimen
Consortium for Emergency Contraception United Kingdom PC-4 Yuzpe regimen launched
(http://www.path.org/cec.htm) 1985
Uruguay Postinor 4 and Postinor 10
List of Countries for which Emergency levonorgestrel regimens
Contraception has been Registered as a Dedicated USA Preven Yuzpe regimen
Product launched Sept 1998
Plan B (levonorgestrel)
Argentina Immediate Yuzpe regimen Vietnam Postinor 4 and Postinor 10
Brazil Postinor 2 approved 1999 levonorgestrel regimen
Bulgaria Postinor 4 and Postinor 10
levonorgestrel regimens
Czech Republic Postinor 4 and Postinor 10
levonorgestrel regimens
422 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Note City 84111-4270, USA
Tel: 801 328 BABY
Fax: 801 538 6510
Countries that support an emergency contraception
http://orpheus.ucsd.edu/ctis/index.html
program in ocial guidelines include Brazil, Educator,
Ethiopia, Honduras, India, Indonesia, Kenya, USA.
WHO includes Yuzpe regimen for emergency contra-
Electronic
ception as essential drug list (will consider adding
levonorgestrel-only regimen at next meeting).
National Library of Medicine, MEDLARS Service Desk
Consortium for Emergency Contraception is introduc-
(Grateful med TOXLINE, TOXNET, DART and
ing a specially packaged levonorgestrel roduct, Pos-
Medlinesources for bibliographic search) Bethesda,
tinor 2, manufactured by Gedeon Richter in Hungary.
MD 800-638-8480, USA
Product will be marketed in Indonesia, Mexico, Kenya,
http://www.nlm.nih.gov/pubs/factsheets/toxlinfs.html
Sri Lanka. Lessons learned from introductory experi-
http://www.nlm.nih,gov/pubs/factsheets/darfs.html
ences will be written up.
http://www.nlm.gov/pubs/factsheets/toxnetfs.html
Population Services International is conducting pro-
jects in Nigeria, Pakistan, Uganda, Venezuela. Teratogen Information System (TERIS and Shepard
Population Council and WHO have been introducing Catalogue of teratogenic agents) University of
an emergency contraception program in Zambia: Washington, Seattle, WA 206-543-2465, USA
Emergency Contraception in Zambia: setting a new http://weber.u.washington.edu/:terisweb/teris/
agenda for research and action. index.html
In countries where no dedicated product is available http://weber.u.washington.edu/:terisweb/computer
(and even in countries where a product is marketed), info.html
many service providers use regular combined oral Micromedix, Inc (Reprorisk-CD-ROM system including
contraceptives. The obvious drawback tot this ap- the following teratogenic catalogs: Reprotext, Reprotox,
proach is that there is room for error in the selection of Shepard catalogue of Teratogenic Agents and TERIS)
pills (placebo versus hormone, selecting the correct pills Englewood, CO 800-293-5137, USA
from multiphasic packs, and dosage. In addition com-
bination oral contraceptives do not come with special
instructions. Despite this availability, emergency Her Own WayAdvice for the Woman Traveler
contraception is largely unknown to women in devel-
oping countries and many women in developed coun- To obtain addtional free copies of this booklet, write to:
tries. Enquiries Service
Department of Foreign Aairs and International Trade
125 Sussex Drive
Ottawa, ON K1A 0G2, Canada
Teratogen Reference Resources or call 1-800-267-8376 (in Canada) or (613) 944-4000
The Department is on the Internet at:
Books http://www.dfait-maeci.gc.ca/
Briggs GG, Freeman RK et al. (1998) Drugs in This publication in alternative formats upon request.
Pregnancy and Lactation: A Reference Guide to Fetal and Department of Foreign Aairs and International
Neonatal Risk. Williams and Wilkins, Baltimore Trade
November 1999
Cat. No.: E2-172/1999E-1
Information Centers ISBN 0-662-28092-X
25
inuenza travelling in summer to the other hemisphere, Congenital Immune Deciency Due to a Cellular
vaccination should be considered. However, availability or Humoral Immune Deciency
of the vaccine could be a practical problem, and it might
not be the most ecacious protection for the country of Although this is a group of rare disorders, from time to
destination. time patients with one of these conditions, needing special
Prescribing antibiotics for these patients during travel consideration before travelling, will be encountered.
is advisable. These are to be taken in the event of a Table 25.2 lists the conditions seen most frequently. A few
respiratory tract infection or diarrhoea presenting with will be discussed here.
fever. Co-amoxiclav (or a cephalosporin in case of penicil- Severe combined immune deciency (SCID) is a rare
lin allergy) and ciprooxacin, respectively, are the prefer- T-cell disorder, which usually presents within the rst
red choice under these circumstances. months of life. In addition, B-cell function is mostly com-
Apart from the increased incidence of diarrhoea in promised, leading to both cell-mediated and humoral
these patients owing to their immunological problem, deciencies. Life expectancy will generally be short; how-
several of these conditions will lead to more severe illness ever, if these patients reach travelling age, travel should be
in diarrhoea due to nonimmunological causes. Water discouraged because of disseminated or persistent infec-
salt balance, in chronic congestive heart failure for in- tion after live attenuated vaccines. This has been de-
stance, can be severely disturbed because of diarrhoea. scribed after BCG and oral polio vaccination, but the
Dehydration due to this cause in diabetics can lead to same can be expected after oral typhoid vaccine and
severe glucose metabolism disturbance. These consider- yellow fever vaccine.
ations are important reasons to provide additional pre- In the group of B-cell and humoral immune de-
travel advice for these travellers. ciencies, the age of onset is early, usually before the age of
THE IMMUNOCOMPROMISED TRAVELLER 425
2, for the rarely seen X-linked agammaglobulinaemia. ciprooxacin and tinidazole. Of course malaria
Other types do not usually become clinically relevant prophylaxis was included.
until the third decade. The presenting infections are pre- After 4 weeks in India he entered Nepal, where
dominantly with encapsulated bacteria such as he developed watery diarrhoea, bloating of the ab-
pneumococci, meningococci and Haemophilus inuenzae. domen and nausea. He suspected according to his
Common variable immunodeciency (CVI) and, to a les- instructions, Giardia lamblia infection and took
ser extent, IgA deciency are a heterogeneous group of tinidazole 4 tablets of 500 mg once. He recovered
diseases that share the features of hypogamma- over the succeeding days, but gradually developed
globulinaemia and an increased susceptibility to chronic intermittent diarrhoea with nausea and weight loss
enteric infections with Giardia lamblia, Campylobacter of 6 kg over 6 weeks. On return home he was diag-
spp and disseminated echoviral infections, in addition to nosed again with G. lamblia in his stool, but also
sinopulmonary bacterial infections. IgA also plays a role Plesiomonas shigelloides, a bacterium more often
as an antiadhesive agent for H. inuenzae B and menin- found in immunocompromised patients. After ad-
gococci. A person with one of these conditions travelling equate treatment he recovered fully.
to less hygienic destinations need specically to be pro-
tected by vaccination against pneumococci, common
meningococci and H. inuenzae. Response to vaccination
will usually be diminished and ideally seroconversion Acquired Immune Deciency
should be checked. Special attention needs to be given to
infections such as typhoid fever (vaccination) but also the In haematological malignancies it is obvious that im-
standby treatment for infections with Shigella, Salmonella mune deciency can occur because of either T- and/or
and Campylobacter spp (all can be treated with cipro- B-cell impairment. Depending upon the clinical situation,
oxacin) and G. lamblia (tinidazole). travel should be discouraged or appropriate measures
Immune deciency disorder due to insucient phago- should be in place, as mentioned above. Metastatic solid
cytosis is a rare life-threatening condition and will not be tumour disease will lead to immune suppression, depend-
discussed here. ing on the type and measure of progressive disease. Ad-
A problem in the complement-mediated immunity is vice on travel should be in relation to the patients condi-
that the clinical presentation (with certain bacterial sys- tion (Karnofski scale). The level of immune deciency in
temic infections) can be as late as young adulthood. This these patients is often dicult to establish. When travel is
might not even be known to the traveller. The clinical considered in such patients, common sense should pre-
picture depends on the decient complement. For in- vail.
stance, late complement defects (C5C9) are associated The spleen provides a multitude of important host
with recurrent Neisseria spp. (bacteraemia and meningi- defence functions. Surgical removal of the spleen, or
tis); early complement pathway defects are associated splenic dysfunction because of disease, results in a
with bacterial pneumonia. As soon as the complement heightened predisposition to sepsis caused by pneu-
defect has become obvious, these patients should be vac- mococci and other streptococci, H. inuenzae, menin-
cinated against Neisseria spp or pneumococci. It is essen- gococci and a variety of other encapsulated bacteria, such
tial that these vaccinations be checked before travel. In as Capnocytophaga canimorsus. Splenic hypo- or non-
addition, antibiotics need to be prescribed for standby function also predisposes to severe infection with intra-
treatment in case of respiratory tract infection with fever erythrocytic parasites such as Plasmodium falciparum,
(co-amoxiclav). and Babesia microti (after dog bites).
Congenital asplenia and its consequences for travel will The risk of acquiring these infections in these patients is
be discussed in the next section. determined largely by the age at which the splenectomy
was performed and the reason for it. If splenectomy is
carried out above the age of 5, acquired immunity leads to
Case History reduced risk of infectious problems. It is suggested that in
A 24-year-old man came for advice before trekking post-traumatic splenectomy, splenic cells adhere to the
through India and Nepal. He had an IgA de- peritoneum and might partially take over splenic func-
ciency, and had been treated on and o until the tion. There is no evidence for this hypothesis. However,
age of 18 by a paediatrician with several experi- the risk of postsplenectomy sepsis after splenectomy for
mental treatments. He had to be treated regularly splenic trauma appears to be lower than that found in
for respiratory tract infections and had been patients who were splenectomised for other reasons, such
plagued by chronic nasal congestion. As a child he as a haematological disorders (malignancy, idiopathic
had received the usual vaccinations without prob- thrombocytopenia, hereditary spherocytosis, etc.). In
lems. He received diphtheria-tetanus and polio general, after any splenectomy the risk of developing
boosters, typhoid fever vaccine, hepatitis A vaccine, fulminant sepsis decreases after 23 years, but a lifelong
meningococcal A/C vaccine and Haemophilus inu- increased risk of a serious course of certain infections will
enzae vaccine. Instructions were given on the use of exist.
standby treatment consisting of co-amoxiclav, The same problem can be seen in the hypofunctional
426 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
spleen, as occurs in sickle cell disease, thalassaemia, cer- After treatment she had an uneventful recovery.
tain lymphoid malignancies and irradiated spleens. Be- Because she was eager to continue work in devel-
fore travel, patients without a functioning spleen, or who oping countries, all necessary vaccinations and
have undergone splenectomy, need to be protected su- precautions indicated for the splenectomised pa-
ciently against encapsulated bacteria and malaria. tient were given. In the following years she was seen
Ideally, before splenectomy, patients should have twice for a check-up. She had worked in refugee
received pneumococcal vaccination, as the response to camps in the Middle East and in a public health
pneumococcal vaccine is reduced thereafter. Whether this project in Cameroon, so far without any further
also applies to other vaccinations is unknown. In pre- problems.
travel advice these patients should be given adequate
vaccination coverage against pneumococci, menin-
gococci A/C, H. inuenzae B.
Malaria prophylaxis needs to be optimal, and standby
treatment should be available in case of an unexpected Drug-induced Immune Suppression
breakthrough. Travel to multiresistant malaria fal-
ciparum areas without adequate medical facilities should The drugs responsible most frequently for serious im-
be discouraged. Antimosquito measures are self-evident. mune suppression are listed in Table 25.4. The exact
In case of fever with or without signs of respiratory tract amount of systemic glucocorticosteroids and the dura-
infection, penicillin treatment (or a macrolide in the case tion of administration needed to suppress immunity are
of penicillin allergy) should be started promptly. A thick not known. Controlled randomised studies indicated that
blood lm to exclude malaria should be done without the rate of infectious complications in patients given a
delay at the same time. After bites by dogs or cats immedi- daily dose of less than 10 mg prednisone or a cumulative
ate prophylactic antibiotic treatment must be initiated, dose of less than 700 mg prednisone was not increased
with co-amoxiclav (7 days) or, in case of penicillin allergy, compared with that of controls.
clindamycin (300 mg thrice daily for 7 days). As a general rule, it is accepted that immune sup-
pression caused by drugs continues for 3 months after the
drugs are stopped. It should not be forgotten that these
Case History drugs are often prescribed in diseases with an inherent
A 24-year-old nurse was engaged at short notice to immune deciency. In general, all of them have the poten-
start work for a nongovernmental organisation tial to cause serious immune suppression. With patients
(NGO) in a malarial area of Ethiopia. Her parents using them for a short period, postponement of travel
general practitioner, who was not aware of her should therefore be discussed. Live attenuated vaccines
personal medical history, gave pretravel advice. cannot be administered to patients using drugs that cause
She was given adequate malaria prophylaxis, con- serious immune suppression. These vaccines may induce
sisting of meoquine and the usual vaccines for a disseminated infection. Therefore generally BCG, MMR,
healthy traveller. Two weeks after arrival at the site yellow fever, oral typhoid fever and oral polio vaccines
she experienced the rst of several prolonged per- are contraindicated. Not all drugs of this type cause im-
iods of febrile illness. Plasmodium falciparum was mune suppression to the same extent, and much depends
diagnosed once and treated, and a second time on the dose and the duration of treatment. The literature
treated as such without laboratory investigation. does not provide good data. The use of live vaccines
Recovery every time, however, was of limited dur- should therefore be applied with common sense.
ation. After a short recovery she was treated for The second problem in administering these vaccines is
pneumonia, which was diagnosed on physical the diminished immune response. In serious immune sup-
examination. After a stay of 4 months she still pression, serological tests should be carried out before
experienced physical untness and was unable to and after vaccination in the case of hepatitis A, hepatitis
work. At this time she was fully examined by the B, rabies and tick-borne encephalitis. In all these diseases,
visiting doctor of her NGO. He noted a large ab- if seroconversion has not been achieved by vaccination,
dominal scar. On questioning she mentioned a
laparotomy because of intra-abdominal bleeding
after a motorcycle accident at the age of 11. The Table 25.4 Immunosuppressive and cytotoxic drugs
physician decided to repatriate her. On admission
to a hospital of tropical diseases in her native coun- Alkylating agents: chlorambucil, cyclophosphamide,
try she was found to have no spleen. Pneumococcal estramustine, bisulfan, treosulfan, mustine and procarbazine
pneumonia was diagnosed. She also had serologi- Antimetabolites: methotrexate, mercaptopurine and tioguanine
Glucocorticosteroids: 9 10 mg prednisone daily, for more than
cal evidence of a recent EpsteinBarr viral infec-
2 weeks; or : 10 mg prednisone daily but 9 700 mg totally in
tion. On the planned day of hospital discharge, 3 continuous use
weeks after arriving from the endemic malaria area Others: hydroxycarbamide; azathioprine and mycophenolate
in Ethiopia, she developed rigor and high fever. mofetil; ciclosporin and tacrolimus
Her blood lm showed P. falciparum trophozoites.
THE IMMUNOCOMPROMISED TRAVELLER 427
protection with specic immune globulins is possible in (HAART) is taken, usually a combination of HIV reverse
case of the risk of infection. Patients receiving these drugs transcriptase and protease inhibitors, viral replication is
do not run a higher risk of contracting malaria. inhibited and the CD4; level increases. However, it is
not known whether this also indicates a recovery of T and
B cell function. The lowest CD4; count before HAART
Case History therapy is the point of reference for establishing the im-
A 57-year-old man is planning to make a trip mune status of the patient.
through Southeast Asia. At the age of 50 he devel- In advising HIV-infected travellers several issues are
oped a nephropathy with proteinuria due to important for consideration: the increased vulnerability
HenochSchonlein disease. He gradually develop- to infection; the decreased ecacy of or contraindications
ed end-stage renal insuciency for which, after 2 for vaccines; interaction of anti-HIV drugs with, most
years of dialysis, he received a kidney transplant. importantly, the antimalarial prophylactic drugs; and,
Since the transplant 1 year ago, he has been treated lastly, practical problems encountered at the borders of
with mycophenolate mofetil (500 mg t.d.s.) and many countries. The availability of treatment in many
prednisolone (10 mg o.d.). He is in good general parts of the world and corresponding insurance dicul-
condition with only an unchanging mild renal in- ties should also be considered carefully.
suciency. He is advised to have malaria prophy- Table 25.5 summarises the risk of infection, the use and
laxis with meoquine, in adjusted dosage accord- side-eects of vaccines and other advice necessary in
ing to the level of renal insuciency. Meoquine HIV-infected patients.
does not interact with mycophenolate mofetil or In HIV infection an increased risk of a fulminant
prednisolone. He had a diphtheria-tetanus and po- course of malaria has never been established. All malaria
lio booster 8 years ago just before the onset of the prophylactic drugs can be used in HIV-infected patients,
kidney problem. He is advised to have vaccination but interaction with drugs used in HAART should be
against typhoid fever, and antibodies against hepa- considered and be monitored before travel. Interaction
titis A are also measured. In the case of a negative between meoquine and chloroquine and HIV protease
serology result, immunoglobulin will be adminis- inhibitors is known to exist. Depending on the type of
tered just before departure, as this will avoid the enzymatic change induced in the liver, the doses of mef-
problem of insucient antibody response after loquine and chloroquine can either be raised or lowered.
hepatitis A vaccine. He receives instructions about On theoretical grounds interaction with proguanil and
the use of antibiotics in the case of invasive diar- quinine is also possible but insucient data are available
rhoeal disease. Japanese encephalitis could be a to determine whether this constitutes a problem. New
risk because of his itinerary. As there are no data on anti-HIV drugs become available rapidly and therefore a
the safety of the live attenuated Japanese encepha- full discussion of the specic interactions of these drugs
litis vaccine, he is instructed to take antimosquito and antimalarial prophylactic drugs is indicated. In pa-
measures. tients using several anti-HIV drugs, thorough advice
from the hospital pharmacist should be sought. If anti-
HIV drugs interfere with appropriate antimalarial pro-
phylaxis, adjustment of the travel itinerary to nonmalari-
HIV-RELATED IMMUNE DEFICIENCY ous areas should be considered. Meoquine and chloro-
quine should be used with reservation in HIV patients
Infection with the human immunedociency virus (HIV) who have been treated for cerebral space-occupying
causes a gradual decrease of CD4; T lymphocytes. Be- lesions such as non-Hodgkin lymphoma and toxoplas-
cause of the main role in the human defence system of mosis. In these cases the drugs have the potential to
these cells, not only the cellular but also the humoral induce seizures.
defence system is diminished, leading to increased vulner- Ciprooxacin and doxycycline, used respectively for
ability to opportunistic infections. A less eective immune travellers diarrhoea and antimalarial prophylaxis, also
response to immunisation and an increased risk of com- interfere with reverse transcriptase inhibitors (e.g.
plications after administration of live attenuated vaccines didanosine) and need to be given 2 h before or 6 h after
are then seen. In daily practice, the number of CD4; cells these drugs.
in the peripheral blood is a measure of the level of im- In every pretravel consultation with an HIV-infected
mune suppression by HIV. traveller the following items should be considered in or-
CD4; counts above 500 mm\ correspond with a der to ensure tailor-made advice:
normal immune state. Counts between 200 and
499 mm\ indicate a moderate immune suppression, What is the travellers degree of immune suppression?
while a CD4; level below 200 mm\ indicates a severe What are the risks of (tropical) infection during this
suppression of the immune system. The lower the CD4; particular journey?
count the greater the risk of opportunistic infections. This Which advice on hygiene is indicated?
correlates reciprocally with the amount of viral load in Which contraindications for live attenuated vaccines
these patients. When highly active antiretroviral therapy are present?
428 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Table 25.5 Considerations in pre- and post-travel advice to HIV-infected travellers
Which other vaccines should be advised? protease inhibitors. He was started on meoquine
Is there a need for antibody tests after vaccination? treatment 6 weeks before travel, and weekly mef-
Is there a need for standby medication in case of diar- loquine blood levels were measured and were
rhoea, malaria or other conditions? found to be within the normal range. He was given
Is instruction needed for the time of administration of diphtheria-tetanus and inactivated polio booster
HAART when passing to other time zones? plus immunoglobulin before departure. Since there
Is it necessary to consider interaction between HAART was a high risk for yellow fever, he was
and prophylactic medication (and standby treatment)? immunised because the CD4; count was expected
Is there any need for medical check-up during travel? to be sucient to counteract a complicating vir-
aemia and also sucient to lead to adequate im-
mune response. His yellow fever IgG titre 4 weeks
Case History after vaccination, compared with the prevaccina-
A 60-year-old HIV-positive patient planned to tion titre, was found to be protective. The vaccine
travel to Tanzania for a visit to relatives. Before caused no side-eects.
starting HAART his lowest CD4; count was
10 mm\, and has now risen to 280 mm\, with a
viral load between 500 and 1000 copies mm\. The
course of his HIV infection was complicated 34 THE PREGNANT TRAVELLER
years ago by Pneumocystis carinii pneumonia. Co-
trimoxazole was discontinued recently when his Very often it is forgotten that the pregnant woman is
CD4; count rose above 200 mm\. His medica- immune compromised to some degree. In pregnancy the
tion consists of abacavir, stavudine, lamivudine risk of complications with certain infections is increased.
and evavirenz, of which two are newly introduced The risk is not only conned to the pregnant woman but
THE IMMUNOCOMPROMISED TRAVELLER 429
Table 25.6 Antimalarial drugs during pregnancy for immigration purposes. There are few case reports
concerning oral typhoid vaccine and this is better avoided
Antimalarial First 2nd/3rd Breast therefore in pregnancy. With modern vaccines such as
drugs trimester trimester feeding hepatitis A and hepatitis B there have been no formal
studies into any eect on the fetus, but these are killed
Quinolone derivates
vaccines. Nevertheless, if indicated, inactivated vaccines
Quinine ; ; ;
Chloroquine ; ; ;
such as hepatitis B, inuenza, diphtheria and tetanus can
Meoquine ? ; ; be administered to the pregnant woman under the same
Primaquine 9 9 9 circumstances as those in which they would be given to
nonpregnant travellers. Japanese encephalitis vaccine has
Folic acid never been studied in pregnant women; however, data
antagonists from case reports and accidental vaccinations show it to
Proguanil ; ; ; be safe. There are few data for hepatitis A vaccine. In
Pyrimethamine ; ; ? general, vaccinations in pregnant women should be
Sulphonamides avoided and the traveller and her physician should weigh
Sulfa drugs 9 ; ? the pros and cons in every case.
Dapsone ; ; 9 Concerning the risk of life attenuated vaccines to the
Antibiotics
children of breast-feeding women, even less data are
Tetracycline 9 9 9 available. The mother herself is considered to have re-
Doxycycline 9 9 9 gained her normal immune status soon after giving birth.
Clindamycin 9 9 ? Both in the pregnant and the breast-feeding female travel-
ler, administration of immunoglobulin, toxoid vaccines
Other drugs and killed or inactivated vaccines are certainly not
Atoquavone ; ? ? ? contraindicated.
proguanil Altogether, advice against travel should be considered
Artemisinin ? ? ? regularly in pregnant women especially, when travelling
to West Africa for leisure. The obligatory yellow fever
; : Safe; 9 : harmful; ? : no data available. vaccination, the high risk of acquiring falciparum malaria
and other febrile illnesses are sucient reasons to con-
also threatens the fetus. Infections increase further the sider postponing this kind of travel.
risk of premature delivery. It is therefore important to
weigh the risks of travel to the tropics for the pregnant
woman.
The pregnant woman is immunocompromised because
of physiological changes in cortisol levels and a decreased
cellular immunity. In the specic case of malaria in preg- FURTHER READING
nancy, the maternal anaemia contributes to a more seri-
Driessen SO, Cobelens FGJ and Ligthelm RJ (1999) Travel-
ous course. Infection with malaria of the placenta causes related morbidity in travelers with insulin-dependent dia-
obstetric problems and the nonimmune pregnant woman betes mellitus. Journal of Travel Medicine, 6, 1215.
also seems to be more susceptible to a serious course of Janeway C (1996) Immunobiology: The Immune System in Health
malarial infection. Every pregnancy runs some risk of and Disease. Current Biology, London.
early activity of the uterus in case of fever, whatever the Kroon FP (1999) Humoral immune response to vaccinations in
course. In nonimmune women, 10% who contract fal- HIV-infected individuals. Thesis, University of Leiden, The
ciparum malaria during pregnancy die. The course and Netherlands.
treatment of falciparum malaria in pregnant women is Mandell GL, Bennett JE and Dolin R (1995) Principles and
Practice of Infectious Diseases. Churchill Livingstone, New
complicated by acute oedema of the lungs, secondary
York.
bacterial infections and hypoglycaemia. In 50% of pa- Nossal GJV (1997) Host immunobiology and vaccine develop-
tients, labour starts during the malarial infection, leading ment. Lancet, 350, 13161319.
to stillbirth, premature birth and low birthweight. Phillips-Howard PA, Steen R, Kerr L et al. (1998) Safety of
Prevention and treatment of malaria in pregnancy is meoquine and other antimalarial agents in the rst trimes-
complicated by the fact that several medications generally ter of pregnancy. Journal of Travel Medicine, 5, 121126.
used are either contraindicated in pregnancy or have not Pirofski LA and Casadevall A (1998) Use of licensed vaccines for
been tested (Table 25.6). active immunisation of the immunocompromised host. Clini-
Another problem in pregnant women is the theoretical cal Microbiology Reviews, 11, 954963.
Plotkin SA and Orenstein WA (1999) Vaccines. WB Saunders,
contraindication against giving live attenuated vaccina-
Philadelphia.
tions. In the case of yellow fever and oral polio vaccines, Samuel BU and Barry M (1998) The pregnant traveller. Infec-
there is evidence from case reports that harm to the fetus tious Disease Clinics of North America, 12(2), 325354.
is extremely unlikely. If the risk of acquiring yellow fever Silver HM (1997) Malarial infection during pregnancy. Infectious
is nonexistent, a letter of contraindication should be given Disease Clinics of North America, 11(1)1, 99107.
430 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Sneller MC, Strober E, Eisenstein E et al. (1993) The new insights Stuck AE, Minder CE and Frey FJ (1989) Risk of infectious
into common variable immunodeciency. Annals of Interna- complications in patients taking glucocorticosteroids. Re-
tional Medicine, 118, 720730. view of Infectious Diseases, 11, 954963.
Principles and Practice of Travel Medicine. Edited by Jane N. Zuckerman
Copyright 2001 John Wiley & Sons Ltd
ISBNs: 0-471-49079-2 (Hardback); 0-470-84251-2 (Electronic)
26
Vaccine-Preventable Illnesses Travelers who rely on hearing aids should carry extra
batteries for their units. Hearing impaired and deaf
Routine immunizations (measles/mumps/rubella, polio, travelers may also benet from traveling with a compan-
tetanus toxoid, varicella, if appropriate) should be up- ion and discount airfares may apply. They should inform
transportation carriers of their hearing impairment if
dated prior to travel. One dose of 23-valent pneumococ-
cal vaccine and annual inuenza immunization are rec- overhead announcements are likely to go unheard, and
ommended for healthy adults 65 years and older, and for can request that information be delivered to them indi-
vidually.
high-risk individuals below age 65.
Age alone is not a contraindication to any vaccine,
although seroconversion rates may decrease with age.
For the healthy older traveler, general recommendations The Physically Disabled Traveler
for both routine and travel vaccines apply. Hepatitis A
seropositivity rates are higher in older travelers who have The physically disabled traveler should discuss his or her
lived in or traveled extensively to endemic areas, or have a specic needs with the travel agent. Facilities and assist-
prior history of jaundice; serologic hepatitis A antibody ance that can be provided during travel and at the desti-
screening prior to immunization in these individuals may nation(s) should be conrmed prior to booking. Help
be cost-eective (Castelli et al., 1996; Schwartz and with boarding and disembarking may be requested and/
Raveh, 1998). or required. Disabled travelers should not expect ight
Live vaccines (oral typhoid, oral polio, varicella, yellow attendants to help them with eating, administering medi-
fever) should not be given routinely to immunocom- cations, or providing assistance in washrooms. If the
promised travelers. Elderly travelers are at higher risk of degree of assistance required during travel is beyond that
adverse events related to yellow fever vaccine (Martin et which can be provided by ight attendants, the carrier
al., 1999). Immunologically impaired individuals, includ- may not allow travel unless the individual is accompanied
ing those on hemodialysis, require a higher vaccine dose by a companion. Discount fares for travel companions
for hepatitis B (usually double, but consult the manufac- are often available. A recent ruling states that cruise ships,
turers recommendations). whether registered in the United States or abroad, must
accommodate disabled travelers under the Americans
with Disabilities Act.
Personal mobility devices, including wheelchairs,
ADVICE FOR THE DISABLED TRAVELER canes, crutches, and folding walkers, can usually be stored
in the aircraft cabin. Transfer to smaller wheelchairs,
The Visually Impaired Traveler which should be provided by the airline, may be required
to board certain aircraft. Wheelchairs cannot yet be ac-
Travelers needing eyeglasses should take an extra pair commodated in most aircraft washrooms; the carrier can
during travel, as well as a copy of their current prescrip- provide details regarding washroom space, if requested.
tion. Tools for emergency eyeglass repairs, sold in phar- Wheelchair batteries may be damaged in baggage com-
macies or at opticians oces, may come in handy. partments. It is the airlines responsibility to transport
Contact lens wearers should take all required equip- mobility devices intact. If any device is damaged in tran-
ment and solutions with them, as well as an extra pair of sit, the carrier is obliged to pay for repairs or replace it
glasses. Iodine-puried water should not be used for lens with a similar model, and to provide a temporary replace-
care as it will permanently stain lenses. Daily disposable ment if needed. To avoid these problems, lightweight or
contact lenses are an attractive, relatively inexpensive, smaller sized, nonmotorized wheelchairs may be prefer-
maintenance-free alternative to conventional contact able for travel. Tools for emergency repairs may be in-
lenses. valuable.
SPECIAL HIGH-RISK TRAVEL GROUPS 441
CONSIDERATIONS FOR TRAVELERS gen begins to fall and active cabin pressurization is re-
WITH OTHER CHRONIC MEDICAL quired, resulting in an atmosphere equivalent to that
CONDITIONS found between 5000 and 8000 feet (1529 and 2438 m)
above sea level.
Cardiovascular Disease Active cabin pressurization can adversely aect sinusi-
tis and otitis. Air travel is contraindicated in those with
Cardiovascular diseases, including myocardial infarction pneumothorax or pneumomediastinum, and should be
and cerebrovascular events, are the leading causes of delayed for several weeks following middle-ear or tho-
death, accounting for 49% of all deaths in American racic surgery (Gong, 1991). The reduction in atmospheric
travelers outside the United States; most occur in those 55 oxygen during ight, while well tolerated by healthy
years of age and older (Hargarten et al., 1991; Paixao et travelers, can lead to marked hypoxemia in travelers with
al., 1991; Sneizek and Smith, 1991; Prociv, 1995). Cardiac cardiopulmonary compromise, although the clinical sig-
events accounted for 11% of medical emergencies in nicance of this is not completely clear (Gong, 1992).
travelers at the Seattle-Tacoma International Airport Dillard et al. (1991) found that pulmonary symptoms,
over a 1 year period, occurring both within the airport, including dyspnea, edema, wheezing, chest pain, and cy-
where they accounted for 7% of all airport emergencies, anosis, worsened during ight in 8 of 44 travelers (18.2%)
and in the air, where they accounted for 20% of all inight with chronic obstructive lung disease. Assessment of the
emergencies (Cummins and Schubach, 1989). need for supplemental oxygen is therefore recommended
Cummins et al. (1988) reviewed 577 deaths which oc- in travelers with underlying cardiopulmonary disease.
curred during ight between the years 1977 and 1984, of The minimum desired Pa during ight is 50 mmHg,
and supplemental oxygen should be used if the predicted
which 56% were attributed to cardiac events. Most (66%)
occurred in men, with a mean age of about 54 years. Pa will be below this level. Using a hypoxiaaltitude
simulation test (HAST), Gong et al. (1984) determined
Strikingly, cardiac deaths in apparently healthy travelers
were common, accounting for 63% of all deaths in this that the arterial oxygen tension (Pa ) measured at sea
level in normocapnic individuals with chronic airway
group and 78% of all sudden cardiac deaths. Sudden
cardiac events during ight frequently necessitate un- obstruction is the best predictor of the resting Pa at a
given altitude. They developed a nomogram that can be
scheduled landings, which can be especially problematic
during overseas ights. used to predict the estimated Pa during ight (Figure
26.1). Using the HAST, a sea level Pa of 72 mmHg
For individuals with cardiovascular disease, contrain-
correlates to a Pa of at least 50 mmHg in a cabin
dications to air travel include myocardial infarction, un-
altitude of 8000 feet (2438 m) in most normocapnic indi-
controlled angina, congestive heart failure, and/or signi-
cant dysrhythmias within the previous month, or viduals.
cerebrovascular infarction within the past 2 weeks (Table The inspired oxygen concentration (Fi ) required dur-
26.1). Implanted cardiac devices are not contraindi- ing ight can be estimated using several methods. For
cations to ying. Proper functioning of such devices travelers who do not require supplemental oxygen on
should be ensured prior to travel, and batteries replaced if land, an Fi of 30% (2 l min\) should be adequate. The
HAST nomogram can be used, with baseline Pa meas-
needed. Electronic pacemaker checks by phone cannot
ured using supplemental oxygen. Alternatively, Dillard et
yet be relayed by satellite from overseas destinations, but
relay will soon be available aboard aircraft (Micromedi- al. (1989) devised a formula which also incorporates the
cal Biolog monitors). It may be prudent to determine the measured forced expiratory volume in the rst second
facility closest to the travel destination that is best equip- (FEV ):
ped to service travelers with such devices in the event of Pa (at 8000 feet) : [0.519(Pa at sea level)]
an emergency. It is important to note that portable secur- ; [11.855(FEV in litres)] 9 1.760
ity magnets may interfere with the functioning of an
implantable debrillator; a physicians letter may be use- Regardless of the method used, the Pa (and FEV , if
used) should be measured within 2 weeks of scheduled
ful for such travelers. Supplemental oxygen may be re-
quired for some travelers with cardiovascular disease. travel (Gong, 1989).
Guidelines for assessing oxygen requirements are dis- Pulmonary function should be optimized prior to and
cussed in the following section. during ight by using bronchodilators and/or corticos-
teroids, if indicated. If oxygen is required, provide the
airline with at least 48 h notice prior to scheduled depar-
ture. A prescription for oxygen (indicating the ow rate or
Pulmonary Disease Fi , and specifying continuous versus intermittent oxy-
gen) is required, as is a physicians letter outlining the
Most commercial aircraft cruise at altitudes between individuals tness to travel. Inight oxygen and equip-
22 000 and 44 000 feet (6706 to 13 411 m) above sea level. ment will be supplied by the carrier, at a cost to the
Cabin pressure equivalent to sea-level pressure can be traveler, usually based on ight segments and/or the
maintained up to an altitude of roughly 22 500 feet number of oxygen canisters required. Check with the air
(6858 m). Above this altitude, the partial pressure of oxy- carrier for charges, and be aware that delivery systems
442 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
several weeks if possible. Travelers with colostomies
should use a larger bag and have an extra bag on hand for
the same reason.
Anemia
Orthopedic Conditions
27
Selective Interventions
Medical Assessment
Selective interventions are services oered to asympto-
Medical screening that is limited to a complete medical matic persons with one or more risk factors for a target
with a pass/fail outcome has been abandoned in favor of condition, if there is a signicant burden of suering and if
a more selective approach to the prevention and detec- treatment at a preclinical stage oers a better outcome
tion of health problems (American College of Physicians, than waiting until after the disease manifests itself. Pul-
1981). Protocols based on practice guidelines for preven- monary function tests would clearly be justied for the
tive care ensure that appropriate general and selective individual noted above because the ndings will further
interventions are part of the evaluation while excluding clarify the risk, which in turn could impact decisions
routine testing that has no proven merit (Hayward et al, made by the client and management team.
1991). Many will present for a preassignment medical Appropriate selective interventions for other target
assessment without a travel history that would prompt conditions, such as diabetes mellitus, coronary artery
screening for geographic specic risk factors: therefore it disease, some types of cancer, osteoporosis and sexually
is sucient to follow national guidelines that set forth the transmitted diseases, should be recommended in accord-
appropriate general and selective interventions. ance to the standard of care in the applicants country of
AID WORKERS, EXPATRIATES AND TRAVEL 451
Table 27.1 Routine and selective laboratory investigations p. 398) reported: relief workers themselves have used
phrases such as martyr, mist, masochist, or running away
Routine tests Complete blood count from bad relationships to categorize the motivations of
Urine chemistry test: glucose, others around them, perhaps not their own, for entering
blood, protein relief work (italics in original).
Selective screening based on Chest X-ray Paluszny and Zrull (1971) studied 50 applicants for
symptoms or identied risk ECG/stress testing
missionary service. They found that, although the major-
factors Glucose
ity appeared to be well adjusted, seven (14%) had signi-
Hepatitis serology
Liver function tests
cant psychological diculties. One anonymous aid or-
Sexually transmitted disease ganization admitted in a survey that: Some situations
screen/HIV require people who can destroy themselves and thrive on
Thyroid-stimulating hormone chaos . . . at times we have employed workaholics and
Selective screening based on Bone density studies alcoholics (McCall and Salama, 1999, p. 114).
age- and sex-specic risk Cholesterol, triglycerides A small proportion of the people who apply to go
factors Colon cancer screen overseas as aid workers or expatriates do so because of
Mammogram emotional diculties, perhaps being motivated by guilt
Papanicolaou test or a desire to escape from their current situation. The vast
Prostrate-specic antigen majority, on the other hand, are psychologically healthy
Selective screening based on Schistosomiasis serology (Lovell, 1997). Among those with no current diculties,
identied risk factors for Stool for ova and parasites some are more vulnerable than others to experiencing
parasitic and tropical (one) diculty in adjusting to the demands of the new culture.
diseases Strongyloides serology Those who cannot work eectively in the new culture
Filaria serology may suer from a loss of self-esteem and from stress-
related problems. They may have to return home early,
which can cause family problems and career diculties.
Their colleagues may also be adversely aected. Recruit-
origin. Understandably, these guidelines vary. Recom- ing people for positions overseas, training them, and
mendations for colorectal cancer surveillance range from transporting them abroad is a costly business. Diculties
a colonoscopy for all persons over the age of 40 to nation- carry a nancial cost, as well as an emotional one. More-
al guidelines that limit colonoscopy to persons with addi- over, if an organization is perceived as having inadequate
tional risk factors (Hayward et al., 1991) (Table 27.1). selection or support procedures, they may in future be
It is folly to assume that all primary care physicians refused entry visas or funding (Fawcett, 1999).
have already uniformly applied these standards for all of In an attempt to reduce such problems, many organiz-
their patients. T.L. Dwelle (personal communication, ations now include psychological screening in the selec-
1996) evaluated the les of 204 missionaries who were tion process. Researchers have generated long lists of
assigned to an international setting and determined that qualities that are desirable among expatriates, which
88% of the records did not have evidence to conrm that have been summarized as follows:
the applicant had been appropriately screened for cancer
in accordance to the USA guidelines. Furthermore, one he should have the stamina of an Olympic runner, the mental
could overlook the signicance of an equivocal nding in agility of an Einstein, the conversational skill of a professor of
a client who will be living in a remote setting where languages, the detachment of a judge, the tact of a diplomat, and
the perseverance of an Egyptian pyramid builder . . . he should
follow-up testing is both costly and disruptive. Thus, the also have a feeling for culture; his moral judgment should not be
consultation serves the applicant by apprising him or her too rigid; he should be able to merge with the local environment
of the health risks and serves the agency by delineating with a chameleon-like ease; and he should show no signs of
the responsibilities that they should assume in the context prejudice (Oates, 1970, p. 24).
of placement, services and support.
Given that no one could possibly meet these criteria, what
type of psychological screening will provide the most
Psychological Assessment useful predictive information about how the individual
will adjust, cope and perform overseas?
What sort of person would apply for a job far from family
and friends, leaving the comfort of home, their belongings
and all that is familiar, to work in a place where he or she Psychometric Tests
would have to learn new skills, customs and maybe even a
language, perhaps in an extreme climate? Are some It is rare for an expatriate assignment to fail due to lack
people drawn to expatriate work because of pre-existing of skill or ability: 80% of failed assignments are due to
problems or a desire to escape? Engel (1980, p. 304) wrote, adjustment diculties (Holmes and Piker, 1980). There-
there is a tendency for individuals with personality prob- fore, the focus here will be on tests that help to assess the
lems to volunteer for the tropics. Smith et al. (1996, presence and severity of psychological diculties, and
452 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
measures which give an indication of personality charac- for another position (Doll et al., 1969). Some people want
teristics, as these may help to predict adjustment. a test that can help screen out applicants with psychologi-
There are three main advantages of psychometric test- cal disorders, while others are interested in one that could
ing. First, the candidates score can be compared with help to identify strengths and weaknesses, or interests and
standardized scores; therefore, a test score may be per- values. The latter can assist in deciding where an individ-
ceived as more objective than a judgment based on intu- ual will best be placed, in terms of both location and role.
ition during an interview. Second, test results may pick Ones and Viswesvaran (1997) reviewed the literature
up indications of, for example, a personality disorder that on personality-related predictors of expatriate success,
might not have been apparent during an interview. The and recommended that the big ve dimensions of per-
third advantage is that some psychometric tests are cost- sonality should be considered (emotional stability, ex-
eective, especially if they can be sent to the candidate for traversion, openness to experience, agreeableness, and
completion and scored relatively quickly. A major disad- conscientiousness). A number of questionnaires consider
vantage is that tests can provide a false sense of security. such dimensions. Discussion with a psychologist can as-
Many factors interact to inuence how an expatriate will sist in ascertaining which test is most appropriate for a
adjust and perform overseas, and no single test measures particular organization.
all of these factors. It is not dicult for intelligent candidates to modify
Little research has been conducted on the eectiveness their responses to hide symptoms of depression or other
of psychometric tests for predicting expatriate adjust- diculties, and even the validity scales of the MMPI-2,
ment. The limited research, which has been published, has which are sensitive to global deception or defensiveness,
mainly concerned the use of the Minnesota Multiphasic can miss subtle toning down of responses. Therefore, it is
Personality Inventory (MMPI, and the revised version important that psychological tests, if used, are taken in
MMPI-2) (Hathaway and McKinley, 1989). The MMPI combination with a clinical interview. The interview may
is the most widely used personality test. It was originally uncover diculties that were not apparent from ques-
developed to diagnose psychological disorders, but has tionnaire scores. In cases where the questionnaire results
been revised and standardized on normal populations, appear abnormal, the interview provides an opportunity
and has been used eectively in some areas of personnel to assess why. It is possible that an unusual prole is a
selection (Westefeld and Maples, 1998). The MMPI has sign of creativity or cultural dierence, rather than psy-
been described as the gold standard for detection of chopathology. Psychometric tests are of greatest use if
personality disorders (Schubert, 1992, p.85). It also pro- they are appropriate for the applicants culture, selected
vides a broad range of information about other psycho- carefully to answer specic questions, interpreted skil-
logical disorders, and normal personality traits. Norms fully, and used in combination with a psychological inter-
exist for people of dierent backgrounds and cultures view.
(Butcher, 1996). Although computer programs are avail-
able to assist in the rapid scoring of responses, someone
who has appropriate training and expertise should inter- Psychological Assessment Interview
pret the results.
Research suggests that the MMPI has some use in the It is recommended that every applicant for an expatriate
prediction of expatriate adjustment (Guthrie and Zektick, post receive an in-depth psychological assessment inter-
1967; Dicken, 1969; Dillon, 1983; Schnurr et al., 1993). view. Ideally, a psychiatrist or clinical psychologist, who
Schubert and Ganter (1996) conducted a double-blind is able to assess the candidates mental state, should con-
study of 129 missionary candidates (or couples). They duct this interview. A skilled interviewer should be able to
concluded that the MMPI was inadequate as a sole in- put the candidate at ease and elicit honest responses, or at
strument in evaluating candidates, but had a high poten- least detect when a candidate is being defensive or dishon-
tial for use in combination with an in-depth psychological est. The manner in which people speak about their experi-
interview. Schubert (1999, p. 88) stated: The MMPI ences, and what they choose not to say, can be just as
allows insight into unconscious issues . . . and vulnerable important as what they say.
underlying personality traits not apparent in clinical in- The interview should include a life history covering the
terviews alone. . . . [Certain subscales] appear to tap candidates childhood and adolescence, and education
some unconscious aspects of personality which are help- and employment up to the present. The interviewer
ful in cross-cultural predictions. Schuberts research was should attempt to build up a picture of the candidates
based on the original MMPI, and not the MMPI-2. strengths and weaknesses. It is important to consider
There are advantages and disadvantages to using each of what causes candidates stress and how they handle it;
these measures (Hargrave et al., 1994; Westefeld and how they deal with anger and frustration; how resilient,
Maples, 1998; Schubert, 1999). resourceful and exible they are, and where they get their
Despite the attention paid to the MMPI, it is not support from. Their motivation for applying for a post
necessarily the most appropriate measure. It is important overseas should be explored, and interviewers should
to choose a test that is not only reliable, valid and stan- assess how realistic their expectations are, and discuss
dardized, but will also answer the questions of interest. A any previous experience of working overseas. As interper-
test that is useful for one type of post may be of little value sonal problems are a major cause of stress and possibly of
AID WORKERS, EXPATRIATES AND TRAVEL 453
premature return home (Lovell, 1997; Carter, 1999), it is Other Forms of Psychological Assessment
also important to assess how they relate to other people.
The interviewer should also take a detailed history of Some agencies use simulation activities as part of their
any experience of traumatic incidents (including abuse), assessment (Fawcett, 1999). Some organizations inform
and any personal or family history of psychological prob- candidates that their entire period of training is a pro-
lems. Where there is a vulnerability to psychological dis- longed assessment period. Additional assessment such as
orders, this should be carefully assessed. Foyle et al. this may have value, but as yet research on such activities
(1998) found that aective disorders among expatriates is lacking, and so they should only be used in addition to
were associated with a past personal history of depressed a psychological interview, and not in place of one.
mood, and a family psychiatric history. They concluded
(p. 282):
Conclusions Concerning Psychological Assessment
Those with heavily loaded family and personal psychiatric histories
should not be accepted for overseas service unless there is clear It is recommended that a psychological assessment inter-
evidence that they have remained well for several years, have a view should be part of the selection procedure for every
good work record in their home country, and have shown a capacity
assignment and reassignment. The interviewer should
for coping in general, and for maintaining good interpersonal rela-
tionships. There must also be good personal and medical support in have some knowledge of expatriate life and the relevant
the locations to which they will go (italics in original). environment. A major purpose of the interview is to check
whether the candidate is currently suering from any
A psychological assessment can be used not only to say psychological disorder, and to assess areas of vulnerabil-
yes or no but to provide recommendations that will ity. If more detailed information is desired, a carefully
help to maximize the probability that the candidate will selected psychometric test might provide this.
adjust well. Knowledge of vulnerabilities can highlight
any special support that might be benecial. In some
cases it is wise to advise delaying overseas work until PREDEPARTURE: PREPARATION
there has been time to engage in personal or marital
therapy. It may also be advisable to recommend a delay if Many of the guidelines for predeparture preparation will
the candidate has suered from a recent bereavement or also apply to the short-term traveller and thus will be
relationship breakdown. dealt with in more detail in other chapters. Suce it to say
If a couple will be moving overseas together, both that one cannot assume that the organizations guidelines
partners should be interviewed separately, even if only will be in accordance with current standards of care, nor
one of them will be working. One of the predictors of an can one assume that the person has been adequately
expatriates adjustment is the spouses adjustment (Stroh prepared if he or she has seen the local health practitioner
et al., 1994), and there is a strong relationship between (Beallor et al., 1997; Dwelle, 1995; Lange et al., 1987).
marital satisfaction and depression among expatriate
couples (Sweatman, 1999). If the couple have children, it is
useful to assess the whole family. Concern about children Immunizations
is a common cause of early return, and potential prob-
lems might be identied during the assessment, avoiding Immunization advice is thoroughly addressed elsewhere;
much distress later (Foyle, 1994). however, there are some risk factors that are particularly
The eectiveness of a psychological interview depends signicant for the expatriate community and will be brief-
to a large extent on the skill and experience of the inter- ly addressed.
viewer. Fisher et al. (1967) found that assessment ratings
made by more experienced psychiatrists correlated sig-
nicantly and positively with the later performance of Hepatitis B
Peace Corps volunteers, while the ratings of less experi-
enced interviewers did not. Likewise, Gunderson and Hepatitis B is an established risk for expatriates, in part
Kapfer (1966) found that the psychological interview had related to unprotected intercourse in nonmonogamous
a weak predictive validity when the interviewer was poor- relationships and in part related to inadvertent exposure
ly informed about the placement environment, but better in communities where the prevalence of hepatitis B is
predictions were made when interviewers were provided high. Given the potential for adverse outcomes, the e-
with more information. cacy of the vaccine and the relatively low cost, universal
Even if the applicant has worked overseas previously, immunization for the expatriate task force can readily be
there should be a brief reassessment before every new justied (Lange and Frame, 1990; Smalligan et al., 1995).
assignment. It is not rare for applicants with psychiatric
disorders to be accepted for reassignments without fur-
ther psychological screening, to the detriment of them- Japanese Encephalitis B
selves and those who have to support them in their post
(Lovell, 1997). Japanese encephalitis B vaccine is one of few vaccines
454 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
where there is potential for harm to the recipient. How- Cholera
ever, clinical disease is associated with a mortality rate
ranging from 10 to 25%, with up to 50% of survivors Routine immunization against cholera is not recommen-
demonstrating permanent psychoneurological sequelae ded; however, the oral cholera vaccine eectively reduces
(Vaughn and Hoke, 1992). Although persons in urban the volume of uid loss and therefore is recommended for
settings are usually exempt, one should determine if the persons residing in endemic areas where access to rehyd-
cumulative risk could exceed 4 weeks during the pro- ration therapy may be limited (Advisory Committee
posed assignment (CDC, 1993). Statement, 1998).
It is dicult to assess the risk of exposure to rabies but the In terms of aid workers and the military, tick-borne en-
rate of postexposure treatment closely approximates 1 cephalitis vaccine is an important issue, given the need for
per 1000 volunteers per month among expatriates living ongoing aid and peacekeeping in the Balkans, and for
in rabies enzootic regions (Arguin et al., 2000; Bernard long-term health and development programs in eastern
and Fishbein, 1991; Bjorvatn and Gundersen, 1980; Hatz Europe and in the endemic band, which runs across the
et al., 1994; LeGuerrier et al., 1996). The risk of children former Soviet Union.
being bitten is conservatively estimated to be four times On balance, aid workers, expatriates, longer term
greater than that of adults (LeGuerrier et al., 1996). Fur- travelers and environmentalists should consider having
thermore, bites in children are usually higher on the trunk this vaccine if spending signicant time in rural settings,
or face and are more severe or, conversely, minimized and especially in forested areas in late spring and summer in
neglected. pockets where the disease is known to exist (Department
Dogs are usually the source of risk. Often pets are of Health, 1996).
involved but it is disturbing to note that many expatriates
keep pets that are not appropriately vaccinated against
rabies. Postexposure treatments are often delayed, bio- Malaria
logics may not be available in less auent countries and
frequently management is not in accordance to World Risk Factors
Health Organization (WHO) guidelines (Arguin et al.,
2000). Malaria was the leading cause of death among expatri-
There are two options for the prevention of rabies: ates who died from infectious diseases (Frame et al., 1992)
pre-exposure rabies immunization with three doses of a and continues to pose a threat in sub-Saharan Africa,
tissue culture rabies vaccine; or relying exclusively on where the rate of malaria is at least 10-fold greater than in
postexposure immunization. Pre-exposure immunization other malarious countries (Adera et al., 1995), with the
does not eliminate the need for careful wound manage- exception of Papua New Guinea and Irian Jaya (Ohrt et
ment and immunization with two doses of a potent tissue al., 1997). The true incidence of malaria in expatriates is
culture; it obviates the need for rabies immune globulin dicult to determine but rough estimates range from 31
(RIG). per 1000 per year in Asia to 209 per 1000 per year in West
Expatriates residing in rabies enzootic countries with Africa (Schneider, 1998; Peppiatt and Byass, 1990; Phil-
limited access to rabies biologics, particularly RIG, are at lips-Howard et al., 1990). The majority make the diag-
greater than average risk for contracting rabies should nosis based on the presence of fever or are diagnosed by
they be exposed. For postexposure vaccination to work laboratories where the false-positive rate could be as high
and be cost-eective, it is essential that medical expertise as 75% (Lobel et al., 1998).
be available on an urgent basis and that there be access to The risk of malaria appears to increase over time,
tissue culture vaccines plus RIG or puried equine RIG. particularly evident in persons who resided in malaria-
Given that rabies prevention for persons previously endemic regions for 23 years or longer (Adera et al.,
immunized with a cell culture vaccine relies on the anam- 1995; Schneider, 1998). In sub-Saharan Africa, children,
nestic response to the two postexposure doses of the persons who do not take antimalarial prophylaxis and
vaccine, routine booster doses are not required for ex- persons living and working in rural areas are at greater
patriates unless there is judged to be a signicant risk for risk for contracting malaria. Environmental factors that
inadvertent exposure, or there is a likelihood that access have been found to be protective are altitudes above
to care will be limited so as to prevent timely administra- 2000 m and arid climates (World Health Organization,
tion of the postexposure doses. Persons at risk for inad- 1997).
vertent exposure must follow the usual guidelines for
serological testing and booster doses (ACIP, 1999).
Chemoprophylaxis
Diarrheal Diseases
HIV
Diarrheal diseases related to bacterial infections account
for the majority of illnesses among expatriates (Bernard et There is little doubt that human immunodeciency virus
al., 1989). There is both a seasonal variation and a signi- (HIV) transmission is primarily related to sexual activity
cant variation from one region to another. Foods cooked and occupational hazards. Of the 2000 Dutch expatriates
earlier in the day, such as lasagna and quiche, as well as working in sub-Saharan Africa, 0.4% of men and 0.1% of
blended fruit and yogurt drinks have recently been identi- women contracted HIV. One case related to occupational
ed as risk factors. Other dominant risk factors include: exposure (Houweling and Coutinho, 1991).
younger age, shorter duration of stay and eating in res- There is less known about the incidence of HIV
taurants. Although the severity of diarrhea in expatriates amongst aid and relief workers (Lange et al., 1989; Lange
may be somewhat less than that found among short-term and Frame, 1991). Although extremely rare in some
travelers, the morbidity is still signicant and remains so groups, Schouten and Bordo (1995) conrm that cases
for up to 2 years (Hoge et al., 1996; Shlim et al., 1999). are occurring and Dutch medics in HIV/AIDS endemic
Handwashing for household food handlers and em- areas were found to have a mean occupational risk of
ployees should be emphasized in addition to standard HIV of 0.11% per person per year. Elsewhere, 1.1% of
advice regarding water purication and food precautions. Belgian advisers working in Africa and 0.9% of European
AID WORKERS, EXPATRIATES AND TRAVEL 457
expatriates living in Africa were found to be HIV-positive job performance, and crosscultural skills development.
in a voluntary screening program (Bonneux et al., 1988). Holmes and Piker (1980) estimated that expatriate attri-
We can expect the number of reported cases to increase, tion averaged around 40% among companies who nei-
given the explosive increase in HIV infection in many ther screened candidates for cultural adaptability nor
parts of the world where aid workers are posted and provided cultural orientation, compared with 25%
expatriates live (World Health Organization, 1999). among those with orientation programs only, and 510%
Aid workers and expatriates may need predeparture among those using both screening and orientation pro-
testing for the following reasons: visa applications; eligi- grams.
bility to join a Trusted Donor Blood Group (Walking An important part of the preparation package should
Blood Bank); to assess employer liability if personnel be to explain what to expect in terms of culture shock, and
return HIV-positive after their assignment; to provide the longer-term adjustment process. It is not unusual for
health counsel for management of unique health risks, expatriates to have stress-related symptoms at some
especially as it pertains to opportunistic infections and point. Those who have been informed that this often
live vaccines; and to oer treatment to persons found to happens tend to be able to normalize their symptoms.
be HIV-positive. Those who have not been informed about normal symp-
There remains the vexed issue of postexposure prophy- toms of stress may worry that they are over-reacting.
laxis following an occupational health exposure (or sex- This is likely to add to their distress and to maintain and
ual assault). Kits are increasingly availablemade up in 7 intensify the symptoms (Lovell, 1997).
or 28 day packs and comprising two or three antiret- Aid workers have a greater tendency to deny stress-
roviral drugs, commonly comprising zidovudine, related symptoms than other people in helping profes-
lamivudine and sometimes a protease inhibitor such as sions (Chester, 1983). Some believe that they have been
indinavir. These kits are largely designed for aid workers trained to be tough and not to let certain feelings aect
perceived to have a high occupational risk of HIV expo- them (Grant, 1995, p. 75). Teaching them the benets of
sure, including doctors, nurses and medical students. An gaining relief through sharing concerns may help them to
increasing number of agencies are now providing these cope better in the long run.
kits. Detailed guidelines and instructions about the best Perhaps a parallel can be drawn with marriage prep-
ways of using these are currently being hammered out in aration. If a couple have been helped to prepare, they are
the hopes that a degree of consensus will emerge. The area more likely to perceive diculties as a normal part of
is fraught with medical, nancial, logistical and moral married life, and to cope with them and remain together.
issues. Some agencies including Medicins sans Frontie`res Likewise, expatriates are likely to face diculties at times.
are following clearly dened and managed protocols If they have received adequate preparation, they are more
(Medecins sans Frontie`res, 1997; and revised draft 2000). likely to be able to cope with the problems and resolve
them. A lack of preparation may result in them giving up,
or else developing stress-related symptoms.
Psychological Training and Preparation As part of stress management training, expatriates
should be given information about the importance of
Many people who show no particular signs of vulnerabil- taking sucient time to rest and relax. Excessive working
ity at assessment go on to develop diculties while over- hours contribute to the diculties that can cause prema-
seas, or return home early because of stress (Christy and ture return (Lovell, 1999a). Couples and families benet
Rasmussen, 1963; Dally, 1985). Can adequate training from scheduling sucient quality time together. Discuss-
and preparation make a dierence? ing how to create and maintain a strong social support
Tung (1988) investigated why the rate of premature network can also take place at the preparation stage.
repatriation was more than twice as high among expatri- Some organizations have found it benecial to provide
ates from the USA compared with those from Europe or training in team building, and to teach expatriates about
Japan. Tung found that American companies were much personality dierences, in order to help team members to
less likely than European or Japanese companies to pro- understand each other better. Acquiring an understand-
vide formal training for crosscultural posts. ing of dierences can be extended to understanding cross-
Not all groups of American expatriates have a high cultural dierences. The preparation package should in-
attrition rate, and so the dierence cannot be explained in clude ample opportunity to learn about the relevant
terms cultural dierences in expectations or attitudes. culture, so that unrealistic expectations can be exchanged
Henry (1965, p. 18) observed that only 34% of American for realistic ones. Unmet expectations are a common
Peace Corps volunteers were sent home early as out-and- cause of frustration, and modifying them in advance can
out selection errors, compared with 30% of expatriates reduce diculties later on.
sent abroad by American companies. One of the major It is important that training does not focus on crises to
dierences between the groups was the 3 month training the exclusion of other potential stressors. Many expatri-
course received by the Peace Corps volunteers. ates cope well with political instability and war situations
Deshpande and Viswesvaran (1992), in a meta-analysis because the conict is external and not aimed at them
of 21 studies, concluded that crosscultural training had a personally. Personal criticism and relationship conict
strong and positive eect on crosscultural adjustment, can be more detrimental (Lovell, 1997). Ongoing frustra-
458 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
tions may be more harmful psychologically than short- our orientation, most any employee will encounter di-
lived traumatic events, as they can be a cause of chronic culties . . . we can never leave even the best employee
stress. Training in problem-solving skills, negotiation alone.
techniques and conict resolution can help to reduce As part of the preparation package, expatriates should
stress. receive information about where they can go for help
Many expatriates report feeling underprepared for should they have health problems or other diculties
their assignment (Dunbar and Ehrlich, 1993), which adds overseas. Sending agencies should have a policy on this
to their levels of stress and uncertainty. A comprehensive issue. For mild diculties, information may be sucient.
preparation program, including the components de- In more severe cases, consultation with a health profes-
scribed above, could help to reduce both emotional prob- sional should be arranged. Ideally, organizations should
lems and attrition among expatriates. obtain information about health services in the area, and
how they can be accessed, before the expatriate arrives.
Ongoing contact from the sending agency can reduce
the sense of isolation and anxiety, including anxiety about
Safety While Abroad
what will happen when they return home. Aycan (1997,
p. 33) reported that, expatriates who feel condent about
Training in crisis management may also be appropriate
company support are likely to adjust better than those
(Goode, 1995). Many expatriates are at increased risk of
who experience uncertainty and stress about their future.
experiencing traumatic incidents, perhaps related to ter-
It can be useful to check that they are not working
rorist bombing, war situations, evacuations, hostage tak-
excessively long hours, and that they are taking days o
ing, rape, robbery, riots, trac accidents, land mines,
regularly. They should be informed about how they can
natural disasters, or illness epidemics. A crisis manage-
provide feedback, make requests or ask for help (practical
ment package should include a security brieng covering
or emotional) at any time should they require it. Ad-
measures to prevent crises wherever possible, by being
equate supervision should be provided. Inviting their sug-
alert to potential danger and taking precautions to en-
gestions for changes and improvements can foster job
hance safety. The package should also provide informa-
satisfaction. Chronic stress problems are less likely to
tion about established policies. Training can also be given
materialize in an environment where people feel free to
in the importance of not abandoning hope during a crisis,
acknowledge diculties and request help at an early
but rather trying to engage in active problem solving, as
stage.
this is associated with a reduction in negative psychologi-
Very little has been written about models of care that
cal after-eects (Ehlers et al., 1998).
can be provided in international settings and there are no
In some areas, expatriates are targeted for hostage
data in the literature that would distinguish one model of
taking or assassination (Slim, 1995; Rogers, 1998). Ex-
care as being more eective than another. The possibili-
patriates who are involved with humanitarian work in
ties include: (1) self-reliant sta who develop their own
conict zones may face particularly severe diculties.
network and health care providers; (2) national sta who
Helping people on one side can be perceived as being an
have received international training who are familiar with
enemy of the other side. People suspected of war crimes
the culture of the home country; (3) international clinics
may attempt to kill expatriates, fearing that they might
staed by persons who are also members of that expatri-
speak out at criminal tribunals. Although the survival
ate community; (4) clinics staed by members of the same
rates among expatriates taken hostage mirrors that of the
organization; and (5) reliance on networks that have been
general population, fatalities are not rare. It is reported
established by the embassy for their personnel.
that at least 160 United Nations civilian personnel were
Although self-care is necessary, it appears that most
killed in the 7 years leading up to 1999 (Editorial, 1999),
do seek help from health care professionals for more
and the UN is only one of many organizations working in
complex medical problems. Professional help should also
such areas.
be sought in cases of psychosis, severe depression, suicidal
Kidnapping often follows cycles of terrorism, at times
ideation, anorexia nervosa, PTSD, serious diculties
involving multiple victims. Unlike random crimes, kid-
with a child (including the possibility of abuse), or any
napping usually involves preselected targets. Crisis man-
mental health problem that appears to be getting worse.
agement and contingency preparation seminars are now
Organizations could increase the potential for more eec-
available and it is prudent for those orientating and car-
tive care by fostering a culture that promotes help-seek-
ing for expatriates to become familiar with risk manage-
ing behaviour (MMWR, 1999).
ment principles.
Future Trends
CARING FOR EXPATRIATES IN
INTERNATIONAL SETTINGS Expatriates can feel isolated and undervalued if they are
not asked periodically how their workload is, and how
Sieveking et al. (1981, pp 101102) remind us that, Re- they are coping personally. Even without sophisticated
gardless of how valid our selection is, and how thorough technology, satellite telephones and e-mail links will often
AID WORKERS, EXPATRIATES AND TRAVEL 459
provide timely counsel for persons in remote regions. is trained in such debrieng. CISD was proposed orig-
Self-care is often strengthened by access to reputable inally as an intervention where groups of people who had
web sites, many of which have been developed for experienced a traumatic incident would meet together
travelers who do not have formal medical training. Pa- 2472 h after the incident, and describe in a structured
tients now have the potential to access their medical way the facts about what had happened, and then their
records via the Internet. Although care through elec- thoughts, followed by their feelings. Participants would
tronic mediums is often limited to general advice rather then be helped to normalize their reactions, and then to
than formulation of a specic diagnosis and management move towards future planning.
plan, one can often provide guidance that will help ex- There is currently considerable debate about the eec-
patriates to determine an appropriate course of action. tiveness of CISD. No randomized controlled trials have
Results of laboratory testing can be faxed, and good been conducted for CISD in groups, and there have only
quality lms from a variety of diagnostic imaging services been six such trials using CISD with individuals (Rose
can be couriered to a tertiary care center for a fraction of and Bisson, 1998). These six trials had mixed results,
the cost of repatriation. possibly due to methodological shortcomings. It appears
Soon that will seem archaic. With technology that is from the literature that most people who receive CISD
currently available, telemedicine is experiencing a resur- report nding it helpful, although it is not clear whether it
gence of interest. Several models of medical care have actually leads to a reduction in post-traumatic symptoms.
been developed that can serve as practical examples, such Further research will hopefully add further insight to this
as the Yale Telemedicine Center which has created links debate.
with physicians in Saudi Arabia. It is probable that the After any traumatic incident, it is wise to ensure that
military will establish a number of precedents, given their there is adequate time to rest. Accidents are more
established communication links. When utilizing tele- common following a stressful experience, and so the indi-
medicine it is dicult to know the limits of medical vidual should be encouraged to take particular care, es-
licensure and dicult to determine medicallegal bound- pecially when driving. PTSD can develop months or even
aries. Many are critical of endorsement without careful years after a traumatic event, perhaps being triggered by a
attention being given to the standards of care and the subsequent event, and so follow-up support should be
appraisal process. oered should the expatriate wish to receive it at any
point.
If appropriate treatment is not available locally, or the HEALTH SCREENING AND CARE ON
expatriate is unwilling to accept it, there may be a need for RETURN
repatriation. A local medical professional may be able to
liaise with the organization in such cases. The expatriate The Context
should be helped to accept that repatriation is not a sign
of failure. Comprehensive travel insurance includes cover Expatriates will generally be exposed to similar patho-
for emergency repatriation (Medivac). By accessing the gens as other travelers. Of course they may be exposed to
companys helpline (given on the insurance documents), more of them and they may be exposed over a longer
travel arrangements will be made by the assistance com- period of time.
pany. Longer-term expatriates will have often developed dif-
A common situation is evacuation due to deterioration ferent ways of perceiving themselves, their lives and the
in the security situation. It is very helpful if organizations world. They may have collected a medical worry list
have clear evacuation policies, which expatriates are because of local health care they perceive to be inad-
asked to adhere to as a condition of their contract. It is equate. They may be suering from acute, or more prob-
not uncommon for expatriates to refuse to follow an ably a degree of, cumulative stress. These factors can
evacuation policy, perhaps because they do not believe cause or confound their medical symptoms. As a result,
that there is any danger, or because in the heat of a crisis some will be introspectively concerned about what is
they develop a martyr instinct and insist that they will going on in their bodies (and their minds), and may have
not abandon their local friends. Expatriates who have consulted a range of friends.
consented to a policy before going overseas, having been The dierent mindset of longer-term expatriates means
informed of the reasons for it, are more likely to adhere to that a purely mechanistic, evidence-based approach to
it later. Organizations should also have policies on such screening is, on its own, woefully inadequate. Many ex-
issues as abuse and hostage situations. patriates will need to unravel concerns and bid into an
If an expatriate does experience evacuation or any action plan of which they feel ownership. We must be
other traumatic incident, it may be appropriate to oer prepared to think in either postmodern or modern para-
critical incident stress debrieng (CISD) (Mitchell, 1983). digms with this subgroup of travelers, without losing our
If there are several expatriates working in close proxim- evidence-based, cost-eective approach as the foundation
ity, it may be benecial to ensure that at least one of them of what we advise and recommend.
460 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
Purpose of Postreturn Screening and Care problems unrelated to travel. Eosinophilia was found in
67 out of 852 samples, positive schistosomal antibodies in
What we mean by screening in this section is the follow- 10.7%; 18.7% had abnormalities on stool tests. Although
ing: to diagnose, treat and manage any real or perceived eosinophilia is often an important marker of helminth
problem in the returning traveler that has a signicant infection, its signicance should be interpreted in the
physical or mental health component. Most readers will context of other risk factors and the absence of
recognize this as being radically dierent from the techni- eosinophilia does not rule out helminth infection (Lib-
cal denition used by epidemiologists: The systematic man et al., 1993; MacLean and Libman, 1998; Moore and
application of a test or enquiry, to identify individuals at Nutman, 1998).
sucient risk of a specic disorder to warrant further Peppiatt and Byass (1991) looked at the health of 212
investigations or direct preventive action, amongst per- returning missionaries serving in 27 countries for 488
sons who have not sought medical attention on account person-years: 6.5% of adults had a raised eosinophil
of symptoms of that disorder (Department of Health, count, but only 13 out of 157 had cysts of pathogenic
1997). organisms on stool test, lower than in many reported
In practice, the tropical check-up is a hybrid, a combi- studies. Self-reporting from overseas showed malaria, di-
nation of screening and case nding in such a way that the arrhea and giardia infection to be the most common
needs of both practitioner and patient are met, within the perceived illnesses, but psychiatric illness accounted for
limits of an aordable system. Churchill et al. (1993) begin nearly 110 episodes per 1000 person years, underlining
pointing us to a model beyond that of classical, mechanis- the need for careful assessment and stress management
tic screening. Patients perceptions and wishes should be seminars before leaving, and appropriate debrieng and
guiding factors which lead us to dene two particular counseling on return.
subgroups: returnees concerned that they may have latent The screening of children returning from the tropics
infections that could cause problems later, and those has been studied by Brouwer el al. (1999). They looked at
wishing to have retrospective diagnoses of illness suered 282 check-ups of children, aged from 3 months to 16
abroad. years, with stays ranging from 3 months to 13 years. Of
these, 62% were on children who had lived in sub-
Saharan Africa; 156 diagnoses of travel-related infectious
Evidence for the Validity of Screening and parasitic illnesses were found. Quoting from gures
in this paper from asymptomatic cases: 23% of check-ups
This continues to generate a great deal of debate (Conlon, showed asymptomatic giardiasis, 10% eosinophilia and
1993; Genton and Gehri, 1999; Okereke and Gelletie, 8% schistosomiasis. The jury is still out on the value and
1999). A major problem is the denition of validity, which cost-eectiveness of screening asymptomatic children.
will be dened dierently by the practitioner, epidemiol- However, a holistic paradigm, which takes into account
ogist, health economist and client. the broader picture of parental concern and perceived
A few papers have been written on the value of screen- public health risks in the schools they join, probably tilts
ing longer-term travelers, or indeed of the major health the balance in favor of screening.
problems they suer while abroad. One reason is the
diculty of monitoring or remembering episodes of ill-
ness or threats to health that may have occurred many
Who Needs a Medical Check-up?
months ago. The only way to investigate such health
problems reliably is to provide regular and systematic
In a postmodern culture, practitioners are expected to be
monitoring of expatriates health while they are overseas.
facilitators, placing evidence and benets before their
Without the bedrock knowledge of what illnesses have
patients and their sending agencies, so both can make
occurred abroad, health screening on return gives only a
informed choices; however, some will wish to consult in a
patchy idea of the expatriates overall state of health
more classical paradigm. Equally there will be some em-
during their overseas assignment.
ployers, including the military, certain companies and
The screening of the returned traveler is covered in
many relief agencies, that will have strict pre-employment
Chapter 12. In this section we will refer only to more
protocols that must be adhered to.
recent papers concerned with aid workers and expatri-
The following outline underscores the variety of rea-
ates.
sons for medical consultations on return from overseas:
Carroll et al. (1993) looked at a mixed group of
travelers including diplomats, long-term volunteers and Signicant symptoms or concerns
trekkers. The authors concluded that screening was use- Signicant exposure to serious diseases
ful but could be largely conducted through structured Being t on return but subsequently developing symp-
history taking and relevant laboratory tests: specialist toms
examination added little. One in four of those screened Somatization, with the client blaming parasites for
had an abnormal result. In addition, nontropical abnor- worsening or recurrent symptoms
malities where found in a signicant number, reecting Establishing a diagnosis for illness experienced abroad
the value to the individual of opportunistic screening for Medical assessment and/or psychological debrieng
AID WORKERS, EXPATRIATES AND TRAVEL 461
following high-risk assignments vote with their feet and stop referring their employees
Screening asymptomatic personnel returning from (Libman et al., 1993).
long-term assignment ( 9 6 months). In practice we should do the minimum tests necessary
consistent with evidence-based medicine, our profes-
Almost any problem, worry or symptom can be pres-
sional judgment and the concerns of the traveler. Selec-
ented, often representing a life crisis or chronic personal
tive interventions are based on risk factors identied
dilemma. There may be unresolved problems from over-
during the general assessment phase of the evaluation
seas or from before the assignment, including a myriad of
(Table 27.1). There is a growing body of literature that
nontropical ailments such as failed birth control, an alco-
will help the pratitioner to distinguish the appropriate
holic spouse, unexplained exhaustion, worries about
tests (MacLean and Libman, 1998; MacPherson, 1999).
debt, loss of role, temporary unemployment, a failing
marriage, undisclosed rape or tormented dreams.
Health care practitioners may well be the only person
Postassignment HIV Screening
travelers have the courage to speak to about such issues.
For some, quick, rm reassurance may be all that is
Questions surrounding HIV testing on return are some-
needed; but, for others, referrals or a broader, multidiscip-
what dierent. Aid workers may qualify for screening
linary team, including ministers of religion, counsellors or
because of occupational and sometimes lifestyle risk.
group therapy with other individuals experiencing similar
Many returning aid workers and expatriates are worried
situations may be required.
about risks, even if they are negligible. Sensitive pretest
counseling is a prerequisite to testing, and a strategy for
follow-up counseling for persons found to be seropositive
What Should Screening Consist Of? is essential.
History
Tuberculosis Surveillance
To consult eectively we will need to have a wide under-
standing of both world geography and world news so that An equally important issue is to monitor travelers ex-
we can make informed leaps of faith into our clients situ- posed to tuberculosis, to detect whether they have been
ation. infected before any signs of active infection develop. Stan-
Medical history taken for expatriates needs some ex- dard screening involves tuberculin tests with puried pro-
ploration of specic components. These include any un- tein derivative (PPD) before and after possible exposure
usual health and safety risks, psychosocial factors, failed to tuberculosis. In the UK, PPD is often administered as
expectations, causes of sleep disturbance, signs of abnor- a Heaf test. In North America, the Mantoux skin test with
mal stress, sexual health risks, alcohol consumption, risks 5 tuberculin units of PPD administered intradermally is
specic to hostile or dangerous environments and occu- the standard protocol.
pational health risks from HIV, hepatitis B or hepatitis C. Tuberculin skin testing has many practical drawbacks.
Structured questionnaires or protocols can provide the Many aid workers are on short-term contracts, and re-
majority of the information and make the consultation turn to their home countries every 3, 6 or 12 months.
more eective. Many are poorly compliant with preventative health
measures, and some are on relief registers and have to
respond rapidly when called. Arranging routine pre- and
Carrying Out the Examination postassignment tuberculin skin testing is dicult and is
likely to have low compliance. For those on longer as-
The clinical examination seeks to substantiate the nd- signments and with more time to prepare, tuberculin skin
ings discovered in the history and identify signs that were testing remains a workable option.
not revealed by the history and investigations: this is Recently a blood test has become available which de-
especially important with the skin, lymph nodes, liver and tects IgC antibodies to Mycobacterium tuberculosis and is
spleen. claimed to detect active infection (Desem and Jones, 1998;
Streeton et al., 1998). Further validation is required but
initial research is promising.
Laboratory Investigations
There are two mistakes to avoid: doing too few tests, and Concluding the Consultation
doing too many. The minimalists risk leaving their pa-
tients dissatised and missing important pathology. The At the end of the consultation, we need to make sure that
maximalists may do unnecessary tests out of clinical inse- the patient does not leave in a confused muddle, especial-
curity, for research interests or for medicolegal reasons. In ly as many issues may have been touched on and plans
overtesting, they risk making the tropical check-up so suggested. Furthermore, the mobile nature of this com-
expensive that companies and voluntary agencies will munity can make follow-up communication a logistical
462 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
nightmare. pare for their return home, several months before they
Patients will need to be clear about the following: actually return. Preparation should include information
about reverse culture shock. A book such as Re-entry
How and when results will be relayed to them
(Jordan, 1992) may be helpful. Assistance with practical
How to determine the results of condential testing,
and employment concerns is also greatly appreciated.
such as for HIV
Whether any counseling or debrieng is agreed to
Action to be taken if symptoms suggestive of malaria
arise over the coming weeks. Debrieng: A Reective Pause
28
IDPs and
Asylum returned others of
Region Refugees seekers refugees concern Total
Africa 3 523 250 61 110 933 890 1 732 290 6 250 540
Asia 4 781 750 24 750 617 620 1 884 740 7 308 860
Europe 2 608 380 473 060 952 060 3 252 300 7 285 800
Latin America 61 200 1 510 6 260 21 200 90 170
and Caribbean
North America 636 300 605 630 1 241 930
Oceania 64 500 15 540 80 040
Total 11 675 380 1 181 600 2 509 830 6 890 530 22 257 340
and more stringent administrative barriers are being im- Taking into account the successive stages of the migra-
plemented to contain this inux of newcomers. This has tory steps allows for a more systematic analysis of the
resulted in a signicant increase of irregular migration factors inuencing the present health condition of an
and human tracking of migrants. The United Nations individual or a community. The successive and intercon-
estimates that 4 million persons are victims of interna- nected steps are the predeparture phase, the journey
tional tracking each year (Gushulak and MacPherson, phase of migration, the arrival and settling phase and for
2000a). Of these, 700 000 are women or children, of whom some migrants the returning phase. At each of these steps
175 000 are estimated to come from the former Soviet of the migratory process, several specic factors may have
bloc; approximately 45 00050 000 arrive in the United consequences and inuence the nal outcome.
States. There are an estimated 5 million irregular mi-
grants in the USA and 3 million in western Europe The predeparture phase. This is characterised by the
(Ghosh, 1998). Tracking in migrants has become a very inuences on health of the environment in which one
lucrative illegal market, with worldwide ramications. individual or a group of migrants has lived. This refers to
Having no legal status and living with the constant fear of a broad spectrum of factors. One thinks immediately of
being deported, illegal migrants represent a very vulner- exposure to endemic diseases such as malaria, tuberculo-
able population with very little access to health care. sis, intestinal parasites or hepatitis. Nutritional factors
Table 28.1 gives statistics on persons of concern to the such as sucient intake of micronutrients, vitamins and
UNHCR for 1999. proteins will shape the nutritional status and normal
As economic inequalities between the developing growth of children. Social and economic factors such as
world and industrialised countries, between the East and poverty, illiteracy, unemployment, occupational hazards,
the West, are not levelling rapidly, migration pressure will poor housing and unhygienic living conditions are
not diminish in the near future. Simultaneously, the age- among key factors shaping the future health status of
ing of the population of the western world coupled to low migrants, as will exposure to insecurity, war, violence,
fertility rates will lead to negative demographic trends. torture and other human rights violations. Religion and
Policies encouraging selective and controlled migration cultural background are of course of key importance in
into Europe can be anticipated in order to counterbal- inuencing health belief and behaviours. Finally, experi-
ance these demographic trends, leading to new inuxes of ences encountered in contact with the medical services in
migrants. the country of origin and with other traditional and lay
medical providers will also inuence expectations of and
rapport with medical services in the country of settle-
ment.
THE MIGRATION PROCESS AND HEALTH
The journey phase of migration. This may be very short
Migrant populations are very heterogeneous in origin, in and uneventful in the case of a regular ight to the new
experienced exposure to risk factors, conditions of living destination. For many refugees and migrants the journey
in the host country and access to health care services. No may be a long process, characterised by uncertainty,
doubt these many factors will inuence their health deprivation, insecurity, abuse, trauma and sometimes life-
status. One way of looking at the health of migrants is to threatening events. This may be particularly the case for
consider it in relation with the very process of migration. illegal migrants smuggled into a new country. Several
THE HEALTH OF MIGRANTS AND REFUGEES 469
tragedies have been reported: for instance, drowning of from surveys on specic groups of migrants or services, or
migrants crossing the Gibraltar straits or o the coast of through medical screening programmes at the time of
Florida; the recent discovery of 50 Chinese migrants entry into the host country. Routinely gathered data on
found dead from suocation in a trailer in Dover; and the health of ethnic minorities or of foreign-born residents
those frozen after a intercontinental ight hidden in the are often lacking in this area. Thus caution should be
wheel compartment of an aeroplane. Women being sex- exercised in extrapolating the conclusions of specic stu-
ually abused, repeated threats of being denounced to the dies to all migrants and, in so doing, contributing to the
local police, and the very process of being tracked with- negative perception of migrants and to some indirect
out proper documents, completely dependent on Maa form of discrimination.
networks, place illegal migrants under great physical and A recent review of health issues and problems of mi-
psychological strain. grants in the European Union found that, compared with
the host population, migrants have less access to health
The postmigration environment. This may dier greatly services and often have a higher rate of certain conditions
according to the legal status of a particular person or such as tuberculosis, HIV, hepatitis B, accidental injuries,
community. The level of education, professional skills, psychosomatic problems and depression (Carballo et al.,
language and communication skills will inuence the ca- 1998). Does migration in itself constitute an unhealthy
pacity of migrants to adjust to the new cultural, profes- process and put people on the move at higher risk of
sional and social environment and progressively interact disease? Do we have a biased view on the health of
with and integrate into the new society. Previous expo- migrants from studies uncontrolled for socioeconomic
sure to violence and trauma may pose a serious barrier to disadvantages or unequal access to health services?
adaptation, as persons suering from post-traumatic (Junghaus, 1998). Migration is a very selective process
stress disorder (PTSD) may avoid contacts or over-react and those arriving in industrialised nations as immi-
to new unexpected constraints or situations. Living con- grants, refugees or asylum seekers may not be representa-
ditions, such as overcrowding or isolation, may accelerate tive of the population from which they come. They are
the transmission of diseases such as tuberculosis and probably the stronger, mentally and physically.
varicella, or may have an important psychological im-
pact. Restrictive policies aimed at discouraging new-
comers from seeking asylum may have also a deleterious
eect on the mental health of asylum seekers or migrants FIRST ENCOUNTER WITH HEALTH
(Silove et al., 2000). Access to health services may be SERVICES
restricted. Arriving in the receiving country may also be a
relief and gives the opportunity to start a new life, with The introduction of communicable diseases by foreigners
access to services and better living conditions inuencing and travellers has always been of concern to health
positively the health of newcomers. authorities. International regulations, quarantine pro-
cedures and medical screening have been designed to
The return back home. This is being experienced by a control the spread of diseases. At a time of worldwide
growing number of migrants. Recently, a large propor- mobility of millions of travellers, medical screening is still
tion of refugees having ed the war in Kosovo have been implemented for immigrants and refugees before or at the
given incentives to return home. Those who were not time of entry in the receiving country. It is most frequently
willing have been put under strong pressure to comply mandatory and in some instances it determines accept-
with this policy, some being deported against their will. ance for entering the country. No doubt migrants may be
The return to a country under reconstruction, where afraid that such a medical examination that may hinder
insecurity still prevails, with the possibility of retaliation them from reaching their destination. Medical screening
towards those who have ed abroad, may pose specic is aimed mainly at identifying communicable diseases
risks to these persons. such as tuberculosis, hepatitis B, syphilis, HIV or other
In taking into account the successive steps of the mi- health conditions that may cause a nancial burden on
gratory process, it is possible to build a clearer view of the receiving country. Preventive measures such as vacci-
potential exposures and risk factors that may inuence nations are often implemented at that time. Much of the
the present health condition of specic persons or a com- data available on the health of migrants are drawn from
munity. This can help primary care providers to identify medical screening at time of entry.
the present complaint or illness with the previous events Obviously, mandatory medical screening is the result
related to the persons migration process. of public health concern both for protecting the host
Thus, the health of migrants is largely inuenced by population and identifying sick individuals in order to
specic living conditions, previous exposure to communi- provide them with care. This is not patient-centred medi-
cable diseases, deprivation or violence, professional risks, cine. Immigrants and refugees have health needs that
the degree of integration in the new society, the access to often are not met by medical screening and many health
health care, the capability to communicate and the pres- professionals question its medical soundness, moving to-
ence or absence of a community or family safety net. At wards a normal medical interview and examination, pro-
present, most of the data on migration and health come moting access to local medical facilities and responding to
470 PRINCIPLES AND PRACTICE OF TRAVEL MEDICINE
specic health needs individual migrants have. result of population growth, as a coinfection with HIV
Furthermore, the diminishing impact of classical infec- and with insucient access to adequate treatment leading
tious diseases in a globally mobile world forces us to to the spread of resistant strains. Although in North
explore new approaches and responses. Until recently, America and Europe there has been a steady decrease in
most of the emphasis has been put on the diseases respon- cases of tuberculosis, there is an increase in the propor-
sible for epidemics (yellow fever, cholera, smallpox). Ac- tion of cases diagnosed in the foreign born (Rieder et al.,
cess to clean water, immunisation and use of antibiotics 1994; Zuber et al., 1997). In Denmark, the proportion of
have reduced drastically their prevalence and population foreign-born cases has risen from 18% in 1986 to 60% in
health impact, thus reducing the eectiveness and need 1996 (Carballo et al., 1998). The incidence in foreign-born
for mass medical screening (Gushulak and MacPherson, children was very high, probably due to intrafamilial
2000b). With mobile populations becoming a larger com- transmission (Mortensen et al., 1989). In Switzerland the
ponent of societies, diseases with long latency periods or incidence of tuberculosis in native Swiss is 7.8 per 100 000;
subclinical or chronic stable infectious periods pose prob- it is 24.7 per 100 000 in foreign-born residents of
lems not solved by screening at the time of entry. Chronic European origin; and 147 per 100 000 for asylum seekers
infectious diseases, such as tuberculosis, hepatitis B or C, (Zellweger, 1996). In England, travellers visiting friends
schistosomiasis or diseases with a long latency such as and relatives in Asia accounted for 20% of all notica-
malaria vivax, will often be recognised after many months tions, with 80% reported within 3 years of return to the
in the host country. Even in the case of tuberculosis, 47% UK, suggesting a signicant risk of transmission, in par-
of cases recorded in foreign-born people in the USA are ticular for children returning to their country of origin
detected more than 5 years after their arrival (Binkin et (McCarthy, 1984). Pulmonary symptoms lasting more
al., 1996). This shift towards chronic diseases creates a than 2 weeks, fatigue and weight loss should always raise
situation where the rst interaction with the health care the possibility of an underlying tuberculosis. In patients
system is likely to be at community level with primary coming from countries of endemicity, a signicant pro-
care providers. This has direct implications on how and portion of cases of tuberculosis are extrapulmonary and
where to reinforce surveillance systems and provide the this should be looked for. In a recent survey of cases of
family doctors with adequate knowledge and training in tuberculosis in illegal migrants in Geneva, 36% had an
recognising and managing diseases they are not familiar isolated extrapulmonary lesion (Aebischer Perone et al.,
with. 1999). Resistant strains of tuberculosis are emerging all
over the world, including in industrialised countries. In
areas where access to treatment is inadequate, there has
CARE OF MIGRANTS AT THE been a marked increase in the appearance of drug resis-
PRACTITIONERS OFFICE tance. Of particular concern are some east European
countries.
Primary care providers and travel medicine professionals
may frequently see foreign-born patients of diverse ori-
gins, both for treatment and for preventive measures such
as immunisation. They need to be able to recognise dis-
eases that are more exotic than those prevalent in the
local native population. They should also be aware of Hepatitis
long-term eects of exposure to violence, as many refu-
gees and immigrants come from war-torn regions of the Hepatitis A is highly prevalent in the developing world. In
world. They also need to develop cultural competence to general, by the age of 10, the vast majority of children
communicate with patients and identify clearly their con- have been exposed and have lifelong protective antibo-
cerns, their health beliefs and how to address their needs dies. Sometimes, child refugees, some incubating the dis-
in a culturally sensitive manner. ease, have caused limited outbreaks in persons having
close contacts with them (Castelli et al., 1999). In Asia and
Infectious Diseases Africa, the endemicity of hepatitis B is high, with over 5%
carriers of hepatitis B surface antigen. Table 28.2 shows
Coming from regions where many cosmopolitan or tropi- the seroprevalence of hepatitis B in asylum seekers
cal communicable diseases are more prevalent, a signi- screened in Switzerland at the time of arrival, according
cant proportion of migrants may have been in contact to their origin (Raeber et al., 1990). This illustrates its
with, may be infected with or may be a carrier of some variability as the result of the level of endemicity in their
specic disease. This is particularly the case with tubercu- country of origin; it is also related to some selection
losis. inherent in the migratory process. Counselling and pro-
viding medical care to those who are chronically infected,
and immunising relatives to prevent intrafamilial infec-
Tuberculosis tion, should be carried out by medical providers. Hepati-
tis C is also of concern, with high prevalence rates
Tuberculosis is a disease that is increasing worldwide as a ( 9 10%) in the developing world.
THE HEALTH OF MIGRANTS AND REFUGEES 471
Table 28.2 Results of hepatitis B screening in asylum seekers
Pos : positive.
HBeAg tested only in a limited sample of HBsAg-positive persons (756/827).
Adapted from Raeber et al. (1990).
Index
abdominal pain S-adenosylhomocysteine hydrolase 75 age
fever with 195 adenoviruses, enteric 56, 57 acute mountain sickness and 2489
in Latrodectus envenoming 335 adjuvants 167 cruise ship passengers 278
abdominal surgery, air travel after 302, adolescents decompression sickness and 219
442 body uid exposures 376 fatigue and 222
abortion risk-taking behavior 18990, 244 motion sickness and 225, 282
induced 3912 see also children; young people ultraviolet light damage and 343
spontaneous, meoquine and 406 adoption, children for 204, 376 see also children; elderly travelers;
abscesses, skin 134 adrenaline see epinephrine young people
acanthamoeba corneal infections 354 adventure travel 186, 247 aggressive behavior, air passengers
acceleration forces, air travel 300 gender-related issues 41518 2401
accidents insurance 295 agricultural workers 189
air 2412, 31819 see also expedition travelers AIDS 52
in children 3734 advertising, in injury prevention 2934 denition 55
epidemiology 34 advice, pretravel see pretravel advice risk to travelers 35
see also drowning; injury, AEA/SOS International 394, 395 travelers diarrhea risk 156
travel-related; motor vehicle Aedes aegypti see also HIV infection; human
accidents dengue fever 10, 678 immunodeciency virus
acclimatization to high altitude 248, 253 yellow fever 64, 65, 67 aid workers 189, 44766
in pregnancy 418 Aedes albopictus 10 see also expatriates
acetaminophen (paracetamol) Aedes mosquitoes 35, 65, 678, 119 ainhum 149
for children 374 aerodontalgia 218 air
in decompression illness 271 aerodynamic suck, in cabin lters, in aircraft 220, 228
acetazolamide decompression 221 ow rates, in aircraft 220
in acute glaucoma 353 aeromedical repatriation 297309 pollution 317
in acute mountain sickness 251 expatriates and aid workers 459 recirculation, in aircraft 220
in altitude illness prophylaxis 250, in eye trauma 357 air ambulance transfers 230, 297309
2534 see also air ambulance transfers aircraft 297, 303, 304
in children 376 Aeromonas sp. 153, 154 costs 2978
in eye trauma 357 aerophagia, by divers 271 deciding on need 2989
in high-altitude cerebral edema 252 Aerospace Medical Association 227 detrimental eects 3001
for periodic breathing at high altitude Africa equipment 303, 304, 305
254 fever in travelers from 192 guidelines 308
side-eects 250, 360 HIV infection 54 physics and physiology 299300
acetylsalicylic acid see aspirin meningitis belt 35, 176 primary 297
achlorhydria, travelers diarrhea risk African green monkey 72, 73 problems encountered 3012
156 African tick typhus 139 secondary 297
aciclovir 62, 352 African trypanosomiasis 10914 service providers 2978
acquired immune deciency syndrome clinical features 111, 196, 198 stages 3038
see AIDS diagnosis 11113 arrival at aircraft 3078
actinic keratoses 1467, 344 disease suppression 114 arrival at destination 308
Actinomadura infections 1378 East 110, 111 arrival at referring hospital 3057
actinomycetoma 1378 epidemiology 11011 ground transfer 307
activities, for child travelers 373 haemolymphatic stage 111, 113 initial information 3035, 306
acupressure wrist bands 283 international spread 9 preparing patient 307
adaptability, motion sickness and 226 life cycle 10910 prior planning 305
adaptation meningoencephalitic stage 111, take o and ascent 308
migrants and refugees 4723 11314 aircraft
to motion sickness 227 pathogenesis 111 acceleration and deceleration 300
retention of 226 prevention 114 accidents 2412, 31819
adder treatment 11314 for aeromedical repatriation 297, 303,
pu (Bitis arietans) 321, 326, 329 West 11011 304
South African Berg 326 in women 41314 cabin, stressful environment 241
478 INDEX
cabin pressurization 215, 2201, 227 stressful nature 2378, 243 composition of air 21516
air ambulances 299 transmeridian see time zone changes failure of uid clearance 253
eects of rapid decompression 221, venous thrombosis risk 34, 190, 227 amantadine 60
300 see also jet lag Amblyomma 132
environmental requirements 220 albendazole ambulances
loss of pressure 2201, 300 in cutaneous larva migrans 128 air see air ambulance transfers
methods 220 in lariasis 120 for ground transfer 307
chemical incidents 31719 in pregnancy 411 amebiasis 154, 198
emergency medical equipment 232, presumptive treatment 377 gender-related issues 409, 413
2334 alcohol consumption 186 in pregnancy 408, 413
emergency oxygen supplies 230, 300 air passengers 223, 241 amebic liver abscess 198, 413
rst-aid kits 232, 233, 234 decompression sickness and 219 American College of Emergency
infant seating 3734 driving and 294 Physicians (ACEP) 285
medical diversion 231 expatriates 456 Cruise Ship and Maritime Section
oxygen supplies 230, 300 fatigue and 222 27881
see also oxygen, supplemental in hepatitis C 52 Health Care Guidelines for Cruise Ship
inight motion sickness and 2256 Medical Facilities 281, 2867
pesticide disinfection 31516 alcohol nystagmus, positional 2256 American Council of the Blind 444
resuscitation equipment 2325 alcohol poisoning, visual eects 3601 American Diabetes Association (ADA)
aircrew Alexander Graham Bell Association for 436
in air accidents 2412 the Deaf 444 American Society of Tropical Medicine
death in ight procedures 235 allergies and Hygiene (ASTMH) 24, 25
disrupted relationships 2378 bee, wasp and hornet stings 337 contact details 28, 285
rst aid/medical training 230, 232, food 17 travel medicine training 378
235 to vaccines 169 Americas, tourism to 4
scheduling 222 alopecia, oral contraceptive-related 149 amodiaquine
sleep disturbances and fatigue 222 alpha herpesvirinae 61 malaria resistant to 1001
stress 241 alternative remedies, toxic eects malaria therapy 98, 99100
airline medical advisor 2356 31314 in pregnancy 407
airport altitude 24757 amphotericin B 108
environment, in disability 228 acclimatization 248, 253, 418 liposomal 108
malaria 191 alveolar air composition at 21516 ampicillin
air rage 2401 ascent rates 250, 252, 253 in pregnancy 408
air sickness 223, 224 in cardiorespiratory disease 16, 2557 in travelers diarrhea 158
see also motion sickness children and 255, 3746 analgesics
air travel 22735 decompression sickness and 21819, in acute mountain sickness 251
after decompression illness 229, 272 272 in decompression illness 271
children 373 descent from 251, 252, 254 anaphylactic reactions
in diabetes 3478, 437 in diabetes 257, 437 bee, wasp and hornet stings 337
in disability/immobility 227, 228, 236, eects of 21819 snake venom 332
440 equivalent aircraft cabin 299 Ancylostoma brasiliense 128
eects of reduced pressure 21819 exercise at, in pregnancy 41518 Ancylostoma caninum 128
infants and 3745 expeditions 2579 Ancylostoma ceylanicum 128
with infectious diseases 190, 228 extreme 247 Ancylostoma duodenale 410, 411
inight medical emergencies see inight heart disease and 2556 Ancylostoma stenocephalae 128
medical emergencies high 247 anemia 186, 442
medical contraindications 229, 432, illness 24854 in immigrants 472
4412 in children 255, 374, 3756 in pregnancy 17, 394
passengers in expedition travelers 259 screening children 376
advice for 244 see also high-altitude cerebral edema; angels trumpets brugmansia 314
contact lens wear 353 high-altitude pulmonary edema; angina
death in ight 235, 441 mountain sickness air ambulance transfers and 301
disrupted relationships 2378, 243 intermediate 247 altitude travel 2556
disruptive behavior 2401 long-term residents 252 animal bites 33
eye disorders 229, 3468 ocular changes 348 in immunocompromised travelers 426
fear of ying 23840 oxygen requirements 21416 rabies prophylaxis 64
giving birth 235 pre-existing medical conditions and rabies transmission 63, 454
medical clearance 22730 2557 see also insect bites; snake bites; tick(s),
medical support 227, 297 respiratory disease and 2567 bites
risk-taking behavior 2434 sleeping 250 Anopheles mosquitoes 91, 102, 119
safety 2412 venous thrombosis risk 255, 393 anthelminthics
on stretchers 227, 22830, 297 very high 247 in pregnancy 411
in pregnancy 229, 3945 aluminium acetate, for swimmers ear presumptive treatment 205
scheduled, for medical repatriation 270 see also specic agents
22830, 297 alveoli 214 anthrax vaccine 171, 172
INDEX 479
antibiotics Chironex 339 see also aircraft, cabin pressurization
in children 370 scorpion 334 eects of reduced 21819
cholera vaccine interaction 181 snake see snake antivenoms at high altitude 247, 248
in chronic disease 424 sources 3401 oxygen requirements and 21516
in eumycetoma 142 spider 336 atopic disorders, eosinophilia 201
in eye infections 349, 354, 356 stonesh 338 atovaquone-proguanil (Malarone)
in leptospirosis 87 antiviral drugs in children 368, 369
oral contraceptive interactions 390 in hepatitis B 47 in expatriates and aid workers 455
in pregnancy 17, 408 in inuenza 60 in immunocompromised travelers 20
in pyogenic skin infections 135 see also antiretroviral therapy malaria prophylaxis 103
in relapsing fever 89 anxiety malaria therapy 98, 101
resistance 187 ight 239 in pregnancy 405, 406, 407
emerging 7, 8, 34, 36 in motion sickness 226 Atrax robustus (funnel-web spider) 335
prophylactic therapy and 162 aorta, coarctation of 256 signs and symptoms of bites 3356
travelers diarrhea 155, 158 aphthoviruses 58 treatment of bites 336
in syphilis 135 Apicomplexa 91 attapulgite 159
topical 135 Arenavirus infections 756 avalanche phenomenon, in motion
travelers diarrhea prophylaxis 157, Argentinian hemorrhagic fever 77 sickness 223
1612, 433 arrhythmias aviation medicine 21336
travelers diarrhea therapy 156, altitude travel 256 aviation psychology 23745
1578, 4323 deceleration forces and 300 Ayurvedic remedies, toxic 313
urgent treatment 81 arsenic, in traditional remedies 313 azithromycin
for women travelers 416 artemether in children 370
anticoagulants, bismuth subsalicylate in malaria 98, 101 in immunocompromised travelers 20
and 161 in schistosomiasis 118 in legionellosis 83
antiemetics artemisinin (qinghaosu) derivatives in pregnancy 405, 408
in acute mountain sickness 251 in children 369 in travelers diarrhea 157, 158
for sea sickness 2823 in expatriates and aid workers 455 aztreonam, in travelers diarrhea 157
antifungal agents 141, 143 malaria therapy 98, 101
antigenic drift 59 in pregnancy 407 Babesia 91, 434
antigenic shift 59 arterial gas embolism, in divers 263, 264 Baby Comp 390
antigenic variation artesunate, in malaria 98, 101 bacille CalmetteGuerin vaccine see BCG
malaria parasites 923, 95 arthralgia, fever with 195 vaccine
trypanosomes 111 Ascaris lumbricoides (ascariasis) 202, 203 backpackers 186
antihistamines in pregnancy 411, 414 back pain, in decompression illness 271
in antivenom reactions 331 in women 409, 410 bacterial infections 819
for sea sickness 282, 283 ascent rates clinical history 81
antimalarial agents aircraft 299 eye 349, 350, 351, 352, 354
in elderly 43940 at high altitude 250, 252, 253 skin 1338
in immunocompromised travelers underwater 263 snake bite wounds 324, 328
434, 435 Asia Pacic Travel Health Association travelers diarrhea 1534
malaria prophylaxis see malaria, (APTHA) 24 urgent treatment 81
chemoprophylaxis aspirin 187 see also specic infections
malaria treatment 98101, 199201 altitude illness prophylaxis 251 bacterial mycetoma 1378
ocular toxicity 35960 bismuth subsalicylate and 161 bacterial vaginosis 383, 416
photosensitive reactions 149 venous thrombosis prophylaxis 393 bandaging, pressure see pressure
in pregnancy 101, 4048, 429 asplenic travelers 4256, 4334 bandaging
see also specic agents vaccinations 177, 434 barometric pressure see atmospheric
antimonials, pentavalent, in assassinations 458 pressure
leishmaniasis 108, 130 asthma barotrauma
anti-peristaltic (anti-motility) agents altitude travel 256 gastrointestinal 2701
1589, 432 in divers 266 inner ear 26970
in children 370 astroviruses 56, 57 middle ear 218, 269
in immunocompromised travelers 20 asylum seekers 467, 468 pulmonary 218, 2623, 271
in pregnancy 408 factors aecting health 469 sinus 218, 270
antiprogestins 392 hepatitis B prevalence 470, 471 barotraumatic facial palsy 270
antiretroviral therapy see also immigrants; migration basal cell carcinoma 147, 344
highly active (HAART) 427 ataxia, in high-altitude cerebral edema B cells 165
in HIV infection 55 251, 252 congenital deciency 4245
HIV postexposure prophylaxis 416, athletes foot 140, 141 BCG vaccine 166, 171, 1801
457 atmosphere 21314 booster doses 1801
antiseptics, topical 135 composition 213, 215 in children 171, 371, 372
antisera, animal 166 physical gas laws 21314 in expatriates and aid workers 456
antivenom atmospheric pressure 213 in immunocompromised travelers 18
bee, wasp and hornet 337 aircraft cabin 227, 299 intradermal administration 168
480 INDEX
beach-related trauma 2934 blood samples Calabar swellings 119, 202, 363
bed nets 103, 367 diabetes self-monitoring 437 calcium antagonists
bee stings 3367, 361 toxicological assessment 312 for motion sickness 2267
bends, the 219, 269 blood transfusion see also nifedipine
see also decompression illness Chagas disease risk 11415, 116 calcium gluconate, in Latrodectus
benznidazole, in Chagas disease 11516 on cruise ships 284 envenoming 336
benzodiazepines exchange, in severe malaria 199 caliciviruses 56
in elderly travelers 439 HIV risk 54, 55 Calloselasma rhodostoma 321, 322
for sleep disturbances at altitude 254 in snake envenoming 333 Campylobacter (jejuni) infection 153,
benzolamide, altitude illness viral hepatitis risk 41, 456, 48, 51 154, 198
prophylaxis 250 bluebottle (Physalia spp.) 338, 339 antibiotic resistance 158
Berloque 146 B lymphocytes see B cells antimicrobial therapy 158
beta-blockers body uids epidemiology 155
in divers 268 exposures, children and adolescents Canadian National Institute for the
eyedrops, side-eects 360 376 Blind 444
for fear of ying 240 hepatitis B transmission 456 Canadian Transportation Agency 445
bicozamycin 161 Bolivian hemorrhagic fever 778 cancellation, trip 432
bilirubin, raised 199 bone marrow transplant recipients 170, cancer
see also jaundice 434 chemotherapy 170, 426, 435
Binational Third Culture 448 borders, international, restrictions on immunodeciency 4256
Bioself Fertility Indicator 390 crossing 1920 role of infectious agents 7
birth, in ight 235 Bordetella pertussis 167 screening, expatriates and aid
bisexual men 54 Borrelia burgdorferi 176, 363, 401 workers 451
bismuth subsalicylate (BSS) 57 see also Lyme disease treatment 170, 4267
in children 370 Borrelia recurrentis 88, 89 see also skin cancer
travelers diarrhea prophylaxis 161, Borrelia species 88, 89 Candida infections (candidiasis)
162 Bothrops atrox (Barba amarilla) 321 antibiotic prophylaxis and 162
travelers diarrhea treatment 154, 158, boutonneuse fever 85, 139 in diabetes 438
159 bovine diarrhoea virus 65 skin and nail 141
bites 34, 12733 box jellysh (Chironex eckeri) 338, 339 vaginitis 383, 416
venomous 32141 Boyles law 213, 218, 262, 300 cap, contraceptive 386, 388
see also animal bites; insect bites; snake breastfeeding see lactation capillary tube centrifugation, in
bites; stings; tick(s), bites breast masses, parasitic 409 trypanosomiasis 111
Bitis arietans (pu adder) 321, 326, 329 breathing carbocyclic 3-deazaadenosine 75
Bitis caudalis 326 periodic, at high altitude 254 carbon dioxide
black ies (Simulium spp.) 119, 130, 361 pressure 216, 217 carriage in body 214
avoiding bites 362 breathlessness, in high-altitude exchange 214
control measures 121 pulmonary edema 253 partial pressure (PCO ) 21415
blackwater fever 97 BrillZinsser disease 139 toxicity, in divers 265
bleeding see hemorrhage/bleeding British SubAqua Club (BSAC) 273, 274 carbon monoxide poisoning 317
blepharitis 346, 351, 352 BrocqLyell syndrome 148 carbuncle 134
blindness Brucella abortus 87 card agglutination test for
childhood 364 Brucella melitensis 87 trypanosomiasis (CATT) 112
global problem 364 Brucella suis 87 card indirect agglutination test for
in leprosy 363 brucellosis 82, 878 trypanosomiasis (TrypTect
river see onchocerciasis clinical features 87, 198 CIATT) 11213
snow 344, 348 transmission in laboratories 191 cardiomyopathies, tness to dive 268
in trachoma 362 Brugia malayi 119, 202 cardiopulmonary resuscitation (CPR),
travelers with 440 in women 410 inight 2325
blisters, snake bites 324, 328 see also lymphatic lariasis cardiorespiratory problems see
blood disorders, tness to y 229 Brugia timori 119 cardiovascular disease; respiratory
blood donors see also lymphatic lariasis disease
Chagas disease 115, 116 Brugmansia spp. 31415 cardiotoxicity, snake envenoming 324
exclusion of travelers as 205 buclizine, for sea sickness 283 cardiovascular disease 16, 34, 441
blood lms 199 Bunyaviridae 78 air ambulance transfers 3012
in lariasis 120 Burkholderia pseudomallei 438 altitude travel 16, 2556
for malaria 81, 97, 1934, 195 burnout, expatriates 448 death rates 13
for trypanosomiasis 111, 112 burns, tness to y 229 tness to dive 268
blood group O, travelers diarrhea risk Buruli ulcer 136, 137 tness to y 228, 229, 441
156 business travel 56, 241 in migrants and refugees 472
blood pressure measurements, during air susceptibility to infections 423
travel 302 C3F8, intraocular 347 cardiovascular function, in air ambulance
blood products cabin pressurization see aircraft, cabin transfers 300, 3012
HIV spread 54, 55 pressurization cardioviruses 58
viral hepatitis risk 41, 456, 48, 51 caeine 223 -carotene 145
INDEX 481
car sickness 223 chemoreceptors 21415 side eects 98, 149, 187
car travel see motor vehicle travel chemotherapy, cancer 170, 426, 435 chloroquine/proguanil
Carukia barnesi 338 chest trauma in children 368, 369
cataract 3456, 364 air transport after 302 in expatriates and aid workers 455
risk factors 3456 diving after 2667 malaria prophylaxis 103
surgery, ying after 347 chest wall disorders, altitude travel in pregnancy 405, 406
catsh 337 2567 chlorpheniramine, for antivenom
cats chest X-rays reactions 331
bites 426 in high-altitude pulmonary edema chokes 219
cutaneous larva migrans and 1278 253 cholera 198
toxoplasmosis spread 414 in legionellosis 83 clinical features 156
CD4; T cells CheyneStokes respiration, at high epidemiology 33
counts 55 altitude 254 trends 35
susceptibility to infection and 427, Chiclero ulcer 106, 129 vaccine 162, 1713
428 chigoe (jigger) infestation 131, 201 in children 371, 372
travelers diarrhea risk 156 children 36779 in expatriates and aid workers 454
HIV infection 53, 54, 427 for adoption 204, 376 in pregnancy 398
cell-mediated immunity 165 aeromedical repatriation 302 chromoblastomycosis 1423
congenital deciency 4245 air travel 373 chronic disease
in pregnancy 396 altitude illness 255, 374, 3756 immunodeciency of 4234
cellulitis 134, 135 altitude travel 255, 3746 in migrants and refugees 472
orbital 351 blindness 364 travelers with 4412
preseptal 351 body uid exposures 376 see also medical conditions,
Center for Reproductive Law and comfort 373 pre-existing
Policy 385, 391 diarrhea 56, 36970, 377 chronic fatigue syndrome, in aid
Centers for Disease Control and expatriate 448, 453, 4556, 460 workers 449
Prevention (CDC) 24, 25, 28 with fever 191, 192, 377 chronic obstructive pulmonary disease
cruise ship health 2834 hepatitis A 41, 42, 372 4412
travelers hotline 285, 444 immigrant 3767 altitude travel 256
vaccinations in pregnancy 397 insect-borne diseases 3679 special cruises 276
Central European encephalitis virus 70, malaria 96, 191, 3679, 4556 susceptibility to infections 423, 424
71 motion sickness 225, 282, 373 Chrysops (tabanid) ies 119, 121, 362
central nervous system (CNS) post-travel screening and care 186, cinchonism 99
damage, in divers 268 3767 Cinerama sickness 223, 224
oxygen toxicity, in divers 265 rabies risk 454 cinnarizine, for motion sickness 226, 283
see also neurological disorders safety 3734 ciprooxacin
cercariae 116 snake bites 322, 329, 331 in children 370
cercarial dermatitis (swimmers itch) vaccination 3703 in HIV infection 427
116, 150, 202 routine immunizations 171, 3702 in immunocompromised travelers 20
Cercopithicus aethiops (African green travel-related vaccines 371, 3723 in pregnancy 408
monkey) 72, 73 see also adolescents; infants; neonates; in rickettsial infections 140
cerebral edema young people travelers diarrhea prophylaxis 162
in acute mountain sickness 24950 China International Travel Health travelers diarrhea therapy 157
high altitude see high-altitude cerebral Association (CIHTA) 24 for women 416
edema Chironex eckeri (sea wasp) 338, 339 circadian desynchronisation see jet lag
cerebral embolism, gas, in divers 264 chlamydial conjunctivitis (trachoma) circadian rhythm 222, 223, 242
cerebral thromboembolism, at high 349, 362, 364 circulation 214
altitude 254 chloasma 149 circulatory disorders, tness to y 229
cerebrospinal uid (CSF) chloramphenicol circumsporozoite protein (CSP, CS) 91
examination, in trypanosomiasis 112, ocular 349, 355 antibodies 12, 13
113 in rickettsial infections 140 candidate malaria vaccines 105
leaks, in eye trauma 358 side-eects 360 cirrhosis 186
cerebrovascular events 441 in travelers diarrhea 158 in hepatitis C 52
cestodes (tapeworms) 203, 409 chloroquine travelers with 435
Chagas disease see South American in children 368, 369 Cladosporium 1423
trypanosomiasis in elderly 440 clam diggers itch 150
chagoma 115, 196 in expatriates and aid workers 455 Clear Plan Fertility Monitor 390
chalazion 350 in HIV infection 427 climate change 10
chancre, trypanosomal 111 malaria prophylaxis 103 climatic droplet keratopathy 345
charcoal, activated 162 malaria stand-by treatment 105 clindamycin, for malaria therapy 98, 101
Charless law 213 malaria therapy 98, 99 clinic, travel see travel clinic
Chemical Incident Response Service ocular toxicity 35960 clinical examination, expatriates 461
(CIRS) 312 in porphyria cutanea tarda 146 clioquinol, in travelers diarrhea 158
database 313, 31619 in pregnancy 105, 404, 405, 407 Clonorchis (clonorchiasis) 202, 203
chemicals, detection techniques 31213 -resistant malaria 34, 99100, 404, 405 reproductive eects 409
482 INDEX
Clostridium dicile infection 158, 162 conjunctivitis 349 in scrub typhus 85
clothes acute bacterial 349 Councilman bodies 66
for children 374 chlamydial (trachoma) 349, 362, 364 coxsackie virus 58
insecticide-impregnated 367 viral 350 Creative Age Publications 444
clotting test, whole blood see whole blood consciousness, disturbances of creeps 219
clotting test, 20 minute in diabetic divers 267 CrimeanCongo hemorrhagic fever 72,
coagulopathy, in snake envenoming 325 in high-altitude cerebral edema 2512 78
management 32930, 332, 333 in hyperventilation 217 virus 72, 78
pathophysiology 323 in hypoxia 217 crisis management training 458
coarctation of aorta 256 Consortium for Emergency critical incident stress debrieng (CISD)
cobras 321, 324, 329 Contraception 421 459, 462
spitting construction workers 189 critically ill patients
bites 324, 329 contact dermatitis, photoallergic 145 aeromedical repatriation 297, 3001,
eye injuries 327, 333, 361 contact lenses 347, 3534, 440 308
Thai 322 daily disposable 354, 440 evacuation see evacuation
Coca-Cola incident, Belgium 316 hard 3534 at sea 2845
Coccidioides immitis 143 lost in eye 354 crosscultural training 457
coccidioidomycosis 143 problems and complications 354 Crotalus durissus 321, 326
Cochliomyia homnivorax 201 soft 354 cruise ship(s) 27587
cockpit resource management training contraception 38492, 416 critical care 2845
242 choice of method 384, 3867 disabled travelers 276, 440
cognitive-behavioral treatment, fear of emergency see emergency health care guidelines 2867
ying 240 contraception inuenza outbreaks 32, 283
cognitive dissonance theory 2434 at high altitude 257 medical care 27881
cognitive dysfunction, in divers 268 options 384 medical facilities 275, 27881, 2867
cognitive impairment, travelers with 20 potentially available methods 3889 medicine 275
cold vaccines/immunocontraceptives 389 onboard maladies 190, 2814
hypoxia susceptibility and 217 web sites 385 physicians 275, 278, 281
rapid cabin decompression 221 see also condoms; oral contraceptives; in pregnancy 396
cold, common other specic methods pre-travel planning 2758
air travel risks 218 coordination, impaired, in hypoxia 216 telemedicine 2845
high altitude travel and 3756 Cordylobia (anthropophaga) 131, 201 travelers rst-aid kit 2778
colostomy patients 442 cornea travel medical insurance 277
colubrid snakes, venomous 321 abrasions 347, 355 useful addresses 2856
coma bee stings 361 cryotherapy, cutaneous larva migrans
diabetic, in divers 267 disorders 3513 128
in high-altitude cerebral edema 252 foreign bodies 3556 Cryptosporidium (cryptosporidiosis) 91,
comfort, children during travel 373 ulcers 3512, 354 154
common variable immunodeciency ultraviolet light damage 3445 risk factors 155
(CVD) 425 coronary artery disease transmission 19
communication altitude travel 2556 Culex mosquitoes 69, 70, 119
air ambulance transfers 298, 307 tness to dive 268 Culex tritaenorhynchus 69
by divers 262 corticosteroids 435 cultural competence, acquiring 473
ight deck crew 242 in African trypanosomiasis 113 cultural issues, women travelers 41819
for injury prevention 2945 immunosuppression 426 culture shock, reverse 205, 243, 462
rapid cabin decompression and 221 in schistosomiasis 202 cutaneous larva migrans 1278, 201, 203
compartmental syndromes, in snake topical ocular 357 cutaneous lupus erythematosus 1456
envenoming 324, 333 vaccinations and 170, 435 cyanosis, in hypoxia 217
complement deciency 425 see also dexamethasone cyclizine, for sea sickness 283
compliance Corynebacterium diphtheriae 88, 136 cyclopentolate 355, 357
air travelers 244 co-trimoxazole Cyclospora cayetanensis 154
malaria advice 243, 244, 455 (trimethoprim-sulfamethoxazole) Cyclospora infections 198
conditioning, fear of ying 239 in children 370 cytokines
condoms 384, 386 in immunocompromised travelers 20 as adjuvants 167
HIV prevention 55 in pregnancy 408 in cerebral malaria 96
use by expatriates 456 travelers diarrhea prophylaxis 162 in leishmaniasis 106
cone shells 339 travelers diarrhea therapy 157 cytomegalovirus, human 61
conference travel 56 cough cytotoxic drugs 426
confusional state, acute, in diabetic fevers with 195, 198
divers 267 at high altitude 255 Daboia russelii (Russells viper) 321, 322,
congenital heart disease, altitude travel in high-altitude pulmonary edema 324, 326
256 253 dactylolysis, spontaneous 149
congenital protozoan infections 412, in legionellosis 83 Daltons law 214
414 in malaria 97 dapsone/pyrimethamine see
conjunctival disorders 34950 in pulmonary oxygen toxicity 265 pyrimethamine/dapsone
INDEX 483
DDT 102, 114 referred to eye 347 travelers see travelers diarrhea
resistance 102 Depo-Provera 387 dieldrin resistance 102
deafness see hearing impairment depression, in expatriates and aid dietary advice 19, 161
death workers 449, 4623 diethylcarbamazine (DEC)
in altitude illness 252, 253 Dermacentor ticks 132, 139 in lariasis 120, 202
causes 13, 34 dermatitis in pregnancy 411
certicates 36 cercarial (swimmers itch) 116, 150, prophylaxis 121
expatriates and aid workers 44950 202 N,N-diethyl-m-toluamide see DEET
in ight 235, 441 photoallergic contact 145 diusion 214
injuries as cause 13, 34, 291 see also eczema --diuoromethylornithine, in African
snake bites 322 Dermatobia (hominis) 131, 201 trypanosomiasis 113
debrieng dermatophyte infections 1401 dimenhydrinate, for motion sickness
critical incident stress (CISD) 459, descent 283, 373
463 in altitude illness 251, 252, 254 diphenhydramine, for sea sickness 283
returned expatriates 4623 rates, aircraft 299 diphenoxylate 158, 408
deceleration forces, air travel 300 desensitisation diphtheria 82, 88
decompression bee, wasp and hornet stings 337 antitoxin 88
collapse 219 fear of ying 23840 changing pattern 35
divers 263 motion sickness 227 clinical features 88, 197
decompression illness (DCI) 264, 269, developing countries cutaneous 136
2713 blindness in 364 epidemiology 33, 88
clinical features 219, 271 burden of infectious diseases 78 toxin 88
during ying 21819 child immigrants from 376 vaccine 88, 171, 173
causes 21819, 221 incidence of travel-related health in children 3701
treatment 219 problems 11, 32 in pregnancy 3979
ying after 229, 272 tourism to 4 with tetanus (DT) 173
management 2713 travelers diarrhea risk 154 diphtheria, tetanus and pertussis vaccine
drugs 273 dexamethasone see DTP vaccine
recompression therapy 272 altitude illness prophylaxis 2501 diplopia 348
outcome 272 altitude illness therapy 251, 252 dipteran larvae, skin colonization
in pregnancy 418 in expedition medical kits 259 (myiasis) 1312, 201
return to diving after 268 diabetes mellitus 1516, 186, 4358 direct agglutination testing (DAT), in
versus diabetic coma 267 altitude travel 257, 437 leishmaniasis 108
deep venous thrombosis see venous complications 16 disability, physical 20, 440
thrombosis tness to dive 267 air travel 227, 228, 236, 440
DEET (N,N-diethyl-m-toluamide) 102, identity bracelets/cards 15, 436 cruise ship travel 276, 440
439 infections 16, 423, 438 disease, travel-related 317
for children 3678, 456 insulin products 436 epidemiology 316
in pregnancy 404 new insulin delivery systems 4367 changes in 346
debrillation, inight 235 new technological advances 437 surveillance 367
debrillators prolonged air travel 437 information dissemination 367
automatic advisory external (AED) time zone changes 437 sources of data 36
2345 travelers diarrhea 424 displaced persons 204
implanted 441 trip preparation 4356 internally (IDPs) 468
dehydration diabetic retinopathy 3478, 437 see also immigrants; refugees
avoidance in pregnancy 408, 415, 418 diagnostic methods 37 disruptive behavior, air passengers
in decompression illness 271 dialysis 2401
venous thrombosis risk 395 travelers on 435 disseminated intravascular coagulation
delta hepatitis 489 see also peritoneal dialysis (DIC), in snake envenoming 323
dengue fever 10, 678 Dialysis Traveler/Dialysis at Sea diuresis, at high altitude 248
clinical features and diagnosis 68, Cruises 445 diuretics 187
1946 Dialysis Travel and Vacations 445 diving 26174
epidemiology 1213, 34, 35, 678 diamidines, aromatic, in leishmaniasis assessment of tness 2659
pathology 68 109 breath-hold 262
prevention 68 diaphragm, contraceptive 386, 388 depth limits 264
surveillance 36 diarrhea emergency helpline 274
versus yellow fever 67 air transport 302 ying after 219, 229
dengue hemorrhagic fever 68 bloody (dysentery) 156, 198 gas toxicity 2645
dengue shock syndrome 68 chronic 153 mask 261
dengue virus 67, 68 denition 153 in pregnancy 418
dental health in expatriates and aid workers 456 pressure eects 2624
expedition travelers 257 fever with 195, 1989 protective measures 273
immigrants 472 in intestinal schistosomiasis 117 recreational 261, 2656
dental pain in malaria 192 -related disorders 26971
in air travelers 218 oral contraception and 38590 underwater environment 2612
484 INDEX
diving (cont.) infections 12 international availability 4212
see also decompression illness earache, in children 373 venous thrombosis risk 393
dizziness, in hyperventilation 217 eardrum, ruptured 269 web site 385, 391
DNA vaccines 163 Ebola fever 72, 745 emergency medical equipment, aircraft
doctors see physicians experimental prophylaxis and 232, 2334
dogs treatment 745 emerging infectious diseases 78, 10,
bites 426 outbreaks 35, 74 346
cutaneous larva migrans and 1278 prevention 75 emotional exhaustion, expatriates 448
guide, travel with 440 Ebola virus 72, 74 emotional reactions, returned
rabies 63, 454 ECG expatriates 462
Rocky Mountain spotted fever 85, 139 in Chagas disease 115 emphysema
domestic animals telemedicine 232 interstitial, in divers 2623
brucellosis 87 Echinococcus spp. 409 mediastinal, in divers 2623
imported 191 echinoderm stings 339 surgical, in orbital fractures 358
leptospirosis 86 Echis ocellatus 322, 326 encephalitis
trypanosomiasis 111, 114 Echis spp. 321, 322 fever with 196, 198
domestic products, overseas 315 economics, international tourism 45 aviruses causing 6871
doxycycline economy-class syndrome 34 St Louis 6970
bismuth subsalicylate interaction 162 ectoparasites 12733 tick-borne see tick-borne encephalitis
in brucellosis 878 eczema see also Japanese encephalitis
in children 368, 369 atopic, fungal infections 140 endotracheal cus, air ambulance
contraindications 105 pyogenic infections 135 transfers 301
in expatriates and aid workers 455 see also dermatitis Entamoeba dispar 413
in HIV infection 427 edema Entamoeba histolytica 154, 198
in immunocompromised travelers 20 in acute mountain sickness 249 gender-related issues 413
malaria prophylaxis 103 peripheral, at high altitude 254 reproductive eects 409
malaria stand-by treatment 105 see also cerebral edema; pulmonary see also amebiasis
malaria therapy 98, 101 edema enteric fever 196, 198
in pregnancy 407, 408 education, pretravel see pretravel advice see also typhoid
in rickettsial infections 86, 140 Edwardsiella lineata 150 ENTERNET 37
side eects 187 eornithine, in African trypanosomiasis Enterobius vermicularis (pinworm)
in travelers diarrhea 158 113 in pregnancy 411, 414
driving conditions, varying 294 egg in women 409, 410
drowning 13, 269, 291 allergies, vaccination and 169 enteroviruses 40, 589
risk-based approach 293 raw or undercooked 19 Entonox, in decompression illness 271
drowsiness, in motion sickness 224 elapid snakes environmental risks,
drug-induced disorders eects of envenoming 324, 325, 326 immunocompromised travelers
eosinophilia 201 venomous 321, 323 19
immunosuppression 4267 elderly travelers 17, 43940 environmental samples, toxicological
ocular 35960 heatstroke and hypothermia 439 assessment 312
skin diseases 1489 injuries and accidents 439 eosinophilia 198, 199, 2024
drugs see medications jet lag 439 denition 202
Drugs in Pregnancy and Lactation malaria 43940 in expatriates and aid workers 460
(Briggs) 402 motion sickness 439 investigation 204
dry eye 346, 350 thromboembolic disease 439 in migrants and refugees 472
dry suits, for diving 262 travelers diarrhea 4323 screening asymptomatic travelers 205
DTP vaccine 173, 177, 180 travel insurance 295 tropical pulmonary 119, 203
adverse events 169 vaccine-preventable illness 440 epidemics 187
routine immunization 171, 3701 electrical stimulation wrist bands 283 epidemiology
Duy (FyFy) blood group glycoprotein electrocardiogram see ECG health risks and travel 714
92 elephantiasis 119 travel-related disease 316
Dugbe virus 78 ELISA tests, snake envenoming 327 Epidermophyton 140
Duvenhage virus 62 e-mail discussion groups 25 epilepsy 442
dysentery 156, 198 embolism contraindicating diving 267
amebic see amebiasis arterial gas 263, 264 malaria chemoprophylaxis 368
dysfunctional uterine bleeding 416 see also pulmonary embolism; post-traumatic, assessment of risk
thromboembolism 2678
ear emergencies epinephrine (adrenaline)
barotrauma 218, 26970 evacuation see evacuation bee, wasp and hornet sting reactions
function underwater 2612 expatriates and aid workers 459 337
infections 12, 198, 441 inight medical see inight medical in food allergies 17
squeeze, external (reversed ears) 270 emergencies in snake antivenom reactions 331
swimmers 270 in pregnancy 394, 395 EPINET 313
ear, nose and throat (ENT) emergency contraception 3901, 392, episcleritis 350
disorders, air travel 229 416 EpsteinBarr virus 61
INDEX 485
equipment 199 major 3569
air ambulances 303, 304, 305 exercise minor 3556
resuscitation, on aircraft 2325 decompression sickness and 219 penetrating 356
see also medical kits hypoxia susceptibility and 217 eyedrops, stability 359
erythema multiforme 148 in pregnancy 41518 eyeglasses see spectacles
erythema nodosum 149 at altitude 41518 eyelids
erythrocytapheresis, in severe malaria guidelines 415 disorders 3501
201 stress testing 432 lacerations/injuries 3589
erythrocyte membrane-binding protein tolerance, tness to y and 228 in red eye 349
(EBA-175) 923 exotic viruses 712 ultraviolet light damage 3434
erythrocyte membrane protein 1, expatriates 186, 44766
Plasmodium falciparum debrieng 4623 F(ab) fragments, snake antivenoms
(PfEMP1) 945 morbidity 4489 329, 330
erythrocytes mortality 44950 Fab fragments, snake antivenoms 329,
increased mass, at altitude 248 overseas medical care 4589 330
malaria life cycle 915 in emergencies 459 facial nerve palsy
parasitised (pRBC) 94 future trends 4589 barotraumatic 270
erythromycin postreturn screening and care 45963 in leprosy 363
in legionellosis 83 components 4612 facies latrodectismica 335
in pregnancy 408 evidence for validity 460 faecal examination see stool examination
in travelers diarrhea 158 indications 4601 Faget sign 66
erythropoietin, at high altitude 248 purpose 460 fainting see syncope
eschar predeparture assessment 4503 falls, on beaches 293
in poisonous spider bites 335, 336 medical assessment 4501 famciclovir 47
in typhus 85, 86, 139 psychological assessment 4513 family see relatives
Escherichia coli purpose of screening 450 family planning, natural 390
cholera vaccine cross-protection 171 predeparture preparation 4538 Fansidar see sulfadoxine-pyrimethamine
enterohemorrhagic 155 diarrheal diseases 456 Fasciola hepatica (fascioliasis) 202, 203
enterotoxigenic (ETEC) 31, 153, 154, HIV 4567 fasciotomy, in snake envenoming 333
198 immunizations 4534 fasting, religious, in diabetes 436
in children 369 malaria 4546 fatigue 2213
epidemiology 155 psychological 4578 in acute mountain sickness 249
milk immunoglobulins 163 risk behavior 456 hypoxia susceptibility and 217
treatment 159 safety aspects 458 motor vehicle accidents and 294
vaccine 371, 372 sexually transmitted diseases 456 prevention and management 2223
espundia (mucocutaneous tuberculosis 456 FDA see Food and Drug Administration
leishmaniasis) 106, 107 premature attrition 449 fear of ying 23840
treatment 108, 109 re-entry issues 463 febrile convulsions, malaria
estrogen expedition travelers 190, 2579 chemoprophylaxis after 368
for emergency contraception 391 evacuation 259 Federal Aviation Regulations (USA),
replacement therapy 393, 417 immunizations and health check 257 aircraft emergency medical
vaginal absorption 390 managing illness/injury 259 equipment 233
ethambutol, ocular toxicity 360 medical kits 258, 259 feeding, in travelers diarrhea 157
eucalyptus oil 102 pre-expedition planning 257 female genital schistosomiasis (FGS)
eumycetoma 142 pretravel education 2579 409, 410, 41213
Europe expiratory positive airways pressure, in female genital tract disorders, in parasitic
outbound tourism 5 high-altitude pulmonary edema infections 40911
tourism to 4 254 Fem Cap 388
European bat virus 62 eye feminine hygiene products 382, 416
European Joint Aviation Requirements, air travel and 229, 3468 fertility, eects of parasitic infections
aircraft emergency medical at altitude 348 409
equipment 234 discharge, sticky 348 fetus
European Working Group on Legionella dry 346, 350 eects of altitude 41718
Infections (EWGLI) 37 examination 349 parasitic infections 409
evacuation itchy 349 in scuba diving 418
in altitude illness 252, 254 light reection from 349 fever 191201
cruise ship travelers 284 in onchocerciasis 119, 130, 3612 in African trypanosomiasis 111
in decompression illness 272 red 3489 in antivenom reactions 331
expatriates and aid workers 459 shields 347 causes 189, 192
expedition travelers 259 snake venom in 327, 333, 361 children with 191, 192, 377
insurance cover 277 sunlight exposure 343, 344 common syndrome/disease
see also aeromedical repatriation surgery, ying after 347 associations 195
evolved gas dysbarism 218 trauma 3549 in dengue fever 68, 1946
examination rooms, patient 25 adnexal tissues 3589 diagnostic algorithm 200
exchange transfusion, in severe malaria blunt 3568 diarrhea with 195, 1989
486 INDEX
fever (cont.) in travelers diarrhea treatment 157, laws, physical 21314
in early pregnancy 396 4323 toxicity, in divers 2645
frequency 12 ying see also carbon dioxide; nitrogen;
investigations 199 fear of 23840 oxygen
lymphadenopathy with 1967 see also air travel gastric contents, aspiration 302
in malaria 934, 96, 1914 folic acid supplements 406, 435 gastric rupture, in divers 271
in neurological syndromes/diseases folinic acid supplements 407 gastroenteritis, viral 567, 154
196, 198 folliculitis 134 see also travelers diarrhea
in pregnant travelers 407 Fonsecaea 1423 gastrointestinal disease
rashes with 196 food aeromedical repatriation 302
in respiratory infections 1978 allergies 17 in Chagas disease 115
treatment 81, 199201 extra, in diabetes 1516 tness to y 229, 442
in typhoid and paratyphoid fever imported 191 in schistosomiasis 117
84 safety precautions 19, 161 travelers diarrhea risk 156
in yellow fever 66 toxic contamination 313, 316 gastrointestinal tract
lariasis 11921, 2023 food-borne illness 31 barotrauma 2701
clinical features 119 cruise ships 2834 gas expansion within 218, 2701, 302
consequences of not hepatitis A 41 GB viruses 39
detecting/treating 205 in immunocompromised travelers 19 gender dierences
diagnosis 120 travelers diarrhea 155 acute mountain sickness 248
global burden 7, 9 typhoid and paratyphoid fever 834 sea sickness 282
prevention and control 121 Food and Drug Administration (FDA) gender-related issues
treatment 1201 use-in-pregnancy categories 399 sports and adventure activities
in women 409, 410 vaccination in pregnancy guidelines 41518
see also loiasis; lymphatic lariasis; 396 tropical diseases 381, 40814
onchocerciasis foot see also women
res, air pollution from 317 care, in diabetes 16, 438 genital herpes 612
rst aid fungal infections 1401 Geosentinel 37
snake bites 327 injuries, on beaches 293 G forces, air travel 300
training, expedition travelers 257 Madura 1378, 142 Giardia lamblia (giardiasis) 154, 1989
rst-aid kits foramen ovale, patent, in divers 264 in expatriates and aid workers 460
aircraft 232, 233, 234 foreign body in immunocompromised travelers 425
see also medical kits corneal 3556 in pregnancy 408, 413
sh stings 3378 intraocular 356 prevalence in returned travelers 205
sh-tank granuloma 136 sensation, eye 348 reproductive eects 409
tness forestry workers 189 screening children 377
to dive 2659 fractures, air travel and 228, 229, 442 treatment 158
to y 22730, 432 frequency, urinary, in women 383 ginger root, for sea sickness 283
improving, before travel 4312 friends girdle pain, in decompression illness 271
physical, divers 266 travel by 1901 glandular fever infections 196
to travel 1521, 4312 visiting see visiting friends/relatives glaucoma
ts see seizures frusemide, in high-altitude cerebral acute 349, 353
ashes, visual 357 edema 252 drug-induced 360
Flavirus 65, 67 fungal diseases 1404 post-traumatic 357
aviviruses 65, 6871 cornea 355 Global Malaria Control Strategy 102
eas 133 furazolidone, in travelers diarrhea 158 global warming 10
burrowing 131, 201 furuncle 134 Glossina species see tsetse ies
Flight Anxiety Modality questionnaire glucagon, in diabetes 1516, 437
238 gametocytes, malaria 95 glucocorticosteroids see corticosteroids
Flight Anxiety Situations questionnaire gangrene 134, 135 glucose
238 in Rocky Mountain spotted fever 139 for diabetic divers 267
ight crew see aircrew Ganjam virus 78 monitoring, in diabetes 437
oaters, intraocular 357 gardening holidays 146 glucose-6-phosphate dehydrogenase
ucytosine 143 gas (G6PD) deciency
uid replacement dysbarism antimalarial chemotherapy 97, 98, 99
in decompression illness 271 evolved 218 in immigrants 472
in snake envenoming 333 trapped 218 malaria chemoprophylaxis 369
in viral gastroenteritis 57 embolism, arterial, in divers 263, 264 melarsoprol treatment 113
see also oral rehydration therapy equation (general gas law) 213 glycemic control, diabetic travelers 436,
ukes see trematodes exchange, in body 214 437
uorescein staining, eye 349, 354, 355 expansion gnathostomiasis 131, 203
uoroquinolones during air travel 300 gonorrhoea 33
in immunocompromised travelers 20 in gut 218, 2701, 302 Good Samaritan law 231
in travelers diarrhea prophylaxis 162, inert, absorption during diving 263 Good Samaritans 231
433 intraocular, air travel and 347, 348 governments, injury prevention 2956
INDEX 487
granuloma tness to dive 268 174, 175
annulare 1401 heart failure in immunocompromised travelers
sh-tank 136 altitude travel 256 19
swimming 136 congestive 16, 424 interaction with immunoglobulins
green monkey disease 72 heart rate, at high altitude 248 175
grittiness, ocular 348 heat loss, during diving 262 in older travelers 440
Guadalajara incident (April 1992) 319 heatstroke 439 in pregnancy 169, 398, 400
Guanarito virus 75 Helicobacter pylori infection 436 in transplant recipients 434
Guggul 313 helicopter rescue and typhoid vaccine combination
guide dogs, travel with 440 cruise ship travelers 284 174, 181
gut see gastrointestinal tract in decompression illness 272 virus (HAV) 39, 40, 58
gynaecologic problems, parasitic diseases helium hepatitis B 438
causing 40911 absorption, during diving 263 carriers 43, 400
Gyneseal 388 use by divers 265 clinical features 467
heliumoxygen mixtures (heliox) 262, diagnosis 467
H-2 blockers, travelers diarrhea risk 265 e antigen 47
156 hemagglutinin, inuenza virus 59 epidemiology 33, 456
HACE see high-altitude cerebral edema hematological malignancies 425 immune responses 46
Haemagogus mosquitoes 65 hematuria, in schistosomiasis 117 immunization 478, 49
Haemaphysalis 132 hemoconcentration, at high altitude 248 immunoglobulin 47, 175
Haemophilus inuenzae b (Hib) vaccine hemodialysis, during travel 435 incubation period 187
for children 171, 173, 371 hemoglobin 214 management 47
in pregnancy 398, 400 oxygen saturation curve 216 in migrants and refugees 470, 471
Hajj pilgrims (Mecca) 35, 176, 472 hemolysis, in malaria 97, 98, 99 pathology 46
haloes, visual 348 hemophilia 54 prevention 478
halofantrine 455 hemoptysis 198 reservoir 46
Hamman sign 263 hemorrhage/bleeding risk to travelers 48, 376, 400
hantavirus infections 198 in CrimeanCongo hemorrhagic fever screening children for 376
HAPE see high-altitude pulmonary 78 surface antigen (HBsAg) 43, 46, 47
edema in Marburg virus disease 74 delta antigen and 48
Hazara virus 78 massive, cruise ship travelers 284 epitopes 445
Hazard Analysis Critical Control Point in snake envenoming 323, 325, 326, mutants 45
(HACCP) program 284 332 vaccine 478, 175
headache subconjunctival 349 adverse events 169
in acute mountain sickness 249 hemorrhagic factors, snake venom 323 booster doses 175
in motion sickness 224 hemorrhagic fevers, viral 345, 718 in children 171, 371
head injury Henrys law 214, 218 in diabetes mellitus 15
aeromedical repatriation 302 Hepacivirus 65 eectiveness 187
diving after 2678 hepatitis expatriates and aid workers 453
Health Canada 285 infectious 40 hepatitis A vaccine combination
health care see medical care non-A, non-B 501 174, 175
HealthCare Abroad 444 serum 43 in older travelers 440
health care workers viral 3952 in pregnancy 169, 398, 400
air ambulance transfers 308 clinical features 412, 197 in renal disease 435
cruise ships 278, 281 in migrants and refugees 470 route of administration 168
expatriate and aid worker services versus yellow fever 667 routine immunization 172, 371
458 hepatitis A 403 virus (HBV) 39, 434
infection control precautions 199 active immunization see hepatitis A, core antigen antibodies 46, 47
in travel clinics 234 vaccine hepatitis delta virus and 48
travel-related risks 189 in children 41, 42, 372 open reading frames (ORFs) 434
see also physicians clinical features 412 precore mutants 45
health reasons, travel for 6 diagnosis 42 replication 45
health risks, travel-related epidemiology 32, 401 subtypes 445
epidemiology 1013 in immunocompromised travelers 19 hepatitis C 502
pretravel assessment 257 in migrants and refugees 470 in migrants and refugees 470
health status, travelers 26 passive immunization 42, 174, 400 risk in pregnancy 400
hearing, underwater 2612 pathology 41 screening 377
hearing impairment prevention 423 virus (HCV) 39, 51
diving-related 269, 270 reservoir of infection 41 hepatitis D 489
travelers with 20, 440 risk to travelers 48 hepatitis delta antigen (HDAg) 48, 49
heart treatment 42 hepatitis delta virus (HDV) 39, 48
in Chagas disease 115 vaccine 423, 48, 172, 1734 genotypes 48, 49
in yellow fever 66 in children 371, 372 molecular detection 49
heart disease 16, 433 eectiveness 187 hepatitis de Sierra Nevada de Santa
altitude travel 2556 and hepatitis B combined vaccine Marta 48
488 INDEX
hepatitis E 4950, 191 management 55 hydroxychloroquine
prevention 401 pathology 54 ocular toxicity 35960
vaccine, in pregnancy 4001 postexposure prophylaxis 384, 416, photosensitive reactions 149
virus (HEV) 39, 49 457 for polymorphic light eruption 145
hepatitis G virus (HGV) 39 prevention 556 hygiene measures
hepatocellular carcinoma 43, 52 reservoir 54 cruise ships 284
hepatomegaly risk to travelers 35, 190, 376 hepatitis A prevention 42
fevers with 197 screening trachoma prevention 362
in malaria 193 asymptomatic travelers 205 viral gastroenteritis prevention 57
Hepatovirus 40 children 3767 hymenoptera stings 3367
Her Own Way Advice for the Woman returned expatriates and aid hyoscine (scopolamine)
Traveler 419, 422 workers 461 contraindications 431
herpes, genital 612 travelers with 1720, 4278 in elderly travelers 439
herpes simplex virus crossing international borders for motion sickness 226, 282, 283
corneal (dendritic) ulcer 351, 352 1920 hyperbaric chambers, portable 251, 252,
type 1 (HSV-1) 61 environmental risks 19 254, 259
type 2 (HSV-2) 61 malaria chemoprophylaxis 20, 427 hypercapnia, in divers 265
herpesviruses 61 susceptibility to infection 20, 428 hypersensitivity reactions, to vaccines
herpes zoster ophthalmicus 3512 travelers diarrhea 20, 156 169
hiatus hernia, paraoesophageal, in vaccination 1819, 170, 178, 428 hypertension
divers 271 yellow fever vaccination 67, 182 altitude travel 255
high-altitude cerebral edema (HACE) see also AIDS tness to dive 268
2512 hog cholera virus 65 hyperthermia, avoidance in pregnancy
clinical and pathological features homesickness 243 415
2512 homosexual men 54 hyperventilation 217
pathophysiology 24950, 251 honey bee, Africanized 336 factors inducing 217
prevention 250, 251 hookworms 202, 203 in hypoxia 217
treatment 251, 259 animal 1278, 201, 202, 203 symptoms 217
high-altitude pulmonary edema (HAPE) gender-specic issues 409, 410 hyphaema, traumatic 3567
2524 in pregnancy 411 hypnozoites 91
in children 3756 hormone replacement therapy 393, 417 Hypoderma ies 131
clinical features 253 hornet stings 3367 hypoglycemia 199
dierential diagnosis 253 hospitals avoidance in pregnancy 415
pathophysiology 2523 admission, in fever ?malaria 194 in diabetes 16, 436
prevention 250, 2534 CrimeanCongo hemorrhagic fever in diabetic divers 267
prognosis and mortality 253 78 in malaria 99, 102, 199
recurrence rates 252 as data sources 36 hypopyon 352, 354
treatment 254, 259 Ebola virus transmission 74, 75 hypotension, in snake envenoming 323,
high-altitude retinopathy (HAR) 254, hostage taking 458 325
348 host factors, individual 186 hypothermia 269, 439
high frequency radio communication hotels, legionellosis risk 82 hypoxia 21617
(HF), aircraft 232 hot water treatment, painful stings 338, air passenger behavior and 241
highly active antiretroviral therapy 339 decompression sickness and 219
(HAART) 427 human chorionic gonadotropin (hCG), factors increasing susceptibility 217
histidine-rich protein II, Plasmodium beta core 383 at high altitude 216, 248
falciparum (Pf HRPII) 98, 194, human enterovirus 71 58 acclimatization 248
195 human herpesviruses (HHV) 61 fetal eects 418
Histoplasma capsulatum 143 human immunodeciency virus (HIV) 9, in high-altitude pulmonary edema
history 534 253
medical, expatriates 61 drug resistance 55 inducing hyperventilation 217
travel see travel history infection see HIV infection inight 227, 299300
HIV see human immunodeciency virus laboratory tests 55 in air ambulance transfers 301
HIV infection 526 transmission 54 assessing ability to tolerate 228,
acute seroconversion 545, 196 in dialysis centers 435 4412
clinical features 545 type 1 (HIV-1) 534 in pregnancy 394
consequences of not type 2 (HIV-2) 53, 54 in pulmonary disease 4412
detecting/treating 205 vaccine development 556 in rapid cabin decompression 221
diagnosis 545 human T-cell leukaemia virus 1 symptoms 21617
epidemiology 54 (HTLV-1) 53 hypoxiaaltitude simulation test
in expatriates and aid workers 4567 human T-cell leukaemia virus 2 (HAST) 441, 442
female genital schistosomiasis and 412 (HTLV-2) 53 hypoxic ventilatory response (HVR) 248
geographical distribution 54 humoral immunity 165
home testing kits 384 congenital deciency 4245 ibuprofen, for children 374
in immigrants and refugees 471 hydatid cysts 203 ice 19, 155
leishmaniasis risk 109 hydrouoric acid 315 identity bracelets/cards (Medic-Alert)
INDEX 489
423, 433 immunosuppression vaccine-preventable 16583
in diabetes 15, 436 immunouorescent antibody testing epidemiology 323
in food allergies 17 (IFAT), in leishmaniasis 108 in older travelers 440
IgA deciency, congenital 425 immunoglobulins 165, 175 see also immunization; vaccination
immigrants (migrants) 186, 46775 hepatitis B 47, 175 infertility
child 3767 hyper immune 1656 in female genital schistosomiasis 412
factors aecting health 4689 live vaccine interactions 166, 175, 178 parasitic diseases causing 409
rst encounter with health services measles 397 inammatory illness, high-altitude
46970 normal human 165, 175 pulmonary edema and 252, 254
health care 4703 hepatitis A immunization 42, 174 inight medical emergencies 190, 2305,
illegal 468, 469 in pregnancy 399 236
infectious diseases 469, 4702 rabies 64, 175, 179, 454 aircraft diversion 231
international tracking 468 tetanus 175 causes 230, 231
medical screening 204, 46970 varicella-zoster 19, 175, 397 denition 230
mental health and violence 4723 immunosuppression emergency medical equipment 232,
noninfectious diseases 472 drug-induced 4267 2334
numbers and trends 8, 10, 4678 in pregnancy 396, 403, 4289 good samaritans 231
presumptive treatment 2056 see also immunodeciency resuscitation equipment 2325
return home 469 immunosuppressive drugs 426, 434, 435 telemedicine 2312
rubella vaccination 179 impetigo 134, 135 inuenza 32, 5961
tuberculosis 1801, 470 implanted cardiac devices 441 clinical features and diagnosis 60
varicella risk 182, 472 incoordination, in hypoxia 216 cruise ship outbreaks 32, 283
visiting friends/relatives 6, 186, 471 incubation periods 187, 188, 470 epidemiology 9, 59
see also migration; refugees indemnity, inight medical emergencies high-risk groups 60
immobility 231 management 60
in air passengers 228 indinavir 416 pathology 60
medical risks 228 infants prevention 601
immune complexes, in hepatitis B 46 aeromedical repatriation 302 risk factors 190
immune enhancement, in dengue virus air travel and 3745 vaccine 601, 171, 176
infections 68 altitude travel 255, 375 in chronic disease 424
immune responses, in hepatitis B 46 diarrhea 369 contraindications 169
immunization seating in aircraft 3734 in HIV infection 170
active 165 see also children; neonates in pregnancy 398, 399
for cruise ship passengers 276 infections virus 59
expatriates and aid workers 4534 bacterial 819, 1338 information
for expedition travel 257 in diabetes 16, 423, 438 for air ambulance transfers 3035,
history 1867 needing urgent treatment 81 306
immigrant children 376 ocular 3614 brochures, patient 27
immunological mechanisms 1656 opportunistic 54, 55 sources, travel clinics 245
passive 1656 skin 12744 on travel-related disease 367
in pregnancy 17, 169, 396402, 429 susceptibility to 186 infusions, in air ambulance transfers 301
records of previous 256 in chronic disease 4234 injecting drug users see intravenous drug
routine 171, 3702 in diabetes 16, 423, 438 users
travel 172 in HIV infection 20, 428 injury, travel-related 2916
see also vaccination in immunocompromised travelers on the beach 2934
immunocompromised travelers 7, 20, 4256, 433 case-based approach 2913
1720, 42330, 4338 in pregnancy 17, 396 epidemiology 12, 13, 291
environmental risks 19 virus 3980, 144 eye 3549
rabies vaccination 179 infectious diseases government approach 2956
susceptibility to infection 20, 4256, contraindicating travel 20 insurance 295
433 death rates 13 mortality 13, 34, 291
travelers diarrhea 20, 156 drug resistance 7, 8, 34 in older travelers 439
vaccines 1819, 170 emerging and re-emerging 78, 10, operated eyes 347
see also HIV infection; 346 pre-travel advice 295
immunodeciency; in expatriates and aid workers 448, prevention 2956
immunosuppression 460 protection of children 3734
immunocontraceptives 389 tness to y 228, 229 risk management framework 2923
immunodeciency gender-related issues 381, 40814 tourism industry approach 295
acquired 424, 4256 global burden 78, 9 see also motor vehicle accidents
in chronic disease 4234 importation and spread 910, 11 inner-ear barotrauma 26970
common variable (CVD) 425 incubation periods 187, 188, 470 insect bites 1323, 201
congenital 424 mandatory notication 36 epidemiology 12, 34
non-HIV-related 4237 in migrants and refugees 469, 4702 hepatitis B transmission 46
vaccination 170 spread in aircraft 190, 228 protection of children 3678
see also HIV infection; surveillance 36 see also specic insects
490 INDEX
insecticides International Travel Health Guide jigger 131, 201
ea control 133 (Rose) 444 judgement, impaired, in hypoxia 216
impregnated bed nets 103, 367 Internet resources see web sites Junin virus 75, 77
malaria vector control 102 interpreters 473
onchocerciasis control 121 intracranial pressure, increased 442 kala-azar see leishmaniasis, visceral
reduviid bug control 116 intradermal administration, vaccines Kaposi sarcoma 144
topical, for scabies 132 168 Katayama fever 116, 202
toxic risks 31516 intramuscular administration, vaccines kdr (knock-down resistance) 102
tsetse y control 114 168 keratitis
vector resistance 102 intrauterine contraceptive devices acute 3445
insect repellents 102 (IUDs) 387, 389 chronic 345
for children 3678 for emergency contraception 391, 392 Labrador 345
in older travelers 439 intrauterine growth retardation, at high keratotomy, radial 257
in pregnancy 404 altitude 418 kerion 141
see also DEET intravaginal contraceptive rings 389 kidnapping 458
insulin intravenous drug users kidneys, in yellow fever 66
delivery systems 4367 hepatitis A risk 41 kraits 321
lispro, rapidly acting 4367 HIV risk 54, 55 Kunjin virus 70
melioidosis and 438 iodine, for water disinfection 408 Kyasanur Forest disease virus 70
preparations 16, 436 Ipecac 374 kyphoscoliosis, altitude travel 2567
pumps 436, 437 iritis, acute 3523
insurance, travel 201, 295, 444 irrigation schemes 116, 11819 laboratories 25
for aeromedical repatriation 298, 459 Irukandji syndrome 338, 339 as data sources 36
companies, disease surveillance 37 ischaemia, in decompression illness 264 information provision to 191
for cruise ship passengers 277 ischaemic heart disease see coronary transmission risks in 191
for divers 273 artery disease Laboratory Centre for Disease Control,
for expedition travelers 259 isolation 199 Canada 20, 21, 24
for high-risk travel groups 432 isoniazid, in children 376 Labrador keratitis 345
importance 227 isoprenaline, for bee, wasp and hornet Labrea black fever 48
in pregnancy 17, 394 stings 337 lacrimal system injuries 359
intensive care patients see critically ill Isospora 91 lactase deciency, transient 198
patients itching see pruritus lactate dehydrogenase (LDH),
intercostal drain, air ambulance itinerary, review of 267 Plasmodium 98, 194, 195
transfers 301 itraconazole 143 lactation
interferon ivermectin malaria chemoprophylaxis 406
in hepatitis B 47 in cutaneous larva migrans 128 medical supplies 417
in hepatitis C 52 in lariasis 120 vaccination 429
in hepatitis D 49 mass treatment 121, 131 yellow fever vaccination 401
International Air Transport Association in onchocerciasis 120, 121, 131 Lactobacillus preparations 162
(IATA) 227 in pregnancy 411 Lady Comp 390
International Association for Medical in scabies 132 Lagos bat virus 62
Assistance to Travellers Ixodes 132, 401 lamivudine 47, 416
(IAMAT) 21, 2856, 395, 433, Ixodes persulcatus 70 language barriers 473
444 Ixodes ricinus 70 Larium see meoquine
International Committee of the Red larva currens 203
Cross (ICRC) 448 Japanese encephalitis 69 larva migrans
International Council of Cruise Lines epidemiology 33, 69 cutaneous 1278, 201, 203
(ICCL) 281, 286 vaccine 69, 172, 176 visceral 203
International Diabetes Federation 16, in children 371, 372 LASIK surgery 257
21, 436 in expatriates and aid workers Lassa fever 72, 756
International Dialysis Organization 445 4534 clinical features and diagnosis 76,
International Health Regulations 165 in pregnancy 398, 401, 429 1978
International Maritime Health virus (JEV) 68, 69 epidemiology 34, 76
Association 286 JarischHerxheimer reaction 89 Lassa virus 72, 75, 76
International Maritime Organization jaundice Latrodectus spp. (black widow spiders)
281, 286 fevers with 197 3345
International Planned Parenthood in malaria 192 antivenoms 336
Federation (IPPF) 385, 391 in viral hepatitis 41 envenoming (latrodectism) 335, 336
International Programme on Chemical in yellow fever 66 symptoms and signs of bites 335
Safety (IPCS) 311 jellysh stings 3389 lead poisoning 313, 314
International Society of Travel Medicine jet injectors, for vaccination 168 Leas Shield 388
(ISTM) 24, 25, 423 jet lag 222, 242 Legionella pneumophila 81, 82
contact details 28, 286 in children 373 legionellosis (Legionnaires disease)
travel medicine training 378 in elderly travelers 439 813
International SOS 444 management 223, 242 clinical features 823, 198
INDEX 491
epidemiology 32, 82 levator aponeurosis injuries 359 diagnosis 120, 2023
management 83 levooxacin, in travelers diarrhea 157, in pregnancy 411
risk factors 186, 190 162 prevention and control 121
surveillance 37 levonorgestrel treatment 120
Leishmania 1056 for emergency contraception 390, 391, lymph node aspiration, in
Leishmania aethiopica 106, 107, 108 392 trypanosomiasis 112
Leishmania chagasi 106, 107 intrauterine system (LNg IUS) 389 lymphocytic choriomeningitis virus 75,
Leishmania donovani 106, 107, 109, 129 liability, Good Samaritans 231 76
Leishmania infantum 106, 107 lidocaine (lignocaine) lymphoedema 119
Leishmania (L.) amazonensis 106, 107, in decompression illness 273 lyssaviruses 62
108 inltration, sh stings 338
Leishmania (L.) garnhami 107 light, bright 223 Machupo virus 75, 778
Leishmania (L.) mexicana 106, 107, 201 limb pain, in decompression illness 271 Madura foot 1378, 142
Leishmania (L.) pifanoi 106, 107 lionsh 337 Madurella mycetomatis 142
Leishmania major 106, 107, 108 liposomes 167 maggots, skin colonization (myiasis)
leishmaniasis 1059 liver 1312, 201
clinical features 1067 cancer 43, 52 malaria 91105
cutaneous 105, 107, 12930 function abnormalities 199 airport 191
clinical features 106, 12930, 201 in Lassa fever 76 algid 97
diagnosis 107, 108, 12930 in yellow fever 656 in asplenic travelers 434
treatment 108, 109, 130 see also cirrhosis; hepatitis cerebral 967, 198
diagnosis 1078 Loeer syndrome 118, 203 chemoprophylaxis 103, 104
disseminated cutaneous 106, 107, 109 loiasis (Loa loa) 119, 203, 3623 for children 3689, 4556
etiology and pathogenesis 129 diagnosis 120 diving safety and 269
life cycle 106 prevention and control 121 in expatriates and aid workers
mucocutaneous (espundia) 106, 107, treatment 120, 363 4545
108, 109 Lomotil 158 in HIV infection 20, 427
post-kala-azar dermal (PKDL) 109, loperamide immunocompromised travelers 20,
129 in children 370 426, 434, 435
in pregnancy 414 in pregnancy 408 in migrants visiting home 471
prevention 109 in travelers diarrhea 157, 158, 159 in pregnancy 105, 4047
recidivans 107 in viral gastroenteritis 154 presentation of malaria and 192
reproductive eects 409 loss control 295 pretravel advice 26
treatment 1089 louse-borne relapsing fever 88, 89 rabies vaccination and 64, 179
visceral (kala-azar) 105, 106, 107 louse-borne typhus 85, 139 in transplant recipients 434
clinical features 106 Loxosceles spiders 335 typhoid vaccination and 181
diagnosis 1078 signs and symptoms of bites 335, 336 in children 96, 191, 3679, 4556
infantile 106, 107 treatment of bites 336 chloroquine-resistant 34, 99100, 404,
in pregnancy 414 lumbar puncture, in high-altitude 405
treatment 108, 109 cerebral edema 252 classication 91
Leishmania tropica 106, 107, 108, 201 lung clinical features 96, 1923
Leishmania (Viannia) braziliensis 107 barotrauma 218, 2623, 271 complications of falciparum 967
clinical features 106, 129 disease, chronic see chronic obstructive diagnosis 978, 1934, 195, 199
treatment 108, 201 pulmonary disease self-diagnostic kits 455
Leishmania (Viannia) columbiensis 107 oxygen toxicity, in divers 265 endemic 956
Leishmania (Viannia) guyanensis 107, rupture, in divers 262, 266 epidemiology 12, 32, 956
108 volumes, depth underwater and 262, in expatriates and aid workers 4546
Leishmania (Viannia) panamensis 107 263 fever in 934, 96, 1914
Leishmania (Viannia) peruviana 107 lupus erythematosus geographical origins 192, 193
Leishmania (Viannia) venezuelensis 107 cutaneous 1456 global burden 7, 9
lenses, contact see contact lenses discoid 146 global distribution 91, 92
leprosy 1367 systemic (SLE) 145 in immunocompromised travelers 20
eye involvement 363 lupus vulgaris 137 life cycle 915
incubation period 187 Lutzomyia sandies 106, 129 in migrants and refugees 471
treatment 363 Lyme disease 176 multidrug resistant 1001, 4067
Leptosphaeria senegalensis 142 clinical presentation 196 in older travelers 43940
leptospirosis 82, 867 ocular features 363 post-travel advice 205
clinical features 867, 197 in pregnancy 4012 pregnancy and see pregnancy, malaria
management 81, 87 vaccine 172, 176 prevention 1025
versus yellow fever 67 in pregnancy 399, 402 compliance 243, 244, 455
letter of authorisation, to carry lymphadenopathy in expatriates and aid workers
medications 15, 16, 423, 432 in African trypanosomiasis 111 4556
leucocytosis, polymorph, in snake fevers with 1967 in immunocompromisedtravelers 20
envenoming 325 local, in snake envenoming 325 in pregnancy 17, 105, 4034
leukemia 435 lymphatic lariasis 119 reproductive eects 409
492 INDEX
malaria (cont.) expedition travel and 257 melanoma, malignant 1478, 344
risk factors 186, 454 tness to dive 2669 melarsoprol, in African trypanosomiasis
treatment 98102, 199201 tness to y 228, 229, 432, 4412 113
in children 369 tness to travel 1521, 4312 melatonin
expatriates and aid workers 455 insurance cover 21, 277, 295 in children 373
in pregnancy 101, 105, 4078 Medic-Alert bracelets/cards see identity for jet lag 223, 439
presumptive 205, 369 bracelets/cards melioidosis 186, 438
stand-by emergency 105, 4078 Medic Alert Foundation 444 memory, immunological 165
urgent 81 medical facilities, cruise ship 275, memory impairment, in hypoxia 216
vaccine 1035, 369, 373 27881, 2867 meningitis
versus yellow fever 66 medical information form belt, Africa 35, 177
Malarone see atovaquone-proguanil airline (MEDIF) 227 in brucellosis 87
Malassezia furfur 141 cruise ship travelers 278, 27980 eosinophilic 203
malasseziosis 1401 medical kits 432 fever with 196, 198
mal de debarquement 282 air ambulances 303, 304, 305 herpes simplex 62
syndrome (MDDS) 282 aircraft emergency 232, 2334 meningococcal see meningococcal
mal morado 130 for children 374 disease
Maloprim see pyrimethamine/dapsone for cruise ship travelers 276, 2778 meningococcal disease
Mansonella perstans 202, 409 for expeditions 258, 259 clinical features 196
Marburg virus 723 for women 41617 epidemiology 33, 35
disease 724 medical records in migrants and refugees 472
Marie Stopes International 385, 3912 high-risk travel groups 433 meningococcal vaccines 33, 172, 177
marital relationships immunocompromised travelers 423 in children 371, 372
air travel and 2378, 243 in pregnancy 3934 in immunocompromised travelers 434
expatriates 453 medical supplies in pregnancy 398, 399400
Mastomys rats 76 traveling with 15, 16, 432 menopausal women 417
Mazzotti reaction 120, 202 see also medical kits; medications menstrual cycle
Mazzotti test 120 Medical Toxicology Laboratory 31213 charting 382
meals Medical Toxicology Unit (MTU) control 382
insulin therapy and 4367 31113 menstrual supplies 382, 416
special, in diabetes 16 medications menstruation 3823
measles for air ambulance transfers 305 mental health, migrants and refugees
epidemiology 33 in aircraft emergency medical kits 4723
immune globulin, in pregnancy 397 232, 233, 234 mental illness see psychiatric disorders
vaccine contaminated 313 mental status, in high-altitude cerebral
in children 3712 for cruise ship passengers 276, 278 edema 2512
in pregnancy 397, 398 in diabetes 1516 mepacrine 149
measles, mumps and rubella (MMR) diving safety 268 mercury 167
vaccine 171, 177 history 1867 merozoites 913
adverse events 169 hypoxia susceptibility and 217 merozoite surface proteins (MSP-15)
in children 3712 ocular, stability 359 92
contraindications 169 in pregnancy 402 metastatic tumours 425
in immunocompromised travelers 18, traveling with 15, 16, 423, 432 methanol poisoning 361
170 see also drug-induced disorders methemoglobinaemia, antimalarial drugs
in pregnancy 397, 398 MedicinePlanet 395 inducing 98, 99
meat Mediterranean spotted fever 85, 139 metoclopramide, for sea sickness 283
raw or undercooked 19 meoquine metrifonate, in schistosomiasis 118
tenderiser, for bee stings 337 adverse eects 103, 187 metronidazole, in pregnancy 408, 413
mebendazole, in pregnancy 411 for children 3689 microlariae 119
Mecca, pilgrimage to 35, 176, 472 contraindications 431 detection 120, 361
meclozine, for sea sickness 283 diving safety 269 in follicular uid 409
medical advisors, airline 2356 in elderly 440 microhaematocrit centrifugation
medical assistance companies 298, 394, in expatriates and aid workers 455 technique, in trypanosomiasis
395 in HIV infection 427 111
medical attendants, sick air passengers in immunocompromised travelers 20 Microsporum 140
22830 in liver disease 435 middle ear
medical care malaria prophylaxis 103 barotrauma 218, 269
abroad 433 malaria stand-by treatment 105 oxygen absorption syndrome 270
cruise ships 27881 malaria therapy 98, 1001 mifepristone (RU-486) 391, 392
expatriates and aid workers 4589 in pregnancy 105, 405, 406, 407, 455 migraine, at high altitude 254
migrants and refugees 4703 resistant malaria 407 migrants see immigrants
medical conditions, pre-existing 4412 typhoid vaccine interaction 181 migration 3
altitude travel and 2557 meglumine antimoniate, in journey phase 4689
cruise ship travelers 276 leishmaniasis 108 numbers and trends 8, 10, 4678
expatriates and aid workers 450 meibomian cyst 350 postmigration environment 469
INDEX 493
predeparture phase 468 risk-based analysis 294 Necator (americanus) 410, 411
process, health impact 4689 motor vehicle travel necrosis, in snake bites 3245, 333
tropical infectious diseases and 910 with children 373, 374 necrotizing soft tissue lesions 134, 135
military personnel 189 in pregnancy 396 needles, travel with 15
motion sickness 227 risk analysis 294 needlestick injuries 191
miniature anion-exchange centrifugation mountain climbers Negri bodies 62, 63
technique, in trypanosomiasis ocular hazards 345, 348 Neisseria meningitidis 177
11112 see also altitude; expedition travelers see also meningococcal disease
Minnesota Multiphasic Personality mountain sickness nematode infections 2013
Inventory (MMPI) 452 acute (AMS) 24851, 259 gender-specic issues 409, 410
missionary workers 447, 44950 in children 375 intestinal 203, 409, 410
MMR vaccine see measles, mumps and clinical features 249 neonates
rubella (MMR) vaccine pathophysiology 24950 aeromedical repatriation 302
mobility prevention 2501, 253 air travel 229
concept of global 4734 treatment 251 hepatitis B prophylaxis 47
problems see disability, physical chronic 248 yellow fever vaccination 401
Mobility International 445 subacute infantile (SIMS) 255 see also children; infants
Mokola virus 62 mud huts, relapsing fever risk 89 neural mismatch theory, motion
moles, assessment of 147 mumps vaccine sickness 2245, 282
molluscicides 118 in children 3712 neuraminidase, inuenza virus 59
molluscum contagiosum 144 in pregnancy 398 neurocysticercosis 203
monkeys see also measles, mumps and rubella neurological disorders 442
African green 72, 73 (MMR) vaccine aeromedical repatriation 302
cynomolgus, Ebola virus 74 muramyl dipeptide (MDP) 167 African trypanosomiasis 111
mortality see death muscle infections, in diabetes 438 cerebral malaria 967
mosquito coils 102 myalgia decompression illness 219, 268, 271
mosquitoes fever with 195 fevers with 196, 198
attraction to pregnant women 404 in snake envenoming 3256 tness to y 229
bite avoidance 1023, 367, 4034 mycetoma at high altitude 2545
control measures 68, 70, 102, 121 bacterial 1378 neurosurgery, aeromedical repatriation
dengue fever 678 true fungal (eumycetoma) 142 after 302
insecticide resistance 102 mycobacterial infections neurotic reactions, in motion sickness
Japanese encephalitis 69 management 137 226
lymphatic lariasis 119 skin 1367 neurotoxic snake bite reactions
malaria life cycle 91, 93, 95 see also leprosy; tuberculosis clinical features 325, 326
malaria transmission 96 Mycobacterium leprae 136 management 329, 330, 332, 333
repellents 102 Mycobacterium marinum 136 pathophysiology 323
Rift Valley fever 72, 78 Mycobacterium tuberculosis 136 neurotoxins, cone shell 339
St Louis encephalitis 70 see also tuberculosis neutropenia 199
yellow fever 64, 65 Mycobacterium ulcerans 136 neutrophilia 199
mosquito nets (bed nets) 103, 367 mycolactone 136 niacin deciency 14950
mosquito netting 102 mycosis, systemic 1434 nifedipine
motion sickness 2237 myeloma 435 in expedition medical kits 259
in aeromedical repatriation 302 myiasis 1312, 201 high-altitude pulmonary edema
in children 225, 282, 373 myocardial infarction 441 prophylaxis 253
in elderly travelers 439 altitude travel after 256 for motion sickness 227
etiology 2245, 282 in cruise ship passengers 284 in scorpion stings 334
factors aecting susceptibility 2256 myotoxicity, in snake envenoming 324, nifurtimox, in Chagas disease 115
incidence 224 3256 Nipah virus 35
prevention and treatment 2267 nitrogen
symptoms and signs 2234 Nairobi sheep disease virus 78 absorption, in diving 263
see also sea sickness Nairovirus 78 in decompression sickness 218
motivation, expatriates and aid workers Naja kaouthia 322 narcosis 264
451 Naja nigricollis 324 partial pressure (PN ), depth
motorcycle accidents 13 National Association for the Deaf 444 underwater and 263
expatriates and aid workers 450 National Health and Medical Research nitrous oxide and oxygen, in
insurance cover 295 Council (NHMRC), Australian decompression illness 271
motor vehicle accidents 2945 24 Nocardia infections 1378
deaths 13, 34 National Poisons Information Service noroxacin, in travelers diarrhea 157,
epidemiology 34, 291 (NPIS), London 31112 162
expatriates and aid workers 450 database 31316 NorLevo 391
eye trauma 355 National Water Safety Council 294 Norplant 1 and 2 387
in older travelers 439 nausea Norwalk-like viruses 56
in pregnancy 3956 in motion sickness 223, 224 Norwalk virus 56, 283
prevention 2945, 374 oral contraceptive pill and 385 nosocomial infections, HIV 54
494 INDEX
nurses, cruise ship 278, 281 interactions 175, 178, 181 red eye with 348
nutritional deciencies 472 in pregnancy 397 scorpion stings 334
nystagmus, positional alcohol 2256 oral rehydration therapy Pan American Health Organization 286
in children 370 papulonecrotic tuberculide 137
obesity, decompression sickness and 219 in travelers diarrhea 157 paracetamol see acetaminophen
OBGYN.net 395 in viral gastroenteritis 57 paracoccidioidomycosis 1434
obstetric patients, aeromedical oral vaccines 168 paragonimiasis (Paragonimus infections)
repatriation 3023 orbit 203
occupational groups blow-out fractures 358 diagnosis 198, 202
post-travel checks 204 cellulitis 351 reproductive eects 409
travel-related risks 189 disorders 3501 paralysis
ultraviolet light damage 343 oor fractures 358 in poliomyelitis 58
ocean fractures 3578 in snake envenoming 325
rescues 293 organ donors, Chagas disease screening Parasight-F test 98, 194
travel see cruise ship(s) 116 parasitic diseases
ocular preparations organ transplant recipients 170, 434 in asymptomatic travelers 204
side-eects 360 oriental sore 105, 106 consequences of not
stability 359 see also leishmaniasis, cutaneous detecting/treating 2045
oedema see edema Ornithodoros ticks 89 eosinophilia 2013
oestrogen see estrogen orthopedic conditions 442 in expatriates and aid workers 460
Oce of Population Research 385 Oseltamivir 60 gender-related issues 40814
ooxacin ossicles, auditory, dislocation 269 in migrants and refugees 4712
in eye infections 354 otic barotrauma 218, 26970 in pregnancy 40912
in travelers diarrhea 157, 162 otitis externa, in swimmers 270 screening asymptomatic children 376,
older travelers see elderly travelers outbreaks 187 377
Omsk hemorrhagic fever virus 70 Oves 388 skin 12733, 201
Onchocerca volvulus 119, 202, 361 oxamniquine, in schistosomiasis 118 travelers diarrhea 154
onchocerciasis (river blindness) 1301, oxygen vector-borne 91124
3612 absorption syndrome, middle ear 270 paratyphoid fever 834
clinical features 119, 130, 361 carriage in body 214 clinical features 84, 196
diagnosis 120, 130, 202 dissociation curve 216 see also typhoid
etiology and pathogenesis 119, 130 exchange 214 paromomycin, in pregnancy 408, 413
global problem 364 hyperbaric 348 patent foramen ovale, in divers 264
international spread 9 lack see hypoxia PATH (Program for Appropriate
in pregnancy 411 requirements at altitude 21416 Technology in Health) 385
prevention and control 121, 362 saturation patient information brochures 27
treatment 1201, 131, 202 at altitude 216 Peace Corps personnel 448, 450, 457
Onchocerciasis Control Programme inight 227, 394 pediatric travel medicine 36779
(OCP) 121 supplemental inight 215, 230 service organization 3778
onchocercomas 361 after decompression illness 272 training 378
onychomycosis 140 in chronic medical conditions 16, see also children; infants; neonates
ophthalmia neonatorum 364 4412 pellagra 14950
ophthalmic conditions 34364 in pregnancy 17, 394 pentamidine
Opisthorchis spp. 202 supplies in African trypanosomiasis 113
opportunistic infections 54, 55 aircraft emergency 230, 300 in leishmaniasis 109
OptiMAL test 194 expeditions 259 performance, eects of jet lag 222
oral contraceptives 38590 tension (partial pressure) perinatal transmission
drug interactions 390 in alveolar air 215, 299 HIV 54
for emergency contraception 390, 391, depth underwater and 263 parasitic infections 412
392 in hypoxia 216, 299300 viral hepatitis 46, 47, 51
at high altitude 257 therapy periodic breathing, at high altitude 254
for menstrual cycle control 382 air ambulance transfers 303 peritoneal dialysis
missed pills 385 in altitude illness 251, 252, 254 during travel 435
pill absorption problems 38590 cruise ship travelers 276 in snake envenoming 333
pros and cons 3867 in decompression illness 271 Persona 390
skin complications 1489 toxicity, in divers 265 personality
time zone changes and 385 Oxyuranus scutellatus (canni) 322, 326 assessment, expatriates and aid
vaginal administration 385 oysters, raw 19 workers 452
venous thrombosis risk 3923 ozone layer 343, 346 change, in hypoxia 216
oral health see dental health fear of ying and 238
oral polio (Sabin) vaccine (OPV) 589, pacemakers, cardiac 441 Personal Physicians Worldwide 433,
178 pain 444
adverse events 169 in decompression illness 271 pertussis immunization 177
in immunocompromised travelers 19, sh stings 337, 338 children 3701
178 ocular, after air travel 347 see also DTP vaccine
INDEX 495
pesticides malaria polymorphic light reaction 144, 145
toxic risks 31516 chemotherapy 98, 99101 Pontiac fever 81
see also insecticides complications 967 porphyria 144
Pestivirus 65 geographical origins 193 cutanea tarda 146, 149
petroleum-related incidents 319 mortality 192 portable hyperbaric chambers 251, 252,
pets, international movement 191 in pregnancy 403 254, 259
Pf60 antigens 93 multidrug-resistant Portuguese man-o-war (Physalia spp.)
PFT 1-2-3-KIT 390 chemoprophylaxis 103 338, 339
pharmacies 25 chemotherapy 1001 positional alcohol nystagmus 2256
pharmacokinetics, in pregnancy 402 Plasmodium malariae postdecompression collapse 219
pharyngitis 197 life cycle 912, 934 Postinor 391, 392
Phialophora 1423 malaria post-kala-azar dermal leishmaniasis
Phlebotomus sandies 106, 129 chemotherapy 98, 99 (PKDL) 109, 129
Phlebovirus 78 presentation 193 post-traumatic stress disorder (PTSD)
phobia, ight 23840 Plasmodium ovale in aid workers 449, 462
Phoneutria nigriventer 335, 336 life cycle 912, 934 in migrants and refugees 469, 472
phospholipases A , in snake venom 323, malaria prevention 459
324 chemotherapy 989 post-travel check 2046
photoageing 1468 presentation 193 children 3767
photoallergic reactions 149 treatment in pregnancy 4046 expatriates see expatriates, postreturn
photodermatoses 1445 Plasmodium vivax screening and care
photophobia 348 life cycle 912, 934 screening methods 205
photophytodermatitis 146 malaria treatment versus screening 2056
photosensitivity, drug-induced 149 chemotherapy 989, 201 potassium iodide 142
phototoxic reactions 1445, 149 geographical origins 193 potassium permanganate 134
Physalia spp. 338, 339 in pregnancy 403 poultry, raw or undercooked 19
physical activity see exercise presentation 193 Powassan virus 70
physical disability see disability, physical treatment in pregnancy 4046 praziquantel
physical examination, expatriates 461 pleasure, travel for 5, 6 insusceptibility 118
physicians (doctors) Plesiomonas shigelloides 154, 425 in pregnancy 411
abroad, nding 433 pneumococcal vaccine 171, 178 in schistosomiasis 118, 202
air ambulance transfers 308 in asplenic travelers 426, 434 prazosin, for scorpion stings 334
airline 2356 in chronic disease 4234 pregnancy 17, 393408
assistance at inight emergencies 231 in HIV infection 170 aeromedical repatriation 3023
care of migrants and refugees 4703 in pregnancy 398, 399 air travel 229, 3945
conrmation of death 235 Pneumocystis carinii, reproductive altitude travel 257
cruise ship 275, 278, 281 eects 409 amebiasis 408, 413
cultural competence 473 pneumonia 1978 birth in ight 235
injury prevention role 295 in diabetes 438 Chagas disease screening 116
travel medicine training 378 pneumothorax 441 contraindications to travel 394
picornaviruses 40, 56, 58 air ambulance transfers 301 emergency care 394, 395
pigmentation, ultraviolet light damage in divers 262 female genital schistosomiasis and 412
and 343 diving after 2667 giardiasis 408, 413
pigmented skin lesions, assessment of poisons 31120 helminth infections 414
147 police, notication of deaths 235 immunizations 17, 169, 396402, 429
pilgrims 6 poliomyelitis 589 immunosuppression 396, 403, 4289
meningococcal disease 35, 176, 472 clinical features and diagnosis 58 malaria 186, 4028, 429
pilocarpine eyedrops, side-eects 360 epidemiology 33, 36, 58 chemoprophylaxis 105, 4047, 429
pilot error 242 eradication 59 in expatriates and aid workers 455
pingueculum 345 in pregnancy 397 pathogenesis 403
pinworms see Enterobius vermicularis prevention 589, 1789 prevention 17, 105, 4034
piperazine, in pregnancy 414 vaccine-associated 178 treatment 101, 105, 4078
placenta polio vaccines 589, 171, 1789 medical and obstetric risk factors
drug transfer 402 in children 371 3934
in malaria 403 enhanced inactivated (eIPV) 1789, medical supplies 417
in parasitic infections 40911 397 parasitic infections 40912
plague 356, 1778 in HIV infection 170 pretravel assessment 17, 393
vaccine 172, 178 inactivated (Salk) 589, 1789 susceptibility to infections 17, 396
plants, exposure to 146, 31415 in pregnancy 169, 397, 398 teratogen reference sources 422
Plasmodium falciparum in transplant recipients 434 termination 3912
chemoprophylaxis 103 see also oral polio (Sabin) vaccine tests 383, 417
chloroquine-resistant poliovirus 58 timing of travel 394
chemoprophylaxis 103 polymerase chain reaction (PCR) toxoplasmosis 3634, 414
chemotherapy 98, 99100 in malaria 194, 195 travelers diarrhea 17, 408
life cycle 91, 925 in trypanosomiasis 113 travel insurance 17, 394
496 INDEX
pregnancy (cont.) proton pump inhibitors, travelers in drug reactions 148
unplanned 3912 diarrhea risk 156 in Rocky Mountain spotted fever 86
venous thrombosis risk 17, 393, 395 protozoan infections pyogenic skin infections 1334
water sports 418 in pregnancy 41112, 414 pyomyositis, in diabetes 438
Premarin 416 reproductive eects 409 pyrethrins, toxicity 316
premature labor, at high altitude 418 pruritus pyrethroids
premenstrual symptoms 382 in onchocerciasis 119, 130 toxicity 315, 316
prescriptions 432 vaginal 3834 vector control 114, 116
for diabetic travelers 436 Pseudoallescheria boydii 142 pyrexia see fever
preseptal cellulitis 351 pseudoephedrine, in children 373 pyrimethamine
pressure psittacosis 191, 198 in expatriates and aid workers 455
aircraft cabin 227, 299 psoralenUVA (PUVA) phototherapy malaria therapy 98, 99
atmospheric see atmospheric pressure 145 with sulfadoxine see
breathing 216, 217 psoriasis sulfadoxine-pyrimethamine
eects, in divers 2624 antimalarial agents and 149 pyrimethamine/dapsone (Maloprim)
pressure bandaging dierential diagnosis 1401, 150 in expatriates and aid workers 455
jellysh stings 339 guttate 134, 135 malaria prophylaxis 103
snake bites 327, 328 psychiatric disorders 442 in pregnancy 405, 407
pressurization, aircraft cabin see aircraft, aeromedical repatriation 303
cabin pressurization air passenger behavior and 240 Q fever 198
pretravel advice 256, 244 in expatriates and aid workers 4489, qinghaosu derivatives see artemisinin
air travelers 244 460 (qinghaosu) derivatives
disabled travelers 440 fear of ying 238 quantitative buy coat (QBC) technique
elderly travelers 439 fevers with 198 in malaria 978, 194, 195
expatriates and aid workers 4538 tness to y 229 in trypanosomiasis 111
expedition travelers 2579 in migrants and refugees 4723 quarantine period 190
high-risk travel groups 4313 psychological assessment Queensland tick typhus 139
injury prevention 294 expatriates and aid workers 4513 quinidine
malaria prevention 26 interview 4523 malaria therapy 99, 199
travelers diarrhea 26, 15961, 257, psychological interventions in pregnancy 407
4323 expatriates and aid workers 4578 quinine
pretravel assessment 257 in fear of ying 239 in children 369
for air travel 22730 psychology, aviation 23745 malaria stand-by treatment 105
expatriates and aid workers 4503 psychometric testing 4512 malaria therapy 98, 99, 101
health status 26 pterygium 345, 350 in pregnancy 407
in pregnancy 17, 393 ptosis, in snake envenoming 325 side eects 99, 149
review of itinerary 267 PTSD see post-traumatic stress disorder
three basic topics 256 Public Health Laboratory Service rabies 624, 179
women travelers 382 (PHLS) 24 clinical features and diagnosis 63, 198
primaquine puce chique 131 epidemiology 33, 63
in children 368, 369 Pulex irritans 133 furious 63
for malaria therapy 99 pulmonary artery immunoglobulin 64, 175, 179, 454
in pregnancy 404 congenital hypoplasia/absence 252, importation of animals and 191
prochlorperazine, for sea sickness 283 253, 254 management 634
Professional Association of Diving gas embolism 263 paralytic 63
Instructors (PADI) 273, 274 obstruction 252, 253, 254 postexposure immunization 64, 179,
progestin pulmonary barotrauma 218, 2623, 271 454
for emergency contraception 390, 391, pulmonary edema prevention 634
392 high altitude see high-altitude reservoirs 63
only contraceptive pill 386 pulmonary edema vaccine 172, 179
Program for Appropriate Technology in immersion, in divers 268 in children 371, 3723
Health (PATH) 385 pulmonary embolism in expatriates and aid workers 454
proguanil at high altitude 255 in immunocompromised travelers
in children 368, 369 risk factors 190 179
malaria prophylaxis 103 pulmonary eosinophilia, tropical 119, malaria chemoprophylaxis and 64,
in pregnancy 105 203 179
in renal disease 435 pulmonary hypertension postexposure 64, 179, 454
side eects 187 in HAPE 2523 pre-exposure 64, 179
see also chloroquine/proguanil in infants at high altitude 255, 375 in pregnancy 399, 402
ProMED 25, 28 pulmonary vasoconstriction, in HAPE route of administration 179
prone position, in retinal detachment 253 virus 623
357 pulse oximetry, telemedicine 232 radial keratotomy 257
Protectaid Sponge 388 Pulsineuron 313 radiation exposure
protein deciency 472 pupils, irregular, in ocular trauma 356 accidental 31819
proteinuria, in yellow fever 66 purpura in air travel 395
INDEX 497
radiographs, telemedicine 285 pulmonary disease ringworm 140
radiotherapy 170 respiratory failure risk
rapid eye movement (REM) sleep 221 altitude travel 2567 analysis 292, 293, 294
rash in snake envenoming 326 assessment, pretravel see pretravel
in decompression illness 271 respiratory function, in air ambulance assessment
in dengue fever 68 transfers 301 evaluation 292, 293, 294
drug reactions causing 148 respiratory paralysis, in snake identication 291, 292, 293, 294
in Marburg virus disease 74 envenoming 325 treatment 292, 2934
in Rocky Mountain spotted fever 139 respiratory tract infections risk-based approach, travel-related
in typhus fevers 85, 86 altitude illness and 253, 255, 3756 injury 2915
rats, leptospirosis 86 clinical presentation 1978 risk-taking behavior 2434, 456
rattlesnake, tropical 321, 326 epidemiology 1112, 312 river blindness see onchocerciasis
readjustment, returned expatriates 462 risk factors 190 road trac accidents see motor vehicle
rebreathers, diving using 265 resuscitation accidents
receptivity, motion sickness and 226 during air ambulance transfers 307 road travel see motor vehicle travel
recompression chambers 272 equipment, aircraft 2325 Robles disease see onchocerciasis
recompression therapy 271, 272 reticulocytes, malaria life cycle 92 Rocky Mountain spotted fever (RMSF)
ying after 272 retinal detachment 856, 139
outcome 272 surgery, air travel after 347, 348 rodents
red blood cells see erythrocytes traumatic 357 arenaviruses 756
red eye 3489 retinal hemorrhages leishmaniasis 106, 109
examination 349 in cerebral malaria 96 typhus 139, 140
symptoms 3489 at high altitude 254, 348 Roll Back Malaria 102
reduviid bugs 114, 115, 116 in high-altitude cerebral edema 252 Roma na sign 115
re-emerging infectious diseases 78, retinopathy rose oxide 317, 318
346 diabetic 3478, 437 rose spots 196
re-entry shock 243 high-altitude (HAR) 254, 348 rosetting 94
refractive errors 364 retroviruses 53 rosettins/rins 94, 95
refugees 186, 204, 46775 returned travelers 185209 rotaviruses 56, 154
cholera risk 35 children 3767 gastroenteritis 567
numbers and trends 18, 20, 4678 eosinophilia 2013, 204 vaccine (RRV-TV) 57, 372
presumptive treatment 2056 fever 191201 round window, ruptured 270
relapsing fever risk 89 history 18591 Royal Navy recompression table 272
return home 469 post-travel check see post-travel check RU-486 (mifepristone) 391, 392
see also immigrants skin disease 201 rubella 179
relapsing fever 66, 82, 889 tropical diseases in asymptomatic 204 vaccine
louse-borne 88, 89 reverse culture shock 205, 243, 462 adverse events 169
tick-borne 88, 89, 132 ribavirin in children 3712
relationships, impact of air travel 2378, in hepatitis C 52 in pregnancy 397, 398
243 in Lassa fever 76 see also measles, mumps and rubella
relatives Rickettsia akari 139 (MMR) vaccine
aeromedical repatriation 307 Rickettsia australis 139 Russian SpringSummer encephalitis
travel by 1901 Rickettsia conorii 85, 139 virus 70, 71
visiting see visiting friends/relatives rickettsial infections 846, 138
relaxation training, for fear of ying 239 clinical features 856, 196 Sabin vaccine see oral polio (Sabin)
Relenza 60 diagnosis 86, 138 vaccine
religious fasting, in diabetes 436 skin diseases 13840 SAFEtrip 395
religious pilgrims see pilgrims spotted fever group 1389 safety
renal failure treatment 86, 140 air passengers 2412
acute, in snake envenoming 3234, typhus group 138, 13940 children 3734
326, 333 see also typhus expatriates and aid workers 458
aeromedical repatriation 302 rickettsialpox 139 women travelers 41819
travel with 276, 435 Rickettsia mooseri 139 St Louis encephalitis 6970
repatriation Rickettsia prowazeki 139 virus 6970
aeromedical see aeromedical Rickettsia rickettsii 85, 139 Salk (inactivated poliovirus) vaccine
repatriation Rickettsia sibirica 139 589, 1789
expatriates and aid workers 459 Rickettsia tsutsugamushi 85 Salmonella gastroenteritis 1534, 198
reports, on returned expatriates 462 rifampicin, in brucellosis 878 epidemiology 155
respiration 214 rifaximin, in travelers diarrhea 157, 158 in HIV infection 20
control 21415 rins 94, 95 surveillance 37
respiratory disease 4412 Rift Valley fever 72, 78 Salmonella paratyphi 83, 84
altitude travel 16, 2567 imported 191 Salmonella typhi 83, 84, 1534
cruise ship passengers 283 vaccine 78 antibiotic resistance 33
tness to y 228, 229 virus 72, 77, 78 attenuation 166
see also asthma; chronic obstructive rimantadine 60 risk factors 155
498 INDEX
Salmonella typhi (cont.) Scytalidium infections 141 reduction of risk 55, 62
see also typhoid sea anemone larvae 150 viral hepatitis 41, 46, 48
Samaritans, Good 231 sea-bathers eruption 150 shellsh
sandea 131 seaborne infections, skin 1356 hepatitis A risk 41
sandies seaborne skin conditions 150 venomous (cone shells) 339
bite avoidance 109 seafood, raw or undercooked 19 Shigella infection (shigellosis) 153, 198
leishmaniasis transmission 106, 129, sea sickness 223, 224, 2813 regional distribution 154
414 factors aecting susceptibility 282 treatment 158
sanitation prevention and treatment 2823 vaccine 163
cruise ships 284 see also motion sickness ships see cruise ship(s)
hepatitis A prevention 42 sea snakes 321, 322 shock, in snake envenoming 323, 325,
schistosomiasis prevention 118 envenoming 324, 325, 326 333
Sarcoptes scabiei 132 seasonal variations, travelers diarrhea Shorelands EnCompass 433, 444
satellite communication system (satcom), risk 155 Siberian tick typhus 139
aircraft 232 seatbelts 294 sickle cell disease 186, 426, 442
scabies 132 for children 374 altitude travel 257, 442
Schistosoma haematobium 11617 in pregnancy 396 simian immunodeciency virus 54
diagnosis 118, 189, 202 sea travel see cruise ship(s) simulator sickness 223, 224
treatment 118 sea urchin stings 339 Simulium spp. see blackies
typhoid coinfection 84 sea wasp (Chironex eckeri) 338, 339 sine nombre virus 198
Schistosoma intercalatum 11617 sedation sinus barotrauma 218, 270
Schistosoma japonicum 11617, 202 for aeromedical repatriation 303 sinusitis, paranasal 198, 347, 441
Schistosoma mansoni 11617 children 373 skiing
diagnosis 202 seizures (ts) eye protection 345
international spread 9 fever with 196 in pregnancy 415
treatment 118 malaria chemoprophylaxis after 368 skin cancer 1468
Schistosoma mekongi 11617 post-traumatic, assessment of risk eyelids 344
schistosomiasis 11619 2678 in transplant recipients 434
changing patterns 34 self-defense, women travelers 419 skin diseases 12751, 201
clinical features 11617 self-ecacy 239 bacterial infections 1338
diagnosis 11718, 2023 sensory loss, in hypoxia 216 drug-related 145, 1489
epidemiology 116, 117 septicaemia with fevers 196
in expatriates and aid workers 460 in typhoid and paratyphoid fever 84 frequency in travelers 12, 127, 128
female genital (FGS) 409, 410, 41213 Vibrio vulnicus 1356 fungal 1404
global burden 7, 9 serological tests miscellaneous 14950
incubation periods 187, 189 asymptomatic travelers 205 in onchocerciasis 119
intestinal 11617 in Chagas disease 115 parasites, ectoparasites and bites
in migrants and refugees 472 in fever 199 12733
prevention 11819 in leishmaniasis 108 rickettsial 13840
in returned travelers 2045, 377 in malaria 194, 195 seaborne/waterborne 150
treatment 118, 2023 in schistosomiasis 118 sun-related 1448
schizont 934 in trypanosomiasis 11213, 114 viral 144
scleritis 350 serum sickness reactions, snake skin infections
scoop stretchers 307, 308 antivenom 3312 bacterial 1338
scopolamine see hyoscine severe combined immune deciency pyogenic 1334
scorpion antivenom 334 (SCID) 424 seaborne 1356
scorpion-sh 337 sex dierences see gender dierences skull fractures, aeromedical repatriation
scorpion stings 3334 sexual behavior 302
avoiding 334 expatriates 456 sleep 2213
clinical features 334 high risk 18990, 243, 244 debt 221
treatment 334 sexual harassment, women travelers disturbance, at altitude 254
screening 41819 habits, good 223
epidemiological denition 460 sexual history 18990 loss 221
immigrants and refugees 46970 sexually transmitted diseases (STDs) physiology 2212
postreturn 204 in adolescents 376 scheduling 2223
asymptomatic children 3767 epidemiology 12, 334 sleep apnoea, altitude travel 2567
expatriates and aid workers 45963 in expatriates 456 sleepiness 222
methods 205 female genital schistosomiasis and sleeping altitude 250
validity 460 412 sleeping sickness see African
versus treatment 2056 in immigrants and refugees 471 trypanosomiasis
predeparture, expatriates and aid travelers at high risk 18990, 243, 244 small round structured viruses (SRSVs)
workers 4503 in women 384, 417 56, 57
screens, tsetse y 114 sexual transmission smoking 186
scrub typhus 85, 86 genital herpes 61 chronic pulmonary disease and 442
scuba diving see diving HIV 54 hypoxia susceptibility and 217
INDEX 499
snails, fresh-water 116, 11819 spermicides 386 triggering air rage 2401
snake antivenoms 32830 Spf66 malaria vaccine 105 stress incontinence, in women 383
dose and administration 32930 spider bites 3346 stretchers
indications for use 3289 avoiding 335 air passengers on 227, 22830, 297
mono- and polyspecic 329 clinical features 3356 scoop 307, 308
personal supply 332 treatment 336 strongyloidiasis (Strongyloides
reactions 3302 spiders infections) 187, 202, 203
early 331 antivenoms 336 in migrants and refugees 472
late 3312 black widow see Latrodectus spp. in pregnancy 411
prediction and prevention 3301 Brazilian wolf (Phoneutria nigriventer) in women 409, 410
pyrogenic 331 335, 336 stye 350, 351
types 329 funnel-web see Atrax robustus subaqua swimming, ying after 219
unavailability 333 spinal cord subarachnoid hemorrhage, aeromedical
snake bites 34, 32133 in decompression illness 271 repatriation after 302
avoiding 323 injuries, aeromedical repatriation 302 subcellular vaccines 167
epidemiology 3223 spirochaetes 86, 889 subconjunctival hemorrhage 349
snake envenoming splenectomy 186, 4256, 4334 subcutaneous administration, vaccines
antivenoms see snake antivenoms splenic aspiration, in leishmaniasis 168
clinical features 324 1078 suction, snake bite wounds 327
diagnosis 3267 splenomegaly sudden cardiac death 441
early management 328 fevers with 197 sudden infant death syndrome (SIDS)
rst aid and prehospital treatment in malaria 193 255, 3745
327 sponge, contraceptive 386, 388 suicide 44950
local 323, 3245 Sporothrix schenckii 141 sulfadoxine-pyrimethamine
ocular 327, 333, 361 sporotrichosis 1412 in children 369
pathophysiology 3234 sporozoites 91, 95 in expatriates and aid workers 455
supportive therapy 3323 sports activities, gender-related issues malaria resistant to 1001
systemic 3256 41518 malaria stand-by treatment 105
snakes sprue, tropical 1989 malaria therapy 98, 99, 101
identication 3267 squamous cell carcinoma, cutaneous in pregnancy 405, 4067
venomous 3212 147, 344 sulfalene-pyrimethamine
Snellen chart 349 sta, travel clinic 234 malaria stand-by treatment 105
snorkeling 293, 418 staggers 219 malaria therapy 98
see also diving staphylococcal scalded-skin syndrome sulsoxasole/proguanil, in pregnancy
snow blindness 344, 348 (SSSS) 136 407
Society for the Advancement of Travel for Staphylococcus aureus infections, in sulphonamides
the Handicapped 445 diabetes 438 hypersensitivity 99
sodium stilbogluconate, in leishmaniasis Staphylococcus skin infections 133, malaria therapy 98, 99, 101
108 1345 sumatriptan, in acute mountain sickness
soft drinks 19 STDs see sexually transmitted diseases 251
solar keratoses 1467, 344 StevensJohnson syndrome 148, 360 sunbeds 344
solar urticaria 144, 145 stillbirths, meoquine and 406 sunburn 12, 145
sore throat stingrays 337, 338 in children 374
fever with 195 stings 34 eyelids 343
at high altitude 255 bee, wasp and hornet 3367, 361 risk-taking behavior and 243
SOS/AEA International 394, 395 echinoderm 339 sunglasses 344, 345, 346
South African tick bite fever 85 sh 3378 sunlight exposure
South American trypanosomiasis jellysh 3389 cataracts and 3456
(Chagas disease) 11416 scorpion 3334 dermatoses exacerbated by 144
clinical features and pathogenesis venomous 32141 eye protection 346
115, 196 see also bites ocular damage 3436
congenital 115 stonesh 337, 338 skin diseases caused by 1448
diagnosis 115 stool examination in transplant recipients 434
epidemiology 11415 asymptomatic travelers 205, 377 sunscreens, for children 374
in pregnancy 413 Schistosoma diagnosis 118 suramin
prevention 116 Streptococcus pneumoniae 198 in African trypanosomiasis 113
transfusion-associated 11415, 116 Streptococcus skin infections 133, 1345 in onchocerciasis 1201
treatment 11516 Streptomyces skin infections 1378 side-eects 113
SP303 159 stress surng 293
space sickness 223, 224, 225 aircrew 241 surveillance, disease in travelers 367
space vehicles, cabin pressurization 220 air travel 2378, 243 sweating, in motion sickness 223
spectacles 440 expatriates and aid workers 4478, swimmers ear 270
dark (sunglasses) 344, 345, 346 449 swimmers itch 116, 150, 202
for refractive errors 364 hyperventilation 217 swimming
speech, while diving 262 management training 4578 accident prevention 374
500 INDEX
swimming (cont.) air ambulance transfers and 302 reproductive eects 409
in freshwater 155 in older travelers 439 tracheostomy 442
granuloma 136 see also venous thrombosis trachoma 349, 362, 364
in pregnancy 418 thrombophlebitis, in pregnancy 17 traditional healers, snake bite
swing sickness 223, 224 thrombosis management 322
syncope at high altitude 255 traditional remedies, toxic eects
in rapid cabin decompression 221 see also venous thrombosis 31314
in snake envenoming 323 thrombospondin-related adhesive protein training
syphilis 135, 190 (TRAP) 91 aircrew 230, 232, 235
epidemiology 34 tiabendazole 128, 143 crisis management 458
in immigrants and refugees 471 tick(s) divers 273
screening in children 377 bites 1323, 133 rst aid 257
syringes 15 avoidance 86 pediatric travel medicine 378
systemic lupus erythematosus (SLE) 145 clinical features 133 psychological, expatriates and aid
management 133 workers 4578
tabanid (Chrysops) ies 119, 121, 362 CrimeanCongo hemorrhagic fever transdermal contraceptive patches 388
Tacaribe complex viruses 75, 76 72, 78 transmeridian travel see time zone
tache noir (eschar), in typhus 85, 86, 139 repellents 71 changes
Taenia solium 203 Rocky Mountain spotted fever 139 transplant recipients 170, 434
Taenia spp. 409 tick-borne encephalitis 701 trapped gas dysbarism 218
taipan 326 clinical features and diagnosis 71 traps, tsetse y 114
Papuan 322 epidemiology 33, 701 trauma
Taiwan Travel Health Association 24 prevention 71 eye 3549
Tamiu 60 vaccine 71, 172, 180 travel-related see injury, travel-related
tapeworms (cestodes) 203, 409 in expatriates and aid workers 454 travel
T cells see T lymphocytes in pregnancy 399, 401 destinations 4
team building training 457 tick-borne relapsing fever 88, 89, 132 tness for 1521, 4312
tears, articial 346, 350 tick typhus 85 international 36
teenagers see adolescents clinical features 85, 139, 196 rapid growth 34, 8, 10
teeth, eects of altitude 218 treatment 86 tropical infectious diseases and
telemedicine tigersh 337 910, 11
cruise ship 285 time zone changes 222, 242 types 56
for expatriates and aid workers 459 in diabetes 437 travel clinic 238
inight 2312 oral contraceptives and 385 immunization 1623
temazepam, for jet lag 223 see also jet lag information requirements 245
temperature tinea 1401 models 23, 24
body, control in pregnancy 415 corporis 140 operations 25
environmental pedis (athletes foot) 140, 141 patient information brochures 27
decompression sickness and 219 tingling sensations, in hyperventilation sta 234
hypoxia susceptibility and 217 217 trip risk assessment see pretravel
stability of ocular preparations 359 tinnitus, in barotrauma 270 assessment
teratogen reference sources 422 tiredness see fatigue web sites 28
terminal illness, tness to y 229 T lymphocytes travelers 467
terrorism 458 HIV infection 53, 54 health risks 1013
tetanus 17980 in immunization 165 returned 185209
immunoglobulin 175 tobaccoalcohol amblyopia 361 risk-taking behavior 2434
neonatal 397 torture victims 472, 473 see also pretravel advice; pretravel
vaccines 171, 173, 17980 tourism 36 assessment
in childhood 3701 destinations 4 travelers diarrhea 15363
with low-dose diphtheria (Td) 173, economics 45 antibiotic resistance 155, 158
17980, 397 government legislation 2956 antimicrobial prophylaxis 20, 157,
in ocular trauma 356 industry, risk management 295 1612, 433
in pregnancy 3979 outbound 5 in children 56, 36970, 377
snake bite victims 328 rapid growth 34, 8, 10 in chronic disease 424
see also DTP vaccine types 56 in cirrhosis 435
tetracycline tourniquets, snake bites 327, 328 clinical features 156, 1989
in children 369 toxic epidermal necrolysis 148 on cruise ships 2834
malaria stand-by treatment 105 toxicodermias 148 epidemiology 1545, 369
for malaria therapy 98, 101 toxicology, medical 31120 etiology 1534, 369
in pregnancy 408 toxocariasis 203 frequency 1112, 31, 153
in rickettsial infections 86, 140 toxoid immunization 166 in high-risk travel groups 4323
thalassaemia 426, 472 toxoids 167 host susceptibility factors 1556, 433
thiomersal 167 toxoplasmosis (Toxoplasma infections) in immunocompromised travelers 20,
thrombocytopenia 199 91, 3634 156
thromboembolism in pregnancy 3634, 414 in pregnancy 17, 408
INDEX 501
pretravel advice 26, 15961, 257 control measures 114 vision 261
prevention 15963, 36970 T. brucei life cycle 10910 see also diving
risk factors 1556, 190 T. brucei transmission 11011 United States (US)
self-treatment 1567 tsutsugamushi fever 85 outbound tourism 5
for children 370 TT virus 39 State Department Travel Warnings
in diabetes 16 tuberculide, papulonecrotic 137 286
in immunocompromised travelers tuberculin skin testing 180 tourism to 4
20 children 376 uranium, depleted (DU) 31819
in transplant recipients 434 in diabetes 438 urgency, in women 383
treatment 1569 expatriates and aid workers 461 urinary catheterisation, air ambulance
algorithm 159, 160 immigrants 1801 transfers 302
antimicrobial therapy 1578 tuberculosis (TB) 32, 1801 urinary tract infections
in children 370 cutaneous 136, 137 in diabetes 438
symptom management 1589 ethambutol therapy 360 in women 383, 416
vaccination 159, 1623 in expatriates and aid workers 456 urinary tract problems
viruses causing 567, 154 extrapulmonary 470 in schistosomiasis 117
travel health clinics 23, 24 in immigrants 1801, 470 in women 383
travel history 18591 incubation period 187 urine
countries/localities visited 187 occupational risks 189 pregnancy testing 383
drugs and vaccinations 1867 risk factors 190 Schistosoma detection 118
mode of travel 190 screening toxicological assessment 312
patients who havent traveled 1901 expatriates and aid workers 461 urticaria
reasons/activities undertaken 189 immigrant children 376 in drug reactions 148
sexual activities 18990 transmission in aircraft 32 solar 144, 145
timing of travel 1879 vaccine see BCG vaccine uta 106, 107
type of travel 1856 verrucosa cutis 137 uveitis 349
travel immunization clinics 23, 24, 25 tularaemia 198 anterior 3523
travel medicine clinics 23, 24 tumbu y (Cordylobia anthropophaga)
travel medicine physicians, training 378 201 vaccination 16570
travel and tropical medicine clinics 23, tumours, in AIDS 54 allergies and hypersensitivity
24, 25 Tunga penetrans 131, 201 reactions 16970
TravMed 444 tungiasis 131 asplenic travelers 177, 434
tree datura 314 tympanic membrane rupture, in divers booster 165
trematodes (ukes) 2012, 203 269 in cancer patients 435
gender-specic issues 409, 410 typhoid 82, 834, 1812 children 171, 3703
treponemal skin lesions 135 clinical features 84, 196, 198 in congenital immunodeciency 425
Treponema pallidum pertenue 135 epidemiology 323, 834 contraindications 16970
Trichinella spiralis 409, 410 risk factors 155 in corticosteroid-treated patients 170,
trichinosis 203 typhoid vaccines 1623, 172, 1812 435
Trichuris trichiura (trichuriasis) 202, 203 in children 371, 372 in diabetes mellitus 15, 16, 438
reproductive eects 409 eectiveness 187 history 1867
in women 411 hepatitis A vaccine combination 174, in HIV infection 1819, 170, 178, 428
trimethobenzamide, for sea sickness 283 182 in immunocompromised travelers
trimethoprim-sulfamethoxazole see oral 178, 181 1819, 170, 4267
co-trimoxazole in children 372 in lactation 429
trimix 265 interactions 181 in older travelers 440
tropical pulmonary eosinophilia 119, in pregnancy 398, 400 in pregnancy 17, 169, 396402, 429
203 in pregnancy 398, 400 in transplant recipients 170, 434
tropical skin diseases 12751 typhus 846, 138, 13940 in travel clinics 25
tropical sprue 1989 clinical features 856 see also immunization; vaccines
Trychophyton 140 epidemic 85, 139 vaccines 16670
Trypanosoma brucei epidemiology 82, 85 adverse events/safety 16870
life cycle 10910 louse-borne 85, 139 combination 167
var. gambiense 109, 11213 murine 13940 components 167
var. rhodesiense 109, 11213 scrub 85, 86 contraceptive 389
Trypanosoma cruzi 114, 115 sporadic 139 inactivated (killed) 165, 166, 167
trypanosomiasis 10916 tick see tick typhus live attenuated 166, 167, 431
African see African trypanosomiasis treatment 81, 86, 140 in asplenic travelers 434
gender-related issues 409, 41314 in immunocompromised travelers
South American see South American ultraviolet (UV) radiation 343, 344 18, 170, 426
trypanosomiasis ocular damage 3436 immunoglobulin interactions 166,
trypanosomiasis agglutination card test skin disorders 1448 175
(TACT) 112 underwater environment 2612 interactions between 178
TryptTect CIATT 11213 hearing 2612 mechanism of immunization 165
tsetse ies heat loss 262 in pregnancy 169, 396, 397, 429
502 INDEX
vaccines (cont.) in inner-ear barotrauma 270 in snake envenoming 325
novel approaches 163 Vessel Sanitation Program (VSP) 284
route of administration 168 vestibular system, in motion sickness war, exposure to 4723
routine and travel-related 17082 224, 225 warts, plantar 144
storage 1678 veterinarians 189 wasp stings 3367
subcellular 167 vibration, inducing hyperventilation 217 water 261
toxoid 167 Vibrio cholerae 154 chemical contamination 31617
travelers diarrhea 159, 1623 0139 35 hot, for stings 338, 339
types 1667 attenuation 166 pressure eects 2624
see also immunization; vaccination; see also cholera resource engineering 11819
specic vaccines Vibrio vulnicus 1356, 435 safety precautions 19, 161, 4356
vacuum mattress 307, 308 videoconferencing 285 treatment (disinfection) 19, 408
vagina vinegar, for jellysh stings 339 see also underwater environment
discharge/itching 3834 violence water-borne illness 31
dryness 383 against women 418 cruise ships 2834
oral contraceptive administration eects on migrants and refugees in diabetes 4356
38590 4723 hepatitis E 50
vaginitis, candidal 383, 416 vipers 321 in immunocompromised travelers 19
Valsalva manoeuvre, forcible carpet 321, 322 leptospirosis 86
underwater 26970 eects of envenoming 324, 325, 326 schistosomiasis 116, 118, 202
valvular heart disease, tness to dive Malayan pit 321, 322 skin conditions 150
268 pit 321 travelers diarrhea 155
variant surface glycoprotein, Russells (Daboia russelli) 321, 322, typhoid and paratyphoid fever 834
trypanosomal 111 324, 326 water sports
varicella 144, 182 true 321 in pregnancy 418
in migrants and refugees 182, 472 viral gastroenteritis 567, 154 see also diving; swimming
vaccine 172, 182 clinical features 567 web sites
in children 371, 372 on cruise ships 283 for expatriates and aid workers 459
in immunocompromised travelers diagnosis 57 for travel clinics 245, 28
19 epidemiology 567 travel-related 38
in pregnancy 397, 398 management 57 for women travelers 385
varicella zoster immune globulin pathology 57 weeversh 337
(VZIG) 19, 175, 397 prevention 57 Weill disease 86
varicella-zoster virus 61 viral hemorrhagic fevers 345, 718 welders ash 344, 345
vascular injury presentation 196 West Nile-like virus 70
in decompression illness 264 South American 778 wet suits, diving 262
in typhus 85 viral hepatitis see hepatitis, viral wheelchairs 440
vasculitis, in drug reactions 148 virus infections 3980 whipworms see Trichuris trichiura
vector-borne parasitic diseases 91124 eye 350, 3512 whole blood clotting test, 20 minute
vectors high-altitude pulmonary edema and (20WBCT)
control measures 102, 114 252 snake antivenom therapy and 330
imported 191 skin 144 in snake envenoming 326, 327, 328
international spread 10 visceral larva migrans 203 Wilderness Medical Society 286
South American trypanosomiasis 114 vision Winterbottom sign 111
see also black ies; mosquitoes; tick(s); blurred 348 women 381422
tsetse ies double 348 contraception 38492
Venezuelan hemorrhagic fever 75 in hyperventilation 217 cultural and safety issues 41819
venomous bites and stings 32141 system, in motion sickness 225 medical kit 41617
venous thrombosis underwater 261 menstruation 3823
air travel risks 34, 190, 227 Vision 20/20: right to sight program pretravel assessment 382
at high altitude 255, 393 364 sexually transmitted diseases 384
in older travelers 439 visiting friends/relatives 6, 186 sports and adventure activities
in pregnancy 17, 393, 3945 malaria in pregnancy risk 403 41518
in women 3923 malaria risk 471 tropical parasitic diseases 40814
ventilation, mechanical, in air ambulance visual acuity assessment 349 urinary tract problems 383
transfers 301, 303, 307 visual impairment useful websites 385
ventilators travelers with 20, 440 vaginal discharge/itching 3834
air ambulances 301, 303 see also blindness venous thrombosis risk 3923
ground ambulances 307 vitamin A deciency 364 see also gender dierences; pregnancy
ventilatory failure see respiratory failure vitamin B deciency 361 World Health Organization (WHO)
vertical transmission see perinatal vitamin deciencies 472 286, 444
transmission vitreous detachment, posterior 357 Gender and Health Technical Paper
vertigo vomiting 385
alternobaric 270 in motion sickness 223 Gender and Tropical Disease Task
caloric 270 oral contraceptive absorption 385 Force 381, 408
INDEX 503
information provision 24, 25, 28 bush 106 eectiveness 187
International Health Regulations 165 crab 135 in immunocompromised travelers
malaria chemoprophylaxis 103, 104 forest 107 18, 182
malaria stand-by treatment 105 yellow fever 647, 71, 182 in older travelers 440
malaria treatment 99101 clinical features and diagnosis 667 in pregnancy 398, 401
Roll Back Malaria campaign 102 epidemiology 33, 65 in transplant recipients 434
Weekly Epidemiological Record jungle 64, 65 virus (YFV) 645, 68
(WER) 36 management 67 young people
Worldwide Assistance 394, 444 pathology 656 risk-taking behavior 18990, 244
wound management prevention 67 travelers diarrhea risk 155
in rabies exposure 64 reservoirs 65 ultraviolet light damage 343
in snake bites 327, 328, 333 trends 345 see also children
Wuchereria bancrofti 119, 202, 203 urban 64, 65
in women 410 vaccination certicate 182 zaldaride 159
see also lymphatic lariasis vaccination exemption certicate 18, Zanamavir 60
67, 182, 401 zebrash 337
Xenopsylla cheopis 133 vaccine 67, 172, 182 Zeitgebers 222
in children 371, 372 zidovudine 416
yaws 135 contraindications 67, 169, 182 Zithromax see azithromycin